0001628280-21-001797.txt : 20210210 0001628280-21-001797.hdr.sgml : 20210210 20210210160937 ACCESSION NUMBER: 0001628280-21-001797 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 86 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CareTrust REIT, Inc. CENTRAL INDEX KEY: 0001590717 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 463999490 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36181 FILM NUMBER: 21613861 BUSINESS ADDRESS: STREET 1: 905 CALLE AMANECER, SUITE 300 CITY: SAN CLEMENTE STATE: CA ZIP: 92673 BUSINESS PHONE: (949) 542-3140 MAIL ADDRESS: STREET 1: 905 CALLE AMANECER, SUITE 300 CITY: SAN CLEMENTE STATE: CA ZIP: 92673 10-K 1 ctre-20201231.htm 10-K ctre-20201231
00015907172020FYfalseus-gaap:HealthCareResidentServiceMemberus-gaap:HealthCareResidentServiceMemberus-gaap:HealthCareResidentServiceMemberus-gaap:HealthCareResidentServiceMemberus-gaap:HealthCareResidentServiceMemberus-gaap:HealthCareResidentServiceMemberP1YP1Y00015907172020-01-012020-12-31iso4217:USD00015907172020-06-30xbrli:shares00015907172021-02-0900015907172020-12-3100015907172019-12-31iso4217:USDxbrli:shares00015907172019-01-012019-12-3100015907172018-01-012018-12-310001590717us-gaap:CommonStockMember2017-12-310001590717us-gaap:AdditionalPaidInCapitalMember2017-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2017-12-3100015907172017-12-310001590717us-gaap:CommonStockMember2018-01-012018-12-310001590717us-gaap:AdditionalPaidInCapitalMember2018-01-012018-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2018-01-012018-12-310001590717us-gaap:CommonStockMember2018-12-310001590717us-gaap:AdditionalPaidInCapitalMember2018-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2018-12-3100015907172018-12-310001590717us-gaap:CommonStockMember2019-01-012019-12-310001590717us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2019-01-012019-12-310001590717us-gaap:CommonStockMember2019-12-310001590717us-gaap:AdditionalPaidInCapitalMember2019-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2019-12-310001590717us-gaap:CommonStockMember2020-01-012020-12-310001590717us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-01-012020-12-310001590717us-gaap:CommonStockMember2020-12-310001590717us-gaap:AdditionalPaidInCapitalMember2020-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-12-31ctre:facility0001590717ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember2020-12-31ctre:bed0001590717ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember2020-01-012020-12-31ctre:state0001590717us-gaap:BridgeLoanMemberctre:PriorityLifeCareLLCMember2019-12-31xbrli:pure0001590717us-gaap:BridgeLoanMemberctre:PriorityLifeCareLLCMember2019-01-012019-12-310001590717us-gaap:BuildingMembersrt:MinimumMember2020-01-012020-12-310001590717srt:MaximumMemberus-gaap:BuildingMember2020-01-012020-12-310001590717us-gaap:BuildingImprovementsMembersrt:MinimumMember2020-01-012020-12-310001590717srt:MaximumMemberus-gaap:BuildingImprovementsMember2020-01-012020-12-310001590717us-gaap:FurnitureAndFixturesMember2020-01-012020-12-31ctre:segment0001590717ctre:EnsignMemberctre:EnsignMasterLeasesMember2020-12-310001590717srt:MinimumMemberctre:EnsignMember2020-12-310001590717srt:MaximumMemberctre:EnsignMember2020-12-310001590717ctre:EnsignMemberctre:EnsignOtherLeasesMember2020-01-012020-12-310001590717ctre:EnsignMemberctre:EnsignOtherLeasesMember2020-12-310001590717ctre:PriorityManagementGroupLLCMember2020-12-31ctre:renewal_option0001590717ctre:PriorityManagementGroupLLCMembersrt:MinimumMember2020-12-310001590717srt:MaximumMemberctre:PriorityManagementGroupLLCMember2020-12-310001590717ctre:VariousOtherOperatorsMember2020-12-31ctre:property0001590717ctre:AssistedLivingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2021Member2020-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationJanuary2031FirstOption2022Member2020-12-310001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationMarch2030FirstOption2022Memberctre:SkilledNursingFacilityMember2020-12-310001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2032FirstOption2023Memberctre:SkilledNursingAndCampusFacilitiesMember2020-12-310001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2034FirstOption2024Memberctre:SkilledNursingFacilityMember2020-12-310001590717ctre:AssistedLivingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2026Member2020-12-31ctre:operator0001590717ctre:LeaseIncomeContractualRentMember2019-01-012019-12-310001590717ctre:LeaseIncomeStraightLineRentMember2019-01-012019-12-310001590717ctre:LeaseIncomePropertyTaxesMember2019-01-012019-12-310001590717ctre:SkilledNursingPropertiesMember2020-01-012020-12-31ctre:unit0001590717ctre:MultiServiceCampusPropertiesMember2020-01-012020-12-310001590717ctre:AssistedLivingFacilityMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMember2019-01-012019-12-310001590717ctre:MultiServiceCampusPropertiesMember2019-01-012019-12-310001590717ctre:AssistedLivingFacilityMember2019-01-012019-12-310001590717ctre:SkilledNursingPropertiesMember2018-01-012018-12-310001590717ctre:MultiServiceCampusPropertiesMember2018-01-012018-12-310001590717ctre:AssistedLivingFacilityMember2018-01-012018-12-310001590717ctre:MultiServiceCampusPropertiesMember2018-12-310001590717ctre:NobleSeniorServicesMember2020-12-0100015907172020-12-01ctre:extension_option0001590717ctre:NobleSeniorServicesMember2020-12-012020-12-010001590717ctre:EnsignMemberctre:EnsignMasterLeasesMember2019-10-010001590717ctre:PennantMember2019-10-010001590717ctre:PennantMember2019-10-012019-10-010001590717ctre:EnsignMemberctre:EnsignMasterLeasesMember2019-10-012019-10-010001590717ctre:TrilliumHealthcareGroupLLCMemberstpr:IA2019-07-150001590717ctre:TrilliumHealthcareGroupLLCMemberstpr:OH2019-07-150001590717stpr:GActre:TrilliumHealthcareGroupLLCMember2019-07-150001590717ctre:TrilliumHealthcareGroupLLCMemberstpr:IA2019-08-160001590717stpr:GActre:TrilliumHealthcareGroupLLCMember2019-08-160001590717us-gaap:TradeAccountsReceivableMember2019-07-012019-09-300001590717ctre:ProvidenceGroupMemberstpr:OHctre:SkilledNursingPropertiesMember2019-09-010001590717ctre:TrilliumHealthcareGroupLLCMemberstpr:OHctre:SkilledNursingPropertiesMember2019-07-150001590717ctre:ProvidenceGroupMemberctre:AmendedTripleNetMasterLeaseMember2019-09-010001590717ctre:TrioHealthcareIncMemberctre:TrioHealthcareMasterLeaseMember2019-11-040001590717ctre:PristineLeaseTerminationAgreementMember2018-02-270001590717ctre:PristineLeaseTerminationAgreementMemberctre:TrioHealthcareIncMember2018-05-012018-05-010001590717ctre:TrioHealthcareMasterLeaseMember2018-05-010001590717ctre:HillstoneHealthcareIncMemberctre:PristineLeaseTerminationAgreementMember2018-05-012018-05-010001590717ctre:HillstoneHealthcareMasterLeaseMember2018-05-010001590717ctre:TrioHealthcareAndHillstoneHealthcareMasterLeaseMember2018-05-012018-05-010001590717ctre:TrilliumSkilledNursingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2019-09-010001590717ctre:TrilliumSkilledNursingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2019-10-012019-12-310001590717ctre:CommuniCareMemberus-gaap:MortgageReceivablesMember2019-09-010001590717us-gaap:DiscontinuedOperationsHeldforsaleMemberctre:MetronSkilledNursingFacilitiesMember2019-09-300001590717us-gaap:DiscontinuedOperationsHeldforsaleMemberctre:MetronSkilledNursingFacilitiesMember2019-07-012019-09-300001590717ctre:MetronSkilledNursingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2020-02-290001590717ctre:MetronSkilledNursingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2020-02-012020-02-290001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-02-290001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-04-012020-04-300001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-04-300001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-07-012020-07-310001590717ctre:OwnedAndOperatedLivingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2020-11-010001590717ctre:OwnedAndOperatedLivingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2020-11-012020-11-010001590717ctre:OwnedAndOperatedLivingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2019-12-310001590717ctre:OwnedAndOperatedLivingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2019-01-012019-12-310001590717ctre:IdahoAssistedLivingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2018-12-310001590717ctre:IdahoAssistedLivingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2018-01-012018-12-310001590717us-gaap:DiscontinuedOperationsHeldforsaleMemberctre:FiveOaksMember2020-12-310001590717ctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-300001590717srt:MinimumMemberctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-300001590717srt:MaximumMemberctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-300001590717ctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-012020-11-300001590717ctre:ProvidenceGroupMemberus-gaap:MortgageReceivablesMember2017-10-310001590717ctre:CovenantCareMemberus-gaap:MortgageReceivablesMember2019-02-280001590717ctre:CovenantCareMemberus-gaap:MortgageReceivablesMember2019-02-012019-02-280001590717ctre:MantecaValleyPostAcuteMemberus-gaap:MortgageReceivablesMember2019-07-012019-07-310001590717ctre:MantecaValleyPostAcuteMemberus-gaap:MortgageReceivablesMember2019-07-310001590717ctre:MantecaValleyPostAcuteMember2019-07-012019-07-310001590717ctre:CommuniCareMemberus-gaap:MortgageReceivablesMember2019-09-300001590717ctre:CascadeCapitalGroupLLCMember2020-04-300001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:MortgageReceivablesMember2020-04-300001590717us-gaap:MortgageReceivablesMember2020-12-310001590717ctre:MezzanineAndMortgageLoanReceivablesMember2020-01-012020-12-310001590717ctre:MezzanineAndMortgageLoanReceivablesMember2019-01-012019-12-310001590717ctre:MezzanineAndMortgageLoanReceivablesMember2018-01-012018-12-310001590717us-gaap:LoansReceivableMember2020-01-012020-12-310001590717us-gaap:LoansReceivableMember2019-01-012019-12-310001590717us-gaap:LoansReceivableMember2018-01-012018-12-310001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember2016-07-310001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMemberus-gaap:PrimeRateMember2016-07-012016-07-310001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember2016-07-012016-07-310001590717ctre:SkilledNursingPropertiesMember2019-06-012019-06-300001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember2019-06-012019-06-300001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2016-09-300001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMemberus-gaap:PrimeRateMember2016-09-012016-09-300001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2016-09-012016-09-300001590717ctre:SkilledNursingPropertiesMember2020-01-012020-01-310001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2020-01-012020-01-310001590717us-gaap:FairValueInputsLevel1Memberctre:MezzanineLoanMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:MezzanineLoanMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:MezzanineLoanMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001590717ctre:MezzanineLoanMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageReceivablesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgageReceivablesMember2020-12-310001590717us-gaap:MortgageReceivablesMember2019-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageReceivablesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgageReceivablesMember2019-12-310001590717ctre:SeniorUnsecuredNotesMember2020-12-310001590717ctre:SeniorUnsecuredNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310001590717ctre:SeniorUnsecuredNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001590717ctre:SeniorUnsecuredNotesMember2019-12-310001590717ctre:SeniorUnsecuredNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001590717ctre:SeniorUnsecuredNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001590717us-gaap:SeniorNotesMember2020-12-310001590717us-gaap:SeniorNotesMember2019-12-310001590717ctre:SeniorUnsecuredTermLoanMember2020-12-310001590717ctre:SeniorUnsecuredTermLoanMember2019-12-310001590717us-gaap:LineOfCreditMember2020-12-310001590717us-gaap:LineOfCreditMember2019-12-310001590717ctre:SeniorUnsecuredNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2017-05-100001590717ctre:SeniorUnsecuredNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2017-05-102017-05-100001590717ctre:SeniorUnsecuredNotesMemberctre:FivePointEightSevenFiveSeniorNotesDue2021Member2017-05-102017-05-100001590717ctre:SeniorUnsecuredNotesMemberctre:FivePointEightSevenFiveSeniorNotesDue2021Member2017-05-100001590717ctre:SeniorUnsecuredNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2020-06-012020-06-010001590717us-gaap:LineOfCreditMemberctre:RevolvingCreditFacilityAsAmendedMember2016-02-010001590717us-gaap:LineOfCreditMemberctre:PriorTermLoanMember2016-02-010001590717us-gaap:LineOfCreditMemberctre:RevolvingCreditFacilityAsAmendedMember2016-02-012016-02-010001590717us-gaap:LineOfCreditMemberctre:PriorTermLoanMember2016-02-012016-02-010001590717us-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-080001590717us-gaap:LetterOfCreditMember2019-02-080001590717ctre:SwinglineLoanMember2019-02-080001590717ctre:NewTermLoanFeb2019Memberctre:SeniorUnsecuredTermLoanMember2019-02-080001590717srt:MinimumMemberus-gaap:BaseRateMemberus-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-082019-02-080001590717srt:MaximumMemberus-gaap:BaseRateMemberus-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-082019-02-080001590717srt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-082019-02-080001590717srt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-082019-02-080001590717ctre:NewTermLoanFeb2019Membersrt:MinimumMemberus-gaap:BaseRateMemberctre:SeniorUnsecuredTermLoanMember2019-02-082019-02-080001590717srt:MaximumMemberctre:NewTermLoanFeb2019Memberus-gaap:BaseRateMemberctre:SeniorUnsecuredTermLoanMember2019-02-082019-02-080001590717ctre:NewTermLoanFeb2019Membersrt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberctre:SeniorUnsecuredTermLoanMember2019-02-082019-02-080001590717srt:MaximumMemberctre:NewTermLoanFeb2019Memberus-gaap:LondonInterbankOfferedRateLIBORMemberctre:SeniorUnsecuredTermLoanMember2019-02-082019-02-080001590717srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-082019-02-080001590717srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-082019-02-080001590717us-gaap:RevolvingCreditFacilityMemberctre:NewRevolvingFacilityMember2019-02-082019-02-080001590717ctre:UnderwrittenPublicOfferingMember2019-04-152019-04-150001590717ctre:UnderwrittenPublicOfferingMember2019-04-150001590717us-gaap:OverAllotmentOptionMember2019-04-152019-04-150001590717srt:MaximumMemberctre:AtTheMarketOfferingProgramMember2020-03-100001590717ctre:AtTheMarketOfferingProgramMember2020-01-012020-12-310001590717ctre:PriorAtTheMarketOfferingProgramMember2019-01-012019-12-310001590717ctre:AtTheMarketOfferingProgramMember2020-12-3100015907172020-03-2000015907172020-01-012020-03-3100015907172020-04-012020-06-3000015907172020-07-012020-09-3000015907172020-10-012020-12-3100015907172020-03-3100015907172020-09-3000015907172019-01-012019-03-3100015907172019-04-012019-06-3000015907172019-07-012019-09-3000015907172019-10-012019-12-3100015907172019-03-3100015907172019-06-3000015907172019-09-3000015907172018-01-012018-03-3100015907172018-04-012018-06-3000015907172018-07-012018-09-3000015907172018-10-012018-12-3100015907172018-03-3100015907172018-06-3000015907172018-09-300001590717ctre:RestrictedStockAndPerformanceSharesMember2018-12-310001590717ctre:RestrictedStockAndPerformanceSharesMember2019-01-012019-12-310001590717ctre:RestrictedStockAndPerformanceSharesMember2019-12-310001590717ctre:RestrictedStockAndPerformanceSharesMember2020-01-012020-12-310001590717ctre:RestrictedStockAndPerformanceSharesMember2020-12-31ctre:company00015907172014-06-010001590717ctre:EnsignEmployeesMemberus-gaap:RestrictedStockMember2014-06-012014-06-010001590717ctre:EnsignEmployeesMemberus-gaap:RestrictedStockMember2020-01-012020-12-310001590717ctre:EnsignEmployeesMemberus-gaap:RestrictedStockMember2020-12-310001590717us-gaap:RestrictedStockMemberctre:OfficerAndEmployeeMember2020-01-012020-01-310001590717us-gaap:RestrictedStockMemberctre:OfficerAndEmployeeMember2020-03-012020-03-31ctre:installment0001590717us-gaap:RestrictedStockMemberctre:OfficerAndEmployeeMember2020-03-310001590717us-gaap:RestrictedStockMemberctre:OfficerAndEmployeeMember2020-01-310001590717us-gaap:PerformanceSharesMembersrt:OfficerMember2020-03-012020-03-310001590717srt:MinimumMemberus-gaap:PerformanceSharesMembersrt:OfficerMember2020-03-012020-03-310001590717srt:MaximumMemberus-gaap:PerformanceSharesMembersrt:OfficerMember2020-03-012020-03-310001590717us-gaap:RestrictedStockMembersrt:DirectorMember2020-04-012020-04-300001590717us-gaap:RestrictedStockMemberctre:OfficerAndEmployeeMember2019-02-012019-02-280001590717us-gaap:RestrictedStockMemberctre:OfficerAndEmployeeMember2019-02-280001590717us-gaap:PerformanceSharesMembersrt:OfficerMember2019-02-012019-02-280001590717srt:MinimumMemberus-gaap:PerformanceSharesMembersrt:OfficerMember2019-02-012019-02-280001590717srt:MaximumMemberus-gaap:PerformanceSharesMembersrt:OfficerMember2019-02-012019-02-280001590717us-gaap:RestrictedStockMembersrt:DirectorMember2019-05-012019-05-310001590717ctre:EnsignAndPennantMember2020-12-310001590717ctre:ConstructionAndCapitalImprovementsAtTripleNetLeasedFacilitiesMember2020-12-310001590717ctre:EnsignMemberctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember2020-12-31ctre:unit_bed0001590717ctre:EnsignMember2020-01-012020-12-310001590717ctre:EnsignMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001590717ctre:EnsignMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-12-310001590717ctre:EnsignMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:SkilledNursingAndCampusFacilitiesMember2020-12-310001590717ctre:PriorityManagementGroupLLCMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001590717ctre:PriorityManagementGroupLLCMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-12-310001590717ctre:PriorityManagementGroupLLCMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-310001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:SkillNursingFacilityWashingtonMemberus-gaap:SubsequentEventMember2021-02-010001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:SkillNursingFacilityWashingtonMemberus-gaap:SubsequentEventMember2021-02-012021-02-010001590717ctre:SkilledNursingPropertiesMemberctre:EnsignHighlandLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EnsignHighlandLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MeadowbrookHealthAssociatesLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MeadowbrookHealthAssociatesLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TerraceHoldingsAzLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TerraceHoldingsAzLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RillitoHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RillitoHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ValleyHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ValleyHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CedarAvenueHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CedarAvenueHoldingsLlcMember2020-01-012020-12-310001590717ctre:GranadaInvestmentsLlcMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:GranadaInvestmentsLlcMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PlazaHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PlazaHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MountainviewCommunityCareLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MountainviewCommunityCareLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CmHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CmHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PolkHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PolkHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SnohomishHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SnohomishHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CherryHealthHoldingsIncMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CherryHealthHoldingsIncMember2020-01-012020-12-310001590717ctre:GolfviewHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:GolfviewHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TenthEastHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TenthEastHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TrinityMillHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TrinityMillHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CottonwoodHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CottonwoodHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:VerdeVillaHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:VerdeVillaHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MesquiteHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MesquiteHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArrowTreeHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArrowTreeHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FortStreetHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FortStreetHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:TrousdaleHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:TrousdaleHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EnsignBellflowerLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EnsignBellflowerLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RbHeightsHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RbHeightsHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SanCorrineHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SanCorrineHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TempleHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TempleHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:AnsonHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:AnsonHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillitsHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillitsHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LufkinHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LufkinHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JeffersonRalstonHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JeffersonRalstonHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:HillendahlHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:HillendahlHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PriceHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PriceHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SilverLakeHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SilverLakeHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JordanHealthPropertiesLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JordanHealthPropertiesLlcMember2020-01-012020-12-310001590717ctre:RegalRoadHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:RegalRoadHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ParedesHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ParedesHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ExpresswayHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ExpresswayHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RioGrandeHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RioGrandeHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FifthEastHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FifthEastHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EmmettHealthcareHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EmmettHealthcareHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BurleyHealthcareHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BurleyHealthcareHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JoseyRanchHealthcareHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JoseyRanchHealthcareHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EvergladesHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EvergladesHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IrvingHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IrvingHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FallsCityHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FallsCityHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GilletteParkHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GilletteParkHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GazeboParkHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GazeboParkHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OlesonParkHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OlesonParkHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArapahoeHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArapahoeHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:DixieHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:DixieHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MemorialHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MemorialHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BogardusHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BogardusHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SouthDoraHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SouthDoraHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SilveradaHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:SilveradaHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OremHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OremHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WisteriaHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WisteriaHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RenneAvenueHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RenneAvenueHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:StillhouseHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:StillhouseHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FigStreetHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FigStreetHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellLakeHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellLakeHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:QueenswayHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:QueenswayHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LongBeachHealthAssociatesLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LongBeachHealthAssociatesLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:KingsCourtHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:KingsCourtHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FiftyOneAvenueHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FiftyOneAvenueHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IvesHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IvesHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GuadalupeHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GuadalupeHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:FortyNineStreetHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:FortyNineStreetHealthHoldingsLlcMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TulalipBayHoldingsMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TulalipBayHoldingsMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SkyHoldingsAzLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SkyHoldingsAzLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LemonRiverHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LemonRiverHoldingsLlcMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:BethanyRehabilitationCenterMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:BethanyRehabilitationCenterMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:MiraVistaCareCenterMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:MiraVistaCareCenterMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ShorelineHealthAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ShorelineHealthAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:ShamrockNursingAndRehabilitationCenterMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:ShamrockNursingAndRehabilitationCenterMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BeaverCreekHealthAndRehabMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BeaverCreekHealthAndRehabMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PristineSeniorLivingofCincinnatiRiverviewMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PristineSeniorLivingofCincinnatiRiverviewMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:EnglewoodHealthAndRehabMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:EnglewoodHealthAndRehabMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PortsmouthHealthAndRehabMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PortsmouthHealthAndRehabMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:WestCoveCareAndRehabilitationCenterMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:WestCoveCareAndRehabilitationCenterMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BellBrookHealthAndRehabMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BellBrookHealthAndRehabMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:XeniaHealthAndRehabMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:XeniaHealthAndRehabMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:JamestownPlaceHealthAndRehabMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:JamestownPlaceHealthAndRehabMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CasadePazMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CasadePazMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DenisonCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DenisonCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GardenViewCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GardenViewCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GrandviewHealthCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GrandviewHealthCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GrundyCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GrundyCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:IowaCityRehabandHealthCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:IowaCityRehabandHealthCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:LenoxCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:LenoxCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:OsageMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:OsageMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PleasantAcresCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PleasantAcresCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CedarFallsHealthCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CedarFallsHealthCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:VictoryParkNursingHomeMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:VictoryParkNursingHomeMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ShawMountainAtCascadiaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ShawMountainAtCascadiaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheOaksMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheOaksMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ArborNursingCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ArborNursingCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BroadmoorMedicalLodgeRockwallMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BroadmoorMedicalLodgeRockwallMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DecaturMedicalLodgeMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DecaturMedicalLodgeMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:RoyceCityHealthandRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:RoyceCityHealthandRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:SalineCareNursingAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:SalineCareNursingAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CarrierMillsNursingAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CarrierMillsNursingAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:StoneBridgeNursingAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:StoneBridgeNursingAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DuQuoinNursingAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DuQuoinNursingAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PinckneyvilleNursingAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PinckneyvilleNursingAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:WellspringHealthAndRehabilitationOfCascadiaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:WellspringHealthAndRehabilitationOfCascadiaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheRioAtFoxHollowMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheRioAtFoxHollowMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:TheRioAtCabezonMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:TheRioAtCabezonMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:EldoradoRehabAndHealthcareMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:EldoradoRehabAndHealthcareMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:SecoraHealthAndRehabilitationOfCascadiaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:SecoraHealthAndRehabilitationOfCascadiaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationMountainValleyMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationMountainValleyMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationCaldwellMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationCaldwellMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationCanyonWestMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationCanyonWestMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredTransitionalCareAndRehabilitationLewistonMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredTransitionalCareAndRehabilitationLewistonMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationNampaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationNampaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationWeiserMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationWeiserMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationAspenParkMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredNursingAndRehabilitationAspenParkMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredTransitionalCareandRehabilitationRidgmarMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredTransitionalCareandRehabilitationRidgmarMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredTransitionalCareandRehabilitationMansfieldPlazaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:KindredTransitionalCareandRehabilitationMansfieldPlazaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationGrapevineMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationGrapevineMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BrookfieldHealthAndRehabMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BrookfieldHealthAndRehabMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheOaksAtLakewoodMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheOaksAtLakewoodMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheOaksAtTimberlineMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheOaksAtTimberlineMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ProvidenceWatermanNursingCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ProvidenceWatermanNursingCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ProvidenceOrangeTreeMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ProvidenceOrangeTreeMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:ProvidenceOntarioMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:ProvidenceOntarioMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GreenvilleNursingandRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:GreenvilleNursingandRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CopperRidgeHealthAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CopperRidgeHealthAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PrairieHeightsHealthcareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:PrairieHeightsHealthcareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheMeadowsOnUniversityMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:TheMeadowsOnUniversityMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:TheSuitesParkerMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:TheSuitesParkerMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:HuntingtonParkNursingCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:HuntingtonParkNursingCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:ShorelineCareCenterMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:ShorelineCareCenterMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DowneyCareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:DowneyCareCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CourtyardHealthcareCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CourtyardHealthcareCenterMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:AlpineSkilledNursingandRehabilitationMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:AlpineSkilledNursingandRehabilitationMember2020-01-012020-12-310001590717ctre:TheBradfordSkilledNursingandRehabilitationMemberctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMember2020-12-310001590717ctre:TheBradfordSkilledNursingandRehabilitationMemberctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ColonialOaksSkilledNursingAndRehabilitationMemberctre:GulfCoastBuyer1LLCMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ColonialOaksSkilledNursingAndRehabilitationMemberctre:GulfCoastBuyer1LLCMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TheGuestHouseSkilledNursingAndRehabilitationMemberctre:GulfCoastBuyer1LLCMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TheGuestHouseSkilledNursingAndRehabilitationMemberctre:GulfCoastBuyer1LLCMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PilgrimManorSkilledNursingAndRehabilitationMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PilgrimManorSkilledNursingAndRehabilitationMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:ShreveportManorSkilledNursingAndRehabilitationMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:ShreveportManorSkilledNursingAndRehabilitationMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BookerTWashingtonSkilledNursingAndRehabilitationMemberctre:GulfCoastBuyer1LLCMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BookerTWashingtonSkilledNursingAndRehabilitationMemberctre:GulfCoastBuyer1LLCMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LegacyWestRehabilitationAndHealthcareMemberctre:GulfCoastBuyer1LLCMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LegacyWestRehabilitationAndHealthcareMemberctre:GulfCoastBuyer1LLCMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:LegacyAtJacksonvilleMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:LegacyAtJacksonvilleMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PecanTreeRehabilitationAndHealthcareMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PecanTreeRehabilitationAndHealthcareMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LakewestRehabilitationAndSkilledCareMemberctre:LakewestSNFRealtyLLCMember2020-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LakewestRehabilitationAndSkilledCareMemberctre:LakewestSNFRealtyLLCMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CascadiaOfNampaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CascadiaOfNampaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:ValleySkilledNursingMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:ValleySkilledNursingMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CascadiaOfBoiseMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CascadiaOfBoiseMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CooneyHealthcareAndRehabilitationMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:CooneyHealthcareAndRehabilitationMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ElkhornHealthcareAndRehabilitationMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:ElkhornHealthcareAndRehabilitationMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BeaconHarborHealthcareAndRehabilitationMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:BeaconHarborHealthcareAndRehabilitationMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:PleasantManorHealthcareAndRehabilitationMemberctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:PleasantManorHealthcareAndRehabilitationMemberctre:SkilledNursingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:RowlettHealthAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingPropertiesMemberctre:RowlettHealthAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:SkilledNursingPropertiesMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:EnsignSouthlandLlcMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:EnsignSouthlandLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:MissionCcrcLlcMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:MissionCcrcLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:WayneHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:WayneHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:FourthStreetHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:FourthStreetHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:BigSiouxRiverHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:BigSiouxRiverHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:PrairieHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:PrairieHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:SalmonRiverHealthHoldingsLlcMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:SalmonRiverHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:CentervilleSeniorIndependentLivingCentervilleHealthAndRehabCentervillePlaceAssistedLivingMemberctre:SkilledNursingCampusPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:CentervilleSeniorIndependentLivingCentervilleHealthAndRehabCentervillePlaceAssistedLivingMemberctre:SkilledNursingCampusPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:LibertyNursingCenterOfWillardMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:LibertyNursingCenterOfWillardMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:PremierEstatesofNorwoodTowersPremierRetirementEstatesofNorwoodTowersMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:PremierEstatesofNorwoodTowersPremierRetirementEstatesofNorwoodTowersMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:TurlockNursingandRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:TurlockNursingandRehabilitationCenterMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:BridgeportMedicalLodgeMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:BridgeportMedicalLodgeMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:TheVillasAtSaratogaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:TheVillasAtSaratogaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:MadisonParkHealthcareMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:MadisonParkHealthcareMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:OakviewHeightsNursingAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:OakviewHeightsNursingAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:SpringLakeSkilledNursingAndRehabilitationMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:SpringLakeSkilledNursingAndRehabilitationMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:TheVillageAtHeritageOaksMemberctre:GulfCoastBuyer1LLCMember2020-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:TheVillageAtHeritageOaksMemberctre:GulfCoastBuyer1LLCMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:CityCreekPostAcuteAndAssistedLivingMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:CityCreekPostAcuteAndAssistedLivingMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:CrestwoodHealthAndRehabilitationCenterMember2020-12-310001590717ctre:CtrPartnershipMemberctre:SkilledNursingCampusPropertiesMemberctre:CrestwoodHealthAndRehabilitationCenterMember2020-01-012020-12-310001590717ctre:SkilledNursingCampusPropertiesMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:AvenueNHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:AvenueNHoldingsLlcMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MoeniumHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MoeniumHoldingsLlcMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:ExpoParkHealthHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:ExpoParkHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:WisteriaHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:WisteriaHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:EvergladesHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:EvergladesHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:FlamingoHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:FlamingoHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:EighteenthPlaceHealthHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:EighteenthPlaceHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:BoardwalkHealthHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:BoardwalkHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LockwoodHealthHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LockwoodHealthHoldingsLlcMember2020-01-012020-12-310001590717ctre:SaratogaHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:SaratogaHealthHoldingsLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:SkyHoldingsAzLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:SkyHoldingsAzLlcMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LemonRiverHoldingsLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LemonRiverHoldingsLlcMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MissionCcrcLlcMember2020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MissionCcrcLlcMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:PreludeCottagesOfWoodburyMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:PreludeCottagesOfWoodburyMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:EnglishMeadowsSeniorLivingCommunityMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:EnglishMeadowsSeniorLivingCommunityMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:BristolCourtAssistedLivingMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:BristolCourtAssistedLivingMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AsburyPlaceAssistedLivingMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AsburyPlaceAssistedLivingMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:NewHavenAssistedLivingofSanAngeloMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:NewHavenAssistedLivingofSanAngeloMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:LamplightInnOfFortWayneMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:LamplightInnOfFortWayneMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:LamplightInnOfWestAllisMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:LamplightInnOfWestAllisMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:LamplightInnOfBaltimoreMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:LamplightInnOfBaltimoreMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:FortMyersAssistedLivingMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:FortMyersAssistedLivingMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:EnglishMeadowsElksHomeCampusMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:EnglishMeadowsElksHomeCampusMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:CroatanVillageMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:CroatanVillageMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:CountrysideVillageMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:CountrysideVillageMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ThePinesofClarkstonMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ThePinesofClarkstonMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:ThePinesofGoodrichMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:ThePinesofGoodrichMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ThePinesofBurtonMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ThePinesofBurtonMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ThePinesofLapeerMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ThePinesofLapeerMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ArborPlaceMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ArborPlaceMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:ApplewoodofBrookfieldMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:ApplewoodofBrookfieldMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ApplewoodofNewBerlinMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:ApplewoodofNewBerlinMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:TangerineCoveOfBrooksvilleMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:TangerineCoveOfBrooksvilleMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:MemoryCareCottagesinWhiteBearLakeMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:MemoryCareCottagesinWhiteBearLakeMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AmerisistOfCulpeperMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AmerisistOfCulpeperMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:AmerisistOfLouisaMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:AmerisistOfLouisaMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:AmerisistOfWarrentonMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:AmerisistOfWarrentonMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:VistaDelLagoMember2020-12-310001590717ctre:CtrPartnershipMemberctre:AssistedAndIndependentLivingPropertiesMemberctre:VistaDelLagoMember2020-01-012020-12-310001590717ctre:CtrPartnershipMemberctre:InnAtBartonCreekMemberctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:CtrPartnershipMemberctre:InnAtBartonCreekMemberctre:AssistedAndIndependentLivingPropertiesMember2020-01-012020-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMember2020-12-310001590717ctre:SkilledNursingFacilityMemberctre:NextVAStarRealtyHoldingsLLCMember2020-01-012020-12-310001590717ctre:SkilledNursingFacilityMemberctre:NextVAStarRealtyHoldingsLLCMember2020-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
 (Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission file number 001-36181
CareTrust REIT, Inc.
(Exact name of registrant as specified in its charter)
Maryland46-3999490
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
905 Calle Amanecer, Suite 300, San Clemente, CA 92673
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code (949) 542-3130
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareCTREThe Nasdaq Stock Market LLC
(Nasdaq Global Select Market)
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes    No 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes    No 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes    No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act.) Yes    No 
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $1.6 billion.
As of February 9, 2021, there were 95,893,541 shares of the registrant’s common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE


Portions of the definitive Proxy Statement for the registrant’s 2021 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission within 120 days after the end of fiscal year 2020, are incorporated by reference into Part III of this Report.



TABLE OF CONTENTS
 
PART I
Item 1.Business
Item 1A.Risk Factors
Item 1B.Unresolved Staff Comments
Item 2.Properties
Item 3.Legal Proceedings
Item 4.Mine Safety Disclosures
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities
Item 6. Selected Financial Data
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 7A.Quantitative and Qualitative Disclosures About Market Risk
Item 8.Financial Statements and Supplementary Data
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosures
Item 9A.Controls and Procedures
Item 9B.Other Information
PART III
Item 10.Directors, Executive Officers and Corporate Governance
Item 11.Executive Compensation
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13.Certain Relationships and Related Transactions, and Director Independence
Item 14.Principal Accountant Fees and Services
PART IV
Item 15.Exhibits, Financial Statements and Financial Statement Schedules
Item 16.10-K Summary
Signatures



3

STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this report may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations, including, but not limited to, statements regarding: future financing plans, business strategies, growth prospects and operating and financial performance; expectations regarding the making of distributions and the payment of dividends; and compliance with and changes in governmental regulations.
Words such as “anticipate(s),” “expect(s),” “intend(s),” “plan(s),” “believe(s),” “may,” “will,” “would,” “could,” “should,” “seek(s)” and similar expressions, or the negative of these terms, are intended to identify such forward-looking statements. These statements are based on management’s current expectations and beliefs and are subject to a number of risks and uncertainties that could lead to actual results differing materially from those projected, forecasted or expected. Although we believe that the assumptions underlying the forward-looking statements are reasonable, we can give no assurance that our expectations will be attained. Factors which could have a material adverse effect on our operations and future prospects or which could cause actual results to differ materially from our expectations include, but are not limited to: (i) the COVID-19 pandemic and the measures taken to prevent its spread and the related impact on our business or the businesses of our tenants; (ii) the ability and willingness of our tenants to meet and/or perform their obligations under the triple-net leases we have entered into with them, including without limitation, their respective obligations to indemnify, defend and hold us harmless from and against various claims, litigation and liabilities; (iii) the ability of our tenants to comply with applicable laws, rules and regulations in the operation of the properties we lease to them; (iv) the ability and willingness of our tenants to renew their leases with us upon their expiration, and the ability to reposition our properties on the same or better terms in the event of nonrenewal or in the event we replace an existing tenant, as well as any obligations, including indemnification obligations, we may incur in connection with the replacement of an existing tenant; (v) the availability of and the ability to identify (a) tenants who meet our credit and operating standards, and (b) suitable acquisition opportunities and the ability to acquire and lease the respective properties to such tenants on favorable terms; (vi) the ability to generate sufficient cash flows to service our outstanding indebtedness; (vii) access to debt and equity capital markets; (viii) fluctuating interest rates; (ix) the ability to retain our key management personnel; (x) the ability to maintain our status as a real estate investment trust (“REIT”); (xi) changes in the U.S. tax law and other state, federal or local laws, whether or not specific to REITs; (xii) other risks inherent in the real estate business, including potential liability relating to environmental matters and illiquidity of real estate investments; and (xiii) any additional factors included in this report, including in the section entitled “Risk Factors” in Item 1A of this Annual Report, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the Securities and Exchange Commission (“SEC”), including subsequent Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
Forward-looking statements speak only as of the date of this report. Except in the normal course of our public disclosure obligations, we expressly disclaim any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any statement is based.
TENANT INFORMATION
This Annual Report on Form 10-K includes information regarding certain of our tenants that lease properties from us, some of which are not subject to SEC reporting requirements. The Ensign Group, Inc. (“Ensign”) and The Pennant Group, Inc. (“Pennant”) are subject to the reporting requirements of the SEC and are required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. You are encouraged to review Ensign and Pennant’s publicly available filings, which can be found at the SEC’s website at www.sec.gov.
The information related to our tenants contained or referred to in this Annual Report on Form 10-K was provided to us by such tenants or derived from SEC filings or other publicly available information. We have not verified this information through an independent investigation or otherwise. We have no reason to believe that this information is inaccurate in any material respect, but we cannot provide any assurance of its accuracy. We are providing this data for informational purposes only.

4

PART I
All references in this report to “CareTrust REIT,” the “Company,” “we,” “us” or “our” mean CareTrust REIT, Inc. together with its consolidated subsidiaries. Unless the context suggests otherwise, references to “CareTrust REIT, Inc.” mean the parent company without its subsidiaries.
ITEM  1.    Business
Our Company
CareTrust REIT is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. As of December 31, 2020, CareTrust REIT’s real estate portfolio consisted of 218 skilled nursing facilities (“SNFs”), multi-service campuses and assisted living facilities (“ALFs”) consisting of 22,466 operational beds and units located in 28 states with the highest concentration of properties by rental income located in California, Texas, Louisiana, Idaho and Arizona. As of December 31, 2020, we also had other real estate investments consisting of one mezzanine loan receivable with a carrying value of $15.0 million.
From January 1, 2020 through February 10, 2021, we acquired six skilled nursing facilities, one multi-service campus and one assisted living facility for approximately $89.8 million, which includes capitalized acquisition costs. These acquisitions are expected to generate initial annual cash revenues of approximately $7.6 million and an initial blended yield of approximately 8.5%. We also made one mezzanine loan with a carrying value of $15.0 million with a fixed interest rate of 12.0%.
We generate revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property (including property taxes, insurance, maintenance and repair costs and capital expenditures, subject to certain exceptions in the case of properties leased to Ensign). From time to time, we also extend secured mortgage loans to healthcare operators, secured by healthcare-related properties and secured mezzanine loans to healthcare operators, secured by membership interests in healthcare-related properties. We conduct and manage our business as one operating segment for internal reporting and internal decision making purposes. We expect to grow our portfolio by pursuing opportunities to acquire additional properties that will be leased to a diverse group of local, regional and national healthcare providers, which may include other skilled nursing operators, as well as seniors housing operators and related businesses. We also anticipate diversifying our portfolio over time, including by acquiring properties in different geographic markets, and in different asset classes. In addition, we actively monitor the clinical, regulatory and financial operating results of our tenants, and work to identify opportunities within their operations and markets that could improve their operating results at our facilities. We communicate such observations to our tenants; however, we have no contractual obligation to do so. Moreover, our tenants have sole discretion with respect to the day-to-day operation of the facilities they lease from us, and how and whether to implement any observation we may share with them. We also actively monitor the overall occupancy, skilled mix, and other operating metrics of our tenants on at least a monthly basis including, beginning in the quarter ended June 30, 2020, any stimulus funds received by each tenant. We have replaced tenants in the past, and may elect to replace tenants in the future, if they fail to meet the terms and conditions of their leases with us. The replacement tenants may include tenants with whom we have had no prior landlord-tenant relationship as well as current tenants with whom we are comfortable expanding our relationships. We have also provided select tenants with strategic capital for facility upkeep and modernization, as well as short-term working capital loans when they are awaiting licensure and certification or conducting turnaround work in one or more of our properties, and we may continue to do so in the future. In addition, we periodically reassess the investments we have made and the tenant relationships we have entered into, and have selectively disposed of facilities or investments, or terminated such relationships, and we expect to continue making such reassessments and, where appropriate, taking such actions.
We elected to be taxed as a REIT for U.S. federal income tax purposes beginning with our taxable year ended December 31, 2014. We believe that we have been organized and have operated, and we intend to continue to operate, in a manner to qualify for taxation as a REIT. We operate through an umbrella partnership, commonly referred to as an UPREIT structure, in which substantially all of our properties and assets are held through CTR Partnership, L.P. (the “Operating Partnership”). The Operating Partnership is managed by CareTrust REIT’s wholly owned subsidiary, CareTrust GP, LLC, which is the sole general partner of the Operating Partnership. To maintain REIT status, we must meet a number of organizational and operational requirements, including a requirement that we annually distribute to our stockholders at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains.
5

Our Industry
The skilled nursing industry has evolved to meet the growing demand for post-acute and custodial healthcare services generated by an aging population, increasing life expectancies and the trend toward shifting of patient care to lower cost settings. We believe this evolution has led to a number of favorable improvements in the industry, as described below:
Shift of Patient Care to Lower Cost Alternatives.  The growth of the senior population in the United States continues to increase healthcare costs. In response, federal and state governments have adopted cost-containment measures that encourage the treatment of patients in more cost-effective settings such as SNFs, for which the staffing requirements and associated costs are often significantly lower than acute care hospitals, inpatient rehabilitation facilities and other post-acute care settings. As a result, SNFs are generally serving a larger population of higher-acuity patients than in the past. The same trend is impacting ALFs, which are now generally serving some patients who previously would have received services at SNFs.
Significant Acquisition and Consolidation Opportunities. The skilled nursing industry is large and highly fragmented, characterized predominantly by numerous local and regional providers. We believe this fragmentation provides significant acquisition and consolidation opportunities for us.
Widening Supply and Demand Imbalance. The number of SNFs has declined modestly over the past several years. According to the American Health Care Association, the nursing home industry was comprised of approximately 15,700 facilities as of December 2016, as compared with over 16,700 facilities as of December 2000. We expect that the supply/demand imbalance in the skilled nursing industry will increasingly favor skilled nursing and assisted living providers due to the shift of patient care to lower cost settings, an aging population and increasing life expectancies.
Increased Demand Driven by Aging Populations and Increased Life Expectancy. As life expectancy continues to increase in the United States and seniors account for a higher percentage of the total U.S. population, we believe the overall demand for skilled nursing services will increase. At present, the primary market demographic for skilled nursing services is individuals age 75 and older. The U.S. Census reported that there were over 54 million people in the United States in 2019 over the age of 65. The U.S. Census estimates this group to be one of the fastest growing segments of the United States population, projecting that it will almost double between 2016 and 2060. According to the Centers for Medicare & Medicaid Services, nursing home care facilities and continuing care retirement expenditures are projected to grow from approximately $169 billion in 2018 to approximately $266 billion in 2028, representing a compounded annual growth rate of 5.0%. We believe that these trends will support an increasing demand for skilled nursing services, which in turn will likely support an increasing demand for the services provided within our properties.
Portfolio Summary
We have a geographically diverse portfolio of properties, consisting of the following types as of December 31, 2020:
Skilled Nursing Facilities. SNFs are licensed healthcare facilities that provide restorative, rehabilitative and nursing care for people not requiring the more extensive and sophisticated treatment available at acute care hospitals. Treatment programs include physical, occupational, speech, respiratory and other therapies, including sub-acute clinical protocols such as wound care and intravenous drug treatment. Charges for these services are generally paid from a combination of government reimbursement and private sources. As of December 31, 2020, our portfolio included 177 SNFs, 20 of which are located on campuses that also have assisted or independent living facilities, which we refer to as multi-service campuses (see below under “Multi-Service Campuses”).
Assisted Living Facilities. ALFs are licensed healthcare facilities that provide personal care services, support and housing for those who need help with activities of daily living, such as bathing, eating and dressing, yet require limited medical care. The programs and services may include transportation, social activities, exercise and fitness programs, beauty or barber shop access, hobby and craft activities, community excursions, meals in a dining room setting and other activities sought by residents. These facilities are often apartment-like buildings with private residences ranging from single rooms to large apartments. Certain ALFs may offer higher levels of personal assistance for residents requiring memory care as a result of Alzheimer’s disease or other forms of dementia. The level of personal assistance that may be provided at ALFs is based in part on state regulations. Since states often apply differing license classifications, and standards, regulatory requirements may differ significantly between states. As of December 31, 2020, our portfolio included 39 ALFs, some of which also contain independent living and memory care units.
Independent Living Facilities. ILFs, also known as retirement communities or senior apartments, are not healthcare facilities and are not licensed to provide healthcare services to residents. The facilities typically consist of entirely
6

self contained apartments, complete with their own kitchens, baths and individual living spaces, as well as parking for tenant vehicles. They are most often rented unfurnished, and generally can be personalized by the tenants, typically an individual or a couple over the age of 55. These facilities offer various services and amenities such as laundry, housekeeping, dining options/meal plans, exercise and wellness programs, transportation, social, cultural and recreational activities, on site security and emergency response programs. As of December 31, 2020, our portfolio included 2 ILFs.
Multi-Service Campuses. Multi-service campuses generally include some combination of co-located SNFs, ALFs, ILFs, and/or memory care units all housed at a single location and operated as a continuum of care. These facilities are often marketed as an opportunity for residents to “age in place,” and tend to attract couples where the individuals may require or benefit from differing levels of care. As of December 31, 2020, our portfolio included 20 facilities that we classify as multi-service campuses.
Our portfolio of SNFs, ALFs, ILFs and multi-service campuses is broadly diversified by geographic location throughout the United States, with concentrations in California, Texas, Louisiana, Idaho and Arizona based on rental income.
Significant Master Leases
We have leased a significant number of our properties to subsidiaries of Ensign on a triple-net basis under eight long-term leases each with its own pool of properties, that have varying maturities and diversity in both property type and geography (each an “Ensign Master Lease” and collectively, the “Ensign Master Leases”). The Ensign Master Leases provide for initial terms in excess of ten years with staggered expiration dates and no purchase options. At Ensign’s option, each Ensign Master Lease may be extended for up to three five year renewal terms beyond the initial term and, if elected, the renewal will be effective for all of the leased property then subject to the applicable Ensign Master Lease. During the year ended December 31, 2020, the Company acquired four additional facilities leased to subsidiaries of Ensign on a triple-net basis which are not included under the Ensign Master Leases. As of December 31, 2020, the annualized contractual rental income from the Ensign Master Leases was $53.4 million, or 31%, and annualized contractual rental income from all Ensign leases was $57.2 million, or 33.0%, of total annualized contractual rental income. Rent is escalated annually in June under the Ensign Master Leases, and in December for the four additional facilities leased to Ensign, by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. The Ensign Master Leases are guaranteed by Ensign and contain cross-default provisions. The four additional facilities leased to subsidiaries of Ensign are guaranteed by Ensign but do not contain cross-default provisions with the Ensign Master Leases.
On October 1, 2019, Ensign completed its previously announced separation of its home health and hospice operations and substantially all of its senior living operations into a separate independent publicly traded company through the distribution of shares of Pennant common stock (the “Pennant Spin”). As a result of the Pennant Spin, on October 1, 2019, the Company amended the Ensign Master Leases to reduce the number of facilities covered by the Ensign Master Leases and entered into one long-term triple-net lease (the “Pennant Master Lease”) to lease those facilities to Pennant. The contractual initial annual cash rent under the Pennant Master Lease was approximately $7.8 million. The Pennant Master Lease carries an initial term of 15 years, with two five-year renewal options and CPI-based rent escalators. The contractual annual cash rent under the amended Ensign Master Leases was reduced by approximately $7.8 million. Ensign has guaranteed the Pennant Master Lease. If Pennant achieves a specified portfolio coverage ratio and continuously maintains it for a specified period, Ensign’s obligations under the guaranty with respect to the Pennant facilities would be released. As of December 31, 2020, the Company leased 89 facilities to subsidiaries of Ensign, which have a total of 9,546 operational beds and 11 facilities to Pennant, which have a total of 1,193 operational beds and Ensign and Pennant represented 33% and 5%, respectively, of the Company’s contractual rental income, exclusive of operating expense reimbursements, on an annualized run-rate basis.
As of December 31, 2020, 15 of our properties were leased to subsidiaries of Priority Management Group (“PMG”) on a triple-net basis under one long-term lease (the “PMG Master Lease”), and have a total of 2,145 operational beds. The PMG Master Lease commenced on December 1, 2016, and provides an initial term of fifteen years, with two five-year renewal options. As of December 31, 2020, PMG represented 16% of the Company’s contractual rental income, exclusive of operating expense reimbursements, on an annualized run-rate basis.
The Ensign Master Leases account for a substantial portion of our revenues, and Ensign’s financial condition and ability and willingness to (i) satisfy its obligations under the Ensign Master Leases, (ii) renew the Ensign Master Leases upon expiration of the initial base terms thereof, and (iii) satisfy its guaranty obligations under the Pennant Master Lease, significantly impacts our revenues and our ability to service our indebtedness and to make distributions to our stockholders. There can be no assurance that Ensign has sufficient assets, income and access to financing to enable it to satisfy its obligations under the Ensign Master Leases or its guaranty of the Pennant Master Lease, and any inability or unwillingness on its part to do so would have a material adverse effect on our business, financial condition, results of operations and liquidity, on our ability to service our indebtedness and other obligations and on our ability to pay dividends to our stockholders, as required for us to qualify, and maintain our status, as a REIT. We also cannot assure you that Ensign will elect to renew the Ensign Master Leases
7

with us upon expiration of the initial base terms or any renewal terms thereof or, if such leases are not renewed, that we can reposition the affected properties on the same or better terms. See “Risk Factors - Risks Related to Our Business - We are dependent on the healthcare operators that lease our properties to successfully operate their business and make contractual lease payments, and an event that materially and adversely affects their business, financial position or results of operations could materially and adversely affect our business, financial position or results of operations.”
We monitor the creditworthiness of our tenants by evaluating the ability of the tenants to meet their lease obligations to us based on the tenants’ financial performance, including the evaluation of any guarantees of tenant lease obligations. The primary basis for our evaluation of the credit quality of our tenants (and more specifically the tenants’ ability to pay their rent obligations to us) is the tenants’ lease coverage ratios. These coverage ratios compare (i) earnings before interest, income taxes, depreciation, amortization and rent (“EBITDAR”) to rent coverage, and (ii) earnings before interest, income taxes, depreciation, amortization, rent and management fees (“EBITDARM”), to rent coverage. We utilize a standardized 5% management fee when we calculate lease coverage ratios. We obtain various financial and operational information from our tenants each month. We regularly review this information to calculate the above-described coverage metrics, to identify operational trends, to assess the operational and financial impact of the changes in the broader industry environment (including the potential impact of government reimbursement and regulatory changes), and to evaluate the management and performance of the tenant’s operations. These metrics help us identify potential areas of concern relative to our tenants’ credit quality and ultimately the tenants’ ability to generate sufficient liquidity to meet their ongoing obligations, including their obligations to continue paying contractual rents due to us and satisfying other financial obligations to third parties, as prescribed by our triple-net leases.
8

Properties by Type:
The following table displays the geographic distribution of our facilities by property type and the related number of beds and units available for occupancy by asset class, as of December 31, 2020. The number of beds or units that are operational may be less than the official licensed capacity.
 TotalSNFsMulti-Service Campuses
ALFs and ILFs
StateProperties
Beds/Units
Facilities
Beds
Campuses
Beds/Units
Facilities
Beds/Units
TX 41 5,207 35 4,426 539 242 
CA 34 3,965 25 2,806 710 449 
ID 17 1,457 16 1,388 69 — — 
IA 15 984 13 815 169 — — 
OH 13 1,284 734 550 — — 
UT13 1,392 913 330 149 
WA 12 1,082 11 980 — — 102 
AZ 11 1,352 986 — — 366 
IL 772 644 128 — — 
LA 1,164 949 215 — — 
CO 785 522 — — 263 
NE 366 220 146 — — 
VA 279 — — — — 279 
FL 404 — — — — 404 
MI189 — — — — 189 
MT260 260 — — — — 
NV 304 92 — — 212 
WI 206 — — — — 206 
MN62 — — — — 62 
NC100 — — — — 100 
GA105 105 — — — — 
IN162 — — — — 162 
MD120 — — — — 120 
ND110 110 — — — — 
NM136 136 — — — — 
OR53 53 — — — — 
SD99 99 — — — — 
WV67 — — 67 — — 
Total218 22,466 157 16,238 20 2,923 41 3,305 
 
        















9

Occupancy by Property Type:
The following table displays occupancy by property type for each of the years ended December 31, 2020 and 2019. Percentage occupancy in the below table is computed by dividing the average daily number of beds occupied by the total number of beds available for use during the periods indicated (beds of acquired facilities are included in the computation following the date of acquisition only).
 Year Ended December 31,
Property Type20202019
Facilities Leased to Tenants: (1)
  
     SNFs75 %78 %
     Multi-Service Campuses73 %76 %
     ALFs and ILFs86 %83 %
Facilities Operated by CareTrust REIT:(2)
     ILFs91 %89 %
 
(1)    Occupancy data derived solely from information provided by our tenants without independent verification by us. The leased facility financial performance data is presented one quarter in arrears.
(2)    As of December 31, 2019, we owned and operated one ILF. Occupancy data for the year ended December 31, 2020 and December 31, 2019 includes the one ILF owned and operated. We sold the one remaining ILF during the three months ended December 31, 2020.
 
Property Type - Rental Income:
The following tables display the annual rental income and total beds/units for each property type leased to third-party tenants for the years ended December 31, 2020 and 2019.
 For the Year Ended December 31, 2020
Property TypeRental Income
(in thousands)
Percent
of Total 
Total Beds/
Units 
SNFs$127,200 73 %16,238 
Multi-Service Campuses21,517 13 %2,923 
ALFs and ILFs24,895 14 %3,305 
Total$173,612 100 %22,466 

 For the Year Ended December 31, 2019
Property TypeRental Income
(in thousands)
Percent
of Total 
Total Beds/
Units 
SNFs$115,362 74 %16,262 
Multi-Service Campuses18,109 12 %2,460 
ALFs and ILFs22,196 14 %3,241 
Total$155,667 100 %21,963 







10

Geographic Concentration - Rental Income:
The following table displays the geographic distribution of annual rental income for properties leased to third-party tenants for the years ended December 31, 2020 and 2019 (in thousands, except percentages).
 For the Year Ended December 31, 2020For the Year Ended December 31, 2019
State 
Rental Income
Percent of Total 
Rental Income
Percent of Total 
CA$36,853 21 %$35,297 23 %
TX33,276 19 %32,364 21 %
LA16,022 %15,880 10 %
ID13,482 %11,717 %
AZ12,466 %12,461 %
OH9,225 %964 %
UT7,289 %6,740 %
MI5,729 %6,007 %
CO5,561 %5,485 %
WA5,201 %5,145 %
IL4,824 %4,725 %
IA4,672 %2,815 %
VA3,248 %3,171 %
WI2,937 %2,535 %
NV2,092 %2,091 %
FL1,572 %550 — %
NC1,107 %1,097 %
MT1,079 %550 — %
NM1,008 %987 %
NE956 %956 %
SD905 %886 %
IN829 %760 — %
GA810 — %485 — %
WV714 — %384 — %
MD567 — %229 — %
ND442 — %433 — %
OR380 — %376 — %
MN366 — %577 — %
Total$173,612 100 %$155,667 100 %

ILFs Operated by CareTrust REIT:
As of December 31, 2019, we owned and operated one ILF, Lakeland Hills Independent Living, located in Dallas, Texas, with 168 units. During the quarter ended December 31, 2020, we sold the one remaining ILF to a third party leaving us with no remaining owned and operated ILFs at December 31, 2020.
Investment and Financing Policies
Our investment objectives are to increase cash flow, provide quarterly cash dividends, maximize the value of our properties and acquire properties with cash flow growth potential. We intend to invest primarily in SNFs and seniors housing, including ALFs and ILFs, although we may determine in the future to expand our investments to include medical office buildings, long-term acute care hospitals and inpatient rehabilitation facilities. Our properties are located in 28 states and we intend to continue to acquire properties in other states throughout the United States. Although our portfolio currently consists primarily of owned real property, future investments may include first mortgages, mezzanine debt and other securities issued by, or joint ventures with, REITs or other entities that own real estate consistent with our investment objectives.
11

Our Competitive Strengths
We believe that our ability to acquire, integrate and improve facilities is a direct result of the following key competitive strengths:
Geographically Diverse Property Portfolio. Our properties are located in 28 different states, with concentrations in California, Texas, Louisiana, Idaho and Arizona based on rental income. The properties in any one state do not account for more than 21% of our total rental income as of December 31, 2020. We believe this geographic diversification will limit the effect of changes in any one market on our overall performance.
Long-Term, Triple-Net Lease Structure. All of our properties are leased to our tenants under long-term, triple-net leases, pursuant to which the operators are responsible for all facility maintenance and repair, insurance required in connection with the leased properties and the business conducted on the leased properties, taxes levied on or with respect to the leased properties and all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties.
Financially Secure Primary Tenant. Ensign is an established provider of healthcare services with strong financial performance and accounted for 32% of our 2020 rental income, exclusive of operating expense reimbursements. Ensign is subject to the reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s publicly available filings can be found at the SEC’s website at www.sec.gov.
Ability to Identify Talented Operators. We have purchased 138 properties since June 1, 2014, the date we became a separate and independent publicly-traded company, through December 31, 2020 and have increased total rental income from $41.2 million for the year ended December 31, 2013, the last full fiscal year prior to becoming a separate and independent publicly-traded company, to $173.6 million for the year ended December 31, 2020. We have grown to 22 operators including local, regional and national operators, including Ensign and PMG, which account for 32% and 16% of our total rental income, in each case exclusive of operating expense reimbursements, for the year ended December 31, 2020, respectively. As a result of our management team’s operating experience and network of relationships and insight, we believe that we are able to identify and pursue working relationships with qualified local, regional and national healthcare providers and seniors housing operators. We expect to continue our disciplined focus on pursuing investment opportunities, primarily with respect to stabilized assets but also some strategic investment in new and/or improving properties, while seeking dedicated and engaged operators who possess local market knowledge, have solid operating records and emphasize quality services and outcomes. We intend to support these operators by providing strategic capital for facility acquisition, upkeep and modernization. Our management team’s experience gives us a key competitive advantage in objectively evaluating an operator’s financial position, care and service programs, operating efficiencies and likely business prospects.
Experienced Management Team. Gregory K. Stapley, our Chief Executive Officer, has extensive experience in the real estate and healthcare industries. Mr. Stapley has more than 30 years of experience in the acquisition, development, financing and disposition of real estate including healthcare facilities and office, retail and industrial properties, including nearly 15 years at Ensign where he was a co-founder, and was instrumental in assembling the portfolio that we now lease back to Ensign and Pennant. David M. Sedgwick, our President and Chief Operating Officer, has more than 20 years of experience in the skilled nursing and seniors housing industry. Mr. Sedgwick served as our Vice President-Operations from 2014 to 2018, as our Chief Operating Officer from 2018 to the present, and was appointed President in February 2021. Mr. Sedgwick’s duties involve him in matters related to new investments, asset management, portfolio management, portfolio optimization, investor relations and capital markets for the Company. Prior to joining CareTrust, Mr. Sedgwick served as the Chief Human Capital Officer and President of Corporate Services at Ensign. Mr. Sedgwick has been a licensed nursing home administrator since 2001. Our Chief Financial Officer, William M. Wagner, has more than 25 years of accounting and finance experience, primarily in real estate, including more than 15 years of experience working extensively for REITs. Most notably, he worked for both Nationwide Health Properties, Inc., a healthcare REIT, and Sunstone Hotel Investors, Inc., a lodging REIT, serving as Senior Vice President and Chief Accounting Officer of each company prior to joining us as our Chief Financial Officer. Mark D. Lamb has served as our Chief Investment Officer since August 2018. Mr. Lamb previously served as our Director of Investments from July 2014 to August 2018, and has been instrumental in building the Company’s portfolio since becoming a public company. Mr. Lamb is a licensed nursing home administrator and, prior to joining the Company in 2014, served as an administrator at one of Plum Healthcare’s flagship post-acute facilities from 2011 to 2014. Prior to 2011, Mr. Lamb served in acquisition and portfolio management capacities for various entities for more than nine years. Our executives have years of public company experience, including experience accessing both debt and equity capital markets to fund growth and maintain a flexible capital structure.
Flexible UPREIT Structure. We operate through an umbrella partnership, commonly referred to as an UPREIT structure, in which substantially all of our properties and assets are held through the Operating Partnership. Conducting business through the Operating Partnership will allow us flexibility in the manner in which we structure the acquisition of properties. In particular, an UPREIT structure enables us to acquire additional properties from sellers in exchange for limited
12

partnership units, which provides property owners the opportunity to defer the tax consequences that would otherwise arise from a sale of their real properties and other assets to us. As a result, this structure allows us to acquire assets in a more efficient manner and may allow us to acquire assets that the owner would otherwise be unwilling to sell because of tax considerations.
Business Strategies
Our primary goal is to create long-term stockholder value through the payment of consistent cash dividends and the growth of our asset base. To achieve this goal, we intend to pursue a business strategy focused on opportunistic acquisitions and property diversification. We also intend to further develop our relationships with tenants and healthcare providers with a goal to progressively expand the mixture of tenants managing and operating our properties.
The key components of our business strategies include:
Diversify Asset Portfolio. We diversify through the acquisition of new and existing facilities from third parties and the expansion and upgrade of current facilities and strategically investing in new developments with options to acquire the developments at stabilization. We employ what we believe to be a disciplined, opportunistic acquisition strategy with a focus on the acquisition of SNFs, ALFs and ILFs, and we may determine in the future to expand our acquisitions to include medical office buildings, long-term acute care hospitals and inpatient rehabilitation facilities. As we acquire additional properties, we expect to further diversify by geography, asset class and tenant within the healthcare and healthcare-related sectors.
 
Maintain Balance Sheet Strength and Liquidity. We maintain a capital structure that provides the resources and flexibility to support the growth of our business. We intend to maintain a mix of credit facility debt, unsecured debt and possibly secured mortgage debt, which, together with our anticipated ability to complete future equity financings, including issuances of our common stock via registered public offerings or under an at-the-market equity program, we expect will fund the growth of our property portfolio.
Develop New Tenant Relationships. We cultivate new relationships with tenants and healthcare providers in order to expand the mix of tenants operating our properties. We expect that this objective will be achieved over time as part of our overall strategy to acquire new properties and further diversify our portfolio of healthcare properties.
Provide Capital to Underserved Operators. We believe there is a significant opportunity to be a capital source to healthcare operators, through the acquisition and leasing of healthcare properties to them that are consistent with our investment and financing strategy at appropriate risk-adjusted rates of return, which, due to size and other considerations, are not a focus for larger healthcare REITs. We pursue acquisitions and strategic opportunities that meet our investing and financing strategy and that are attractively priced, including funding development of properties through preferred equity or construction loans and thereafter entering into sale and leaseback arrangements with such developers as well as other secured term financing and mezzanine lending. We utilize our management team’s operating experience, network of relationships and industry insight to identify both large and small quality operators in need of capital funding for future growth. In appropriate circumstances, we may negotiate with operators to acquire individual healthcare properties from those operators and then lease those properties back to the operators pursuant to long-term triple-net leases.
Fund Strategic Capital Improvements. We support operators by providing capital to them for a variety of purposes, including capital expenditures and facility modernization. We expect to structure these investments as either lease amendments that produce additional rents or as loans that are repaid by operators during the applicable lease term.
Pursue Strategic Development Opportunities. We work with operators and developers to identify strategic development opportunities. These opportunities may involve replacing or renovating facilities that may have become less competitive. We also identify new development opportunities that present attractive risk-adjusted returns. We may provide funding to the developer of a property in conjunction with entering into a sale leaseback transaction or an option to enter into a sale leaseback transaction for the property.
Competition
We compete for real property investments with other REITs, investment companies, private equity and hedge fund investors, sovereign funds, pension funds, healthcare operators, lenders and other institutional investors. Some of these competitors are significantly larger and have greater financial resources and lower costs of capital than us. Increased competition will make it more challenging to identify and successfully capitalize on acquisition opportunities that meet our investment objectives. Our ability to compete is also impacted by national and local economic trends, availability of investment alternatives, availability and cost of capital, construction and renovation costs, existing laws and regulations, new legislation and population trends.
In addition, revenues from our properties are dependent on the ability of our tenants and operators to compete with other healthcare operators. Healthcare operators compete on a local and regional basis for residents and patients and their ability to successfully attract and retain residents and patients depends on key factors such as the number of facilities in the local market,
13

the types of services available, the quality of care, reputation, age and appearance of each facility and the cost of care in each locality. Private, federal and state payment programs and the effect of other laws and regulations may also have a significant impact on the ability of our tenants and operators to compete successfully for residents and patients at the properties.
Sustainability
As a healthcare-focused real estate investment trust, our assets are an integral part of the overall healthcare continuum in the communities that our tenants serve. We believe that environmental sustainability is an important part of our commitment to helping people live and age well in those communities. We are working to implement sustainable practices and providing tenant education, support and incentives to avoid or reduce practices in our corporate offices and by our tenants at our net-leased properties that may have negative environmental impacts. In addition, as a landlord and capital supplier to a key segment of the healthcare industry, we seek opportunities to use our influence to encourage and incentivize fair and healthy work environments for healthcare workers and suitable living conditions for patients and residents, and to promote diversity, inclusion and the ethical treatment of employees, residents, patients and others wherever our activities and influence can be felt.
Human Capital Resources
Supporting our people is a foundational value for us. We believe our success depends on our ability to attract, develop and retain key personnel. Our core philosophies and policies in this regard include:
Compensation and Benefits. The skills, experience and industry knowledge of key employees significantly benefit our performance. We believe we offer competitive compensation (including salary, incentive bonus and equity) and benefits packages (including a 401(k) plan with a fixed employer contribution and Flexible Spending Accounts (FSAs), among others). Our compensation program is designed to attract and reward talented individuals who possess the skills necessary to support our business objectives, assist in the achievement of our strategic goals and create long-term value for our stockholders.
As of December 31, 2020, we employed approximately 15 full-time employees (including our executive officers), none of whom is subject to a collective bargaining agreement. Prior to the COVID-19 pandemic, all of our employees were based out of our corporate office in San Clemente, California, other than three full-time employees who worked remotely. With the COVID-19 pandemic, we have temporarily closed our corporate office and most of our employees are currently working remotely. To address the dynamic nature of COVID-19 and remote work, the Company has offered workforce flexibility for all employees.
Retention and Turnover. Recruiting, hiring, training and retaining excellent employees is a high priority for us. These activities carry real and substantial costs, which we regard as a meaningful investment in our workforce and our company. We believe that employee turnover is costly both in direct and indirect ways, and we are committed to employee retention and satisfaction. During the year ended December 31, 2020, and excluding the ILF that we sold during 2020, we experienced turnover of two full-time employees, neither of whom were executive officers.
Sphere of Influence. We believe that the creation of an engaging and mutually supportive corporate culture that acknowledges and celebrates the value and contributions of all stakeholders is core to our long-term success. As an extension of our commitment to the many people who contribute to our success, we encourage and incentivize our triple-net tenants through subsidies and other economic incentives to reflect a similar commitment to integrity and corporate responsibility by voluntarily participating in our Tenant Code of Conduct and Corporate Responsibility Program (the “Tenant ESG Program”), and particularly by valuing the healthcare workers in their employ who deliver care in our facilities every day. These principles are reflected in our Policy on Human Capital, our Policy on Human Rights and Responsibilities and our proprietary Tenant ESG Program.
Government Regulation, Licensing and Enforcement
Overview
As operators of healthcare facilities, tenants of our healthcare properties are typically subject to extensive and complex federal, state and local healthcare laws and regulations relating to fraud and abuse practices, government reimbursement, licensure and certificate of need and similar laws governing the operation of healthcare facilities, and we expect that the healthcare industry, in general, will continue to face significant regulation and pressure in the areas of fraud, waste and abuse, cost control, healthcare management and provision of services, among others. These regulations are wide-ranging and can subject our tenants to civil, criminal and administrative sanctions. Affected tenants may find it increasingly difficult and costly to comply with this complex and evolving regulatory environment because of a relative lack of guidance in many areas as certain of our healthcare properties are subject to oversight from several government agencies and the legal requirements often vary from one jurisdiction to another. Changes in laws and regulations and reimbursement enforcement activity and regulatory non-compliance by our tenants could have a significant effect on their operations and financial condition, which in turn may adversely affect us, as detailed below and set forth under “Risk Factors - Risks Related to Our Business.”
14

The following is a discussion of certain laws and regulations generally applicable to our tenants (as operators of our healthcare facilities) and, in certain cases, to us.
Enforcement
There are various extremely complex federal and state laws and regulations governing healthcare providers’ relationships and arrangements and prohibiting fraudulent and abusive practices by such providers. These laws include, but are not limited to, (i) federal and state false claims acts, which, among other things, prohibit providers from filing false claims or making false statements to receive payment from Medicare, Medicaid or other federal or state healthcare programs, (ii) federal and state anti-kickback and fee-splitting statutes, including the Medicare and Medicaid anti-kickback statute, which prohibit the payment or receipt of remuneration to induce referrals or recommendations of healthcare items or services, (iii) federal and state provider self-referral laws (including the federal law commonly referred to as the “Stark Law”), which generally prohibit referrals by physicians and in some cases other providers to entities with which the physician or an immediate family member has a financial relationship, and (iv) the federal Civil Monetary Penalties Law, which prohibits, among other things, the knowing presentation of a false or fraudulent claim for certain healthcare services. Violations of healthcare fraud and abuse laws carry civil, criminal and administrative sanctions, including punitive sanctions, monetary penalties, imprisonment, denial of Medicare and Medicaid reimbursement and potential exclusion from Medicare, Medicaid or other federal or state healthcare programs. These laws are enforced by a variety of federal, state and local agencies and can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or “whistleblower” actions. Ensign and our other tenants are (and many of our future tenants are expected to be) subject to these laws, and some of them may in the future become the subject of governmental enforcement actions if they fail to comply with applicable laws.
State and Federal “Fraud and Abuse” Laws and Regulations. The Medicare and Medicaid anti-fraud and abuse amendments to the Social Security Act (the “Anti-Kickback Law”) make it a felony, subject to certain exceptions, for any person to engage in illegal remuneration arrangements with vendors, physicians and other health care providers for the referral of Medicare beneficiaries or Medicaid recipients. When a violation occurs, the government may proceed criminally or civilly. If the government proceeds criminally, a violation is a felony and may result in imprisonment for up to five years, fines of up to $25,000 and mandatory exclusion from participation in all federal health care programs. If the government proceeds civilly, it may impose a civil monetary penalty of $50,000 per violation and an assessment of not more than three times the total amount of remuneration involved, and it may exclude the parties from participation in all federal health care programs. Violations of the Anti-Kickback Statute also serve as a basis for federal False Claims Act cases. Many states have enacted laws similar to, and in some cases broader than, the Anti-Kickback Law.
The scope of prohibited payments in the Anti-Kickback Law is broad. The U. S. Department of Health and Human Services has promulgated regulations which describe certain “safe harbor” arrangements that will not be deemed to constitute violations of the Anti-Kickback Law. An arrangement that fits squarely into a safe harbor is immune from prosecution under the Anti-Kickback Statute. The safe harbors described in the regulations are narrow and do not cover a wide range of economic relationships which many SNFs, physicians and other health care providers consider to be legitimate business arrangements not prohibited by the statute. Because the regulations describe safe harbors and do not purport to describe comprehensively all lawful and unlawful economic arrangements or other relationships between health care providers and referral sources, health care providers entering into these arrangements or relationships may be required to alter them in order to ensure compliance with the Anti-Kickback Law and may be subject to significant liability should an arrangement that does not fully satisfy a safe harbor be determined to be illegal. On November 20, 2020, the US Department of Health and Human Services (“HHS”) promulgated significant new Anti-Kickback Law regulations, including changes to existing safe harbors and the creation of new safe harbors, in an effort to reduce regulatory burden and incentivize coordinated care, including value-based arrangements.
The False Claims Act provides that any person who “knowingly presents, or causes to be presented” a “false or fraudulent claim for payment or approval” to the U.S. government, or its agents and contractors, is liable for a civil penalty ranging from $5,500 to $11,000 per claim, plus three times the amount of damages sustained by the government. Under the False Claims Act’s so-called “reverse false claims,” liability also could arise for “using” a false record or statement to “conceal,” “avoid” or “decrease” an “obligation” (which can include the retention of an overpayment) “to pay or transmit money or property to the government.” The False Claims Act also empowers and provides incentives to private citizens (commonly referred to as qui tam relator or whistleblower) to file suit on the government’s behalf. The qui tam relator’s share of the recovery can be between 15% and 25% in cases in which the government intervenes, and 25% to 30% in cases in which the government does not intervene. Notably, the Affordable Care Act amended certain jurisdictional bars to the False Claims Act, effectively narrowing the “public disclosure bar” (which generally requires that a whistleblower suit not be based on publicly disclosed information) and expanding the “original source” exception (which generally permits a whistleblower suit based on publicly
15

disclosed information if the whistleblower is the original source of that publicly disclosed information), thus potentially broadening the field of potential whistleblowers.
Restrictions on Referrals. The federal physician self-referral law and its implementing regulations (commonly referred to as the “Stark Law”) prohibits providers of “designated health services” from billing Medicare or Medicaid if the patient is referred by a physician (or his/her immediate family member) with a financial relationship with the entity, unless an exception applies. “Designated health services” include clinical laboratory services; physical therapy services; occupational therapy services; outpatient speech-language pathology; radiology services, including magnetic resonance imaging, computerized axial tomography scans, and ultrasound services; radiation therapy services and supplies; durable medical equipment and services; parenteral and enteral nutrients, equipment and services; prosthetics, orthotics, and prosthetic devices and supplies; home health services; outpatient prescription drugs; and inpatient and outpatient hospital services. The Stark Law also prohibits the furnishing entity from submitting a claim for reimbursement or otherwise billing Medicare or any other person or entity for improperly referred designated health services. Many designated health services are commonly provided in SNFs and ALFs. The new regulations promulgated by HHS, discussed above in “State and Federal ‘Fraud and Abuse’ Laws and Regulations”, include significant changes to the Stark Law regulations, including (i) new exceptions designed to enable more value-based arrangements, (ii) a modification to the existing exception for electronic health records items and services, and (iii) new exceptions for limited remuneration to physicians and for cybersecurity technology and related services.
An entity that submits a claim for reimbursement in violation of the Stark Law must refund any amounts collected and may be: (1) subject to a civil penalty of up to $15,000 for each self-referred service; and (2) excluded from participation in federal health care programs. In addition, a physician or entity that has participated in a “scheme” to circumvent the operation of the Stark Law is subject to a civil penalty of up to $100,000 and possible exclusion from participation in federal health care programs.
Reimbursement
Sources of revenue for our tenants include (and for our future tenants is expected to include), among other sources, governmental healthcare programs, such as the federal Medicare program and state Medicaid programs, and non-governmental payors, such as insurance carriers and health maintenance organizations. As federal and state governments focus on healthcare reform initiatives, and as the federal government and many states face significant budget deficits, efforts to reduce costs by these payors will likely continue, which may result in reduced or slower growth in reimbursement for certain services provided by Ensign and our other tenants. Federal and state authorities are likely to continue to implement new and modified reimbursement methodologies, including value-based methodologies, that could have a negative impact on our tenants. Such changes to reimbursement methodologies could have a material impact on our tenants and we cannot provide assurances that the current revenue levels will be maintained under any future reimbursement arrangements. In addition, the impact of other health care reform efforts, such as “Medicare for all” or the provision of a new Medicare-like public option for consumers to receive health insurance, are impossible to predict.
The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “Affordable Care Act”) serves as the primary vehicle for comprehensive healthcare reform in the United States. Efforts by the Trump administration and certain members of Congress to repeal or make significant changes to the Affordable Care Act, its implementation and/or its interpretation including the successful repeal of the penalty associated with the individual mandate of the Affordable Care Act, continue to cast uncertainty on the future of the Affordable Care Act. For example, on December 14, 2018, a U.S. District Court in Texas ruled the Affordable Care Act unconstitutional in its entirety. This decision was appealed, and on December 18, 2019, the Fifth Circuit Court of Appeals ruled that the Affordable Care Act’s individual mandate was unconstitutional but remanded the case for further analysis. On November 10, 2020, the Supreme Court of the United States heard oral arguments, but a decision has not yet been issued. This and other changes may impact the number of individuals that elect to obtain public or private health insurance or the scope of such coverage, if purchased. Given the change in control of Congress, we anticipate Congress will renew efforts to expand health insurance coverage and to assess alternative health care delivery and payment systems. Congress may in the future propose and adopt legislation effecting additional fundamental changes in the health care system. For example, some members of Congress have suggested expanding the coverage of government-funded programs, including single-payor models. The Biden administration supports building on PPACA to expand health insurance coverage to more citizens, including through the addition of a Medicare-like public option, increasing the value of certain tax credits to lower premiums, and expanding access to Medicaid; it has not yet publicly supported a single-payor model. In addition, although the Democratic Party now controls the United States House of Representatives (by a slim majority) and Senate (by virtue of the Vice President casting the tie-breaking vote), legislation would likely require at least some support from both Republican and Democratic lawmakers to become law. At this time, it is uncertain whether any additional healthcare reform legislation will ultimately become law and we cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on our business. If our
16

tenants’ residents do not have insurance, it could adversely impact the tenants’ ability to satisfy their obligations to us. Expansion of health insurance coverage to more citizens could have a positive financial impact on our tenants’ and their ability to satisfy their obligations to us.
Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted, which also may impact our business. For instance, CMS is required to measure, track, and publish readmission rates of SNFs and to implement a value-based purchasing program for SNFs (the “SNF VBP Program”). The SNF VBP Program increases Medicare reimbursement rates for SNFs that achieve certain levels of quality performance measures developed by CMS, relative to other facilities. The value-based payments authorized by the SNF VBP Program are funded by reducing Medicare payment for all SNFs by 2% and redistributing up to 70% of those funds to high-performing SNFs. However, there is no assurance that payments made by CMS as a result of the SNF VBP Program will be sufficient to cover a facility’s costs. If Medicare reimbursement provided to our healthcare tenants is reduced under the SNF VBP Program, that reduction may have an adverse impact on the ability of our tenants to meet their obligations to us.
See “Risk Factors - Risks Related to Our Business - Healthcare reform legislation impacts cannot accurately be predicted and could adversely affect our results of operations” for additional risks related to changes in Medicare reimbursement.
Increased Government Oversight of Skilled Nursing Facilities
Section 1150B of the Social Security Act requires employees of federally funded long-term care facilities to immediately report any reasonable suspicion of a crime committed against a resident of that facility. Those reports must be submitted to at least one law enforcement agency and the applicable Centers for Medicare & Medicaid Services (“CMS”) Survey Agency. Covered individuals who fail to report under Section 1150B are subject to various penalties, including civil monetary penalties of up to $300,000 and possible exclusion from participation in any Federal health care program. Medicare regulations require SNFs to establish and implement written policies to ensure the reporting of crimes that occur in federally funded SNFs in accordance with Section 1150B.
In August 2017, the U.S. Department of Health & Human Services (“HHS”) Office of Inspector General (“OIG”) issued a preliminary report regarding quality of care concerns by operators of SNFs. In its report, the OIG determined that CMS has inadequate procedures in place to ensure that incidents of potential abuse or neglect of Medicare beneficiaries residing in SNFs are identified and reported. The report was issued in connection with the OIG’s ongoing review of potential abuse and neglect of Medicare beneficiaries residing in SNFs.
As a result of the OIG report, CMS enforcement activity against SNF operators may increase, especially with regard to the reporting of potential abuse or neglect of SNF residents. If any of our tenants or their employees are found to have violated any applicable reporting requirements, they may become subject to penalties or other sanctions up to and including loss of licensure.
Healthcare Licensure and Certificate of Need
Our healthcare facilities are subject to extensive federal, state and local licensure, certification and inspection laws and regulations. In addition, various licenses and permits are required to operate SNFs and ALFs, dispense narcotics, operate pharmacies, handle radioactive materials and operate equipment. Many states require certain healthcare providers to obtain a certificate of need, which requires prior approval for the construction, modification and closure of certain healthcare facilities. The ability to obtain such approval and/or the approval process may impact some of our tenants’ abilities to expand or change their businesses. Any failure to comply with any of these laws, regulations, or standards could result in penalties which may include loss or restriction of license, loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from federal and state healthcare programs, or closure of the facility.
Privacy, Security and Data Breach Notification Laws
The Health Insurance Portability and Accountability Act of 1996, as amended (“HIPAA”) regulates the privacy and security of certain health information (“Protected Health Information”) and requires entities subject to HIPAA to provide notification of breaches of Protected Health Information. Entities subject to HIPAA include health plans, healthcare clearinghouses, and most health care providers (including many of our tenants). Business associates of these entities who create, receive, maintain or transmit Protected Health Information are also subject to HIPAA. Violations of the HIPAA requirements may result in civil monetary penalties of up to $50,000 per violation with a maximum civil penalty of $1.5 million in a calendar year for violations of the same requirement. However, a single breach or incident can result in violations of multiple requirements, resulting in possible penalties well in excess of $1.5 million. Breaches of unsecured Protected Health Information and other violations of HIPAA may have other material adverse consequences including material loss of business, business interruption, loss of patient or other critical data, regulatory enforcement, substantial legal liability and reputational harm. Certain violations of HIPAA can result in criminal penalties and enforcement.
17

Various other state and federal laws relate to privacy, security and the reporting of data breaches involving personal information (together with HIPAA, “Privacy Laws”). For example, various state laws and regulations may regulate the privacy and security of personal information, and require notification of affected individuals in the event of a data breach involving such individual’s personal information (including an individual’s name plus social security number, date of birth or credit card information, for example). Failure of the Company or its tenants to comply with applicable Privacy Laws could have a materially adverse effect on our Company. Failure of our tenants to comply with applicable Privacy Laws could have a material adverse effect on their ability to meet their obligations to us. Furthermore, the adoption of new Privacy Laws at the federal and state level could require us or our tenants to incur significant compliance costs.
Americans with Disabilities Act (the “ADA”)
Although most of our properties are not required to comply with the ADA because of certain “grandfather” provisions in the law, some of our properties must comply with the ADA and similar state or local laws to the extent that such properties are “public accommodations,” as defined in those statutes. These laws may require removal of barriers to access by persons with disabilities in certain public areas of our properties where such removal is readily achievable. Under our triple-net lease structure, our tenants would generally be responsible for additional costs that may be required to make our facilities ADA-compliant. Noncompliance with the ADA could result in the imposition of fines or an award of damages to private litigants.
Environmental Matters
A wide variety of federal, state and local environmental and occupational health and safety laws and regulations affect healthcare facility operations. These complex federal and state statutes, and their enforcement, involve a myriad of regulations, many of which involve strict liability on the part of the potential offender. Some of these federal and state statutes may directly impact us. Under various federal, state and local environmental laws, ordinances and regulations, an owner of real property, such as us, may be liable for the costs of removal or remediation of hazardous or toxic substances at, under or disposed of in connection with such property, as well as other potential costs relating to hazardous or toxic substances (including government fines and damages for injuries to persons and adjacent property). The cost of any required remediation, removal, fines or personal or property damages and the owner’s liability therefore could exceed or impair the value of the property and/or the assets of the owner. In addition, the presence of such substances, or the failure to properly dispose of or remediate such substances, may adversely affect the owner’s ability to sell or rent such property or to borrow using such property as collateral which, in turn, could reduce our revenues. See “Risk Factors - General Risk Factors - Environmental compliance costs and liabilities may materially impair the value of properties owned by us.”
REIT Qualification
We elected to be taxed as a REIT for U.S. federal income tax purposes beginning with our taxable year ended December 31, 2014. Our qualification as a REIT will depend upon our ability to meet, on a continuing basis, various complex requirements under the Internal Revenue Code of 1986, as amended (the “Code”), relating to, among other things, the sources of our gross income, the composition and values of our assets, our distribution levels to our stockholders and the concentration of ownership of our capital stock. We believe that we are organized in conformity with the requirements for qualification and taxation as a REIT under the Code and that our manner of operation has and will enable us to continue to meet the requirements for qualification and taxation as a REIT.
The Operating Partnership
We own substantially all of our assets and properties and conduct our operations through the Operating Partnership. We believe that conducting business through the Operating Partnership provides flexibility with respect to the manner in which we structure the acquisition of properties. In particular, an UPREIT structure enables us to acquire additional properties from sellers in tax deferred transactions. In these transactions, the seller would typically contribute its assets to the Operating Partnership in exchange for units of limited partnership interest in the Operating Partnership (“OP Units”). Holders of OP Units will have the right, after a 12-month holding period, to require the Operating Partnership to redeem any or all of such OP Units for cash based upon the fair market value of an equivalent number of shares of CareTrust REIT’s common stock at the time of the redemption. Alternatively, we may elect to acquire those OP Units in exchange for shares of our common stock on a one-for-one basis. The number of shares of common stock used to determine the redemption value of OP Units, and the number of shares issuable in exchange for OP Units, is subject to adjustment in the event of stock splits, stock dividends, distributions of warrants or stock rights, specified extraordinary distributions and similar events. The Operating Partnership is managed by our wholly owned subsidiary, CareTrust GP, LLC, which is the sole general partner of the Operating Partnership and owns one percent of its outstanding partnership interests. As of December 31, 2020, CareTrust REIT is the only limited partner of the Operating Partnership, owning 99% of its outstanding partnership interests, and we have not issued OP Units to any other party.
18

The benefits of our UPREIT structure include the following:
Access to capital. We believe the UPREIT structure provides us with access to capital for refinancing and growth. Because an UPREIT structure includes a partnership as well as a corporation, we can access the markets through the Operating Partnership issuing equity or debt as well as the corporation issuing capital stock or debt securities. Sources of capital include possible future issuances of debt or equity through public offerings or private placements.
Growth. The UPREIT structure allows stockholders, through their ownership of common stock, and the limited partners, through their ownership of OP Units, an opportunity to participate in future investments we may make in additional properties.
Tax deferral. The UPREIT structure provides property owners who transfer their real properties to the Operating Partnership in exchange for OP Units the opportunity to defer the tax consequences that otherwise would arise from a sale of their real properties and other assets to us or to a third party. As a result, this structure allows us to acquire assets in a more efficient manner and may allow us to acquire assets that the owner would otherwise be unwilling to sell because of tax considerations.
Insurance
We maintain, or require in our leases that our tenants maintain, all applicable lines of insurance on our properties and their operations. The amount and scope of insurance coverage provided by our policies and the policies maintained by our tenants is customary for similarly situated companies in our industry. However, we cannot assure you that our tenants will maintain the required insurance coverages, and the failure by any of them to do so could have a material adverse effect on us. We also cannot assure you that we will continue to require the same levels of insurance coverage under our leases, including the Ensign Master Leases, that such insurance will be available at a reasonable cost in the future or that the insurance coverage provided will fully cover all losses on our properties upon the occurrence of a catastrophic event, nor can we assure you of the future financial viability of the insurers.
Available Information
We file annual, quarterly and current reports, proxy statements and other information with SEC. The SEC maintains an internet site that contains these reports, and other information about issuers, like us, which file electronically with the SEC. The address of that site is http://www.sec.gov. We make available our reports on Form 10-K, 10-Q, and 8-K (as well as all amendments to these reports), and other information, free of charge, on the Investor Relations section of our website at www.caretrustreit.com. The information found on, or otherwise accessible through, our website is not incorporated by reference into, nor does it form a part of, this report or any other document that we file with the SEC.

19

ITEM 1A.    Risk Factors
Risks Related to Our Business
We are dependent on the healthcare operators that lease our properties to successfully operate their businesses and make contractual lease payments, and an event that materially and adversely affects their business, financial position or results of operations could materially and adversely affect our business, financial position or results of operations.
Because all of our properties are operated by our tenants pursuant to triple-net master leases, we are unable to directly implement strategic business decisions regarding the daily operation and marketing of these properties. While we have rights as the property owner under our triple-net leases and monitor our tenants’ and operators’ performance, we may have limited recourse under our master leases if we believe that a tenant or operator is not performing adequately and any failure by a tenant to effectively conduct its operations or to maintain and improve our properties could adversely affect its business reputation and its ability to attract and retain residents in our properties, which in turn, could adversely affect their ability to make rental payments to us and otherwise adversely affect our results of operations, including our ability to repay our outstanding indebtedness or our ability to pay dividends to our stockholders as required to maintain our REIT status. Additionally, because each master lease is a triple-net lease, we depend on our tenants to pay all insurance, taxes, utilities and maintenance and repair expenses and to indemnify, defend and hold us harmless from and against various claims, litigation and liabilities arising in connection with their business. There can be no assurance that our tenants will have sufficient assets, income and financing to enable them to satisfy their contractual lease payment or indemnification obligations.
Ensign leases or provides a guaranty for a significant portion of our properties. As of December 31, 2020, properties leased to Ensign under all Ensign leases represented $57.2 million, or 33%, of our rental income, exclusive of operating expense reimbursements, on an annualized run-rate basis, and properties leased to Pennant under the Pennant Master Lease for which Ensign provides a guaranty (the “Pennant Guaranty”) represented $7.8 million, or 5%, of our rental income, exclusive of operating expense reimbursements, on an annualized run-rate basis. Ensign’s inability or unwillingness to meet its lease obligations or its obligations pursuant to the Pennant Guaranty could materially adversely affect our business, financial position or results of operations. In addition, Ensign’s inability to satisfy its other lease obligations including payment of insurance, taxes and utilities, could materially and adversely affect the condition of the properties leased to Ensign as well as Ensign’s business, financial position and results of operations. Accordingly, if Ensign were to experience a material and adverse effect on its business, financial position or results of operations, our business, financial position or results of operations could also be materially and adversely affected.
Further, our dependence on Ensign’s rental payments for a substantial portion of our rental income may limit our ability to enforce our rights under the Ensign leases or the Pennant Guaranty or to terminate the Ensign leases. Ensign’s failure to comply with its lease obligations or its obligations pursuant to the Pennant Guaranty, or with federal and state healthcare laws and regulations to which the leased properties are subject, could require us to find another lessee for such leased properties and result in a decrease in or cessation of rental payments. In such event, we may be unable to locate a suitable lessee at similar rental rates or at all, which would reduce our rental income.
The ongoing COVID-19 pandemic and measures intended to prevent its spread could have a material adverse effect on our business, results of operations, cash flows and financial condition.
Long-term care residents are at high risk for infection and severe illness or possible death from COVID-19 due to their advanced age, likelihood of underlying medical conditions, and the group living setting of long-term care facilities. To date, there have been significant COVID-19 outbreaks in long-term care facilities all over the world. These outbreaks have affected not only the residents, but also the health care providers and visitors to these facilities. The COVID-19 pandemic has led governments and other authorities around the world, including federal, state and local authorities in the United States, to impose measures intended to reduce its spread. These measures impose restrictions on movement and business operations such as travel bans, border closings, business limitations and closures (subject to exceptions for essential operations and businesses), quarantines and shelter-in-place orders. Although some of these restrictions have been lifted or scaled back, resurgences of COVID-19 and the emergence of more readily transmissible variants have resulted in the re-imposition of certain restrictions and may lead to other restrictions being implemented.
Recently, two COVID-19 vaccines were approved for full use. While the supply of COVID-19 vaccine in the United States is currently limited, states have generally prioritized residents of long-term care facilities, health care providers, and, increasingly, people 65 and older to receive the vaccine. However, distribution of the vaccine has taken longer than expected due to logistics, lack of resources, scheduling, staffing issues and vaccine resistance, and availability is expected to remain scarce for the next several months, even as newer, more contagious variants of COVID-19 circulate worldwide. To meet these challenges, the Biden administration has announced a vaccine offensive plan that calls for greatly expanding access to the vaccine and using the Defense Production Act to expand vaccine production. Experts do not know how long immunity lasts after vaccination or exactly what percentage of the population would need to be vaccinated to achieve herd (or population)
20

immunity to COVID-19. The Biden administration also proposed a $1.9 trillion spending package to combat the economic downturn and the pandemic, including $20 billion for a national vaccine program. At this time, it is uncertain whether any such proposal will ultimately become law and we cannot predict the ultimate content, timing or effect of any such legislation or the impact of potential legislation on our business.
Given the adverse impact the pandemic and pandemic-related restrictions have had, and may continue to have, on the economy generally and the prevalence of outbreaks within long-term care facilities, our business, results of operations and financial condition have been adversely impacted, and may in the future be materially adversely impacted, by the COVID-19 pandemic.
The COVID-19 pandemic and measures to prevent its spread subject us to various risks and uncertainties, some of which have adversely affected our business, and all of which could materially adversely affect our business, results of operations and financial condition, including the following:
the inability of our tenants to pay contractual rent in full, on a timely basis or at all due to increases in operating costs incurred by our tenants or declines in occupancy rates at their facilities, which would adversely impact our rental income, and the adverse impact on our rental income if we grant rent deferrals, reductions or other restructurings or accommodations to any of our tenants;
the possibility that we may be required to write-off unpaid rental payments, incur lease accounting charges due to the uncollectibility of rental payments and/or accede to unfavorable modifications of lease terms if a tenant is unable to pay contractual rent; and/or the possibility that adverse market conditions or declines in the operating performance of our tenants or borrowers may result in asset impairment charges or credit losses on our loans receivable if we determine that the full amount of our investments are not recoverable;
the financial deterioration of one or more of our tenants or borrowers (which has, and could continue to result from, among other reasons (i) temporary cessation or limitations on certain medical procedures which in turn results in a reduction in hospital patients and the need for post-acute care services offered by our tenants, (ii) increased operating costs and staffing requirements related to compliance with Centers for Disease Control and Prevention (“CDC”) protocols, (iii) increased scrutiny by regulators of infection control and prevention measures, (iv) potential repayments of relief funds received by tenants as changes in federal guidelines are published and potential false claims act and whistleblower liability for violations of relief fund terms and conditions, (v) nursing or other staffing shortages exacerbated by the pandemic; or (vi) decisions by elderly individuals to avoid or delay entrance into assisted living and other long-term care facilities in order to minimize their potential for exposure to COVID-19 in group living situations), which may result in such tenant(s) experiencing insolvency or initiating bankruptcy or similar proceedings which adversely affect our ability to collect rent or interest payments from such tenants and result in increased costs to us;
increased costs or delays that we have incurred, and may continue to incur, if we need to reposition or transition any of our currently-leased properties to another tenant or operator, which have, and may continue to, adversely impact our revenues and results of operations;
risks related to lawsuits and regulatory enforcement actions related to COVID-19 outbreaks involving us, our tenants, operators or borrowers, including increases in the costs of business, negative publicity and/or further decreases in occupancy and/or profitability at our facilities (we note, however, that liability protections provided to health care providers under the PREP Act, as summarized below, may reduce the risk of legal liability for certain actions taken by our operators in connection with the COVID-19 pandemic);
deterioration of state and local economic conditions and job losses, which has, and may continue to, decrease demand for and occupancy levels of our properties and cause our rental rates and property values to be negatively impacted;
possible complete or partial closures of, or other operational issues at, one or more of our properties resulting from government actions or directives, which may intensify the risk of rent deferrals or non-payment of contractual obligations by our tenants or operators;
material increases in COVID-19 related claims and litigation against nursing home and seniors housing operators (whether by residents, employees, contractors, suppliers, etc.) causing their insurance coverage to increase to levels which could negatively impact their financial performance and ability to meet their contractual lease obligations to us;
limitations on our access to capital and other sources of funding, which could adversely affect the availability and terms of future borrowings or refinancings or other forms of capital raising, including issuances under our New ATM Program (as defined below), and which could adversely impact our ability to make new property investments;
our ability to continue to make cash distributions to our stockholders commensurate with historical levels; and
21

our ability to repay outstanding debt or maintain compliance with covenants under our Amended Credit Facility (as defined below) and the indenture governing our Notes.
The Public Readiness and Emergency Preparedness Act (the “PREP Act”), enacted in 2005, authorizes the HHS Secretary to issue a declaration to provide liability immunity to certain individuals and entities, including health care providers, against any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration or use of medical countermeasures, including a qualified pandemic, except for cases involving willful misconduct. The HHS Secretary first declared on January 31, 2020 that a public health emergency exists under the PREP Act in connection with the COVID-19 pandemic, which triggered the PREP Act provisions. A declaration lasts until the HHS Secretary declares that the public health emergency no longer exists or upon the expiration of the 90-day period beginning on the date that the HHS Secretary declared a public health emergency exists, whichever occurs first. The HHS Secretary has renewed this declaration multiple times, and is currently set to be in force through April 2021. The PREP Act is intended to protect health care providers, including many of our tenants, operators or borrowers, from liability for using or administering medical devices or medications that have been sanctioned on some level, even if not formally approved by the United States Food and Drug Administration or CDC. The PREP Act is especially important for our tenants that want to offer treatment options to their residents who test positive for COVID-19. If courts do not enforce the provisions of the PREP Act to provide liability immunity for certain health care providers, such as nursing home and seniors housing operators, or if the Biden administration scales back or rescinds any previous declarations to invoke the PREP Act, our tenants, operators or borrowers, the financial performance of our tenants, operators or borrowers and ability to meet their contractual obligations to us could be adversely affected.
The duration and extent of the COVID-19 pandemic’s effect on our operational and financial performance, and the operational and financial performance of our tenants, will depend on future developments, which are highly uncertain and cannot be predicted at this time, including new information which may emerge concerning the severity of COVID-19 and the current and future variants thereof, actions taken to contain COVID-19, resurgences of COVID-19 that may continue to occur, the efficacy of COVID-19 vaccines and how quickly and to what extent normal economic and operating conditions resume. Even after the COVID-19 pandemic has subsided, we may experience adverse impacts to our business, financial condition, results of operations, and prospects as a result of its global economic impact, including any economic downturn or recession that has occurred or may occur in the future. The adverse impact of the COVID-19 pandemic on our business, results of operations and financial condition could be material.
Our tenants depend on reimbursement from government and other third-party payors and if reimbursement rates from such payors are reduced by future legislative reform, it could cause our tenants’ revenues to decline and could affect their ability to meet their obligations to us.
Sometimes, governmental payors freeze or reduce payments to healthcare providers, or provide annual reimbursement rate increases that are smaller than expected, due to budgetary and other pressures. Healthcare reimbursement will likely continue to be of significant importance to federal and state authorities. For example, the federal government and a number of states are currently managing budget deficits and, as a result, many states are focusing on the reduction of expenditures under their Medicaid programs, which may result in a freeze on Medicaid rates or a decrease in reimbursement rates for our tenants. The need to control Medicaid expenditures may be exacerbated by the potential for increased enrollment in Medicaid due to unemployment and declines in family incomes. These potential reductions could be compounded by the potential for federal cost-cutting efforts that could lead to reductions in reimbursement to our tenants under both the Medicaid and Medicare programs. While we cannot make any assessment as to the ultimate timing or the effect that any future legislative reforms may have on our tenants’ costs of doing business and on the amount of reimbursement by government and other third-party payors, potential reductions in Medicaid and Medicare reimbursement, or in non-governmental third-party payor reimbursement, to our tenants could reduce the revenues of our tenants and their ability to meet their obligations to us.
Bankruptcy, insolvency or financial deterioration of our tenants could delay or prevent collection of unpaid rents or require us to find new tenants.
We receive substantially all of our income as rental payments under leases of our properties. We have no control over the success or failure of our tenants’ businesses and, at any time, any of our tenants may experience a downturn in its business that may weaken its financial condition. As a result, our tenants have in the past, and may in the future, fail to make rent payments when due, or our tenants may declare bankruptcy. Tenant bankruptcies or failures to make rent payments when due could result in termination of the tenant’s lease and could have a material adverse effect on our business, financial condition and results of operations and our ability to make distributions to our stockholders (which could adversely affect our ability to raise capital or service our indebtedness). This risk is magnified where we lease multiple properties to a single tenant, such as Ensign.
If a tenant is unable to comply with the terms of its lease, we may be forced to write off unpaid amounts due to us from the tenant, move to a cash basis method of accounting for recognizing rental income from the tenant or otherwise modify the tenant’s lease in ways that are unfavorable to us. Alternatively, failure of a tenant to perform under a lease could require us to declare a default, repossess the property, find a suitable replacement tenant, hire third-party managers to operate the property or
22

sell the property. See Note 2, Summary of Significant Accounting Policies and Note 3, Real Estate Investments, Net for further information.
If one or more of our tenants files for bankruptcy relief, the U.S. Bankruptcy Code provides that a debtor has the option to assume or reject the unexpired lease within a certain period of time. Any bankruptcy filing by or relating to one of our tenants could bar all efforts by us to collect pre-bankruptcy debts from that tenant or seize its property. A tenant bankruptcy could also delay our efforts to collect past due balances under the leases and could ultimately preclude collection of all or a portion of these sums. It is possible that we may recover substantially less than the full value of any unsecured claims we hold, if any, which may have a material adverse effect on our business, financial condition and results of operations, and our ability to make distributions to our stockholders.
Replacement tenants or operators may be difficult to identify and we may be required to incur substantial renovation costs to make our healthcare properties suitable for such tenants or operators.
If our tenants terminate or do not renew their leases with us, we would attempt to reposition the properties with another tenant or operator. Rental payments on such properties could decline or cease altogether while we reposition the properties with a suitable replacement tenant or operator and we may be required to fund certain expenses and obligations (e.g., real estate taxes, debt costs and maintenance expenses) to preserve the value of, and avoid the imposition of liens on, such properties while they are being repositioned.
Healthcare facilities are typically highly customized and may not be easily adapted to non-healthcare-related uses. The improvements generally required to conform a property to healthcare use, such as upgrading electrical, gas and plumbing infrastructure and security, are costly and at times tenant-specific. A new or replacement tenant may require different features in a property, depending on that tenant’s particular operations. If a current tenant is unable to pay rent and vacates a property, we may incur substantial expenditures to modify a property before we are able to secure another tenant. In addition, approvals of local authorities for any required modifications and/or renovations may be necessary, resulting in delays in transitioning a facility to a new tenant. These expenditures or renovations and delays could materially and adversely affect our business, financial condition or results of operations.
In addition, we may fail to identify suitable replacements or enter into leases or other arrangements with new tenants or operators on a timely basis or on terms as favorable to us as our current leases, if at all. If we experience a significant number of un-leased properties due to the inability to find suitable replacement tenants or successfully reposition the property, our operating expenses could increase significantly. Even after a suitable replacement tenant or operator has taken over operation of a property, it may still take an extended period of time before such property is fully repositioned and value restored, if at all. Any of these results could have a material adverse effect on our business, financial condition and results of operations and our ability to make distributions to stockholders.
The geographic concentration of some of our facilities could leave us vulnerable to an economic downturn, regulatory changes or acts of nature in those areas.
As a result of the concentration of our properties in California, Texas, Louisiana, Idaho and Arizona as described in “Portfolio Summary” under Item 1 of this Annual Report on Form 10-K, the conditions of local economies and real estate markets, including increases in real estate taxes, changes in governmental rules, regulations and reimbursement rates or criteria, changes in demographics, state funding, acts of nature and other factors that may result in a decrease in demand and/or reimbursement for skilled nursing services in these states could have a disproportionately adverse effect on our tenants’ revenue, costs and results of operations, which may affect their ability to meet their obligations to us.
Our facilities located in Texas and Louisiana are especially susceptible to natural disasters such as hurricanes, tornadoes and flooding, and our facilities located in California are particularly susceptible to natural disasters such as fires, earthquakes and mudslides. These acts of nature may cause disruption to our tenants, their employees and our facilities, which could have an adverse impact on our tenants’ patients and businesses. In order to provide patient care, our tenants are dependent on consistent and reliable delivery of food, pharmaceuticals, utilities and other goods to our facilities, and the availability of employees to provide services at the facilities. If the delivery of goods or the ability of employees to reach our facilities is interrupted in any material respect due to a natural disaster or other reasons, it would have a significant impact on our facilities and our tenants’ businesses at those facilities. Furthermore, the impact, or impending threat, of a natural disaster may require that our tenants evacuate one or more facilities, which would be costly and would involve risks, including potentially fatal risks, for the patients at such facilities. The impact of disasters and similar events is inherently uncertain. Such events could harm our tenants’ patients and employees, severely damage or destroy one or more of our facilities, harm our tenants’ business, reputation and financial performance, or otherwise cause our tenants’ businesses to suffer in ways that we currently cannot predict.
In addition, to the extent that significant changes in the climate occur in areas where our properties are located, we may experience extreme weather and changes in precipitation and temperature, all of which may result in physical damage to or a decrease in demand for properties located in these areas or affected by these conditions. Should the impact of climate change be
23

material in nature, including destruction of our properties, or occur for lengthy periods of time, our financial condition or results of operations may be adversely affected. In addition, changes in federal and state legislation and regulation on climate change could result in increased capital expenditures to improve the energy efficiency of our existing properties and could also require us to spend more on our new development properties without a corresponding increase in revenue.
We pursue property acquisitions and seek strategic opportunities in the ordinary course of our business, which may result in significant usage of management resources or costs, and we may not fully realize the potential benefits of such transactions.
We regularly review, evaluate, engage in discussions regarding, and pursue acquisitions of properties and seek other strategic opportunities in the ordinary course of business in order to maximize stockholder value. We may devote a significant amount of our management resources to, and incur significant costs in connection with, such transactions, which may not result in definitive agreements or the completion of any transaction and, could negatively impact our operations. In addition, there is no assurance that we will fully realize the potential benefits of any past or future acquisition or strategic transaction.
Additionally, from time to time, we may invest in preferred equity interests in joint ventures. Our use of joint ventures may be subject to risks that may not be present with other ownership methods. Our joint ventures may involve property development, which presents additional risks that could render a development project less profitable or not profitable at all and, under certain circumstances, may prevent completion of development activities once undertaken.
If we cannot identify and purchase a sufficient quantity of suitable properties at favorable prices or if we are unable to finance acquisitions on commercially favorable terms, or at all, our business, financial position or results of operations could be materially and adversely affected. Furthermore, any future acquisitions may require the issuance of securities, the incurrence of debt, assumption of contingent liabilities or incurrence of significant expenditures, each of which could materially adversely impact our business, financial condition or results of operations. Additionally, the fact that we must distribute 90% of our REIT taxable income in order to maintain our qualification as a REIT may limit our ability to rely upon rental payments from our leased properties or subsequently acquired properties in order to finance acquisitions. As a result, if debt or equity financing is not available on acceptable terms, further acquisitions might be limited.
Increased competition has resulted and may further result in lower net revenues for some of our tenants and may affect their ability to meet their financial and other contractual obligations to us.
The healthcare industry is highly competitive. The occupancy levels at, and results of operations from, our facilities are dependent on our ability and the ability of our tenants to compete with other tenants and operators on a number of different levels, including the quality of care provided, reputation, the physical appearance of a facility, price, the range of services offered, family preference, amenities, alternatives for healthcare delivery, the supply of competing properties, physicians, staff, referral sources, location, and the size and demographics of the population in the surrounding area. In addition, our tenants face an increasingly competitive labor market for skilled management personnel and nurses together with Medicaid reimbursement in some states that does not cover the full cost of caring for residents. Significant turnover, or a shortage of nurses or other trained personnel or general inflationary pressures on wages, may force tenants to enhance pay and benefits packages to compete effectively for skilled personnel, or to use more expensive contract personnel, but they be unable to offset these added costs by increasing the rates charged to residents. Any increase in labor costs and other property operating expenses or any failure by our tenants to attract and retain qualified personnel could reduce the revenues of our tenants and their ability to meet their obligations to us.
Our tenants also compete with numerous other companies providing similar healthcare services or alternatives such as home health agencies, life care at home, community-based service programs, retirement communities and convalescent centers. We cannot be certain that our tenants will be able to achieve occupancy and rate levels, or manage their expenses, in a way that will enable them to meet all of their obligations to us. Further, many competing companies may have resources and attributes that are superior to those of our tenants. They may encounter increased competition that could limit their ability to maintain or attract residents or expand their businesses or to manage their expenses, either of which could adversely affect their ability to meet their obligations to us, potentially decreasing our revenues, impairing our assets, and/or increasing our collection and dispute costs.
In addition, if development of seniors housing facilities outpaces demand for those assets in markets in which we are located, those markets may become saturated and our seniors housing tenants and operators could experience decreased occupancy, which may affect their ability to meet their financial and other contractual obligations to us.
Required regulatory approvals can delay or prohibit transfers of our healthcare properties, which could result in periods in which we are unable to receive rent for such properties.
Our tenants that operate SNFs and other healthcare facilities must be licensed under applicable state law and, depending upon the type of facility, certified or approved as providers under the Medicare and/or Medicaid programs. Prior to the transfer of the operations of such healthcare properties to successor operators, the new operator generally must become licensed under state law and, in certain states, receive change of ownership approvals under certificate of need laws (which provide for a
24

certification that the state has made a determination that a need exists for the beds located on the property) and, if applicable, file for a Medicare and Medicaid change of ownership. Upon termination or expiration of existing leases, delays or the failure of the new tenant in receiving regulatory approvals from the applicable federal, state or local government agencies, may prolong the period during which we are unable to collect rent and the property may experience performance declines. We could also incur substantial additional expenses in connection with any licensing, receivership or change of ownership proceedings.
We may not be able to sell properties when we desire because real estate investments are relatively illiquid, which could materially and adversely affect our business, financial position or results of operations.
Real estate investments are generally illiquid. As a result, we may be unable to vary our portfolio promptly in response to changes in the real estate market. A downturn in the real estate market could materially and adversely affect the value of our properties and our ability to sell such properties for acceptable prices or terms. We also cannot predict the length of time needed to find a willing purchaser and to close the sale of a property or portfolio of properties. These factors and any others that would impede our ability to respond to adverse changes in the performance of our properties could materially and adversely affect our business, financial position or results of operations and our ability to pay dividends and make distributions.
We or our tenants may experience uninsured or underinsured losses, which could result in a significant loss of the capital we have invested in a property, decrease anticipated future revenues or cause us to incur unanticipated expenses.
Our lease agreements require that the tenant maintain general and professional liability insurance and comprehensive liability and hazard insurance. However, there are certain types of losses (including, but not limited to, losses arising from environmental conditions or of a catastrophic nature, such as earthquakes, wildfires, hurricanes and floods) that may be uninsurable or not economically insurable. In addition, insurance coverage may be insufficient to pay the full current market value or replacement cost of any loss. Inflation, changes in tort liability laws, changes in building codes and ordinances, environmental considerations, and other factors also might make it infeasible to use insurance proceeds to protect a tenant in a liability claim or replace a property after such property has been damaged or destroyed. Under such circumstances, the insurance proceeds received might not be adequate to restore the economic position with respect to such tenant or property.
If one of our tenants experiences a material general or professional liability loss that is uninsured or exceeds policy coverage limits, it may be unable to satisfy its lease payment obligations to us. If one of our properties experiences a loss that is uninsured or that exceeds policy coverage limits, we could lose the capital invested in the damaged property as well as the anticipated future cash flows from the property.
In addition, even if damage to our properties is covered by insurance, business disruptions caused by a casualty event may result in lost revenue for our tenants or us for which insurance may not fully compensate them or us for such loss of revenue. If one of our tenants experiences such a loss, it may be unable to satisfy its lease payment obligations to us.
The ownership by our chief executive officer, Gregory K. Stapley, of shares of Ensign and Pennant common stock may create, or may create the appearance of, conflicts of interest.
Because of his former position with Ensign, our chief executive officer, Gregory K. Stapley, owns shares of Ensign common stock. Mr. Stapley also owns shares of our common stock. In 2019, in connection with the Pennant Spin, each holder of Ensign common stock received one half share of Pennant common stock per share of Ensign common stock. As a result, Mr. Stapley now also owns shares of Pennant common stock. His individual holdings of shares of our common stock, Ensign common stock and Pennant common stock may be significant compared to his respective total assets. These equity interests may create, or appear to create, conflicts of interest when he is faced with decisions that may not benefit or affect CareTrust REIT, Ensign or Pennant in the same manner.
We are, and may continue to be, exposed to contingent rent escalators, which could hinder our profitability and growth. 
We derive revenue primarily by leasing our assets under long-term triple-net leases with rental rates that, subject to certain limitations, are generally fixed with annual rent escalations contingent on changes in the Consumer Price Index, subject to maximum fixed percentages. If the Consumer Price Index does not increase, our revenues may not increase. In addition, if economic conditions result in significant increases in the Consumer Price Index, but the escalations under our leases are capped, our growth and profitability also may be limited.
Risks Related to Laws and Regulations
Healthcare reform legislation impacts cannot accurately be predicted and could adversely affect our results of operations.
We and the healthcare operators leasing our properties depend on the healthcare industry and are susceptible to risks associated with healthcare reform. Legislative proposals are introduced each year that would introduce major changes in the healthcare system, both nationally and at the state level. In light of the transfer of power from the Trump administration to the Biden administration, and the change in control of the United States Senate, we believe that efforts may be made to, among other things: (i) repeal much of the deregulation and regulatory changes made to the PPACA during the previous
25

administration; (ii) expand health insurance coverage to more individuals, potentially by enacting legislation creating a single-payor health insurance model; and (iii) transition Federal payment programs further in the direction of value based care, but we cannot predict whether or in what form any of these measures will be enacted, or what effect they would have on our business or the businesses of our tenants if enacted. Efforts may also be made to reduce the age at which individuals become eligible for Medicare, which could have an adverse impact on our tenants because Medicare sometimes reimburses long term care providers at rates lower than those paid by commercial payors. We also believe that additional resources may be dedicated to regulatory enforcement, which could increase our tenants’ costs of doing business and negatively impact their ability to pay their rent obligations to us. Additional stimulus funding for state and local governments may have a positive impact on our tenants because it may alleviate some pressures on state and local governments to reduce overall Medicaid expenditures.
Our tenants are subject to extensive federal, state and local laws and regulations affecting the healthcare industry that include those relating to, among other things, licensure, conduct of operations, ownership of facilities, addition of facilities and equipment, allowable costs, services, prices for services, qualified beneficiaries, quality of care, patient rights and insurance, fraudulent or abusive behavior, and financial and other arrangements that may be entered into by healthcare providers. See “Government Regulation, Licensing and Enforcement” in Item 1 of this Annual Report on Form 10-K for more information. If our tenants or operators fail to comply with the laws, regulations and other requirements applicable to their businesses and the operation of our properties, they could become ineligible to receive reimbursement from governmental and private third-party payor programs, face bans on admissions of new patients or residents, suffer civil or criminal penalties or be required to make significant operational changes. Changes in enforcement policies by federal and state governments have also resulted in a significant increase in inspection rates, citations of regulatory deficiencies and sanctions, including terminations from Medicare and Medicaid programs, bars on Medicare and Medicaid payments for new admissions, civil monetary penalties and criminal penalties. Our tenants and operators could be forced to expend considerable resources responding to an investigation, lawsuit or other enforcement action under applicable laws or regulations. Additionally, if our tenants’ residents do not have insurance, it could adversely impact the tenants’ ability to satisfy their obligation to us. We cannot predict whether any future legislative proposals will be adopted or, if adopted, the impact these proposals would have on our tenants or our business.
Tenants that fail to comply with applicable requirements of governmental reimbursement programs, such as Medicare or Medicaid, may cease to operate or be unable to meet their financial and other contractual obligations to us.
Our tenants are subject to the following risks, among others, relating to governmental healthcare reimbursement programs: statutory and regulatory changes; retroactive rate adjustments; recovery of program overpayments or set-offs; administrative rulings; policy interpretations; payment or other delays by fiscal intermediaries or carriers; government funding restrictions (at a program level or with respect to specific facilities); and interruption or delays in payments due to any ongoing governmental investigations and audits.
We expect healthcare reimbursement will continue to be a significant focus for federal and state authorities in their cost control efforts. We cannot predict the timing or effects of any future legislative reforms on our tenants’ business costs or government and other third-party payor reimbursement. More generally, because of the dynamic nature of the legislative and regulatory environment for health care products and services, and in light of existing federal budgetary concerns, we cannot predict the impact that broad-based, far-reaching legislative or regulatory changes could have on the U.S. economy, our business or that of our operators and tenants. The failure of any of our tenants to comply with these laws, requirements and regulations could materially and adversely affect their ability to meet their financial and contractual obligations to us.
Government investigations and enforcement actions brought against the health care industry have increased dramatically over the past several years and are expected to continue, particularly in the area of Medicare/Medicaid false claims, as well as an increase in the intensity of enforcement actions resulting from these investigations. Some of these enforcement actions represent novel legal theories and expansions in the application of the False Claims Act.
Medicare, Medicaid and other governmental health care payors require reporting of extensive financial information in a specific format or content. These requirements are technical and complex and may not be properly implemented by billing or reporting personnel. For certain required information, False Claims Act violations may occur without any intent to defraud by mere negligence or recklessness in information submission to the government. New billing systems, medical procedures and procedures for which there is not clear guidance may all result in liability. In addition, violations of the Anti-Kickback Law or Stark Law and, for provider tenants who received pandemic relief funds, the failure to comply with terms and conditions related to receipt or repayment of those funds, may form the basis for a federal False Claims Act violation. See “Government Regulation, Licensing and Enforcement,” in Item 1 of this Annual Report on Form 10-K for more information.
Many states have adopted laws similar to the False Claims Act, some of which apply to claims submitted to private and commercial payors, not just governmental payors. Violations of such laws by an operator of a health care property could result in loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from government healthcare programs, civil liability, and in certain limited instances, criminal penalties, loss of license or closure of the property and/or the incurrence of considerable costs arising from an investigation or regulatory action.
26

If we or our tenants fail to adhere to applicable privacy and security laws, or experience a security incident or breach, this could have a material adverse effect on us or on our tenants’ ability to meet their obligations to us.
We and our tenants are subject to HIPAA and various other state and federal laws that relate to privacy, security and the reporting of data breaches involving personal information as discussed in “Government Regulation, Licensing and Enforcement - Privacy, Security and Data Breach Notification Laws” in Item 1 of this Annual Report on Form 10-K. Failure to comply with these requirements could have a materially adverse effect on us and the ability of our tenants to meet their obligations to us. Furthermore, the adoption of new privacy, security and data breach notification laws at the federal and state level could require us or our tenants to incur significant compliance costs.
While we and our tenants maintain various security controls, there is a risk of security incidents or breaches resulting from unintentional or deliberate acts by third parties or insiders attempting to obtain unauthorized access to information, destroy or manipulate data, or disrupt or sabotage information systems. The trend toward increased remote work and rapid implementation of telehealth within the health care industry in response to the pandemic may have created new or increased cyber risks. Cyber-attacks range from individual attempts to gain unauthorized access to our IT systems to sophisticated attacks by hacking groups and some nation-state actors. Information technology systems are a vital part of the business of our Company and our tenants, and a security incident or breach could result in a material loss of business, business interruption, loss of patient or other critical data, regulatory enforcement, substantial legal liability and reputational harm. Despite the deployment of commercially reasonable efforts and sophisticated techniques to prevent cyber-attacks, information systems remain potentially vulnerable because the techniques used by hackers continue to evolve and may not be identified until launched against a target, and may be designed not to be detected. In fact, some cyber-attacks may not be detected for an extended period of time. As a result, we or our tenants may be unsuccessful in implementing successful cybersecurity protections. A successful cyber-attack, security incident or breach occurring at or involving the Company could have a material adverse impact on our Company. Where the cyber-attack, incident or breach occurs at or involves a tenant, this could jeopardize the tenant’s ability to fulfill its obligations to us.
Tenants that fail to comply with federal, state and local licensure, certification and inspection laws and regulations may cease to operate our healthcare facilities or be unable to meet their financial and other contractual obligations to us.
The healthcare operators to whom we lease properties are subject to extensive federal, state, local and industry-related licensure, certification and inspection laws, regulations and standards. Our tenants’ failure to comply with any of these laws, regulations or standards could result in penalties which may include loss or restriction of license, loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from federal and state healthcare programs, or closure of the facility. Though the regulatory environment in which SNFs operate is more restrictive than for ALFs, ALFs face similar penalties for noncompliance with applicable legal requirements. For example, operations at our properties may require a license, registration, certificate of need, provider agreement or certification. Failure of any tenant to obtain, or the loss or imposition of restrictions on any required license, registration, certificate of need, provider agreement or certification would prevent a facility from operating in the manner intended by such tenant. Additionally, failure of our tenants to generally comply with applicable laws and regulations could adversely affect facilities owned by us, result in adverse publicity and reputational harm, and therefore could materially and adversely affect us. See “Government Regulation, Licensing and Enforcement - Healthcare Licensure and Certificate of Need” in Item 1 of this Annual Report on Form 10-K for additional information.
Environmental compliance costs and liabilities may materially impair the value of properties owned by us.
Under various federal, state and local laws, ordinances and regulations, as a current or previous owner of real estate, we may be required to investigate and clean up certain hazardous or toxic substances or petroleum released at a property, and may be held liable to a governmental entity or to third parties for property damage and for investigation and cleanup costs incurred by the third parties in connection with the contamination. In addition, some environmental laws create a lien on the contaminated site in favor of the government for damages and the costs it incurs in connection with the contamination. Neither we nor our tenants carry environmental insurance on our properties. Contamination or the failure to remediate contamination may materially adversely affect our ability to sell or lease the real estate or to borrow using the real estate as collateral. As the owner of a site, we may also be held liable to third parties for damages and injuries resulting from environmental contamination emanating from the site. Although we generally require our tenants, as operators of our healthcare properties, to indemnify us for environmental liabilities they cause, such liabilities could exceed the financial ability of the tenant to indemnify us or the value of the contaminated property. We may also experience environmental liabilities arising from conditions not known to us.
Risks Related to Our Status as a REIT
If we fail to qualify or remain qualified as a REIT, we will be subject to U.S. federal income tax as a regular corporation and could face substantial tax liability, which could adversely affect our ability to raise capital or service our indebtedness.
We currently operate, and intend to continue to operate, in a manner that will allow us to continue to qualify to be taxed as a REIT for U.S. federal income tax purposes. We elected to be taxed as a REIT for U.S. federal income tax purposes
27

beginning with our taxable year ended December 31, 2014. We received an opinion of our counsel with respect to our qualification as a REIT in connection with the Spin-Off. Investors should be aware, however, that opinions of advisors are not binding on the IRS or any court. The opinion of our counsel represents only the view of our counsel based on its review and analysis of existing law and on certain representations as to factual matters and covenants made by us, including representations relating to the values of our assets and the sources of our income. The opinion is expressed as of the date issued. Our counsel has no obligation to advise us or the holders of any of our securities of any subsequent change in the matters stated, represented or assumed or of any subsequent change in applicable law. Furthermore, both the validity of the opinion of our counsel and our qualification as a REIT will depend on our satisfaction of certain asset, income, organizational, distribution, stockholder ownership and other requirements on a continuing basis, the results of which will not be monitored by our counsel. Our ability to satisfy the asset tests depends upon our analysis of the characterization and fair market values of our assets, some of which are not susceptible to a precise determination, and for which we will not obtain independent appraisals.
If we fail to qualify to be taxed as a REIT in any year, we would be subject to U.S. federal income tax, including any applicable alternative minimum tax, on our taxable income at regular corporate rates, and dividends paid to our stockholders would not be deductible by us in computing our taxable income. Any resulting corporate liability could be substantial and would reduce the amount of cash available for distribution to our stockholders, which could have an adverse impact on the value of our common stock. Unless we were entitled to relief under certain Code provisions, we also would be disqualified from re-electing to be taxed as a REIT for the four taxable years following the year in which we failed to qualify to be taxed as a REIT, which could adversely affect our financial condition and results of operations.
Legislative or other actions affecting REITs could have a negative effect on us.
The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Department of the Treasury (the “Treasury”). Changes to the tax laws or interpretations thereof, with or without retroactive application, could materially and adversely affect our investors or us. We cannot predict how changes in the tax laws, including any tax reform called for by the new presidential administration, might affect our investors or us. New legislation, Treasury regulations, administrative interpretations or court decisions could significantly and negatively affect our ability to qualify to be taxed as a REIT or the U.S. federal income tax consequences to our investors and us of such qualification. For instance, the “Tax Cuts and Jobs Act” (the “Act”) significantly changed the U.S. federal income tax laws applicable to businesses and their owners, including REITs and their shareholders. Technical corrections or other amendments to the Act or administrative guidance interpreting the Act may be forthcoming at any time. We cannot predict the long-term effect of the Act or any future law changes on REITs or their shareholders. Changes to the U.S. federal tax laws and interpretations thereof, whether under the Act or otherwise, could adversely affect an investment in our stock
No prediction can be made regarding whether new legislation or regulation (including new tax measures) will be enacted by legislative bodies or governmental agencies, nor can we predict what consequences would result from this legislation or regulation. Accordingly, no assurance can be given that the currently anticipated tax treatment of an investment will not be modified by legislative, judicial or administrative changes, possibly with retroactive effect.
We could fail to qualify to be taxed as a REIT if income we receive from our tenants is not treated as qualifying income.
Under applicable provisions of the Code, we will not be treated as a REIT unless we satisfy various requirements, including requirements relating to the sources of our gross income. Rents received or accrued by us from our tenants will not be treated as qualifying rent for purposes of these requirements if the leases are not respected as true leases for U.S. federal income tax purposes and are instead treated as service contracts, joint ventures or arrangement. If the leases are not respected as true leases for U.S. federal income tax purposes, we will likely fail to qualify to be taxed as a REIT.
In addition, subject to certain exceptions, rents received or accrued by us from our tenants will not be treated as qualifying rent for purposes of these requirements if we or a beneficial or constructive owner of 10% or more of our stock beneficially or constructively owns 10% or more of the total combined voting power of all classes of stock entitled to vote or 10% or more of the total value of all classes of stock. CareTrust REIT’s charter provides for restrictions on ownership and transfer of CareTrust REIT’s shares of stock, including restrictions on such ownership or transfer that would cause the rents received or accrued by us from our tenants to be treated as non-qualifying rent for purposes of the REIT gross income requirements. Nevertheless, there can be no assurance that such restrictions will be effective in ensuring that rents received or accrued by us from our tenants will not be treated as qualifying rent for purposes of REIT qualification requirements.
Dividends payable by REITs do not qualify for the reduced tax rates available for some dividends.
The maximum U.S. federal income tax rate applicable to income from “qualified dividends” payable by U.S. corporations to U.S. stockholders that are individuals, trusts and estates is currently 20%. Dividends payable by REITs, however, generally are not eligible for the reduced rates. However, for taxable years beginning after December 31, 2017 and before January 1, 2026, under the recently enacted Tax Cuts and Jobs Act, noncorporate taxpayers may deduct up to 20% of certain qualified business income, including "qualified REIT dividends" (generally, dividends received by a REIT shareholder that are not
28

designated as capital gain dividends or qualified dividend income), subject to certain limitations, resulting in an effective maximum U.S. federal income tax rate of 29.6% on such income.  Although these rules do not adversely affect the taxation of REITs, the more favorable rates applicable to regular corporate qualified dividends, together with the recently reduced corporate tax rate (currently, 21%), could cause investors who are individuals, trusts and estates to perceive investments in REITs to be relatively less attractive than investments in the stocks of non-REIT corporations that pay dividends, which could adversely affect the value of the stock of REITs, including our stock. Although these rules do not adversely affect the taxation of REITs, the more favorable rates applicable to regular corporate qualified dividends could cause investors who are individuals, trusts and estates to perceive investments in REITs to be relatively less attractive than investments in the stocks of non-REIT corporations that pay dividends, which could adversely affect the value of the stock of REITs, including our stock.
REIT distribution requirements could adversely affect our ability to execute our business plan.
We generally must distribute annually at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains, in order for us to qualify to be taxed as a REIT (assuming that certain other requirements are also satisfied) so that U.S. federal corporate income tax does not apply to earnings that we distribute. To the extent that we satisfy this distribution requirement and qualify for taxation as a REIT but distribute less than 100% of our REIT taxable income, determined without regard to the dividends paid deduction and including any net capital gains, we will be subject to U.S. federal corporate income tax on our undistributed net taxable income. In addition, we will be subject to a 4% nondeductible excise tax if the actual amount that we distribute to our stockholders in a calendar year is less than a minimum amount specified under U.S. federal income tax laws. We intend to make distributions to our stockholders to comply with the REIT requirements of the Code.
Our funds from operations are generated primarily by rents paid under leases with our tenants. From time to time, we may generate taxable income greater than our cash flow as a result of differences in timing between the recognition of taxable income and the actual receipt of cash or the effect of nondeductible capital expenditures, the creation of reserves or required debt or amortization payments. If we do not have other funds available in these situations, we could be required to borrow funds on unfavorable terms, sell assets at disadvantageous prices or distribute amounts that would otherwise be invested in future acquisitions in order to make distributions sufficient to enable us to pay out enough of our taxable income to satisfy the REIT distribution requirement and to avoid being subject to corporate income tax and the 4% excise tax in a particular year. These alternatives could increase our costs or reduce our equity.
Even if we remain qualified as a REIT, we may face other tax liabilities that reduce our cash flow.
Even if we remain qualified for taxation as a REIT, we may be subject to certain U.S. federal, state, and local taxes on our income and assets, including taxes on any undistributed income and state or local income, property and transfer taxes. For example, we may hold some of our assets or conduct certain of our activities through one or more taxable REIT subsidiaries (each, a “TRS”) or other subsidiary corporations that will be subject to U.S. federal, state, and local corporate-level income taxes as regular C corporations. In addition, we may incur a 100% excise tax on transactions with a TRS if they are not conducted on an arm’s-length basis. Any of these taxes would decrease cash available for distribution to our stockholders.
Complying with REIT requirements may cause us to forgo otherwise attractive acquisition opportunities or liquidate otherwise attractive investments.
To qualify as a REIT for U.S. federal income tax purposes, we must on an ongoing basis satisfy tests concerning, among other things, the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of our shares of beneficial interest. We may be required to make distributions to our stockholders at disadvantageous times or when we do not have funds readily available for distribution. Thus, compliance with the REIT requirements may hinder our ability to make certain attractive investments.
Complying with REIT requirements may limit our ability to hedge effectively and may cause us to incur tax liabilities.
The REIT provisions of the Code substantially limit our ability to hedge our assets and liabilities. Income from certain hedging transactions that we may enter into to manage risk of interest rate changes with respect to borrowings made or to be made to acquire or carry real estate assets does not constitute “gross income” for purposes of the 75% or 95% gross income tests that apply to REITs, provided that certain identification requirements are met. For taxable years beginning after December 31, 2015, income from new transactions entered into to hedge the income or loss from prior hedging transactions, where the indebtedness or property which was the subject of the prior hedging transaction was extinguished or disposed of, will not constitute gross income for purposes of the 75% or 95% gross income tests. To the extent that we enter into other types of hedging transactions or fail to properly identify such transaction as a hedge, the income is likely to be treated as non-qualifying income for purposes of both of the gross income tests. As a result of these rules, we may be required to limit our use of advantageous hedging techniques or implement those hedges through a TRS. This could increase the cost of our hedging activities because the TRS may be subject to tax on gains or expose us to greater risks associated with changes in interest rates
29

than we would otherwise want to bear. In addition, losses in the TRS will generally not provide any tax benefit, except that such losses could theoretically be carried back or forward against past or future taxable income in the TRS.
Risks Related to Our Capital Resources and Indebtedness
From time to time, we may have substantial indebtedness and we are able to incur significant additional indebtedness.
As of December 31, 2020, we had approximately $550.0 million of indebtedness, consisting of $300.0 million representing our 5.25% Senior Notes due 2025 (the “Notes”), $200.0 million under our unsecured term loan credit facility (the “Term Loan”) and $50.0 million in borrowings outstanding under our unsecured revolving credit facility (the “New Revolving Facility”). High levels of indebtedness could have one or more of the following adverse consequences, among others: require us to dedicate a substantial portion of our cash flow from operations to make principal and interest payments on our indebtedness, thereby reducing our cash flow available to fund working capital, dividends, capital expenditures and acquisitions and other general corporate purposes; require us to maintain certain debt coverage and other financial ratios at specified levels, thereby reducing our financial flexibility; make it more difficult for us to satisfy our financial obligations, including the Notes and borrowings under the Amended Credit Facility (as defined below); increase our vulnerability to general adverse economic and industry conditions or a downturn in our business; limit, along with the financial and other restrictive covenants in our indebtedness, our ability to borrow additional funds on favorable terms or at all to expand our business or ease liquidity constraints; limit our ability to refinance all or a portion of our indebtedness on or before maturity on the same or more favorable terms or at all; and require us to dispose of one or more of our properties at disadvantageous prices in order to service our indebtedness or to raise funds to pay such indebtedness at maturity.
In addition, failure to satisfy our obligations under the Notes or our other debt or to comply with the financial and other restrictive covenants contained in the indenture governing the Notes or the Amended Credit Agreement (as defined below), could result in an event of default, which could result in all of our debt becoming immediately due and payable and permit certain of our lenders to foreclose on our assets securing such debt. Further, our Amended Credit Agreement and the indenture governing the Notes permit us to incur substantial additional debt, including secured debt, subject to our compliance with certain financial covenants set forth in the Amended Credit Agreement and the indenture governing the Notes. See “Risk Factors - Risks Related to Our Capital Resources and Indebtedness - Covenants in our debt agreements restrict our activities and could adversely affect our business” for a summary of these covenants.
We may be unable to service our indebtedness.
Our ability to make scheduled payments on and to refinance our indebtedness depends on and is subject to our future financial and operating performance, which in turn is affected by general and regional economic, financial, competitive, business and other factors beyond our control, including the availability of financing in the international banking and capital markets. Our business may fail to generate sufficient cash flow from operations or future borrowings may be unavailable to us under the Amended Credit Facility or from other sources in an amount sufficient to enable us to service our debt, to refinance our debt or to fund our other liquidity needs. If we are unable to meet our debt obligations or to fund our other liquidity needs, we will need to restructure or refinance all or a portion of our debt. We may be unable to refinance such debt on commercially reasonable terms or at all. If we were unable to make payments or refinance our debt or obtain new financing under these circumstances, we would have to consider other options, such as asset sales, equity issuances and/or negotiations with our lenders to restructure such debt. The Amended Credit Agreement and the indenture governing the Notes restrict, and market or business conditions may limit our ability to take these actions. Any debt restructuring or refinancing could be at higher interest rates and may require us to comply with more onerous covenants that could further restrict our business operations.
We rely on our subsidiaries for our operating funds.
We conduct our operations through subsidiaries and depend on our subsidiaries for the funds necessary to operate and repay our debt obligations, including funds transfers to us which are necessary to make the payments due under the Notes. While all of our subsidiaries are currently guarantors of the Notes, under certain circumstances, one or more of our subsidiaries may be released from, or may not be required to provide, a guarantee of the Notes, and in such circumstances, will not be responsible for any obligations with respect to the Notes. Each of our subsidiaries is a distinct legal entity and has no obligation, contingent or otherwise, to transfer funds to us. In addition, the ability of our subsidiaries to transfer funds to us could be restricted by the terms of subsequent financings.
Covenants in our debt agreements restrict our activities and could adversely affect our business.
Our debt agreements contain covenants that limit our and our subsidiaries’ ability to engage in various transactions including, as applicable: incurring or guaranteeing additional secured and unsecured debt; creating liens on our and our subsidiaries’ assets; paying dividends or making other distributions on, redeeming or repurchasing capital stock; making investments or other restricted payments; entering into transactions with affiliates; issuing stock of or interests in subsidiaries; engaging in non-healthcare related business activities; creating restrictions on the ability of our subsidiaries to pay distributions
30

or other amounts to us; selling assets; effecting a consolidation or merger or selling all or substantially all of our assets; making acquisitions; and amending certain material agreements, including material leases and debt agreements.
These covenants limit our operational flexibility and could prevent us from taking advantage of business opportunities as they arise, growing our business or competing effectively. The Amended Credit Agreement requires us to comply with financial maintenance covenants to be tested quarterly and also contains customary events of default, including the failure to make timely payments under the Amended Credit Facility or other material indebtedness, failure to satisfy certain covenants (including financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency. We also must maintain total unencumbered assets of at least 150% of our unsecured indebtedness under the indenture governing the Notes. Our ability to meet these requirements may be affected by events beyond our control and, if we fail to do so, we may be unable to obtain waivers from the lenders or amend the covenants.
Increases in interest rates could increase our existing and future debt borrowing costs and adversely affect our stock price.
Certain of our existing debt obligations require interest and related payments to vary with the movement of certain indices, and we may incur additional indebtedness in connection with new credit facilities or financing of acquisitions or development activities. Increased interest rates would increase our interest costs for any new debt and our obligations under our New Revolving Facility and Term Loan, which could make acquisition financings more costly or lower our current period earnings. Rising interest rates could limit our ability to refinance existing debt when it matures or cause us to pay higher interest rates upon refinancing. In addition, interest rate increases could decrease credit access globally, thereby decreasing the amount others are willing to pay for our assets and limiting our ability to reposition our portfolio promptly in response to changes in economic or other conditions. Further, the dividend yield on our common stock, as a percentage of the price of such common stock, will influence the price of such common stock. Thus, an increase in market interest rates may lead prospective purchasers of our common stock to expect a higher dividend yield, which could adversely affect the market price of our common stock.
Our Amended Credit Agreement uses LIBOR as a reference rate for our Term Loan and Revolving Facility, such that the interest rate applicable to such loans may, at our option, be calculated based on LIBOR. In July 2017, the U. K.’s Financial Conduct Authority, which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. In the U.S., it is anticipated that publication of 1-week and 2-month U.S. dollar LIBOR will end on December 31, 2021, with all other U.S. dollar LIBOR tenors ceasing on June 30, 2023. The U.S. Federal Reserve has begun publishing a Secured Overnight Funding Rate (“SOFR”), which is intended to replace U.S. dollar LIBOR, and has proposed a paced market transition plan to SOFR from LIBOR. Organizations are currently working on industry wide and company specific transition plans as it relates to financial and other derivative contracts exposed to LIBOR. Additionally, plans for alternative reference rates for other currencies have also been announced. From time to time, we have material borrowings under our Amended Credit Agreement that are indexed to LIBOR.  We cannot predict how markets will respond to these proposed alternative rates or the effect of any changes to LIBOR or the discontinuation of LIBOR. However, if future rates based upon a successor reference rate such as SOFR (or a new method of calculating LIBOR) are higher than LIBOR rates as currently determined or if our lenders have increased costs due to changes in LIBOR, we may experience increases in interest rates on our variable rate debt, which could adversely impact our interest expense, results of operations and cash flows.
A credit rating downgrade could impair our ability to obtain additional debt financing on favorable terms, if at all, and significantly reduce the trading price of our common stock.
Our credit rating can affect the amount, type and terms of capital financings we obtain. Factors affecting our credit rating include, among others, our financial performance, success in raising sufficient equity capital, adverse changes in our debt and fixed charge coverage ratios, our capital structure, level of indebtedness and future changes in the regulatory framework applicable to our operators and industry. We may be unable to maintain our current credit ratings, and in the event that our current credit ratings deteriorate, a ratings agency downgrades our credit rating or places our rating under watch or review for possible downgrade, we would likely incur higher borrowing costs, which would make it more difficult or expensive to obtain additional financing or refinance existing obligations and commitments and the trading price of our common stock may decline.
Risks Related To Our Common Stock and Organizational Documents
Our charter restricts the ownership and transfer of our outstanding stock, which may have the effect of delaying, deferring or preventing a transaction or change of control of our company.
In order for us to qualify to be taxed as a REIT, not more than 50% in value of our outstanding shares of stock may be owned, beneficially or constructively, by five or fewer individuals at any time during the last half of each taxable year after our first taxable year as a REIT. Additionally, at least 100 persons must beneficially own our stock during at least 335 days of a taxable year (other than our first taxable year as a REIT). Our charter, with certain exceptions, authorizes our board of directors to take such actions as are necessary and desirable to preserve our qualification as a REIT. Our charter also provides that, unless exempted by the board of directors, no person may own more than 9.8% in value or in number of shares, whichever is more restrictive, of the outstanding shares of our common stock, or more than 9.8% in value of the outstanding shares of all classes or
31

series of our stock. The constructive ownership rules are complex and may cause shares of stock owned directly or constructively by a group of related individuals or entities to be constructively owned by one individual or entity. These ownership limits could delay or prevent a transaction or a change in control of us that might involve a premium price for shares of our stock or otherwise be in our stockholders’ best interests. The acquisition of less than 9.8% of our outstanding stock by an individual or entity could cause that individual or entity to own constructively in excess of 9.8% in value of our outstanding stock, and thus violate our charter’s ownership limit. Our charter also prohibits any person from owning shares of our stock that would result in our being “closely held” under Section 856(h) of the Code or otherwise cause us to fail to qualify to be taxed as a REIT. In addition, our charter provides that (i) no person shall beneficially or constructively own shares of stock to the extent such beneficial or constructive ownership of stock would result in us failing to qualify as a “domestically controlled qualified investment entity” within the meaning of Section 897(h) of the Code, and (ii) no person shall beneficially or constructively own shares of stock to the extent such beneficial or constructive ownership would cause us to own, beneficially or constructively, more than a 9.9% interest (as set forth in Section 856(d)(2)(B) of the Code) in a tenant of our real property. Any attempt to own or transfer shares of our stock in violation of these restrictions may result in the transfer being automatically void.
Maryland law and provisions in our charter and bylaws may inhibit our stockholders from realizing a premium on their stock by delaying or preventing takeover attempts by third parties.
Our charter, bylaws and Maryland law contain provisions intended to deter coercive takeovers and inadequate takeover bids and to encourage prospective acquirors to negotiate with our board of directors rather than to attempt a hostile takeover. As currently in effect, our charter and bylaws, among other things, (1) contain transfer and ownership restrictions on the percentage by number and value of outstanding shares of our stock that may be owned or acquired by any stockholder; (2) prohibit stockholders action by non-unanimous written consent; (3) permit the board of directors, without further action of the stockholders, to amend the charter to increase or decrease the aggregate number of authorized shares or the number of shares of any class or series that may be issued; (4) permit the board of directors to classify or reclassify any unissued shares of common or preferred stock and set the preferences, rights and other terms of the classified or reclassified shares; (5) establish certain advance notice procedures for stockholder proposals, and provide procedures for the nomination of candidates for our board of directors; (6) provide that special meetings of stockholders may only be called by the Company or upon written request of 25% of all the votes entitled to be cast at such meeting; (7) provide that a director may only be removed by stockholders for cause and upon the vote of two-thirds of the outstanding shares of common stock; and (8) require supermajority approval to amend or repeal certain charter provisions. In addition, specific anti-takeover provisions of the Maryland General Corporation Law (“MGCL”) could make it more difficult for a third party to attempt a hostile takeover, including:
“business combination” provisions that, subject to limitations, prohibit certain business combinations between us and an “interested stockholder” (defined generally as any person who beneficially owns 10% or more of the voting power of our shares or an affiliate thereof) for five years after the most recent date on which the stockholder becomes an interested stockholder, and thereafter impose special appraisal rights and special stockholder voting requirements on these combinations; and
“control share” provisions that provide that “control shares” of our company (defined as shares which, when aggregated with other shares controlled by the stockholder, entitle the stockholder to exercise one of three increasing ranges of voting power in electing directors) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of “control shares”) have no voting rights except to the extent approved by our stockholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares.
We believe these provisions protect our stockholders from coercive or unfair takeover tactics by requiring potential acquirors to negotiate with our board of directors and by providing our board of directors with more time to assess any acquisition proposal. These provisions are not intended to prevent all takeovers, but they may delay, defer or prevent a change of control transaction even if such transaction involves a premium price for our common stock or our stockholders it is in their best interests. These provisions may also prevent or discourage attempts to remove and replace incumbent directors.
Our bylaws provide that the Circuit Court for Baltimore City, Maryland will be the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees.
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland is the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of us, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee, (iii) any action asserting a claim arising pursuant to any provision of the MGCL, or (iv) any action asserting a claim governed by the internal affairs doctrine, and any of our record or beneficial stockholders who commences such an action shall cooperate in a request that the action be assigned to the Court’s Business & Technology Case Management Program. This exclusive forum provision is intended to apply to claims arising under the MGCL and would not apply to claims brought pursuant to the Exchange Act of
32

1934 or Securities Act of 1933, each as amended, or any other claim for which the federal courts have exclusive jurisdiction. The exclusive forum provision in our bylaws will not relieve us of our duties to comply with the federal securities laws and the rules and regulations thereunder, and our stockholders will not be deemed to have waived our compliance with these laws, rules and regulations.
This exclusive forum provision may limit a stockholder's ability to bring a claim in a judicial forum of its choosing for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. In addition, stockholders who do bring a claim in the Circuit Court for Baltimore City, Maryland could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near Maryland. The Circuit Court for Baltimore City, Maryland may also reach different judgments or results than would other courts, including courts where a stockholder would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. However, the enforceability of similar exclusive forum provisions in other companies' certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find this type of provision and/or the jurisdictional limitation contained therein to be inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings. If a court were to find the exclusive forum provision contained in our bylaws to be inapplicable or unenforceable in an action, we might incur additional costs associated with resolving such action in other jurisdictions.
General Risk Factors
We rely on information technology in our operations, and any material failure, inadequacy, interruption or security failure of that technology could harm our business.
We rely on information technology networks and systems, including the internet, to process, transmit and store electronic information, and to manage or support our business processes, including financial transactions and records, and maintaining personal information and tenant and lease data. We purchase some of our information technology from vendors, on whom our systems depend. We rely on commercially available systems, software, tools and monitoring to provide security for the processing, transmission and storage of confidential tenant and customer data, including financial account information. Although we have taken steps to protect the security of our information systems, we have, from time to time, experienced threats to our data and systems, including malware and computer virus attacks and it is possible that in the future our safety and security measures will not prevent the systems’ improper functioning or damage, or the improper access or disclosure of personally identifiable information such as in the event of cyber-attacks. In addition, due to the fast pace and unpredictability of cyber threats, long-term implementation plans designed to address cybersecurity risks become obsolete quickly.
Security breaches, including physical or electronic break-ins, computer viruses, malware, works, attacks by hackers or foreign governments, disruptions from unauthorized access and tampering (including through social engineering such as phishing attacks), coordinated denial-of-service attacks, impersonation of authorized users and similar breaches, can create system disruptions, shutdowns or result in a loss of company assets or unauthorized disclosure of confidential information. The risk of security breaches has generally increased as the number, intensity and sophistication of attacks and intrusions from around the world have increased. In some cases, it may be difficult to anticipate or immediately detect such incidents and the damage they cause. In addition, our technology infrastructure and information systems are vulnerable to damage or interruption from natural disasters, power loss and telecommunications failures. Failure to maintain proper function, security and availability of our information systems and the data maintained in those systems could interrupt our operations, damage our reputation, subject us to liability claims or regulatory penalties and could have a material adverse effect on our business, financial condition and results of operations.
We have and may in the future incur impairment charges, which could negatively impact our results of operations.
At each reporting period, we evaluate our real estate investments and other assets for impairment indicators whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The existence of impairment indicators is based on factors such as market conditions, operator performance and legal structure. If we determine that an impairment has occurred, we are required to adjust the net carrying value of the asset, which could have a material adverse effect on our results of operations in the period in which the write-off occurs. For example, in the three months ended September 30, 2019, we recorded impairment charges of approximately $16.7 million, resulting in a net loss of $10.1 million for the quarter. Such impairment charges may make it more difficult for us to meet the financial ratios in our Amended Credit Agreement and may reduce the borrowing base available to us under our Revolving Facility, which may reduce the amounts of cash we would otherwise have available to pay expenses, service other indebtedness and operate our business.
Environmental, social and governance matters may cause us to incur additional costs, make personnel changes, and affect the attractiveness of our stock to investors.
Shareholder, public and governmental expectations have been increasing with respect to corporate responsibility, sustainability, diversity and inclusion and related environmental, social and governance (collectively “ESG”) matters. Shareholder advisory services and other organizations have developed and publish, and others may in the future develop and
33

publish, rating systems and other scoring and reporting mechanisms to evaluate and compare the ESG performance of our Company and others. These ratings systems frequently change, and scores are often based on a relative ranking which may cause a company’s score to deteriorate if peer companies’ rankings improve. Keeping up with such changes may divert management’s time and attention from other business priorities. In addition, current shareholders and prospective investors may use these ratings and/or their own internal ESG benchmarks to determine whether and to what extent they may choose to invest in our securities, engage with us to advocate for improved ESG performance or disclosure, make voting decisions as shareholders, or take other actions to hold us and our board of directors accountable with respect to ESG matters.
Some legislatures, government agencies and listing exchanges have mandated or proposed, and others may in the future further mandate, certain ESG disclosure or performance. For example, board diversity and inclusion is an ESG topic that is receiving heightened attention from lawmakers and listing exchanges. The State of California, where we currently maintain our principal executive offices, has enacted laws requiring companies to meet stated gender and diversity requirements on their boards of directors by specific deadlines. In addition, the Nasdaq Stock Market LLC, where our common stock is currently listed, has filed a proposal with the SEC that, if approved, would require most Nasdaq-listed companies to meet specified board diversity requirements within a defined compliance period and face potential delisting if they do not explain any failure to meet the requirements. If we are unable to recruit, attract and/or retain qualified members of our board of directors to maintain compliance with the diversity requirements of applicable mandates within the prescribed timelines, we could be exposed to costly fines and penalties. We may also face reputational damage in the event our corporate responsibility initiatives or objectives, including with respect to board diversity, do not meet the standards or expectations of shareholders, prospective investors, lawmakers, listing exchanges or other constituencies, or if we are unable to achieve acceptable ESG ratings from third party rating services. Failure to comply with ESG-related laws, exchange policies or stakeholder expectations could materially and adversely impact the value of our stock and related cost of capital, and limit our ability to fund future growth.
We cannot assure you of our ability to pay dividends in the future.
We expect to make quarterly dividend payments in cash with the annual dividend amount no less than 90% of our annual REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains. Our ability to pay dividends may be adversely affected by a number of factors, including the risk factors described in this annual report. Dividends are authorized by our board of directors and declared by us based upon a number of factors, including but not limited to actual results of operations, restrictions under Maryland law or applicable debt covenants, our financial condition, our taxable income, the annual distribution requirements under the REIT provisions of the Code and our operating expenses. There is no assurance that our operating results will allow for specified levels of cash dividends or year-to-year increases in the future.
Furthermore, while we are required to pay dividends in order to maintain our REIT status (as described under “Risks Related to Our Status as a REIT - REIT distribution requirements could adversely affect our ability to execute our business plan”), we may elect not to maintain our REIT status and discontinue paying dividends. Even if we do elect to maintain our REIT status, after completing various procedural steps, we may elect to comply with the applicable distribution requirements by distributing, under certain circumstances, a portion of the required amount in the form of shares of our common stock in lieu of cash. Either of these actions could negatively affect our business and financial condition as well as the market price of our common stock.
ITEM 1B.    Unresolved Staff Comments
None.
34

ITEM 2. Properties

As of December 31, 2020, all of our properties are leased under long-term, triple-net leases. The following table displays the expiration of the annualized contractual cash rental income under our lease agreements as of December 31, 2020 by year and total investment (dollars in thousands) and, in each case, without giving effect to any renewal or purchase options:

Lease
MaturityPercent of TotalPercent of
Year
Investment(1)
Investment
Rent(1)
Total Rent
2026$58,157 3.3 %$5,241 3.0 %
202746,801 2.6 %4,897 2.8 %
202868,193 3.8 %7,573 4.4 %
2029114,040 6.4 %8,624 5.0 %
2030207,160 11.6 %18,925 10.9 %
2031558,768 31.3 %53,356 30.8 %
2032200,931 11.2 %19,495 11.2 %
2033214,247 12.0 %23,147 13.3 %
2034318,373 17.8 %32,173 18.6 %
Total$1,786,670 100.0 %$173,431 100.0 %
 (1)    Amounts exclude our one mezzanine loan receivable and properties classified as held for sale as of December 31, 2020.
See the “Tenant Purchase Options” section of Note 3, Real Estate Investments, Net in the Notes to consolidated financial statements for additional information on leases subject to purchase options.
The information set forth under “Portfolio Summary” in Item 1 of this Annual Report on Form 10-K is incorporated by reference herein.
ITEM  3.    Legal Proceedings
The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, but none of the Company or any of its subsidiaries is, and none of their respective properties are, the subject of any material legal proceedings. Claims and lawsuits may include matters involving general or professional liability asserted against our tenants, which are the responsibility of our tenants and for which we are entitled to be indemnified by our tenants under the insurance and indemnification provisions in the applicable leases.
ITEM  4.    Mine Safety Disclosures
None.
PART II
ITEM  5.    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Common Equity
Our common stock is listed on the Nasdaq Global Select Market under the symbol “CTRE.”
At February 9, 2021, we had approximately 43 stockholders of record.

To maintain REIT status, we are required each year to distribute to stockholders at least 90% of our annual REIT taxable income after certain adjustments. All distributions will be made by us at the discretion of our board of directors and will depend on our financial position, results of operations, cash flows, capital requirements, debt covenants (which include limits on distributions by us), applicable law, and other factors as our board of directors deems relevant. For example, while the Notes and our Amended Credit Agreement permit us to declare and pay any dividend or make any distribution that is necessary to maintain our REIT status, those distributions are subject to certain financial tests under the indenture governing the Notes, and therefore, the amount of cash distributions we can make to our stockholders may be limited.

35

Distributions with respect to our common stock can be characterized for federal income tax purposes as taxable ordinary dividends, nondividend distributions or a combination thereof. Following is the characterization of our annual cash dividends on common stock:
 
Year Ended December 31,
Common Stock20202019
Ordinary dividend$0.6435 $0.8120 
Non-dividend distributions0.1065 0.0880 
Total taxable distribution0.7500 0.9000 
Distributions allocated to subsequent tax year(1)
0.2500 — 
Total distributions declared$1.0000 $0.9000 
(1) Because our aggregate 2020 cash distributions exceeded our 2020 earnings and profits, the cash distribution declared in the fourth quarter of 2020 and paid in January 2021, of $0.25 per share, will be treated as a 2021 distribution for federal income tax purposes.
Unregistered Sales of Equity Securities

During the three months ended December 31, 2020, we acquired shares of our common stock held by an employee who tendered shares to satisfy tax withholding obligations upon the vesting of previously issued restricted stock awards. Specifically, the number of shares of common stock acquired from the employee and the average prices paid per share for each month in the fourth quarter ended December 31, 2020 are as follows:
PeriodTotal Number of Shares PurchasedAverage Price Paid per Share
October 1 - October 31, 2020533 $17.10 
November 1 - November 30, 2020— $— 
December 1 - December 31, 2020— $— 
Total533 $17.10 
On March 20, 2020, our board of directors authorized a share repurchase program to repurchase up to $150.0 million of outstanding shares of our common stock (the “Repurchase Program”). Repurchases under the Repurchase Program, which expires on March 31, 2023, may be made through open market purchases, privately negotiated transactions, structured or derivative transactions, including accelerated share repurchase transactions, or other methods of acquiring shares, in each case subject to market conditions and at such times as shall be permitted by applicable securities laws and determined by management. Repurchases under the Repurchase Program may also be made pursuant to a plan adopted under Rule 10b5-1 promulgated under the Exchange Act. We expect to finance any share repurchases under the Repurchase Program using available cash and may also use short-term borrowings under the Revolving Facility. We did not repurchase any shares of common stock under the Repurchase Program during the year ended December 31, 2020. The Repurchase Program may be modified, discontinued or suspended at any time.
36


Stock Price Performance Graph
The graph below compares the cumulative total return of our common stock, the S&P 500 Index, the S&P 500 REIT Index, the RMS (MSCI U.S. REIT Total Return Index) and the SNL U.S. REIT Healthcare Index for the period from December 31, 2015 to December 31, 2020. Total cumulative return is based on a $100 investment in CareTrust REIT common stock and in each of the indices at the market close on December 31, 2015 and assumes quarterly reinvestment of dividends before consideration of income taxes. Stockholder returns over the indicated periods should not be considered indicative of future stock prices or stockholder returns.
 COMPARISON OF CUMULATIVE TOTAL RETURN
AMONG S&P 500, S&P 500 REIT INDEX, RMS, SNL US REIT HEALTHCARE AND CARETRUST REIT, INC.
RATE OF RETURN TREND COMPARISON
DECEMBER 31, 2015 - DECEMBER 31, 2020
(DECEMBER 31, 2015 = $100)
Stock Price Performance Graph Total Return
The stock performance graph shall not be deemed soliciting material or to be filed with the SEC or subject to Regulation 14A or 14C under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or to the liabilities of Section 18 of the Exchange Act, nor shall it be incorporated by reference into any past or future filing under the Securities Act of 1933 or the Exchange Act, except to the extent we specifically request that it be treated as soliciting material or specifically incorporate it by reference into a filing under the Securities Act of 1933 or the Exchange Act
ctre-20201231_g1.jpg
December 31,
201520162017201820192020
CareTrust REIT Inc.$100.00 $146.86 $167.48 $193.93 $225.46 $256.27 
S&P 500$100.00 $111.96 $136.40 $130.42 $171.49 $203.04 
RMS$100.00 $108.60 $114.11 $108.89 $137.03 $126.65 
SNL US REIT Healthcare$100.00 $105.24 $106.44 $114.12 $138.67 $129.69 
S&P 500 Real Estate$100.00 $103.39 $114.61 $112.06 $144.58 $141.44 
37


ITEM 6.    Selected Financial Data
The following table sets forth selected financial data and other data for our company on a historical basis. The following data should be read in conjunction with our audited consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations included elsewhere in this Annual Report on Form 10-K. Our historical operating results may not be comparable to our future operating results. The comparability of the selected financial data presented below is significantly affected by our acquisitions and new investments in each of the years presented. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
 
 
As of or For the Year Ended December 31, 
 20202019201820172016
(dollars in thousands, except per share amounts)
Income statement data:   
Total revenues$178,332 $163,401 $156,941 $132,982 $104,679 
Income before provision for income taxes80,867 46,359 57,923 25,874 29,353 
Net income80,867 46,359 57,923 25,874 29,353 
Net income per share, basic0.85 0.49 0.73 0.35 0.52 
Net income per share, diluted0.85 0.49 0.72 0.35 0.52 
Balance sheet data:
Total assets$1,503,559 $1,518,861 $1,291,762 $1,184,986 $925,358 
Senior unsecured notes payable, net296,669 295,911 295,153 294,395 255,294 
Senior unsecured term loan, net198,925 198,713 99,612 99,517 99,422 
Unsecured revolving credit facility50,000 60,000 95,000 165,000 95,000 
Total equity914,142 927,591 768,247 594,617 452,430 
Other financial data:
Dividends declared per common share$1.00 $0.90 $0.82 $0.74 $0.68 
FFO(1)133,617113,029101,536 62,275 61,483 
FAD(1)139,280117,751104,989 66,406 65,118 
(1)    We believe that net income, as defined by U.S. generally accepted accounting principles (“GAAP”), is the most appropriate earnings measure. We also believe that Funds From Operations (“FFO”), as defined by the National Association of Real Estate Investment Trusts (“NAREIT”), and Funds Available for Distribution (“FAD”) are important non-GAAP supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation except on land, such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative. Thus, NAREIT created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP. FFO is defined as net income computed in accordance with GAAP, excluding gains or losses from real estate dispositions, plus real estate related depreciation and amortization and real estate impairment charges. We define FAD as FFO excluding noncash income and expenses such as amortization of stock-based compensation, amortization of deferred financing costs and the effect of straight-line rent. We believe that the use of FFO and FAD, combined with the required GAAP presentations, improves the understanding of operating results of REITs among investors and makes comparisons of operating results among such companies more meaningful. We consider FFO and FAD to be useful measures for reviewing comparative operating and financial performance because, by excluding gains or losses from real estate dispositions, impairment charges and real estate depreciation and amortization, and, for FAD, by excluding noncash income and expenses such as amortization of stock-based compensation, amortization of deferred financing costs, and the effect of straight-line rent, FFO and FAD can help investors compare our operating performance between periods and to other REITs. However, our computation of FFO and FAD may not be comparable to FFO and FAD reported by other REITs that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define FAD differently than we do. Further, FFO and FAD do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating our liquidity or operating performance.
38

The following table reconciles our calculations of FFO and FAD for the five years ended December 31, 2020, 2019, 2018, 2017 and 2016 to net income, the most directly comparable financial measure according to GAAP, for the same periods:
 
For the Year Ended December 31,
 20202019201820172016
(dollars in thousands)
Net income$80,867 $46,359 $57,923 $25,874 $29,353 
Real estate related depreciation and amortization52,713 51,755 45,664 39,049 31,865 
Loss (gain) on sale of real estate37 (1,777)(2,051)— 265 
Impairment of real estate investments— 16,692 — 890 — 
Gain on disposition of other real estate investment— — — (3,538)— 
FFO133,617 113,029 101,536 62,275 61,483 
Amortization of deferred financing costs1,950 2,003 1,938 2,059 2,239 
Amortization of stock-based compensation3,790 4,104 3,848 2,416 1,546 
Straight-line rental income(77)(1,385)(2,333)(344)(150)
FAD$139,280 $117,751 $104,989 $66,406 $65,118 
 

ITEM 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
The discussion below contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those which are discussed in the section titled “Risk Factors.” Also see “Statement Regarding Forward-Looking Statements” preceding Part I.
The following discussion and analysis should be read in conjunction with the “Selected Financial Data” above and our accompanying consolidated financial statements and the notes thereto.
Our Management’s Discussion and Analysis of Financial Condition and Results of Operations is organized as follows:
Overview
Recent Developments
Results of Operations
Liquidity and Capital Resources
Obligations and Commitments
Capital Expenditures
Critical Accounting Policies
Impact of Inflation
Off-Balance Sheet Arrangements
Overview
CareTrust REIT is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. As of December 31, 2020, CareTrust REIT’s real estate portfolio consisted of 218 skilled nursing facilities (“SNFs”), multi-service campuses and assisted living facilities (“ALFs”) consisting of 22,466 operational beds and units located in 28 states with the highest concentration of properties by rental income located in California, Texas, Louisiana, Idaho and Arizona. As of December 31, 2020, we also had other real estate investments consisting of one mezzanine loan receivable with a carrying value of $15.0 million.
39

Recent Developments
COVID-19
The COVID-19 pandemic has led governments and other authorities around the world, including federal, state and local authorities in the United States, to impose measures intended to reduce its spread, including restrictions on freedom of movement and business operations such as travel bans, border closings, business limitations and closures (subject to exceptions for essential operations and businesses), quarantines and shelter-in-place orders. Although some of these governmental restrictions have since been lifted or scaled back, resurgences of COVID-19 and the emergence of new variants thereof have resulted in the reimposition of certain restrictions and may lead to other restrictions being implemented in response to efforts to reduce the spread of COVID-19 and its variants. Given the dynamic nature of these circumstances and the related adverse impact these restrictions have had, and may continue to have, on the economy generally, our business, results of operations and financial condition may be adversely impacted by the COVID-19 pandemic.
Tenants operating our properties pursuant to triple-net master leases have been adversely impacted, and we expect that they will continue to be adversely impacted, by the COVID-19 pandemic. Our tenants are experiencing increased operating costs as a result of actions they are taking to prevent or mitigate the outbreak or spread of COVID-19 at their facilities, including in connection with their implementation of safety protocols and procedures, the cost of increased purchases of personal protective equipment, the costs of mandated testing and other regulatory requirements, and increased staffing costs. To assist and protect our tenants and their residents, patients and staffs, we employed our scale and purchasing power to procure approximately $1.2 million of then-scarce personal protective equipment (“PPE”) from March 27, 2020 to December 31, 2020, and offered it to our tenants at our volume-discounted cost. This not only enabled them to obtain critical PPE at a time when its availability was limited to smaller purchasers, it also enabled them to benefit from the cost efficiencies of our bulk order. Tenants who received PPE from us have fully reimbursed the discounted cost thereof to us as of December 31, 2020.
At a portfolio wide level, occupancy levels at our seniors housing facilities have remained relatively stable from the onset of the COVID-19 pandemic through the third quarter of 2020, but began to decline slightly in the fourth quarter of 2020, while occupancy levels at our skilled nursing facilities (“SNFs”), which declined at the onset of the COVID-19 pandemic, continued to decline during the three months ended December 31, 2020 compared to occupancy levels in the third quarter of 2020, and may continue to decline primarily due to, among other things, (i) state mandated temporary suspensions on new admissions during COVID-19 outbreaks, (ii) with respect to our SNFs, governmental restrictions that require the temporary deferral of elective surgeries in referring hospitals, (iii) with respect to our SNFs, the imposition of strict visitation policies that may deter prospective patients from seeking admission, and (iv) with respect to our seniors housing properties, declines in inquiries and tours, deferred move-ins and increased move-outs due to concerns about possible COVID-19 outbreaks. Beginning in early 2020, the federal government temporarily suspended the three-day hospital stay requirement for a patient’s Medicare benefits to refresh. Providers can now “skill in place,” eliminating the risk of transferring the patient to the hospital. Because of this temporary rule change, skilled mix in some facilities has continued to increase during the three months ended December 31, 2020, compared to the third quarter of 2020, while overall occupancy has declined. An increase in skilled mix could, but may not necessarily, offset some or all of the adverse financial impact to the operator of the SNF from a decline in occupancy.
The higher operating costs affecting our tenants, and the impact of lower occupancy levels, have adversely impacted and may continue to adversely impact the ability of our tenants to satisfy their rental obligations to us in full or on a timely basis. Two SNF tenants proposed rent deferrals shortly after the pandemic was declared; however, after undergoing a financial and operating performance review, and considering the impact of stimulus funding, both tenants determined that no rent deferral or other assistance was necessary. One seniors housing tenant proposed partial rent relief, and in the fourth quarter of 2020 the five facilities operated by the tenant were transitioned to another operator with whom we had an existing landlord-tenant relationship, with all outstanding rent paid in full upon transition. While we have not seen a need to grant any rent relief to any tenant to date, future adverse changes to tenants’ operating fundamentals, or a reduction in or discontinuation of government support, could change our expectations. Approximately 100% of our contractual rent obligations due for January 2021 have been collected from our tenants before considering any cash deposits on-hand from which we may offset any shortfalls in rent received. Additionally, all of our outstanding mortgage loans receivable were repaid during the year ended December 31, 2020, except for one mezzanine loan entered into during the fourth quarter of 2020 which is current but not yet due.
The following relief programs enacted by the government have provided, and we expect will continue to provide some benefits to our tenants subject to the programs’ respective terms and conditions, including, but not limited to, attestation, recordkeeping and reporting requirements to Department of Health and Human Services (“HHS”):
40

The Families First Coronavirus Response Act (“Families First Act”) - Under the Families First Act, a temporary 6.2% increase in Federal Medical Assistance Percentages (“FMAP”) was approved retroactive to January 1, 2020, and several states have directed FMAP funds to SNFs, including some of our tenants.
The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) - Under the CARES Act, a substantial number of our tenants have received, or are expected to receive, assistance from a relief fund in excess of $100 billion (such funds, the “Provider Relief Funds”) provided for eligible health care providers, which includes operators of SNFs. Additionally, a Payroll Protection Program was established under the CARES Act to provide Small Business Administration loans to businesses with fewer than 500 employees that may be partially forgivable. The CARES Act also includes a temporary suspension from May 1, 2020 through March 31, 2021 of a 2% Medicare sequestration cut, and a deferral of the employer’s Social Security remittances through December 31, 2020 with a repayment period through December 31, 2021.
On December 27, 2020, the President signed a stimulus package which includes two important provisions impacting the Provider Relief Funds for those recipients that accepted one or more payments exceeding $10,000 in the aggregate. Recipients of relief funds will be required to report their use of funds by submitting healthcare related expenses attributable to COVID-19 that another source has not reimbursed and lost revenues, up to the amount of difference between such provider’s budgeted revenue and actual revenue if such budgeted revenue had been established and approved prior to March 27, 2020 or by comparing year-over-year revenue. The new stimulus package allows the parent organization to allocate all or any portion of such reimbursement among the subsidiary eligible health care providers of the parent organization. Under the current rules, recipients of Provider Relief Funds have until June 30, 2021 to expend relief funds. Any funds received in excess of expenses attributable to COVID-19 and the recipient’s lost revenue, as described above, will be required to be returned. The estimated federal and state COVID-19-related relief approved, received and retained to date by our operators, as reported by our operators, is approximately $150.8 million. At December 31, 2020, two of our operators who have received Provider Relief Funds have disclosed that they have returned, or plan to return, all or a portion of the Provider Relief Funds issued to them.
In July 2020, the federal government announced that it would send point-of-care testing supplies for COVID-19 to all SNFs in the country. In connection with the initiatives discussed above, the federal government is requiring that all SNFs in states with a 5% positivity rate or greater test all SNF staff each week. The new testing mandate has resulted in higher operating costs when the amount of tests received does not cover the amount of tests required by each facility.
In December 2020, the U.S. Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of COVID-19 which allows distribution in the United States, followed by a second vaccine in the same month. The Centers for Disease Control and Prevention recommends that health care workers, long-term care workers and residents of long-term care facilities should be among the first to receive the vaccine. As of February 10, 2021, based on information provided by operators who have reported such information to us, the majority of our operators’ residents have received the first dose of the vaccine, while less than half of such operators’ staff have been vaccinated.
The duration and extent of the COVID-19 pandemic’s effect on our operational and financial performance, and the operational and financial performance of our tenants, will depend on future developments, which are highly uncertain and cannot be predicted at this time, including new information which may emerge concerning the severity of COVID-19, timing of vaccine rollouts, public acceptance and usage of vaccines and the effectiveness of vaccines in limiting the spread of COVID-19 and its variants, actions taken to contain the spread of COVID-19, resurgences of COVID-19 and its variants that may continue to occur, and how quickly and to what extent normal economic and operating conditions can resume. The adverse impact of the COVID-19 pandemic on our business, results of operations and financial condition could be material.
Portfolio Changes
Twenty/20 Lease Termination and New Noble Master Lease
On December 1, 2020, five assisted living facilities in Virginia operated by Twenty/20 Management, Inc. (“Twenty/20”) were transferred to affiliates of Noble Senior Services (“Noble”). In connection with the transfer, we entered into a new triple-net master lease with Noble. The new lease has a remaining initial term of approximately 14 years, with two five-year renewal options and CPI-based rent escalators. Initial annual cash rent under the new lease is approximately $3.2 million.

41

Asset Sales and Assets Held for Sale
On February 14, 2020, we closed on the sale of six skilled nursing facilities formerly operated by affiliates of Metron Integrated Health Systems (“Metron”). In connection with the sale for $36.0 million, we received $3.5 million in cash and provided subsidiaries of Cascade Capital Group, LLC (“Cascade”), the purchaser of the properties, with a short-term mortgage loan secured by these properties for $32.4 million. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In connection with the sale, we recognized a loss of approximately $0.1 million during the three months ended March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between us and a third-party institutional lender as co-lenders, pursuant to which we received $18.9 million in cash and a new mortgage loan for $13.9 million. The new mortgage loan with Cascade was secured by the same six skilled nursing facilities purchased by Cascade and was for a combined principal amount of $33.9 million, with our $13.9 million portion of the indebtedness initially bearing interest at a variable rate equal to LIBOR plus 4.00%, subject to a LIBOR floor of 1.75%. The new mortgage loan had a maturity date of April 29, 2022 and included two six-month extension options. In July 2020, prepayment for the mortgage loan of $13.9 million and accrued interest was received in full by us.
On November 1, 2020, we sold our one remaining owned and operated independent living facility consisting of 168 units located in Texas with an aggregate carrying value of $4.2 million for gross proceeds of $4.5 million. In connection with the sale, we recognized a gain of $20,000.
During the fourth quarter of 2020, we met the criteria to classify one skilled nursing facility operated by affiliates of Five Oaks as held for sale. As of December 31, 2020, the property continued to be held for sale and the carrying value of $7.2 million is primarily comprised of real estate assets. In February 2021, the property was sold. See Note 13, Subsequent Events, for further detail.

At-The-Market Offering of Common Stock
On March 10, 2020, we entered into a new equity distribution agreement to issue and sell, from time to time, up to $500.0 million in aggregate offering price of our common stock through an “at-the-market” equity offering program (the “New ATM Program”). In connection with the entry into the equity distribution agreement and the commencement of the New ATM Program, our “at-the-market” equity offering program pursuant to our prior equity distribution agreement, dated as of March 4, 2019, was terminated (the “Prior ATM Program”). There was no New ATM Program or Prior ATM Program activity (or activity under any predecessor at-the-market equity offering programs) during 2020.
As of December 31, 2020, we had $500.0 million available for future issuances under the New ATM Program. See  Liquidity and Capital Resources for additional information.
Share Repurchase Program
On March 20, 2020, our board of directors authorized a share repurchase program to repurchase up to $150.0 million of outstanding shares of our common stock (the “Repurchase Program”). Repurchases under the Repurchase Program, which expires on March 31, 2023, may be made through open market purchases, privately negotiated transactions, structured or derivative transactions, including accelerated share repurchase transactions, or other methods of acquiring shares, in each case subject to market conditions and at such times as shall be permitted by applicable securities laws and determined by management. Repurchases under the Repurchase Program may also be made pursuant to a plan adopted under Rule 10b5-1 promulgated under the Exchange Act. We expect to finance any share repurchases under the Repurchase Program using available cash and may also use short-term borrowings under the Revolving Facility. We did not repurchase any shares of common stock under the Repurchase Program during the year ended December 31, 2020. The Repurchase Program may be modified, discontinued or suspended at any time.
Recent Investments
From January 1, 2020 through February 10, 2021, we acquired six skilled nursing facilities, one multi-service campus and one assisted living facility for approximately $89.8 million, which includes capitalized acquisition costs. These acquisitions are expected to generate initial annual cash revenues of approximately $7.6 million and an initial blended yield of approximately 8.5%. See Note 3, Real Estate Investments, Net in the Notes to consolidated financial statements for additional information.
In November 2020, we provided Next VA Star Realty Holdings, LLC a mezzanine loan for nine skilled nursing facilities secured by membership interests in affiliates of Next VA Star Realty Holdings, LLC for approximately $15.0 million, at an annual fixed interest rate of 12%. The loan requires monthly interest payments, is set to mature on November 30, 2025 and may (subject to certain restrictions) be prepaid before the maturity date if paid in full and for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments equal to 24 months (less the amount of monthly interest payments made by the borrower through the date of the prepayment).

42

Results of Operations

Operating Results
Our primary business consists of acquiring, developing, financing and owning real property to be leased to third party tenants in the healthcare sector.
Year Ended December 31, 2020 Compared to Year Ended December 31, 2019  
 Year Ended December 31,Increase
(Decrease)
Percentage
Difference
 20202019
 (dollars in thousands)
Revenues:
Rental income$173,612 $155,667 $17,945 12 %
Independent living facilities2,077 3,389 (1,312)(39)%
Interest and other income2,643 4,345 (1,702)(39)%
Expenses:
Depreciation and amortization52,760 51,822 938 %
Interest expense23,661 28,125 (4,464)(16)%
Property taxes2,836 3,048 (212)(7)%
Independent living facilities 1,869 2,898 (1,029)(36)%
Impairment of real estate investments— 16,692 (16,692)(100)%
Provision for loan losses— 1,076 (1,076)(100)%
General and administrative16,302 15,158 1,144 %
Other (loss) income:
(Loss) gain on sale of real estate(37)1,777 (1,814)(102)%
Rental income. Rental income was $173.6 million for the year ended December 31, 2020 compared to $155.7 million for the year ended December 31, 2019. The $17.9 million, or 12%, increase in rental income is primarily due to $12.9 million from real estate investments made after January 1, 2019, a $11.7 million reversal for collectibility of rental income during the year ended December 31, 2019, $1.8 million from increases in rental rates for our existing tenants, $1.2 million of lease termination revenue, $1.0 million from recovery of previously reversed rent, and $0.3 million increase in tenant reimbursements, partially offset by a $6.2 million decrease in rental income due to the disposal of assets in September 2019 and February 2020, a $4.4 million decrease in cash rents due to lease amendments and $0.4 million decrease from replacing existing tenants during the prior year.
Independent living facilities. Revenues for the ILFs that we owned and operated was $2.1 million for the year ended December 31, 2020 compared to $3.4 million for the year ended December 31, 2019. The $1.3 million, or 39%, decrease in ILF revenues is primarily due to a reduction in revenue of $1.5 million related to the sale of one ILF to a third party and the lease of a second ILF to Ensign concurrently with the Pennant Spin during the fourth quarter ended December 31, 2019, partially offset by a $0.2 million increase in revenue for our remaining ILF, due to occupancy increases, through the date of sale on November 1, 2020. Expenses for the ILFs were $1.9 million for the year ended December 31, 2020 compared to $2.9 million for the year ended December 31, 2019. The $1.0 million, or 36%, decrease in expenses was primarily for the same reasons indicated for the decrease in revenues.
Interest and other income. Interest and other income decreased $1.7 million, or 39%, for the year ended December 31, 2020 to $2.6 million compared to $4.3 million for the year ended December 31, 2019. The decrease was primarily due to a decrease in preferred return related to the repayment of two preferred equity investments in June 2019 and January 2020, respectively, of $1.3 million and a decrease in interest income of $1.6 million due to the repayment of mortgage loans receivable by Covenant Care in August 2019, Providence Group in December 2019, Manteca in May 2020 and CommuniCare in May 2020, partially offset by approximately $1.2 million of interest income related to our mortgage and other loans receivable that we provided to Manteca in July 2019, CommuniCare in September 2019, Cascade in February 2020 and a mezzanine loan to Next VA Star Realty Holdings, LLC in November 2020. See Note 4, Other Real Estate Investments, Net.
Depreciation and amortization. Depreciation and amortization expense increased $0.9 million, or 2%, for the year ended December 31, 2020 to $52.8 million compared to $51.8 million for the year ended December 31, 2019. The $0.9 million increase was primarily due to depreciation and amortization of $3.4 million related to new real estate investments made after
43

January 1, 2019, partially offset by $2.0 million of depreciation related to the disposal of assets and $0.5 million due to assets becoming fully depreciated during the year ended December 31, 2020.
Interest expense. Interest expense decreased $4.5 million, or 16%, for the year ended December 31, 2020 to $23.7 million compared to $28.1 million for the year ended December 31, 2019 due to a lower weighted average debt balance of approximately $18.0 million and lower weighted average interest rates of approximately 0.7%.
Property taxes. Property taxes decreased $0.2 million, or 7%, for the year ended December 31, 2020 compared to December 31, 2019. The decrease was primarily due to $1.0 million of property taxes related to the disposal of assets and the transfer of certain properties to new operators in the year ended December 31, 2020 that make direct tax payments, partially offset by property taxes of $0.8 million due to new real estate investments made after January 1, 2019.
Impairment of real estate investments. On September 1, 2019, we sold three of the seven skilled nursing properties in Ohio operated by Trillium for a purchase price of $28.0 million. Prior to the disposition, we recorded an impairment of approximately $7.8 million during the three months ended September 30, 2019. Additionally, during the three months ended September 30, 2019, we met the criteria to classify six skilled nursing facilities operated by Metron as held for sale, which resulted in an impairment expense of approximately $8.8 million to reduce the carrying value to fair value less costs to sell the facilities. There was no impairment of real estate investments during the year ended December 31, 2020.
Provision for loan losses. During the year ended December 31, 2019, we determined the remaining contractual obligations under the bridge loan agreement to Priority Life Care, LLC (“Priority”) were not collectible and recorded a $1.1 million provision for loan losses. There was no provision for loan losses during the year ended December 31, 2020.
General and administrative expense. General and administrative expense increased $1.1 million, or 8%, for the year ended December 31, 2020 to $16.3 million compared to $15.2 million for the year ended December 31, 2019. The increase is primarily related to higher cash wages of $1.0 million, an increase of $0.4 million in state franchise tax and a $0.2 million increase in due diligence costs, partially offset by a decrease of $0.3 million related to stock-based compensation and $0.1 million related to other corporate expenses.
Gain on sale of real estate. During the year ended December 31, 2020, we recorded a $0.1 million loss on sale of real estate related to the sale of six skilled nursing facilities and a $20,000 gain on sale of real estate related to the sale of our last remaining owned and operated ILF. During the year ended December 31, 2019, we recorded a $1.6 million gain on sale of real estate related to the sale of one independent living facility and a $0.2 million gain on sale of real estate related to the sale of three skilled nursing facilities.

Year Ended December 31, 2019 Compared to Year Ended December 31, 2018
For discussion related to the results of operations and changes in financial condition for fiscal 2019 compared to fiscal 2018, refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our fiscal 2019 Annual Report on Form 10-K, which was filed with the SEC on February 20, 2020.
Liquidity and Capital Resources
To qualify as a REIT for federal income tax purposes, we are required to distribute at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains, to our stockholders on an annual basis. Accordingly, we intend to make, but are not contractually bound to make, regular quarterly dividends to common stockholders from cash flow from operating activities. All such dividends are at the discretion of our board of directors.
 As of December 31, 2020, we had cash and cash equivalents of $18.9 million.
During the year ended December 31, 2019, we sold 2.5 million shares of common stock under our predecessor ATM Program for gross proceeds of $47.9 million. No shares of common stock were sold under the New ATM Program or Prior ATM Program during the year ended December 31, 2020 and, as of December 31, 2020, we had $500.0 million available for future issuances under the New ATM Program.
As of December 31, 2020, there was $50.0 million outstanding under the Revolving Facility (as defined below). We believe that our available cash, expected operating cash flows, and the availability under the New ATM Program and Amended Credit Facility (as defined below) will provide sufficient funds for our operations, anticipated scheduled debt service payments and dividend plans for at least the next twelve months.
44

We intend to invest in and/or develop additional healthcare and seniors housing properties as suitable opportunities arise and adequate sources of financing are available. We expect that future investments in and/or development of properties, including any improvements or renovations of current or newly-acquired properties, will depend on and will be financed by, in whole or in part, our existing cash, borrowings available to us under the Amended Credit Facility, future borrowings or the proceeds from sales of shares of our common stock pursuant to our New ATM Program or additional issuances of common stock or other securities. In addition, we may seek financing from U.S. government agencies, including through Fannie Mae and the U.S. Department of Housing and Urban Development, in appropriate circumstances in connection with acquisitions and refinancing of existing mortgage loans.
We have filed an automatic shelf registration statement with the U.S. Securities and Exchange Commission that expires in March 2023, which will allow us or certain of our subsidiaries, as applicable, to offer and sell shares of common stock, preferred stock, warrants, rights, units and debt securities through underwriters, dealers or agents or directly to purchasers, in one or more offerings on a continuous or delayed basis, in amounts, at prices and on terms we determine at the time of the offering.
Although we are subject to restrictions on our ability to incur indebtedness, we expect that we will be able to refinance existing indebtedness or incur additional indebtedness for acquisitions or other purposes, if needed. However, there can be no assurance that we will be able to refinance our indebtedness, incur additional indebtedness or access additional sources of capital, such as by issuing common stock or other debt or equity securities, on terms that are acceptable to us or at all.
Cash Flows
The following table presents selected data from our consolidated statements of cash flows for the years presented:
 Year Ended December 31,
 20202019
 (dollars in thousands)
Net cash provided by operating activities$145,735 $126,295 
Net cash used in investing activities(41,582)(316,007)
Net cash (used in) provided by financing activities(105,561)173,247 
Net decrease in cash and cash equivalents(1,408)(16,465)
Cash and cash equivalents at beginning of period20,327 36,792 
Cash and cash equivalents at end of period$18,919 $20,327 
Year Ended December 31, 2020 Compared to Year Ended December 31, 2019
Net cash provided by operating activities for the year ended December 31, 2020 was $145.7 million compared to $126.3 million for the year ended December 31, 2019, an increase of $19.4 million. The increase was primarily due to an increase of $12.9 million in rental income due to acquisitions, $5.0 million in improved rent collections compared to the prior year, $1.8 million in increases in rental rates for existing tenants subsequent to December 31, 2018, a decrease of $4.5 million in interest paid on outstanding indebtedness due to lower weighted average interest rates and a lower weighted average debt balance, $1.2 million of lease termination revenue and $1.0 million from recovery of previously reversed rent, partially offset by a decrease in rental income of $6.2 million due to the disposal of assets in September 2019 and February 2020 and higher cash wages of $1.0 million.
Cash used in investing activities for the year ended December 31, 2020 was primarily comprised of $123.1 million in acquisitions of real estate, investments in real estate mortgage and other loans receivable and escrow deposits for potential acquisitions, and $8.3 million of purchases of, and improvements to, equipment, furniture and fixtures and real estate, partially offset by $83.3 million of payments received from our preferred equity investment and mortgage and other loans receivable and $6.6 million in net proceeds from real estate sales. Cash used in investing activities for the year ended December 31, 2019 was primarily comprised of $339.7 million in acquisitions of real estate, investments in real estate mortgage and other loans receivable and $6.3 million of purchases of, and improvements to, equipment, furniture and fixtures and real estate, partially offset by $26.5 million of payments received from our preferred equity investment and mortgage and other loans receivable and $3.5 million in net proceeds from real estate sales.
 
Our cash flows used in financing activities for the year ended December 31, 2020 were primarily comprised of $93.2 million in dividends paid, a $2.0 million net settlement adjustment on restricted stock, $0.4 million in costs paid for the issuance
45

of common stock and $10.0 million in net repayments under our Amended Credit Facility (as defined below). Our cash flows provided by financing activities for the year ended December 31, 2019 were primarily comprised of $196.0 million in net proceeds from common stock sales under our predecessor ATM Program and April 2019 equity offering and $65.0 million in net borrowings under our Amended Credit Facility and Prior Credit Facility, partially offset by $80.6 million in dividends paid, $4.5 million in payments of deferred financing costs and $2.5 million net settlement adjustment on restricted stock.

Year Ended December 31, 2019 Compared to Year Ended December 31, 2018
For discussion related to the cash flows for fiscal 2019 compared to fiscal 2018, refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our fiscal 2019 Annual Report on Form 10-K, which was filed with the SEC on February 20, 2020.

Indebtedness
5.25% Senior Unsecured Notes due 2025 and Issuer and Guarantor Financial Information
On May 10, 2017, our wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed a public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2017.
As of June 1, 2020, the Issuers may redeem the Notes any time at the redemption prices set forth in the indenture. As of December 31, 2020, the Issuers have not elected to redeem any of the Notes. If certain changes of control of CareTrust REIT occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.
The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by CareTrust REIT (the “Parent Guarantor”) and CareTrust REIT’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers) (the “Subsidiary Guarantors”); provided, however, that such guarantees are subject to automatic release under certain customary circumstances, including if the Subsidiary Guarantor is sold or sells all or substantially all of its assets, the Subsidiary Guarantor is designated “unrestricted” for covenant purposes under the indenture, the Subsidiary Guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied.
The following provides information regarding the entity structure of the Parent Guarantor, the Issuers and the Subsidiary Guarantors:
CareTrust REIT, Inc. – The Parent Guarantor was formed on October 29, 2013 and became a separate and independent publicly-traded company on June 1, 2014. The Parent Guarantor has not conducted any operations or had any business since that time.
CTR Partnership, L.P. and CareTrust Capital Corp. – The Issuers, each of which is a wholly owned subsidiary of the Parent Guarantor, were formed on May 8, 2014 and May 9, 2014, respectively. The Issuers did not conduct any operations or have any business prior to June 1, 2014, the date the Parent Guarantor became a separate and independent publicly-traded company. The Operating Partnership directly invests in real estate and real estate related assets and therefore does not rely solely on the cash flow generated by the Subsidiary Guarantors and their ability to make cash available to the Issuers, by dividend or otherwise. However, in the event that the earnings or available assets of the Issuers are insufficient, the Issuers’ ability to pay principal and interest on the Notes could be dependent on the cash flow generated by the Subsidiary Guarantors and their ability to make such cash available to the Issuers. CareTrust Capital Corp., a co-issuer of the Notes, has no material assets and conducts no operations. Therefore, it has no independent ability to service the interest and principal obligations under the Notes.
Subsidiary Guarantors – The Subsidiary Guarantors consist of all of the subsidiaries of the Parent Guarantor other than the Issuers. The Parent Guarantor conducts a substantial portion of its business operations through the Subsidiary Guarantors.
The assets and liabilities and results of operations of the combined guarantors (the Parent Issuer and the Subsidiary Guarantors) and the Issuers of the Notes are not materially different than the corresponding amounts presented in our consolidated financial statements.
46

The indenture contains customary covenants such as limiting the ability of CareTrust REIT and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets, and pay dividends or distributions on, or redeem or repurchase, capital stock, including a restriction on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers, subject to certain other exceptions, unless: (i) there is no default or event of default under the indenture; (ii) the Issuers are in compliance with specified limitations on indebtedness under the indenture; and (iii) the payments do not exceed a specified restricted payment basket. Dividends or distributions are also permitted if the Parent Guarantor’s board of directors believes in good faith they are necessary to maintain Parent Guarantor’s REIT status or to avoid any excise tax or income tax imposed on Parent Guarantor, provided there is no default or event of default under the indenture. Further, the Issuers and their restricted subsidiaries are not permitted to create or cause to become effective any encumbrance or restriction on the ability of the Issuers to, among other things, pay dividends or make distributions, pay indebtedness, make loans or advances to the Issuers or their restricted subsidiaries or transfer property or assets to the Issuers or their restricted subsidiaries, other than in connection with certain customary exceptions such as in respect of the indenture or the Amended Credit Facility.
The indenture also requires CareTrust REIT and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.
As of December 31, 2020, we were in compliance with all applicable financial covenants under the indenture.
Unsecured Revolving Credit Facility and Term Loan
On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Prior Credit Agreement”). As later amended on February 1, 2016, the Prior Credit Agreement provided the following: (i) a $400.0 million unsecured asset based revolving credit facility (the “Prior Revolving Facility”), (ii) a $100.0 million non-amortizing unsecured term loan (the “Prior Term Loan” and, together with the Prior Revolving Facility, the “Prior Credit Facility”), and (iii) a $250.0 million uncommitted incremental facility. The Prior Revolving Facility was scheduled to mature on August 5, 2019, subject to two, six-month extension options. The Prior Term Loan was scheduled to mature on February 1, 2023, and could be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance.
On February 8, 2019, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries entered into an amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Amended Credit Agreement”). The Amended Credit Agreement, which amended and restated the Prior Credit Agreement, provides for: (i) an unsecured revolving credit facility (the “Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) an unsecured term loan credit facility (the “Term Loan” and together with the Revolving Facility, the “Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Borrowing availability under the Revolving Facility is subject to no default or event of default under the Amended Credit Agreement having occurred at the time of borrowing. The proceeds of the Term Loan were used, in part, to repay in full all outstanding borrowings under the Prior Term Loan and Prior Revolving Facility under the Prior Credit Agreement. Future borrowings under the Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
The interest rates applicable to loans under the Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.10% to 0.55% per annum or LIBOR plus a margin ranging from 1.10% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or LIBOR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and its consolidated subsidiaries (unless the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based off
47

the credit ratings of the Company’s senior long-term unsecured debt). As of December 31, 2020, we had $200.0 million outstanding under the Term Loan and $50.0 million outstanding under the Revolving Facility.
The Revolving Facility has a maturity date of February 8, 2023, and includes, at our sole discretion, two, six-month extension options. The Term Loan has a maturity date of February 8, 2026.
The Amended Credit Facility is guaranteed, jointly and severally, by the Company and its wholly-owned subsidiaries that are party to the Amended Credit Agreement (other than the Operating Partnership). The Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend organizational documents and pay certain dividends and other restricted payments. The Amended Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio, a maximum secured recourse debt to asset value ratio, a maximum unsecured debt to unencumbered properties asset value ratio, a minimum unsecured interest coverage ratio and a minimum rent coverage ratio. The Amended Credit Agreement also contains certain customary events of default, including the failure to make timely payments under the Amended Credit Facility or other material indebtedness, the failure to satisfy certain covenants (including the financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency.
As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.
Obligations and Commitments
The following table summarizes our contractual obligations and commitments at December 31, 2020 (in thousands):
 
 Payments Due by Period
 TotalLess
than
1 Year
1 Year
to Less
than
3 Years
3 Years
to Less
than
5 Years
More
than
5 years
Senior unsecured notes payable (1)$370,875 $15,750 $31,500 $323,625 $— 
Senior unsecured term loan (2)217,071 3,348 6,679 6,687 200,357 
Unsecured revolving credit facility (3)53,262 1,551 51,711 — — 
Operating lease3,793 261 337 104 3,091 
Total$645,001 $20,910 $90,227 $330,416 $203,448 
(1)Amounts include interest payments of $70.9 million.
(2)Amounts include interest payments of $17.1 million.
(3)Amounts include payments related to the credit facility fee of $1.9 million and interest payments of $1.3 million.
Capital Expenditures
Capital expenditures for each property leased under our triple-net leases are generally the responsibility of the tenant, except that, for the facilities leased to subsidiaries of The Ensign Group, Inc. and The Pennant Group, Inc., the tenant will have an option to require us to finance certain capital expenditures up to an aggregate of 20% of our initial investment in such property, subject to a corresponding rent increase at the time of funding. For our other triple-net master leases, subject to approval by us, the tenants may request capital expenditure funding that would generally be subject to a corresponding rent increase at the time of funding, which are subject to tenant compliance with the conditions to our approval and funding of their requests. As of December 31, 2020, we had committed to fund expansions, construction and capital improvements at certain triple-net leased facilities totaling $15.4 million, of which $14.2 million is subject to rent increase at the time of funding.
Critical Accounting Policies
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions. 
48

Certain accounting policies are considered to be critical accounting policies. Critical accounting policies are those policies that require management to make significant estimates and/or assumptions about matters that are
uncertain at the time the estimates and/or assumptions are made or where we are required to make significant judgments and assumptions with respect to the practical application of accounting principles in our business operations. Critical accounting policies are by definition those policies that are material to our financial statements and for which the impact of changes in estimates, assumptions, and judgments could have a material impact to our financial statements.
The following critical accounting policies discussion reflects what we believe are the most significant estimates,
assumptions, and judgments used in the preparation of our consolidated financial statements. This discussion of our
critical accounting policies is intended to supplement the description of our accounting policies in the footnotes to our consolidated financial statements and to provide additional insight into the information used by management when evaluating significant estimates, assumptions, and judgments. For further discussion of our significant accounting policies, see Note 2, Summary of Significant Accounting Policies, to our consolidated financial statements included in this report.
Real Estate Depreciation and Amortization. Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. We consider the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. Determining whether expenditures meet the criteria for capitalization and the assignment of depreciable lives requires management to exercise significant judgment. We anticipate the estimated useful lives of our assets by class to be generally as follows:
Buildings25-40 years
Building improvements10-25 years
Tenant improvementsShorter of lease term or expected useful life
Integral equipment, furniture and fixtures5 years
Identified intangible assetsShorter of lease term or expected useful life
Real Estate Acquisition Valuation. In accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, our acquisitions of real estate investments generally do not meet the definition of a business, and are treated as asset acquisitions. The assets acquired and liabilities assumed are measured at their acquisition date relative fair values. Acquisition costs are capitalized as incurred. We allocate the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. We exercise judgment to determine the key assumptions used to allocate the purchase price of real estate acquired among its components. We assess fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of land is derived from comparable sales of land within the same submarket and/or region. The fair value of buildings and improvements and integral equipment, furniture and fixtures considers the value of the property as if it was vacant as well as replacement costs, depreciation factors, and other relevant market information. The use of different assumptions in these fair value inputs could significantly affect the reported amounts of the allocation of the acquisition on a relative fair value basis and the related depreciation expense recorded for such assets. We have not materially changed the assumptions used in the analysis during the year ended December 31, 2020.
As part of the real estate acquisitions, we may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement. Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis when the earn-out becomes probable and estimable. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.
Impairment of Long-Lived Assets. At each reporting period, we evaluate our real estate investments to be held and used for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, we evaluate the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a
49

terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.
We classify our real estate investments as held for sale when the applicable criteria have been met, which entails a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, we write down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and cease depreciation.
In the event of impairment, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers.
Our ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While we believe our assumptions are reasonable, changes in these assumptions may have a material impact on financial results. We have not materially changed the assumptions used in the analysis during the year ended December 31, 2020.
Other Real Estate Investments. Included in other real estate investments, net on our consolidated balance sheets at December 31, 2020, is one mezzanine loan receivable. At December 31, 2019, included in other real estate investments, net is one preferred equity investment and two mortgage loans receivable. The preferred equity investment was accounted for at unpaid principal balance, plus accrued return, net of reserves. We recognize return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, we are not entitled to share in the joint venture’s earnings or losses. Rather, we are entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. Any unpaid accrued preferred return, whether recorded or unrecorded by us, will be repaid upon redemption or as available cash flow is distributed from the joint venture.
Prior to the adoption of Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Subtopic 326) (“ASU 2016-13”), mortgage and mezzanine loans receivable were recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. Interest income on our mortgage and mezzanine loans receivable was recognized over the life of the applicable investment using the interest method. Origination costs and fees directly related to loans receivable were amortized over the term of the loan as an adjustment to interest income.
For instruments recorded at amortized cost, we evaluated at each reporting period each of our other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it was probable that we would be unable to collect all amounts due according to the existing contractual terms. A reserve would be established for the excess of the carrying value of the investment over its fair value.
We adopted ASU 2016-13 on January 1, 2020. With our primary business being leasing real property to third-party tenants, the majority of receivables that arise in the ordinary course of business qualify as operating leases and are not in the scope of ASU 2016-13. However, based on the instruments held upon adoption on January 1, 2020, the standard applied to our then outstanding mortgage loans receivable, for which we elected the fair value option as provided for by ASU 2019-05. Fair value was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other income (loss) on our consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, we had one mezzanine loan receivable for which the fair value option had been elected.
Revenue Recognition. We recognize lease revenue in accordance with ASC 842, Leases. Our lease agreements typically contain annual escalators based on the percentage change in the Consumer Price Index which are accounted for as variable lease payments in the period in which the change occurs. For lease agreements that contain fixed rent escalators, we generally recognize lease revenue on a straight-line basis of accounting. We generate revenues primarily by leasing healthcare-related
50

properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Tenant reimbursements related to property taxes and insurance paid by lessee directly to a third party on behalf of a lessor are required to be excluded from variable payments and from recognition in the lessors’ income statements. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental income recognized by the lessor on a gross basis in its income statements.
For the year ended December 31, 2018, we recognized tenant recoveries for real estate taxes of $11.9 million, which were classified as tenant reimbursements on our consolidated income statements. Prior to the adoption of ASC 842, we recognized tenant recoveries as tenant reimbursement revenues regardless of whether the third party was paid by the lessor or lessee. Effective January 1, 2019, such tenant recoveries are recognized to the extent that we pay the third party directly and classified as rental income on our consolidated income statements. Due to the application of ASC 842, we recognized, on a gross basis, tenant recoveries related to real estate taxes of $3.1 million and $2.9 million, for the years ended December 31, 2020 and December 31, 2019, respectively.
Our assessment of collectibility of tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection. This assessment involves significant judgment by management and considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Such write-offs and recoveries are recorded as decreases or increases through rental income on our consolidated income statements. For the year ended December 31, 2020, we recorded recovery adjustments of $1.0 million and did not recognize any write-off adjustments to rental income. For the year ended December 31, 2019, we recorded $11.8 million of write-off adjustments to rental income related to rental income recognized in prior periods. See Note 3, Real Estate Investments, Net, in the Notes to the Consolidated Financial Statements for further detail.
Income Taxes. We elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). We believe we have been organized and have operated, and we intend to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to our stockholders at least 90% of our annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, we generally will not be subject to federal income tax to the extent we distribute as qualifying dividends all of our REIT taxable income to our stockholders. If we fail to qualify as a REIT in any taxable year, we will be subject to federal income tax on our taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants us relief under certain statutory provisions. 
Impact of Inflation
Our rental income in future years will be impacted by changes in inflation. Almost all of our triple-net lease agreements, including the Ensign leases, provide for an annual rent escalator based on the percentage change in the Consumer Price Index (but not less than zero), subject to maximum fixed percentages.
Off-Balance Sheet Arrangements
None.

ITEM 7A.     Quantitative and Qualitative Disclosures About Market Risk
Our primary market risk exposure is interest rate risk with respect to our variable rate indebtedness.
Our Amended Credit Agreement provides for: (i) an unsecured revolving credit facility (the “Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) an unsecured term loan credit facility (the “Term Loan”) in an aggregate principal amount of $200.0 million from a syndicate of banks and other financial institutions.
51

The interest rates applicable to loans under the Revolving Facility are, at our option, equal to either a base rate plus a margin ranging from 0.10% to 0.55% per annum or LIBOR plus a margin ranging from 1.10% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if we obtain certain specified investment grade ratings on our senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan are, at our option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or LIBOR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if we obtain certain specified investment grade ratings on our senior long-term unsecured debt). As of December 31, 2020, we had a $200.0 million Term Loan outstanding and there was $50.0 million outstanding under the Revolving Facility.
An increase in interest rates could make the financing of any acquisition by us more costly as well as increase the costs of our variable rate debt obligations. Rising interest rates could also limit our ability to refinance our debt when it matures or cause us to pay higher interest rates upon refinancing and increase interest expense on refinanced indebtedness. Increased inflation may also have a pronounced negative impact on the interest expense we pay in connection with our outstanding indebtedness, as these costs could increase at a rate higher than our rents.
In addition, there is currently uncertainty around whether LIBOR will continue to exist after 2021. If LIBOR ceases to exist, we will need to enter into an amendment to the Amended Credit Agreement and we cannot predict what alternative index would be negotiated with our lenders. If our lenders have increased costs due to changes in LIBOR, we may experience potential increases in interest rates on our variable rate debt, which could adversely impact our interest expense, results of operations and cash flows. Based on our outstanding debt balance as of December 31, 2020 described above and the interest rates applicable to our outstanding debt at December 31, 2020, assuming a 100 basis point increase in the interest rates related to our variable rate debt, interest expense would have increased approximately $2.5 million for the year ended December 31, 2020.
We may, in the future, manage, or hedge, interest rate risks related to our borrowings by means of interest rate swap agreements. However, the REIT provisions of the Code substantially limit our ability to hedge our assets and liabilities. See “Risk Factors - Risks Related to Our Status as a REIT - Complying with REIT requirements may limit our ability to hedge effectively and may cause us to incur tax liabilities.” As of December 31, 2020, we had no swap agreements to hedge our interest rate risks. We also expect to manage our exposure to interest rate risk by maintaining a mix of fixed and variable rates for our indebtedness.
ITEM  8. Financial Statements and Supplementary Data
See the Index to Consolidated Financial Statements on page F-1 of this report.
ITEM  9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures
None.
ITEM  9A.    Controls and Procedures
Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is processed, recorded, summarized and reported within the time periods specified in the SEC’s rules and regulations and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As of December 31, 2020, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, regarding the effectiveness of our disclosure controls and procedures. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2020.
Management’s Annual Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) to provide reasonable assurance regarding the reliability of our
52

financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and our directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, regarding the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013). Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2020.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended December 31, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Attestation Report of the Independent Registered Public Accounting Firm

The effectiveness of our internal control over financial reporting as of December 31, 2020 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report which is included herein.
53



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of CareTrust REIT Inc.

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of CareTrust REIT, Inc. and subsidiaries (the “Company”) as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2020, of the Company and our report dated February 10, 2021, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.


/s/ DELOITTE & TOUCHE LLP

Costa Mesa, California
February 10, 2021
54


ITEM 9B.    Other Information
Appointment of New President
On February 9, 2021, our board of directors appointed David Sedgwick, who has served as our Chief Operating Officer since August 2018, to serve as our President, effective immediately. Mr. Sedgwick will continue to serve as Chief Operating Officer. Mr. Sedgwick’s biographical information is described in our definitive proxy statement on Schedule 14A, filed with the SEC on March 20, 2020. In connection with his appointment to President, Mr. Sedgwick’s annual base salary has been increased to $495,000 effective as of January 1, 2021.
There are no arrangements or understandings between Mr. Sedgwick and any other person pursuant to which Mr. Sedgwick was appointed as President and Chief Operating Officer and there are no transactions in which Mr. Sedgwick has an interest that would require disclosure under Item 404(a) of Regulation S-K. Other than as disclosed in our definitive proxy statement on Schedule 14A filed with the SEC on March 20, 2020, no family relationship exists between Mr. Sedgwick and any director or other executive officer of the Company.
Concurrently with Mr. Sedgwick’s appointment as President and Chief Operating Officer, Mr. Greg Stapley relinquished the position of President. Mr. Stapley will continue to serve as Chief Executive Officer and Chairman of the Board of Directors.
PART III
ITEM  10.    Directors, Executive Officers and Corporate Governance
The information required under Item 10 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2020 in connection with our 2021 Annual Meeting of Stockholders.
Code of Conduct and Ethics
We have adopted a code of business conduct and ethics that applies to all employees, including employees of our subsidiaries, as well as each member of our Board of Directors. The code of business conduct and ethics is available at our website at www.caretrustreit.com under the Investors-Corporate Governance section. We intend to satisfy any disclosure requirement under applicable rules of the Securities and Exchange Commission or Nasdaq Stock Market regarding an amendment to, or waiver from, a provision of this code of business conduct and ethics by posting such information on our website, at the address specified above.
ITEM  11.    Executive Compensation
The information required under Item 11 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2020 in connection with our 2021 Annual Meeting of Stockholders.
ITEM  12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required under Item 12 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2020 in connection with our 2021 Annual Meeting of Stockholders.
ITEM 13. Certain Relationships and Related Transactions, and Director Independence

The information required under Item 13 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2020 in connection with our 2021 Annual Meeting of Stockholders.
ITEM  14.    Principal Accountant Fees and Services
The information required under Item 14 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2020 in connection with our 2021 Annual Meeting of Stockholders.
55

PART IV
ITEM  15.    Exhibits, Financial Statements and Financial Statement Schedules
(a)(1)Financial Statements
 See Index to Consolidated Financial Statements on page F-1 of this report.
(a)(2)Financial Statement Schedules
 Schedule III: Real Estate Assets and Accumulated Depreciation
Schedule IV: Mortgage Loans on Real Estate
 Note: All other schedules have been omitted because the required information is presented in the financial statements and the related notes or because the schedules are not applicable.
(a)(3)Exhibits


*101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
*101.SCHXBRL Taxonomy Extension Schema Document
*101.CALXBRL Taxonomy Extension Calculation Linkbase Document
*101.DEFXBRL Taxonomy Extension Definition Linkbase Document
*101.LABXBRL Taxonomy Extension Label Linkbase Document
*101.PREXBRL Taxonomy Extension Presentation Linkbase Document
*104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
 
*    Filed herewith.
**    Furnished herewith.
+    Management contract or compensatory plan or arrangement.
ITEM 16.     10-K Summary
None.
57




SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
CARETRUST REIT, INC.
By:
/S/ GREGORY K. STAPLEY
 Gregory K. Stapley
 Chief Executive Officer
Dated: February 10, 2021
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Name 
Title
Date 
/s/ GREGORY K. STAPLEYDirector and Chief Executive Officer (Principal Executive Officer)February 10, 2021
Gregory K. Stapley
/s/ WILLIAM M. WAGNERChief Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer)February 10, 2021
William M. Wagner
/s/ ALLEN C. BARBIERIDirectorFebruary 10, 2021
Allen C. Barbieri
/s/ JON D. KLINEDirectorFebruary 10, 2021
Jon D. Kline
/s/ DIANA LAINGDirectorFebruary 10, 2021
Diana Laing
/s/ SPENCER PLUMBDirectorFebruary 10, 2021
Spencer Plumb



58

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
Page  
Reports of Independent Registered Public Accounting Firms with respect to CareTrust REIT, Inc.
Consolidated Balance Sheets as of December 31, 2020 and 2019
Consolidated Income Statements for the years ended December 31, 2020, 2019 and 2018
Consolidated Statements of Equity for the years ended December 31, 2020, 2019 and 2018
Consolidated Statements of Cash Flows for the years ended December 31, 2020, 2019 and 2018
Notes to Consolidated Financial Statements
Schedule III: Real Estate Assets and Accumulated Depreciation
Schedule IV: Mortgage Loans on Real Estate

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of CareTrust REIT, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of CareTrust REIT, Inc. and subsidiaries (the "Company") as of December 31, 2020 and 2019, the related consolidated income statements and statements of equity and cash flows, for each of the two years in the period ended December 31, 2020, and the related notes and the schedules listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 10, 2021, expressed an unqualified opinion on the Company's internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Impairment of Long-Lived Assets — Refer to Note 2 to the financial statements
Critical Audit Matter Description
At each reporting period, the Company evaluates its real estate investments to be held and used for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, the Company evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value.
We identified the impairment of long-lived assets as a critical audit matter because of the significant estimates and assumptions
F-2

management makes to evaluate the recoverability of the long-lived assets, specifically the estimates of lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate for the applicable long lived assets or group of assets.
Auditing the assumptions used by the Company in estimating future undiscounted cash flows required a high degree of auditor judgment and an increased extent of effort, when performing audit procedures to evaluate the reasonableness of the Company’s recoverability analysis.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to the significant inputs to the recoverability assessment of undiscounted cash flows included the following, among others:
We tested the effectiveness of controls over management’s evaluation of the recoverability of long-lived assets based on undiscounted cash flows, including those over the lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate used in the assessment.
We evaluated the reasonableness of significant assumptions in the undiscounted cash flow analyses, including estimates of the lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate, for properties with impairment indicators.
We evaluated the reasonableness of management’s assertions regarding the intended hold period of its real estate assets, more specifically by performing the following:
Engaged in discussions with management, including the Chief Executive Officer and Chief Financial Officer,
Inspected Board of Directors meeting minutes regarding the assumptions utilized in the determination of intended hold periods,
Performed a retrospective review around the Company’s estimates of hold periods used in previous periods in relation to real estate assets with impairment indicators, including those that were subsequently disposed of, and
Evaluated audit evidence to determine whether it supported or contradicted the conclusions reached by management.
We developed independent estimates of the lease coverage ratio and a terminal capitalization rate, focusing on property type, historical transactions of the Company and external market sources and compared our independent estimates to the estimates and assumptions used by the Company.
In addition, we tested the mathematical accuracy of the undiscounted cash flow analyses.
We evaluated whether the assumptions were consistent with evidence obtained in other areas of the audit.

/s/ DELOITTE & TOUCHE LLP
Costa Mesa, California
February 10, 2021

We have served as the Company's auditor since 2019.

F-3

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors of CareTrust REIT, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated income statement, statement of equity and cash flows of CareTrust REIT, Inc. (the Company) for the year ended December 31, 2018, and the related notes and the financial statement schedules listed in the Index at Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company at December 31, 2018, and the consolidated results of its operations and its cash flows for the year ended December 31, 2018, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ ERNST & YOUNG LLP

We served as the Company’s auditor from 2014 to 2019.
Irvine, California
February 13, 2019



F-4

CARETRUST REIT, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
December 31,
20202019
Assets:
Real estate investments, net$1,448,099 $1,414,200 
Other real estate investments, net15,000 33,300 
Assets held for sale, net7,226 34,590 
Cash and cash equivalents18,919 20,327 
Accounts and other receivables, net1,823 2,571 
Prepaid expenses and other assets, net10,450 10,850 
Deferred financing costs, net2,042 3,023 
Total assets$1,503,559 $1,518,861 
Liabilities and Equity:
Senior unsecured notes payable, net$296,669 $295,911 
Senior unsecured term loan, net198,925 198,713 
Unsecured revolving credit facility50,000 60,000 
Accounts payable and accrued liabilities19,572 14,962 
Dividends payable24,251 21,684 
Total liabilities589,417 591,270 
Commitments and contingencies (Note 10)
Equity:
Preferred stock, $0.01 par value; 100,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2020 and December 31, 2019
  
Common stock, $0.01 par value; 500,000,000 shares authorized, 95,215,797 and 95,103,270 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively
952 951 
Additional paid-in capital1,164,402 1,162,990 
Cumulative distributions in excess of earnings(251,212)(236,350)
Total equity914,142 927,591 
Total liabilities and equity$1,503,559 $1,518,861 
See accompanying notes to consolidated financial statements.

F-5

CARETRUST REIT, INC.
CONSOLIDATED INCOME STATEMENTS
(in thousands, except per share amounts)
 
 Year Ended December 31,
 202020192018
Revenues:
Rental income$173,612 $155,667 $140,073 
Tenant reimbursements— — 11,924 
Independent living facilities2,077 3,389 3,379 
Interest and other income2,643 4,345 1,565 
Total revenues178,332 163,401 156,941 
Expenses:
Depreciation and amortization52,760 51,822 45,766 
Interest expense23,661 28,125 27,860 
Property taxes2,836 3,048 11,924 
Independent living facilities 1,869 2,898 2,964 
Impairment of real estate investments 16,692  
Provision for loan losses 1,076  
General and administrative16,302 15,158 12,555 
Total expenses97,428 118,819 101,069 
Other (loss) income:
(Loss) gain on sale of real estate(37)1,777 2,051 
Net income$80,867 $46,359 $57,923 
Earnings per common share:
Basic$0.85 $0.49 $0.73 
Diluted$0.85 $0.49 $0.72 
Weighted-average number of common shares:
Basic95,200 93,088 79,386 
Diluted95,207 93,098 79,392 
See accompanying notes to consolidated financial statements.

F-6

CARETRUST REIT, INC.
CONSOLIDATED STATEMENTS OF EQUITY
(in thousands, except share and per share amounts)
 
 Common StockAdditional
Paid-in
Capital
Cumulative
Distributions
in Excess
of Earnings
Total
Equity
SharesAmount
Balance as of December 31, 201775,478,202 $755 $783,237 $(189,375)$594,617 
Issuance of common stock, net10,264,981 103 179,783 — 179,886 
Vesting of restricted common stock, net of shares withheld for employee taxes123,861 1 (1,290)— (1,289)
Amortization of stock-based compensation— — 3,848 — 3,848 
Common dividends ($0.82 per share)
— — — (66,738)(66,738)
Net income— — — 57,923 57,923 
Balance as of December 31, 201885,867,044 859 965,578 (198,190)768,247 
Issuance of common stock, net9,100,250 91 195,833 — 195,924 
Vesting of restricted common stock, net of shares withheld for employee taxes135,976 1 (2,525)— (2,524)
Amortization of stock-based compensation— — 4,104 — 4,104 
Common dividends ($0.90 per share)
— — — (84,519)(84,519)
Net income— — — 46,359 46,359 
Balance as of December 31, 201995,103,270 951 1,162,990 (236,350)927,591 
Issuance of common stock, net  (404)— (404)
Vesting of restricted common stock, net of shares withheld for employee taxes112,527 1 (1,996)— (1,995)
Amortization of stock-based compensation— — 3,812 — 3,812 
Common dividends ($1.00 per share)
— — — (95,729)(95,729)
Net income— — — 80,867 80,867 
Balance as of December 31, 202095,215,797 $952 $1,164,402 $(251,212)$914,142 
See accompanying notes to consolidated financial statements.

F-7

CARETRUST REIT, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 Year Ended December 31,
 202020192018
Cash flows from operating activities:
Net income$80,867 $46,359 $57,923 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including below-market ground leases)52,819 51,866 45,783 
Amortization of deferred financing costs1,950 2,003 1,938 
Amortization of stock-based compensation3,790 4,104 3,848 
Straight-line rental income(77)(1,385)(2,333)
Adjustment for collectibility of rental income 11,774  
Noncash interest income (797)(238)
Loss (gain) on sale of real estate37 (1,777)(2,051)
Interest income distribution from other real estate investment1,346 463  
Impairment of real estate investments 16,692  
Provision for loan losses 1,076  
Change in operating assets and liabilities:
Accounts and other receivables, net825 (6,283)(3,800)
Prepaid expenses and other assets, net387 (495)(270)
Accounts payable and accrued liabilities3,791 2,695 (1,443)
Net cash provided by operating activities145,735 126,295 99,357 
Cash flows from investing activities:
Acquisitions of real estate, net of deposits applied(89,650)(321,458)(111,640)
Purchases of, and improvements to, equipment, furniture and fixtures and real estate(8,297)(6,289)(9,012)
Investment in real estate mortgage and other loans receivable(30,498)(18,246)(5,648)
Principal payments received on real estate mortgage and other loans receivable 80,928 24,283 3,227 
Repayment of other real estate investment2,327 2,204  
Escrow deposits for potential acquisitions of real estate(3,000) (5,000)
Net proceeds from sales of real estate6,608 3,499 13,004 
Net cash used in investing activities(41,582)(316,007)(115,069)
Cash flows from financing activities:
Proceeds from (costs paid for) the issuance of common stock, net(404)195,924 179,882 
Proceeds from the issuance of senior unsecured term loan 200,000  
Borrowings under unsecured revolving credit facility65,000 243,000 65,000 
Payments on senior unsecured term loan (100,000) 
Payments on unsecured revolving credit facility(75,000)(278,000)(135,000)
Payments of deferred financing costs (4,534) 
Net-settle adjustment on restricted stock(1,996)(2,524)(1,288)
Dividends paid on common stock(93,161)(80,619)(62,999)
Net cash (used in) provided by financing activities(105,561)173,247 45,595 
Net (decrease) increase in cash and cash equivalents(1,408)(16,465)29,883 
Cash and cash equivalents, beginning of period20,327 36,792 6,909 
Cash and cash equivalents, end of period$18,919 $20,327 $36,792 
Supplemental disclosures of cash flow information:
Interest paid$21,691 $26,005 $25,941 
Supplemental schedule of noncash investing and financing activities:
Increase in dividends payable$2,568 $3,900 $3,739 
Right-of-use asset obtained in exchange for new operating lease obligation$599 $1,010 $ 
Transfer of pre-acquisition costs to acquired assets$168 $242 $ 
Sale of real estate settled with notes receivable$32,400 $27,500 $ 
See accompanying notes to consolidated financial statements.
F-8

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. ORGANIZATION
Description of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of December 31, 2020, the Company owned and leased to independent operators, 218 skilled nursing, multi-service campuses, assisted living and independent living facilities consisting of 22,466 operational beds and units located in 28 states with the highest concentration of properties by rental income located in California, Texas, Louisiana, Idaho and Arizona.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation—The accompanying consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its wholly-owned subsidiaries prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). All intercompany transactions and account balances within the Company have been eliminated.
 
Recent Accounting Standards Adopted by the Company—In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Loses on Financial Instruments (“ASU 2016-13”), that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected credit losses, rather than incurred losses as previously required by the other-than-temporary impairment model. ASU 2016-13 applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans receivable, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). In November 2018, the FASB released ASU No. 2018-19, Codification Improvements to Topic 326 Financial Instruments - Credit Losses (“ASU 2018-19”). ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of ASU 2016-13. Instead, impairment of receivables arising from operating leases should be accounted for under Subtopic 842-30 “Leases - Lessor.” Additionally, the FASB issued ASU No. 2019-05, Targeted Transition Relief (“ASU 2019-05”), to allow companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option on financial instruments. The fair value option election does not apply to held-to-maturity debt securities. Entities are required to make this election on an instrument-by-instrument basis. ASU 2016-13 became effective for reporting periods beginning after December 15, 2019, and was applied as a cumulative adjustment to retained earnings as of the effective date. The Company adopted ASU 2016-13 on January 1, 2020. With the Company’s primary business being leasing real property to third-party tenants, the majority of receivables that arise in the ordinary course of business qualify as operating leases and are not in the scope of ASU 2016-13.  However, based on the instruments held upon adoption on January 1, 2020, the standard applied to the Company’s then outstanding mortgage loans receivable, for which the Company elected the fair value option as provided for by ASU 2019-05. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other (loss) income on the Company’s consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) (“ASU 2018-13”), which modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. ASU 2018-13 was effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods, with early adoption permitted. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company adopted ASU 2018-13 on January 1, 2020. Adoption of the new standard did not have a material impact on the Company’s consolidated financial statements.
In October 2020, the FASB issued ASU No. 2020-09, Debt (Topic 470) (“ASU 2020-09”), which amends and supersedes the SEC paragraphs in the Accounting Standards Codification (“ASC”) to reflect the issuance of SEC Release No. 33-10762. In March 2020, the SEC adopted amendments to reduce and simplify the financial disclosure requirements for guarantors and issuers of guaranteed registered securities. The amendments were effective January 4, 2021, but voluntary compliance with the amendments in advance of January 4, 2021 was permitted. The Company elected to comply with these amendments effective in the first quarter of 2020. As a result, the Company will no longer include in the financial statement footnotes of its Quarterly and Annual Reports on Form 10-Q and Form 10-K separate condensed consolidating financial
F-9

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
information for its wholly owned subsidiaries that issued or guaranteed the Notes (See Note 6, Debt, for further detail). In addition, in accordance with the amendments adopted by the SEC and FASB, because the assets, liabilities and results of operations of the combined issuers and guarantors of the Notes are not materially different than the corresponding amounts presented in the Company’s consolidated financial statements, it is also not required to present combined summary financial information regarding such subsidiary issuers and guarantors.
Lessor Accounting—The Company recognizes lease revenue in accordance with ASC 842, Leases. The Company’s lease agreements typically contain annual escalators based on the percentage change in the Consumer Price Index which are accounted for as variable lease payments in the period in which the change occurs. For lease agreements that contain fixed rent escalators, the Company generally recognizes lease revenue on a straight-line basis of accounting. The Company generates revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Tenant reimbursements related to property taxes and insurance paid by lessee directly to a third-party on behalf of a lessor are required to be excluded from variable payments and from recognition in the lessor’s income statements. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental revenues recognized by the lessor on a gross basis in its income statements.
For the year ended December 31, 2018, the Company recognized tenant recoveries for real estate taxes of $11.9 million which was classified as tenant reimbursements on the Company’s consolidated income statements. Prior to the adoption of ASC 842, the Company recognized tenant recoveries as tenant reimbursement revenues regardless of whether the third party was paid by the lessor or lessee. Effective January 1, 2019, such tenant recoveries are recognized to the extent that the Company pays the third party directly and classified as rental income on the Company’s consolidated income statements. Due to the application of ASC 842, the Company recognized, on a gross basis, tenant recoveries related to real estate taxes of $3.1 million and $2.9 million, for the years ended December 31, 2020 and December 31, 2019, respectively.
The Company’s assessment of collectibility of its tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection. The Company considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Such write-offs and recoveries are recorded as decreases or increases through rental income on the Company’s consolidated income statements. For the year ended December 31, 2020, the Company recorded recovery adjustments of $1.0 million and did not recognize any write-off adjustments to rental income. For the year ended December 31, 2019, the Company recorded $11.8 million of write-off adjustments to rental income related to rental income recognized in prior periods. See Note 3, Real Estate Investments, Net for further detail.
Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions. 
 
Real Estate Acquisition Valuation— In accordance with ASC 805, Business Combinations, the Company’s acquisitions of real estate investments generally do not meet the definition of a business, and are treated as asset acquisitions. The assets acquired and liabilities assumed are measured at their acquisition date relative fair values. Acquisition costs are capitalized as incurred. The Company allocates the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.

As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement.
F-10

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis when earn-out becomes probable and estimable. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.
Impairment of Long-Lived Assets—At each reporting period, the Company evaluates its real estate investments to be held and used for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, the Company evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.

The Company classifies its real estate investments as held for sale when the applicable criteria have been met, which entails a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, the Company writes down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and ceases depreciation.

In the event of impairment, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers.

The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.
Other Real Estate Investments—Included in other real estate investments, net, on the Company’s consolidated balance sheets at December 31, 2020, is one mezzanine loan receivable. At December 31, 2019, included in other real estate investments, net is one preferred equity investment and two mortgage loans receivable. The preferred equity investment was accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. Any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.
Prior to the adoption of ASU 2016-13, mortgage and mezzanine loans receivable were recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. Interest income on the Company’s mortgage and mezzanine loans receivable was recognized over the life of the applicable investment using the interest method. Origination costs and fees directly related to loans receivable were amortized over the term of the loan as an adjustment to interest income.
For instruments recorded at amortized cost, the Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.
The Company adopted ASU 2016-13 on January 1, 2020. Fair value was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. Instruments for which the fair value option has been elected are measured at fair value on a
F-11

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
recurring basis with changes in fair value recognized in other (loss) income on our consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.
Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. Included in other loans receivable at December 31, 2019 is a bridge loan to Priority Life Care, LLC (“Priority”) under which the Company agreed to fund up to $1.4 million until the earlier of (i) October 31, 2019, (ii) the date that a new credit facility is established such that the borrower may submit draw requests to the applicable lender, or (iii) the date on which Priority’s lease is terminated with respect to any facility. Borrowings under the bridge loan accrue interest at an annual base rate of 8.0%. During the year ended December 31, 2019, the Company determined that the remaining contractual obligations under the bridge loan agreement to Priority were not collectible and recorded a $1.1 million provision for loan losses in the Company’s consolidated income statements.
Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. 
Real Estate Depreciation and Amortization—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:
Building
25-40 years
Building improvements
10-25 years
Tenant improvementsShorter of lease term or expected useful life
Integral equipment, furniture and fixtures
5 years
Identified intangible assetsShorter of lease term or expected useful life
 Cash and Cash Equivalents—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.
The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.
Deferred Financing Costs—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. For senior unsecured notes payable and the senior unsecured term loan, deferred financing costs are netted against the outstanding debt amounts on the balance sheet. For the unsecured revolving credit facility, deferred financing costs are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in
F-12

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
the consolidated income statements. Accumulated amortization of deferred financing costs was $9.0 million and $7.1 million at December 31, 2020 and December 31, 2019, respectively.
When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s consolidated income statements.
Stock-Based Compensation—The Company accounts for share-based payment awards in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees. The Company measures and recognizes compensation expense for all share-based payment awards made to directors, officers and employees based on the grant date fair value, amortized over the requisite service period of the award. Net income reflects stock-based compensation expense of $3.8 million, $4.1 million and $3.8 million for the years ended December 31, 2020, 2019 and 2018, respectively.
Concentration of Credit Risk—The Company is subject to concentrations of credit risk consisting primarily of operating leases on its owned properties. See Note 11, Concentration of Risk, for a discussion of major operator concentration.
Segment Disclosures —The Company is subject to disclosures about segments of an enterprise and related information in accordance with ASC Topic 280, Segment Reporting. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.
Earnings Per Share—The Company calculates earnings per share (“EPS”) in accordance with ASC 260, Earnings Per Share. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities.
Beds, Units, Occupancy and Other Measures—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the consolidated financial statements are presented on an unaudited basis and are not subject to audit by the independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board.
Recent Accounting Pronouncements— In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), that provides optional relief to applying reference rate reform to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”), which will be discontinued by the end of 2021. The amendments in this update are effective immediately and may be applied through December 31, 2022. The Company is still evaluating the impact of ASU 2020-04 and expects to take full advantage of the offered optional expedients and exceptions, but does not expect the adoption of the standard to have a material impact on the Company’s consolidated financial statements.

3. REAL ESTATE INVESTMENTS, NET
The following table summarizes the Company’s investment in owned properties at December 31, 2020 and December 31, 2019 (dollars in thousands):
 
December 31, 2020December 31, 2019
Land$205,356 $204,154 
Buildings and improvements1,477,849 1,400,927 
Integral equipment, furniture and fixtures97,836 93,005 
Identified intangible assets2,352 1,650 
Real estate investments1,783,393 1,699,736 
Accumulated depreciation and amortization(335,294)(285,536)
Real estate investments, net$1,448,099 $1,414,200 
F-13

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
As of December 31, 2020, 85 of the Company’s 218 facilities were leased to subsidiaries of Ensign on a triple-net basis under multiple long-term leases (each, an “Ensign Master Lease” and, collectively, the “Ensign Master Leases”) which commenced on June 1, 2014 and were subsequently modified (see “Pennant Spin” below for further information). The obligations under the Ensign Master Leases are guaranteed by Ensign. A default by any subsidiary of Ensign with regard to any facility leased pursuant to an Ensign Master Lease will result in a default under all of the Ensign Master Leases. As of December 31, 2020, annualized contractual rental income from the Ensign Master leases was $53.4 million and are escalated annually, in June, by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the Ensign Master Leases are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). During the year ended December 31, 2020, the Company acquired four additional facilities leased to subsidiaries of Ensign on a triple-net basis which are not included under the Ensign Master Leases. As of December 31, 2020, annualized contractual rental income from the four additional Ensign facilities was $3.8 million and are escalated annually, in December, by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the four additional facilities are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). The four additional facilities leased to subsidiaries of Ensign are guaranteed by Ensign but do not contain cross-default provisions with the Ensign Master Leases.
As of December 31, 2020, 15 of the Company’s facilities were leased to subsidiaries of Priority Management Group (“PMG”) on a triple-net basis under one long-term lease (the “PMG Master Lease”). The PMG Master Lease commenced on December 1, 2016, and provides an initial term of fifteen years, with two five-year renewal options. As of December 31, 2020, annualized contractual rental income from the PMG Master Lease were $27.9 million and are escalated annually by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 3.0%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of PMG that are tenants under the PMG Master Lease are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs).
As of December 31, 2020, 114 of the Company’s 218 facilities were leased to various other operators under triple-net leases. All of these leases contain annual escalators based on the percentage change in the CPI (but not less than zero), some of which are subject to a cap, or fixed rent escalators.
As of December 31, 2020, the Company’s total future contractual minimum rental income for all of its tenants, excluding operating expense reimbursements, were (dollars in thousands):
YearAmount
2021$174,400 
2022174,497 
2023174,193 
2024174,294 
2025174,396 
Thereafter1,026,675 
$1,898,455 

F-14

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Tenant Purchase Options
Certain of the Company’s operators hold purchase options allowing them to acquire properties they currently lease from the Company. A summary of these purchase options is presented below (dollars in thousands):
Asset TypePropertiesLease Expiration1st Option Open DateOption Type
Current Cash Rent(1)
ALF7October 20341/1/2021A$3,207 
SNF11January 20311/1/2022C$4,800 
SNF1March 20304/1/2022
B / C(2)
$766 
SNF / Campus2October 20321/1/2023B$959 
SNF4November 203412/1/2024B$3,789 
ALF2October 20341/1/2026A$1,559 
Option Type:
A - Fixed base price plus a specified share on any appreciation.
B - Fixed base price.
C - Fixed capitalization rate on lease revenue.
Notes:
(1) Based on annualized cash revenue for contracts in place at December 31, 2020.
(2) Purchase option reflects two option types.
Rental Income
The following table summarizes components of the Company’s rental income (dollars in thousands):
For the Year Ended December 31,
20202019
Rental Income
Contractual rent due(1)
$171,309 $166,056 
Straight-line rent77 1,385 
Adjustment for collectibility(2)
 (11,774)
Recovery of previously reversed rent(3)
1,047  
Lease termination revenue(4)
1,179  
Total$173,612 $155,667 

(1)Includes initial cash rent and tenant operating expense reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by the Company. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received.
(2)During the year ended December 31, 2019, and in accordance with ASC 842, the Company evaluated the collectibility of lease payments through maturity and determined that it was not probable that the Company would collect substantially all of the contractual obligations from five operators through maturity. As such, the Company reversed $7.8 million of contractual rent, $3.5 million of straight-line rent and $0.5 million of property tax reimbursements during the year ended December 31, 2019. If lease payments are subsequently deemed probable of collection, the Company increases rental income for such recoveries.
(3)During the year ended December 31, 2020, the Company recovered $1.0 million in rental income that was previously written off related to one operator.
(4)During the year ended December 31, 2020, in connection with the agreement to terminate its lease agreements with affiliates of Metron Integrated Health Systems (“Metron”) and to sell the facilities to a third-party, the Company received $1.2 million from Metron affiliates.

F-15

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Recent Real Estate Acquisitions
The following table summarizes the Company’s acquisitions for the year ended December 31, 2020 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$75,545 $6,453 6 715 
Multi-service campuses6,876 555 1 184 
Assisted living7,396 590 1 62 
Total$89,817 $7,598 8 961 
The following table summarizes the Company’s acquisitions for the year ended December 31, 2019 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$254,760 $22,909 17 2,099 
Multi-service campuses59,344 5,203 4 762 
Assisted living12,596 1,031 1 96 
Total$326,700 $29,143 22 2,957 
The following table summarizes the Company’s acquisitions for the year ended December 31, 2018 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$85,814 $7,715 10 926 
Multi-service campuses27,520 (4)2,240 2 177 
Assisted living    
Total$113,334 $9,955 12 1,103 
(1)    Purchase price includes capitalized acquisition costs.
(2)    Initial annual cash rent excludes ground lease income.
(3)    The number of beds/units includes operating beds at acquisition date.
(4)    The Company committed to fund approximately $1.4 million in revenue-producing capital expenditures over 24 months based on the in-place yield, which was included in the purchase price.

Lease Amendments
Twenty/20 Lease Termination and New Noble Master Lease. On December 1, 2020, five assisted living facilities in Virginia operated by Twenty/20 Management, Inc. (“Twenty/20”) were transferred to affiliates of Noble Senior Services (“Noble”). In connection with the transfer, the Company entered into a new triple-net master lease with Noble. The new lease has a remaining initial term of approximately 14 years, with two five-year renewal options and CPI-based rent escalators. Initial annual cash rent under the new lease is approximately $3.2 million.
Pennant Spin. On October 1, 2019, Ensign completed its previously announced separation of its home health and hospice operations and substantially all of its senior living operations into a separate independent publicly traded company through the distribution of shares of common stock of Pennant. As a result of the Pennant Spin, as of October 1, 2019, the Company amended the Ensign Master Leases to lease 85 facilities to subsidiaries of Ensign, which had a total of 8,908 operational beds, and entered into a new triple-net master lease with subsidiaries of Pennant (the “Pennant Master Lease”) to lease 11 facilities, which had a total of 1,151 operational beds. The contractual initial annual cash rent under the Pennant Master Lease is approximately $7.8 million. The Pennant Master Lease carried an initial term of 15 years, with two five-year renewal options and CPI-based rent escalators. The contractual annual cash rent under the amended Ensign Master Leases was reduced by approximately $7.8 million. Ensign continues to guarantee obligations under the Ensign Master Leases and the Pennant Master Lease. If Pennant achieves a specified portfolio coverage and continuously maintains it for a specified period, Ensign’s obligations under the guaranty with respect to the Pennant Master Lease would be released.
F-16

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Trillium Lease Termination and New Master Lease. On July 15, 2019, the Company terminated its existing master lease (the “Original Trillium Lease”) with affiliates of Trillium Healthcare Group, LLC (“Trillium”), which covered ten properties in Iowa, seven properties in Ohio and one property in Georgia.  On August 16, 2019, the Company entered into a new master lease (the “New Trillium Lease”) with Trillium’s Iowa and Georgia affiliates covering the ten properties in Iowa and the one property in Georgia. The Company recorded an adjustment to reduce rental income recognized under the Original Trillium Lease for unpaid contractual rent, straight-line rent and property tax reimbursements by approximately $3.8 million in the three months ended September 30, 2019.
On September 1, 2019, four of the seven skilled nursing properties in Ohio operated by Trillium under the Original Trillium Lease were transferred to affiliates of Providence Group, Inc. (“Providence”). In connection with the transfer, the Company amended its triple-net master lease with Providence. The amended lease had a remaining initial term of approximately 13 years as of September 1, 2019, and includes two five-year renewal options and CPI-based rent escalators. Annual cash rent under the amended lease increased by approximately $2.1 million.
Trio Lease Amendment. On November 4, 2019, the Company amended its existing master lease with affiliates of Trio Healthcare, Inc. (“Trio”), which covered seven facilities based in Dayton, Ohio. The amended lease has a remaining initial term of approximately 13 years, with two five-year renewal options and CPI-based rent escalators. The annual base rent due under the amended lease with Trio is approximately $4.7 million and provides for payment of percentage rent if Trio achieves certain increases in portfolio revenue.
Pristine Lease Termination. On February 27, 2018, the Company announced that it entered into a Lease Termination Agreement (the “LTA”) with Pristine for its nine remaining properties, with a target completion date of April 30, 2018. Under the LTA, Pristine agreed to continue to operate the facilities until possession could be surrendered, and the operations therein transitioned, to operator(s) designated by the Company. Among other things, Pristine also agreed to amend certain pending agreements to sell the rights to certain Ohio Medicaid beds (the “Bed Sales Agreements”) and cooperate with the Company to turn over any claim or control it might have had with respect to the sale process and the proceeds thereof, if any, to the Company. The transactions were timely completed, and on May 1, 2018, Trio took over operations in the seven facilities based primarily in the Dayton, Ohio area under a new 15-year master lease, while Hillstone Healthcare, Inc. (“Hillstone”) assumed the operation of the two facilities in Willard and Toledo, Ohio under a new 12-year master lease. In addition, amendments to the Bed Sales Agreements were subsequently executed, confirming the Company as the sole seller of the bed rights and the sole recipient of any proceeds therefrom. The aggregate annual base rent due under the new master leases with Trio and Hillstone is approximately $10.0 million, subject to CPI-based or fixed escalators.
Under the LTA, the Company agreed, upon Pristine’s full performance of the terms thereof, to terminate Pristine’s master lease and all future obligations of the tenant thereunder; however, under the terms of the master lease the Company’s security interest in Pristine’s accounts receivable has survived any such termination. Such security interest was subject to the prior lien and security interest of Pristine’s working capital lender, Capital One, National Association (“CONA”), with whom the Company has an existing intercreditor agreement that defines the relative rights and responsibilities of CONA and with its respect to the loan and lease collateral represented by Pristine’s accounts receivable and the Company’s respective security interests therein.
Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale
On September 1, 2019, the Company sold three of the seven skilled nursing properties in Ohio operated by Trillium under the Original Trillium Lease for a purchase price of $28.0 million. During the three months ended September 30, 2019 and prior to the disposition, the Company recorded an impairment expense of approximately $7.8 million. In connection with the sale, the Company provided affiliates of CommuniCare Family of Companies (“CommuniCare”), the purchaser of the three Ohio properties, with a mortgage loan secured by the three Ohio properties for approximately $26.5 million. See Note 4, Other Real Estate Investments, Net for additional information.
As of September 30, 2019, the Company met the criteria to classify six skilled nursing facilities operated by affiliates of Metron as held for sale, which resulted in an impairment expense of approximately $8.8 million to reduce the carrying value to fair value less costs to sell the properties. The fair values of the assets impaired during the three months ended September 30, 2019 were based on contractual sales prices, which are considered to be Level 2 measurements within the fair value hierarchy. As of December 31, 2019, the properties continued to be held for sale and the carrying value of $34.6 million was primarily comprised of real estate assets. In February 2020, the six skilled nursing facilities were sold. In connection with
F-17

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
the sale for $36.0 million, the Company received $3.5 million in cash and provided subsidiaries of Cascade Capital Group, LLC (“Cascade”), the purchaser of the properties, with a short-term mortgage loan secured by these properties for $32.4 million. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In connection with the sale, the Company recognized a loss of approximately $0.1 million during the three months ended March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between the Company and a third-party institutional lender as co-lenders, pursuant to which we received $18.9 million in cash and a new mortgage loan for $13.9 million. In July 2020, the Company received prepayment in full, including accrued interest, for the new $13.9 million mortgage loan. See Note 4, Other Real Estate Investments, Net, for further detail on the new mortgage loan.
On November 1, 2020, the Company sold the one remaining owned and operated independent living facility consisting of 168 units located in Texas with an aggregate carrying value of $4.2 million for gross proceeds of $4.5 million. In connection with the sale, the Company recognized a gain of $20,000.
During the year ended December 31, 2019, the Company sold one of its owned and operated independent living facilities consisting of 38 units located in Texas with an aggregate carrying value of $1.7 million for net proceeds of $3.3 million. In connection with the sale, the Company recognized a gain of $1.6 million.
During the year ended December 31, 2018, the Company sold three assisted living facilities consisting of 102 units located in Idaho with an aggregate carrying value of $10.9 million for an aggregate price of $13.0 million. In connection with the sale, the Company recognized a gain of $2.1 million.
During the fourth quarter of 2020, the Company met the criteria to classify one skilled nursing facility operated by affiliates of Five Oaks as held for sale. Assets held for sale includes the net book value of property the Company plans to sell within the next year. If the determination is made that the Company no longer expects to sell an asset within the next year, the asset is reclassified out of assets held for sale. As of December 31, 2020, the property continued to be held for sale and the carrying value of $7.2 million is primarily comprised of real estate assets. In February 2021, the property was sold. See Note 13, Subsequent Events, for additional information.

4. OTHER REAL ESTATE INVESTMENTS, NET

Mezzanine Loan Receivable—In November 2020, the Company provided Next VA Star Realty Holdings, LLC a mezzanine loan for nine skilled nursing facilities secured by membership interests in affiliates of Next VA Star Realty Holdings, LLC for approximately $15.0 million, at an annual interest rate of 12%. The loan requires monthly interest payments, is set to mature on November 30, 2025, and may (subject to certain restrictions) be prepaid before the maturity date if paid in full and for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments equal to 24 months (less the amount of monthly interest payments made by the borrower through the date of prepayment).
Mortgage Loans Receivable—In October 2017, the Company provided an affiliate of Providence a mortgage loan secured by a skilled nursing facility for approximately $12.5 million inclusive of transaction costs, which bore a fixed interest rate of 9%. The mortgage loan, which required Providence to make monthly principal and interest payments, was set to mature on October 26, 2020 and had an option to be prepaid before the maturity date. During the three months ended December 31, 2019, Providence exercised its option to prepay the loan in full, and prepayment was received by the Company.
In February 2019, the Company provided affiliates of Covenant Care a mortgage loan secured by first mortgages on five skilled nursing facilities for approximately $11.4 million, at an annual interest rate of 9%. The loan required monthly interest payments, was set to mature on February 11, 2020, and included twosix-month extension options. During the three months ended September 30, 2019, Covenant Care exercised its option to prepay the loan in full, and prepayment was received by the Company.
In July 2019, the Company provided MCRC, LLC a real estate loan secured by a 176 bed skilled nursing facility in Manteca, California for $3.0 million, which bore a fixed interest rate of 8% and required monthly interest payments. Concurrently, the Company entered into a purchase and sale agreement to purchase the Manteca facility from MCRC, LLC for approximately $16.4 million subject to normal diligence and other contingencies. The loan documents provided for a maturity date of the earlier to occur of the closing date of the acquisition, or five business days following the termination of the purchase and sale agreement. MCRC, LLC breached its obligation to sell the Manteca facility to the Company on the terms outlined in the purchase and sale agreement and to repay the real estate loan upon its stated maturity. As a result, the Company commenced non-judicial foreclosure proceedings with respect to the Manteca facility. In January 2020, the borrower further collateralized the loan by causing one of its affiliates to grant the Company a deed of trust in the real estate and improvements that constitute
F-18

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Palm Gardens Assisted Living Facility in Yolo County, California. During the three months ended June 30, 2020, payment for the loan principal and accrued interest, including default interest, as well as reimbursement for attorney’s fees and certain other costs of suit, were received in full by the Company and, as a result, the Company withdrew all foreclosure-related proceedings related to the Manteca facility loan.
In September 2019, the Company provided affiliates of CommuniCare a $26.5 million loan secured by mortgages on the three skilled nursing facilities sold to CommuniCare, which bore a fixed interest rate of 10%. The mortgage loan, which required CommuniCare to make monthly interest payments, was set to mature on February 29, 2020, and included an option to be prepaid before the maturity date. In January 2020, the Company amended the mortgage loan’s maturity date to April 30, 2020. In April 2020, the Company amended the mortgage loan’s maturity date to May 29, 2020. During the three months ended June 30, 2020, payment for the mortgage loan and accrued interest was received in full by the Company.
In February 2020, the Company provided provided subsidiaries of Cascade a $32.4 million loan secured by mortgages on the six skilled nursing facilities formerly operated by affiliates of Metron sold to Cascade in February 2020, as discussed in Note 3, Real Estate investments, Net. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between the Company and a third-party institutional lender as co-lenders, pursuant to which the Company received $18.9 million in cash and a new mortgage loan for $13.9 million. The new mortgage loan with Cascade was secured by the same six skilled nursing facilities purchased by Cascade and was for a combined principal amount of $33.9 million, with the Company’s $13.9 million portion of the indebtedness initially bearing interest at a variable rate equal to LIBOR plus 4.00%, subject to a LIBOR floor of 1.75%. The new mortgage loan had a maturity date of April 29, 2022 and included two six-month extension options. In July 2020, prepayment for the mortgage loan of $13.9 million and accrued interest was received in full by the Company.
As of December 31, 2020, the Company had no remaining mortgage loan receivables.
During the years ended December 31, 2020, 2019 and 2018, the Company recognized $2.3 million, $2.8 million and $1.2 million, respectively, of interest income related to the mortgage and mezzanine loans. During the years ended December 31, 2020, 2019 and 2018, the Company recognized $0.3 million, $0.2 million and $0.2 million, respectively, of interest income related to its other loans receivable.
Preferred Equity Investments—In July 2016, the Company completed a $2.2 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Nampa, Idaho. In connection with its investment, CareTrust REIT obtained an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the fourth quarter of 2017 and began lease-up during the first quarter of 2018. In June 2019, the Company purchased the skilled nursing facility for approximately $16.2 million, inclusive of transaction costs. The Company paid $12.9 million after receiving back its initial investment of $2.2 million and cumulative contractual preferred return through June 18, 2019, the acquisition date, of $1.1 million.
In September 2016, the Company completed a $2.3 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Boise, Idaho. In connection with its investment, CareTrust REIT obtained an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the first quarter of 2018 and began lease-up during the second quarter of 2018. In January 2020, the Company purchased the skilled nursing facility for approximately $18.7 million, inclusive of transaction costs. The Company paid $15.0 million after receiving back its initial investment of $2.3 million and cumulative contractual preferred return through January 17, 2020, the acquisition date, of $1.4 million.
During the years ended December 31, 2020, 2019 and 2018, the Company recognized less than $0.1 million, $1.3 million (including $0.6 million for unrecognized preferred return related to prior periods) and $0.2 million, respectively, of interest income related to these preferred equity investments.
As of December 31, 2020, the Company had no remaining preferred equity investments.

F-19

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. FAIR VALUE MEASUREMENTS
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. GAAP guidance defines three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.

Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.

The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and, depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. The Company does not expect that changes in classifications between levels will be frequent.
Items Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2020, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands):
Level 1Level 2Level 3Balance as of December 31, 2020
Assets:
Mezzanine loan receivable$ $ $15,000 $15,000 
Mezzanine loan receivable: The fair value of the mezzanine loan receivable was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. As such, the Company classifies the instrument as Level 3 due to the significant unobservable inputs used in determining market interest rates for investments with similar terms. However, the fair value is not sensitive to changes in market interest rates due to the recent issuance of the loan at market interest rates. Future changes in market interest rates could materially impact the estimated discounted cash flows. As of December 31, 2020, the Company did not have any loans that were 90 days or more past due.
For the year ended December 31, 2020, there were no changes in assets and liabilities with Level 3 inputs in the fair value hierarchy.
Items Measured at Fair Value on a Non-Recurring Basis
Real Estate Investments: The Company performs quarterly impairment review procedures, primarily through continuous monitoring of events and changes in circumstances that could indicate the carrying value of its real estate assets may not be recoverable. The Company estimates fair values using Level 3 inputs and uses a combined income and market approach. Specifically, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. For the year ended December 31, 2020, there were no real estate assets deemed to be impaired. For the year ended December 31, 2019, the Company recorded an impairment expense of $16.7 million. See Note 3, Real Estate Investments, Net, for additional information.
F-20

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Items Disclosed at Fair Value
Considerable judgment is necessary to estimate the fair value disclosure of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020 and December 31, 2019 using Level 2 inputs for the Notes (as defined in Note 6, Debt, below), and Level 3 inputs, for all other financial instruments, is as follows (dollars in thousands):  
 December 31, 2020December 31, 2019
Face
Value
Carrying
Amount
Fair
Value
Face
Value
Carrying
Amount
Fair
Value
Financial assets:
Preferred equity investments$ $ $ $2,327 $3,800 $3,674 
Mortgage loans receivable   29,500 29,500 29,500 
Financial liabilities:
Senior unsecured notes payable$300,000 $296,669 $311,430 $300,000 $295,911 $312,750 
Cash and cash equivalents, accounts and other receivables, other loans receivable, and accounts payable and accrued liabilities: These balances approximate their fair values due to the short-term nature of these instruments.
Preferred equity investments: The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements.
Mortgage loans receivable: The fair values of the mortgage loans receivable were estimated using an internal valuation model that considered the expected future cash flows of the investments, the underlying collateral value, market interest rates and other credit enhancements.
Senior unsecured notes payable: The fair value of the Notes (as defined in Note 6, Debt, below) was determined using third-party quotes derived from orderly trades.
Unsecured revolving credit facility and senior unsecured term loan: The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates for similar debt arrangements.

6. DEBT
The following table summarizes the balance of the Company’s indebtedness as of December 31, 2020 and 2019 (in thousands):
December 31, 2020December 31, 2019
PrincipalDeferredCarryingPrincipalDeferredCarrying
AmountLoan FeesValueAmountLoan FeesValue
Senior unsecured notes payable$300,000 $(3,331)$296,669 $300,000 $(4,089)$295,911 
Senior unsecured term loan200,000 (1,075)198,925 200,000 (1,287)198,713 
Unsecured revolving credit facility50,000  50,000 60,000  60,000 
$550,000 $(4,406)$545,594 $560,000 $(5,376)$554,624 
Senior Unsecured Notes Payable
On May 10, 2017, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed an underwritten public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The Company used the net proceeds from the offering of the Notes to redeem all $260.0 million aggregate principal amount outstanding of its 5.875% Senior Notes due 2021, including payment of
F-21

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
the redemption price at 102.938% and all accrued and unpaid interest thereon. The Company used the remaining portion of the net proceeds of the Notes offering to pay borrowings outstanding under its senior unsecured revolving credit facility. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2017.
As of June 1, 2020, the Issuers may redeem the Notes any time at the redemption prices set forth in the indenture. As of December 31, 2020, the Issuers have not elected to redeem any of the Notes. If certain changes of control of the Company occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.
The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and certain of the Company’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers); provided, however, that such guarantees are subject to automatic release under certain customary circumstances, including if the subsidiary guarantor is sold or sells all or substantially all of its assets, the subsidiary guarantor is designated “unrestricted” for covenant purposes under the indenture, the subsidiary guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied.
The indenture contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.
As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the indenture.

Unsecured Revolving Credit Facility and Term Loan
On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Prior Credit Agreement”). As later amended on February 1, 2016, the Prior Credit Agreement provided the following: (i) a $400.0 million unsecured asset based revolving credit facility (the “Prior Revolving Facility”), (ii) a $100.0 million non-amortizing unsecured term loan (the “Prior Term Loan” and, together with the Prior Revolving Facility, the “Prior Credit Facility”), and (iii) a $250.0 million uncommitted incremental facility. The Prior Revolving Facility was scheduled to mature on August 5, 2019, subject to two, six-month extension options. The Prior Term Loan was scheduled to mature on February 1, 2023 and could be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance.
On February 8, 2019, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries entered into an amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Amended Credit Agreement”). The Amended Credit Agreement, which amended and restated the Prior Credit Agreement, provides for: (i) an unsecured revolving credit facility (the “Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) an unsecured term loan credit facility (the “Term Loan” and, together with the Revolving Facility, the “Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Borrowing availability under the Revolving Facility is subject to no default or event of default under the Amended Credit Agreement having occurred at the time of borrowing. The proceeds of the Term Loan were used, in part, to repay in full all outstanding borrowings under the Prior Term Loan and Prior Revolving Facility under the Prior Credit Agreement. Future borrowings under the Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
F-22

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The interest rates applicable to loans under the Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.10% to 0.55% per annum or LIBOR plus a margin ranging from 1.10% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or LIBOR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and its consolidated subsidiaries (unless the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based on the credit ratings of the Company’s senior long-term unsecured debt). As of December 31, 2020, the Operating Partnership had $200.0 million outstanding under the Term Loan and $50.0 million outstanding under the Revolving Facility.
The Revolving Facility has a maturity date of February 8, 2023, and includes, at the sole discretion of the Operating Partnership, two, six-month extension options. The Term Loan has a maturity date of February 8, 2026.
The Amended Credit Facility is guaranteed, jointly and severally, by the Company and its wholly owned subsidiaries that are party to the Amended Credit Agreement (other than the Operating Partnership). The Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend organizational documents and pay certain dividends and other restricted payments. The Amended Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio, a maximum secured recourse debt to asset value ratio, a maximum unsecured debt to unencumbered properties asset value ratio, a minimum unsecured interest coverage ratio and a minimum rent coverage ratio. The Amended Credit Agreement also contains certain customary events of default, including the failure to make timely payments under the Amended Credit Facility or other material indebtedness, the failure to satisfy certain covenants (including the financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency.
As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.
Schedule of Debt Maturities
As of December 31, 2020, the Company’s debt maturities were (dollars in thousands):  
Year
Amount
2021$ 
2022 
202350,000 
2024 
2025300,000 
Thereafter200,000 
 $550,000 

F-23

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7. EQUITY
Common Stock
Public Offering of Common Stock—On April 15, 2019, the Company completed an underwritten public offering of 6,641,250 shares of its common stock, par value $0.01 per share, at an initial price to the public of $23.35, including 866,250 shares of common stock sold pursuant to the full exercise of an option to purchase additional shares of common stock granted to the underwriters, resulting in approximately $149.0 million in net proceeds, after deducting the underwriting discount and offering expenses. The Company used the proceeds from the offering to repay a portion of the outstanding borrowings on its Revolving Facility, which had been used to fund a portion of the purchase price of acquisitions in the second quarter of 2019.
At-The-Market Offering—On March 10, 2020, the Company entered into a new equity distribution agreement to issue and sell, from time to time, up to $500.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “New ATM Program”). In connection with the entry into the equity distribution agreement and the commencement of the New ATM Program, the Company’s “at-the-market” equity offering program pursuant to the Company’s prior equity distribution agreement, dated as of March 4, 2019, was terminated (the “Prior ATM Program”).
There was no New ATM Program or Prior ATM Program activity (or activity under any predecessor at-the-market equity offering programs) for 2020. The following table summarizes predecessor at-the-market equity offering program activity for the year ended 2019 (in thousands, except per share amounts):
For the Year Ended December 31,
2019
Number of shares2,459 
Average sales price per share$19.48 
Gross proceeds(1)
$47,893 
(1)    Total gross proceeds is before $0.6 million of commissions paid to the sales agents during the year ended December 31, 2019 under the predecessor ATM Program.
As of December 31, 2020, the Company had $500.0 million available for future issuances under the New ATM Program.
Share Repurchase Program — On March 20, 2020, the Company’s Board of Directors authorized a share repurchase program up to $150.0 million of outstanding shares of the Company’s common stock (the “Repurchase Program”). Repurchases under the Repurchase Program, which expires on March 31, 2023, may be made through open market purchases, privately negotiated transactions, structured or derivative transactions, including accelerated share repurchase transactions, or other methods of acquiring shares, in each case subject to market conditions and at such times as shall be permitted by applicable securities laws and determined by management. Repurchases under the Repurchase Program may also be made pursuant to a plan adopted under Rule 10b5-1 promulgated under the Exchange Act. The Company expects to finance any share repurchases under the Repurchase Program using available cash and may also use short-term borrowings under the Revolving Facility. The Company did not repurchase any shares of common stock under the Repurchase Program during the year ended December 31, 2020. The Repurchase Program may be modified, discontinued or suspended at any time.
F-24

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Dividends on Common StockThe following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2020, 2019 and 2018 (dollars in thousands, except per share amounts):
For the Three Months Ended
2020March 31,June 30,September 30,December 31,
Dividends declared$0.25 $0.25 $0.25 $0.25 
Dividends payment dateApril 15, 2020July 15, 2020October 15, 2020January 15, 2021
Dividends payable as of record date$23,931 $23,931 $23,934 $23,933 
Dividends record dateMarch 31, 2020June 30, 2020September 30, 2020December 31, 2020
2019
Dividends declared$0.225 $0.225 $0.225 $0.225 
Dividends payment dateApril 15, 2019July 15, 2019October 15, 2019January 15, 2020
Dividends payable as of record date$20,011 $21,508 $21,500 $21,500 
Dividends record dateMarch 29, 2019June 28, 2019September 30, 2019December 31, 2019
2018
Dividends declared$0.205 $0.205 $0.205 $0.205 
Dividends payment dateApril 13, 2018July 13, 2018October 15, 2018January 15, 2019
Dividends payable as of record date$15,608 $16,224 $17,196 $17,710 
Dividends record dateMarch 30, 2018June 29, 2018September 28, 2018December 31, 2018

8. STOCK-BASED COMPENSATION
All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company.
The following table summarizes restricted stock award and performance award activity for the years ended December 31, 2020 and 2019:
SharesWeighted Average Share Price
Unvested balance at December 31, 2018519,272 $14.69 
Granted180,629 22.22 
Vested(247,534)14.50 
Forfeited(134)15.21 
Unvested balance at December 31, 2019452,233 17.90 
Granted270,191 19.11 
Vested(201,563)17.41 
Forfeited(3,175)20.30 
Unvested balance at December 31, 2020517,686 $18.71 

The following table summarizes the stock-based compensation expense recognized (dollars in thousands):
 For Year Ended December 31,
 202020192018
Stock-based compensation expense$3,790 $4,104 $3,848 
F-25

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
As of December 31, 2020, there was $5.5 million of unamortized stock-based compensation expense related to these unvested awards and the weighted-average remaining vesting period of such awards was 2.3 years. 
In connection with the separation of Ensign’s healthcare business and its real estate business into two separate and independently publicly traded companies (the “Spin-Off”) on June 1, 2014, employees of Ensign who had unvested shares of restricted stock were given one share of CareTrust REIT unvested restricted stock totaling 207,580 shares at the Spin-Off. These restricted shares were subject to a time vesting provision only and the Company did not recognize any stock compensation expense associated with these awards. During the year ended December 31, 2020, 1,760 shares were forfeited. At December 31, 2020, there were no unvested restricted stock awards outstanding.
In January 2020 and March 2020, the Compensation Committee of the Company’s Board of Directors granted 27,000 and 107,790 shares of restricted stock, respectively, to officers and employees. Each share had a fair market value on the date of grant of $22.18 and $19.06 per share, respectively, based on the closing market price of the Company’s common stock on that date, and the shares vest in four equal installments beginning on the first anniversary of the grant date. Additionally, in March 2020, the Compensation Committee granted 107,790 performance stock awards to officers. Each share had a fair market value on the date of grant of $19.06 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a one-to four-year period. The amount of performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding a fixed per share amount.
In April 2020, the Compensation Committee of the Company’s Board of Directors granted 27,611 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $16.48 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in full on the earlier to occur of April 29, 2021 or the Company’s 2021 Annual Meeting of Stockholders.
In February 2019, the Compensation Committee of the Company’s Board of Directors granted 91,440 shares of restricted stock to officers and employees. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in four equal annual installments beginning on the first anniversary of the grant date. Additionally, in February 2019, the Compensation Committee granted 71,440 performance stock awards to officers. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a one- to four-year period. The amount of performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding fiscal year over year growth of 5.0% or greater.
In May 2019, the Compensation Committee of the Company's Board of Directors granted 17,749 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $24.23 per share, based on the closing market price of the Company's common stock on that date, and the shares vested in full on April 30, 2020.

F-26

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. EARNINGS PER COMMON SHARE
The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the years ended December 31, 2020, 2019 and 2018, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the years ended December 31, 2020, 2019 and 2018 (amounts in thousands, except per share amounts):
 
 Year Ended December 31,
 202020192018
Numerator:
Net income$80,867 $46,359 $57,923 
Less: Net income allocated to participating securities(298)(296)(364)
Numerator for basic and diluted earnings available to common stockholders$80,569 $46,063 $57,559 
Denominator:
Weighted-average basic common shares outstanding95,200 93,088 79,386 
   Dilutive performance stock awards7 10 6 
Weighted-average diluted common shares outstanding95,207 93,098 79,392 
Earnings per common share, basic$0.85 $0.49 $0.73 
Earnings per common share, diluted$0.85 $0.49 $0.72 
The Company’s unvested restricted shares associated with its incentive award plan and unvested restricted shares issued to employees of Ensign at the Spin-Off have been excluded from the above calculation of earnings per share for the years ended December 31, 2020, 2019 and 2018, when their inclusion would have been anti-dilutive.

10. COMMITMENTS AND CONTINGENCIES
The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which are not individually or in the aggregate anticipated to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. Claims and lawsuits may include matters involving general or professional liability asserted against the Company’s tenants, which are the responsibility of the Company’s tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.
Capital expenditures for each property leased under the Company’s triple-net leases are generally the responsibility of the tenant, except that, for the facilities leased to subsidiaries of Ensign, under the Ensign Master Leases, and The Pennant Group, Inc., the tenant will have an option to require the Company to finance certain capital expenditures up to an aggregate of 20% of its initial investment in such property, subject to a corresponding rent increase at the time of funding. For the Company’s other triple-net master leases, the tenants also have the option to request capital expenditure funding that would generally be subject to a corresponding rent increase at the time of funding, which are subject to tenant compliance with the conditions to the Company’s approval and funding of their requests. As of December 31, 2020, the Company had committed to fund expansions, construction and capital improvements at certain triple-net leased facilities totaling $15.4 million, of which $14.2 million is subject to rent increase at the time of funding.

11. CONCENTRATION OF RISK
Major operator concentration – As of December 31, 2020, Ensign leased 89 skilled nursing, assisted living and independent living facilities which had a total of 9,546 beds and units and are located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Texas, Utah and Washington. The four states in which Ensign leases the highest concentration of properties are Texas, California, Arizona and Utah. During the years ended December 31, 2020, 2019 and 2018, Ensign represented 32%, 38% and 42%, respectively, of the Company’s rental income, exclusive of operating expense reimbursements. On October 1, 2019, Ensign completed the Pennant Spin. See Note 3, Real Estate Investments, Net, for additional information regarding the Company’s facilities leased to Ensign subsequent to the Pennant Spin.
F-27

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Ensign is subject to the registration and reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s financial statements, as filed with the SEC, can be found at http://www.sec.gov. The Company has not verified this information through an independent investigation or otherwise.
As of December 31, 2020, PMG leased 15 skilled nursing facilities which had a total of 2,145 beds and units and are located in Louisiana and Texas. During the years ended December 31, 2020, 2019 and 2018, PMG represented 16%, 15% and 8%, respectively, of the Company’s rental income, exclusive of operating expense reimbursements.

12. SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)
The following table presents selected quarterly financial data for the Company. This information has been prepared on a basis consistent with that of the Company’s audited consolidated financial statements. The Company’s quarterly results of operations for the periods presented are not necessarily indicative of future results of operations. This unaudited quarterly data should be read together with the accompanying consolidated financial statements and related notes thereto (in thousands, except per share amounts):
 For the Year Ended December 31, 2020
 First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Operating data:
Total revenues$44,340 $44,168 $45,687 $44,137 
Net income$19,325 $18,935 $21,552 $21,055 
Earnings per common share, basic$0.20 $0.20 $0.23 $0.22 
Earnings per common share, diluted$0.20 $0.20 $0.23 $0.22 
Other data:
Weighted-average number of common shares outstanding, basic95,161 95,208 95,214 95,215 
Weighted-average number of common shares outstanding, diluted95,161 95,208 95,214 95,244 
 For the Year Ended December 31, 2019
 First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Operating data:
Total revenues$39,658 $46,201 $33,314 $44,228 
Net income (loss)$16,053 $19,698 $(10,054)$20,662 
Earnings per common share, basic$0.18 $0.21 $(0.11)$0.22 
Earnings per common share, diluted$0.18 $0.21 $(0.11)$0.22 
Other data:
Weighted-average number of common shares outstanding, basic88,010 94,036 95,103 95,103 
Weighted-average number of common shares outstanding, diluted88,010 94,036 95,103 95,144 

13. SUBSEQUENT EVENTS
The Company evaluates subsequent events in accordance with ASC 855, Subsequent Events. The Company evaluates subsequent events up until the date the consolidated financial statements are issued.
Asset Sale
On February 1, 2021, the Company closed on the sale of one skilled nursing facility consisting of 90 units located in Washington with a carrying value of $7.2 million, for gross sales proceeds of $7.3 million. The Company does not expect to record a material gain or loss in connection with the sale. The facility was classified as held for sale as of December 31, 2020.

F-28

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)

Initial Cost to Company Gross Carrying Value
DescriptionFacilityLocationEncum.LandBuilding
Improvs.
Costs
Cap.
Since
Acq.
LandBuilding
Improvs.
Total (1)Accum. Depr.Const./Ren. DateAcq.
Date
Skilled Nursing Properties:
Ensign Highland LLCHighland ManorPhoenix, AZ$ $257 $976 $926 $257 $1,902 $2,159 $(1,311)20132000
Meadowbrook Health Associates LLCSabino CanyonTucson, AZ 425 3,716 1,940 425 5,656 6,081 (3,103)20122000
Terrace Holdings AZ LLCDesert TerracePhoenix, AZ 113 504 971 113 1,475 1,588 (865)20042002
Rillito Holdings LLCCatalinaTucson, AZ 471 2,041 3,055 471 5,096 5,567 (3,029)20132003
Valley Health Holdings LLCNorth MountainPhoenix, AZ 629 5,154 1,519 629 6,673 7,302 (3,801)20092004
Cedar Avenue Holdings LLCUplandUpland, CA 2,812 3,919 1,994 2,812 5,913 8,725 (3,475)20112005
Granada Investments LLCCamarilloCamarillo, CA 3,526 2,827 1,522 3,526 4,349 7,875 (2,595)20102005
Plaza Health Holdings LLCPark ManorWalla Walla, WA 450 5,566 1,055 450 6,621 7,071 (3,878)20092006
Mountainview Communitycare LLCPark View GardensSanta Rosa, CA 931 2,612 653 931 3,265 4,196 (2,082)19632006
CM Health Holdings LLCCarmel MountainSan Diego, CA 3,028 3,119 2,071 3,028 5,190 8,218 (2,981)20122006
Polk Health Holdings LLCTimberwoodLivingston, TX 60 4,391 1,167 60 5,558 5,618 (3,116)20092006
Snohomish Health Holdings LLCEmerald HillsLynnwood, WA 741 1,663 1,998 741 3,661 4,402 (2,564)20092006
Cherry Health Holdings LLCPacific CareHoquiam, WA 171 1,828 2,038 171 3,866 4,037 (2,525)20102006
Golfview Holdings LLCCambridge SNFRichmond, TX 1,105 3,110 1,067 1,105 4,177 5,282 (2,246)20072006
Tenth East Holdings LLCArlington HillsSalt Lake City, UT 332 2,426 2,507 332 4,933 5,265 (3,054)20132006
Trinity Mill Holdings LLCCarrolltonCarrollton, TX 664 2,294 902 664 3,196 3,860 (2,262)20072006
Cottonwood Health Holdings LLCHolladaySalt Lake City, UT 965 2,070 958 965 3,028 3,993 (2,275)20082007
Verde Villa Holdings LLCLake VillageLewisville, TX 600 1,890 470 600 2,360 2,960 (1,438)20112007
Mesquite Health Holdings LLCWillow BendMesquite, TX 470 1,715 8,661 470 10,376 10,846 (7,112)20122007
Arrow Tree Health Holdings LLCArbor GlenGlendora, CA 2,165 1,105 324 2,165 1,429 3,594 (1,010)19652007
Fort Street Health Holdings LLCDraperDraper, UT 443 2,394 759 443 3,153 3,596 (1,603)20082007
Trousdale Health Holdings LLCBrookfieldDowney, CA 1,415 1,841 1,861 1,415 3,702 5,117 (2,052)20132007
Ensign Bellflower LLCRose VillaBellflower, CA 937 1,168 357 937 1,525 2,462 (925)20092007
RB Heights Health Holdings LLCOsbornScottsdale, AZ 2,007 2,793 1,762 2,007 4,555 6,562 (2,528)20092008
San Corrine Health Holdings LLCSalado CreekSan Antonio, TX 310 2,090 719 310 2,809 3,119 (1,456)20052008
Temple Health Holdings LLCWellingtonTemple, TX 529 2,207 1,163 529 3,370 3,899 (1,806)20082008
Anson Health Holdings LLCNorthern OaksAbilene, TX 369 3,220 1,725 369 4,945 5,314 (2,544)20122008
Willits Health Holdings LLCNorthbrookWillits, CA 490 1,231 500 490 1,731 2,221 (889)20112008
Lufkin Health Holdings LLCSouthlandLufkin, TX 467 4,644 782 467 5,426 5,893 (1,630)19882009
Lowell Health Holdings LLCLittletonLittleton, CO 217 856 1,735 217 2,591 2,808 (1,421)20122009
Jefferson Ralston Holdings LLCArvadaArvada, CO 280 1,230 834 280 2,064 2,344 (920)20122009
Lafayette Health Holdings LLCJulia TempleEnglewood, CO 1,607 4,222 6,195 1,607 10,417 12,024 (5,021)20122009
F-29

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)
Hillendahl Health Holdings LLCGolden AcresDallas, TX 2,133 11,977 1,421 2,133 13,398 15,531 (5,530)19842009
Price Health Holdings LLCPinnaclePrice, UT 193 2,209 849 193 3,058 3,251 (1,102)20122009
Silver Lake Health Holdings LLCProvoProvo, UT 2,051 8,362 2,011 2,051 10,373 12,424 (3,208)20112009
Jordan Health Properties LLCCopper RidgeWest Jordan, UT 2,671 4,244 1,507 2,671 5,751 8,422 (1,817)20132009
Regal Road Health Holdings LLCSunviewYoungstown, AZ 767 4,648 729 767 5,377 6,144 (2,063)20122009
Paredes Health Holdings LLCAlta VistaBrownsville, TX 373 1,354 190 373 1,544 1,917 (464)19692009
Expressway Health Holdings LLCVerandaHarlingen, TX 90 675 430 90 1,105 1,195 (455)20112009
Rio Grande Health Holdings LLCGrand TerraceMcAllen, TX 642 1,085 870 642 1,955 2,597 (934)20122009
Fifth East Holdings LLCParamountSalt Lake City, UT 345 2,464 1,065 345 3,529 3,874 (1,355)20112009
Emmett Healthcare Holdings LLCRiver's EdgeEmmet, ID 591 2,383 69 591 2,452 3,043 (801)19722010
Burley Healthcare Holdings LLCParke ViewBurley, ID 250 4,004 424 250 4,428 4,678 (1,589)20112010
Josey Ranch Healthcare Holdings LLCHeritage GardensCarrollton, TX 1,382 2,293 478 1,382 2,771 4,153 (934)19962010
Everglades Health Holdings LLCVictoria VenturaVentura, CA 1,847 5,377 682 1,847 6,059 7,906 (1,667)19902011
Irving Health Holdings LLCBeatrice ManorBeatrice, NE 60 2,931 245 60 3,176 3,236 (1,063)20112011
Falls City Health Holdings LLCCareage Estates of Falls CityFalls City, NE 170 2,141 82 170 2,223 2,393 (677)19722011
Gillette Park Health Holdings LLCCareage of CherokeeCherokee, IA 163 1,491 12 163 1,503 1,666 (576)19672011
Gazebo Park Health Holdings LLCCareage of ClarionClarion, IA 80 2,541 97 80 2,638 2,718 (1,052)19782011
Oleson Park Health Holdings LLCCareage of Ft. DodgeFt. Dodge, IA 90 2,341 759 90 3,100 3,190 (1,527)20122011
Arapahoe Health Holdings LLCOceanviewTexas City, TX 158 4,810 759 128 5,599 5,727 (2,030)20122011
Dixie Health Holdings LLCHurricaneHurricane, UT 487 1,978 98 487 2,076 2,563 (525)19782011
Memorial Health Holdings LLCPocatelloPocatello, ID 537 2,138 698 537 2,836 3,373 (1,077)20072011
Bogardus Health Holdings LLCWhittier EastWhittier, CA 1,425 5,307 1,079 1,425 6,386 7,811 (2,258)20112011
South Dora Health Holdings LLCUkiahUkiah, CA 297 2,087 1,621 297 3,708 4,005 (2,096)20132011
Silverada Health Holdings LLCRosewoodReno, NV 1,012 3,282 103 1,012 3,385 4,397 (803)19702011
Orem Health Holdings LLCOremOrem, UT 1,689 3,896 3,235 1,689 7,131 8,820 (2,940)20112011
Wisteria Health Holdings LLCWisteriaAbilene, TX 746 9,903 290 746 10,193 10,939 (2,267)20082011
Renee Avenue Health Holdings LLCMonte VistaPocatello, ID 180 2,481 966 180 3,447 3,627 (1,219)20132012
Stillhouse Health Holdings LLCStillhouseParis, TX 129 7,139 6 129 7,145 7,274 (1,079)20092012
Fig Street Health Holdings LLCPalomar VistaEscondido, CA 329 2,653 1,094 329 3,747 4,076 (1,627)20072012
Lowell Lake Health Holdings LLCOwyheeOwyhee, ID 49 1,554 29 49 1,583 1,632 (312)19902012
Queensway Health Holdings LLCAtlantic MemorialLong Beach, CA 999 4,237 2,331 999 6,568 7,567 (2,886)20082012
Long Beach Health Associates LLCShorelineLong Beach, CA 1,285 2,343 2,172 1,285 4,515 5,800 (1,943)20132012
Kings Court Health Holdings LLCRichland HillsFt. Worth, TX 193 2,311 318 193 2,629 2,822 (635)19652012
51st Avenue Health Holdings LLCLegacyAmarillo, TX 340 3,925 32 340 3,957 4,297 (895)19702013
Ives Health Holdings LLCSan MarcosSan Marcos, TX 371 2,951 274 371 3,225 3,596 (697)19722013
Guadalupe Health Holdings LLCThe Courtyard (Victoria East)Victoria, TX 80 2,391 15 80 2,406 2,486 (422)20132013
49th Street Health Holdings LLCOmahaOmaha, NE 129 2,418 24 129 2,442 2,571 (629)19602013
F-30

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)
Willows Health Holdings LLCCascade VistaRedmond, WA 1,388 2,982 202 1,388 3,184 4,572 (909)19702013
Tulalip Bay Health Holdings LLCMountain ViewMarysville, WA 1,722 2,642 (980)742 2,642 3,384 (660)19662013
Sky Holdings AZ LLCBella Vita Health and Rehabilitation CenterGlendale, AZ 228 1,124 1,380 228 2,504 2,731 (1,727)20042002
Lemon River Holdings LLCPlymouth TowerRiverside, CA 152 357 1,493 152 1,850 2,002 (1,163)20122009
CTR Partnership, L.P.Bethany Rehabilitation CenterLakewood, CO 1,668 15,375 56 1,668 15,431 17,099 (2,285)19892015
CTR Partnership, L.P.Mira Vista Care CenterMount Vernon, WA 1,601 7,425  1,601 7,425 9,026 (1,067)19892015
CTR Partnership, L.P.Shoreline Health and Rehabilitation CenterShoreline, WA 1,462 5,034  1,462 5,034 6,496 (703)19872015
CTR Partnership, L.P.Shamrock Nursing and Rehabilitation CenterDublin, GA 251 7,855  251 7,855 8,106 (1,080)20102015
CTR Partnership, L.P.BeaverCreek Health and RehabBeavercreek, OH 892 17,159 13 892 17,172 18,064 (2,254)20142015
CTR Partnership, L.P.Premier Estates of Cincinnati-RiverviewCincinnati, OH 833 18,086 192 833 18,278 19,111 (2,416)19922015
CTR Partnership, L.P.Englewood Health and RehabEnglewood, OH 1,014 18,541 88 1,014 18,629 19,643 (2,464)19622015
CTR Partnership, L.P.Portsmouth Health and RehabPortsmouth, OH 282 9,726 428 282 10,154 10,436 (1,400)20082015
CTR Partnership, L.P.West Cove Care & Rehabilitation CenterToledo, OH 93 10,365  93 10,365 10,458 (1,360)20072015
CTR Partnership, L.P.BellBrook Health and RehabBellbrook, OH 214 2,573 231 214 2,804 3,018 (385)20032015
CTR Partnership, L.P.Xenia Health and RehabXenia, OH 205 3,564 23 205 3,587 3,792 (471)19812015
CTR Partnership, L.P.Jamestown Place Health and RehabJamestown, OH 266 4,725 268 266 4,993 5,259 (694)19672015
CTR Partnership, L.P.Casa de PazSioux City, IA 119 7,727  119 7,727 7,846 (950)19742016
CTR Partnership, L.P.Denison Care CenterDenison, IA 96 2,784  96 2,784 2,880 (342)20152016
CTR Partnership, L.P.Garden View Care CenterShenandoah, IA 105 3,179  105 3,179 3,284 (391)20132016
CTR Partnership, L.P.Grandview Health Care CenterDayton, IA 39 1,167  39 1,167 1,206 (143)20142016
CTR Partnership, L.P.Grundy Care CenterGrundy Center, IA 65 1,935  65 1,935 2,000 (238)20112016
CTR Partnership, L.P.Iowa City Rehab and Health Care CenterIowa City, IA 522 5,690  522 5,690 6,212 (699)20142016
CTR Partnership, L.P.Lenox Care CenterLenox, IA 31 1,915  31 1,915 1,946 (235)20122016
CTR Partnership, L.P.OsageOsage, IA 126 2,255  126 2,255 2,381 (277)20142016
CTR Partnership, L.P.Pleasant Acres Care CenterHull, IA 189 2,544  189 2,544 2,733 (313)20142016
CTR Partnership, L.P.Cedar Falls Health Care CenterCedar Falls, IA 324 4,366  324 4,366 4,690 (518)20152016
CTR Partnership, L.P.Premier Estates of HighlandsNorwood, OH 364 2,199 282 364 2,481 2,845 (293)20122016
CTR Partnership, L.P.Shaw Mountain at CascadiaBoise, ID 1,801 6,572 395 1,801 6,967 8,768 (908)19892016
CTR Partnership, L.P.The OaksPetaluma, CA 3,646 2,873 110 3,646 2,983 6,629 (353)20152016
CTR Partnership, L.P.Arbor Nursing CenterLodi, CA 768 10,712  768 10,712 11,480 (1,183)19822016
CTR Partnership, L.P.Broadmoor Medical LodgeRockwall, TX 1,232 22,152  1,232 22,152 23,384 (2,262)19842016
CTR Partnership, L.P.Decatur Medical LodgeDecatur, TX 990 24,909  990 24,909 25,899 (2,543)20132016
CTR Partnership, L.P.Royse City Medical LodgeRoyse City, TX 606 14,660  606 14,660 15,266 (1,497)20092016
F-31

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)
CTR Partnership, L.P.Saline Care Nursing & Rehabilitation CenterHarrisburg, IL 1,022 5,713  1,022 5,713 6,735 (547)20092017
CTR Partnership, L.P.Carrier Mills Nursing & Rehabilitation CenterCarrier Mills, IL 775 8,377  775 8,377 9,152 (803)19682017
CTR Partnership, L.P.StoneBridge Nursing & Rehabilitation CenterBenton, IL 439 3,475  439 3,475 3,914 (333)20142017
CTR Partnership, L.P.DuQuoin Nursing & Rehabilitation CenterDuQuoin, IL 511 3,662  511 3,662 4,173 (351)20142017
CTR Partnership, L.P.Pinckneyville Nursing & Rehabilitation CenterPinckneyville, IL 406 3,411  406 3,411 3,817 (327)20142017
CTR Partnership, L.P.Wellspring Health and Rehabilitation of CascadiaNampa, ID 774 5,044 111 774 5,155 5,929 (462)20112017
CTR Partnership, L.P.The Rio at Fox HollowBrownsville, TX 1,178 12,059  1,178 12,059 13,237 (1,080)20162017
CTR Partnership, L.P.The Rio at CabezonAlbuquerque, NM 2,055 9,749  2,055 9,749 11,804 (873)20162017
CTR Partnership, L.P.Eldorado Rehab & HealthcareEldorado, IL 940 2,093  940 2,093 3,033 (183)19932017
CTR Partnership, L.P.Secora Health and Rehabilitation of CascadiaPortland, OR 1,481 2,216 110 1,481 2,326 3,807 (194)20122017
CTR Partnership, L.P.Mountain ValleyKellogg, ID 916 7,874  916 7,874 8,790 (656)19712017
CTR Partnership, L.P.Caldwell CareCaldwell, ID 906 7,020 516 906 7,536 8,442 (585)19472017
CTR Partnership, L.P.Canyon WestCaldwell, ID 312 10,410 431 312 10,841 11,153 (868)19692017
CTR Partnership, L.P.Lewiston Health and RehabilitationLewiston, ID 625 12,087 152 625 12,239 12,864 (982)19642017
CTR Partnership, L.P.The OrchardsNampa, ID 785 8,923 47 785 8,970 9,755 (725)19582017
CTR Partnership, L.P.Weiser CareWeiser, ID 80 4,419 30 80 4,449 4,529 (359)19642017
CTR Partnership, L.P.Aspen ParkMoscow, ID 698 5,092 274 698 5,366 6,064 (438)19652017
CTR Partnership, L.P.Ridgmar Medical LodgeFort Worth, TX 681 6,587 1,256 681 7,843 8,524 (702)20062017
CTR Partnership, L.P.Mansfield Medical LodgeMansfield, TX 607 4,801 1,178 607 5,979 6,586 (513)20062017
CTR Partnership, L.P.Grapevine Medical LodgeGrapevine, TX 1,602 4,536 891 1,602 5,427 7,029 (486)20062017
CTR Partnership, L.P.Brookfield Health and RehabBattle Ground, WA 320 500  320 500 820 (42)20122017
CTR Partnership, L.P.The Oaks at LakewoodTacoma, WA 1,000 1,779  1,000 1,779 2,779 (145)19892017
CTR Partnership, L.P.The Oaks at TimberlineVancouver, WA 445 869  445 869 1,314 (71)19722017
CTR Partnership, L.P.Providence Waterman Nursing CenterSan Bernardino, CA 3,831 19,791  3,831 19,791 23,622 (1,608)19672017
CTR Partnership, L.P.Providence Orange TreeRiverside, CA 2,897 14,700  2,897 14,700 17,597 (1,194)19692017
CTR Partnership, L.P.Providence OntarioOntario, CA 4,204 21,880  4,204 21,880 26,084 (1,778)19802017
CTR Partnership, L.P.Greenville Nursing & Rehabilitation CenterGreenville, IL 188 3,972  188 3,972 4,160 (366)19732017
CTR Partnership, L.P.Copper Ridge Health and Rehabilitation CenterButte, MT 220 4,974  220 4,974 5,194 (398)20102018
CTR Partnership, L.P.Prairie Heights Healthcare CenterAberdeen, SD 1,372 7,491  1,372 7,491 8,863 (510)19652018
CTR Partnership, L.P.The Meadows on UniversityFargo, ND 989 3,275  989 3,275 4,264 (196)19662018
CTR Partnership, L.P.The Suites - ParkerParker, CO 1,178 17,857  1,178 17,857 19,035 (952)20122018
F-32

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)
CTR Partnership, L.P.Huntington Park Nursing CenterHuntington Park, CA 3,131 8,876 299 3,131 9,175 12,306 (464)19552019
CTR Partnership, L.P.Shoreline Care CenterOxnard, CA 1,699 9,004  1,699 9,004 10,703 (443)19622019
CTR Partnership, L.P.Downey Care CenterDowney, CA 2,502 6,141  2,502 6,141 8,643 (303)19672019
CTR Partnership, L.P.Courtyard Healthcare CenterDavis, CA 2,351 9,256  2,351 9,256 11,607 (464)19692019
Gulf Coast Buyer 1 LLCAlpine Skilled Nursing and RehabilitationRuston, LA 2,688 23,825  2,688 23,825 26,513 (1,100)20142019
Gulf Coast Buyer 1 LLCThe Bradford Skilled Nursing and RehabilitationShreveport, LA 3,758 21,325 17 3,758 21,342 25,100 (992)19802019
Gulf Coast Buyer 1 LLCColonial Oaks Skilled Nursing and RehabilitationBossier City, LA 1,635 21,180  1,635 21,180 22,815 (954)20132019
Gulf Coast Buyer 1 LLCThe Guest House Skilled Nursing and RehabilitationShreveport, LA 3,437 20,889 184 3,437 21,073 24,510 (984)20062019
Gulf Coast Buyer 1 LLCPilgrim Manor Skilled Nursing and RehabilitationBossier City, LA 2,979 24,617  2,979 24,617 27,596 (1,123)20082019
Gulf Coast Buyer 1 LLCShreveport Manor Skilled Nursing and RehabilitationShreveport, LA 676 10,238 361 676 10,599 11,275 (481)20082019
Gulf Coast Buyer 1 LLCBooker T. Washington Skilled Nursing and RehabilitationShreveport, LA 2,452 9,148 113 2,452 9,261 11,713 (447)20132019
Gulf Coast Buyer 1 LLCLegacy West Rehabilitation and HealthcareCorsicana, TX 120 6,682 409 120 7,091 7,211 (340)20022019
Gulf Coast Buyer 1 LLCLegacy at JacksonvilleJacksonville, TX 173 7,481 127 173 7,608 7,781 (369)20062019
Gulf Coast Buyer 1 LLCPecan Tree Rehabilitation and HealthcareGainesville, TX 219 10,097 285 219 10,382 10,601 (481)19902019
Lakewest SNF Realty, LLCLakewest Rehabilitation and Skilled CareDallas, TX  6,905   6,905 6,905 (322)20112019
CTR Partnership, L.P.Cascadia of NampaNampa, ID 880 14,117  880 14,117 14,997 (594)20172019
CTR Partnership, L.P.Valley Skilled NursingModesto, CA 798 7,671  798 7,671 8,469 (249)20162019
CTR Partnership, L.P.Cascadia of BoiseBoise, ID 1,597 15,692  1,597 15,692 17,289 (412)20182020
CTR Partnership, L.P.Cooney Healthcare and RehabilitationHelena, MT 867 7,431  867 7,431 8,298 (65)19842020
CTR Partnership, L.P.Elkhorn Healthcare and RehabilitationClancy, MT 183 7,380  183 7,380 7,563 (66)19602020
CTR Partnership, L.P.Beacon Harbor Healthcare and RehabilitationRockwall, TX 1,295 17,069  1,295 17,069 18,364 (76)19962020
CTR Partnership, L.P.Pleasant Manor Healthcare and RehabilitationWaxahachie, TX 629 7,433  629 7,433 8,062 (33)19722020
CTR Partnership, L.P.Rowlett Health and Rehabilitation CenterRowlett, TX 1,036 10,516  1,036 10,516 11,552 (47)19902020
 145,155 963,927 92,226 144,145 1,057,163 1,201,307 (194,390)
Multi-Service Campus Properties:
Ensign Southland LLCSouthland CareNorwalk, CA 966 5,082 2,213 966 7,295 8,261 (5,292)20111999
Mission CCRC LLCSt. Joseph's VillaSalt Lake City, UT 1,962 11,035 464 1,962 11,499 13,461 (3,327)19942011
Wayne Health Holdings LLCCareage of WayneWayne, NE 130 3,061 122 130 3,183 3,313 (994)19782011
F-33

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)
4th Street Holdings LLCWest Bend Care CenterWest Bend, IA 180 3,352  180 3,352 3,532 (991)20062011
Big Sioux River Health Holdings LLCHillcrest HealthHawarden, IA 110 3,522 75 110 3,597 3,707 (998)19742011
Prairie Health Holdings LLCColonial Manor of RandolphRandolph, NE 130 1,571 22 130 1,593 1,723 (758)20112011
Salmon River Health Holdings LLCDiscovery Care CenterSalmon, ID 168 2,496  168 2,496 2,664 (525)20122012
CTR Partnership, L.P.Centerville Senior Independent LivingDayton, OH 3,912 22,458 117 3,781 22,706 26,487 (3,018)20072015
CTR Partnership, L.P.Liberty Nursing Center of WillardWillard, OH 143 11,097 50 143 11,147 11,290 (1,477)19852015
CTR Partnership, L.P.Premier Estates of Middletown/Premier Retirement Estates of MiddletownMiddletown, OH 990 7,484 172 990 7,656 8,646 (1,025)19852015
CTR Partnership, L.P.Premier Estates of Norwood Towers/Premier Retirement Estates of Norwood TowersNorwood, OH 1,316 10,071 499 1,316 10,570 11,886 (1,249)19912016
CTR Partnership, L.P.Turlock Nursing and Rehabilitation CenterTurlock, CA 1,258 16,526  1,258 16,526 17,784 (1,825)19862016
CTR Partnership, L.P.Bridgeport Medical LodgeBridgeport, TX 980 27,917  980 27,917 28,897 (2,850)20142016
CTR Partnership, L.P.The Villas at SaratogaSaratoga, CA 8,709 9,736 1,396 8,709 11,132 19,841 (617)20042018
CTR Partnership, L.P.Madison Park HealthcareHuntington, WV 601 6,385  601 6,385 6,986 (359)19242018
CTR Partnership, L.P.Oakview Heights Nursing & Rehabilitation CenterMt. Carmel, IL 298 8,393  298 8,393 8,691 (455)20042019
Gulf Coast Buyer 1 LLCSpring Lake Skilled Nursing and RehabilitationShreveport, LA 3,217 21,195 2,525 3,217 23,720 26,937 (1,008)20082019
Gulf Coast Buyer 1 LLCThe Village at Heritage OaksCorsicana, TX 143 11,429 549 143 11,978 12,121 (560)20072019
CTR Partnership, L.P.City Creek Post-Acute and Assisted LivingSacramento, CA 3,980 10,106 408 3,980 10,514 14,494 (344)19902019
CTR Partnership, L.P.Crestwood Health and Rehabilitation CenterWills Point, TX 143 6,075  143 6,075 6,218 (28)19802020
 29,336 198,991 8,612 29,205 207,734 236,939 (27,700)
Assisted and Independent Living Properties:
Avenue N Holdings LLCCambridge ALFRosenburg, TX 124 2,301 392 124 2,693 2,817 (1,367)20072006
Moenium Holdings LLCGrand CourtMesa, AZ 1,893 5,268 1,210 1,893 6,478 8,371 (3,453)19862007
Lafayette Health Holdings LLCChateau Des MonsEnglewood, CO 420 1,160 189 420 1,349 1,769 (433)20112009
Expo Park Health Holdings LLCCanterbury GardensAurora, CO 570 1,692 248 570 1,940 2,510 (858)19862010
Wisteria Health Holdings LLCWisteria INDAbilene, TX 244 3,241 81 244 3,322 3,566 (1,487)20082011
Everglades Health Holdings LLCLexingtonVentura, CA 1,542 4,012 113 1,542 4,125 5,667 (894)19902011
Flamingo Health Holdings LLCDesert Springs ALFLas Vegas, NV 908 4,767 281 908 5,048 5,956 (2,509)19862011
18th Place Health Holdings LLCRose CourtPhoenix, AZ 1,011 2,053 490 1,011 2,543 3,554 (937)19742011
Boardwalk Health Holdings LLCPark PlaceReno, NV 367 1,633 51 367 1,684 2,051 (510)19932012
Willows Health Holdings LLCCascade PlazaRedmond, WA 2,835 3,784 395 2,835 4,179 7,014 (1,199)20132013
Lockwood Health Holdings LLCSanta MariaSanta Maria, CA 1,792 2,253 585 1,792 2,838 4,630 (1,248)19672013
F-34

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)
Saratoga Health Holdings LLCLake RidgeOrem, UT 444 2,265 176 444 2,441 2,885 (464)19952013
Sky Holdings AZ LLCDesert Sky Assisted LivingGlendale, AZ 61 304 372 61 676 738 (466)20042002
Lemon River Holdings LLCThe Grove Assisted LivingRiverside, CA 342 802 3,360 342 4,162 4,504 (2,616)20122009
Mission CCRC LLCSt. Joseph's Villa INDSalt Lake City, UT 411 2,312 258 411 2,570 2,981 (1,432)19942011
CTR Partnership, L.P.Prelude Cottages of WoodburyWoodbury, MN 430 6,714  430 6,714 7,144 (1,007)20112014
CTR Partnership, L.P.English Meadows Senior Living CommunityChristiansburg, VA 250 6,114 43 250 6,157 6,407 (919)20112014
CTR Partnership, L.P.Bristol Court Assisted LivingSaint Petersburg, FL 645 7,322 421 645 7,512 8,157 (1,013)20102015
CTR Partnership, L.P.Asbury Place Assisted LivingPensacola, FL 212 4,992 240 212 5,213 5,425 (672)19972015
CTR Partnership, L.P.New Haven Assisted Living of San AngeloSan Angelo, TX 284 4,478  284 4,478 4,762 (550)20122016
CTR Partnership, L.P.Lamplight Inn of Fort WayneFort Wayne, IN 452 8,703 214 452 8,889 9,341 (1,052)20152016
CTR Partnership, L.P.Lamplight Inn of West AllisWest Allis, WI 97 6,102 173 97 6,255 6,352 (737)20132016
CTR Partnership, L.P.Lamplight Inn of BaltimoreBaltimore, MD  3,697 267  3,919 3,919 (447)20142016
CTR Partnership, L.P.Fort Myers Assisted LivingFort Myers, FL 1,489 3,531 765 1,489 4,665 6,154 (455)19802016
CTR Partnership, L.P.English Meadows Elks Home CampusBedford, VA 451 9,023 268 451 9,291 9,742 (1,107)20142016
CTR Partnership, L.P.Croatan VillageNew Bern, NC 312 6,919  312 6,919 7,231 (807)20102016
CTR Partnership, L.P.Countryside VillagePikeville, NC 131 4,157  131 4,157 4,288 (485)20112016
CTR Partnership, L.P.The Pines of ClarkstonVillage of Clarkston, MI 603 9,326  603 9,326 9,929 (1,069)20102016
CTR Partnership, L.P.The Pines of GoodrichGoodrich, MI 241 4,112 9 241 4,121 4,362 (471)20142016
CTR Partnership, L.P.The Pines of BurtonBurton, MI 492 9,199  492 9,199 9,691 (1,054)20142016
CTR Partnership, L.P.The Pines of LapeerLapeer, MI 302 5,773  302 5,773 6,075 (662)20082016
CTR Partnership, L.P.Arbor PlaceLodi, CA 392 3,605  392 3,605 3,997 (398)19842016
CTR Partnership, L.P.Applewood of BrookfieldBrookfield, WI 493 14,002  493 14,002 14,495 (1,371)20132017
CTR Partnership, L.P.Applewood of New BerlinNew Berlin, WI 356 10,812  356 10,812 11,168 (1,059)20162017
CTR Partnership, L.P.Tangerine Cove of BrooksvilleBrooksville, FL 995 927 463 995 1,364 2,359 (114)19842017
CTR Partnership, L.P.Memory Care Cottages in White Bear LakeWhite Bear Lake, MN 1,611 5,633  1,611 5,633 7,244 (493)20162017
CTR Partnership, L.P.CulpeperCulpepper, VA 318 3,897 85 318 3,982 4,300 (374)19972017
CTR Partnership, L.P.LouisaLouisa, VA 407 4,660 97 407 4,757 5,164 (455)20022017
CTR Partnership, L.P.WarrentonWarrenton, VA 1,238 7,247 98 1,238 7,345 8,583 (671)19992017
CTR Partnership, L.P.Vista Del LagoEscondido, CA 4,362 7,997  4,362 7,997 12,359 (279)20152019
CTR Partnership, L.P.Inn at Barton CreekBountiful, UT 2,479 4,804 15 2,479 4,819 7,298 (119)19992020
 32,006 201,593 11,359 32,006 212,952 244,959 (37,713)
 $206,497 $1,364,511 $112,197 $205,356 $1,477,849 $1,683,205 $(259,803)
(1) The aggregate cost of real estate for federal income tax purposes was $1.7 billion.
F-35

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2020
(dollars in thousands)

 Year Ended December 31,
Real estate:202020192018
Balance at the beginning of the period$1,605,081 $1,368,157 $1,266,484 
Acquisitions84,630 318,070 106,208 
Improvements7,223 3,103 7,230 
Impairment (21,465) 
Sales of real estate(13,729)(62,784)(11,765)
Balance at the end of the period$1,683,205 $1,605,081 $1,368,157 
Accumulated depreciation:
Balance at the beginning of the period$(220,359)$(185,926)$(152,185)
Depreciation expense(41,914)(40,373)(34,676)
Impairment 5,220  
Sales of real estate2,470 720 935 
Balance at the end of the period$(259,803)$(220,359)$(185,926)

F-36

SCHEDULE IV
MORTGAGE LOANS ON REAL ESTATE
DECEMBER 31, 2020
(dollars in thousands)



DescriptionContractual Interest RateMaturity DatePeriodic Payment TermsPrior LiensPrincipal Balance
Book Value (2)
Carrying Amount of Loans Subject to Delinquent Principal or Interest
Mezzanine Loan:
Virginia (9 SNF facilities)12.0 %2025(1)$110,000 (3)$15,000 $15,000 N/A
$110,000 $15,000 $15,000 

(1)     Interest is due monthly, and principal is due at the maturity date.
(2)    The aggregate cost of investments in real estate mortgage loans for federal income tax purposes was $15.0 million.
(3)    The first mortgage loans on these properties are not held by the Company. Accordingly, the amounts of the prior liens at December 31, 2020 are estimated.

Changes in mortgage loans are summarized as follows (in thousands):

Year Ended December 31,
202020192018
Balance at beginning of period$29,500 $12,375 $12,517 
Additions during period:
New mortgage loans61,258 40,889  
Deductions during period:
Paydowns/Repayments(75,758)(23,764)(142)
Balance at end of period$15,000 $29,500 $12,375 

F-37
EX-21.1 2 ctre20201231ex211q4.htm EX-21.1 Document



EXHIBIT 21.1
LIST OF SUBSIDIARIES OF CARETRUST REIT, INC.*
1CareTrust GP, LLC**51.Lockwood Health Holdings LLC
2CTR Partnership, L.P.**52.Long Beach Health Associates LLC
3CareTrust Capital Corp.**53.Lowell Health Holdings LLC
418th Place Health Holdings LLC54.Lowell Lake Health Holdings LLC
549th Street Health Holdings LLC55.Lufkin Health Holdings LLC
64th Street Holdings LLC56.Meadowbrook Health Associates LLC
751st Avenue Health Holdings LLC57.Memorial Health Holdings LLC
8Anson Health Holdings LLC58.Mesquite Health Holdings LLC
9Arapahoe Health Holdings LLC59.Mission CCRC LLC
10Arrow Tree Health Holdings LLC60.Moenium Holdings LLC
11Avenue N Holdings LLC61.Mountainview Communitycare LLC
12Big Sioux River Health Holdings LLC62.Northshore Healthcare Holdings LLC
13Boardwalk Health Holdings LLC63.Oleson Park Health Holdings LLC
14Bogardus Health Holdings LLC64.Orem Health Holdings LLC
15Burley Healthcare Holdings LLC65.Paredes Health Holdings LLC
16Casa Linda Retirement LLC66.Plaza Health Holdings LLC
17Cedar Avenue Holdings LLC67.Polk Health Holdings LLC
18Cherry Health Holdings LLC68.Prairie Health Holdings LLC
19CM Health Holdings LLC69.Price Health Holdings LLC
20Cottonwood Health Holdings LLC70.Queen City Health Holdings LLC
21Dallas Independence LLC71.Queensway Health Holdings LLC
22Dixie Health Holdings LLC72.RB Heights Health Holdings LLC
23Emmett Healthcare Holdings LLC73.Regal Road Health Holdings LLC
24Ensign Bellflower LLC74.Renee Avenue Health Holdings LLC
25Ensign Highland LLC75.Rillito Holdings LLC
26Ensign Southland LLC76.Rio Grande Health Holdings LLC
27Everglades Health Holdings LLC77.Salmon River Health Holdings LLC
28Expo Park Health Holdings LLC78.Salt Lake Independence LLC
29Expressway Health Holdings LLC79.San Corrine Health Holdings LLC
30Falls City Health Holdings LLC80.Saratoga Health Holdings LLC
31Fifth East Holdings LLC81.Silver Lake Health Holdings LLC
32Fig Street Health Holdings LLC82.Silverada Health Holdings LLC
33Flamingo Health Holdings LLC83.Sky Holdings AZ LLC
34Fort Street Health Holdings LLC84.Snohomish Health Holdings LLC
35Gazebo Park Health Holdings LLC85.South Dora Health Holdings LLC
36Gillette Park Health Holdings LLC86.Stillhouse Health Holdings LLC
37Golfview Holdings LLC87.Temple Health Holdings LLC
38Granada Investments LLC88.Tenth East Holdings LLC
39Guadalupe Health Holdings LLC89.Terrace Holdings AZ LLC
40Gulf Coast Buyer 1 LLC**90.Trinity Mill Holdings LLC
41Hillendahl Health Holdings LLC91.Trousdale Health Holdings LLC
42Hillview Health Holdings LLC92.Tulalip Bay Health Holdings LLC
43Irving Health Holdings LLC93.Valley Health Holdings LLC
44Ives Health Holdings LLC94.Verde Villa Holdings LLC
45Jefferson Ralston Holdings LLC95.Wayne Health Holdings LLC
46Jordan Health Properties LLC96.Willits Health Holdings LLC
47Josey Ranch Healthcare Holdings LLC97.Willows Health Holdings LLC
48Kings Court Health Holdings LLC98.Wisteria Health Holdings LLC
49Lafayette Health Holdings LLC99.CTR Arvada Preferred, LLC**
50.Lemon River Holdings LLC100.CTR Cascadia Preferred, LLC**
*    Unless otherwise indicated, the jurisdiction of formation or incorporation, as applicable, of each of the subsidiaries listed herein is Nevada.
**    Formed or incorporated in Delaware.


EX-23.1 3 ctre20201231ex231q4.htm EX-23.1 Document

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in Registration Statement No. 333-237056 on Form S-3 and Registration Statement No. 333-196634 on Form S-8 of our reports dated February 10, 2021, relating to the financial statements of CareTrust REIT, Inc., and the effectiveness of CareTrust REIT Inc.'s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.

/s/ DELOITTE & TOUCHE LLP
Costa Mesa, California
February 10, 2021







EX-23.2 4 ctre20201231ex232q4.htm EX-23.2 Document

Exhibit 23.2

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements:

1.Registration Statement (Form S-3 No. 333-237056) of CareTrust REIT, Inc., and
2.Registration Statement (Form S-8 No. 333-196634) pertaining to the Incentive Award Plan of CareTrust REIT, Inc.;

of our report dated February 13, 2019, with respect to the consolidated financial statements and schedules for the year ended December 31, 2018 of CareTrust REIT, Inc., included in this Annual Report (Form 10-K) of CareTrust REIT, Inc. for the year ended December 31, 2020.

/s/ ERNST & YOUNG LLP
Irvine, California
February 10, 2021







EX-31.1 5 ctre20201231ex311q4.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION
I, Gregory K. Stapley, certify that:
1. I have reviewed this Annual Report on Form 10-K of CareTrust REIT, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
By:/s/ Gregory K. Stapley
Gregory K. Stapley
Chief Executive Officer
Date: February 10, 2021

EX-31.2 6 ctre20201231ex312q4.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION
I, William M. Wagner, certify that:
1. I have reviewed this Annual Report on Form 10-K of CareTrust REIT, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
By:/s/ William M. Wagner
William M. Wagner
Chief Financial Officer and Treasurer
Date: February 10, 2021

EX-32 7 ctre20201231ex32q4.htm EX-32 Document

Exhibit 32
Certification of Chief Executive Officer and
Chief Financial Officer Pursuant to
18 U.S.C. Section 1350, As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of CareTrust REIT, Inc. (the “Company”) for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Gregory K. Stapley, Chief Executive Officer of the Company, and William M. Wagner, as Chief Financial Officer and Treasurer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Gregory K. Stapley
Name:Gregory K. Stapley
Title:Chief Executive Officer
Date:February 10, 2021
/s/ William M. Wagner
Name:William M. Wagner
Title:Chief Financial Officer and Treasurer
Date:February 10, 2021

The foregoing certification is being furnished pursuant to 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, and it is not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in such filing.

EX-101.SCH 8 ctre-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Consolidated Income Statements link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Consolidated Statements of Equity link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Consolidated Statements of Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 2103102 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2108103 - Disclosure - Real Estate Investments, Net link:presentationLink link:calculationLink link:definitionLink 2309302 - Disclosure - Real Estate Investments, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Real Estate Investments, Net - Investment in Owned Properties (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Real Estate Investments, Net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Real Estate Investments, Net - Future Contractual Minimum Rental Income (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - Real Estate Investments, Net - Tenant Purchase Options (Details) link:presentationLink link:calculationLink link:definitionLink 2414408 - Disclosure - Real Estate Investments, Net - Rental Income (Details) link:presentationLink link:calculationLink link:definitionLink 2415409 - Disclosure - Real Estate Investments, Net - Recent Real Estate Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 2416410 - Disclosure - Real Estate Investments, Net - Lease Amendments (Details) link:presentationLink link:calculationLink link:definitionLink 2417411 - Disclosure - Real Estate Investments, Net - Pristine Lease Termination (Details) link:presentationLink link:calculationLink link:definitionLink 2418412 - Disclosure - Real Estate Investments, Net - Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale (Details) link:presentationLink link:calculationLink link:definitionLink 2119104 - Disclosure - Other Real Estate Investments, Net link:presentationLink link:calculationLink link:definitionLink 2420413 - Disclosure - Other Real Estate Investments, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2121105 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2322303 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2423414 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 2424415 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2425416 - Disclosure - Fair Value Measurements - Fair Value and Carrying Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2126106 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2327304 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2428417 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2429418 - Disclosure - Debt - Senior Unsecured Notes Payable Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2430419 - Disclosure - Debt - Unsecured Revolving Credit Facility and Term Loan Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2431420 - Disclosure - Debt - Schedule of Debt Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 2132107 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 2333305 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2434421 - Disclosure - Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2435422 - Disclosure - Equity - At-The-Market Offering (Details) link:presentationLink link:calculationLink link:definitionLink 2436423 - Disclosure - Equity - Dividends on Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2137108 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2338306 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2439424 - Disclosure - Stock-Based Compensation - Restricted Stock and Performance Awards (Details) link:presentationLink link:calculationLink link:definitionLink 2440425 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2441426 - Disclosure - Stock-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2142109 - Disclosure - Earnings Per Common Share link:presentationLink link:calculationLink link:definitionLink 2343307 - Disclosure - Earnings Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2444427 - Disclosure - Earnings Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 2145110 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2446428 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2147111 - Disclosure - Concentration of Risk link:presentationLink link:calculationLink link:definitionLink 2448429 - Disclosure - Concentration of Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2149112 - Disclosure - Selected Quarterly Financial Data (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2350308 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 2451430 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 2152113 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2453431 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2154114 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation link:presentationLink link:calculationLink link:definitionLink 2455432 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation - By Property (Details) link:presentationLink link:calculationLink link:definitionLink 2456433 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation - Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 2157115 - Disclosure - Schedule IV - Mortgage Loans on Real Estate link:presentationLink link:calculationLink link:definitionLink 2458434 - Disclosure - Schedule IV - Mortgage Loans on Real Estate - Mortgage Loan (Details) link:presentationLink link:calculationLink link:definitionLink 2459435 - Disclosure - Schedule IV - Mortgage Loan on Real Estate - Mortgage Loan Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 ctre-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 ctre-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 ctre-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Granted (shares) Number of shares granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Accounts and other receivables Trade Accounts Receivable [Member] Impairment SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Deduction Receivable Type [Axis] Receivable Type [Axis] Unvested, beginning balance (usd per share) Unvested, ending balance (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Bridge loan Bridge Loan [Member] Combined principal amount of loan Mortgage Loan, Combined Principal Mortgage Loan, Combined Principal Lewiston Health and Rehabilitation Kindred Transitional Care And Rehabilitation - Lewiston [Member] Kindred Transitional Care And Rehabilitation - Lewiston Real Estate Properties [Line Items] Real Estate Properties [Line Items] Officers and Employees Officer And Employee [Member] Officer And Employee [Member] Pleasant Acres Care Center Pleasant Acres Care Center [Member] Pleasant Acres Care Center [Member] Deferred Loan Fees Debt Issuance Costs, Gross Mansfield Medical Lodge Kindred Transitional Care and Rehabilitation - Mansfield Plaza [Member] Kindred Transitional Care and Rehabilitation - Mansfield Plaza [Member] Beds, Units, Occupancy and Other Measures Other Non-financial Measures [Policy Text Block] Other Non-financial Measures [Policy Text Block] Bridge loan funding in loans receivable Loans Receivable with Fixed Rates of Interest Skilled nursing, assisted living and independent living facilities Skilled Nursing, Assisted Living and Independent Living Facilities [Member] Skilled Nursing, Assisted Living and Independent Living Facilities [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Liabilities and Equity: Liabilities and Equity [Abstract] 2025 Lessor, Operating Lease, Payment to be Received, Year Five Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Security Exchange Name Security Exchange Name Less: Net income allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic and Diluted Undistributed earnings (loss) allocated to participating securities, basic and diluted. The Guest House Skilled Nursing And Rehabilitation The Guest House Skilled Nursing And Rehabilitation [Member] The Guest House Skilled Nursing And Rehabilitation [Member] Lease Arrangements [Domain] Lease Arrangements [Domain] [Domain] for Lease Arrangements [Axis] Hillstone Healthcare Hillstone Healthcare Inc [Member] Hillstone Healthcare Inc [Member] Arapahoe Health Holdings LLC Arapahoe Health Holdings LLC [Member] Arapahoe Health Holdings LLC [Member] Noble Noble Senior Services [Member] Noble Senior Services Premier Estates of Highlands Victory Park Nursing Home [Member] Victory Park Nursing Home [Member] Performance Stock Award Performance Shares [Member] Mission CCRC LLC Mission CCRC LLC [Member] Mission CCRC LLC [Member] Variable Rate [Domain] Variable Rate [Domain] Real Estate, Type of Property [Axis] Real Estate, Type of Property [Axis] Number of separate and independent companies after spin-off Number Of Separate And Independent Companies After Spin Off Number Of Separate And Independent Companies After Spin Off Assets: Assets [Abstract] Investment, Name [Axis] Investment, Name [Axis] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Gulf Coast Buyer 1 LLC Gulf Coast Buyer 1 LLC [Member] Gulf Coast Buyer 1 LLC [Member] 2023 Long-Term Debt, Maturity, Year Three Acquisitions of real estate, net of deposits applied Payment to acquire facility Payments to Acquire Commercial Real Estate Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Prairie Heights Healthcare Center Prairie Heights Healthcare Center [Member] Prairie Heights Healthcare Center [Member] Shares repurchased (shares) Treasury Stock, Shares, Acquired Unamortized stock-based compensation expense related to unvested awards Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Restricted stock award conversion ratio related to the spin-off Stockholders' Equity Note, Spinoff Transaction, Restricted Stock Award Conversion Ratio Stockholders' Equity Note, Spinoff Transaction, Restricted Stock Award Conversion Ratio Initial Annual Cash Rent Initial annual cash rent Operating Leases, Anticipated Initial Annual Lease Revenues Operating Leases, Anticipated Initial Annual Lease Revenues Beginning balance (shares) Ending balance (shares) Shares, Outstanding Preferred stock, $0.01 par value; 100,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2020 and December 31, 2019 Preferred Stock, Value, Issued Senior Unsecured Notes Senior Unsecured Notes [Member] Senior Unsecured Notes [Member] Triple-net master lease Amended Triple Net Master Lease [Member] Amended Triple Net Master Lease [Member] Building Building [Member] Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Skill Nursing Facility Washington [Member] Skill Nursing Facility Washington [Member] Skill Nursing Facility Washington Expansion, construction and capital improvements at triple-net leased facilities Construction And Capital Improvements At Triple-Net Leased Facilities [Member] Construction And Capital Improvements At Triple-Net Leased Facilities [Member] Willows Health Holdings LLC Willows Health Holdings Llc [Member] Willows Health Holdings Llc [Member] Fort Street Health Holdings LLC Fort Street Health Holdings LLC [Member] Fort Street Health Holdings LLC [Member] Number of facilities acquired Number of Properties Number Of Properties Acquired Number Of Properties Acquired Measurement Frequency [Domain] Measurement Frequency [Domain] Concentration risk (percent) Concentration Risk, Percentage Lowell Lake Health Holdings LLC Lowell Lake Health Holdings Llc [Member] Lowell Lake Health Holdings Llc [Member] Statement [Line Items] Statement [Line Items] Weighted Average Share Price Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward] Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward] Loan receivable interest rate (percent) Mortgage loan receivable interest rate (percent) Loans Receivable, Fixed Interest Rate Loans Receivable, Fixed Interest Rate Covenant Care Covenant Care [Member] Covenant Care [Member] The Villas at Saratoga The Villas At Saratoga [Member] The Villas At Saratoga [Member] Independent living facilities, cost of services Cost, Product and Service [Extensible List] Statement [Table] Statement [Table] Write-off of accounts and straight-line rent receivable Accounts Receivable, Allowance for Credit Loss, Writeoff Statistical Measurement [Axis] Statistical Measurement [Axis] Increase in dividends payable Increase Decrease In Dividends Payable Increase Decrease In Dividends Payable Purchase and sale agreement amount Purchase And Sale Agreement, Amount Purchase And Sale Agreement, Amount Gazebo Park Health Holdings LLC Gazebo Park Health Holdings LLC [Member] Gazebo Park Health Holdings LLC [Member] Fig Street Health Holdings LLC Fig Street Health Holdings Llc [Member] Fig Street Health Holdings Llc [Member] Payments on unsecured revolving credit facility Repayments of Long-term Lines of Credit Reduction to contractual annual cash rent as result of spin Operating Leases, Reduction To Anticipated Initial Annual Lease Revenues Due To Spin Operating Leases, Reduction To Anticipated Initial Annual Lease Revenues Due To Spin Interest income related to preferred equity investments Interest Income, Other Entity Small Business Entity Small Business Bristol Court Assisted Living Bristol Court Assisted Living [Member] Bristol Court Assisted Living [Member] Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Bethany Rehabilitation Center Bethany Rehabilitation Center Member Bethany rehabilitation center. Amendment Flag Amendment Flag Cascadia of Boise Cascadia Of Boise [Member] Cascadia Of Boise Metron skilled nursing facilities Metron Skilled Nursing Facilities [Member] Metron Skilled Nursing Facilities [Member] Weighted-average number of common shares: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Prior ATM Program Prior At-The-Market Offering Program [Member] Prior At-The-Market Offering Program [Member] Golfview Holdings LLC Golfview Holdings LLC [Member] Golfview Holdings LLC [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Current Cash Rent Lessor, Annualized Cash Revenue For Contracts In Place Lessor, Annualized Cash Revenue For Contracts In Place Cascadia Development, Boise ID Preferred Equity Investment, Cascadia Development, Boise ID [Member] Preferred Equity Investment, Cascadia Development, Boise ID [Member] Adjustment for collectibility of rental income Sales-type Lease, Net Investment in Lease, Credit Loss Expense (Reversal) Fair Value Measurement [Domain] Fair Value Measurement [Domain] Pristine Lease Termination Agreement Pristine Lease Termination Agreement [Member] Pristine Lease Termination Agreement [Member] Accounts payable and accrued liabilities Accounts Payable and Other Accrued Liabilities City Creek Post-Acute and Assisted Living City Creek Post-Acute And Assisted Living [Member] City Creek Post-Acute And Assisted Living [Member] Subsequent Events Subsequent Events [Text Block] Real Estate [Table] Real Estate [Table] Burley Healthcare Holdings LLC Burley Healthcare Holdings LLC [Member] Burley Healthcare Holdings LLC [Member] Payments on senior unsecured term loan Repayments of Unsecured Debt Lessor Accounting Lessor, Leases [Policy Text Block] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Summary of Restricted Stock and Performance Award Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Providence Orange Tree Providence Orange Tree [Member] Providence Orange Tree [Member] Accounting Policies [Line Items] Other Commitments [Line Items] Other Commitments [Line Items] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Orem Health Holdings LLC Orem Health Holdings LLC [Member] Orem Health Holdings LLC [Member] 5.25% Senior Notes due 2025 Five Point Two Five Senior Notes Due 2025 [Member] Five Point Two Five Senior Notes Due 2025 [Member] Concentration Risk [Table] Concentration Risk [Table] Total assets Assets SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] Unvested, beginning balance (shares) Unvested, ending balance (shares) Unvested stock awards outstanding (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Lafayette Health Holdings LLC Lafayette Health Holdings LLC [Member] Lafayette Health Holdings LLC [Member] Principal Balance SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages The Suites - Parker The Suites Parker [Member] The Suites Parker [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Lessor, Lease, Description [Table] Lessor, Lease, Description [Table] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] 5.875% Senior Notes due 2021 Five Point Eight Seven Five Senior Notes Due 2021 [Member] Five Point Eight Seven Five Senior Notes Due 2021 [Member] Construction/Renovation Date Real Estate and Accumulated Depreciation, Year of Construction Year real estate investment property was constructed for entities with a substantial portion of business acquiring and holding investment real estate, in CCYY format. Total liabilities Liabilities Paredes Health Holdings LLC Paredes Health Holdings LLC [Member] Paredes Health Holdings LLC [Member] Mezzanine loan receivable Mezzanine Loan [Member] Mezzanine Loan Aggregate required financing of capital expenditures as percentage of initial investment in property (percent) Aggregate Required Financing Of Capital Expenditures As Percentage Of Initial Investment In Property Aggregate Required Financing Of Capital Expenditures As Percentage Of Initial Investment In Property ATM Program Activity Class of Stock Disclosures [Abstract] Summary of the At-The-Market Equity Offering Program Schedule of Stock by Class [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Beacon Harbor Healthcare and Rehabilitation Beacon Harbor Healthcare And Rehabilitation [Member] Beacon Harbor Healthcare And Rehabilitation Real Estate [Abstract] Real Estate [Abstract] SNF Skilled Nursing Facility Skilled Nursing Facility [Member] Skilled Nursing Facility [Member] Number of states with properties Number of States in which Entity Operates Emmett Healthcare Holdings LLC Emmett Healthcare Holdings LLC [Member] Emmett Healthcare Holdings LLC [Member] The Rio at Cabezon The Rio At Cabezon [Member] The Rio At Cabezon [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Financial assets: Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Accumulated amortization of deferred financing costs Accumulated Amortization, Debt Issuance Costs Oakview Heights Nursing and Rehabilitation Center Oakview Heights Nursing And Rehabilitation Center [Member] Oakview Heights Nursing And Rehabilitation Center [Member] Lease Expiration October 2034, First option 2026 Properties With Purchase Option, Lease Expiration October 2034. First Option 2026 [Member] Properties With Purchase Option, Lease Expiration October 2034. First Option 2026 Number of properties sold Number Of Properties Sold Number Of Properties Sold Preferred equity investment Equity Method Investments Common stock, outstanding (shares) Common Stock, Shares, Outstanding Grundy Care Center Grundy Care Center [Member] Grundy Care Center [Member] Revolving Credit Facility Revolving Credit Facility [Member] Lamplight Inn of Baltimore Lamplight Inn Of Baltimore [Member] Lamplight Inn Of Baltimore [Member] New mortgage loans SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan Premier Estates of Cincinnati-Riverview Pristine Senior Living of Cincinnati-Riverview [Member] Pristine Senior Living of Cincinnati-Riverview [Member] Madison Park Healthcare Madison Park Healthcare [Member] Madison Park Healthcare [Member] Common stock, authorized (shares) Common Stock, Shares Authorized Dilutive performance stock awards (shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Assets held for sale, net Assets Held-for-sale, Not Part of Disposal Group Summary of Investment in Owned Properties Schedule of Real Estate Properties [Table Text Block] Big Sioux River Health Holdings LLC Big Sioux River Health Holdings LLC [Member] Big Sioux River Health Holdings LLC [Member] Income Statement [Abstract] Income Statement [Abstract] Noncash interest income Other Noncash Income Booker T Washington Skilled Nursing and Rehabilitation Booker T Washington Skilled Nursing And Rehabilitation [Member] Booker T Washington Skilled Nursing And Rehabilitation [Member] Trio and Hillstone Master Lease Trio Healthcare And Hillstone Healthcare Master Lease [Member] Trio Healthcare And Hillstone Healthcare Master Lease [Member] Prepaid expenses and other assets, net Increase (Decrease) in Prepaid Expense and Other Assets Over-Allotment Option Over-Allotment Option [Member] Name of Property [Domain] Name of Property [Domain] Estimates and Assumptions Use of Estimates, Policy [Policy Text Block] Lakewest Rehabilitation and Skilled Care Lakewest Rehabilitation And Skilled Care [Member] Lakewest Rehabilitation And Skilled Care [Member] Everglades Health Holdings Everglades Health Holdings LLC [Member] Everglades Health Holdings LLC [Member] Trillium Trillium Healthcare Group LLC [Member] Trillium Healthcare Group LLC [Member] Officers Officer [Member] Number of facilities in agreement secured by membership interests Loan Receivable, Number Of Facilities In Agreement Secured By Membership Interests Loan Receivable, Number Of Facilities In Agreement Secured By Membership Interests Other Real Estate Investments Real Estate, Other Investments [Policy Text Block] Real Estate, Other Investments [Policy Text Block] Improvements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Improvements Renne Avenue Health Holdings LLC Renne Avenue Health Holdings LLC [Member] Renne Avenue Health Holdings LLC [Member] Premier Estates of Middletown/Premier Retirement Estates of Middletown Premier Estates Of Middletown Premier Retirement Estates Of Middletown [Member] Premier Estates Of Middletown Premier Retirement Estates Of Middletown [Member] Warrenton Amerisist Of Warrenton [Member] Amerisist Of Warrenton [Member] Counterparty Name [Domain] Counterparty Name [Domain] Number of properties Number Of Properties Number Of Properties Board of Directors Director [Member] New Haven Assisted Living of San Angelo New Haven Assisted Living of San Angelo [Member] New Haven Assisted Living of San Angelo [Member] Shoreline Care Center Shoreline Care Center [Member] Shoreline Care Center [Member] Recognition of unrecognized preferred return from prior periods Unrecognized Preferred Return From Prior Period, Recognized In Current Period Unrecognized Preferred Return From Prior Period, Recognized In Current Period Net-settle adjustment on restricted stock Payment, Tax Withholding, Share-based Payment Arrangement Temple Health Holdings LLC Temple Health Holdings LLC [Member] Temple Health Holdings LLC [Member] Pilgrim Manor Skilled Nursing And Rehabilitation Pilgrim Manor Skilled Nursing And Rehabilitation [Member] Pilgrim Manor Skilled Nursing And Rehabilitation [Member] Future Contractual Minimum Rental Income Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Selected Quarterly Financial Data (Unaudited) Quarterly Financial Information [Text Block] Contractual Interest Rate SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate Shoreline Health and Rehabilitation Center Shoreline Health And Rehabilitation Center [Member] Shoreline Health And Rehabilitation Center [Member] Boardwalk Health Holdings LLC Boardwalk Health Holdings LLC [Member] Boardwalk Health Holdings LLC [Member] Trillium skilled nursing facilities Trillium Skilled Nursing Facilities [Member] Trillium Skilled Nursing Facilities [Member] Integral equipment, furniture and fixtures Fixtures and Equipment, Gross Estimated useful life (in years) Property, Plant and Equipment, Useful Life Copper Ridge Health and Rehabilitation Center Copper Ridge Health And Rehabilitation Center [Member] Copper Ridge Health And Rehabilitation Center [Member] Lowell Health Holdings LLC Lowell Health Holdings LLC [Member] Lowell Health Holdings LLC [Member] Cherry Health Holdings LLC Cherry Health Holdings, Inc. [Member] Cherry Health Holdings, Inc. [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Number of beds in leased facilities Number Of Beds In Leased Facilities Number Of Beds In Leased Facilities Restricted Stock Award Restricted Stock [Member] Deferred Financing Costs Deferred Charges, Policy [Policy Text Block] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Cascadia Development, Nampa ID Preferred Equity Investment, Cascadia Development, Nampa ID [Member] Preferred Equity Investment, Cascadia Development, Nampa ID [Member] Gillette Park Health Holdings LLC Gillette Park Health Holdings LLC [Member] Gillette Park Health Holdings LLC [Member] Number of operators for which collectability not probable Number Of Operators, Collection Of Lease Payment Through Maturity Not Probable Number Of Operators, Collection Of Lease Payment Through Maturity Not Probable Class of Financing Receivable [Domain] Class of Financing Receivable [Domain] Fair Value Measurements Fair Value Disclosures [Text Block] Prior Liens SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Prior Lien, Amount Real Estate [Line Items] Real Estate [Line Items] Customer [Domain] Customer [Domain] Lease Expiration October 2032, First option 2023 Properties With Purchase Option, Lease Expiration October 2032, First Option 2023 [Member] Properties With Purchase Option, Lease Expiration October 2032, First Option 2023 Ensign Master leases Ensign Master Leases [Member] Ensign Master Leases [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Number of renewal options Lessor, Operating Lease, Number Of Renewal Options Lessor, Operating Lease, Number Of Renewal Options Concentration Risk [Line Items] Concentration Risk [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Denison Care Center Denison Care Center [Member] Denison Care Center [Member] Real estate investments Real Estate Investment Property, at Cost Josey Ranch Healthcare Holdings LLC Josey Ranch Healthcare Holdings LLC [Member] Josey Ranch Healthcare Holdings LLC [Member] Prepayment premium in second year (percent) Line Of Credit Facility, Prepayment Premium In Second Year After Issuance Line Of Credit Facility, Prepayment Premium In Second Year After Issuance Deferred financing costs, net Debt Issuance Costs, Net Culpeper Amerisist Of Culpeper [Member] Amerisist Of Culpeper [Member] English Meadows Senior Living Community English Meadows Senior Living Community [Member] English Meadows Senior Living Community [Member] Dividends paid on common stock Payments of Ordinary Dividends, Common Stock Memorial Health Holdings LLC Memorial Health Holdings LLC [Member] Memorial Health Holdings LLC [Member] Prior Term Loan Prior Term Loan [Member] Prior Term Loan [Member] Next VA Star Realty Holdings LLC Next Healthcare Inc - Virginia Next VA Star Realty Holdings LLC [Member] Next VA Star Realty Holdings LLC Portion of funding commitments subject to rent increase at time of funding Portion Of Commitment Subject To Rent Increase At Time Of Funding Portion Of Commitment Subject To Rent Increase At Time Of Funding Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Real Estate [Domain] Real Estate [Domain] Dividends record date Dividends Payable, Date of Record Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Impairment SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Other Deduction Share price to the public (usd per share) Shares Issued, Price Per Share The Pines of Goodrich The Pines of Goodrich [Member] The Pines of Goodrich [Member] Sale of Stock [Axis] Sale of Stock [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code SNF / Campus Skilled Nursing and Campus Facilities Skilled Nursing And Campus Facilities [Member] Skilled Nursing And Campus Facilities Prairie Health Holdings LLC Prairie Health Holdings LLC [Member] Prairie Health Holdings LLC [Member] Queensway Health Holdings LLC Queensway Health Holdings Llc [Member] Queensway Health Holdings Llc [Member] Gross Carrying Value SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross [Abstract] Common dividend (usd per share) Dividends declared (usd per share) Common Stock, Dividends, Per Share, Declared Senior unsecured notes payable - face value Debt instrument face amount Debt Instrument, Face Amount Transfer of pre-acquisition costs to acquired assets Transfer Of Preacquisition Costs To Acquired Assets Transfer Of Preacquisition Costs To Acquired Assets Equity [Abstract] Equity [Abstract] Lease Expiration November 2034, First option 2024 Properties With Purchase Option, Lease Expiration November 2034, First Option 2024 [Member] Properties With Purchase Option, Lease Expiration November 2034, First Option 2024 Supplemental schedule of noncash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Aggregate cost of real estate for federal income tax purposes SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Federal Income Tax Basis Redemption price, percentage upon change of control (percent) Debt Instrument Redemption Price Upon Change Of Control As Percentage Of Principal Amount Debt instrument redemption price upon change of control as percentage of principal amount. Customer Concentration Risk Customer Concentration Risk [Member] Diluted (shares) Weighted-average diluted common shares outstanding (shares) Weighted-average number of common shares outstanding, diluted (shares) Weighted Average Number of Shares Outstanding, Diluted Letter of Credit Letter of Credit [Member] Summary of Fair Value and Carrying Value of Financial Instruments Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Forfeited (shares) Shares forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Amortization of deferred financing costs Amortization of Debt Issuance Costs and Discounts Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Prelude Cottages of Woodbury Prelude Cottages of Woodbury [Member] Prelude Cottages of Woodbury [Member] Schedule of Tenant Purchase Options Schedule Of Tenant Purchase Options [Table Text Block] Schedule Of Tenant Purchase Options Purchase Price Aggregate purchase price Asset Acquisition, Consideration Transferred Asset Acquisition, Consideration Transferred Counterparty Name [Axis] Counterparty Name [Axis] Common stock, $0.01 par value; 500,000,000 shares authorized, 95,215,797 and 95,103,270 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Jordan Health Properties LLC Jordan Health Properties LLC [Member] Jordan Health Properties LLC [Member] Document Fiscal Year Focus Document Fiscal Year Focus SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] Underwritten Public Offering Underwritten Public Offering [Member] Underwritten Public Offering Lamplight Inn of Fort Wayne Lamplight Inn Of Fort Wayne [Member] Lamplight Inn Of Fort Wayne [Member] Properties in terminated master lease Number Of Properties, Terminated Master Lease Number Of Properties, Terminated Master Lease Adjustment for collectibility of rental income Adjustment for collectibility Operating Lease, Lease Income, Adjustments For Collectibility Operating Lease, Lease Income, Adjustments For Collectibility Lease Expiration October 2034, First option 2021 Properties With Purchase Option, Lease Expiration October 2034, First Option 2021 [Member] Properties With Purchase Option, Lease Expiration October 2034, First Option 2021 Entity Current Reporting Status Entity Current Reporting Status Rio Grande Health Holdings LLC Rio Grande Health Holdings LLC [Member] Rio Grande Health Holdings LLC [Member] Facility fee on revolving commitment fee based on investment grade ratings (percent) Line Of Credit, Commitment Fee Based On Investment Grade Rating, Percentage Line Of Credit, Commitment Fee Based On Investment Grade Rating, Percentage Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Ridgmar Medical Lodge Kindred Transitional Care and Rehabilitation - Ridgmar [Member] Kindred Transitional Care and Rehabilitation - Ridgmar [Member] Trio Healthcare Master Lease Trio Healthcare Master Lease [Member] Trio Healthcare Master Lease [Member] Common stock, issued (shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value DuQuoin Nursing and Rehabilitation Center DuQuoin Nursing And Rehabilitation Center [Member] DuQuoin Nursing And Rehabilitation Center [Member] Independent living facilities, revenue services Revenue from Contract with Customer, Product and Service [Extensible List] Shamrock Nursing and Rehabilitation Center Shamrock Nursing And Rehabilitation Center [Member] Shamrock Nursing And Rehabilitation Center [Member] Pecan Tree Rehabilitation and Healthcare Pecan Tree Rehabilitation And Healthcare [Member] Pecan Tree Rehabilitation And Healthcare [Member] Location [Domain] Location [Domain] Accounts and other receivables, net Accounts Receivable, after Allowance for Credit Loss Legacy at Jacksonville Legacy At Jacksonville [Member] Legacy At Jacksonville [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Total equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent 51st Avenue Health Holdings LLC Fifty One Avenue Health Holdings Llc [Member] Fifty One Avenue Health Holdings Llc [Member] Lemon River Holdings LLC Lemon River Holdings LLC [Member] Lemon River Holdings LLC [Member] Costs Capitalized Since Acquisition SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Cost Capitalized Subsequent to Acquisition, Cost Wellspring Health and Rehabilitation Of Cascadia Wellspring Health And Rehabilitation Of Cascadia [Member] Wellspring Health And Rehabilitation Of Cascadia [Member] Number of properties transferred Number Of Properties Transferred Number Of Properties Transferred Lease Arrangements [Axis] Lease Arrangements [Axis] Lease Arrangements [Axis] Entity Address, City or Town Entity Address, City or Town Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] The Meadows on University The Meadows On University [Member] The Meadows On University [Member] Purchases of, and improvements to, equipment, furniture and fixtures and real estate Payments To Acquire Equipment, Furniture And Fixtures And Develop Real Estate Assets Payments To Acquire Equipment, Furniture And Fixtures And Develop Real Estate Assets Preferred equity instrument minimum yield Equity Method Investment, Rate Of Return, Floor Equity Method Investment, Rate Of Return, Floor Applewood of New Berlin Applewood of New Berlin [Member] Applewood of New Berlin [Member] Valley Skilled Nursing Valley Skilled Nursing [Member] Valley Skilled Nursing [Member] Senior unsecured term loan, net Loans Payable, Noncurrent Number of operational beds and units in facilities Number Of Operational Beds And Units In Facilities Number Of Operational Beds And Units In Facilities Falls City Health Holdings LLC Falls City Health Holdings LLC [Member] Falls City Health Holdings LLC [Member] CTR Partnership, L.P. CTR Partnership, L.P. [Member] CTR Partnership, L.P. [Member] Gross Carrying Value, Buildings and Improvements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Building and Improvements, Amount Arbor Place Arbor Place [Member] Arbor Place [Member] Stillhouse Health Holdings LLC Stillhouse Health Holdings LLC [Member] Stillhouse Health Holdings LLC [Member] Accumulated depreciation: SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation [Roll Forward] Investment, Name [Domain] Investment, Name [Domain] Asbury Place Assisted Living Asbury Place Assisted Living [Member] Asbury Place Assisted Living [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Earnings per common share: Earnings Per Share [Abstract] Crestwood Health and Rehabilitation Center Crestwood Health And Rehabilitation Center [Member] Crestwood Health And Rehabilitation Center Mortgage loan receivable Mortgage Receivable [Member] Disposal Group Name [Domain] Disposal Group Name [Domain] Tangerine Cove Of Brooksville Tangerine Cove Of Brooksville [Member] Tangerine Cove Of Brooksville [Member] Skilled nursing Skilled Nursing Properties Skilled Nursing Properties [Member] Skilled Nursing Properties [Member] Equity: Stockholders' Equity Attributable to Parent [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Price Health Holdings LLC Price Health Holdings LLC [Member] Price Health Holdings LLC [Member] Pinckneyville Nursing and Rehabilitation Center Pinckneyville Nursing And Rehabilitation Center [Member] Pinckneyville Nursing And Rehabilitation Center [Member] Senior unsecured term loan New Term Loan Senior Unsecured Term Loan [Member] Senior Unsecured Term Loan [Member] Tulalip Bay Health Holdings LLC Tulalip Bay Holdings [Member] Tulalip Bay Holdings [Member] Grapevine Medical Lodge Kindred Transitional Care and Rehabilitation - Grapevine [Member] Kindred Transitional Care and Rehabilitation - Grapevine [Member] Sales of real estate SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Investment in Real Estate Sold Spring Lake Skilled Nursing and Rehabilitation Spring Lake Skilled Nursing And Rehabilitation [Member] Spring Lake Skilled Nursing And Rehabilitation [Member] Lenox Care Center Lenox Care Center [Member] Lenox Care Center [Member] Initial lease term (in years) Lease term (in years) Lessor, Operating Lease, Term of Contract Other loans receivable Loans Receivable [Member] Redemption price of notes (percent) Debt Instrument, Redemption Price, Percentage Guadalupe Health Holdings LLC Guadalupe Health Holdings Llc [Member] Guadalupe Health Holdings Llc [Member] Entity Filer Category Entity Filer Category Alpine Skilled Nursing and Rehabilitation Alpine Skilled Nursing and Rehabilitation [Member] Alpine Skilled Nursing and Rehabilitation [Member] Schedule of Stock-Based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Common Stock Common Stock [Member] Impairment of real estate investments Impairment Losses Related to Real Estate Partnerships Product and Service [Domain] Product and Service [Domain] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Repayment of other real estate investment Return of initial investment Proceeds from Equity Method Investment, Distribution, Return of Capital Other Commitments [Axis] Other Commitments [Axis] Pleasant Manor Healthcare and Rehabilitation Pleasant Manor Healthcare And Rehabilitation [Member] Pleasant Manor Healthcare And Rehabilitation Lease Contractual Term [Axis] Lease Contractual Term [Axis] Cedar Avenue Holdings LLC Cedar Avenue Holdings LLC [Member] Cedar Avenue Holdings LLC [Member] 2021 Lessor, Operating Lease, Payment to be Received, Year One Fort Myers Assisted Living Fort Myers Assisted Living [Member] Fort Myers Assisted Living [Member] Number of beds and units in facilities Number Of Units And Beds In Facilities Number Of Units And Beds In Facilities Revenue, exclusive of operating expense reimbursements Revenue Benchmark [Member] Interest rate (percent) Debt Instrument, Interest Rate, Stated Percentage Dividends payable as of record date Dividends Payable, Current Initial Cost to Company, Land SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Land Cumulative contractual preferred return through acquisition date Equity Method Investment, Cumulative Contractual Preferred Return Equity Method Investment, Cumulative Contractual Preferred Return Mortgage loans receivable - face value Financing Receivable, before Allowance for Credit Loss Sale of real estate settled with notes receivable Noncash or Part Noncash Divestiture, Amount of Consideration Received Name of Property [Axis] Name of Property [Axis] Polk Health Holdings LLC Polk Health Holdings LLC [Member] Polk Health Holdings LLC [Member] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Initial lease yield (percent) Initial Lease Yield Initial Lease Yield Subsequent Events [Abstract] Subsequent Events [Abstract] Sale of Stock [Domain] Sale of Stock [Domain] 2025 Long-Term Debt, Maturity, Year Five Garden View Care Center Garden View Care Center [Member] Garden View Care Center [Member] Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] Debt, Fiscal Year Maturity [Abstract] Long-term Debt, Fiscal Year Maturity [Abstract] Moenium Holdings LLC Moenium Holdings LLC [Member] Moenium Holdings LLC [Member] Bogardus Health Holdings LLC Bogardus Health Holdings LLC [Member] Bogardus Health Holdings LLC [Member] Organization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Terrace Holdings AZ LLC Terrace Holdings AZ LLC [Member] Terrace Holdings AZ LLC [Member] Total revenues Total revenues Revenues Hillendahl Health Holdings LLC Hillendahl Health Holdings LLC [Member] Hillendahl Health Holdings LLC [Member] Properties covered in new master lease Number Of Properties, New Master Lease Number Of Properties, New Master Lease Broadmoor Medical Lodge Broadmoor Medical Lodge - Rockwall [Member] Broadmoor Medical Lodge - Rockwall [Member] Diluted (usd per share) Earnings per common share, diluted (usd per share) Earnings Per Share, Diluted Vista Del Lago Vista Del Lago [Member] Vista Del Lago [Member] Encumbrances SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Amount of Encumbrances Properties Number Of Properties With Tenant Purchase Option Number Of Properties With Tenant Purchase Option Interest income related to mortgage loans Interest and Fee Income, Loans, Commercial, Real Estate Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Memory Care Cottages in White Bear Lake Memory Care Cottages in White Bear Lake [Member] Memory Care Cottages in White Bear Lake [Member] Schedule of Debt Instruments Schedule of Long-term Debt Instruments [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Eldorado Rehab & Healthcare Eldorado Rehab And Healthcare [Member] Eldorado Rehab And Healthcare [Member] Prepayment premium in first year (percent) Line Of Credit Facility, Prepayment Premium In First Year After Issuance Line Of Credit Facility, Prepayment Premium In First Year After Issuance Prime Rate Prime Rate [Member] Colonial Oaks Skilled Nursing And Rehabilitation Colonial Oaks Skilled Nursing And Rehabilitation [Member] Colonial Oaks Skilled Nursing And Rehabilitation [Member] Portsmouth Health and Rehab Portsmouth Health And Rehab [Member] Portsmouth Health And Rehab [Member] Entity Emerging Growth Company Entity Emerging Growth Company Basis spread on variable rate for loan (percent) Loans Receivable, Basis Spread on Variable Rate Real Estate Investments, Net Real Estate Owned [Text Block] CM Health Holdings LLC CM Health Holdings LLC [Member] CM Health Holdings LLC [Member] CommuniCare CommuniCare [Member] CommuniCare [Member] Maximum Maximum [Member] Preferred stock, authorized (shares) Preferred Stock, Shares Authorized SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward] SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward] Valley Health Holdings LLC Valley Health Holdings LLC [Member] Valley Health Holdings LLC [Member] Gross Carrying Value, Total Balance at the beginning of the period Balance at the end of the period SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Concentration of Risk Concentration Risk Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] 2023 Lessor, Operating Lease, Payment to be Received, Year Three Property taxes Lease Income, Property Taxes [Member] Lease Income, Property Taxes [Member] Trading Symbol Trading Symbol Aggregate annual base rent due under master lease Rental Income, Expected Annual Base Rent To Be Received Rental Income, Expected Annual Base Rent To Be Received Disposal Group Classification [Domain] Disposal Group Classification [Domain] Number of properties held for sale Number Of Properties To Be Sold Number Of Properties To Be Sold Avenue N Holdings LLC Avenue N- Holdings LLC [Member] Avenue N Holdings LLC [Member] Senior unsecured notes payable Notes Payable, Fair Value Disclosure Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Entity Shell Company Entity Shell Company Recurring Fair Value, Recurring [Member] Segment Disclosures Segment Reporting, Policy [Policy Text Block] Real estate investments, net Real estate investments, net Real Estate Investment Property, Net Subfacility capacity as percentage of available revolving commitments (percent) Line Of Credit, Subfacility, Capacity As Percentage Of Available Revolving Commitments Line Of Credit, Subfacility, Capacity As Percentage Of Available Revolving Commitments Entity by Location [Axis] Entity by Location [Axis] Owned and operated living facilities Owned And Operated Living Facilities [Member] Owned And Operated Living Facilities [Member] Entity Public Float Entity Public Float Annualized contractual rental income Annualized Lease Revenue Annualized Lease Revenue Bridgeport Medical Lodge Bridgeport Medical Lodge [Member] Bridgeport Medical Lodge [Member] Document Type Document Type ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Casa de Paz Casa de Paz [Member] Casa de Paz [Member] Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Granada Investments LLC Granada Investments LLC [Member] Granada Investments LLC [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Schedule of Real Estate Acquisitions Schedule Of Assets Acquisitions [Table Text Block] Schedule Of Assets Acquisitions [Table Text Block] 49th Street Health Holdings LLC Forty Nine Street Health Holdings Llc [Member] Forty Nine Street Health Holdings Llc [Member] Unsecured revolving credit facility Revolving Facility Line of Credit [Member] Thereafter Lessor, Operating Lease, Payment to be Received, after Year Five Xenia Health and Rehab Xenia Health And Rehab [Member] Xenia Health And Rehab [Member] Arbor Nursing Center Arbor Nursing Center [Member] Arbor Nursing Center [Member] Other real estate investments, net Real Estate Investments, Joint Ventures Croatan Village Croatan Village [Member] Croatan Village [Member] Inn at Barton Creek Inn At Barton Creek [Member] Inn At Barton Creek Providence Ontario Providence Ontario [Member] Providence Ontario [Member] Variable Rate [Axis] Variable Rate [Axis] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and contingencies (Note 10) Commitments and Contingencies Verde Villa Holdings LLC Verde Villa Holdings LLC [Member] Verde Villa Holdings LLC [Member] Vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Integral Equipment, Furniture and Fixtures Furniture and Fixtures [Member] Entity Address, State or Province Entity Address, State or Province Vested (shares) Shares vested (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Mesquite Health Holdings LLC Mesquite Health Holdings LLC [Member] Mesquite Health Holdings LLC [Member] Other Commitments [Table] Other Commitments [Table] Authorized aggregate offering price of common stock Securities Offering, Authorized Amount Securities Offering, Authorized Amount Lakewest SNF Realty LLC Lakewest SNF Realty LLC [Member] Lakewest SNF Realty LLC [Member] Pennant Pennant [Member] Pennant [Member] StoneBridge Nursing and Rehabilitation Center StoneBridge Nursing And Rehabilitation Center [Member] StoneBridge Nursing And Rehabilitation Center [Member] Average sales price per share (usd per share) Shares Issued During Period, Average Price Per Share Shares Issued During Period, Average Price Per Share Regal Road Health Holdings LLC Regal Road Health Holdings LLC [Member] Regal Road Health Holdings LLC [Member] Customer [Axis] Customer [Axis] Income Taxes Income Tax, Policy [Policy Text Block] Payments of deferred financing costs Payments of Financing Costs Amortization of stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Thereafter Long-Term Debt, Maturity, after Year Five Independent living facilities Revenue from Contract with Customer, Excluding Assessed Tax Tenth East Holdings LLC Tenth East Holdings LLC [Member] Tenth East Holdings LLC [Member] Brookfield Health and Rehab Brookfield Health And Rehab [Member] Brookfield Health And Rehab [Member] Numerator for basic and diluted earnings available to common stockholders Net Income Loss Available To Common Stockholders Basic And Diluted Net income (loss) available to common stockholders basic and diluted. Geographical [Domain] Geographical [Domain] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table] Loans receivable exit fee (percent) Loans Receivable, Exit Fee, Percent Loans Receivable, Exit Fee, Percent Preferred equity investments Equity Method Investments, Fair Value Disclosure Lease termination revenue Gain (Loss) on Termination of Lease Borrowings under unsecured revolving credit facility Proceeds from Long-term Lines of Credit BeaverCreek Health and Rehab BeaverCreek Health And Rehab [Member] BeaverCreek Health And Rehab [Member] Entity Voluntary Filers Entity Voluntary Filers Prepaid expenses and other assets Prepaid Expenses And Other Assets [Policy Text Block] Prepaid Expenses And Other Assets [Policy Text Block] Annual cash rent increase under amended lease Annual Cash Rent Increase Under Amended Lease Annual Cash Rent Increase Under Amended Lease Credit Facility [Axis] Credit Facility [Axis] Oleson Park Health Holdings LLC Oleson Park Health Holdings LLC [Member] Oleson Park Health Holdings LLC [Member] Providence Providence Group [Member] Providence Group [Member] Aspen Park] Kindred Nursing And Rehabilitation - Aspen Park [Member] Kindred Nursing And Rehabilitation - Aspen Park [Member] Preferred stock, issued (shares) Preferred Stock, Shares Issued Vested (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested in Period, Weighted Average Exercise Price Land Land Total Lessor, Operating Lease, Payments to be Received Number of units in property sold Number Of Units In Property Sold Number Of Units In Property Sold Straight-line rent Lease Income, Straight Line Rent [Member] Lease Income, Straight Line Rent [Member] Number of transitioned facilities Number Of Transitioned Facilities Number Of Transitioned Facilities Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Number of Beds/Units Number Of Beds Or Units In Properties Acquired Number Of Beds Or Units In Properties Acquired Rowlett Health and Rehabilitation Center Rowlett Health And Rehabilitation Center [Member] Rowlett Health And Rehabilitation Center Accumulated Depreciation Balance at the beginning of the period Balance at the end of the period SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation Proceeds from (costs paid for) the issuance of common stock, net Gross proceeds Proceeds from Issuance of Common Stock Schedule of Rental Income Operating Lease, Lease Income [Table Text Block] Number of equal annual vesting installments Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting, Number Of Equal Annual Installments Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting, Number of Equal Annual Installments Reconciliation of Weighted-Average Common Shares Outstanding Used in Calculation of Basic EPS to Diluted EPS Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Trio Trio Healthcare Inc [Member] Trio Healthcare Inc [Member] Prior Revolving Facility Revolving Credit Facility As Amended [Member] Revolving Credit Facility As Amended [Member] Legacy West Rehabilitation and Healthcare Legacy West Rehabilitation And Healthcare [Member] Legacy West Rehabilitation And Healthcare [Member] Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Unsecured revolving credit facility Long-term Line of Credit Sky Holdings AZ LLC Sky Holdings AZ LLC [Member] Sky Holdings AZ LLC [Member] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Salmon River Health Holdings LLC Salmon River Health Holdings LLC [Member] Salmon River Health Holdings LLC [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Cooney Healthcare and Rehabilitation Cooney Healthcare And Rehabilitation [Member] Cooney Healthcare And Rehabilitation Proceeds from settlement of loan Proceeds from Loans LIBOR floor for loan (percent) Loans Receivable, LIBOR Floor, Percentage Loans Receivable, LIBOR Floor, Percentage Depreciation expense SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Depreciation Expense Wisteria Health Holdings LLC Wisteria Health Holdings LLC [Member] Wisteria Health Holdings LLC [Member] Senior unsecured notes payable Senior Notes [Member] Trinity Mill Holdings LLC Trinity Mill Holdings LLC [Member] Trinity Mill Holdings LLC [Member] Cascade Capital Group, LLC Cascade Capital Group LLC [Member] Cascade Capital Group LLC [Member] The Oaks The Oaks [Member] The Oaks [Member] Geographical [Axis] Geographical [Axis] Multi-Service Campus Properties Skilled Nursing Campus Properties [Member] Skilled Nursing Campus Properties [Member] Number of units available in living facilities Number of Units in Real Estate Property Jamestown Place Health and Rehab Jamestown Place Health And Rehab [Member] Jamestown Place Health And Rehab [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Arrow Tree Health Holdings LLC Arrow Tree Health Holdings LLC [Member] Arrow Tree Health Holdings LLC [Member] 2024 Long-Term Debt, Maturity, Year Four Net proceeds from issuance of senior notes Proceeds from Debt, Net of Issuance Costs Lockwood Health Holdings LLC Lockwood Health Holdings LLC [Member] Lockwood Health Holdings LLC [Member] Lease Expiration January 2031, First option 2022 Properties With Purchase Option, Lease Expiration January 2031, First Option 2022 [Member] Properties With Purchase Option, Lease Expiration January 2031, First Option 2022 San Corrine Health Holdings LLC San Corrine Health Holdings LLC [Member] San Corrine Health Holdings LLC [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Vesting of restricted common stock, net of shares withheld for employee taxes (shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Line of Credit Facility [Table] Line of Credit Facility [Table] Buildings and improvements Investment Building and Building Improvements Interest and other income Interest and Other Income Issuance of common stock, net Stock Issued During Period, Value, New Issues Silver Lake Health Holdings LLC Silver Lake Health Holdings LLC [Member] Silver Lake Health Holdings LLC [Member] Title of 12(b) Security Title of 12(b) Security Disposal Group Classification [Axis] Disposal Group Classification [Axis] Uncommitted incremental facility limit Line Of Credit Facility, Uncommitted Incremental Facility, Limit Line Of Credit Facility, Uncommitted Incremental Facility, Limit Schedule of Real Estate Properties [Table] Schedule of Real Estate Properties [Table] Cost Capitalized Since Acquisition SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Cost Capitalized Subsequent to Acquisition [Abstract] Ensign and Pennant Ensign And Pennant [Member] Ensign And Pennant 2022 Lessor, Operating Lease, Payment to be Received, Year Two Interest expense Interest Expense Depreciation and amortization (including below-market ground leases) Depreciation, Depletion and Amortization Kings Court Health Holdings LLC Kings Court Health Holdings Llc [Member] Kings Court Health Holdings Llc [Member] Ensign Ensign [Member] Ensign [Member] Product and Service [Axis] Product and Service [Axis] Proceeds from the issuance of senior unsecured term loan Gross proceeds from issuance of senior notes Proceeds from Issuance of Unsecured Debt Iowa IOWA The Orchards Kindred Nursing And Rehabilitation - Nampa [Member] Kindred Nursing And Rehabilitation - Nampa [Member] Weighted average remaining vesting period related to expense recognition Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 2022 Long-Term Debt, Maturity, Year Two Ensign Southland LLC Ensign Southland LLC [Member] Ensign Southland LLC [Member] Secora Health and Rehabilitation of Cascadia Secora Health And Rehabilitation Of Cascadia [Member] Secora Health And Rehabilitation Of Cascadia [Member] Principal payments received on real estate mortgage and other loans receivable Proceeds from Collection of Loans Receivable Priority Priority Life Care LLC [Member] Priority Life Care LLC [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Downey Care Center Downey Care Center [Member] Downey Care Center [Member] Sales of real estate SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Cost of Investment in Real Estate Sold Applewood of Brookfield Applewood of Brookfield [Member] Applewood of Brookfield [Member] Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Selected Quarterly Financial Data Quarterly Financial Information [Table Text Block] Cumulative Distributions in Excess of Earnings Accumulated Distributions in Excess of Net Income [Member] Class of Stock [Line Items] Class of Stock [Line Items] Mortgage and mezzanine loans receivable Mezzanine And Mortgage Loan Receivables [Member] Mezzanine And Mortgage Loan Receivables Anson Health Holdings LLC Anson Health Holdings LLC [Member] Anson Health Holdings LLC [Member] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] (Loss) gain on sale of real estate Loss (gain) on sale of real estate Gain (loss) on sale of real estate Gains (Losses) on Sales of Investment Real Estate Liberty Nursing Center of Willard Liberty Nursing Center Of Willard [Member] Liberty Nursing Center Of Willard [Member] Schedule IV - Mortgage Loans on Real Estate SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Text Block] Number of operators for which rental income was recovered after previous write off Number Of Operators, Collection Of Lease Payment Recovered After Write-Off Number Of Operators, Collection Of Lease Payment Recovered After Write-Off Number of extension options Loan Receivable, Number Of Extension Options Loan Receivable, Number Of Extension Options Cumulative distributions in excess of earnings Accumulated Distributions in Excess of Net Income Subsequent event Subsequent Event [Member] Ohio OHIO Shreveport Manor Skilled Nursing and Rehabilitation Shreveport Manor Skilled Nursing And Rehabilitation [Member] Shreveport Manor Skilled Nursing And Rehabilitation [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expo Park Health Holdings LLC Expo Park Health Holdings LLC [Member] Expo Park Health Holdings LLC [Member] Fair Value Estimate of Fair Value Measurement [Member] Trousdale Health Holdings LLC Trousdale Health Holdings LLC [Member] Trousdale Health Holdings LLC [Member] Payments for redemption of senior notes Repayments of Senior Debt Gross Carrying Value, Land SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Land, Amount New Revolving Facility New Revolving Facility [Member] New Revolving Facility [Member] 4th Street Holdings LLC Fourth Street Health Holdings LLC [Member] Fourth Street Health Holdings LLC [Member] Flamingo Health Holdings LLC Flamingo Health Holdings LLC [Member] Flamingo Health Holdings LLC [Member] Real Estate Depreciation and Amortization Depreciation, Depletion, and Amortization [Policy Text Block] Recovery of previously reserved rent Operating Lease Lease Income Adjustments For Recovery Operating Lease Lease Income Adjustments For Recovery Rental income Operating Leases, Income Statement, Lease Revenue 18th Place Health Holdings LLC Eighteenth Place Health Holdings LLC [Member] Eighteenth Place Health Holdings LLC [Member] Preferred stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] 2021 Long-Term Debt, Maturity, Year One City Area Code City Area Code Document Period End Date Document Period End Date Greenville Nursing and Rehabilitation Center Greenville Nursing and Rehabilitation Center [Member] Greenville Nursing and Rehabilitation Center [Member] Silverada Health Holdings LLC Silverada Health Holdings LLC [Member] Silverada Health Holdings LLC [Member] Summary of Dividends on Common Stock Dividends Declared [Table Text Block] Share repurchase program authorization Stock Repurchase Program, Authorized Amount Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Property taxes Real Estate Tax Expense Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information Disclosure [Abstract] Hillstone Healthcare Master Lease Hillstone Healthcare Master Lease [Member] Hillstone Healthcare Master Lease [Member] Schedule III - Real Estate Assets and Accumulated Depreciation SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Text Block] Turlock Nursing and Rehabilitation Center Turlock Nursing and Rehabilitation Center [Member] Turlock Nursing and Rehabilitation Center [Member] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Courtyard Healthcare Center Courtyard Healthcare Center [Member] Courtyard Healthcare Center [Member] Vesting of restricted common stock, net of shares withheld for employee taxes Restricted Stock, Value, Shares Issued Net of Tax Withholdings Cover [Abstract] Cover [Abstract] Base Rate Base Rate [Member] Annualized contractual rental income escalation rate (percent) Lessor, Operating Lease, Annual Escalation Rate Lessor, Operating Lease, Annual Escalation Rate Interest income distribution from other real estate investment Proceeds from Equity Method Investment, Distribution Carrying Value Outstanding borrowings Long-term Debt Mountainview Community Care LLC Mountainview Community Care LLC [Member] Mountainview Community Care LLC [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Independent living facilities Cost of Goods and Services Sold Lease Expiration March 2030, First option 2022 Properties With Purchase Option, Lease Expiration March 2030, First Option 2022 [Member] Properties With Purchase Option, Lease Expiration March 2030, First Option 2022 Total expenses Costs and Expenses Equity Components [Axis] Equity Components [Axis] English Meadows Elks Home Campus English Meadows Elks Home Campus [Member] English Meadows Elks Home Campus [Member] Huntington Park Nursing Center Huntington Park Nursing Center [Member] Huntington Park Nursing Center [Member] Grandview Health Care Center Grandview Health Care Center [Member] Grandview Health Care Center [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Minimum Minimum [Member] Other Real Estate Investments, Net Other Real Estate Investments [Text Block] Other Real Estate Investments [Text Block] Fifth East Holdings Fifth East Holdings LLC [Member] Fifth East Holdings LLC [Member] Acquisition Date Real Estate and Accumulated Depreciation, Year Acquired Real Estate and Accumulated Depreciation, Year Acquired Ensign Highland LLC Ensign Highland LLC [Member] Ensign Highland LLC [Member] Idaho assisted living facilities Idaho Assisted Living Facilities [Member] Idaho Assisted Living Facilities [Member] Additions during period: Additions During Period [Abstract] Additions During Period [Abstract] Real Estate Acquisition Valuation Real Estate Acquisitions [Policy Text Block] Real Estate Acquisitions [Policy Text Block] Entity Interactive Data Current Entity Interactive Data Current ATM Program At-The-Market Offering Program [Member] At-The-Market Offering Program [Member] Revenues: Revenues [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Equity Stockholders' Equity Note Disclosure [Text Block] Funding commitment for revenue-producing capital expenditures Funding Commitment, Capital Expenditures Funding Commitment, Capital Expenditures Investment in real estate mortgage and other loans receivable Payments to Acquire Loans Receivable The Pines of Burton The Pines of Burton [Member] The Pines of Burton [Member] Facility fee on revolving commitment fees (percent) Line of Credit Facility, Commitment Fee Percentage Stock-Based Compensation Share-based Payment Arrangement [Policy Text Block] Saratoga Health Holdings LLC Saratoga Health Holdings LLC [Member] Saratoga Health Holdings LLC [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Wayne Health Holdings LLC Wayne Health Holdings LLC [Member] Wayne Health Holdings LLC [Member] Number of states where Ensign leases the highest concentration of properties Concentration Risk, Number Of States Number of states where the entity's major tenants lease the highest concentration of properties. Shares Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Ensign Employees Ensign Employees [Member] Ensign Employees [Member] Number of reportable segments Number of Reportable Segments BellBrook Health and Rehab BellBrook Health And Rehab [Member] BellBrook Health And Rehab [Member] South Dora Health Holdings LLC South Dora Health Holdings LLC [Member] South Dora Health Holdings LLC [Member] Countryside Village Countryside Village [Member] Countryside Village [Member] ALF Assisted living Assisted Living Facility [Member] Assisted Living Facility [Member] Englewood Health and Rehab Englewood Health And Rehab [Member] Englewood Health And Rehab [Member] Rental income Total Operating Lease, Lease Income Initial Cost to Company, Buildings and Improvements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Building and Improvements Straight-line rental income Straight-line rent Straight Line Rent SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] Book Value Mortgage loans, beginning of period Mortgage loans, end of period SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Meadowbrook Health Associates LLC Meadowbrook Health Associates LLC [Member] Meadowbrook Health Associates LLC [Member] Contractual rent due Operating Lease, Lease Income, Lease Payments Dividends payment date Dividends Payable, Date to be Paid Premier Estates of Norwood Towers/Premier Retirement Estates of Norwood Towers Premier Estates of Norwood Towers Premier Retirement Estates of Norwood Towers [Member] Premier Estates of Norwood Towers Premier Retirement Estates of Norwood Towers [Member] Decatur Medical Lodge Decatur Medical Lodge [Member] Decatur Medical Lodge [Member] Disposed of by sale Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Real estate: SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate [Roll Forward] Lufkin Health Holdings LLC Lufkin Health Holdings LLC [Member] Lufkin Health Holdings LLC [Member] Document Transition Report Document Transition Report Title of Individual [Axis] Title of Individual [Axis] The Village at Heritage Oaks The Village At Heritage Oaks [Member] The Village At Heritage Oaks [Member] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Other (loss) income: Nonoperating Income (Expense) [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] The Pines of Lapeer The Pines of Lapeer [Member] The Pines of Lapeer [Member] Carrier Mills Nursing and Rehabilitation Center Carrier Mills Nursing And Rehabilitation Center [Member] Carrier Mills Nursing And Rehabilitation Center [Member] Various other operators Various Other Operators [Member] Various Other Operators [Member] Georgia GEORGIA PMG Priority Management Group LLC [Member] Priority Management Group LLC [Member] Shaw Mountain at Cascadia Shaw Mountain At Cascadia [Member] Shaw Mountain At Cascadia [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Credit Facility [Domain] Credit Facility [Domain] Net proceeds from sales of real estate Proceeds from sale Proceeds from Sale of Real Estate Held-for-investment Basic (usd per share) Earnings per common share, basic (usd per share) Earnings Per Share, Basic Building Improvements Building Improvements [Member] Royse City Medical Lodge Royce City Health and Rehabilitation Center [Member] Royce City Health and Rehabilitation Center [Member] Entity File Number Entity File Number Number of extension options Line Of Credit Facility, Number Of Extension Options Line Of Credit Facility, Number Of Extension Options 2024 Lessor, Operating Lease, Payment to be Received, Year Four Common dividends ($1.00, $0.90 and $0.82 per share for the years ended 2020, 2019 and 2018, respectively) Dividends, Common Stock Amortization of stock-based compensation Stock-based compensation expense Share-based Payment Arrangement, Expense Swingline Loan Swingline Loan [Member] Swingline Loan [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Document Annual Report Document Annual Report MCRC, LLC Manteca Valley Post Acute [Member] Manteca Valley Post Acute [Member] Vesting metric, Normalized Funds from Operations, minimum (percent) Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Condition, NFFO Growth, Minimum, Percentage Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Condition, NFFO Growth, Minimum, Percentage Centerville Senior Independent Living Centerville Senior Independent Living/Centerville Health And Rehab/Centerville Place Assisted Living [Member] Centerville Senior Independent Living/Centerville Health And Rehab/Centerville Place Assisted Living [Member] Remaining offering amount available Securities Offering, Remaining Authorized Amount Securities Offering, Remaining Authorized Amount Willits Health Holdings LLC Willits Health Holdings LLC [Member] Willits Health Holdings LLC [Member] SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table] SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table] Receivable [Domain] Receivable [Domain] Subsequent Event [Table] Subsequent Event [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Grant date fair market value (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The Pines of Clarkston The Pines of Clarkston [Member] The Pines of Clarkston [Member] Osage Osage [Member] Osage [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Providence Waterman Nursing Center Providence Waterman Nursing Center [Member] Providence Waterman Nursing Center [Member] Mira Vista Care Center Mira Vista Care Center [Member] Mira Vista Care Center [Member] Senior unsecured notes payable, net Unsecured Long-term Debt, Noncurrent Accounts and other receivables, net Increase (Decrease) in Accounts Receivable Paydowns/Repayments SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Collections of Principal Acquisitions SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Acquisition Proceeds from (costs paid for) the issuance of common stock, net Commissions paid on stock issuance Payments of Stock Issuance Costs Caldwell Care Kindred Nursing And Rehabilitation - Caldwell [Member] Kindred Nursing And Rehabilitation - Caldwell [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Loan receivable Receivables, Fair Value Disclosure Total liabilities and equity Liabilities and Equity Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Loan receivable Financing Receivable, after Allowance for Credit Loss General and administrative General and Administrative Expense Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Equity Component [Domain] Equity Component [Domain] The Oaks at Lakewood The Oaks At Lakewood [Member] The Oaks At Lakewood [Member] Snohomish Health Holdings LLC Snohomish Health Holdings LLC [Member] Snohomish Health Holdings LLC [Member] Entity Tax Identification Number Entity Tax Identification Number Assisted and Independent Living Properties Assisted and Independent Living Properties [Member] Assisted and Independent Living Properties [Member] Stock-Based Compensation Share-based Payment Arrangement [Text Block] Net income Net income Net income (loss) Net Income (Loss) Attributable to Parent Change in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Cottonwood Health Holdings LLC Cottonwood Health Holdings LLC [Member] Cottonwood Health Holdings LLC [Member] LIBOR London Interbank Offered Rate (LIBOR) [Member] Provision for loan losses Financing Receivable, Credit Loss, Expense (Reversal) Forfeited (usd per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeited In Period, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeited In Period, Weighted Average Exercise Price Initial Cost to Company SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Expenses: Operating Expenses [Abstract] Mezzanine loan receivable Mortgage loans receivable Loans Receivable, Fair Value Disclosure Financial liabilities: Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] Five Oaks skilled nursing facility Five Oaks [Member] Five Oaks Number of facilities Number of Real Estate Properties Tenant reimbursements Tenant recoveries related to real estate taxes Tenant Reimbursement Revenue Tenant Reimbursement Revenue Iowa City Rehab and Health Care Center Iowa City Rehab and Health Care Center [Member] Iowa City Rehab and Health Care Center [Member] Extension option term (in months) Line Of Credit Facility Extension Option Term Line of credit facility extension option term. Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Preferred equity investments - face value Equity Method Investment, Aggregate Cost Weiser Care Kindred Nursing And Rehabilitation - Weiser [Member] Kindred Nursing And Rehabilitation - Weiser [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Saline Care Nursing and Rehabilitation Center Saline Care Nursing And Rehabilitation Center [Member] Saline Care Nursing And Rehabilitation Center [Member] Restricted Stock Award and Performance Award Restricted Stock And Performance Shares [Member] Restricted Stock And Performance Shares [Member] Summary of Estimated Useful Lives of Assets Property, Plant and Equipment [Table Text Block] Contract purchase price Disposal Group, Including Discontinued Operation, Contract Purchase Price Disposal Group, Including Discontinued Operation, Contract Purchase Price Other Commitments [Domain] Other Commitments [Domain] Issuance of common stock, net (shares) Number of shares (shares) Stock Issued During Period, Shares, New Issues Louisa Amerisist Of Louisa [Member] Amerisist Of Louisa [Member] Ives Health Holdings LLC Ives Health Holdings Llc [Member] Ives Health Holdings Llc [Member] Elkhorn Healthcare and Rehabilitation Elkhorn Healthcare And Rehabilitation [Member] Elkhorn Healthcare And Rehabilitation New Term Loan Feb 2019 New Term Loan Feb 2019 [Member] New Term Loan Feb 2019 [Member] Identified intangible assets Finite-Lived Intangible Assets, Gross Lessor, Lease, Description [Line Items] Lessor, Lease, Description [Line Items] Held for sale Discontinued Operations, Held-for-sale [Member] Dixie Health Holdings Dixie Health Holdings LLC [Member] Dixie Health Holdings LLC [Member] Expressway Health Holdings LLC Expressway Health Holdings LLC [Member] Expressway Health Holdings LLC [Member] Ensign Bellflower LLC Ensign Bellflower LLC [Member] Ensign Bellflower LLC [Member] Irving Health Holdings LLC Irving Health Holdings LLC [Member] Irving Health Holdings LLC [Member] Extension option term (in months) Loan Receivable, Extension Option Term Loan Receivable, Extension Option Term Deductions during period: Deductions During Period [Abstract] Deductions During Period [Abstract] Plaza Health Holdings LLC Plaza Health Holdings LLC [Member] Plaza Health Holdings LLC [Member] Cascadia of Nampa Cascadia Of Nampa [Member] Cascadia Of Nampa [Member] Impairment expense to reduce carrying value to fair value less costs to sell Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Other Ensign leases Ensign Other Leases [Member] Ensign Other Leases Granted (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price Number of beds planned for construction Number Of Beds Planned For Construction Number Of Beds Planned For Construction Basic (shares) Weighted-average basic common shares outstanding (shares) Weighted-average number of common shares outstanding, basic (shares) Weighted Average Number of Shares Outstanding, Basic Basis spread on variable rate (percent) Debt Instrument, Basis Spread on Variable Rate Carrying Amount Reported Value Measurement [Member] Period of unpaid interest payments due upon prepayment Loan Receivable, Period Of Unpaid Interest Payments Due Upon Prepayment Loan Receivable, Period Of Unpaid Interest Payments Due Upon Prepayment Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Dividends payable Dividends Payable Right-of-use asset obtained in exchange for new operating lease obligation Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Mountain Valley Kindred Nursing And Rehabilitation - Mountain Valley [Member] Kindred Nursing And Rehabilitation - Mountain Valley [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] West Cove Care & Rehabilitation Center West Cove Care And Rehabilitation Center [Member] West Cove Care And Rehabilitation Center [Member] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Debt Maturities Schedule of Maturities of Long-term Debt [Table Text Block] Number of beds in facility utilized to secure loan Loan Receivable, Number Of Beds In Property Utilized To Secure Loan Loan Receivable, Number Of Beds In Property Utilized To Secure Loan Lease renewal term (in years) Lessor, Operating Lease, Renewal Term Title of Individual [Domain] Title of Individual [Domain] Local Phone Number Local Phone Number Gross real estate taxes offset to rental income Real Estate Taxes, Paid, Offset To Rental Income, Gross Real Estate Taxes, Paid, Offset To Rental Income, Gross Escrow deposits for potential acquisitions of real estate Payments for Deposits on Real Estate Acquisitions Principal Amount Outstanding amounts Total debt Long-term Debt, Gross Long Beach Health Associates LLC Long Beach Health Associates Llc [Member] Long Beach Health Associates Llc [Member] Facilities utilized to secure mortgage loan Loan Receivable, Number Of Facilities Utilized To Secure Mortgage Loan Loan Receivable Number Of Facilities Utilized To Secure Mortgage Loan Credit facility borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Prepaid expenses and other assets, net Prepaid Expense and Other Assets Class of Financing Receivable [Axis] Class of Financing Receivable [Axis] Cedar Falls Health Care Center Cedar Falls Health Care Center [Member] Cedar Falls Health Care Center [Member] Lease Contractual Term [Domain] Lease Contractual Term [Domain] The Bradford Skilled Nursing and Rehabilitation The Bradford Skilled Nursing and Rehabilitation [Member] The Bradford Skilled Nursing and Rehabilitation [Member] Preferred stock, outstanding (shares) Preferred Stock, Shares Outstanding Measurement Basis [Axis] Measurement Basis [Axis] Basis spread on preferred equity investment yield Equity Method Investments, Basis Spread On Variable Rate Equity Method Investments, Basis Spread On Variable Rate Stock awards unvested during spin-off (shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Spin Off In Period Share based compensation arrangement by share based payment award equity instruments other than options nonvested spin off in period. Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Contractual rent Lease Income, Contractual Rent [Member] Lease Income, Contractual Rent [Member] The Rio at Fox Hollow The Rio At Fox Hollow [Member] The Rio At Fox Hollow [Member] Rillito Holdings LLC Rillito Holdings LLC [Member] Rillito Holdings LLC [Member] Award Type [Domain] Award Type [Domain] Schedule of Total Future Contractual Minimum Rental Income Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block] Lamplight Inn of West Allis Lamplight Inn Of West Allis [Member] Lamplight Inn Of West Allis [Member] The Oaks at Timberline The Oaks At Timberline [Member] The Oaks At Timberline [Member] Jefferson Ralston Holdings LLC Jefferson Ralston Holdings LLC [Member] Jefferson Ralston Holdings LLC [Member] Funding commitment Other Commitment Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Multi-service campuses Multi-Service Campus Properties [Member] Multi-Service Campus Properties [Member] Accumulated depreciation and amortization Real Estate Investment Property, Accumulated Depreciation Earnings Per Common Share Earnings Per Share [Text Block] RB Heights Health Holdings LLC RB Heights Health Holdings LLC [Member] RB Heights Health Holdings LLC [Member] Canyon West Kindred Nursing And Rehabilitation - Canyon West [Member] Kindred Nursing And Rehabilitation - Canyon West [Member] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] EX-101.PRE 12 ctre-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 ctre-20201231_g1.jpg begin 644 ctre-20201231_g1.jpg M_]C_X 02D9)1@ ! 0$ D "0 #_X1#^17AI9@ 34T *@ @ ! $[ ( M 1 (2H=I 0 ! (7)R= $ B 0U.H< < @, /@ M !SJ " M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M ,C R,3HP,CHP-" Q,3HQ,SHR-@ R,#(Q M.C R.C T(#$Q.C$S.C(V 4P!T &4 < !H &$ ;@!I &4 ( !3 &D ;@!G M &4 <@ /_A"R-H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A M8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZDY48WIK8SED M)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(CX\&UL M;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UP;65T83X-"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @ M(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@'!P@* M$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR M)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_ !$( 7<"K ,!(@ "$0$# M$0'_Q ? !!0$! 0$! 0 0(#! 4&!P@)"@O_Q "U$ " 0,# M @0#!04$! 7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S M8G*""0H6%Q@9&B4F)R@I*C0U-C+CY.7FY^CIZO'R\_3U]O?X^?K_Q ? 0 # M 0$! 0$! 0$! 0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$! ! M G< 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?( MRKR\_3U]O?X^?K_V@ , P$ A$#$0 _ /I& MBFR';$Y+B/"D[ST7WKR+PY;7%QHFJ:+/K,\FI*Z744D7B"5(;\L)P'64#S8\ M^4\AC0E<(A!P7R >OT5YKH6KW=[J5EJT>H7ES<7-T+1K>20B-H?[-%P,P*Q1 M'+['W 9^?;NVD"M;P!/(VY/[0N;^&XTJQU!I+BX:<^=,)?,*LQ.U2$0A%PJY MR U ':454EU#R-0@M9+:8+.Q2.?Y-A;:S8^]NZ*>V*MT %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !6*G@WPRFG7&GCP_IALKF6M&L[4_P#D(:/_ -?C?^D\M:- !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% &=J?_(0T?_K\;_TGEK1K.U/_ )"&C_\ M7XW_ *3RUHT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !114C4445D:!1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% 2%4EC@#DD]JY>V^(OARZT^2\AN+MD680K&MA.TLI(9E M9(U0NZE4=@R@C"-SP<=,X)C8!58X.%8X!]C7E>D6GBW1M&U&WT;P]JEC;7-P MD,5JM[!/)9#,GG2P>;*%V;?*1 2 ""^S&0P!W]EXITK4=26RL);BY=D60316 M=/DBTZSTX1M*DAD:#S"TBLA/[LF7"[MK?*257(H MV]3_ .0AH_\ U^-_Z3RUHUD:E"XUO29C#+B_B93?3'R;-",YD(ZX[A1D_@!WJHQ#^2X ZW0<=?2*W=14O=I[]7_D8J#J>]4^X\W;X"^!3:O$+&Z5V&!,+M]Z^XYV M_F#6-_PK;QWX-^?P!XK:[M$Y&G:CTQZ#.5_$;*]AHJ57J=7?UU*=&'16]#SG MP-\54UK4CX>\66O]C>(XFV- X*QSG_8ST/MDYZ@FN^OKZUTRQFO=0N([:V@7 M?)+(V%4>YKFO'?P[TGQU8 70^RZA"/\ 1K^)?GC/H?[R^WY8KS^R^&/C?Q1? M1:?\1=;=]#TQ@L20R@M>XZ,2.>G&Y_F]!U-5RTI^]>W=?Y$\U2'NVOV?^9=; MXL>+/$VJ7!^&_A=-2TNU^62YNP5,C?[/S*!].3W..E.D^)?Q'M(V%W\-KB23 M!"M 9& /8X4-D?C7JNG:;9Z1I\-CIEM':VL*[8XHEP%'^>_>K-+VE/90T'[. M?66IYA\/OA]?/JK>,_'S&ZU^Y.^&"0?+9KVXZ!@.@_A^M4-$_P"*:_:6UC3S M\MOKUG]HB7^\X 8G\UEKUZO(?C#_ ,2#QOX,\6K\J6]W]FN6_P!@D''_ 'R9 M*NG-U)M/JK?Y$S@J<4UT9Z]1117(=(4444 %%%% !1110 4444 %%%% !111 M0 4444 %>9>!M>U3Q%\8/&$AOIGT?3]MI%;%LQ*X;;N4>O[MSGON^E>@ZQJ, M>D:'?:E-CR[.WDG;/<*I/]*\Z^ 6G20^ 9]5NS:ZU6]@LX%ZR3R!%_,]_:C<-BW7B]C_Q M=?XS/?-^]\.>&3M@!Y2>;/7WRPS_ +J+ZT_QI\7X=>T^Z\.?#NVO=4U&\4P_ M:882%C4\,5_B)QD9P ,YSQ7H'@#PE#X+\&VFDQA3.!YMU(/^6DK?>/T' 'L! M74HNC!R>[V_S.=M59**V6YTM%%%I M%5W2612[3VVGYC_WP6KOJK:C91:GI=U87',5U"\+_P"ZRD']#5PERR4NQ,X\ MT7$R/ FL?V]X!T742VYYK1!(<]74;7_\>4UT%>5? *]E7PCJ6A7?%QH]^\3+ M_=5N?_0@]>JU5:/+4:)I2YH)F1XJ\16WA3PO?:S>8*6T9*IG'F.>%4?4D"N M^$'Q*U+Q1=7FC^*F5=351=VQ\L1^9"P!P .N RD'J0>^,U1\?R2?$7XGZ;X$ MLG8Z;IY%WJKH>.!]W(] 0H_VG]JL_%[0)]"ETKQYX:B$=WHC)'/'&,!X.@R! MV&2I_P!EO:MX0ARJ$MY?AV^\PE.7,YQV7X]_N/6Z*S]!UJT\1:#9ZMI[;K>[ MB$B>H]5/N#D'W%:%(2%59^#C(Y'S2%Y]*\,RZ]J^Y]7UY_M4TD@^8(22H/UR6/^\/2 MO0[JU@OK.:UNXUE@GC:.6-NCJ1@@_@:D50BA5 50, =*6L)S0IV\?BKJ?JK>M>OUY'K'_$K_ &HM$FZ) MJ6FLC'U(608_\<7\Z]4_ 2RFE\/:QXDO%Q/K>H/)G^\JD\_P#?;./PKU:MZ_Q\O;0QH_!S M=]0HHHK V"BBB@ HHHH SM3_ .0AH_\ U^-_Z3RUHUG:G_R$-'_Z_&_])Y:T M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHKGO''B^V\#^%9]9NH3<%&6.*!7VF5V/ S@XXR>AX!JUX6\1V?BSPW::SIQQ M%<)DH3EHV'#*?<'_ !JN67+S=">9N9"7Y^@8#\*Y/XZR/JC>&/"ENQ\S5M1 M4N%ZA1A!GVS)G_@->LQ1I#"D42A410JJ.P'05K+W:*7=W,HZU6^V@ZBBBL#< M**** "BBB@ HHHH **** "BBB@ HHHH **** /(_BQ_Q+OB;X U8<+]M,$C> MB[X_Z,U>N5Y-^T)$\?@W2M3A'[RRU-&!] 5;^JK7JT,JSP1S1G*2*&4^H(S6 M]36E!^IC#2I)>@^BBBL#8**YOP]X]T+Q/KVJ:/I<[M=Z8Y64.N!( =I9#GE0 M>,\=NQ%=)3E%Q=F)24E=!7'?%#QD/!?@NXNH&']H7/\ H]DG4F0C[V/11D_7 M [UV->+Z6/\ A:_QEDU9_P![X=\-'9;9Y6:7/!]\D;OHJ>M:T8IOFELC.K)I ML_#[Q=%X2\8%UBUN)+JTDD8G9.XY3)[DY4_P"T!ZYKW2N(^*O@ MD^,O";?8AMU;3R;BQD4X;<.J _[6/S"GM3_A=XU'C3PBDMT=NJ61$%]&1@AQ MT;'^T!GZY':KJ_O(^T7S(I_NY>S?R.TKS+XZZU+9>!H]'LLM>:U<+;1HO5E! M!;'U.U?^!5Z;7C]Y_P 5K^T?;6P^>P\+V_FOZ>=P?SWLG_?LU-!+GYGTU*K/ MW>5==#TSPUHL?ASPOIVD0X*V=NL18?Q,!\S?B/9L!SAMW51H>$MLK:F5[.VOXFM8V14CG#XB.YF+,IC;+_*&##Y5P M:FM/",%OK2ZC/J-]>,")##<&/RVN/)$)N,*@(&;?PY M'(L-W=WC-'' DEVRLT<$8(CA!51E5W,06RQ+$EC0 [4KNW;6])M5GB-PMTSF M$.-X7R)><=<<]:UZSM3_ .0AH_\ U^-_Z3RUHT %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%1SSQ6MM)<7#B.*)"[N>BJ!DG\J M /(OB1_Q6?Q9\-^"D^>TM6^VWX'3'7:?^ KC_MH*@\,2-\*?BM<>%KMRN@:Z M_G:=(Y^6.0\!<^O\!_X >]6_@Q!)XAU_Q+X\O4(?4;DV]KNZK&,$CZ8\M?\ M@)KJ?BEX+_X3/P?)%:C&IV1^T6+@X.\=5S_M#CZX/:NYR49*C+:UGZ]SC47) M>U6_Z'*R_P#%3?M/1)]^W\.V&XC^'>5_GF8?]\^U>O5XY\ ['4+H>(?$NMB4 MWE]AZ/]#':MZH[VL/QKKR^&/!6JZN2 ]M;L8L]Y#\ MJ#_OHBMRO)/C?'/!5BY$VK7BR3;?X8P=H)]LDM_P J:4>>:3*JRY8 M-HX+3O"6K^#/ ^@_$C2&DDOHW:>^@8DB2W=L*3[%>O\ O@]J^AO#^NV7B70+ M35],DWV]U&&7U4]U/N#D'Z5:73[5-+&G>2IM!#Y'DD94Q[=NWZ8XKP2?6=8^ M!^NZMH-E;27VG:FIGT8,2WER$A<'UQT(ZG"GC-;M_6;K[73T_P" 8)?5]>GZ M_P#!.T^*_C6YA,?@KPLAN=>U=?*81MS;QL.23V8C/T&3Z5UW@7PG!X+\(VFC MPE7D0;[B51_K93]YOIV'L!7._"[P!-X?MY=?\2%KGQ+J>9+B64[FA#<[ ?7U MQ]!P.?0ZRJ227LX[?FS6G%M\\M_R"O&_&.CZM\-O'$OCSPO:_:=)NA_Q-K&, MXQD_,^.P)^;=V.<\$U[)2,JNI5P&5A@@C((J*=3D?D5.'.O,YNP\>Z'JO@JY M\3:??!?44GN+CX=R_9[?4\1W^F^:(X\;@P9<\;01G;U';@XKU%#IO@+P M(IN9/*T_1K(>8X')5%Y..Y)'3N36TW"--J#W,HJ+:VRG:O&YY&[*JCDG_]9XJ]I.J6VMZ-9ZII[,]K>P)/"S*5)5@",@].#7F= MGX4\._&JZT3Q_J?]I-I\<+1P:-=X$6Y9&!<@=02.QYP,\<5ZNB+&BI&H55&% M51@ >EH7MUX$\*0ZCH=O+Y2339620XZ_?'UP M2,C/6H?%.M7WQ9\7-X+\+7!BT*T8-JNH1\B3!^Z#W&1@#^(C/09KUK1-%L?# MVC6VEZ3 (+6V3:B#OZDGN2>2?6M+1I1]Y7;Z=B+RJ/W79(\R/Q8\::?SK'PT MU#RQ]^2W9R%]_N$?K5BR_:!\*R2>3JMIJ>F2C[PF@#!?^^23^E>J56O=-L=2 MC\O4;*WNT_NSQ*X_(BIYZ3WC]S*Y*BVE]Z*^AZ_I?B72TU#0[V.\M7. Z9!! M]"#RI]B :T:\=U_X?:SX!U>3Q1\+RS1$[KS1CEDD7J=H[CKQU'\)[5V_@+X@ M:9X\TQY;16MKZWP+JSD/S1'U![KP>?SQ2G35N>&J_+U"-1WY9Z,ZNBBBL38* M*** "BBB@ HHHH **** .=\=>+;?P5X2NM8N KR(-EO"QQYLI^ZO\R?8&N+\ M*_&VWN+F+3?'E@WA_4)%5XY9$98)%89!^;E,^^1[UF7?_%V_C"MHN9/#/AIL MRG^"XFST]\D8_P!U6]:]1\1^%-%\6:<;/7K&.ZC&=C$8>,^JL.0:ZK4X149K M5_@./$5IJ]AI,AEBC4$/NX(XV ?>5222>E$(TXRYN:Z03E4E'EY;7/0?! M?A]?"W@S3-'4#?;0 2D?Q2'YG/\ WT36Y117,VV[LZ$DE9!1112&%%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 R>%;BWDAD&4D4HP]B,5Y3^SW, MT?@W5--F/[RRU-U(] 57^H:O6:\C^$W_ !+OB7X_TD\+]M$\:^B[Y/Z,M;T] M:4UZ&,]*D7ZGKE>/^%/^*R_: UW7V^>ST&+[%:MC@/RF0?\ OZ?^!"N^\>>) MXO"/@O4-6D8"6.,I;K_>E;A!^?)]@:P/@KX2[OO8; 0 M'_@(!^K&G#W:A]Q5BBNIS+!:6D32RR-_"H&35NO,_&ESX<^)VK7WP MP_M2^MKVW5+RYDM$!CPK#,3,>_S*<8P#CG(Q0!O^"?B+I/C7P_::I$&TW[;/ M)#;6]Y(JR3[#@E!GYA].AR*ZVO//&WP=T/Q5X1T[2; MI5UHT>W2[N'.8.G! M&1N!*@D]<\@]-)&EY!&[QLB$ %WP.<,N6('7 M)[F@#TJO//BA!H_C.&'X<>#O EX_Q9U_Q_K=[9W\=X/*T9 MK63>J6Y&-W3 .T*O&L/"V@6VD:5%Y M=O;KC/\ %(W=F/_X%FNHHK' MVD^;FOJ:\D;$-)\%Z*NF:)$RQ[B\DLA!DE;U8@#/ITKVN(S'+&XX92,$5I3GR2OTZF=2'.K=2/2M3M-:TFVU+3I M1-:W48DC<=P?Y'L1V-6Z\6\%ZI+\*O'%SX(\0W!&C7C^?I5Y+PH+'[I/0 ]# MV##T;->TTZD.1Z;= ISYUKOU"BBBLC0**** "BH;N[@L+*>[O)5AM[>-I99& MZ(JC))^@%>4WOQDU'Q#=OIOPQ\/7&JS@[3>W"%8D]\<8'NQ7Z&M(4Y3V(G4C M#<];9@BEG(55&22< "O,?B=\3]/T_P /S:3X7U"&^UV^86L26D@D,.[@L2. M>P'7)'I6=%\(O$GBMOM7Q(\5W4N\Y-A8MB-/;D;0?HOXFNU\._#+PCX7ECGT MO1XC=1G*W,Y,L@/J"V=I^F*U2I4W=N[_ ,FZDU9*POPY\&Q>"/!MMIN%-VX M\Z\D'\4I'(SW X4?3WKJJ**PE)R;DS>,5%604445(PHHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BN=\:^.=$\ :"=5\0SND1;RXHHDW23/C.U1 MZX!Y) ]ZX[2-8\3?&#P)J?DQ:AX&#W"'3M0C8M)/%U/'RG''4$ YX/!R >IT M5YSX%^''B?PMJUQ=ZW\1=4U^&6W:);:X1MJ,>C_/(_(QQ@#WK&^%6L>*M$\> MZ[X \:7-YJKVRF\T_4YP6\R$D#ECG@[E(&3M(=<\"@#U^O(]&_XE?[4.MP]$ MU+35=1ZL%C.?_'&KURO"_BSK+^"_C'H_B6*/>?[*EC"'H[XE5<^V73\JZ,.G M)N*ZIF%=\J4GT9>\8$_$GXPZ?X1A)?1]$/VG42/NL_&5/YA/^!-Z5[*JA5"J M !@ #I7G7P7\+2Z+X1?6-4#-JNN/]KG=Q\VTY* _7)8^[>U>C4JS5U!;+^F M.DG;G>["BBN:\;>/] \ :/\ ;_$%UMW';%;0X::8^BJ2,_4X ]:P-AWBOQWX M?\'264&O:A]FGU"40V\:1F1R2<;MH!. 2.:QOAG\,8?A]'J5S=:@VKZQJD4 %97B+PSHWBS27TWQ%I\-_:OSLE'*'^\K#E3[@@UJT4 > M/>,?ACK>B_"5O!OPN!FMKV[8WGVZZ'F)$^"0A.%"Y !'7!/4DFO2?"/AZ'PG MX0TS0K9MZ6-NL1?^^W5F_%B3^-;%% !1110 4444 %%%9MAXCT75+.ZN].U6 MSN;:S=TN9HIU9(67E@QS@8'//;F@#2HJ@==T@:T-'.JV0U0KO%C]H3SRN,Y\ MO.[&.6M&L[4_^0AH__7XW_I/+6C0 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !116'XP\6:?X+\.3ZMJ;95/EBA!^::0]$'^/89--)R=D)M M)79A_$KXA?\ "%V-M::7 M]KNH.$L[0@L.3C"?B?XM ;Q M7XL71K9^MIIX^8#^Z=FT'\6:K'PO\)W^KZM-\0?&B;]3OOFL(''%O$1PP';C MA?0<]37K%=,I*E[L-^K_ ,C!1=7WI;=CE_ _P_TCP'I\T&E>;-/<,&GNIR#) M)CH. , #=+\; MZ"^FZM'@C+07"CYX'_O#^H[UP'@WQEJG@?7D\#_$.3"C"Z;JC'Y)4Z*I8]NP M)Z=#7K]S_ ,: MD'\<=_S.NHKA_@]KY\0_#'3997+W%H#9S$G)RG"Y/KL*G\:[BLIQ<).+Z&D9 M*45)!1114E'GOQPUC^R?A7?HK;9;]TM$_P"!'+?^.JU=)X(T1?#O@?2=,$8C MDAM4\X 8S(1ES_WT37G_ ,6/^*A^)7@OPFOS(T_VRY3U0'_XE)/SKUZNB?NT MHQ[Z_H81]ZI)]M HHHKG-PHHHH **** "BBB@ HHHH **** "BBL"P\<^&=4 M\37'A[3M:M;C5;=2TEM&^2,=0#T)'< DCOB@#?HHK+\1^(]+\*:#58[2+5@L4=P#C+ M A@#@$\;AVYIG@1?BU;ZG8J@MMWDL$; X)PIP,^E2>*M1^-& MI^*KO3/"&DZ;I&E0R;8=3N9$D,J\?-R3C/H$)'K0!Z?JFKZ=HEBUYK%];V-L MO66YE$:_3)[^U<'XO\8^)-<\-:?+\'(;75AJ4LD,FIEUV66T@9*MCGKR01QT M.14_B'X0Z/XYO-(U/QQ/=7M]8V26\T-M,8K:9QR[[0-PRQ/0CC [5VFD:/IV M@:7%IVBV4-E9PYV0PKM49.3^/O0!R_@KP-=Z;X3CL/'FHKXJOOM9O?-OD\Y8 M)" (]^2 N"0>/O' %=J!@8%%% !7#_%YO$\'P[N[_P3?/::CI[K=N$0,TL2 M9+H,@]OFQWVX[UW%% '-?#[QA#X[\#:=K\,?E/<)MGB'2.53M<#VR#CVQ5'Q MS\-['QWJFBW6H730QZ;(S20K&&^T(Q4E"<_+]WKSU-<]>>-K[P?\=--\)7=O M:6OAG5[4#3Q#"(]DY)SDC@DN",?[:'USZI51DX.\2914E9B*H50J@ 8 Z5 M!=ZC96!A%_>6]L9Y!%#YTJIYCGHJY/)/H*BU?6=.T#2Y=1UJ\ALK.'&^:9MJ MC)P/UKRY?A9JGC/XF2>*/'FK0:AHUG-YFAV-G(3&T6=R,W&.FW.,[B.N ,R4 M177_ NGQ9XLN([*2R\(Z):7A1)'199)XU;AL$-NR.?X0>E=;J'PD\)ZOX\; MQ;JUG->ZB?+(CGF+0J44*I"?@.#D9YQ7;44 %%%% !1110 4444 %%%% !11 M10 V0 Q."I<%3\H/)]J\>TK1FU#P)XIT^'3M2GLH+<+8I?V9BN?-0RX@.U5, MJQ_NRI(<;V8AF(X]CHH XHB^A^(-U#I4VL(EY*TE[#<62_8U46RHLT4X0'=O M2)=AD)^^=@&"%\ 12_-*VGW5A'#I5C8/'-NW&/?=^%:]9VI_\A#1_^OQO_2>6 MM&@ HHHH **** "BBB@ HHHH ***"0!D\"@ HK.NO$.BV6?MNKV%OCKYMRB8 M_,U;M+RVO[6.ZL;B*YMY!E)H7#HX]01P:=GN*Z)J***0RCK.M:=X>TF;4M9N MDM;.'&^5@3C)P ,DG/85D:;\1?!^K8%EXCT]F;HDDPC8_\ 7P:\[\3S2?% MGXH0^%+&1CX>T1_.U*5&P)9!P5!]>J#_ (&>U=CJ/P;\"ZD"7T*.W?LUM*\6 M/P!Q^E=/LZ<$N=N[,.> M$=3.H6-M-=70.8I+QQ)Y'^X ?#G^2"5_MUFIZ!>N!_ MP%U_[X->OU\NR^+_ !;I?Q2T+6_'WA^32+W3G6TO;Y4*V]S$Q8;@>5)VL_0D M';VQ7T]!<0W5ND]K+'-#(H9)(V#*P]01P16];WK3[K\3&E[MX=B2BBJNJ7\6 ME:1>:A=^>RJ6/\JPW-CROPM_Q4O[1GB/5C\]OHL LXC_=?A#^HE_. MO7J\K^ -A*/!M]KEWS<:Q?22L^/O*O'_ *%OKU">Y@M8&GN9HX8D^])(X55^ MI-;U_CY5TT,:/P7[ZDE-DD2*-I)75$0%F9C@*!U)-<]=>-M)FL;]?#-]8:]J MUM:27$6FV=Y&\DNT<# )P"2!GWKB_A[HGQ#UOQ#-XH^(FH-9V-Q \,/AQ>8M MC?\ /1.@('KECW(Z' V+EI\=/#&K^-K+PWX;M]0UJ6YE$Q:!9:#::6L[+:S2.&9HP?E+9).2.ORBO2=#\-: M+X9M&MO#^EVNG0NVYUMX@FX^I(Z_C6G0!YMK'Q6D\(?$32_#7C#3DM++4;6/ MRM8C<^2UQT<8(X0,0,DY&03P6RR"5!N*,C#N& M4@C@D?0UP5C\:+/1O']_X-\8Z8^B/!<)!I*;K0?!7P^N[\VY _M"[5Q!)D Y7&U<=1G?VZ<5Z5HUU=W> MC6DNIP1VU^T*&[MXY XAE*@LF1UP30!=HHKD_B+X]M_A[X=349M/NM1GN)A; M6MM;K_K)2"0"W.T<'L3Z T =6[K&A>1@JJ,EB< 5@0^.O#5W)?PZ;K-IJ-SI M]N]Q/;64JS2!%ZX53R>V!W('>N-T71?$OQ2\"ZC9?%;3O[(M;RX26SM[*0QS M)&. V>3PWI:P7,B>7)/?''Q%\717]AHD.E>"4WJ\EXI\VZ&"!M/KG'08&",FM2T^#'@[PG M<1:]X;T2XDU73%EN+6,7KYN)"IVH2Q(]A]>*?#NHW>N[ M="U'1PQU*SN&(,2@XWC(!(S\I&,AN#U!.9X*W7=,X0=L]ZY&^E\4:UKEQ;:5<1Z?8 MP\"7@^9[YP3_ "K:TC1)K2Q$6K7KZG,'+B23/R@X^7KR..]3&5Y6:=@>VA=@ MU*"XG$46XDCKMXJW6>FE1P:R^I+<2J##Y9@W8B'.=V/7BJ/B*/4[FSM[SPW- M"\T;;N2"'7V/0U3:WL"N;U%YA)")[GJ/UKH-6LY M;_39((+V6Q^VFCF3.-T;!AGTR*2)HY8-JR M"90-K-P<_6N#2WN_"7BD_P!B6\UQIMQ(%FM0"Q3W'\P?P/K1)RCK;3J"LS2^ M)%OI]OX7D\2W>@PZU>^'@;ZRC"]/\ M06:>4MW'^\AW;C%("59,^Q!YP,C![UO21I-$\4J*\;J596&0P/4&O)=!O?#O MPLO-:\ >$H=2N]9-O-J]G;714I<2&/(AC88).$'&.@/)-6(M?%GP5K7Q&UGP M]HMG-"/#MO=&;5RLP$B, -H*YSRI8#'=LGM7IT$$5K;QP6\:QQ1($1%& J@8 M 'X5YC\"?!VJ>'O#6H:WXG69-<\07/VFZCG!#HH+;0P[,=S-_P " [5ZE0 4 M444 %%%% !1110 4444 %%4K[6=-TS O[V"!CT5W&X_AUJXCJZ*Z$,K#((/! M%*ZO8!:***8!1110 4444 9VI_\ (0T?_K\;_P!)Y:T:SM3_ .0AH_\ U^-_ MZ3RUHT %%%% !1110 4444 %0WEY;:?92W=]/';V\*EY)9&"J@'+O'F M@>"K/S=:O )F7,5K%\TLOT7L/%MC:I M=_*@/J 2 /49))_NTU?A!XB\5.)_B/XON;E2=WV*Q.(U/MD;1^"?C7JFE:38 M:)IL6GZ3:QVEK",)%&, >_N?<\FKE5[;E_AJWYD^RYOXCO\ D>:6OP"\#6^/ M-MKRZ_ZZW3#/_?.*P;[PEXI^$U]+J_@*275M!8E[K29B6:,=RN.O'\0Y'<$" MO::*2KSO[SNO,;HP^RK,X?0OB_X.UK1UO9=7@TZ3I);7D@21&]A_$/JZK)J-]H% MO)=2G+LK.BL?4JI"Y]\XCN--\/Z?!/$S):K-6NC/\ AIX*3P1X1BM)0&U&X/G7TH.=TA'W0?1>GYGO77T45A*3E)R9 MM&*BK(****DH**** "BBB@ HHHH **** "BN-UOXM^!?#^HK8:EXCM1=&3RV MB@W3%&SC#; =N/0XKGO&WBOXG-XJG\/^ ?"2>3&JG^V+UAY3!ER2N2%X)QCY MCP>* /1-9UW2O#NG/?:YJ%O86J=9)W"@^P]3["N.UGXL6J^!X/$G@K1[[Q9# M/=&U6*RB=61AG)8;"P' 'W>X]:;J7PIT[QO'H.H?$8-?:MI]J(KB.UF:.VF? MJ25&#U]"N?I@#N=/TZRTFPBL=+M(;.TA&(X((PB(/8#B@#S72KGQG\4O"NNZ M1XIT.Y\%V]S&B6UU%*?./S992K8." 3QD$CZ==X'\!:'\/]#&G:!;;=V#/< MOS+<-ZL?QX'0=JZ6B@#A_C%X=7Q+\+=6MO+WRVT?VN,>\?)Q[E=P_&O)_A9! MX>\"V6F^*)?']S:V,T$@N?#TA\S?+RN0JG.,_,#MST^;!-?1SHLL;1R*&1@5 M92."#VK@]$^"O@G1+DW TUK^3=N7[<_FJGL%X4CZ@GWK>$J?)RS,91GS7@>; MZ'^T5XME$DFJ> GU"U67;]JTLRJD:Y[Y5P3CW7\*S_B-^T*-;T+4?#^A^&[Q M$NXEC-Y<3!2O(+CRU!SP"OWAUZ5])Q0QV\*Q01K%&@PJ(H 4>@ JI>:)I6HR MK)J&F6=U(A#*\]NCE2.A!(J8R@G>Q3C-JUSRQ/AMXD\3?#+PII(UZZ\)PV]J M1J=C;C<\Q8@\L",'J=IR!NYSBN@TKX+>%]-\ 7?A"5]0O=-O+@7,IN+C#^8- MO*[0 !\HXQ]$?A3X/\#Z@]_P"'-*^SW;QF(SR3R2,% M."0-Q('0=*[&BBD,**** "J=SI&FWE_!>W>GVL]W;\0W$L"M)%_NL1D?A5RB M@ KQYO"WB7P5\?5USPW:S:AX?\3OC5(E/%J_>0Y[ G<#Z%U]*]AJCK6EIK>@ MWVERS2P)>V[P-+"VUT#*1D'UYH R/B#K^K>&O!5YJ/AS2)M7U)=J06T,;289 MCC>57DJ.I _3J,?X2^&/$.@>&)KGQEJMU?ZMJDWVJ:&:4NMJ2.$4= ?7'&< M=,G,^$7PIU+P!W""VB5)',20JH4 %%,BGBG M!,4BN!UP>E9_B"+5)M*:/0YHH;AF :20XVIW(XZ]/UI2]U M33HKC-(T?6HM M0@<^*7N8XW!EAD4DN.X^8G\ZZG48GN=-GB@NS:.Z$+.HR4/K23E;6-AZ=&6J MP=2\::%IC,DMZLLJ\&. ;SGTR.!^)I]O?3;(X5NE*6L0,]S+@;P!RQ] <&JB MV_A*UGM&CM[5GU-R()%0OO/?!YV\GVHG&:M846F:FE:[9:OIZ7D#&)') 68A M6X..F:1+34I)K[S[Z-[>8K]F5(\&->X)[YK,>>&2UU/^SM%N9;BPD\M8I"4$ MQSU4YY&.?ICUK06#5)[V#<8;?3'M-LUMDF59".@8<<=,Y[5=DK.^J%KU)'O= M/T66SLIY=DMXY2+Y2=[#&>G3J/SJI)_;>L6-U"F=%FCN=L4PQ+YD8/7';-7] M+T>TTG3X+.V5GC@),;2G0W,'D20M)^[V^ MP]?\34/_ B^EB'3H8HGBCTZ7S;=$D. V<\^O-:]%(#';1+J./5#::M<)+?$ M-$7&Y;<_[(_SVJ/^Q+PSVHEO5GB5,7+NI#NP'5<<#)K/U%LWL,6?$%O#9NJ.[^6^X*HSSW["M6RO;?4;..[LI1+!*,HX!&>W>IV= MF/VLEM=Q++#(,.C=#57>MA'*KXRO-7U5+7PO8?:8$<>=?:NJNUG>SF6S=8YRA$;N,A6QP2*+6TM[*W6"TA2&)>B(N *EJ(QDE[S M&VNA7L%NDL(5U"1);H(!*\8PI;VK ;QWI]OJ\EAJ5OZP5NI8CD2:-9(G5T895E.01 MZ@TRYB>>TFBBE,,DB,JR@9*$C /X=:@TS2[;2--2QL@ZPIG&YB3R^9MH_G3;6[CNXR\78X*GJ*(TU!>ZA.5WJ3444 M50!1110 4444 9VI_P#(0T?_ *_&_P#2>6M&L[4_^0AH_P#U^-_Z3RUHT %% M%% !15'6M8L] T6ZU74Y/*M;6,R2-WQV ]23@ >IKR#0[[XO^.;*37=#UG3] M(TVXF?[+;7,*9" \$'R6)';)/)![5K"FYJ][+S,YU%%VM=GMK]Y_@9WG4T6B_$XWPE\'=,TB\_M?Q1.WB#6Y&WO/=9: M-&]0ISDCU;\ *]'IDLJ0Q-)(<*HR36(FOEM@I+74%NI3'Y4B-C/S#BLR%?$3IIXNKRQAN M%G+74<:DB6+/1<\@_P"?:IT\01PQ7LVK6\FFP6L_E++/]V49P&7CH:FZML59 MW-9F5?O,!]32U!<007B!)#N_B&T\_6H+*&YM9C"Y\RWQE6SR/:BR:"[N7J** M*D8445&]Q#%-'%)-&DDI(C1F +X&3@=^* )**\K\4_';2M*\2'PYX6TB]\3Z MVDQAEMK0%51E.&&[!R1ST! QR:?XT^'?C3Q7XB?4=.^(=_X=T[R4\JQM8W!B M.T;@Q21=W()R<]<=J /4:;++'!"\LSK'&@+,[G 4#J2>U>6ZWX/UK5O!>BZ- M9_$?5M/O=.W?:-16)M][GIOVN#QT&6/OD\U?\*_"BST_PCJ^CZ]K^I^);;6M MOGM>3,H4+G&P;B5.>2<\[5]*;BUN)-/8Z:P\=^%-5UI-)TSQ%IMY?N&*6]O< MK(S;1DXP>< $X] ?2N"O?VD_!5OJ_P#9UE:ZQJ4OF^5NM+0$$YQP&8,?P%;W MAWX;>%?!>J"Z\->%DANX@RI=R2/*^",$@L3C(XX[$UV.G0"))&^Q0VKR.6;R MU WGU..]-Q:5PNFSB?&/Q&U_0O$3Z/X>\"W^M.L*R_;&F$$!R.@8@@D=",@U M7U:U^(OCKP%I3Z7?V_@[4Y7?^T80WFL$R0NR1[8-;G >'?AUXGTCPCK6E:C\0]4U"]U%%%M? MNC%[%@#DIN'?%-OJ^N_$C6==BMPP6SE+K&^Y2/G MW2-D#.<8Z@5Z+=QWK2 VDL:)CD,._P"1HM4OED/VN6-TQP%'.?RHY=+W"^IS M.C_"7P-H6I-J&G>'+07;2&42S[IBC$YRN\G;^&*[&C(SC//I14C"BJFH:I8Z M5#YNH74=NG;>W)^@ZG\*Q;7Q]H=T]Q^]FBC@4,TTD9"D$@<8R>I'45+G%.S> MH[,Z6BL^;7]+M[Z&SFO8DN)U5HT)^\&.!STYK0JKB"BBB@ HHHH ***"0 23 M@#J30 45R%[\1M-AF>+3K:XOV3^*-<(?QZ_I6O::W+"?$^IC[1%=">".S?8,#^$\#(_7 MWJMJOA?4;?4I[_PWJWV.6[;?+#,WRN_J#SZ],4.32O8#KZ*YK1M2\10W4L'B M2QB6"&$R&\B/!QZ@'GOT ^E6U\6Z3);VDL<[-]M#>0OEL"Q4X(Z<<^M.,DU< M'H:&H:E9Z5:FXU"X2"('&YNY] .I_"IK>YAN[=)[:198I!N5U.017)ZOH,_B MV-'E=K9K:<;?-C.UD(&X <9[<^QJOX7TS4]%?4&2.=+-+@I%!..2H_B&.H]Q M_C3M/VG+T%=B@^M<=X>\637_BB6QC97M%B=^02\C#'W?\ M*W_$$VG3Z!C5+DV<5T1$DA'*LW;]#^%'A?0FT'1TM9VAEF5F/FQQ[203D9/4 M_P"?2E+FNHK;K_D"MN8FH"+6--TV_L].U.(R78#1Q?*T>"1N8>GY?45L-H5S MJ%MJ%AKERMQ83,GV=8QM=%'/)^H'K_2MVBJ%8H2Z/;NJ^5NB95"A@<].Y]3[ MU4'A73_[+AL6$@BBN?M*['*_/DG\N>E;5%/F;5@LC/CT+38KRXNEM5\VYB$, MN22&3TP>*LP65M;010V\$<<?:LOP*MSIMQJFAW*2;;2;? M%(R\%6_QP#^)K>\0033Z-*EM>RV,F5(FB7+#D<=1UJ6:*#6='>'SI/*G0H9( MVVL,'!^AR*F<6VI=@5E=$6MZ%:Z_;16]\THCCE$F(VQNP",'VY^M:$<:0Q)' M$H1$ 5548 [4RTMUM+.&W1G=84"!G.6( QDGUJ6A)7OU ****H HK/GUFV2 MYNK.W/VB_MX#,;5>&88X /3G(_.JW]I:M)'IEPMA%;0S$F]2XDP\([8Z9[]O MP% &S16!_:VHZ?8WU[?0K?Q"YVVT=BA+^63@;@>XK7COK:6[:T2>,W*('>'< M-Z@]R* +%%%8>J6J:_<'3Y#(MO$P=FB)VLUO1.2YN%@\\@Q[([C71(M]IZV,OD0WD2)/YP:WF#>66.U=KY1PRC6K:WEL]V]JEQ$UP@W-"'!=1QR5ZCJ/S MH FHHK@/BEX^/A;3(]*T96N/$.J#RK.&(9:/=\OF8^O '<_0U<(.I8N>G4UY?J#?&#POJCKX5\/6&LVUS&LDLMS=+A).* M)_M#C'S/NR">!P .P%:>D^$?#F@W#SZ'H.F:=-(NQY+2TCB9E]"5 ./:I]G M'FYEN.[M8X^R^(WP[U;6+G4M)US=="(6DMPL4JI#N.%/S*!R1U&1Q^-:*^.] M$\-ZY9^%=7U^UN+]5/VBXN;J.)HR?F4,K'J01WSTZYK6A\ >#[>Z6YM_"NBQ M3JXD62/3XE8,#D,"%ZYYS7._$'X3:#XO=M332;4ZQO5FN-S1M*%7 !*DN*Y[5_']U<>&-5O/ FBSZWJ M>G7GV*6RE5H"C<'?A@"RX*D8Z@US=GHFDZWKOAVPU:PETW4=$ED>)?G_ 'NX MAFPP8%<[/<$$]N*[M;'7H;'48K.6Q@D:?=9OM)^3/._WP .E5&<)QNB;-,XO MPO>?$N\L];N_B,]GI%B^GR+#;:9@W5NYZ2*06Q@;L98\XZ8-9/A3X1^%="\5 M:)K6I:EKFN:Q='[3:SW;852HR"P'.1GNQ'X5W^HZ5J=O+R M:#H\5I>7,C&ZGC@2*2=@2-S,.3GU;FK?]AW2RWT\6KW2S74 B0,=R0L!C(I-*6T=C';"=I0ZG!)X4CL?\ /O65 MJ/C1]+T6ROKW2IH);F8HUM(^UD4=6Z<]N..M="FG6D>I27Z0*+J5!&\O^%IM4BTZXUGR[S4+=2LS1G;'(,D@ M%>/7MBM*RTD0*]K+I]G]DF.Z1$B4+GMD8YZ"MFBFK+9(6ODV-]AKBUB: M5%VQR[!OC]-K8R,=161GT'O6U> MV\LZ*;>9HG0Y&#P?K4=E=3O(8+J(K(HSN X-'(FKA>S.-\&>*Y5O$T?49C=Q MR,5M+P _/C^$YYQZ=Q],5W]8]]8-;WUMJ$,PAL[&.5Y+6. 'S"1G(]#_ #JB M^IV>KZGH%S'_ &E%YPDDA"+M3I@B3\NWK[UE&+@K;E-W-C6-7MM$T\WE[O\ M*#!?D7<X/<_T[9IS^$M-FUFXOKF)9DFA$7V9T7RT]67C@\=?WV:QC@@WMRL*8!/X#%6[AY([=FA3>XZ+3+>QM[91Y<8+#^)ADU8I^ZMA:] M2A9V+B7[3>-OF/0=EJQ=V<=Y&%ER"/NL.U3T4W)MW"RM8I6EM=P2XEN!)$!@ M#')J:2QM96A:2!"8<^7Q]W/7%3T4FVW<$K!6;JNEPW4]MJ#1RRW.G[Y((XY- MN]B/NGZXK2HI#.6\-:?K$J-)X@V36DW[Z.VNQYDL,F[U(P !T^O:NIHHI)65 MD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&[C\ZSE0#)*G ]^ MU5='^U+;R1W421JCXA"\,5P.6'8[MU:%23746V:6(%X MXPF 1G@GC_ZW-5=VL*VMSHKR]MM/MFN+V=((5P"[G &:J#7K0ZI:^D@O-'NHHWM[:2'E3@')R/QY_3%6Y=3M(/E# M;B.-J#I_2DDWL#:6Y2C\0M>6NF76F:=<7-O?2['<_*8%SCGV\ MHH4FGH%K[C8XTB0)$H51V K+OM$$UU/=6S+'-/'Y;L!M8K@#&X<]A6M124FG M<&KG/0V.LJEK8I(JV"I)%((M9UB*ZO-8M_LOVB&T\L)&# M*59EW?,Y,S$X*CH !CGM:* .<'A60^)I+Z6_5].:X:\6R\C#K.T'D$F0-@IL M+';MSN;.[ "U)X7\-W&@JYOM174)A;P6<4BP>3M@A#>6&&Y@SY=RS#:#D85< M5OT4 9&I6MNNMZ3=+!$+AKID,P0;ROD2\9ZXXZ5C^*O!KZG=G5M(G>#45"G M?&\KT(/\+8X].!TY-;VI_P#(0T?_ *_&_P#2>6M&IE%25F&QXI?_ !WA\'K< M:7X@C\_4K1"-K*Z.S8^0$%>>1R?0@\GK2\ W-G+J4_C?5I)/$6OWSC[(D,9V M0QD8+*>0N.5YQ@#'K>.;C4A) MK%SI<)D!@D(\\HC_ 'E7E0C #'&0,J'SH^BV*"WDYG:4!W MN&Q]YR>I]N@[ 5T"(L:!(U"J.@%.K/EBFVNII=VU(;>SMK1=MI;Q0+Z1(%'Z M5-113 **** "BBB@ HHHH :8T,@1 9VR+RK>E2&)GM?*>0[BN"Z]<^M4[65A: MC)K^V@?;)* WH!G'Y5,['RV:,;FQE1GJ:KV^G6]NO"!V_O.,FK5#Y>@*_4SK M6QDDF^U7_,F?E3LM:-%%$I-@E8****D84444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 5FP#R]1PR-=J6MGOI+0WBA'_=K+'EP0<2< Y$9!X)( .PHKR"?7;N#33X MAANKBYBN].(L)SKDGFVKC3O/_?VB@0%L*S[P6)+H0N,$=]X37[,VLZ?'=7%U M;6-^(K=[F=YY C6\,A!D1SDDXSCH * -#4_^0AH_P#U^-_Z3RUHUB:S M=S1:II:II]Q,%NBP:-HP'/D2C:-S@YYSS@<'GH*M?VG=_P#0#O\ _ONW_P#C MM &C165;ZW-=VL5Q;Z+?O%,@=&W0#*D9!P9/2B+6YII)DCT6_9H'"2#=!\K; M0V/]9Z,#^- &K163+KW71;\RQHLC+N@X5BP!SYGJK?E2 MRZW-#)"DFBWZM._EQC=!\S;2V/\ 6>BD_A0!JT5G?VG=_P#0#O\ _ONW_P#C MM1V^MS7=K%<6^BW[Q3('1MT RI&0<&3TH U:*R8M;FFDFCCT6_9H'"2#=!\K M;0V/]9Z,#^-++KW71;\RQHLC+N@X5BP!SYGJK?E23ZW-; M1B2?1;]5+J@.Z _,S!5'$GBW[- X20;H/E;:&Q_K/1@? MQI)=;FADA231;]6G?RXQN@^9MI;'^L]%)_"@#6HK*N-;FM+66XN-%OTBA0N[ M;H#A0,DX$GI4G]IW?_0#O_\ ONW_ /CM &C165%KBD_A1<:W-:6LMQ<:+?I%"A=VW0'"@9)P) M/2@#5HK._M.[_P"@'?\ _?=O_P#':BBUN::2:./1;]F@<)(-T'RMM#8_UGHP M/XT :U%93:W,MTENVBWXED1G5=T'*J5!.?,_VE_.B?6YK:,23Z+?JI=4!W0' MYF8*HXD[D@4 :M%9W]IW?_0#O_\ ONW_ /CM10:W-JM^5 &K163/KF'[.;D6Z"0Q?W-V,[>.G2I=.TRPT>Q2RTFRM[&TCR4@MHECC7)R<*H &22: MM44 07C6L$/VN^>..*TS,996VK%A2"Q)Z?*34RLKJ&0AE89!!R"*Y3Q@T\YD ML]0M=NA^5%*VH+\QM9UD+*[)GYXU*(6XP.^5+%9/#%KJEEJUQ!,^HSV*P*&N M+^9)!//GF2+#,0C Y*G &%V@?-0!TZJJ*%0!548 P * JJ6*@ L-Y$#-$V]"?X3@KG\F(_&G,JNI5P&5A@@C((K@/&EQ>ZM//IT6E MJ9[*Y#:>MXH:#43]G!(7=\HE0R%E#<$QGD88IT/A2ZU&XMKI-0>\GBBE"V]U M?6PMYY5*@L'0*HR&)&X* >W3) -^D55484!1DG '<\FEHH C>.'[1',X42@& M-&)YPV"0/KM'Y4]E5AA@&&0<$=QR*\Z\3MJ6KZA"5TXV]]8W$J6L'!J:Z'&NM!Q\H2N_9MSM.,YH U*155%" MH JJ, 8 %+10!6$UE;WYMQ-#'=W69?*+@/)@!2P7J< 9JP55BI8 E3D$CH M>G]:\SECUW4M4LKF[M)[+4Y+>)M3T^RG6*:555MDEO*QQA6EQ)&6XP.2#^\[ M_1#J!T*S_MH 7_E+Y^,?>]]O&?7'&3:?H ME]>6MLUW/;V\DL=NN@PI+<\<W7G1J89'V!D+@.=W\)"DD'GD=* )K"YL)%E MM--FA<6#"WDCB<'R6"@A#Z':5./>K055+%0 6.20.IZ?TKD] MK>RU*WG\.6 M;)IMQ']EO;9CB2TGCW,'<,G M]*YOP];PV.H%M!AC;0=0B66/R %6VEC58RNTX(!55& /E9&S@FNEH 3:I8,0 M-P! ..0/\@4V6&.= DR!U#*X!]5(8'\" :?7+^,KUA%_9=Q#-%I]Y;R&?4E7 M=':,K(%\U>,HVX@\] >*06D0N M&D3["T,%L?-!B6!R2KHR%CM#-MP =OW:[B@!-JABP W$ $XY(_R33)XHI8\3 MJK(K*_S= 5(8'\" ?PJ2N2\6R-?7+:1J-MY&F,MO,FHRQ"6#S_-;$4J' *'8 MN>1]\#()4T =;2*JHH5 %51@ # KCO ,>LV5N-.U&.Y%O;6L:L+B!8UAGR= M\4)4#?$!C:>< ;CT7LJ $"JI)4 %CDD#J>G]*@O)+.WC2YOY(H8X'W++,X5 M48@KG)XZ,1^-6*XWQ5]LN[UK:]B%G90R1R:?J8"LB7!1DVS(P8;#O*[L=6QP M=I(!V)"R(0P#*PP0>012URO@:TU;3[.2ROH[R*QMH((;9+YHFD5U4K)M,?!C MP(]I/.=W;%=50 @55)*@ L2PPMS#')*X7)8CY1GN2 MHX]JL5P'B^UO];DO+&_@%D0TD&DW7R-%="2%0T4@<,$8L2%;N5[?=8 [YE5A MA@",@X([CD4M87A0:F+*Y&II>)$)\6BWYC-PL>Q331#&MP\P0"1U5&;N0"2!_X\?SI]>:ZTM]XF\ZXCLUL]3@M9 M(Q!=F02VRASMO+4HC,S=,H I/RJ2O&X ])95888 C(.".XY%+67X;N+RZT"W MDU)9!/ETW2Q&)Y45V5)&0@%2ZA6*X&"V,#I6I0 BJJ*%0!548 P *;'#'$\ MCQH%:5M[D?Q' 7/Y*!^%+(66)R@RP4D#'>O,;ZTNO$;'5)+9M*U<0VS7D1B: M2^TX*V=]J5!+JP++C&,AMP)W)0!Z>55B"P!*G()'0]/ZT,JNI5P&5A@@C((J MGHTM[/H=E+JL0AO7@0SQ@8VOCGC)QSVR<>IJ[0 5722SBOI($DA6ZF_?/%O& M]N N['7&% S[4^Z:9+.9K50\RQL8U(R"V.!U'?W%>;7^EZAJ[SS&*2QU1I8+ MV]L[6-7NHY55462VF=U7RB$4,"#QO! +$4 >F[5+!B!N (!QR!_D"AE5AA@" M,@X([CD5!8&Z.FVQU%8UO#"GGB,Y428&['MG-6* "J]O)9QS26EM)$)4)DDA M5P64L=Q)'49)S^-1:S-?V^CW$NCV\=S>HN8893A7.>A/8>_./0]#Y]?:3J-U MK#)*R(7BO() M.3)*1D1SH#EF.-^T@%MP"@'H^U0Q8 ;B "<G]:6B@ M!DT,=Q!)#.@>.12CJ>C C!%/KF_%U_JUM;20Z9:))#]AN+B>:0L,A H\I6'W M'8,Q#'(&WH><8_A>VN=*U+3[73M.^SPL-E\UJBK:3)Y19+A5!_=R%MBE>IWG M[P56H [L*JDE0 6.20.IZ?THVJ6#$#< 0#CD#_(%+10!'<1Q36TL5R%:%T*R M!NA4CG/X403PW,*S6TJ31-]UXV#*?H17*>/)M3&C:HBB"/1HM+FEO'D7+3+@ MB2-6W#RR(\D,0PR1V!!;X?AOH/$KK!:0I&F^+4Y[22+[-/* I1_+#;XYL8W MKC!Y9MJ&@#L%55&% R3@#N>31M4,6 &X@ G')'^2:6B@"&Z%N;=FO"@AC(D M9I#A5VD,"3[$ _A4D2=5W[MP \M]C%2I# $9^;*S>%%NAJEPUM91VNFNKB<6\\) \<._9N;+*I(*^88ED9001D#=P>7^,+*>2:ROIXYK[2+7>;W3X"P=LXQ, MO,FSG]WWSD995!Y_1O#>D>+KF_NH+^YN["'=86^H1N'-W:NH,ENTCABZJQ9? M,4AL$KNRI) .I\.SKJ5W=W:SZC<1Q)':QR7:F-9<*&9_*V( Q8X8X_AP,6VGVO^([N'6[>PL+B M&SBV>8]U/&75F.T1@CC]TQ)4N#D-M'&X$ZWB33K>^TII9FN(9K,F>WN;2,O- M X!^9% );@D%<'<"1@YK \,:#_:ECIVI:@LMO%"\SQ6!B,:!B6CWJ&&]8I%^ M<1-P-X!Z8H WM)LGN-)C.M1RRW/V@SLET58Q2!\J$VC&U<#:>I&">2:UZ** M&R2)#$TDKJD:*69V. H'4D]A7":MX_,=Y/+IMY8165M )$^UJR_;),%C#DE3 M$VT*4R&WALC(4U'XJL+NQUJ\U*^O=,M["\(BCN[]YYO)C,01K<6Z%4(8AVW% M\Y?&TD"IO!O@I$\.PR:S)/*;NV#/!*&21' .@ K0I%7:@4$G QDG)-+0!'D>2;3+T,SQZF6.$M?*SM[A#%CD?.IS MN*]?X;\'V'AQA)9M<86-DA@E966V5V#NJD*&;+ $LY8\=: -:TTV"TM;6$E[ MEK4?)/()+2WGNM-BD@%N(EB226!V*,)Q@L)!M=5)!/E,064@Y& M5K*^(AJUM8Z[ -0U"SG,VG:A8!8)Y8"0'V*3M9E7YBH(.54;71F-=UHGAN'3 M9FO;G$U^Y>,D 4 :B6-NEY]K$8-R8A"TW\3J#D M XZX.2/3)QU-6*** (YYU@A=R&T4++%!YF$D1V^\K 8DX#(=P&"N*=XITV.UUVSDL(;QI-3NHUN(;>!RH; M(7[2L@!6*6-3N); =%92&P,=%HFA1Z1]IE>9KF[NI3+-,R! 6( ^51PN0JYQ MU(R>: -".U@BN)KB*)$EGV^:ZC!? P"?4@<9],>E2T51UJTN;_0KZTL+@VUS M/ \<4P)&QB, Y'(^HY'44 ,UK7++0[3SKZ949@WEJ<_,0,DG )"CNV, ?<_9$\O=F:60J)(G98U,910Q8$$X.?1=)\/VVE-','DF MNQ&TX4 MCID]\4^BL?Q3 M8:AJ6@2V^DS^5,65F0.8_/0'+1>8.4W#*[AR,T +X@\2Z?X0PR7=YN3R(HYOD41?*BAT^> M0IECPN6W$ C&M].T?Q-XA@TW3&O(8;>,W=Q;/@R:/=HRB/ <,JEOG)C(9&V* MX'=O0],TZ'2=.CL[8NR(68O(06=F8LS'&!DL2> !SP!0!8CABAW^3&D>]B[; M5 W,>I/J?>GT5B>*D\0'25F\*3PI>V\HD:">(.MR@!S'R1@G.07_E6CV.G7*:.15;YE'4H00J,/1-.TZVTJR2ULT*HI)+,M $EI: M06-I':VD8B@B7;'&O1!V ] /3M4Q..M%07UC;:E8S6=]"LUO,I21&[C^A]QR M* ,;Q7KL^E644>GJ3<3RB/S F_RU!!?:O\4@0EE3JV#C)&TIH*W6HK=3:K<+ M?V\\*1Q-&%-K<1$'YU7DY;/S!B<8 '')Y[3-!?7I=4L;BYU!+6*:**:XFMFB M:^52& 8.H/FIM"^>GWE*G.0"OH$<:11A(U"J.PH (HD@A2*)=J1J%51V X I MU%ZM]4ADL_LMG$=QO+F:-+5]P/G;(A^\( Q@LN!G##)H 7Q%XRBM MKJ*RTN_M8'$KK=W<\;.EJB AGVY4.JN45R&^3=\V.HN^&9$UW3;C4[MFG^VE MK:2$R^9:E8V:,F(8P4?#-DY)# $X YKP=X9-_J%QKCW_FP27CNK16QC2Z'W MBT89B8XFD=V902'8%@=I KO;"PM],LDM+)2D$>=B%BP0$YVC/11G '0 #@4 M 60 J@*, < #M117%>);6&UUZ74/$\\YT::)8H+N*X>$:6XZLVTC 8X/F_PD M!3@,X)=8M-/TV\NX(TGE-W/:VHD8I$Q1]NY6!42X1\#(YQT)&YH44= M]I4]QY6>Y MF:=T**BWFQW6&X92N]69")-@*KND8E6P4] W3V&G*UG M92W\[:A&VNUM-4UZ.X^TK#&JV]Q M*2R!-Q5)1DB0HTDFU^I# G)&ZNPH *1G5%)=@H R23C%+7*>.;2*#3VUB"*1 M[V*,PF)+5[A+R(Y)@E1 24/.&Q\I.>A8, 5K_P 1ZK/XCN;+3)(K80KY<,,T M?S74OS%TW' 1PH5T!RKC)R1G9TMAI\*VUC+,)9[JW@V+<70'G88#=N([G R! MQD#T%9NC>&DMKY-3NIKB:3[,D,,-R06@3=OV,PYD*DX#-DC'7)8GH: "H+V] MM].LWNKV410QXW,03R3@ GW=U9KZO/L,%O;C%WL8 MB/[1$S9#,CD[T*9C .?N_-W<-E! MN%3>UO'Y4,_.8W$D$JO \:>2(0HQA0#_$,[R3\^3GTKI* "JNIZE;:38-=WC% M8U9$ 5)=+KMQ<16U]9-W:6MK#:1>4JPB15E<2B,L'&) ^7& N4QE6/>B")9S,(T$K($,FWYB MH)(!/7 )/YFLS0/#MMX>MGBMYYK@OM4R3!%(1%VH@"*J@*.!QGU)K6H *S+_ M %^QL;>]9)%NI[-HXY;6!U,BR2$"-2"1MW;EP6P,')..:LZI!>7.DW4.F78L MKR2)E@N6C$@B?'#;3P<'M7FUA+X@O?&$,EQ81VFO0Q_9[VXM3^[P 6C>2,G+ M1/AEW+NSP3Y;)M !M>'?$%WXAUBXB:^N(8_M@F2-(5^2-%QY#'G +#>) 2)% M)VD8(&[X9\):=X5@F33_ #99)V&^>=]S[%SLC![(@. ![GJ23/H/AVP\/6OD MV"/]U4#2R&1E15"K&&/.U0 /QZDFM6@ K/UC54TG2I[LA7,2;@"2%&> SD ME4SU;!P,D\ UH5P1T@VGC)-*T=]\L[X W.W)8P[?>; M'<^GL!@#H *T* "N?\4>*(M%M)H+1XI=6:-3;V\F0"SMM3)Z D@[5)7>1M M!SR)/%FEWVK:3'!IWE2,DZR26TUR]NER@!^1I$5F49*MP#G;@\$UPFG: _BK M7W8:K WV6Q6W>:RMI3' F16&F0B&WB!P,DE MB3DLS'EF)))8\DDDTZTTVVL9YY;9&1K@JTOSDAF QNQTW$8R>IP,]*M4 %DPRV%C)(-3<1*A2+<$,C$*,GY=[!'VYXRN6P*?XPLKJ8V5V8YK[3+ M1F:]TZ D/,"!B08Y?9R?+_BSD995!YO2/#VC^+M2O[FRO[JXT^V06EKJ,3AV MEAD4^;;;Y%;>JYP''SKYCJ&!#4 ;=K8V?BZ"^@OI]6NK3[-':^9<%K;>V=[. M$5$VRA@N6 XP,;?F%=18V-KIEA#9:?!';6UN@CBBC7"HHZ "ID18T5$&%48 M]!2T %%%% !1110 4U$6- L:JBCH%& *=10 4444 %(B+'&J1J$10 JJ, #T M%+10 4444 %0WEW!I]C/>7D@BM[>-I99&Z(BC)/X 5-398DFA>*9%DC=2KHX MR&!Z@CN* .$_X7;\/O\ H8/_ "2N/_C='_"[?A]_T,'_ ))7'_QNM_\ X03P MC_T*NB?^"Z+_ .)H_P"$$\(_]"KHG_@NB_\ B:WO0[/\/\C']]W7XF!_PNWX M??\ 0P?^25Q_\;K1T+XH>#_$NKQ:7HNL"XO9@QCB-O*F[:"3@LH'0$]>U7O^ M$$\(_P#0JZ)_X+HO_B:LV'A;P_I5V+K2]"TRRN%! FM[..-P#U&5 -)^QMHG M^ +VM];&7I>I^)=4D6^B&GC2[PS);HL+&6T"[O+ED8R 2!MO**JE2X&X@%JY MJ\\7^*M,A1]1U325C>^N;4RVWAV[N#&L.[+&..X9B#@'/ 7G.:["Q\)V]CJZ MWB7]]+;Q2R36VGR.A@MI),[V3"A_XW #,RJ'(4 8 L6_ARTMKR&Y228O#.@SQ_6L38XRZ\8Z\5T=9&MK:2XM)+HR1^';S4-X$FV-Q'#(&A# M(0V')(W;/<8DWD%MHR0I4$_0]/I7,#P,+9K((X[VRE:.1!9SR>7(,@C%]&NKJ5MTD\^GQ.[GU+%)X-=C; M2+:8037!AD!60XPNPKOSR.U'A;XJ>#/&FJ-IOAK6EO+Q8S*8C;RQ$J.I&]0# MU[5LQ^%/#T.CR:1%H.F1Z;*V^2R6SC$+MQR4QM)X'..PHTKPIX=T*X:XT/0= M,TV9UV-)9V<<+,OH2H!Q0!C>,_$^H^'[J$V[0VMDL#32W-SIMQ;^T+ZP:>W^RW8M&0"ZARQ$;[T; &]\,FUAO.#67>_#32[ MZ]>>74-15,7*P0(\02V6Y4B<)^[SAR=V&+8(&W XH ?X,\43Z]?7EN^KZ/K< M,,$4HOM'C*1([EP8F_>R#< H/# X;E1P3F:?XOUS4/+LQ=V5MJM[=)##;W>B M7,!LE,N<;P1IWFZ?Y%Q=P6UE#!"UJDBF.Y2!]\(D+ M*6^1\ME64G)#;AQ71T %,FFCMX))IG"1QJ7=CT4 9)I](RAU*N RD8((R"* M,V/7=(\NTGCNH@NHOM@?:1YK=/3KVY^E/;7M,7[=F[3_ $#'VG@_N\_AST[5 M8%A9A(4%I $MSNA41C$9]5]/PIQLK4^=FVA/VCB;]V/WG&/F]?QH KKK6G-- M9Q+=H7ODWVXY_>+C.?\ ]=26.IV>I>=]AG6;R)#%)MS\K#J*D%G;!X6%O$&@ M&V([!F,8QA?3\*=#;PV^_P B&.+S&+OL4#T M:-K^YC>S&CW,3&&)S&91=L_E.0?+R N?FV\'D5=+^)6L:AX8T2Z33;634[N\ MDBN[9"RJ(U^[LR3AF$D!Y.!O/I79?\(O9JEN(Y[B.2WU&34(Y59=P>1V9TY7 M&Q@[*1C.#U! (QX?A=X>BBFB?[5-%/%!%*DDBX=8DV:T]Y;ZGYGU.^U2YFC2$37QC+)&A8J@V(HZNQ)(+'/).!C8H *CFGCMX]\S;5SC.*D MIKQI(NV15=?1AFFK=0*RZI9NP59N2<#Y3_A5IF"*68X51DGTJ,6MNI!6"($= M"$%2D C!&0:;MT$K]2G_ &K9?\]O_'&_PI]W=/%I<]U9P&[D2%I(H5;:96 R M%!/3)XI_V.V_Y]XO^^!3;VQMM0TVXL+R(26MS$T,L>2 R,,$<ZKJ.IWM MK*KQSW9B#;5BFC6,B.-05 N)#G&XDC+$ "JEO\/+338K1- U?4]'^QFY$)M? M(?;'/(CM'B6)P$4QH%P 0!C)J1FW<:E-%XML-+54,%S8W5P[$'<&CD@50#G& M,3-GCL.G?D+#QSJ]QJ.E&_\ LMC:7?D)MDTVY9+EI.,I=*3%$=QVB-P2Q7&1 MO4CK-7T$ZHUK-!JE]IMY:AE2[M/*WE& W(5D1T()53]WJHQBLV#P#I]I) EG M?7\%C&;=Y; 2(T5S) $$>?/-++&D9EBD5(^-;O2)7A@M(+J&![ M?^P+N[WJT$4C!KI'$*',C#YEX !(.172WWARQU&?4I+OS'&I64=E,@; "(92 M"O&0V9FYSV7&,K/>VWB;5T$\L4US;[+4QW#I''&2Q,&X;EB7.UE M[XVT 9']N>*;^+PW/I][H]K'K'R2)/ILLQC8122%@PG7@[ ,8XSG)Z59\2>. M?^$>U35K26VN)?LVE1WEL;?3KBY'F,TX(D:)2$7]TF-VW^+GCC9MO#=G:V^C MPQR3E=(8M 6898F-X_FXYX<],7&IS2R3!M2L4L9@K#"QJ92"O'# M?OFZY' XZY ,$_$W1(_$!T.5]^H+#O98YX!ND$/G&,(9 X^0$[F4)G@OGBLA M_BTE\L$_A_36O8BTD,T*SP2.)!-9H-LD>&/. <8:NBNO ME=M>))J M.I+97L;+/8I,JPLYA$)D/R[B=@'REBFX;MN[FJS?#FSD>XGGUG5IKVX9G:[= MH=X M@ &2:?2,H=2K ,I&""."* .>_P"$]\-?]!+_ ,@2?_$UMVL]M?017ELRRHZ? MNY /X3C/N.@_*JO_ CVB_\ 0(L/_ 5/\*OQ11PQ+'"BQQJ,*B# ] *SCS_ M &K#=NA7M-2M+Z:YAM)UEDM9/+F49^1O3_/I4=UK.GV6HV]C=7*QW-S_ *J, M@G=SCKC Y]:M1V\,+2-#%'&TK;G*J 7/J?4TV2SMIKB.>:WBDFB_U]8-#DAXMO;?QI)8:I-;6-F99(XHKJPN(=RI$7$BW9S#(2%)\L $+N).4 M(.)#\0+]_#5G?WVH:'I%[/?+;RW-_;E$MH6B=OWD1F#*?-BDB!+@,4+ 8(%= M1<^!;"[N9_M%[?/I\SS2_P!F;T$"2RJZR2 [/,R?,HWM\\\=Q--1(GB0L$C4<1OM^4#.T$Y.2:$1V_B?4KGX>SZQ; M+!=W:2O%%/9VDL\,ZB;RQ.D2,79"OS[58Y'1B,&J-OXQU29[=K>[T^^AMA;G M4&&GS6SR^?=/ %1'D)A:/RV+*^XL1C"9X[+4K(ZCI\ELEW\2V$<;++"UK,L+;V+$/O)8C"KM ^;.1SO MAGXB:A>![W6KJT:QM]-:_OD31[FS:S3&4822NRSJ=DBY0#.,@X&#V&G^&+;3 MM5E,5L97#R[,*&^=U#'"-,DTVQL7DN?)L[ M*2P.' :>!T"LCD#U"L"NTAE&#C((!AR_&/P[%H']KE':!)V@F"WUD?*8('^] M]HV2$J00L;.W48R,5?OO%E]'X!O-:MQ MS%J,MI&?LTDRA%OC;AO*5@[ML . MU2"3TZXIU[\/H=1MME]XAUJ:=HIK>:Z:6$22P3",/%@1[44^4G,:HV03G)). MA)X3M6\,2Z)%>7<,;W378N$*&5)#<&XR-R%>'/ *GC@YH R++QO+:1V%OJB7 M6J7NH32"%;31Y=/9(XQ'O8PW,F]]N_.4R2,X4[6-0K\4+6UU1+'6M-GLGGU. M2QMW:YM1Y@$HB5PAF\Q@6/.U"1W&.3H:CX%&LV$=IK7B+5]0B60NXF6U D7* M'856$*,% 0X D4D[7&:CE^'-E)K%U?C5M4C%W<1SS6R-"(W,UC#W%N,IYIBC?;YN]@S!AA%8K@E@ M!@GOJYB'P-;VVNW&IVVL:K!]JG$UQ;12QK'+AS(J$A-X4.SGA@3O*L67"CIZ M "FHBQKMC557).%&.2 XML 14 ctre-20201231_htm.xml IDEA: XBRL DOCUMENT 0001590717 2020-01-01 2020-12-31 0001590717 2020-06-30 0001590717 2021-02-09 0001590717 2020-12-31 0001590717 2019-12-31 0001590717 2019-01-01 2019-12-31 0001590717 2018-01-01 2018-12-31 0001590717 us-gaap:CommonStockMember 2017-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2017-12-31 0001590717 2017-12-31 0001590717 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2018-01-01 2018-12-31 0001590717 us-gaap:CommonStockMember 2018-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2018-12-31 0001590717 2018-12-31 0001590717 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2019-01-01 2019-12-31 0001590717 us-gaap:CommonStockMember 2019-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2019-12-31 0001590717 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2020-01-01 2020-12-31 0001590717 us-gaap:CommonStockMember 2020-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2020-12-31 0001590717 ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember 2020-12-31 0001590717 ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember 2020-01-01 2020-12-31 0001590717 ctre:PriorityLifeCareLLCMember us-gaap:BridgeLoanMember 2019-12-31 0001590717 ctre:PriorityLifeCareLLCMember us-gaap:BridgeLoanMember 2019-01-01 2019-12-31 0001590717 srt:MinimumMember us-gaap:BuildingMember 2020-01-01 2020-12-31 0001590717 srt:MaximumMember us-gaap:BuildingMember 2020-01-01 2020-12-31 0001590717 srt:MinimumMember us-gaap:BuildingImprovementsMember 2020-01-01 2020-12-31 0001590717 srt:MaximumMember us-gaap:BuildingImprovementsMember 2020-01-01 2020-12-31 0001590717 us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-12-31 0001590717 ctre:EnsignMember ctre:EnsignMasterLeasesMember 2020-12-31 0001590717 ctre:EnsignMember srt:MinimumMember 2020-12-31 0001590717 ctre:EnsignMember srt:MaximumMember 2020-12-31 0001590717 ctre:EnsignMember ctre:EnsignOtherLeasesMember 2020-01-01 2020-12-31 0001590717 ctre:EnsignMember ctre:EnsignOtherLeasesMember 2020-12-31 0001590717 ctre:PriorityManagementGroupLLCMember 2020-12-31 0001590717 ctre:PriorityManagementGroupLLCMember srt:MinimumMember 2020-12-31 0001590717 ctre:PriorityManagementGroupLLCMember srt:MaximumMember 2020-12-31 0001590717 ctre:VariousOtherOperatorsMember 2020-12-31 0001590717 ctre:AssistedLivingFacilityMember ctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2021Member 2020-12-31 0001590717 ctre:SkilledNursingFacilityMember ctre:PropertiesWithPurchaseOptionLeaseExpirationJanuary2031FirstOption2022Member 2020-12-31 0001590717 ctre:SkilledNursingFacilityMember ctre:PropertiesWithPurchaseOptionLeaseExpirationMarch2030FirstOption2022Member 2020-12-31 0001590717 ctre:SkilledNursingAndCampusFacilitiesMember ctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2032FirstOption2023Member 2020-12-31 0001590717 ctre:SkilledNursingFacilityMember ctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2034FirstOption2024Member 2020-12-31 0001590717 ctre:AssistedLivingFacilityMember ctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2026Member 2020-12-31 0001590717 ctre:LeaseIncomeContractualRentMember 2019-01-01 2019-12-31 0001590717 ctre:LeaseIncomeStraightLineRentMember 2019-01-01 2019-12-31 0001590717 ctre:LeaseIncomePropertyTaxesMember 2019-01-01 2019-12-31 0001590717 ctre:SkilledNursingPropertiesMember 2020-01-01 2020-12-31 0001590717 ctre:MultiServiceCampusPropertiesMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedLivingFacilityMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember 2019-01-01 2019-12-31 0001590717 ctre:MultiServiceCampusPropertiesMember 2019-01-01 2019-12-31 0001590717 ctre:AssistedLivingFacilityMember 2019-01-01 2019-12-31 0001590717 ctre:SkilledNursingPropertiesMember 2018-01-01 2018-12-31 0001590717 ctre:MultiServiceCampusPropertiesMember 2018-01-01 2018-12-31 0001590717 ctre:AssistedLivingFacilityMember 2018-01-01 2018-12-31 0001590717 ctre:MultiServiceCampusPropertiesMember 2018-12-31 0001590717 ctre:NobleSeniorServicesMember 2020-12-01 0001590717 2020-12-01 0001590717 ctre:NobleSeniorServicesMember 2020-12-01 2020-12-01 0001590717 ctre:EnsignMember ctre:EnsignMasterLeasesMember 2019-10-01 0001590717 ctre:PennantMember 2019-10-01 0001590717 ctre:PennantMember 2019-10-01 2019-10-01 0001590717 ctre:EnsignMember ctre:EnsignMasterLeasesMember 2019-10-01 2019-10-01 0001590717 ctre:TrilliumHealthcareGroupLLCMember stpr:IA 2019-07-15 0001590717 ctre:TrilliumHealthcareGroupLLCMember stpr:OH 2019-07-15 0001590717 ctre:TrilliumHealthcareGroupLLCMember stpr:GA 2019-07-15 0001590717 ctre:TrilliumHealthcareGroupLLCMember stpr:IA 2019-08-16 0001590717 ctre:TrilliumHealthcareGroupLLCMember stpr:GA 2019-08-16 0001590717 us-gaap:TradeAccountsReceivableMember 2019-07-01 2019-09-30 0001590717 ctre:ProvidenceGroupMember ctre:SkilledNursingPropertiesMember stpr:OH 2019-09-01 0001590717 ctre:TrilliumHealthcareGroupLLCMember ctre:SkilledNursingPropertiesMember stpr:OH 2019-07-15 0001590717 ctre:ProvidenceGroupMember ctre:AmendedTripleNetMasterLeaseMember 2019-09-01 0001590717 ctre:TrioHealthcareIncMember ctre:TrioHealthcareMasterLeaseMember 2019-11-04 0001590717 ctre:PristineLeaseTerminationAgreementMember 2018-02-27 0001590717 ctre:TrioHealthcareIncMember ctre:PristineLeaseTerminationAgreementMember 2018-05-01 2018-05-01 0001590717 ctre:TrioHealthcareMasterLeaseMember 2018-05-01 0001590717 ctre:HillstoneHealthcareIncMember ctre:PristineLeaseTerminationAgreementMember 2018-05-01 2018-05-01 0001590717 ctre:HillstoneHealthcareMasterLeaseMember 2018-05-01 0001590717 ctre:TrioHealthcareAndHillstoneHealthcareMasterLeaseMember 2018-05-01 2018-05-01 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:TrilliumSkilledNursingFacilitiesMember 2019-09-01 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:TrilliumSkilledNursingFacilitiesMember 2019-10-01 2019-12-31 0001590717 ctre:CommuniCareMember us-gaap:MortgageReceivablesMember 2019-09-01 0001590717 us-gaap:DiscontinuedOperationsHeldforsaleMember ctre:MetronSkilledNursingFacilitiesMember 2019-09-30 0001590717 us-gaap:DiscontinuedOperationsHeldforsaleMember ctre:MetronSkilledNursingFacilitiesMember 2019-07-01 2019-09-30 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:MetronSkilledNursingFacilitiesMember 2020-02-29 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:MetronSkilledNursingFacilitiesMember 2020-02-01 2020-02-29 0001590717 ctre:CascadeCapitalGroupLLCMember us-gaap:MortgageReceivablesMember 2020-02-29 0001590717 ctre:CascadeCapitalGroupLLCMember us-gaap:MortgageReceivablesMember 2020-04-01 2020-04-30 0001590717 ctre:CascadeCapitalGroupLLCMember us-gaap:MortgageReceivablesMember 2020-04-30 0001590717 ctre:CascadeCapitalGroupLLCMember us-gaap:MortgageReceivablesMember 2020-07-01 2020-07-31 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:OwnedAndOperatedLivingFacilitiesMember 2020-11-01 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:OwnedAndOperatedLivingFacilitiesMember 2020-11-01 2020-11-01 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:OwnedAndOperatedLivingFacilitiesMember 2019-12-31 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:OwnedAndOperatedLivingFacilitiesMember 2019-01-01 2019-12-31 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:IdahoAssistedLivingFacilitiesMember 2018-12-31 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:IdahoAssistedLivingFacilitiesMember 2018-01-01 2018-12-31 0001590717 us-gaap:DiscontinuedOperationsHeldforsaleMember ctre:FiveOaksMember 2020-12-31 0001590717 ctre:NextVAStarRealtyHoldingsLLCMember ctre:MezzanineLoanMember 2020-11-30 0001590717 ctre:NextVAStarRealtyHoldingsLLCMember srt:MinimumMember ctre:MezzanineLoanMember 2020-11-30 0001590717 ctre:NextVAStarRealtyHoldingsLLCMember srt:MaximumMember ctre:MezzanineLoanMember 2020-11-30 0001590717 ctre:NextVAStarRealtyHoldingsLLCMember ctre:MezzanineLoanMember 2020-11-01 2020-11-30 0001590717 ctre:ProvidenceGroupMember us-gaap:MortgageReceivablesMember 2017-10-31 0001590717 ctre:CovenantCareMember us-gaap:MortgageReceivablesMember 2019-02-28 0001590717 ctre:CovenantCareMember us-gaap:MortgageReceivablesMember 2019-02-01 2019-02-28 0001590717 ctre:MantecaValleyPostAcuteMember us-gaap:MortgageReceivablesMember 2019-07-01 2019-07-31 0001590717 ctre:MantecaValleyPostAcuteMember us-gaap:MortgageReceivablesMember 2019-07-31 0001590717 ctre:MantecaValleyPostAcuteMember 2019-07-01 2019-07-31 0001590717 ctre:CommuniCareMember us-gaap:MortgageReceivablesMember 2019-09-30 0001590717 ctre:CascadeCapitalGroupLLCMember 2020-04-30 0001590717 ctre:CascadeCapitalGroupLLCMember us-gaap:MortgageReceivablesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-04-30 0001590717 us-gaap:MortgageReceivablesMember 2020-12-31 0001590717 ctre:MezzanineAndMortgageLoanReceivablesMember 2020-01-01 2020-12-31 0001590717 ctre:MezzanineAndMortgageLoanReceivablesMember 2019-01-01 2019-12-31 0001590717 ctre:MezzanineAndMortgageLoanReceivablesMember 2018-01-01 2018-12-31 0001590717 us-gaap:LoansReceivableMember 2020-01-01 2020-12-31 0001590717 us-gaap:LoansReceivableMember 2019-01-01 2019-12-31 0001590717 us-gaap:LoansReceivableMember 2018-01-01 2018-12-31 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember 2016-07-31 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember us-gaap:PrimeRateMember 2016-07-01 2016-07-31 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember 2016-07-01 2016-07-31 0001590717 ctre:SkilledNursingPropertiesMember 2019-06-01 2019-06-30 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember 2019-06-01 2019-06-30 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember 2016-09-30 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember us-gaap:PrimeRateMember 2016-09-01 2016-09-30 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember 2016-09-01 2016-09-30 0001590717 ctre:SkilledNursingPropertiesMember 2020-01-01 2020-01-31 0001590717 ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember 2020-01-01 2020-01-31 0001590717 ctre:MezzanineLoanMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001590717 ctre:MezzanineLoanMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001590717 ctre:MezzanineLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001590717 ctre:MezzanineLoanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0001590717 us-gaap:MortgageReceivablesMember 2019-12-31 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0001590717 ctre:SeniorUnsecuredNotesMember 2020-12-31 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember ctre:SeniorUnsecuredNotesMember 2020-12-31 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember ctre:SeniorUnsecuredNotesMember 2020-12-31 0001590717 ctre:SeniorUnsecuredNotesMember 2019-12-31 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember ctre:SeniorUnsecuredNotesMember 2019-12-31 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember ctre:SeniorUnsecuredNotesMember 2019-12-31 0001590717 us-gaap:SeniorNotesMember 2020-12-31 0001590717 us-gaap:SeniorNotesMember 2019-12-31 0001590717 ctre:SeniorUnsecuredTermLoanMember 2020-12-31 0001590717 ctre:SeniorUnsecuredTermLoanMember 2019-12-31 0001590717 us-gaap:LineOfCreditMember 2020-12-31 0001590717 us-gaap:LineOfCreditMember 2019-12-31 0001590717 ctre:FivePointTwoFiveSeniorNotesDue2025Member ctre:SeniorUnsecuredNotesMember 2017-05-10 0001590717 ctre:FivePointTwoFiveSeniorNotesDue2025Member ctre:SeniorUnsecuredNotesMember 2017-05-10 2017-05-10 0001590717 ctre:FivePointEightSevenFiveSeniorNotesDue2021Member ctre:SeniorUnsecuredNotesMember 2017-05-10 2017-05-10 0001590717 ctre:FivePointEightSevenFiveSeniorNotesDue2021Member ctre:SeniorUnsecuredNotesMember 2017-05-10 0001590717 ctre:FivePointTwoFiveSeniorNotesDue2025Member ctre:SeniorUnsecuredNotesMember 2020-06-01 2020-06-01 0001590717 ctre:RevolvingCreditFacilityAsAmendedMember us-gaap:LineOfCreditMember 2016-02-01 0001590717 ctre:PriorTermLoanMember us-gaap:LineOfCreditMember 2016-02-01 0001590717 ctre:RevolvingCreditFacilityAsAmendedMember us-gaap:LineOfCreditMember 2016-02-01 2016-02-01 0001590717 ctre:PriorTermLoanMember us-gaap:LineOfCreditMember 2016-02-01 2016-02-01 0001590717 us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 0001590717 us-gaap:LetterOfCreditMember 2019-02-08 0001590717 ctre:SwinglineLoanMember 2019-02-08 0001590717 ctre:NewTermLoanFeb2019Member ctre:SeniorUnsecuredTermLoanMember 2019-02-08 0001590717 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 srt:MinimumMember ctre:NewTermLoanFeb2019Member ctre:SeniorUnsecuredTermLoanMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 srt:MaximumMember ctre:NewTermLoanFeb2019Member ctre:SeniorUnsecuredTermLoanMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 srt:MinimumMember ctre:NewTermLoanFeb2019Member ctre:SeniorUnsecuredTermLoanMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 srt:MaximumMember ctre:NewTermLoanFeb2019Member ctre:SeniorUnsecuredTermLoanMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 2019-02-08 0001590717 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 2019-02-08 0001590717 us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 2019-02-08 0001590717 ctre:UnderwrittenPublicOfferingMember 2019-04-15 2019-04-15 0001590717 ctre:UnderwrittenPublicOfferingMember 2019-04-15 0001590717 us-gaap:OverAllotmentOptionMember 2019-04-15 2019-04-15 0001590717 srt:MaximumMember ctre:AtTheMarketOfferingProgramMember 2020-03-10 0001590717 ctre:AtTheMarketOfferingProgramMember 2020-01-01 2020-12-31 0001590717 ctre:PriorAtTheMarketOfferingProgramMember 2019-01-01 2019-12-31 0001590717 ctre:AtTheMarketOfferingProgramMember 2020-12-31 0001590717 2020-03-20 0001590717 2020-01-01 2020-03-31 0001590717 2020-04-01 2020-06-30 0001590717 2020-07-01 2020-09-30 0001590717 2020-10-01 2020-12-31 0001590717 2020-03-31 0001590717 2020-09-30 0001590717 2019-01-01 2019-03-31 0001590717 2019-04-01 2019-06-30 0001590717 2019-07-01 2019-09-30 0001590717 2019-10-01 2019-12-31 0001590717 2019-03-31 0001590717 2019-06-30 0001590717 2019-09-30 0001590717 2018-01-01 2018-03-31 0001590717 2018-04-01 2018-06-30 0001590717 2018-07-01 2018-09-30 0001590717 2018-10-01 2018-12-31 0001590717 2018-03-31 0001590717 2018-06-30 0001590717 2018-09-30 0001590717 ctre:RestrictedStockAndPerformanceSharesMember 2018-12-31 0001590717 ctre:RestrictedStockAndPerformanceSharesMember 2019-01-01 2019-12-31 0001590717 ctre:RestrictedStockAndPerformanceSharesMember 2019-12-31 0001590717 ctre:RestrictedStockAndPerformanceSharesMember 2020-01-01 2020-12-31 0001590717 ctre:RestrictedStockAndPerformanceSharesMember 2020-12-31 0001590717 2014-06-01 0001590717 ctre:EnsignEmployeesMember us-gaap:RestrictedStockMember 2014-06-01 2014-06-01 0001590717 ctre:EnsignEmployeesMember us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0001590717 ctre:EnsignEmployeesMember us-gaap:RestrictedStockMember 2020-12-31 0001590717 ctre:OfficerAndEmployeeMember us-gaap:RestrictedStockMember 2020-01-01 2020-01-31 0001590717 ctre:OfficerAndEmployeeMember us-gaap:RestrictedStockMember 2020-03-01 2020-03-31 0001590717 ctre:OfficerAndEmployeeMember us-gaap:RestrictedStockMember 2020-03-31 0001590717 ctre:OfficerAndEmployeeMember us-gaap:RestrictedStockMember 2020-01-31 0001590717 srt:OfficerMember us-gaap:PerformanceSharesMember 2020-03-01 2020-03-31 0001590717 srt:MinimumMember srt:OfficerMember us-gaap:PerformanceSharesMember 2020-03-01 2020-03-31 0001590717 srt:MaximumMember srt:OfficerMember us-gaap:PerformanceSharesMember 2020-03-01 2020-03-31 0001590717 srt:DirectorMember us-gaap:RestrictedStockMember 2020-04-01 2020-04-30 0001590717 ctre:OfficerAndEmployeeMember us-gaap:RestrictedStockMember 2019-02-01 2019-02-28 0001590717 ctre:OfficerAndEmployeeMember us-gaap:RestrictedStockMember 2019-02-28 0001590717 srt:OfficerMember us-gaap:PerformanceSharesMember 2019-02-01 2019-02-28 0001590717 srt:MinimumMember srt:OfficerMember us-gaap:PerformanceSharesMember 2019-02-01 2019-02-28 0001590717 srt:MaximumMember srt:OfficerMember us-gaap:PerformanceSharesMember 2019-02-01 2019-02-28 0001590717 srt:DirectorMember us-gaap:RestrictedStockMember 2019-05-01 2019-05-31 0001590717 ctre:EnsignAndPennantMember 2020-12-31 0001590717 ctre:ConstructionAndCapitalImprovementsAtTripleNetLeasedFacilitiesMember 2020-12-31 0001590717 ctre:EnsignMember ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember 2020-12-31 0001590717 ctre:EnsignMember 2020-01-01 2020-12-31 0001590717 ctre:EnsignMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001590717 ctre:EnsignMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001590717 ctre:EnsignMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001590717 ctre:PriorityManagementGroupLLCMember ctre:SkilledNursingAndCampusFacilitiesMember 2020-12-31 0001590717 ctre:PriorityManagementGroupLLCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001590717 ctre:PriorityManagementGroupLLCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001590717 ctre:PriorityManagementGroupLLCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:SkillNursingFacilityWashingtonMember us-gaap:SubsequentEventMember 2021-02-01 0001590717 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ctre:SkillNursingFacilityWashingtonMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-01 0001590717 ctre:SkilledNursingPropertiesMember ctre:EnsignHighlandLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:EnsignHighlandLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MeadowbrookHealthAssociatesLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MeadowbrookHealthAssociatesLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TerraceHoldingsAzLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TerraceHoldingsAzLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RillitoHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RillitoHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ValleyHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ValleyHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CedarAvenueHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CedarAvenueHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GranadaInvestmentsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GranadaInvestmentsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:PlazaHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:PlazaHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MountainviewCommunityCareLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MountainviewCommunityCareLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CmHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CmHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:PolkHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:PolkHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SnohomishHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SnohomishHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CherryHealthHoldingsIncMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CherryHealthHoldingsIncMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GolfviewHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GolfviewHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TenthEastHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TenthEastHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TrinityMillHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TrinityMillHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CottonwoodHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CottonwoodHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:VerdeVillaHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:VerdeVillaHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MesquiteHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MesquiteHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ArrowTreeHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ArrowTreeHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FortStreetHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FortStreetHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TrousdaleHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TrousdaleHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:EnsignBellflowerLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:EnsignBellflowerLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RbHeightsHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RbHeightsHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SanCorrineHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SanCorrineHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TempleHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TempleHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:AnsonHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:AnsonHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:WillitsHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:WillitsHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LufkinHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LufkinHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LowellHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LowellHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:JeffersonRalstonHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:JeffersonRalstonHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LafayetteHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LafayetteHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:HillendahlHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:HillendahlHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:PriceHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:PriceHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SilverLakeHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SilverLakeHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:JordanHealthPropertiesLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:JordanHealthPropertiesLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RegalRoadHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RegalRoadHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ParedesHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ParedesHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ExpresswayHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ExpresswayHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RioGrandeHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RioGrandeHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FifthEastHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FifthEastHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:EmmettHealthcareHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:EmmettHealthcareHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:BurleyHealthcareHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:BurleyHealthcareHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:JoseyRanchHealthcareHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:JoseyRanchHealthcareHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:EvergladesHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:EvergladesHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:IrvingHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:IrvingHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FallsCityHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FallsCityHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GilletteParkHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GilletteParkHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GazeboParkHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GazeboParkHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:OlesonParkHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:OlesonParkHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ArapahoeHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:ArapahoeHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:DixieHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:DixieHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MemorialHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:MemorialHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:BogardusHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:BogardusHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SouthDoraHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SouthDoraHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SilveradaHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SilveradaHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:OremHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:OremHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:WisteriaHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:WisteriaHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RenneAvenueHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:RenneAvenueHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:StillhouseHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:StillhouseHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FigStreetHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FigStreetHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LowellLakeHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LowellLakeHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:QueenswayHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:QueenswayHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LongBeachHealthAssociatesLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LongBeachHealthAssociatesLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:KingsCourtHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:KingsCourtHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FiftyOneAvenueHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FiftyOneAvenueHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:IvesHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:IvesHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GuadalupeHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GuadalupeHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FortyNineStreetHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:FortyNineStreetHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:WillowsHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:WillowsHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TulalipBayHoldingsMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:TulalipBayHoldingsMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SkyHoldingsAzLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:SkyHoldingsAzLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LemonRiverHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LemonRiverHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BethanyRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BethanyRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:MiraVistaCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:MiraVistaCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShorelineHealthAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShorelineHealthAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShamrockNursingAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShamrockNursingAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BeaverCreekHealthAndRehabMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BeaverCreekHealthAndRehabMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PristineSeniorLivingofCincinnatiRiverviewMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PristineSeniorLivingofCincinnatiRiverviewMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:EnglewoodHealthAndRehabMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:EnglewoodHealthAndRehabMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PortsmouthHealthAndRehabMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PortsmouthHealthAndRehabMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:WestCoveCareAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:WestCoveCareAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BellBrookHealthAndRehabMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BellBrookHealthAndRehabMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:XeniaHealthAndRehabMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:XeniaHealthAndRehabMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:JamestownPlaceHealthAndRehabMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:JamestownPlaceHealthAndRehabMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CasadePazMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CasadePazMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DenisonCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DenisonCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GardenViewCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GardenViewCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GrandviewHealthCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GrandviewHealthCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GrundyCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GrundyCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:IowaCityRehabandHealthCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:IowaCityRehabandHealthCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:LenoxCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:LenoxCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:OsageMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:OsageMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PleasantAcresCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PleasantAcresCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CedarFallsHealthCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CedarFallsHealthCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:VictoryParkNursingHomeMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:VictoryParkNursingHomeMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShawMountainAtCascadiaMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShawMountainAtCascadiaMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheOaksMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheOaksMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ArborNursingCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ArborNursingCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BroadmoorMedicalLodgeRockwallMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BroadmoorMedicalLodgeRockwallMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DecaturMedicalLodgeMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DecaturMedicalLodgeMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:RoyceCityHealthandRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:RoyceCityHealthandRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:SalineCareNursingAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:SalineCareNursingAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CarrierMillsNursingAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CarrierMillsNursingAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:StoneBridgeNursingAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:StoneBridgeNursingAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DuQuoinNursingAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DuQuoinNursingAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PinckneyvilleNursingAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PinckneyvilleNursingAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:WellspringHealthAndRehabilitationOfCascadiaMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:WellspringHealthAndRehabilitationOfCascadiaMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheRioAtFoxHollowMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheRioAtFoxHollowMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheRioAtCabezonMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheRioAtCabezonMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:EldoradoRehabAndHealthcareMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:EldoradoRehabAndHealthcareMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:SecoraHealthAndRehabilitationOfCascadiaMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:SecoraHealthAndRehabilitationOfCascadiaMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationMountainValleyMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationMountainValleyMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationCaldwellMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationCaldwellMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationCanyonWestMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationCanyonWestMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareAndRehabilitationLewistonMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareAndRehabilitationLewistonMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationNampaMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationNampaMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationWeiserMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationWeiserMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationAspenParkMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredNursingAndRehabilitationAspenParkMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareandRehabilitationRidgmarMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareandRehabilitationRidgmarMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareandRehabilitationMansfieldPlazaMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareandRehabilitationMansfieldPlazaMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareandRehabilitationGrapevineMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:KindredTransitionalCareandRehabilitationGrapevineMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BrookfieldHealthAndRehabMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BrookfieldHealthAndRehabMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheOaksAtLakewoodMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheOaksAtLakewoodMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheOaksAtTimberlineMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheOaksAtTimberlineMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ProvidenceWatermanNursingCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ProvidenceWatermanNursingCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ProvidenceOrangeTreeMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ProvidenceOrangeTreeMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ProvidenceOntarioMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ProvidenceOntarioMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GreenvilleNursingandRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:GreenvilleNursingandRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CopperRidgeHealthAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CopperRidgeHealthAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PrairieHeightsHealthcareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PrairieHeightsHealthcareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheMeadowsOnUniversityMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheMeadowsOnUniversityMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheSuitesParkerMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:TheSuitesParkerMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:HuntingtonParkNursingCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:HuntingtonParkNursingCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShorelineCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ShorelineCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DowneyCareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:DowneyCareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CourtyardHealthcareCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CourtyardHealthcareCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:AlpineSkilledNursingandRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:AlpineSkilledNursingandRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:TheBradfordSkilledNursingandRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:TheBradfordSkilledNursingandRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:ColonialOaksSkilledNursingAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:ColonialOaksSkilledNursingAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:TheGuestHouseSkilledNursingAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:TheGuestHouseSkilledNursingAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:PilgrimManorSkilledNursingAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:PilgrimManorSkilledNursingAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:ShreveportManorSkilledNursingAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:ShreveportManorSkilledNursingAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:BookerTWashingtonSkilledNursingAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:BookerTWashingtonSkilledNursingAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:LegacyWestRehabilitationAndHealthcareMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:LegacyWestRehabilitationAndHealthcareMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:LegacyAtJacksonvilleMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:LegacyAtJacksonvilleMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:PecanTreeRehabilitationAndHealthcareMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:PecanTreeRehabilitationAndHealthcareMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LakewestSNFRealtyLLCMember ctre:LakewestRehabilitationAndSkilledCareMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:LakewestSNFRealtyLLCMember ctre:LakewestRehabilitationAndSkilledCareMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CascadiaOfNampaMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CascadiaOfNampaMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ValleySkilledNursingMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ValleySkilledNursingMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CascadiaOfBoiseMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CascadiaOfBoiseMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CooneyHealthcareAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:CooneyHealthcareAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ElkhornHealthcareAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:ElkhornHealthcareAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BeaconHarborHealthcareAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:BeaconHarborHealthcareAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PleasantManorHealthcareAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:PleasantManorHealthcareAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:RowlettHealthAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember ctre:CtrPartnershipMember ctre:RowlettHealthAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingPropertiesMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:EnsignSouthlandLlcMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:EnsignSouthlandLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:MissionCcrcLlcMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:MissionCcrcLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:WayneHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:WayneHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:FourthStreetHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:FourthStreetHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:BigSiouxRiverHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:BigSiouxRiverHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:PrairieHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:PrairieHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:SalmonRiverHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:SalmonRiverHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:CentervilleSeniorIndependentLivingCentervilleHealthAndRehabCentervillePlaceAssistedLivingMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:CentervilleSeniorIndependentLivingCentervilleHealthAndRehabCentervillePlaceAssistedLivingMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:LibertyNursingCenterOfWillardMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:LibertyNursingCenterOfWillardMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:PremierEstatesofNorwoodTowersPremierRetirementEstatesofNorwoodTowersMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:PremierEstatesofNorwoodTowersPremierRetirementEstatesofNorwoodTowersMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:TurlockNursingandRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:TurlockNursingandRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:BridgeportMedicalLodgeMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:BridgeportMedicalLodgeMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:TheVillasAtSaratogaMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:TheVillasAtSaratogaMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:MadisonParkHealthcareMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:MadisonParkHealthcareMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:OakviewHeightsNursingAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:OakviewHeightsNursingAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:SpringLakeSkilledNursingAndRehabilitationMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:SpringLakeSkilledNursingAndRehabilitationMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:TheVillageAtHeritageOaksMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:GulfCoastBuyer1LLCMember ctre:TheVillageAtHeritageOaksMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:CityCreekPostAcuteAndAssistedLivingMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:CityCreekPostAcuteAndAssistedLivingMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:CrestwoodHealthAndRehabilitationCenterMember 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember ctre:CtrPartnershipMember ctre:CrestwoodHealthAndRehabilitationCenterMember 2020-01-01 2020-12-31 0001590717 ctre:SkilledNursingCampusPropertiesMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:AvenueNHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:AvenueNHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:MoeniumHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:MoeniumHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:LafayetteHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:LafayetteHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:ExpoParkHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:ExpoParkHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:WisteriaHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:WisteriaHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:EvergladesHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:EvergladesHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:FlamingoHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:FlamingoHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:EighteenthPlaceHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:EighteenthPlaceHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:BoardwalkHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:BoardwalkHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:WillowsHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:WillowsHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:LockwoodHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:LockwoodHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:SaratogaHealthHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:SaratogaHealthHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:SkyHoldingsAzLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:SkyHoldingsAzLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:LemonRiverHoldingsLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:LemonRiverHoldingsLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:MissionCcrcLlcMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:MissionCcrcLlcMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:PreludeCottagesOfWoodburyMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:PreludeCottagesOfWoodburyMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:EnglishMeadowsSeniorLivingCommunityMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:EnglishMeadowsSeniorLivingCommunityMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:BristolCourtAssistedLivingMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:BristolCourtAssistedLivingMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AsburyPlaceAssistedLivingMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AsburyPlaceAssistedLivingMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:NewHavenAssistedLivingofSanAngeloMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:NewHavenAssistedLivingofSanAngeloMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:LamplightInnOfFortWayneMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:LamplightInnOfFortWayneMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:LamplightInnOfWestAllisMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:LamplightInnOfWestAllisMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:LamplightInnOfBaltimoreMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:LamplightInnOfBaltimoreMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:FortMyersAssistedLivingMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:FortMyersAssistedLivingMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:EnglishMeadowsElksHomeCampusMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:EnglishMeadowsElksHomeCampusMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:CroatanVillageMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:CroatanVillageMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:CountrysideVillageMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:CountrysideVillageMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofClarkstonMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofClarkstonMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofGoodrichMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofGoodrichMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofBurtonMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofBurtonMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofLapeerMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ThePinesofLapeerMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ArborPlaceMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ArborPlaceMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ApplewoodofBrookfieldMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ApplewoodofBrookfieldMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ApplewoodofNewBerlinMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:ApplewoodofNewBerlinMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:TangerineCoveOfBrooksvilleMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:TangerineCoveOfBrooksvilleMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:MemoryCareCottagesinWhiteBearLakeMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:MemoryCareCottagesinWhiteBearLakeMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AmerisistOfCulpeperMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AmerisistOfCulpeperMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AmerisistOfLouisaMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AmerisistOfLouisaMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AmerisistOfWarrentonMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:AmerisistOfWarrentonMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:VistaDelLagoMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:VistaDelLagoMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:InnAtBartonCreekMember 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember ctre:CtrPartnershipMember ctre:InnAtBartonCreekMember 2020-01-01 2020-12-31 0001590717 ctre:AssistedAndIndependentLivingPropertiesMember 2020-12-31 0001590717 ctre:NextVAStarRealtyHoldingsLLCMember ctre:SkilledNursingFacilityMember 2020-01-01 2020-12-31 0001590717 ctre:NextVAStarRealtyHoldingsLLCMember ctre:SkilledNursingFacilityMember 2020-12-31 iso4217:USD shares iso4217:USD shares ctre:facility ctre:bed ctre:state pure ctre:segment ctre:renewal_option ctre:property ctre:operator ctre:unit ctre:extension_option ctre:company ctre:installment ctre:unit_bed 0001590717 2020 FY false us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember P1Y P1Y 10-K true 2020-12-31 --12-31 false 001-36181 CareTrust REIT, Inc. MD 46-3999490 905 Calle Amanecer Suite 300 San Clemente CA 92673 949 542-3130 Common Stock, par value $0.01 per share CTRE NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 1600000000 95893541 Portions of the definitive Proxy Statement for the registrant’s 2021 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission within 120 days after the end of fiscal year 2020, are incorporated by reference into Part III of this Report. 1448099000 1414200000 15000000 33300000 7226000 34590000 18919000 20327000 1823000 2571000 10450000 10850000 2042000 3023000 1503559000 1518861000 296669000 295911000 198925000 198713000 50000000 60000000 19572000 14962000 24251000 21684000 589417000 591270000 0.01 0.01 100000000 100000000 0 0 0 0 0 0 0.01 0.01 500000000 500000000 95215797 95215797 95103270 95103270 952000 951000 1164402000 1162990000 251212000 236350000 914142000 927591000 1503559000 1518861000 173612000 155667000 140073000 11924000 2077000 3389000 3379000 2643000 4345000 1565000 178332000 163401000 156941000 52760000 51822000 45766000 23661000 28125000 27860000 2836000 3048000 11924000 1869000 2898000 2964000 0 16692000 0 0 1076000 0 16302000 15158000 12555000 97428000 118819000 101069000 -37000 1777000 2051000 80867000 46359000 57923000 0.85 0.49 0.73 0.85 0.49 0.72 95200000 93088000 79386000 95207000 93098000 79392000 75478202 755000 783237000 -189375000 594617000 10264981 103000 179783000 179886000 123861 1000 -1290000 -1289000 3848000 3848000 0.82 66738000 66738000 57923000 57923000 85867044 859000 965578000 -198190000 768247000 9100250 91000 195833000 195924000 135976 1000 -2525000 -2524000 4104000 4104000 0.90 84519000 84519000 46359000 46359000 95103270 951000 1162990000 -236350000 927591000 0 0 -404000 -404000 112527 1000 -1996000 -1995000 3812000 3812000 1.00 95729000 95729000 80867000 80867000 95215797 952000 1164402000 -251212000 914142000 80867000 46359000 57923000 52819000 51866000 45783000 1950000 2003000 1938000 3790000 4104000 3848000 77000 1385000 2333000 0 11774000 0 0 797000 238000 -37000 1777000 2051000 1346000 463000 0 0 16692000 0 0 1076000 0 -825000 6283000 3800000 -387000 495000 270000 3791000 2695000 -1443000 145735000 126295000 99357000 89650000 321458000 111640000 8297000 6289000 9012000 30498000 18246000 5648000 80928000 24283000 3227000 2327000 2204000 0 3000000 0 5000000 6608000 3499000 13004000 -41582000 -316007000 -115069000 404000 195924000 179882000 0 200000000 0 65000000 243000000 65000000 0 100000000 0 75000000 278000000 135000000 0 4534000 0 1996000 2524000 1288000 93161000 80619000 62999000 -105561000 173247000 45595000 -1408000 -16465000 29883000 20327000 36792000 6909000 18919000 20327000 36792000 21691000 26005000 25941000 2568000 3900000 3739000 599000 1010000 0 168000 242000 0 32400000 27500000 0 ORGANIZATIONDescription of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of December 31, 2020, the Company owned and leased to independent operators, 218 skilled nursing, multi-service campuses, assisted living and independent living facilities consisting of 22,466 operational beds and units located in 28 states with the highest concentration of properties by rental income located in California, Texas, Louisiana, Idaho and Arizona. 218 22466 28 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The accompanying consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its wholly-owned subsidiaries prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). All intercompany transactions and account balances within the Company have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Standards Adopted by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Loses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2016-13”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected credit losses, rather than incurred losses as previously required by the other-than-temporary impairment model. ASU 2016-13 applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans receivable, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). In November 2018, the FASB released ASU No. 2018-19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Topic 326 Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2018-19”). ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018-19 clarifies that receivables arising from operating leases are not within the scope of ASU 2016-13. Instead, impairment of receivables arising from operating leases should be accounted for under Subtopic 842-30 “Leases - Lessor.” Additionally, the FASB issued ASU No. 2019-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Transition Relief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2019-05”), to allow companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option on financial instruments. The fair value option election does not apply to held-to-maturity debt securities. Entities are required to make this election on an instrument-by-instrument basis. ASU 2016-13 became effective for reporting periods beginning after December 15, 2019, and was applied as a cumulative adjustment to retained earnings as of the effective date. The Company adopted ASU 2016-13 on January 1, 2020. With the Company’s primary business being leasing real property to third-party tenants, the majority of receivables that arise in the ordinary course of business qualify as operating leases and are not in the scope of ASU 2016-13.  However, based on the instruments held upon adoption on January 1, 2020, the standard applied to the Company’s then outstanding mortgage loans receivable, for which the Company elected the fair value option as provided for by ASU 2019-05. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other (loss) income on the Company’s consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2018-13”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. ASU 2018-13 was effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods, with early adoption permitted. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company adopted ASU 2018-13 on January 1, 2020. Adoption of the new standard did not have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt (Topic 470)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2020-09”), which amends and supersedes the SEC paragraphs in the Accounting Standards Codification (“ASC”) to reflect the issuance of SEC Release No. 33-10762. In March 2020, the SEC adopted amendments to reduce and simplify the financial disclosure requirements for guarantors and issuers of guaranteed registered securities. The amendments were effective January 4, 2021, but voluntary compliance with the amendments in advance of January 4, 2021 was permitted. The Company elected to comply with these amendments effective in the first quarter of 2020. As a result, the Company will no longer include in the financial statement footnotes of its Quarterly and Annual Reports on Form 10-Q and Form 10-K separate condensed consolidating financial </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information for its wholly owned subsidiaries that issued or guaranteed the Notes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (See Note 6, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, in accordance with the amendments adopted by the SEC and FASB, because the assets, liabilities and results of operations of the combined issuers and guarantors of the Notes are not materially different than the corresponding amounts presented in the Company’s consolidated financial statements, it is also not required to present combined summary financial information regarding such subsidiary issuers and guarantors.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company recognizes lease revenue in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company’s lease agreements typically contain annual escalators based on the percentage change in the Consumer Price Index which are accounted for as variable lease payments in the period in which the change occurs. For lease agreements that contain fixed rent escalators, the Company generally recognizes lease revenue on a straight-line basis of accounting. The Company generates revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Tenant reimbursements related to property taxes and insurance paid by lessee directly to a third-party on behalf of a lessor are required to be excluded from variable payments and from recognition in the lessor’s income statements. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental revenues recognized by the lessor on a gross basis in its income statements.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2018, the Company recognized tenant recoveries for real estate taxes of $11.9 million which was classified as tenant reimbursements on the Company’s consolidated income statements. Prior to the adoption of ASC 842, the Company recognized tenant recoveries as tenant reimbursement revenues regardless of whether the third party was paid by the lessor or lessee. Effective January 1, 2019, such tenant recoveries are recognized to the extent that the Company pays the third party directly and classified as rental income on the Company’s consolidated income statements. Due to the application of ASC 842, the Company recognized, on a gross basis, tenant recoveries related to real estate taxes of $3.1 million and $2.9 million, for the years ended December 31, 2020 and December 31, 2019, respectively. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s assessment of collectibility of its tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection. The Company considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Such write-offs and recoveries are recorded as decreases or increases through rental income on the Company’s consolidated income statements. For the year ended December 31, 2020, the Company recorded recovery adjustments of $1.0 million and did not recognize any write-off adjustments to rental income. For the year ended December 31, 2019, the Company recorded $11.8 million of write-off adjustments to rental income related to rental income recognized in prior periods. See Note 3,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Real Estate Investments, Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further detail.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Acquisition Valuation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— In accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company’s acquisitions of real estate investments generally do not meet the definition of a business, and are treated as asset acquisitions. The assets acquired and liabilities assumed are measured at their acquisition date relative fair values. Acquisition costs are capitalized as incurred. The Company allocates the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.</span></div><div><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis when earn-out becomes probable and estimable. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—At each reporting period, the Company evaluates its real estate investments to be held and used for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, the Company evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its real estate investments as held for sale when the applicable criteria have been met, which entails a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, the Company writes down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and ceases depreciation.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of impairment, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. </span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Real Estate Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Included in other real estate investments, net, on the Company’s consolidated balance sheets at December 31, 2020, is one mezzanine loan receivable. At December 31, 2019, included in other real estate investments, net is one preferred equity investment and two mortgage loans receivable. The preferred equity investment was accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. Any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the adoption of ASU 2016-13, mortgage and mezzanine loans receivable were recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. Interest income on the Company’s mortgage and mezzanine loans receivable was recognized over the life of the applicable investment using the interest method. Origination costs and fees directly related to loans receivable were amortized over the term of the loan as an adjustment to interest income.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instruments recorded at amortized cost, the Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-13 on January 1, 2020. Fair value was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. Instruments for which the fair value option has been elected are measured at fair value on a </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recurring basis with changes in fair value recognized in other (loss) income on our consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prepaid expenses and other assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. Included in other loans receivable at December 31, 2019 is a bridge loan to Priority Life Care, LLC (“Priority”) under which the Company agreed to fund up to $1.4 million until the earlier of (i) October 31, 2019, (ii) the date that a new credit facility is established such that the borrower may submit draw requests to the applicable lender, or (iii) the date on which Priority’s lease is terminated with respect to any facility. Borrowings under the bridge loan accrue interest at an annual base rate of 8.0%. During the year ended December 31, 2019, the Company determined that the remaining contractual obligations under the bridge loan agreement to Priority were not collectible and recorded a $1.1 million provision for loan losses in the Company’s consolidated income statements. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Depreciation and Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-25 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or expected useful life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integral equipment, furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or expected useful life</span></td></tr></table></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. For senior unsecured notes payable and the senior unsecured term loan, deferred financing costs are netted against the outstanding debt amounts on the balance sheet. For the unsecured revolving credit facility, deferred financing costs are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated income statements. Accumulated amortization of deferred financing costs was $9.0 million and $7.1 million at December 31, 2020 and December 31, 2019, respectively.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s consolidated income statements.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company accounts for share-based payment awards in accordance with ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation – Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 718”). ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees. The Company measures and recognizes compensation expense for all share-based payment awards made to directors, officers and employees based on the grant date fair value, amortized over the requisite service period of the award. Net income reflects stock-based compensation expense of $3.8 million, $4.1 million and $3.8 million for the years ended December 31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company is subject to concentrations of credit risk consisting primarily of operating leases on its owned properties. See Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a discussion of major operator concentration.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> —The Company is subject to disclosures about segments of an enterprise and related information in accordance with ASC Topic 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company calculates earnings per share (“EPS”) in accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beds, Units, Occupancy and Other Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the consolidated financial statements are presented on an unaudited basis and are not subject to audit by the independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2020-04”), that provides optional relief to applying reference rate reform to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”), which will be discontinued by the end of 2021. The amendments in this update are effective immediately and may be applied through December 31, 2022. The Company is still evaluating the impact of ASU 2020-04 and expects to take full advantage of the offered optional expedients and exceptions, but does not expect the adoption of the standard to have a material impact on the Company’s consolidated financial statements.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The accompanying consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its wholly-owned subsidiaries prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). All intercompany transactions and account balances within the Company have been eliminated.</span> <div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Standards Adopted by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Loses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2016-13”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected credit losses, rather than incurred losses as previously required by the other-than-temporary impairment model. ASU 2016-13 applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans receivable, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). In November 2018, the FASB released ASU No. 2018-19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Topic 326 Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2018-19”). ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018-19 clarifies that receivables arising from operating leases are not within the scope of ASU 2016-13. Instead, impairment of receivables arising from operating leases should be accounted for under Subtopic 842-30 “Leases - Lessor.” Additionally, the FASB issued ASU No. 2019-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Transition Relief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2019-05”), to allow companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option on financial instruments. The fair value option election does not apply to held-to-maturity debt securities. Entities are required to make this election on an instrument-by-instrument basis. ASU 2016-13 became effective for reporting periods beginning after December 15, 2019, and was applied as a cumulative adjustment to retained earnings as of the effective date. The Company adopted ASU 2016-13 on January 1, 2020. With the Company’s primary business being leasing real property to third-party tenants, the majority of receivables that arise in the ordinary course of business qualify as operating leases and are not in the scope of ASU 2016-13.  However, based on the instruments held upon adoption on January 1, 2020, the standard applied to the Company’s then outstanding mortgage loans receivable, for which the Company elected the fair value option as provided for by ASU 2019-05. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other (loss) income on the Company’s consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2018-13”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. ASU 2018-13 was effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods, with early adoption permitted. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company adopted ASU 2018-13 on January 1, 2020. Adoption of the new standard did not have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt (Topic 470)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2020-09”), which amends and supersedes the SEC paragraphs in the Accounting Standards Codification (“ASC”) to reflect the issuance of SEC Release No. 33-10762. In March 2020, the SEC adopted amendments to reduce and simplify the financial disclosure requirements for guarantors and issuers of guaranteed registered securities. The amendments were effective January 4, 2021, but voluntary compliance with the amendments in advance of January 4, 2021 was permitted. The Company elected to comply with these amendments effective in the first quarter of 2020. As a result, the Company will no longer include in the financial statement footnotes of its Quarterly and Annual Reports on Form 10-Q and Form 10-K separate condensed consolidating financial </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information for its wholly owned subsidiaries that issued or guaranteed the Notes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (See Note 6, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, in accordance with the amendments adopted by the SEC and FASB, because the assets, liabilities and results of operations of the combined issuers and guarantors of the Notes are not materially different than the corresponding amounts presented in the Company’s consolidated financial statements, it is also not required to present combined summary financial information regarding such subsidiary issuers and guarantors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2020-04”), that provides optional relief to applying reference rate reform to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”), which will be discontinued by the end of 2021. The amendments in this update are effective immediately and may be applied through December 31, 2022. The Company is still evaluating the impact of ASU 2020-04 and expects to take full advantage of the offered optional expedients and exceptions, but does not expect the adoption of the standard to have a material impact on the Company’s consolidated financial statements.</span> <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company recognizes lease revenue in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company’s lease agreements typically contain annual escalators based on the percentage change in the Consumer Price Index which are accounted for as variable lease payments in the period in which the change occurs. For lease agreements that contain fixed rent escalators, the Company generally recognizes lease revenue on a straight-line basis of accounting. The Company generates revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Tenant reimbursements related to property taxes and insurance paid by lessee directly to a third-party on behalf of a lessor are required to be excluded from variable payments and from recognition in the lessor’s income statements. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental revenues recognized by the lessor on a gross basis in its income statements.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2018, the Company recognized tenant recoveries for real estate taxes of $11.9 million which was classified as tenant reimbursements on the Company’s consolidated income statements. Prior to the adoption of ASC 842, the Company recognized tenant recoveries as tenant reimbursement revenues regardless of whether the third party was paid by the lessor or lessee. Effective January 1, 2019, such tenant recoveries are recognized to the extent that the Company pays the third party directly and classified as rental income on the Company’s consolidated income statements. Due to the application of ASC 842, the Company recognized, on a gross basis, tenant recoveries related to real estate taxes of $3.1 million and $2.9 million, for the years ended December 31, 2020 and December 31, 2019, respectively. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s assessment of collectibility of its tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection. The Company considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Such write-offs and recoveries are recorded as decreases or increases through rental income on the Company’s consolidated income statements. For the year ended December 31, 2020, the Company recorded recovery adjustments of $1.0 million and did not recognize any write-off adjustments to rental income. For the year ended December 31, 2019, the Company recorded $11.8 million of write-off adjustments to rental income related to rental income recognized in prior periods. See Note 3,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Real Estate Investments, Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further detail.</span></div> 11900000 3100000 2900000 1000000.0 0 11800000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.</span> <div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Acquisition Valuation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— In accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company’s acquisitions of real estate investments generally do not meet the definition of a business, and are treated as asset acquisitions. The assets acquired and liabilities assumed are measured at their acquisition date relative fair values. Acquisition costs are capitalized as incurred. The Company allocates the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.</span></div><div><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement. </span></div>Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis when earn-out becomes probable and estimable. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease. <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—At each reporting period, the Company evaluates its real estate investments to be held and used for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, the Company evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its real estate investments as held for sale when the applicable criteria have been met, which entails a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, the Company writes down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and ceases depreciation.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of impairment, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. </span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.</span></div> <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Real Estate Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Included in other real estate investments, net, on the Company’s consolidated balance sheets at December 31, 2020, is one mezzanine loan receivable. At December 31, 2019, included in other real estate investments, net is one preferred equity investment and two mortgage loans receivable. The preferred equity investment was accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. Any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the adoption of ASU 2016-13, mortgage and mezzanine loans receivable were recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. Interest income on the Company’s mortgage and mezzanine loans receivable was recognized over the life of the applicable investment using the interest method. Origination costs and fees directly related to loans receivable were amortized over the term of the loan as an adjustment to interest income.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instruments recorded at amortized cost, the Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-13 on January 1, 2020. Fair value was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. Instruments for which the fair value option has been elected are measured at fair value on a </span></div>recurring basis with changes in fair value recognized in other (loss) income on our consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected. Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. Included in other loans receivable at December 31, 2019 is a bridge loan to Priority Life Care, LLC (“Priority”) under which the Company agreed to fund up to $1.4 million until the earlier of (i) October 31, 2019, (ii) the date that a new credit facility is established such that the borrower may submit draw requests to the applicable lender, or (iii) the date on which Priority’s lease is terminated with respect to any facility. Borrowings under the bridge loan accrue interest at an annual base rate of 8.0%. During the year ended December 31, 2019, the Company determined that the remaining contractual obligations under the bridge loan agreement to Priority were not collectible and recorded a $1.1 million provision for loan losses in the Company’s consolidated income statements. 1400000 0.080 1100000 Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. <div style="margin-bottom:6pt;margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Depreciation and Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-25 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or expected useful life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integral equipment, furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or expected useful life</span></td></tr></table></div> The Company anticipates the estimated useful lives of its assets by class to be generally as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-25 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or expected useful life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integral equipment, furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of lease term or expected useful life</span></td></tr></table> P25Y P40Y P10Y P25Y P5Y <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.</span>The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. For senior unsecured notes payable and the senior unsecured term loan, deferred financing costs are netted against the outstanding debt amounts on the balance sheet. For the unsecured revolving credit facility, deferred financing costs are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in </span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated income statements. Accumulated amortization of deferred financing costs was $9.0 million and $7.1 million at December 31, 2020 and December 31, 2019, respectively.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s consolidated income statements.</span></div> 9000000.0 7100000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company accounts for share-based payment awards in accordance with ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation – Stock Compensation</span> (“ASC 718”). ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees. The Company measures and recognizes compensation expense for all share-based payment awards made to directors, officers and employees based on the grant date fair value, amortized over the requisite service period of the award. 3800000 4100000 3800000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company is subject to concentrations of credit risk consisting primarily of operating leases on its owned properties. See Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a discussion of major operator concentration.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> —The Company is subject to disclosures about segments of an enterprise and related information in accordance with ASC Topic 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.</span> 1 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company calculates earnings per share (“EPS”) in accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span>. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities. Beds, Units, Occupancy and Other Measures—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the consolidated financial statements are presented on an unaudited basis and are not subject to audit by the independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board. REAL ESTATE INVESTMENTS, NET<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s investment in owned properties at December 31, 2020 and December 31, 2019 (dollars in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:60.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.193%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.752%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,356 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400,927 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integral equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,005 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783,393 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699,736 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335,294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448,099 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414,200 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, 85 of the Company’s 218 facilities were leased to subsidiaries of Ensign on a triple-net basis under multiple long-term leases (each, an “Ensign Master Lease” and, collectively, the “Ensign Master Leases”) which commenced on June 1, 2014 and were subsequently modified (see “Pennant Spin” below for further information). The obligations under the Ensign Master Leases are guaranteed by Ensign. A default by any subsidiary of Ensign with regard to any facility leased pursuant to an Ensign Master Lease will result in a default under all of the Ensign Master Leases. As of December 31, 2020, annualized contractual rental income from the Ensign Master leases was $53.4 million and are escalated annually, in June, by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the Ensign Master Leases are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). During the year ended December 31, 2020, the Company acquired four additional facilities leased to subsidiaries of Ensign on a triple-net basis which are not included under the Ensign Master Leases. As of December 31, 2020, annualized contractual rental income from the four additional Ensign facilities was $3.8 million and are escalated annually, in December, by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the four additional facilities are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). The four additional facilities leased to subsidiaries of Ensign are guaranteed by Ensign but do not contain cross-default provisions with the Ensign Master Leases.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, 15 of the Company’s facilities were leased to subsidiaries of Priority Management Group (“PMG”) on a triple-net basis under one long-term lease (the “PMG Master Lease”). The PMG Master Lease commenced on December 1, 2016, and provides an initial term of fifteen years, with two five-year renewal options. As of December 31, 2020, annualized contractual rental income from the PMG Master Lease were $27.9 million and are escalated annually by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 3.0%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of PMG that are tenants under the PMG Master Lease are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs).</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, 114 of the Company’s 218 facilities were leased to various other operators under triple-net leases. All of these leases contain annual escalators based on the percentage change in the CPI (but not less than zero), some of which are subject to a cap, or fixed rent escalators.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company’s total future contractual minimum rental income for all of its tenants, excluding operating expense reimbursements, were (dollars in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026,675 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898,455 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tenant Purchase Options</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s operators hold purchase options allowing them to acquire properties they currently lease from the Company. A summary of these purchase options is presented below (dollars in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Type</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Expiration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1st Option Open Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Type</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALF</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2034</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B / C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF / Campus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2032</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALF</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2034</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Type:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A - Fixed base price plus a specified share on any appreciation.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B - Fixed base price.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C - Fixed capitalization rate on lease revenue.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Based on annualized cash revenue for contracts in place at December 31, 2020.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Purchase option reflects two option types.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rental Income</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes components of the Company’s rental income (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Rental Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual rent due</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line rent</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for collectibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,774)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recovery of previously reversed rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease termination revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,612 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,667 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes initial cash rent and tenant operating expense reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by the Company. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the year ended December 31, 2019, and in accordance with ASC 842, the Company evaluated the collectibility of lease payments through maturity and determined that it was not probable that the Company would collect substantially all of the contractual obligations from five operators through maturity. As such, the Company reversed $7.8 million of contractual rent, $3.5 million of straight-line rent and $0.5 million of property tax reimbursements during the year ended December 31, 2019. If lease payments are subsequently deemed probable of collection, the Company increases rental income for such recoveries. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the year ended December 31, 2020, the Company recovered $1.0 million in rental income that was previously written off related to one operator.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the year ended December 31, 2020, in connection with the agreement to terminate its lease agreements with affiliates of Metron Integrated Health Systems (“Metron”) and to sell the facilities to a third-party, the Company received $1.2 million from Metron affiliates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Real Estate Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s acquisitions for the year ended December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Annual Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Beds/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled nursing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,545 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-service campuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted living</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,817 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,598 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s acquisitions for the year ended December 31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Annual Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Beds/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled nursing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,760 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-service campuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,203 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted living</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,700 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,143 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s acquisitions for the year ended December 31, 2018 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Annual Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Beds/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled nursing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,814 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-service campuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,520 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted living</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,334 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,955 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    Purchase price includes capitalized acquisition costs.</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)    Initial annual cash rent excludes ground lease income. </span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)    The number of beds/units includes operating beds at acquisition date.</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)    The Company committed to fund approximately $1.4 million in revenue-producing capital expenditures over 24 months based on the in-place yield, which was included in the purchase price.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Amendments</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Twenty/20 Lease Termination and New Noble Master Lease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On December 1, 2020, five assisted living facilities in Virginia operated by Twenty/20 Management, Inc. (“Twenty/20”) were transferred to affiliates of Noble Senior Services (“Noble”). In connection with the transfer, the Company entered into a new triple-net master lease with Noble. The new lease has a remaining initial term of approximately 14 years, with two five-year renewal options and CPI-based rent escalators. Initial annual cash rent under the new lease is approximately $3.2 million</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pennant Spin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 1, 2019, Ensign completed its previously announced separation of its home health and hospice operations and substantially all of its senior living operations into a separate independent publicly traded company through the distribution of shares of common stock of Pennant. As a result of the Pennant Spin, as of October 1, 2019, the Company amended the Ensign Master Leases to lease 85 facilities to subsidiaries of Ensign, which had a total of 8,908 operational beds, and entered into a new triple-net master lease with subsidiaries of Pennant (the “Pennant Master Lease”) to lease 11 facilities, which had a total of 1,151 operational beds. The contractual initial annual cash rent under the Pennant Master Lease is approximately $7.8 million. The Pennant Master Lease carried an initial term of 15 years, with two five-year renewal options and CPI-based rent escalators. The contractual annual cash rent under the amended Ensign Master Leases was reduced by approximately $7.8 million. Ensign continues to guarantee obligations under the Ensign Master Leases and the Pennant Master Lease. If Pennant achieves a specified portfolio coverage and continuously maintains it for a specified period, Ensign’s obligations under the guaranty with respect to the Pennant Master Lease would be released.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trillium Lease Termination and New Master Lease.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2019, the Company terminated its existing master lease (the “Original Trillium Lease”) with affiliates of Trillium Healthcare Group, LLC (“Trillium”), which covered ten properties in Iowa, seven properties in Ohio and one property in Georgia.  On August 16, 2019, the Company entered into a new master lease (the “New Trillium Lease”) with Trillium’s Iowa and Georgia affiliates covering the ten properties in Iowa and the one property in Georgia. The Company recorded an adjustment to reduce rental income recognized under the Original Trillium Lease for unpaid contractual rent, straight-line rent and property tax reimbursements by approximately $3.8 million in the three months ended September 30, 2019. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2019, four of the seven skilled nursing properties in Ohio operated by Trillium under the Original Trillium Lease were transferred to affiliates of Providence Group, Inc. (“Providence”). In connection with the transfer, the Company amended its triple-net master lease with Providence. The amended lease had a remaining initial term of approximately 13 years as of September 1, 2019, and includes two five-year renewal options and CPI-based rent escalators. Annual cash rent under the amended lease increased by approximately $2.1 million.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trio Lease Amendment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 4, 2019, the Company amended its existing master lease with affiliates of Trio Healthcare, Inc. (“Trio”), which covered seven facilities based in Dayton, Ohio. The amended lease has a remaining initial term of approximately 13 years, with two five-year renewal options and CPI-based rent escalators. The annual base rent due under the amended lease with Trio is approximately $4.7 million and provides for payment of percentage rent if Trio achieves certain increases in portfolio revenue. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pristine Lease Termination. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2018, the Company announced that it entered into a Lease Termination Agreement (the “LTA”) with Pristine for its nine remaining properties, with a target completion date of April 30, 2018. Under the LTA, Pristine agreed to continue to operate the facilities until possession could be surrendered, and the operations therein transitioned, to operator(s) designated by the Company. Among other things, Pristine also agreed to amend certain pending agreements to sell the rights to certain Ohio Medicaid beds (the “Bed Sales Agreements”) and cooperate with the Company to turn over any claim or control it might have had with respect to the sale process and the proceeds thereof, if any, to the Company. The transactions were timely completed, and on May 1, 2018, Trio took over operations in the seven facilities based primarily in the Dayton, Ohio area under a new 15-year master lease, while Hillstone Healthcare, Inc. (“Hillstone”) assumed the operation of the two facilities in Willard and Toledo, Ohio under a new 12-year master lease. In addition, amendments to the Bed Sales Agreements were subsequently executed, confirming the Company as the sole seller of the bed rights and the sole recipient of any proceeds therefrom. The aggregate annual base rent due under the new master leases with Trio and Hillstone is approximately $10.0 million, subject to CPI-based or fixed escalators. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the LTA, the Company agreed, upon Pristine’s full performance of the terms thereof, to terminate Pristine’s master lease and all future obligations of the tenant thereunder; however, under the terms of the master lease the Company’s security interest in Pristine’s accounts receivable has survived any such termination. Such security interest was subject to the prior lien and security interest of Pristine’s working capital lender, Capital One, National Association (“CONA”), with whom the Company has an existing intercreditor agreement that defines the relative rights and responsibilities of CONA and with its respect to the loan and lease collateral represented by Pristine’s accounts receivable and the Company’s respective security interests therein.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2019, the Company sold three of the seven skilled nursing properties in Ohio operated by Trillium under the Original Trillium Lease for a purchase price of $28.0 million. During the three months ended September 30, 2019 and prior to the disposition, the Company recorded an impairment expense of approximately $7.8 million. In connection with the sale, the Company provided affiliates of CommuniCare Family of Companies (“CommuniCare”), the purchaser of the three Ohio properties, with a mortgage loan secured by the three Ohio properties for approximately $26.5 million. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Real Estate Investments, Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2019, the Company met the criteria to classify six skilled nursing facilities operated by affiliates of Metron as held for sale, which resulted in an impairment expense of approximately $8.8 million to reduce the carrying value to fair value less costs to sell the properties. The</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> fair values of the assets impaired during the three months ended September 30, 2019 were based on contractual sales prices, which are considered to be Level 2 measurements within the fair value hierarchy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December 31, 2019, the properties continued to be held for sale and the carrying value of $34.6 million was primarily comprised of real estate assets. In February 2020, the six skilled nursing facilities were sold. In connection with </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the sale for $36.0 million, the Company received $3.5 million in cash and provided subsidiaries of Cascade Capital Group, LLC (“Cascade”), the purchaser of the properties, with a short-term mortgage loan secured by these properties for $32.4 million. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In connection with the sale, the Company recognized a loss of approximately $0.1 million during the three months ended March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between the Company and a third-party institutional lender as co-lenders, pursuant to which we received $18.9 million in cash and a new mortgage loan for $13.9 million. In July 2020, the Company received prepayment in full, including accrued interest, for the new $13.9 million mortgage loan. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Real Estate Investments, Net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on the new mortgage loan.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company sold the one remaining owned and operated independent living facility consisting of 168 units located in Texas with an aggregate carrying value of $4.2 million for gross proceeds of $4.5 million. In connection with the sale, the Company recognized a gain of $20,000. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company sold one of its owned and operated independent living facilities consisting of 38 units located in Texas with an aggregate carrying value of $1.7 million for net proceeds of $3.3 million. In connection with the sale, the Company recognized a gain of $1.6 million. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2018, the Company sold three assisted living facilities consisting of 102 units located in Idaho with an aggregate carrying value of $10.9 million for an aggregate price of $13.0 million. In connection with the sale, the Company recognized a gain of $2.1 million.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company met the criteria to classify one skilled nursing facility operated by affiliates of Five Oaks as held for sale. Assets held for sale includes the net book value of property the Company plans to sell within the next year. If the determination is made that the Company no longer expects to sell an asset within the next year, the asset is reclassified out of assets held for sale. As of December 31, 2020, the property continued to be held for sale and the carrying value of $7.2 million is primarily comprised of real estate assets. In February 2021, the property was sold. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div> <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s investment in owned properties at December 31, 2020 and December 31, 2019 (dollars in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:60.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.193%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.752%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,356 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400,927 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integral equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,005 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783,393 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699,736 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335,294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448,099 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414,200 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 205356000 204154000 1477849000 1400927000 97836000 93005000 2352000 1650000 1783393000 1699736000 335294000 285536000 1448099000 1414200000 85 218 53400000 0 0.025 4 4 3800000 0 0.025 4 15 P15Y 2 P5Y 27900000 0 0.030 114 218 <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company’s total future contractual minimum rental income for all of its tenants, excluding operating expense reimbursements, were (dollars in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026,675 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898,455 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 174400000 174497000 174193000 174294000 174396000 1026675000 1898455000 <div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s operators hold purchase options allowing them to acquire properties they currently lease from the Company. A summary of these purchase options is presented below (dollars in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Type</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Expiration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1st Option Open Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Type</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALF</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2034</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B / C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF / Campus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2032</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SNF</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALF</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2034</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Type:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A - Fixed base price plus a specified share on any appreciation.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B - Fixed base price.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C - Fixed capitalization rate on lease revenue.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Based on annualized cash revenue for contracts in place at December 31, 2020.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Purchase option reflects two option types.</span></div> 7 3207000 11 4800000 1 766000 2 959000 4 3789000 2 1559000 <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes components of the Company’s rental income (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Rental Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual rent due</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line rent</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for collectibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,774)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recovery of previously reversed rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease termination revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,612 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,667 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes initial cash rent and tenant operating expense reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by the Company. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the year ended December 31, 2019, and in accordance with ASC 842, the Company evaluated the collectibility of lease payments through maturity and determined that it was not probable that the Company would collect substantially all of the contractual obligations from five operators through maturity. As such, the Company reversed $7.8 million of contractual rent, $3.5 million of straight-line rent and $0.5 million of property tax reimbursements during the year ended December 31, 2019. If lease payments are subsequently deemed probable of collection, the Company increases rental income for such recoveries. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the year ended December 31, 2020, the Company recovered $1.0 million in rental income that was previously written off related to one operator.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the year ended December 31, 2020, in connection with the agreement to terminate its lease agreements with affiliates of Metron Integrated Health Systems (“Metron”) and to sell the facilities to a third-party, the Company received $1.2 million from Metron affiliates.</span></div> 171309000 166056000 77000 1385000 0 11774000 1047000 0 1179000 0 173612000 155667000 5 7800000 3500000 500000 1000000.0 1 1200000 <div style="margin-bottom:6pt;margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s acquisitions for the year ended December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Annual Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Beds/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled nursing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,545 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-service campuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted living</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,817 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,598 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s acquisitions for the year ended December 31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Annual Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Beds/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled nursing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,760 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-service campuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,203 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted living</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,700 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,143 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s acquisitions for the year ended December 31, 2018 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Annual Cash Rent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Beds/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled nursing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,814 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-service campuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,520 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted living</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,334 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,955 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    Purchase price includes capitalized acquisition costs.</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)    Initial annual cash rent excludes ground lease income. </span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)    The number of beds/units includes operating beds at acquisition date.</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)    The Company committed to fund approximately $1.4 million in revenue-producing capital expenditures over 24 months based on the in-place yield, which was included in the purchase price.</span></div> 75545000 6453000 6 715 6876000 555000 1 184 7396000 590000 1 62 89817000 7598000 8 961 254760000 22909000 17 2099 59344000 5203000 4 762 12596000 1031000 1 96 326700000 29143000 22 2957 85814000 7715000 10 926 27520000 2240000 2 177 0 0 0 0 113334000 9955000 12 1103 1400000 5 P14Y 2 P5Y 3200000 85 8908 11 1151 7800000 P15Y 2 P5Y 7800000 10 7 1 10 1 3800000 4 7 P13Y 2 P5Y 2100000 7 P13Y 2 P5Y 4700000 9 7 P15Y 2 P12Y 10000000.0 3 7 28000000.0 7800000 3 3 26500000 6 8800000 34600000 6 36000000.0 3500000 32400000 0.075 -100000 18900000 13900000 13900000 1 168 4200000 4500000 20000 1 38 1700000 3300000 1600000 3 102 10900000 13000000.0 2100000 1 7200000 OTHER REAL ESTATE INVESTMENTS, NET<div style="margin-bottom:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mezzanine Loan Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—In November 2020, the Company provided Next VA Star Realty Holdings, LLC a mezzanine loan for nine skilled nursing facilities secured by membership interests in affiliates of Next VA Star Realty Holdings, LLC for approximately $15.0 million, at an annual interest rate of 12%. The loan requires monthly interest payments, is set to mature on November 30, 2025, and may (subject to certain restrictions) be prepaid before the maturity date if paid in full and for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments equal to 24 months (less the amount of monthly interest payments made by the borrower through the date of prepayment).</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—In October 2017, the Company provided an affiliate of Providence a mortgage loan secured by a skilled nursing facility for approximately $12.5 million inclusive of transaction costs, which bore a fixed interest rate of 9%. The mortgage loan, which required Providence to make monthly principal and interest payments, was set to mature on October 26, 2020 and had an option to be prepaid before the maturity date. During the three months ended December 31, 2019, Providence exercised its option to prepay the loan in full, and prepayment was received by the Company.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, the Company provided affiliates of Covenant Care a mortgage loan secured by first mortgages on five skilled nursing facilities for approximately $11.4 million, at an annual interest rate of 9%. The loan required monthly interest payments, was set to mature on February 11, 2020, and included two, six-month extension options. During the three months ended September 30, 2019, Covenant Care exercised its option to prepay the loan in full, and prepayment was received by the Company. </span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Company provided MCRC, LLC a real estate loan secured by a 176 bed skilled nursing facility in Manteca, California for $3.0 million, which bore a fixed interest rate of 8% and required monthly interest payments. Concurrently, the Company entered into a purchase and sale agreement to purchase the Manteca facility from MCRC, LLC for approximately $16.4 million subject to normal diligence and other contingencies. The loan documents provided for a maturity date of the earlier to occur of the closing date of the acquisition, or five business days following the termination of the purchase and sale agreement. MCRC, LLC breached its obligation to sell the Manteca facility to the Company on the terms outlined in the purchase and sale agreement and to repay the real estate loan upon its stated maturity. As a result, the Company commenced non-judicial foreclosure proceedings with respect to the Manteca facility. In January 2020, the borrower further collateralized the loan by causing one of its affiliates to grant the Company a deed of trust in the real estate and improvements that constitute </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Palm Gardens Assisted Living Facility in Yolo County, California. During the three months ended June 30, 2020, payment for the loan principal and accrued interest, including default interest, as well as reimbursement for attorney’s fees and certain other costs of suit, were received in full by the Company and, as a result, the Company withdrew all foreclosure-related proceedings related to the Manteca facility loan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company provided affiliates of CommuniCare a $26.5 million loan secured by mortgages on the three skilled nursing facilities sold to CommuniCare,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which bore a fixed interest rate of 10%. The mortgage loan, which required CommuniCare to make monthly interest payments, was set to mature on February 29, 2020, and included an option to be prepaid before the maturity date. In January 2020, the Company amended the mortgage loan’s maturity date to April 30, 2020. In April 2020, the Company amended the mortgage loan’s maturity date to May 29, 2020. During the three months ended June 30, 2020, payment for the mortgage loan and accrued interest was received in full by the Company.</span></div><div style="margin-bottom:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company provided provided subsidiaries of Cascade a $32.4 million loan secured by mortgages on the six skilled nursing facilities formerly operated by affiliates of Metron sold to Cascade in February 2020, as discussed in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate investments, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between the Company and a third-party institutional lender as co-lenders, pursuant to which the Company received $18.9 million in cash and a new mortgage loan for $13.9 million. The new mortgage loan with Cascade was secured by the same six skilled nursing facilities purchased by Cascade and was for a combined principal amount of $33.9 million, with the Company’s $13.9 million portion of the indebtedness initially bearing interest at a variable rate equal to LIBOR plus 4.00%, subject to a LIBOR floor of 1.75%. The new mortgage loan had a maturity date of April 29, 2022 and included two six-month extension options. In July 2020, prepayment for the mortgage loan of $13.9 million and accrued interest was received in full by the Company.</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had no remaining mortgage loan receivables.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2020, 2019 and 2018, the Company recognized $2.3 million, $2.8 million and $1.2 million, respectively, of interest income related to the mortgage and mezzanine loans. During the years ended December 31, 2020, 2019 and 2018, the Company recognized $0.3 million, $0.2 million and $0.2 million, respectively, of interest income related to its other loans receivable.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred Equity Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—In July 2016, the Company completed a $2.2 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Nampa, Idaho. In connection with its investment, CareTrust REIT obtained an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the fourth quarter of 2017 and began lease-up during the first quarter of 2018. In June 2019, the Company purchased the skilled nursing facility for approximately $16.2 million, inclusive of transaction costs. The Company paid $12.9 million after receiving back its initial investment of $2.2 million and cumulative contractual preferred return through June 18, 2019, the acquisition date, of $1.1 million. </span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, the Company completed a $2.3 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Boise, Idaho. In connection with its investment, CareTrust REIT obtained an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the first quarter of 2018 and began lease-up during the second quarter of 2018. In January 2020, the Company purchased the skilled nursing facility for approximately $18.7 million, inclusive of transaction costs. The Company paid $15.0 million after receiving back its initial investment of $2.3 million and cumulative contractual preferred return through January 17, 2020, the acquisition date, of $1.4 million. </span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2020, 2019 and 2018, the Company recognized less than $0.1 million, $1.3 million (including $0.6 million for unrecognized preferred return related to prior periods) and $0.2 million, respectively, of interest income related to these preferred equity investments.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had no remaining preferred equity investments.</span></div> 9 15000000.0 0.12 0.01 0.03 P24M 12500000 0.09 5 11400000 0.09 2 P6M 176 3000000.0 0.08 16400000 26500000 3 0.10 32400000 6 0.075 18900000 13900000 6 33900000 13900000 0.0400 0.0175 2 P6M 13900000 0 2300000 2800000 1200000 300000 200000 200000 2200000 0.095 0.120 99 0.090 16200000 12900000 2200000 1100000 2300000 0.095 0.120 99 0.090 18700000 15000000.0 2300000 1400000 100000 1300000 600000 200000 0 FAIR VALUE MEASUREMENTS<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. GAAP guidance defines three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and, depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. The Company does not expect that changes in classifications between levels will be frequent.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2020, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine loan receivable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mezzanine loan receiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">able:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the mezzanine loan receivable was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. As such, the Company classifies the instrument as Level 3 due to the significant unobservable inputs used in determining market interest rates for investments with similar terms. However, the fair value is not sensitive to changes in market interest rates due to the recent issuance of the loan at market interest rates. Future changes in market interest rates could materially impact the estimated discounted cash flows. As of December 31, 2020, the Company did not have any loans that were 90 days or more past due.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, there were no changes in assets and liabilities with Level 3 inputs in the fair value hierarchy.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Non-Recurring Basis</span></div><div style="margin-top:9pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Investments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs quarterly impairment review procedures, primarily through continuous monitoring of events and changes in circumstances that could indicate the carrying value of its real estate assets may not be recoverable. The Company estimates fair values using Level 3 inputs and uses a combined income and market approach. Specifically, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of negotiations with purchasers or prospective purchasers. For the year ended December 31, 2020, there were no real estate assets deemed to be impa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ired. For the year ended December 31, 2019, the Company recorded an impairment expense of $16.7 million. See Note 3, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Investments, Net,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Disclosed at Fair Value</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Considerable judgment is necessary to estimate the fair value disclosure of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020 and December 31, 2019 using Level 2 inputs for the Notes (as defined in Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below), and Level 3 inputs, for all other financial instruments, is as follows (dollars in thousands): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred equity investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,911 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents, accounts and other receivables, other loans receivable, and accounts payable and accrued liabilities: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These balances approximate their fair values due to the short-term nature of these instruments.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage loans receivable</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The fair values of the mortgage loans receivable were estimated using an internal valuation model that considered the expected future cash flows of the investments, the underlying collateral value, market interest rates and other credit enhancements. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior unsecured notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The fair value of the Notes (as defined in Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below) was determined using third-party quotes derived from orderly trades.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unsecured revolving credit facility and senior unsecured term loan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates for similar debt arrangements.</span></div> <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. GAAP guidance defines three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and, depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. The Company does not expect that changes in classifications between levels will be frequent.</span></div> <div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2020, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine loan receivable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 15000000 15000000 16700000 A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020 and December 31, 2019 using Level 2 inputs for the Notes (as defined in Note 6, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below), and Level 3 inputs, for all other financial instruments, is as follows (dollars in thousands): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred equity investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,911 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 0 2327000 3800000 3674000 0 0 0 29500000 29500000 29500000 300000000 296669000 311430000 300000000 295911000 312750000 DEBT<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balance of the Company’s indebtedness as of December 31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loan Fees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loan Fees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,669 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,089)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,406)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,594 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,376)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,624 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Unsecured Notes Payable</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2017, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed an underwritten public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The Company used the net proceeds from the offering of the Notes to redeem all $260.0 million aggregate principal amount outstanding of its 5.875% Senior Notes due 2021, including payment of </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the redemption price at 102.938% and all accrued and unpaid interest thereon. The Company used the remaining portion of the net proceeds of the Notes offering to pay borrowings outstanding under its senior unsecured revolving credit facility. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2017.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 1, 2020, the Issuers may redeem the Notes any time at the redemption prices set forth in the indenture. As of December 31, 2020, the Issuers have not elected to redeem any of the Notes. If certain changes of control of the Company occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and certain of the Company’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers); provided, however, that such guarantees are subject to automatic release under certain customary circumstanc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es, including if the subsidiary guarantor is sold or sells all or substantially all of its assets, the subsidiary guarantor is designated “unrestricted” for covenant purposes under the indenture, the subsidiary guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the indenture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unsecured Revolving Credit Facility and Term Loan</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Prior Credit Agreement”). As later amended on February 1, 2016, the Prior Credit Agreement provided the following: (i) a $400.0 million unsecured asset based revolving credit facility (the “Prior Revolving Facility”), (ii) a $100.0 million non-amortizing unsecured term loan (the “Prior Term Loan” and, together with the Prior Revolving Facility, the “Prior Credit Facility”), and (iii) a $250.0 million uncommitted incremental facility. The Prior Revolving Facility was scheduled to mature on August 5, 2019, subject to two, six-month extension options. The Prior Term Loan was scheduled to mature on February 1, 2023 and could be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2019, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries entered into an amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Amended Credit Agreement”). The Amended Credit Agreement, which amended and restated the Prior Credit Agreement, provides for: (i) an unsecured revolving credit facility (the “Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) an unsecured term loan credit facility (the “Term Loan” and, together with the Revolving Facility, the “Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Borrowing availability under the Revolving Facility is subject to no default or event of default under the Amended Credit Agreement having occurred at the time of borrowing. The proceeds of the Term Loan were used, in part, to repay in full all outstanding borrowings under the Prior Term Loan and Prior Revolving Facility under the Prior Credit Agreement. Future borrowings under the Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rates applicable to loans under the Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.10% to 0.55% per annum or LIBOR plus a margin ranging from 1.10% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or LIBOR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and its consolidated subsidiaries (unless the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based on the credit ratings of the Company’s senior long-term unsecured debt). As of December 31, 2020, the Operating Partnership had $200.0 million outstanding under the Term Loan and $50.0 million outstanding under the Revolving Facility. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility has a maturity date of February 8, 2023, and includes, at the sole discretion of the Operating Partnership, two, six-month extension options. The Term Loan has a maturity date of February 8, 2026.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Facility is guaranteed, jointly and severally, by the Company and its wholly owned subsidiaries that are party to the Amended Credit Agreement (other than the Operating Partnership). The Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend organizational documents and pay certain dividends and other restricted payments. The Amended Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio, a maximum secured recourse debt to asset value ratio, a maximum unsecured debt to unencumbered properties asset value ratio, a minimum unsecured interest coverage ratio and a minimum rent coverage ratio. The Amended Credit Agreement also contains certain customary events of default, including the failure to make timely payments under the Amended Credit Facility or other material indebtedness, the failure to satisfy certain covenants (including the financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule of Debt Maturities </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company’s debt maturities were (dollars in thousands): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balance of the Company’s indebtedness as of December 31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loan Fees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loan Fees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,669 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,089)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,406)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,594 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,376)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,624 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 300000000 3331000 296669000 300000000 4089000 295911000 200000000 1075000 198925000 200000000 1287000 198713000 50000000 0 50000000 60000000 0 60000000 550000000 4406000 545594000 560000000 5376000 554624000 300000000.0 0.0525 300000000.0 294000000.0 260000000.0 0.05875 1.02938 0.0525 1.01 400000000.0 100000000.0 250000000.0 2 P6M 0.02 0.01 600000000.0 0.10 0.10 200000000.0 0.0010 0.0055 0.0110 0.0155 0.0050 0.0120 0.0150 0.0220 0.0015 0.0035 0.00125 0.0030 200000000.0 50000000.0 2 P6M <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company’s debt maturities were (dollars in thousands): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 50000000 0 300000000 200000000 550000000 EQUITY<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Public Offering of Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—On April 15, 2019, the Company completed an underwritten public offering of 6,641,250 shares of its common stock, par value $0.01 per share, at an initial price to the public of $23.35, including 866,250 shares of common stock sold pursuant to the full exercise of an option to purchase additional shares of common stock granted to the underwriters, resulting in approximately $149.0 million in net proceeds, after deducting the underwriting discount and offering expenses. The Company used the proceeds from the offering to repay a portion of the outstanding borrowings on its Revolving Facility, which had been used to fund a portion of the purchase price of acquisitions in the second quarter of 2019.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-The-Market Offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—On March 10, 2020, the Company entered into a new equity distribution agreement to issue and sell, from time to time, up to $500.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “New ATM Program”). In connection with the entry into the equity distribution agreement and the commencement of the New ATM Program, the Company’s “at-the-market” equity offering program pursuant to the Company’s prior equity distribution agreement, dated as of March 4, 2019, was terminated (the “Prior ATM Program”). </span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no New ATM Program or Prior ATM Program activity (or activity under any predecessor at-the-market equity offering programs) for 2020. The following table summarizes predecessor at-the-market equity offering program activity for the year ended 2019 (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.468%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average sales price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,893 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    Total gross proceeds is before $0.6 million of commissions paid to the sales agents during the year ended December 31, 2019 under the predecessor ATM Program. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had $500.0 million available for future issuances under the New ATM Program. </span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — On March 20, 2020, the Company’s Board of Directors authorized a share repurchase program up to $150.0 million of outstanding shares of the Company’s common stock (the “Repurchase Program”). Repurchases under the Repurchase Program, which expires on March 31, 2023, may be made through open market purchases, privately negotiated transactions, structured or derivative transactions, including accelerated share repurchase transactions, or other methods of acquiring shares, in each case subject to market conditions and at such times as shall be permitted by applicable securities laws and determined by management. Repurchases under the Repurchase Program may also be made pursuant to a plan adopted under Rule 10b5-1 promulgated under the Exchange Act. The Company expects to finance any share repurchases under the Repurchase Program using available cash and may also use short-term borrowings under the Revolving Facility. The Company did not repurchase any shares of common stock under the Repurchase Program during the year ended December 31, 2020. The Repurchase Program may be modified, discontinued or suspended at any time.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends on Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — The following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2020, 2019 and 2018 (dollars in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.426%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payment date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 15, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable as of record date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends record date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payment date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 15, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 15, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 15, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 15, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable as of record date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,011 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,508 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends record date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 29, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payment date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 13, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 13, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 15, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 15, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable as of record date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,608 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends record date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 29, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td></tr></table></div> 6641250 0.01 23.35 866250 149000000.0 500000000.0 0 The following table summarizes predecessor at-the-market equity offering program activity for the year ended 2019 (in thousands, except per share amounts):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.468%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average sales price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,893 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>(1)    Total gross proceeds is before $0.6 million of commissions paid to the sales agents during the year ended December 31, 2019 under the predecessor ATM Program. 2459000 19.48 47893000 600000 500000000.0 150000000.0 0 The following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2020, 2019 and 2018 (dollars in thousands, except per share amounts):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.426%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payment date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 15, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable as of record date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends record date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payment date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 15, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 15, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 15, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 15, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable as of record date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,011 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,508 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends record date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 29, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payment date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 13, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 13, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 15, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 15, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable as of record date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,608 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends record date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 29, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td></tr></table> 0.25 0.25 0.25 0.25 2020-04-15 2020-07-15 2020-10-15 2021-01-15 23931000 23931000 23934000 23933000 2020-03-31 2020-06-30 2020-09-30 2020-12-31 0.225 0.225 0.225 0.225 2019-04-15 2019-07-15 2019-10-15 2020-01-15 20011000 21508000 21500000 21500000 2019-03-29 2019-06-28 2019-09-30 2019-12-31 0.205 0.205 0.205 0.205 2018-04-13 2018-07-13 2018-10-15 2019-01-15 15608000 16224000 17196000 17710000 2018-03-30 2018-06-29 2018-09-28 2018-12-31 STOCK-BASED COMPENSATION<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company.</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock award and performance award activity for the years ended December 31, 2020 and 2019:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Share Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,272 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.90 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,686 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.71 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:49.5pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock-based compensation expense recognized (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was $5.5 million of unamortized stock-based compensation expense related to these unvested awards and the weighted-average remaining vesting period of such awards was 2.3 years.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the separation of Ensign’s healthcare business and its real estate business into two separate and independently publicly traded companies (the “Spin-Off”) on June 1, 2014, employees of Ensign who had unvested shares of restricted stock were given one share of CareTrust REIT unvested restricted stock totaling 207,580 shares at the Spin-Off. These restricted shares were subject to a time vesting provision only and the Company did not recognize any stock compensation expense associated with these awards. During the year ended December 31, 2020, 1,760 shares were forfeited. At December 31, 2020, there were no unvested restricted stock awards outstanding.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020 and March 2020, the Compensation Committee of the Company’s Board of Directors granted 27,000 and 107,790 shares of restricted stock, respectively, to officers and employees. Each share had a fair market value on the date of grant of $22.18 and $19.06 per share, respectively, based on the closing market price of the Company’s common stock on that date, and the shares vest in four equal installments beginning on the first anniversary of the grant date. Additionally, in March 2020, the Compensation Committee granted 107,790 performance stock awards to officers. Each share had a fair market value on the date of grant of $19.06 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRmOTExOThkMzFiMTRlY2E4NDY2ZGU4ZWVlMjIxNjYyL3NlYzpkZjkxMTk4ZDMxYjE0ZWNhODQ2NmRlOGVlZTIyMTY2Ml8xNDIvZnJhZzo0M2QyN2M5Nzg5M2Y0NzBlYmM4YTEzM2NmMWU1NWE5OS90ZXh0cmVnaW9uOjQzZDI3Yzk3ODkzZjQ3MGViYzhhMTMzY2YxZTU1YTk5XzQ5NDc4MDIzMzg2NTM_86d641f9-a209-41fb-bf9c-9a857e281456">one</span>-to four-year period. The amount of performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding a fixed per share amount. </span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Compensation Committee of the Company’s Board of Directors granted 27,611 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $16.48 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in full on the earlier to occur of April 29, 2021 or the Company’s 2021 Annual Meeting of Stockholders.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, the Compensation Committee of the Company’s Board of Directors granted 91,440 shares of restricted stock to officers and employees. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in four equal annual installments beginning on the first anniversary of the grant date. Additionally, in February 2019, the Compensation Committee granted 71,440 performance stock awards to officers. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRmOTExOThkMzFiMTRlY2E4NDY2ZGU4ZWVlMjIxNjYyL3NlYzpkZjkxMTk4ZDMxYjE0ZWNhODQ2NmRlOGVlZTIyMTY2Ml8xNDIvZnJhZzo0M2QyN2M5Nzg5M2Y0NzBlYmM4YTEzM2NmMWU1NWE5OS90ZXh0cmVnaW9uOjQzZDI3Yzk3ODkzZjQ3MGViYzhhMTMzY2YxZTU1YTk5XzIyODA_87ae1d7d-658e-41e0-a569-71f995387727">one</span>- to four-year period. The amount of performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding fiscal year over year growth of 5.0% or greater.</span></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Compensation Committee of the Company's Board of Directors granted 17,749 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $24.23 per share, based on the closing market price of the Company's common stock on that date, and the shares vested in full on April 30, 2020.</span></div> <div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock award and performance award activity for the years ended December 31, 2020 and 2019:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Share Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,272 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.90 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,686 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.71 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 519272 14.69 180629 22.22 247534 14.50 134 15.21 452233 17.90 270191 19.11 201563 17.41 3175 20.30 517686 18.71 <div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock-based compensation expense recognized (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3790000 4104000 3848000 5500000 P2Y3M18D 2 1 207580 1760 0 27000 107790 22.18 19.06 4 4 107790 19.06 P4Y 27611 16.48 91440 22.00 4 71440 22.00 P4Y 0.050 17749 24.23 EARNINGS PER COMMON SHARE<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the years ended December 31, 2020, 2019 and 2018, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the years ended December 31, 2020, 2019 and 2018 (amounts in thousands, except per share amounts):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,359 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,923 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for basic and diluted earnings available to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,569 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,559 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average basic common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Dilutive performance stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,207 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,098 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,392 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:49.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unvested restricted shares associated with its incentive award plan and unvested restricted shares issued to employees of Ensign at the Spin-Off have been excluded from the above calculation of earnings per share for the years ended December 31, 2020, 2019 and 2018, when their inclusion would have been anti-dilutive.</span></div> <div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the years ended December 31, 2020, 2019 and 2018, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the years ended December 31, 2020, 2019 and 2018 (amounts in thousands, except per share amounts):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,359 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,923 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for basic and diluted earnings available to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,569 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,559 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average basic common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Dilutive performance stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,207 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,098 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,392 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 80867000 46359000 57923000 298000 296000 364000 80569000 46063000 57559000 95200000 93088000 79386000 7000 10000 6000 95207000 93098000 79392000 0.85 0.49 0.73 0.85 0.49 0.72 COMMITMENTS AND CONTINGENCIES The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which are not individually or in the aggregate anticipated to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. Claims and lawsuits may include matters involving general or professional liability asserted against the Company’s tenants, which are the responsibility of the Company’s tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.Capital expenditures for each property leased under the Company’s triple-net leases are generally the responsibility of the tenant, except that, for the facilities leased to subsidiaries of Ensign, under the Ensign Master Leases, and The Pennant Group, Inc., the tenant will have an option to require the Company to finance certain capital expenditures up to an aggregate of 20% of its initial investment in such property, subject to a corresponding rent increase at the time of funding. For the Company’s other triple-net master leases, the tenants also have the option to request capital expenditure funding that would generally be subject to a corresponding rent increase at the time of funding, which are subject to tenant compliance with the conditions to the Company’s approval and funding of their requests. As of December 31, 2020, the Company had committed to fund expansions, construction and capital improvements at certain triple-net leased facilities totaling $15.4 million, of which $14.2 million is subject to rent increase at the time of funding. 0.20 15400000 14200000 CONCENTRATION OF RISK<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Major operator concentration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – As of December 31, 2020, Ensign leased 89 skilled nursing, assisted living and independent living facilities which had a total of 9,546 beds and units and are located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Texas, Utah and Washington. The four states in which Ensign leases the highest concentration of properties are Texas, California, Arizona and Utah. During the years ended December 31, 2020, 2019 and 2018, Ensign represented 32%, 38% and 42%, respectively, of the Company’s rental income, exclusive of operating expense reimbursements. On October 1, 2019, Ensign completed the Pennant Spin. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Investments, Net, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information regarding the Company’s facilities leased to Ensign subsequent to the Pennant Spin.</span>Ensign is subject to the registration and reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s financial statements, as filed with the SEC, can be found at http://www.sec.gov. The Company has not verified this information through an independent investigation or otherwise. As of December 31, 2020, PMG leased 15 skilled nursing facilities which had a total of 2,145 beds and units and are located in Louisiana and Texas. During the years ended December 31, 2020, 2019 and 2018, PMG represented 16%, 15% and 8%, respectively, of the Company’s rental income, exclusive of operating expense reimbursements. 89 9546 4 0.32 0.38 0.42 15 2145 0.16 0.15 0.08 SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents selected quarterly financial data for the Company. This information has been prepared on a basis consistent with that of the Company’s audited consolidated financial statements. The Company’s quarterly results of operations for the periods presented are not necessarily indicative of future results of operations. This unaudited quarterly data should be read together with the accompanying consolidated financial statements and related notes thereto (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,208 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,658 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,662 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,036 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> This unaudited quarterly data should be read together with the accompanying consolidated financial statements and related notes thereto (in thousands, except per share amounts):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,208 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,658 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,662 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share, diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding, diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,036 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 44340000 44168000 45687000 44137000 19325000 18935000 21552000 21055000 0.20 0.20 0.23 0.22 0.20 0.20 0.23 0.22 95161000 95208000 95214000 95215000 95161000 95208000 95214000 95244000 39658000 46201000 33314000 44228000 16053000 19698000 -10054000 20662000 0.18 0.21 -0.11 0.22 0.18 0.21 -0.11 0.22 88010000 94036000 95103000 95103000 88010000 94036000 95103000 95144000 SUBSEQUENT EVENTS<div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates subsequent events in accordance with ASC 855, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company evaluates subsequent events up until the date the consolidated financial statements are issued.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Sale</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021, the Company closed on the sale of one skilled nursing facility consisting of 90 units located in Washington with a carrying value of $7.2 million, for gross sales proceeds of $7.3 million. The Company does not expect to record a material gain or loss in connection with the sale. The facility was classified as held for sale as of December 31, 2020.</span></div> 1 90 7200000 7300000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.567%"><tr><td style="width:1.0%"/><td style="width:16.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Initial Cost to Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Facility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Encum.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Land</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Building<br/>Improvs.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Costs<br/>Cap.<br/>Since<br/>Acq.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Land</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Building<br/>Improvs.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accum. Depr.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Const./Ren. Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Acq.<br/>Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skilled Nursing Properties:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ensign Highland LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Highland Manor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Phoenix, AZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,902 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Meadowbrook Health Associates LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sabino Canyon</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tucson, AZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,940 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,656 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Terrace Holdings AZ LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Desert Terrace</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Phoenix, AZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,588 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2004</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2002</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rillito Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Catalina</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tucson, AZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,096 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2003</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valley Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">North Mountain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Phoenix, AZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,519 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,801)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2004</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cedar Avenue Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Upland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Upland, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,919 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,994 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,725 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2005</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granada Investments LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Camarillo</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Camarillo, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,526 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,827 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,526 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2005</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plaza Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Park Manor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Walla Walla, WA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,621 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,878)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mountainview Communitycare LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Park View Gardens</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Santa Rosa, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,612 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">653 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1963</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CM Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carmel Mountain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Diego, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,119 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,981)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Polk Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Timberwood</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Livingston, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,391 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,167 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Snohomish Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerald Hills</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lynnwood, WA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">741 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,663 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,998 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">741 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,402 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cherry Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pacific Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hoquiam, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,828 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,037 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Golfview Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambridge SNF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Richmond, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tenth East Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arlington Hills</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salt Lake City, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,426 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,507 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,933 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,054)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Mill Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrollton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrollton, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">664 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">664 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cottonwood Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Holladay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salt Lake City, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">965 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">958 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">965 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,028 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Verde Villa Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lake Village</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lewisville, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,960 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mesquite Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Willow Bend</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mesquite, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,715 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,846 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arrow Tree Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arbor Glen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Glendora, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,594 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1965</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fort Street Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Draper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Draper, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">759 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,596 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trousdale Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brookfield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Downey, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,841 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,861 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,702 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,052)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ensign Bellflower LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rose Villa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bellflower, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">357 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(925)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RB Heights Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Osborn</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Scottsdale, AZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,007 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,793 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,007 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,555 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,562 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Corrine Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salado Creek</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Antonio, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,090 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">719 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,809 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Temple Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wellington</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Temple, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,370 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anson Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Northern Oaks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abilene, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Willits Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Northbrook</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Willits, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,731 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lufkin Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Southland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lufkin, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">782 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,426 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1988</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lowell Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Littleton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Littleton, CO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,735 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,808 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jefferson Ralston Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arvada, CO</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,064 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(920)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lafayette Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Julia Temple</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Englewood, CO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,024 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.567%"><tr><td style="width:1.0%"/><td style="width:16.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillendahl Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Golden Acres</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dallas, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,977 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,421 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,398 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1984</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Price Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pinnacle</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Price, UT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">849 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,058 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,251 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Silver Lake Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provo</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provo, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,362 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,011 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jordan Health Properties LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Copper Ridge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Jordan, UT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,671 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,671 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,751 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,422 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,817)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Regal Road Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sunview</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Youngstown, AZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,648 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Paredes Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alta Vista</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brownsville, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,544 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1969</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expressway Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Veranda</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Harlingen, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">675 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rio Grande Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grand Terrace</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">McAllen, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,085 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,955 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fifth East Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Paramount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salt Lake City, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,355)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emmett Healthcare Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">River's Edge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emmet, ID</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(801)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1972</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Burley Healthcare Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Parke View</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Burley, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,678 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Josey Ranch Healthcare Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Heritage Gardens</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrollton, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,382 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,382 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,771 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,153 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1996</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Everglades Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Victoria Ventura</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ventura, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,847 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,847 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,906 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1990</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Irving Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beatrice Manor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beatrice, NE</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,236 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Falls City Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Careage Estates of Falls City</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Falls City, NE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,223 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,393 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1972</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gillette Park Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Careage of Cherokee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cherokee, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(576)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1967</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gazebo Park Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Careage of Clarion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clarion, IA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,718 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,052)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1978</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Oleson Park Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Careage of Ft. Dodge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ft. Dodge, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arapahoe Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Oceanview</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Texas City, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">759 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dixie Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hurricane</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hurricane, UT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,563 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1978</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Memorial Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pocatello</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pocatello, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,077)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bogardus Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Whittier East</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Whittier, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,307 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,079 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Dora Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ukiah</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ukiah, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,621 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,708 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Silverada Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rosewood</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reno, NV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,397 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1970</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orem Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orem</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orem, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,689 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,896 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,235 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,689 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wisteria Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wisteria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abilene, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Renee Avenue Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monte Vista</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pocatello, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,481 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">966 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,447 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stillhouse Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stillhouse</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Paris, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fig Street Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Palomar Vista</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Escondido, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,653 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,747 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lowell Lake Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Owyhee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Owyhee, ID</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,632 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1990</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Queensway Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Atlantic Memorial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long Beach, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long Beach Health Associates LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shoreline</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long Beach, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,343 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kings Court Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Richland Hills</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ft. Worth, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,822 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1965</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51st Avenue Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legacy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amarillo, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,925 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,957 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,297 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(895)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1970</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ives Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Marcos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Marcos, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,951 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,596 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1972</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guadalupe Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Courtyard (Victoria East)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Victoria, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49th Street Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Omaha</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Omaha, NE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1960</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.567%"><tr><td style="width:1.0%"/><td style="width:16.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Willows Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cascade Vista</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redmond, WA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,184 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,572 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1970</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tulalip Bay Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mountain View</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marysville, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,384 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1966</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sky Holdings AZ LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bella Vita Health and Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Glendale, AZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,380 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,731 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2004</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2002</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lemon River Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plymouth Tower</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Riverside, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">357 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bethany Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lakewood, CO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,375 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1989</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mira Vista Care Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mount Vernon, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,026 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1989</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shoreline Health and Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shoreline, WA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,496 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1987</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shamrock Nursing and Rehabilitation Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dublin, GA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,855 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,855 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BeaverCreek Health and Rehab</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beavercreek, OH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,064 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premier Estates of Cincinnati-Riverview</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cincinnati, OH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1992</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Englewood Health and Rehab</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Englewood, OH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,541 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,629 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1962</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Portsmouth Health and Rehab</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Portsmouth, OH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Cove Care &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Toledo, OH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,365 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,365 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BellBrook Health and Rehab</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bellbrook, OH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,573 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Xenia Health and Rehab</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Xenia, OH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,564 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,587 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,792 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1981</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jamestown Place Health and Rehab</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jamestown, OH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(694)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1967</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Casa de Paz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sioux City, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,846 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denison Care Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denison, IA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,880 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Garden View Care Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shenandoah, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grandview Health Care Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dayton, IA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,167 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,167 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grundy Care Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grundy Center, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iowa City Rehab and Health Care Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iowa City, IA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lenox Care Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lenox, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,915 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,915 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Osage</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Osage, IA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,255 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,255 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pleasant Acres Care Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hull, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,544 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,544 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,733 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cedar Falls Health Care Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cedar Falls, IA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premier Estates of Highlands</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Norwood, OH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shaw Mountain at Cascadia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Boise, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,801 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,572 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,801 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,967 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,768 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1989</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Oaks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Petaluma, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,983 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,629 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arbor Nursing Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lodi, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,712 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,712 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1982</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Broadmoor Medical Lodge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rockwall, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1984</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decatur Medical Lodge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decatur, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royse City Medical Lodge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royse City, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,497)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.567%"><tr><td style="width:1.0%"/><td style="width:16.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Saline Care Nursing &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Harrisburg, IL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrier Mills Nursing &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrier Mills, IL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1968</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">StoneBridge Nursing &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benton, IL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,914 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DuQuoin Nursing &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DuQuoin, IL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">511 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,662 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">511 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,662 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pinckneyville Nursing &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pinckneyville, IL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wellspring Health and Rehabilitation of Cascadia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nampa, ID</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,155 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Rio at Fox Hollow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brownsville, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Rio at Cabezon</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Albuquerque, NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(873)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Eldorado Rehab &amp; Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Eldorado, IL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,033 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1993</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Secora Health and Rehabilitation of Cascadia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Portland, OR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,216 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mountain Valley</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kellogg, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">916 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">916 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1971</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caldwell Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caldwell, ID</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,020 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,536 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1947</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canyon West</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caldwell, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,410 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">431 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,841 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lewiston Health and Rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lewiston, ID</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1964</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Orchards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nampa, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,923 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">785 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(725)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1958</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weiser Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weiser, ID</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,449 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1964</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aspen Park</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Moscow, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,064 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1965</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ridgmar Medical Lodge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fort Worth, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,587 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,843 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mansfield Medical Lodge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mansfield, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,801 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grapevine Medical Lodge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grapevine, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,536 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,029 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(486)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brookfield Health and Rehab</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Battle Ground, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Oaks at Lakewood</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tacoma, WA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1989</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Oaks at Timberline</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vancouver, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1972</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Providence Waterman Nursing Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Bernardino, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,791 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,791 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,622 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1967</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Providence Orange Tree</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Riverside, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Providence Ontario</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ontario, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,084 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1980</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Greenville Nursing &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Greenville, IL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,972 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,972 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1973</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Copper Ridge Health and Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Butte, MT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,974 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,974 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prairie Heights Healthcare Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aberdeen, SD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,372 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,372 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1965</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Meadows on University</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fargo, ND</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1966</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Suites - Parker</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Parker, CO</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,035 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.567%"><tr><td style="width:1.0%"/><td style="width:16.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Huntington Park Nursing Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Huntington Park, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1955</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shoreline Care Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Oxnard, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,699 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,699 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1962</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Downey Care Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Downey, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1967</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Courtyard Healthcare Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Davis, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alpine Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ruston, LA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,513 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Bradford Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shreveport, LA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(992)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1980</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colonial Oaks Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bossier City, LA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,815 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Guest House Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shreveport, LA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,073 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pilgrim Manor Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bossier City, LA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shreveport Manor Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shreveport, LA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">361 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Booker T. Washington Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shreveport, LA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legacy West Rehabilitation and Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corsicana, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,091 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legacy at Jacksonville</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jacksonville, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,608 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pecan Tree Rehabilitation and Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gainesville, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1990</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lakewest SNF Realty, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lakewest Rehabilitation and Skilled Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dallas, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cascadia of Nampa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nampa, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">880 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">880 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valley Skilled Nursing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Modesto, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,671 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,671 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cascadia of Boise</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Boise, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cooney Healthcare and Rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helena, MT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1984</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Elkhorn Healthcare and Rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clancy, MT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,563 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1960</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beacon Harbor Healthcare and Rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rockwall, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,295 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,069 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,295 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,069 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1996</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pleasant Manor Healthcare and Rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Waxahachie, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,062 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1972</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rowlett Health and Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rowlett, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1990</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,155 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">963,927 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144,145 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,057,163 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,201,307 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(194,390)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Multi-Service Campus Properties:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ensign Southland LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Southland Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Norwalk, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">966 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">966 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,295 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1999</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mission CCRC LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">St. Joseph's Villa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salt Lake City, UT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,035 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1994</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wayne Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Careage of Wayne</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wayne, NE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1978</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.567%"><tr><td style="width:1.0%"/><td style="width:16.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4th Street Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Bend Care Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Bend, IA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,532 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Big Sioux River Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillcrest Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hawarden, IA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1974</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prairie Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colonial Manor of Randolph</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Randolph, NE</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,593 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,723 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salmon River Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discovery Care Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salmon, ID</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,664 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Centerville Senior Independent Living</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dayton, OH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,018)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liberty Nursing Center of Willard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Willard, OH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1985</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premier Estates of Middletown/Premier Retirement Estates of Middletown</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Middletown, OH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,484 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,656 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1985</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premier Estates of Norwood Towers/Premier Retirement Estates of Norwood Towers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Norwood, OH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,316 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,316 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,570 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1991</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turlock Nursing and Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turlock, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1986</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bridgeport Medical Lodge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bridgeport, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Villas at Saratoga</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Saratoga, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,736 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,841 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(617)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2004</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Madison Park Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Huntington, WV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,986 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1924</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Oakview Heights Nursing &amp; Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mt. Carmel, IL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2004</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spring Lake Skilled Nursing and Rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shreveport, LA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,008)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gulf Coast Buyer 1 LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Village at Heritage Oaks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corsicana, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">City Creek Post-Acute and Assisted Living</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sacramento, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">408 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,514 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,494 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1990</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crestwood Health and Rehabilitation Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wills Point, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,075 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,075 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1980</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,336 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198,991 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,205 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207,734 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">236,939 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,700)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assisted and Independent Living Properties:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Avenue N Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambridge ALF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rosenburg, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Moenium Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grand Court</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mesa, AZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,268 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1986</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lafayette Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chateau Des Mons</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Englewood, CO</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expo Park Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canterbury Gardens</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aurora, CO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,940 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(858)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1986</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wisteria Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wisteria IND</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abilene, TX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Everglades Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lexington</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ventura, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,542 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,542 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,667 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1990</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Flamingo Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Desert Springs ALF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Las Vegas, NV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">908 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">908 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,048 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,956 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1986</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18th Place Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rose Court</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Phoenix, AZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,011 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,011 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Boardwalk Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Park Place</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reno, NV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1993</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Willows Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cascade Plaza</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redmond, WA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lockwood Health Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Santa Maria</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Santa Maria, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">585 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,630 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1967</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr></table><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.567%"><tr><td style="width:1.0%"/><td style="width:16.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Saratoga Health Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lake Ridge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orem, UT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">444 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">444 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,885 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sky Holdings AZ LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Desert Sky Assisted Living</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Glendale, AZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2004</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2002</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lemon River Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Grove Assisted Living</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Riverside, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2009</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mission CCRC LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">St. Joseph's Villa IND</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Salt Lake City, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,570 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,981 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,432)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1994</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prelude Cottages of Woodbury</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Woodbury, MN</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">English Meadows Senior Living Community</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Christiansburg, VA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bristol Court Assisted Living</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Saint Petersburg, FL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asbury Place Assisted Living</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pensacola, FL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,992 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1997</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Haven Assisted Living of San Angelo</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Angelo, TX</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lamplight Inn of Fort Wayne</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fort Wayne, IN</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,052)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lamplight Inn of West Allis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Allis, WI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lamplight Inn of Baltimore</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Baltimore, MD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,697 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,919 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,919 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fort Myers Assisted Living</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fort Myers, FL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">765 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,665 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1980</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">English Meadows Elks Home Campus</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bedford, VA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,023 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Croatan Village</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Bern, NC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,919 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,919 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Countryside Village</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pikeville, NC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,288 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Pines of Clarkston</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Village of Clarkston, MI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,069)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2010</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Pines of Goodrich</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodrich, MI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,362 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Pines of Burton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Burton, MI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">492 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">492 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Pines of Lapeer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lapeer, MI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,773 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,773 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,075 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arbor Place</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lodi, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1984</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Applewood of Brookfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brookfield, WI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,495 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Applewood of New Berlin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Berlin, WI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,168 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tangerine Cove of Brooksville</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brooksville, FL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">927 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">463 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,359 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1984</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Memory Care Cottages in White Bear Lake</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">White Bear Lake, MN</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Culpeper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Culpepper, VA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,982 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1997</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Louisa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Louisa, VA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrenton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrenton, VA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1999</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vista Del Lago</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Escondido, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,362 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,362 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTR Partnership, L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inn at Barton Creek</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bountiful, UT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,298 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1999</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,006 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,593 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,359 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,006 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244,959 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206,497 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,364,511 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,197 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205,356 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,477,849 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,683,205 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(259,803)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The aggregate cost of real estate for federal income tax purposes was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.7 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,081 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368,157 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266,484 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,630 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,465)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,729)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,784)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683,205 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,081 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368,157 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220,359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185,926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259,803)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220,359)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185,926)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 0 257000 976000 926000 257000 1902000 2159000 1311000 2013 2000 0 425000 3716000 1940000 425000 5656000 6081000 3103000 2012 2000 0 113000 504000 971000 113000 1475000 1588000 865000 2004 2002 0 471000 2041000 3055000 471000 5096000 5567000 3029000 2013 2003 0 629000 5154000 1519000 629000 6673000 7302000 3801000 2009 2004 0 2812000 3919000 1994000 2812000 5913000 8725000 3475000 2011 2005 0 3526000 2827000 1522000 3526000 4349000 7875000 2595000 2010 2005 0 450000 5566000 1055000 450000 6621000 7071000 3878000 2009 2006 0 931000 2612000 653000 931000 3265000 4196000 2082000 1963 2006 0 3028000 3119000 2071000 3028000 5190000 8218000 2981000 2012 2006 0 60000 4391000 1167000 60000 5558000 5618000 3116000 2009 2006 0 741000 1663000 1998000 741000 3661000 4402000 2564000 2009 2006 0 171000 1828000 2038000 171000 3866000 4037000 2525000 2010 2006 0 1105000 3110000 1067000 1105000 4177000 5282000 2246000 2007 2006 0 332000 2426000 2507000 332000 4933000 5265000 3054000 2013 2006 0 664000 2294000 902000 664000 3196000 3860000 2262000 2007 2006 0 965000 2070000 958000 965000 3028000 3993000 2275000 2008 2007 0 600000 1890000 470000 600000 2360000 2960000 1438000 2011 2007 0 470000 1715000 8661000 470000 10376000 10846000 7112000 2012 2007 0 2165000 1105000 324000 2165000 1429000 3594000 1010000 1965 2007 0 443000 2394000 759000 443000 3153000 3596000 1603000 2008 2007 0 1415000 1841000 1861000 1415000 3702000 5117000 2052000 2013 2007 0 937000 1168000 357000 937000 1525000 2462000 925000 2009 2007 0 2007000 2793000 1762000 2007000 4555000 6562000 2528000 2009 2008 0 310000 2090000 719000 310000 2809000 3119000 1456000 2005 2008 0 529000 2207000 1163000 529000 3370000 3899000 1806000 2008 2008 0 369000 3220000 1725000 369000 4945000 5314000 2544000 2012 2008 0 490000 1231000 500000 490000 1731000 2221000 889000 2011 2008 0 467000 4644000 782000 467000 5426000 5893000 1630000 1988 2009 0 217000 856000 1735000 217000 2591000 2808000 1421000 2012 2009 0 280000 1230000 834000 280000 2064000 2344000 920000 2012 2009 0 1607000 4222000 6195000 1607000 10417000 12024000 5021000 2012 2009 0 2133000 11977000 1421000 2133000 13398000 15531000 5530000 1984 2009 0 193000 2209000 849000 193000 3058000 3251000 1102000 2012 2009 0 2051000 8362000 2011000 2051000 10373000 12424000 3208000 2011 2009 0 2671000 4244000 1507000 2671000 5751000 8422000 1817000 2013 2009 0 767000 4648000 729000 767000 5377000 6144000 2063000 2012 2009 0 373000 1354000 190000 373000 1544000 1917000 464000 1969 2009 0 90000 675000 430000 90000 1105000 1195000 455000 2011 2009 0 642000 1085000 870000 642000 1955000 2597000 934000 2012 2009 0 345000 2464000 1065000 345000 3529000 3874000 1355000 2011 2009 0 591000 2383000 69000 591000 2452000 3043000 801000 1972 2010 0 250000 4004000 424000 250000 4428000 4678000 1589000 2011 2010 0 1382000 2293000 478000 1382000 2771000 4153000 934000 1996 2010 0 1847000 5377000 682000 1847000 6059000 7906000 1667000 1990 2011 0 60000 2931000 245000 60000 3176000 3236000 1063000 2011 2011 0 170000 2141000 82000 170000 2223000 2393000 677000 1972 2011 0 163000 1491000 12000 163000 1503000 1666000 576000 1967 2011 0 80000 2541000 97000 80000 2638000 2718000 1052000 1978 2011 0 90000 2341000 759000 90000 3100000 3190000 1527000 2012 2011 0 158000 4810000 759000 128000 5599000 5727000 2030000 2012 2011 0 487000 1978000 98000 487000 2076000 2563000 525000 1978 2011 0 537000 2138000 698000 537000 2836000 3373000 1077000 2007 2011 0 1425000 5307000 1079000 1425000 6386000 7811000 2258000 2011 2011 0 297000 2087000 1621000 297000 3708000 4005000 2096000 2013 2011 0 1012000 3282000 103000 1012000 3385000 4397000 803000 1970 2011 0 1689000 3896000 3235000 1689000 7131000 8820000 2940000 2011 2011 0 746000 9903000 290000 746000 10193000 10939000 2267000 2008 2011 0 180000 2481000 966000 180000 3447000 3627000 1219000 2013 2012 0 129000 7139000 6000 129000 7145000 7274000 1079000 2009 2012 0 329000 2653000 1094000 329000 3747000 4076000 1627000 2007 2012 0 49000 1554000 29000 49000 1583000 1632000 312000 1990 2012 0 999000 4237000 2331000 999000 6568000 7567000 2886000 2008 2012 0 1285000 2343000 2172000 1285000 4515000 5800000 1943000 2013 2012 0 193000 2311000 318000 193000 2629000 2822000 635000 1965 2012 0 340000 3925000 32000 340000 3957000 4297000 895000 1970 2013 0 371000 2951000 274000 371000 3225000 3596000 697000 1972 2013 0 80000 2391000 15000 80000 2406000 2486000 422000 2013 2013 0 129000 2418000 24000 129000 2442000 2571000 629000 1960 2013 0 1388000 2982000 202000 1388000 3184000 4572000 909000 1970 2013 0 1722000 2642000 -980000 742000 2642000 3384000 660000 1966 2013 0 228000 1124000 1380000 228000 2504000 2731000 1727000 2004 2002 0 152000 357000 1493000 152000 1850000 2002000 1163000 2012 2009 0 1668000 15375000 56000 1668000 15431000 17099000 2285000 1989 2015 0 1601000 7425000 0 1601000 7425000 9026000 1067000 1989 2015 0 1462000 5034000 0 1462000 5034000 6496000 703000 1987 2015 0 251000 7855000 0 251000 7855000 8106000 1080000 2010 2015 0 892000 17159000 13000 892000 17172000 18064000 2254000 2014 2015 0 833000 18086000 192000 833000 18278000 19111000 2416000 1992 2015 0 1014000 18541000 88000 1014000 18629000 19643000 2464000 1962 2015 0 282000 9726000 428000 282000 10154000 10436000 1400000 2008 2015 0 93000 10365000 0 93000 10365000 10458000 1360000 2007 2015 0 214000 2573000 231000 214000 2804000 3018000 385000 2003 2015 0 205000 3564000 23000 205000 3587000 3792000 471000 1981 2015 0 266000 4725000 268000 266000 4993000 5259000 694000 1967 2015 0 119000 7727000 0 119000 7727000 7846000 950000 1974 2016 0 96000 2784000 0 96000 2784000 2880000 342000 2015 2016 0 105000 3179000 0 105000 3179000 3284000 391000 2013 2016 0 39000 1167000 0 39000 1167000 1206000 143000 2014 2016 0 65000 1935000 0 65000 1935000 2000000 238000 2011 2016 0 522000 5690000 0 522000 5690000 6212000 699000 2014 2016 0 31000 1915000 0 31000 1915000 1946000 235000 2012 2016 0 126000 2255000 0 126000 2255000 2381000 277000 2014 2016 0 189000 2544000 0 189000 2544000 2733000 313000 2014 2016 0 324000 4366000 0 324000 4366000 4690000 518000 2015 2016 0 364000 2199000 282000 364000 2481000 2845000 293000 2012 2016 0 1801000 6572000 395000 1801000 6967000 8768000 908000 1989 2016 0 3646000 2873000 110000 3646000 2983000 6629000 353000 2015 2016 0 768000 10712000 0 768000 10712000 11480000 1183000 1982 2016 0 1232000 22152000 0 1232000 22152000 23384000 2262000 1984 2016 0 990000 24909000 0 990000 24909000 25899000 2543000 2013 2016 0 606000 14660000 0 606000 14660000 15266000 1497000 2009 2016 0 1022000 5713000 0 1022000 5713000 6735000 547000 2009 2017 0 775000 8377000 0 775000 8377000 9152000 803000 1968 2017 0 439000 3475000 0 439000 3475000 3914000 333000 2014 2017 0 511000 3662000 0 511000 3662000 4173000 351000 2014 2017 0 406000 3411000 0 406000 3411000 3817000 327000 2014 2017 0 774000 5044000 111000 774000 5155000 5929000 462000 2011 2017 0 1178000 12059000 0 1178000 12059000 13237000 1080000 2016 2017 0 2055000 9749000 0 2055000 9749000 11804000 873000 2016 2017 0 940000 2093000 0 940000 2093000 3033000 183000 1993 2017 0 1481000 2216000 110000 1481000 2326000 3807000 194000 2012 2017 0 916000 7874000 0 916000 7874000 8790000 656000 1971 2017 0 906000 7020000 516000 906000 7536000 8442000 585000 1947 2017 0 312000 10410000 431000 312000 10841000 11153000 868000 1969 2017 0 625000 12087000 152000 625000 12239000 12864000 982000 1964 2017 0 785000 8923000 47000 785000 8970000 9755000 725000 1958 2017 0 80000 4419000 30000 80000 4449000 4529000 359000 1964 2017 0 698000 5092000 274000 698000 5366000 6064000 438000 1965 2017 0 681000 6587000 1256000 681000 7843000 8524000 702000 2006 2017 0 607000 4801000 1178000 607000 5979000 6586000 513000 2006 2017 0 1602000 4536000 891000 1602000 5427000 7029000 486000 2006 2017 0 320000 500000 0 320000 500000 820000 42000 2012 2017 0 1000000 1779000 0 1000000 1779000 2779000 145000 1989 2017 0 445000 869000 0 445000 869000 1314000 71000 1972 2017 0 3831000 19791000 0 3831000 19791000 23622000 1608000 1967 2017 0 2897000 14700000 0 2897000 14700000 17597000 1194000 1969 2017 0 4204000 21880000 0 4204000 21880000 26084000 1778000 1980 2017 0 188000 3972000 0 188000 3972000 4160000 366000 1973 2017 0 220000 4974000 0 220000 4974000 5194000 398000 2010 2018 0 1372000 7491000 0 1372000 7491000 8863000 510000 1965 2018 0 989000 3275000 0 989000 3275000 4264000 196000 1966 2018 0 1178000 17857000 0 1178000 17857000 19035000 952000 2012 2018 0 3131000 8876000 299000 3131000 9175000 12306000 464000 1955 2019 0 1699000 9004000 0 1699000 9004000 10703000 443000 1962 2019 0 2502000 6141000 0 2502000 6141000 8643000 303000 1967 2019 0 2351000 9256000 0 2351000 9256000 11607000 464000 1969 2019 0 2688000 23825000 0 2688000 23825000 26513000 1100000 2014 2019 0 3758000 21325000 17000 3758000 21342000 25100000 992000 1980 2019 0 1635000 21180000 0 1635000 21180000 22815000 954000 2013 2019 0 3437000 20889000 184000 3437000 21073000 24510000 984000 2006 2019 0 2979000 24617000 0 2979000 24617000 27596000 1123000 2008 2019 0 676000 10238000 361000 676000 10599000 11275000 481000 2008 2019 0 2452000 9148000 113000 2452000 9261000 11713000 447000 2013 2019 0 120000 6682000 409000 120000 7091000 7211000 340000 2002 2019 0 173000 7481000 127000 173000 7608000 7781000 369000 2006 2019 0 219000 10097000 285000 219000 10382000 10601000 481000 1990 2019 0 0 6905000 0 0 6905000 6905000 322000 2011 2019 0 880000 14117000 0 880000 14117000 14997000 594000 2017 2019 0 798000 7671000 0 798000 7671000 8469000 249000 2016 2019 0 1597000 15692000 0 1597000 15692000 17289000 412000 2018 2020 0 867000 7431000 0 867000 7431000 8298000 65000 1984 2020 0 183000 7380000 0 183000 7380000 7563000 66000 1960 2020 0 1295000 17069000 0 1295000 17069000 18364000 76000 1996 2020 0 629000 7433000 0 629000 7433000 8062000 33000 1972 2020 0 1036000 10516000 0 1036000 10516000 11552000 47000 1990 2020 0 145155000 963927000 92226000 144145000 1057163000 1201307000 194390000 0 966000 5082000 2213000 966000 7295000 8261000 5292000 2011 1999 0 1962000 11035000 464000 1962000 11499000 13461000 3327000 1994 2011 0 130000 3061000 122000 130000 3183000 3313000 994000 1978 2011 0 180000 3352000 0 180000 3352000 3532000 991000 2006 2011 0 110000 3522000 75000 110000 3597000 3707000 998000 1974 2011 0 130000 1571000 22000 130000 1593000 1723000 758000 2011 2011 0 168000 2496000 0 168000 2496000 2664000 525000 2012 2012 0 3912000 22458000 117000 3781000 22706000 26487000 3018000 2007 2015 0 143000 11097000 50000 143000 11147000 11290000 1477000 1985 2015 0 990000 7484000 172000 990000 7656000 8646000 1025000 1985 2015 0 1316000 10071000 499000 1316000 10570000 11886000 1249000 1991 2016 0 1258000 16526000 0 1258000 16526000 17784000 1825000 1986 2016 0 980000 27917000 0 980000 27917000 28897000 2850000 2014 2016 0 8709000 9736000 1396000 8709000 11132000 19841000 617000 2004 2018 0 601000 6385000 0 601000 6385000 6986000 359000 1924 2018 0 298000 8393000 0 298000 8393000 8691000 455000 2004 2019 0 3217000 21195000 2525000 3217000 23720000 26937000 1008000 2008 2019 0 143000 11429000 549000 143000 11978000 12121000 560000 2007 2019 0 3980000 10106000 408000 3980000 10514000 14494000 344000 1990 2019 0 143000 6075000 0 143000 6075000 6218000 28000 1980 2020 0 29336000 198991000 8612000 29205000 207734000 236939000 27700000 0 124000 2301000 392000 124000 2693000 2817000 1367000 2007 2006 0 1893000 5268000 1210000 1893000 6478000 8371000 3453000 1986 2007 0 420000 1160000 189000 420000 1349000 1769000 433000 2011 2009 0 570000 1692000 248000 570000 1940000 2510000 858000 1986 2010 0 244000 3241000 81000 244000 3322000 3566000 1487000 2008 2011 0 1542000 4012000 113000 1542000 4125000 5667000 894000 1990 2011 0 908000 4767000 281000 908000 5048000 5956000 2509000 1986 2011 0 1011000 2053000 490000 1011000 2543000 3554000 937000 1974 2011 0 367000 1633000 51000 367000 1684000 2051000 510000 1993 2012 0 2835000 3784000 395000 2835000 4179000 7014000 1199000 2013 2013 0 1792000 2253000 585000 1792000 2838000 4630000 1248000 1967 2013 0 444000 2265000 176000 444000 2441000 2885000 464000 1995 2013 0 61000 304000 372000 61000 676000 738000 466000 2004 2002 0 342000 802000 3360000 342000 4162000 4504000 2616000 2012 2009 0 411000 2312000 258000 411000 2570000 2981000 1432000 1994 2011 0 430000 6714000 0 430000 6714000 7144000 1007000 2011 2014 0 250000 6114000 43000 250000 6157000 6407000 919000 2011 2014 0 645000 7322000 421000 645000 7512000 8157000 1013000 2010 2015 0 212000 4992000 240000 212000 5213000 5425000 672000 1997 2015 0 284000 4478000 0 284000 4478000 4762000 550000 2012 2016 0 452000 8703000 214000 452000 8889000 9341000 1052000 2015 2016 0 97000 6102000 173000 97000 6255000 6352000 737000 2013 2016 0 0 3697000 267000 0 3919000 3919000 447000 2014 2016 0 1489000 3531000 765000 1489000 4665000 6154000 455000 1980 2016 0 451000 9023000 268000 451000 9291000 9742000 1107000 2014 2016 0 312000 6919000 0 312000 6919000 7231000 807000 2010 2016 0 131000 4157000 0 131000 4157000 4288000 485000 2011 2016 0 603000 9326000 0 603000 9326000 9929000 1069000 2010 2016 0 241000 4112000 9000 241000 4121000 4362000 471000 2014 2016 0 492000 9199000 0 492000 9199000 9691000 1054000 2014 2016 0 302000 5773000 0 302000 5773000 6075000 662000 2008 2016 0 392000 3605000 0 392000 3605000 3997000 398000 1984 2016 0 493000 14002000 0 493000 14002000 14495000 1371000 2013 2017 0 356000 10812000 0 356000 10812000 11168000 1059000 2016 2017 0 995000 927000 463000 995000 1364000 2359000 114000 1984 2017 0 1611000 5633000 0 1611000 5633000 7244000 493000 2016 2017 0 318000 3897000 85000 318000 3982000 4300000 374000 1997 2017 0 407000 4660000 97000 407000 4757000 5164000 455000 2002 2017 0 1238000 7247000 98000 1238000 7345000 8583000 671000 1999 2017 0 4362000 7997000 0 4362000 7997000 12359000 279000 2015 2019 0 2479000 4804000 15000 2479000 4819000 7298000 119000 1999 2020 0 32006000 201593000 11359000 32006000 212952000 244959000 37713000 0 206497000 1364511000 112197000 205356000 1477849000 1683205000 259803000 1700000000 1605081000 1368157000 1266484000 84630000 318070000 106208000 7223000 3103000 7230000 0 21465000 0 13729000 62784000 11765000 1683205000 1605081000 1368157000 220359000 185926000 152185000 41914000 40373000 34676000 0 5220000 0 2470000 720000 935000 259803000 220359000 185926000 <div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.360%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Periodic Payment Terms</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior Liens</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Book Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Loans Subject to Delinquent Principal or Interest</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mezzanine Loan:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia (9 SNF facilities)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)     Interest is due monthly, and principal is due at the maturity date.</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)    The aggregate cost of investments in real estate mortgage loans for federal income tax purposes was $15.0 million.</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)    The first mortgage loans on these properties are not held by the Company. Accordingly, the amounts of the prior liens at December 31, 2020 are estimated.</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in mortgage loans are summarized as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:52.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.565%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,517 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions during period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions during period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paydowns/Repayments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,500 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,375 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.120 110000000 15000000 15000000 110000000 15000000 15000000 15000000.0 29500000 12375000 12517000 61258000 40889000 0 75758000 23764000 142000 15000000 29500000 12375000 XML 15 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2020
Feb. 09, 2021
Jun. 30, 2020
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2020    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-36181    
Entity Registrant Name CareTrust REIT, Inc.    
Entity Central Index Key 0001590717    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Incorporation, State or Country Code MD    
Entity Tax Identification Number 46-3999490    
Entity Address, Address Line One 905 Calle Amanecer    
Entity Address, Address Line Two Suite 300    
Entity Address, City or Town San Clemente    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92673    
City Area Code 949    
Local Phone Number 542-3130    
Title of 12(b) Security Common Stock, par value $0.01 per share    
Trading Symbol CTRE    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 1.6
Entity Common Stock, Shares Outstanding   95,893,541  
Documents Incorporated by Reference Portions of the definitive Proxy Statement for the registrant’s 2021 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission within 120 days after the end of fiscal year 2020, are incorporated by reference into Part III of this Report.    
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Assets:    
Real estate investments, net $ 1,448,099 $ 1,414,200
Other real estate investments, net 15,000 33,300
Assets held for sale, net 7,226 34,590
Cash and cash equivalents 18,919 20,327
Accounts and other receivables, net 1,823 2,571
Prepaid expenses and other assets, net 10,450 10,850
Deferred financing costs, net 2,042 3,023
Total assets 1,503,559 1,518,861
Liabilities and Equity:    
Senior unsecured notes payable, net 296,669 295,911
Senior unsecured term loan, net 198,925 198,713
Unsecured revolving credit facility 50,000 60,000
Accounts payable and accrued liabilities 19,572 14,962
Dividends payable 24,251 21,684
Total liabilities 589,417 591,270
Commitments and contingencies (Note 10)
Equity:    
Preferred stock, $0.01 par value; 100,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2020 and December 31, 2019 0 0
Common stock, $0.01 par value; 500,000,000 shares authorized, 95,215,797 and 95,103,270 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively 952 951
Additional paid-in capital 1,164,402 1,162,990
Cumulative distributions in excess of earnings (251,212) (236,350)
Total equity 914,142 927,591
Total liabilities and equity $ 1,503,559 $ 1,518,861
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Preferred stock, par value (usd per share) $ 0.01 $ 0.01
Preferred stock, authorized (shares) 100,000,000 100,000,000
Preferred stock, issued (shares) 0 0
Preferred stock, outstanding (shares) 0 0
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, authorized (shares) 500,000,000 500,000,000
Common stock, issued (shares) 95,215,797 95,103,270
Common stock, outstanding (shares) 95,215,797 95,103,270
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Income Statements - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues:      
Rental income $ 173,612 $ 155,667  
Rental income     $ 140,073
Tenant reimbursements     11,924
Independent living facilities 2,077 3,389 3,379
Interest and other income 2,643 4,345 1,565
Total revenues 178,332 163,401 156,941
Expenses:      
Depreciation and amortization 52,760 51,822 45,766
Interest expense 23,661 28,125 27,860
Property taxes 2,836 3,048 11,924
Independent living facilities 1,869 2,898 2,964
Impairment of real estate investments 0 16,692 0
Provision for loan losses 0 1,076 0
General and administrative 16,302 15,158 12,555
Total expenses 97,428 118,819 101,069
Other (loss) income:      
(Loss) gain on sale of real estate (37) 1,777 2,051
Net income $ 80,867 $ 46,359 $ 57,923
Earnings per common share:      
Basic (usd per share) $ 0.85 $ 0.49 $ 0.73
Diluted (usd per share) $ 0.85 $ 0.49 $ 0.72
Weighted-average number of common shares:      
Basic (shares) 95,200 93,088 79,386
Diluted (shares) 95,207 93,098 79,392
Independent living facilities, revenue services us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember
Independent living facilities, cost of services us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember us-gaap:HealthCareResidentServiceMember
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Cumulative Distributions in Excess of Earnings
Beginning balance at Dec. 31, 2017 $ 594,617 $ 755 $ 783,237 $ (189,375)
Beginning balance (shares) at Dec. 31, 2017   75,478,202    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock, net 179,886 $ 103 179,783  
Issuance of common stock, net (shares)   10,264,981    
Vesting of restricted common stock, net of shares withheld for employee taxes (1,289) $ 1 (1,290)  
Vesting of restricted common stock, net of shares withheld for employee taxes (shares)   123,861    
Amortization of stock-based compensation 3,848   3,848  
Common dividends ($1.00, $0.90 and $0.82 per share for the years ended 2020, 2019 and 2018, respectively) (66,738)     (66,738)
Net income 57,923     57,923
Ending balance at Dec. 31, 2018 768,247 $ 859 965,578 (198,190)
Ending balance (shares) at Dec. 31, 2018   85,867,044    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock, net 195,924 $ 91 195,833  
Issuance of common stock, net (shares)   9,100,250    
Vesting of restricted common stock, net of shares withheld for employee taxes (2,524) $ 1 (2,525)  
Vesting of restricted common stock, net of shares withheld for employee taxes (shares)   135,976    
Amortization of stock-based compensation 4,104   4,104  
Common dividends ($1.00, $0.90 and $0.82 per share for the years ended 2020, 2019 and 2018, respectively) (84,519)     (84,519)
Net income 46,359     46,359
Ending balance at Dec. 31, 2019 927,591 $ 951 1,162,990 (236,350)
Ending balance (shares) at Dec. 31, 2019   95,103,270    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock, net (404) $ 0 (404)  
Issuance of common stock, net (shares)   0    
Vesting of restricted common stock, net of shares withheld for employee taxes (1,995) $ 1 (1,996)  
Vesting of restricted common stock, net of shares withheld for employee taxes (shares)   112,527    
Amortization of stock-based compensation 3,812   3,812  
Common dividends ($1.00, $0.90 and $0.82 per share for the years ended 2020, 2019 and 2018, respectively) (95,729)     (95,729)
Net income 80,867     80,867
Ending balance at Dec. 31, 2020 $ 914,142 $ 952 $ 1,164,402 $ (251,212)
Ending balance (shares) at Dec. 31, 2020   95,215,797    
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Equity (Parenthetical) - $ / shares
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement of Stockholders' Equity [Abstract]                              
Common dividend (usd per share) $ 0.25 $ 0.25 $ 0.25 $ 0.25 $ 0.225 $ 0.225 $ 0.225 $ 0.225 $ 0.205 $ 0.205 $ 0.205 $ 0.205 $ 1.00 $ 0.90 $ 0.82
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income $ 80,867 $ 46,359 $ 57,923
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization (including below-market ground leases) 52,819 51,866 45,783
Amortization of deferred financing costs 1,950 2,003 1,938
Amortization of stock-based compensation 3,790 4,104 3,848
Straight-line rental income (77) (1,385) (2,333)
Adjustment for collectibility of rental income 0 11,774 0
Noncash interest income 0 (797) (238)
Loss (gain) on sale of real estate 37 (1,777) (2,051)
Interest income distribution from other real estate investment 1,346 463 0
Impairment of real estate investments 0 16,692 0
Provision for loan losses 0 1,076 0
Change in operating assets and liabilities:      
Accounts and other receivables, net 825 (6,283) (3,800)
Prepaid expenses and other assets, net 387 (495) (270)
Accounts payable and accrued liabilities 3,791 2,695 (1,443)
Net cash provided by operating activities 145,735 126,295 99,357
Cash flows from investing activities:      
Acquisitions of real estate, net of deposits applied (89,650) (321,458) (111,640)
Purchases of, and improvements to, equipment, furniture and fixtures and real estate (8,297) (6,289) (9,012)
Investment in real estate mortgage and other loans receivable (30,498) (18,246) (5,648)
Principal payments received on real estate mortgage and other loans receivable 80,928 24,283 3,227
Repayment of other real estate investment 2,327 2,204 0
Escrow deposits for potential acquisitions of real estate (3,000) 0 (5,000)
Net proceeds from sales of real estate 6,608 3,499 13,004
Net cash used in investing activities (41,582) (316,007) (115,069)
Cash flows from financing activities:      
Proceeds from (costs paid for) the issuance of common stock, net (404)    
Proceeds from (costs paid for) the issuance of common stock, net   195,924 179,882
Proceeds from the issuance of senior unsecured term loan 0 200,000 0
Borrowings under unsecured revolving credit facility 65,000 243,000 65,000
Payments on senior unsecured term loan 0 (100,000) 0
Payments on unsecured revolving credit facility (75,000) (278,000) (135,000)
Payments of deferred financing costs 0 (4,534) 0
Net-settle adjustment on restricted stock (1,996) (2,524) (1,288)
Dividends paid on common stock (93,161) (80,619) (62,999)
Net cash (used in) provided by financing activities (105,561) 173,247 45,595
Net (decrease) increase in cash and cash equivalents (1,408) (16,465) 29,883
Cash and cash equivalents, beginning of period 20,327 36,792 6,909
Cash and cash equivalents, end of period 18,919 20,327 36,792
Supplemental disclosures of cash flow information:      
Interest paid 21,691 26,005 25,941
Supplemental schedule of noncash investing and financing activities:      
Increase in dividends payable 2,568 3,900 3,739
Right-of-use asset obtained in exchange for new operating lease obligation 599 1,010 0
Transfer of pre-acquisition costs to acquired assets 168 242 0
Sale of real estate settled with notes receivable $ 32,400 $ 27,500 $ 0
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Organization
12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization ORGANIZATIONDescription of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of December 31, 2020, the Company owned and leased to independent operators, 218 skilled nursing, multi-service campuses, assisted living and independent living facilities consisting of 22,466 operational beds and units located in 28 states with the highest concentration of properties by rental income located in California, Texas, Louisiana, Idaho and Arizona.
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation—The accompanying consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its wholly-owned subsidiaries prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). All intercompany transactions and account balances within the Company have been eliminated.
 
Recent Accounting Standards Adopted by the Company—In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Loses on Financial Instruments (“ASU 2016-13”), that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected credit losses, rather than incurred losses as previously required by the other-than-temporary impairment model. ASU 2016-13 applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans receivable, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). In November 2018, the FASB released ASU No. 2018-19, Codification Improvements to Topic 326 Financial Instruments - Credit Losses (“ASU 2018-19”). ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of ASU 2016-13. Instead, impairment of receivables arising from operating leases should be accounted for under Subtopic 842-30 “Leases - Lessor.” Additionally, the FASB issued ASU No. 2019-05, Targeted Transition Relief (“ASU 2019-05”), to allow companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option on financial instruments. The fair value option election does not apply to held-to-maturity debt securities. Entities are required to make this election on an instrument-by-instrument basis. ASU 2016-13 became effective for reporting periods beginning after December 15, 2019, and was applied as a cumulative adjustment to retained earnings as of the effective date. The Company adopted ASU 2016-13 on January 1, 2020. With the Company’s primary business being leasing real property to third-party tenants, the majority of receivables that arise in the ordinary course of business qualify as operating leases and are not in the scope of ASU 2016-13.  However, based on the instruments held upon adoption on January 1, 2020, the standard applied to the Company’s then outstanding mortgage loans receivable, for which the Company elected the fair value option as provided for by ASU 2019-05. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other (loss) income on the Company’s consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) (“ASU 2018-13”), which modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. ASU 2018-13 was effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods, with early adoption permitted. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company adopted ASU 2018-13 on January 1, 2020. Adoption of the new standard did not have a material impact on the Company’s consolidated financial statements.
In October 2020, the FASB issued ASU No. 2020-09, Debt (Topic 470) (“ASU 2020-09”), which amends and supersedes the SEC paragraphs in the Accounting Standards Codification (“ASC”) to reflect the issuance of SEC Release No. 33-10762. In March 2020, the SEC adopted amendments to reduce and simplify the financial disclosure requirements for guarantors and issuers of guaranteed registered securities. The amendments were effective January 4, 2021, but voluntary compliance with the amendments in advance of January 4, 2021 was permitted. The Company elected to comply with these amendments effective in the first quarter of 2020. As a result, the Company will no longer include in the financial statement footnotes of its Quarterly and Annual Reports on Form 10-Q and Form 10-K separate condensed consolidating financial
information for its wholly owned subsidiaries that issued or guaranteed the Notes (See Note 6, Debt, for further detail). In addition, in accordance with the amendments adopted by the SEC and FASB, because the assets, liabilities and results of operations of the combined issuers and guarantors of the Notes are not materially different than the corresponding amounts presented in the Company’s consolidated financial statements, it is also not required to present combined summary financial information regarding such subsidiary issuers and guarantors.
Lessor Accounting—The Company recognizes lease revenue in accordance with ASC 842, Leases. The Company’s lease agreements typically contain annual escalators based on the percentage change in the Consumer Price Index which are accounted for as variable lease payments in the period in which the change occurs. For lease agreements that contain fixed rent escalators, the Company generally recognizes lease revenue on a straight-line basis of accounting. The Company generates revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Tenant reimbursements related to property taxes and insurance paid by lessee directly to a third-party on behalf of a lessor are required to be excluded from variable payments and from recognition in the lessor’s income statements. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental revenues recognized by the lessor on a gross basis in its income statements.
For the year ended December 31, 2018, the Company recognized tenant recoveries for real estate taxes of $11.9 million which was classified as tenant reimbursements on the Company’s consolidated income statements. Prior to the adoption of ASC 842, the Company recognized tenant recoveries as tenant reimbursement revenues regardless of whether the third party was paid by the lessor or lessee. Effective January 1, 2019, such tenant recoveries are recognized to the extent that the Company pays the third party directly and classified as rental income on the Company’s consolidated income statements. Due to the application of ASC 842, the Company recognized, on a gross basis, tenant recoveries related to real estate taxes of $3.1 million and $2.9 million, for the years ended December 31, 2020 and December 31, 2019, respectively.
The Company’s assessment of collectibility of its tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection. The Company considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Such write-offs and recoveries are recorded as decreases or increases through rental income on the Company’s consolidated income statements. For the year ended December 31, 2020, the Company recorded recovery adjustments of $1.0 million and did not recognize any write-off adjustments to rental income. For the year ended December 31, 2019, the Company recorded $11.8 million of write-off adjustments to rental income related to rental income recognized in prior periods. See Note 3, Real Estate Investments, Net for further detail.
Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions. 
 
Real Estate Acquisition Valuation— In accordance with ASC 805, Business Combinations, the Company’s acquisitions of real estate investments generally do not meet the definition of a business, and are treated as asset acquisitions. The assets acquired and liabilities assumed are measured at their acquisition date relative fair values. Acquisition costs are capitalized as incurred. The Company allocates the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.

As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement.
Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis when earn-out becomes probable and estimable. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.
Impairment of Long-Lived Assets—At each reporting period, the Company evaluates its real estate investments to be held and used for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, the Company evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.

The Company classifies its real estate investments as held for sale when the applicable criteria have been met, which entails a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, the Company writes down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and ceases depreciation.

In the event of impairment, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers.

The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.
Other Real Estate Investments—Included in other real estate investments, net, on the Company’s consolidated balance sheets at December 31, 2020, is one mezzanine loan receivable. At December 31, 2019, included in other real estate investments, net is one preferred equity investment and two mortgage loans receivable. The preferred equity investment was accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. Any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.
Prior to the adoption of ASU 2016-13, mortgage and mezzanine loans receivable were recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. Interest income on the Company’s mortgage and mezzanine loans receivable was recognized over the life of the applicable investment using the interest method. Origination costs and fees directly related to loans receivable were amortized over the term of the loan as an adjustment to interest income.
For instruments recorded at amortized cost, the Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.
The Company adopted ASU 2016-13 on January 1, 2020. Fair value was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. Instruments for which the fair value option has been elected are measured at fair value on a
recurring basis with changes in fair value recognized in other (loss) income on our consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.
Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. Included in other loans receivable at December 31, 2019 is a bridge loan to Priority Life Care, LLC (“Priority”) under which the Company agreed to fund up to $1.4 million until the earlier of (i) October 31, 2019, (ii) the date that a new credit facility is established such that the borrower may submit draw requests to the applicable lender, or (iii) the date on which Priority’s lease is terminated with respect to any facility. Borrowings under the bridge loan accrue interest at an annual base rate of 8.0%. During the year ended December 31, 2019, the Company determined that the remaining contractual obligations under the bridge loan agreement to Priority were not collectible and recorded a $1.1 million provision for loan losses in the Company’s consolidated income statements.
Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. 
Real Estate Depreciation and Amortization—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:
Building
25-40 years
Building improvements
10-25 years
Tenant improvementsShorter of lease term or expected useful life
Integral equipment, furniture and fixtures
5 years
Identified intangible assetsShorter of lease term or expected useful life
 Cash and Cash Equivalents—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.
The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.
Deferred Financing Costs—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. For senior unsecured notes payable and the senior unsecured term loan, deferred financing costs are netted against the outstanding debt amounts on the balance sheet. For the unsecured revolving credit facility, deferred financing costs are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in
the consolidated income statements. Accumulated amortization of deferred financing costs was $9.0 million and $7.1 million at December 31, 2020 and December 31, 2019, respectively.
When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s consolidated income statements.
Stock-Based Compensation—The Company accounts for share-based payment awards in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees. The Company measures and recognizes compensation expense for all share-based payment awards made to directors, officers and employees based on the grant date fair value, amortized over the requisite service period of the award. Net income reflects stock-based compensation expense of $3.8 million, $4.1 million and $3.8 million for the years ended December 31, 2020, 2019 and 2018, respectively.
Concentration of Credit Risk—The Company is subject to concentrations of credit risk consisting primarily of operating leases on its owned properties. See Note 11, Concentration of Risk, for a discussion of major operator concentration.
Segment Disclosures —The Company is subject to disclosures about segments of an enterprise and related information in accordance with ASC Topic 280, Segment Reporting. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.
Earnings Per Share—The Company calculates earnings per share (“EPS”) in accordance with ASC 260, Earnings Per Share. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities.
Beds, Units, Occupancy and Other Measures—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the consolidated financial statements are presented on an unaudited basis and are not subject to audit by the independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board.
Recent Accounting Pronouncements— In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), that provides optional relief to applying reference rate reform to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”), which will be discontinued by the end of 2021. The amendments in this update are effective immediately and may be applied through December 31, 2022. The Company is still evaluating the impact of ASU 2020-04 and expects to take full advantage of the offered optional expedients and exceptions, but does not expect the adoption of the standard to have a material impact on the Company’s consolidated financial statements.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net
12 Months Ended
Dec. 31, 2020
Real Estate [Abstract]  
Real Estate Investments, Net REAL ESTATE INVESTMENTS, NET
The following table summarizes the Company’s investment in owned properties at December 31, 2020 and December 31, 2019 (dollars in thousands):
 
December 31, 2020December 31, 2019
Land$205,356 $204,154 
Buildings and improvements1,477,849 1,400,927 
Integral equipment, furniture and fixtures97,836 93,005 
Identified intangible assets2,352 1,650 
Real estate investments1,783,393 1,699,736 
Accumulated depreciation and amortization(335,294)(285,536)
Real estate investments, net$1,448,099 $1,414,200 
As of December 31, 2020, 85 of the Company’s 218 facilities were leased to subsidiaries of Ensign on a triple-net basis under multiple long-term leases (each, an “Ensign Master Lease” and, collectively, the “Ensign Master Leases”) which commenced on June 1, 2014 and were subsequently modified (see “Pennant Spin” below for further information). The obligations under the Ensign Master Leases are guaranteed by Ensign. A default by any subsidiary of Ensign with regard to any facility leased pursuant to an Ensign Master Lease will result in a default under all of the Ensign Master Leases. As of December 31, 2020, annualized contractual rental income from the Ensign Master leases was $53.4 million and are escalated annually, in June, by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the Ensign Master Leases are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). During the year ended December 31, 2020, the Company acquired four additional facilities leased to subsidiaries of Ensign on a triple-net basis which are not included under the Ensign Master Leases. As of December 31, 2020, annualized contractual rental income from the four additional Ensign facilities was $3.8 million and are escalated annually, in December, by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the four additional facilities are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). The four additional facilities leased to subsidiaries of Ensign are guaranteed by Ensign but do not contain cross-default provisions with the Ensign Master Leases.
As of December 31, 2020, 15 of the Company’s facilities were leased to subsidiaries of Priority Management Group (“PMG”) on a triple-net basis under one long-term lease (the “PMG Master Lease”). The PMG Master Lease commenced on December 1, 2016, and provides an initial term of fifteen years, with two five-year renewal options. As of December 31, 2020, annualized contractual rental income from the PMG Master Lease were $27.9 million and are escalated annually by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 3.0%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of PMG that are tenants under the PMG Master Lease are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs).
As of December 31, 2020, 114 of the Company’s 218 facilities were leased to various other operators under triple-net leases. All of these leases contain annual escalators based on the percentage change in the CPI (but not less than zero), some of which are subject to a cap, or fixed rent escalators.
As of December 31, 2020, the Company’s total future contractual minimum rental income for all of its tenants, excluding operating expense reimbursements, were (dollars in thousands):
YearAmount
2021$174,400 
2022174,497 
2023174,193 
2024174,294 
2025174,396 
Thereafter1,026,675 
$1,898,455 
Tenant Purchase Options
Certain of the Company’s operators hold purchase options allowing them to acquire properties they currently lease from the Company. A summary of these purchase options is presented below (dollars in thousands):
Asset TypePropertiesLease Expiration1st Option Open DateOption Type
Current Cash Rent(1)
ALF7October 20341/1/2021A$3,207 
SNF11January 20311/1/2022C$4,800 
SNF1March 20304/1/2022
B / C(2)
$766 
SNF / Campus2October 20321/1/2023B$959 
SNF4November 203412/1/2024B$3,789 
ALF2October 20341/1/2026A$1,559 
Option Type:
A - Fixed base price plus a specified share on any appreciation.
B - Fixed base price.
C - Fixed capitalization rate on lease revenue.
Notes:
(1) Based on annualized cash revenue for contracts in place at December 31, 2020.
(2) Purchase option reflects two option types.
Rental Income
The following table summarizes components of the Company’s rental income (dollars in thousands):
For the Year Ended December 31,
20202019
Rental Income
Contractual rent due(1)
$171,309 $166,056 
Straight-line rent77 1,385 
Adjustment for collectibility(2)
— (11,774)
Recovery of previously reversed rent(3)
1,047 — 
Lease termination revenue(4)
1,179 — 
Total$173,612 $155,667 

(1)Includes initial cash rent and tenant operating expense reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by the Company. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received.
(2)During the year ended December 31, 2019, and in accordance with ASC 842, the Company evaluated the collectibility of lease payments through maturity and determined that it was not probable that the Company would collect substantially all of the contractual obligations from five operators through maturity. As such, the Company reversed $7.8 million of contractual rent, $3.5 million of straight-line rent and $0.5 million of property tax reimbursements during the year ended December 31, 2019. If lease payments are subsequently deemed probable of collection, the Company increases rental income for such recoveries.
(3)During the year ended December 31, 2020, the Company recovered $1.0 million in rental income that was previously written off related to one operator.
(4)During the year ended December 31, 2020, in connection with the agreement to terminate its lease agreements with affiliates of Metron Integrated Health Systems (“Metron”) and to sell the facilities to a third-party, the Company received $1.2 million from Metron affiliates.
Recent Real Estate Acquisitions
The following table summarizes the Company’s acquisitions for the year ended December 31, 2020 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$75,545 $6,453 715 
Multi-service campuses6,876 555 184 
Assisted living7,396 590 62 
Total$89,817 $7,598 961 
The following table summarizes the Company’s acquisitions for the year ended December 31, 2019 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$254,760 $22,909 17 2,099 
Multi-service campuses59,344 5,203 762 
Assisted living12,596 1,031 96 
Total$326,700 $29,143 22 2,957 
The following table summarizes the Company’s acquisitions for the year ended December 31, 2018 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$85,814 $7,715 10 926 
Multi-service campuses27,520 (4)2,240 177 
Assisted living— — — — 
Total$113,334 $9,955 12 1,103 
(1)    Purchase price includes capitalized acquisition costs.
(2)    Initial annual cash rent excludes ground lease income.
(3)    The number of beds/units includes operating beds at acquisition date.
(4)    The Company committed to fund approximately $1.4 million in revenue-producing capital expenditures over 24 months based on the in-place yield, which was included in the purchase price.

Lease Amendments
Twenty/20 Lease Termination and New Noble Master Lease. On December 1, 2020, five assisted living facilities in Virginia operated by Twenty/20 Management, Inc. (“Twenty/20”) were transferred to affiliates of Noble Senior Services (“Noble”). In connection with the transfer, the Company entered into a new triple-net master lease with Noble. The new lease has a remaining initial term of approximately 14 years, with two five-year renewal options and CPI-based rent escalators. Initial annual cash rent under the new lease is approximately $3.2 million.
Pennant Spin. On October 1, 2019, Ensign completed its previously announced separation of its home health and hospice operations and substantially all of its senior living operations into a separate independent publicly traded company through the distribution of shares of common stock of Pennant. As a result of the Pennant Spin, as of October 1, 2019, the Company amended the Ensign Master Leases to lease 85 facilities to subsidiaries of Ensign, which had a total of 8,908 operational beds, and entered into a new triple-net master lease with subsidiaries of Pennant (the “Pennant Master Lease”) to lease 11 facilities, which had a total of 1,151 operational beds. The contractual initial annual cash rent under the Pennant Master Lease is approximately $7.8 million. The Pennant Master Lease carried an initial term of 15 years, with two five-year renewal options and CPI-based rent escalators. The contractual annual cash rent under the amended Ensign Master Leases was reduced by approximately $7.8 million. Ensign continues to guarantee obligations under the Ensign Master Leases and the Pennant Master Lease. If Pennant achieves a specified portfolio coverage and continuously maintains it for a specified period, Ensign’s obligations under the guaranty with respect to the Pennant Master Lease would be released.
Trillium Lease Termination and New Master Lease. On July 15, 2019, the Company terminated its existing master lease (the “Original Trillium Lease”) with affiliates of Trillium Healthcare Group, LLC (“Trillium”), which covered ten properties in Iowa, seven properties in Ohio and one property in Georgia.  On August 16, 2019, the Company entered into a new master lease (the “New Trillium Lease”) with Trillium’s Iowa and Georgia affiliates covering the ten properties in Iowa and the one property in Georgia. The Company recorded an adjustment to reduce rental income recognized under the Original Trillium Lease for unpaid contractual rent, straight-line rent and property tax reimbursements by approximately $3.8 million in the three months ended September 30, 2019.
On September 1, 2019, four of the seven skilled nursing properties in Ohio operated by Trillium under the Original Trillium Lease were transferred to affiliates of Providence Group, Inc. (“Providence”). In connection with the transfer, the Company amended its triple-net master lease with Providence. The amended lease had a remaining initial term of approximately 13 years as of September 1, 2019, and includes two five-year renewal options and CPI-based rent escalators. Annual cash rent under the amended lease increased by approximately $2.1 million.
Trio Lease Amendment. On November 4, 2019, the Company amended its existing master lease with affiliates of Trio Healthcare, Inc. (“Trio”), which covered seven facilities based in Dayton, Ohio. The amended lease has a remaining initial term of approximately 13 years, with two five-year renewal options and CPI-based rent escalators. The annual base rent due under the amended lease with Trio is approximately $4.7 million and provides for payment of percentage rent if Trio achieves certain increases in portfolio revenue.
Pristine Lease Termination. On February 27, 2018, the Company announced that it entered into a Lease Termination Agreement (the “LTA”) with Pristine for its nine remaining properties, with a target completion date of April 30, 2018. Under the LTA, Pristine agreed to continue to operate the facilities until possession could be surrendered, and the operations therein transitioned, to operator(s) designated by the Company. Among other things, Pristine also agreed to amend certain pending agreements to sell the rights to certain Ohio Medicaid beds (the “Bed Sales Agreements”) and cooperate with the Company to turn over any claim or control it might have had with respect to the sale process and the proceeds thereof, if any, to the Company. The transactions were timely completed, and on May 1, 2018, Trio took over operations in the seven facilities based primarily in the Dayton, Ohio area under a new 15-year master lease, while Hillstone Healthcare, Inc. (“Hillstone”) assumed the operation of the two facilities in Willard and Toledo, Ohio under a new 12-year master lease. In addition, amendments to the Bed Sales Agreements were subsequently executed, confirming the Company as the sole seller of the bed rights and the sole recipient of any proceeds therefrom. The aggregate annual base rent due under the new master leases with Trio and Hillstone is approximately $10.0 million, subject to CPI-based or fixed escalators.
Under the LTA, the Company agreed, upon Pristine’s full performance of the terms thereof, to terminate Pristine’s master lease and all future obligations of the tenant thereunder; however, under the terms of the master lease the Company’s security interest in Pristine’s accounts receivable has survived any such termination. Such security interest was subject to the prior lien and security interest of Pristine’s working capital lender, Capital One, National Association (“CONA”), with whom the Company has an existing intercreditor agreement that defines the relative rights and responsibilities of CONA and with its respect to the loan and lease collateral represented by Pristine’s accounts receivable and the Company’s respective security interests therein.
Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale
On September 1, 2019, the Company sold three of the seven skilled nursing properties in Ohio operated by Trillium under the Original Trillium Lease for a purchase price of $28.0 million. During the three months ended September 30, 2019 and prior to the disposition, the Company recorded an impairment expense of approximately $7.8 million. In connection with the sale, the Company provided affiliates of CommuniCare Family of Companies (“CommuniCare”), the purchaser of the three Ohio properties, with a mortgage loan secured by the three Ohio properties for approximately $26.5 million. See Note 4, Other Real Estate Investments, Net for additional information.
As of September 30, 2019, the Company met the criteria to classify six skilled nursing facilities operated by affiliates of Metron as held for sale, which resulted in an impairment expense of approximately $8.8 million to reduce the carrying value to fair value less costs to sell the properties. The fair values of the assets impaired during the three months ended September 30, 2019 were based on contractual sales prices, which are considered to be Level 2 measurements within the fair value hierarchy. As of December 31, 2019, the properties continued to be held for sale and the carrying value of $34.6 million was primarily comprised of real estate assets. In February 2020, the six skilled nursing facilities were sold. In connection with
the sale for $36.0 million, the Company received $3.5 million in cash and provided subsidiaries of Cascade Capital Group, LLC (“Cascade”), the purchaser of the properties, with a short-term mortgage loan secured by these properties for $32.4 million. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In connection with the sale, the Company recognized a loss of approximately $0.1 million during the three months ended March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between the Company and a third-party institutional lender as co-lenders, pursuant to which we received $18.9 million in cash and a new mortgage loan for $13.9 million. In July 2020, the Company received prepayment in full, including accrued interest, for the new $13.9 million mortgage loan. See Note 4, Other Real Estate Investments, Net, for further detail on the new mortgage loan.
On November 1, 2020, the Company sold the one remaining owned and operated independent living facility consisting of 168 units located in Texas with an aggregate carrying value of $4.2 million for gross proceeds of $4.5 million. In connection with the sale, the Company recognized a gain of $20,000.
During the year ended December 31, 2019, the Company sold one of its owned and operated independent living facilities consisting of 38 units located in Texas with an aggregate carrying value of $1.7 million for net proceeds of $3.3 million. In connection with the sale, the Company recognized a gain of $1.6 million.
During the year ended December 31, 2018, the Company sold three assisted living facilities consisting of 102 units located in Idaho with an aggregate carrying value of $10.9 million for an aggregate price of $13.0 million. In connection with the sale, the Company recognized a gain of $2.1 million.
During the fourth quarter of 2020, the Company met the criteria to classify one skilled nursing facility operated by affiliates of Five Oaks as held for sale. Assets held for sale includes the net book value of property the Company plans to sell within the next year. If the determination is made that the Company no longer expects to sell an asset within the next year, the asset is reclassified out of assets held for sale. As of December 31, 2020, the property continued to be held for sale and the carrying value of $7.2 million is primarily comprised of real estate assets. In February 2021, the property was sold. See Note 13, Subsequent Events, for additional information.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Other Real Estate Investments, Net
12 Months Ended
Dec. 31, 2020
Real Estate [Abstract]  
Other Real Estate Investments, Net OTHER REAL ESTATE INVESTMENTS, NET
Mezzanine Loan Receivable—In November 2020, the Company provided Next VA Star Realty Holdings, LLC a mezzanine loan for nine skilled nursing facilities secured by membership interests in affiliates of Next VA Star Realty Holdings, LLC for approximately $15.0 million, at an annual interest rate of 12%. The loan requires monthly interest payments, is set to mature on November 30, 2025, and may (subject to certain restrictions) be prepaid before the maturity date if paid in full and for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments equal to 24 months (less the amount of monthly interest payments made by the borrower through the date of prepayment).
Mortgage Loans Receivable—In October 2017, the Company provided an affiliate of Providence a mortgage loan secured by a skilled nursing facility for approximately $12.5 million inclusive of transaction costs, which bore a fixed interest rate of 9%. The mortgage loan, which required Providence to make monthly principal and interest payments, was set to mature on October 26, 2020 and had an option to be prepaid before the maturity date. During the three months ended December 31, 2019, Providence exercised its option to prepay the loan in full, and prepayment was received by the Company.
In February 2019, the Company provided affiliates of Covenant Care a mortgage loan secured by first mortgages on five skilled nursing facilities for approximately $11.4 million, at an annual interest rate of 9%. The loan required monthly interest payments, was set to mature on February 11, 2020, and included two, six-month extension options. During the three months ended September 30, 2019, Covenant Care exercised its option to prepay the loan in full, and prepayment was received by the Company.
In July 2019, the Company provided MCRC, LLC a real estate loan secured by a 176 bed skilled nursing facility in Manteca, California for $3.0 million, which bore a fixed interest rate of 8% and required monthly interest payments. Concurrently, the Company entered into a purchase and sale agreement to purchase the Manteca facility from MCRC, LLC for approximately $16.4 million subject to normal diligence and other contingencies. The loan documents provided for a maturity date of the earlier to occur of the closing date of the acquisition, or five business days following the termination of the purchase and sale agreement. MCRC, LLC breached its obligation to sell the Manteca facility to the Company on the terms outlined in the purchase and sale agreement and to repay the real estate loan upon its stated maturity. As a result, the Company commenced non-judicial foreclosure proceedings with respect to the Manteca facility. In January 2020, the borrower further collateralized the loan by causing one of its affiliates to grant the Company a deed of trust in the real estate and improvements that constitute
Palm Gardens Assisted Living Facility in Yolo County, California. During the three months ended June 30, 2020, payment for the loan principal and accrued interest, including default interest, as well as reimbursement for attorney’s fees and certain other costs of suit, were received in full by the Company and, as a result, the Company withdrew all foreclosure-related proceedings related to the Manteca facility loan.
In September 2019, the Company provided affiliates of CommuniCare a $26.5 million loan secured by mortgages on the three skilled nursing facilities sold to CommuniCare, which bore a fixed interest rate of 10%. The mortgage loan, which required CommuniCare to make monthly interest payments, was set to mature on February 29, 2020, and included an option to be prepaid before the maturity date. In January 2020, the Company amended the mortgage loan’s maturity date to April 30, 2020. In April 2020, the Company amended the mortgage loan’s maturity date to May 29, 2020. During the three months ended June 30, 2020, payment for the mortgage loan and accrued interest was received in full by the Company.
In February 2020, the Company provided provided subsidiaries of Cascade a $32.4 million loan secured by mortgages on the six skilled nursing facilities formerly operated by affiliates of Metron sold to Cascade in February 2020, as discussed in Note 3, Real Estate investments, Net. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between the Company and a third-party institutional lender as co-lenders, pursuant to which the Company received $18.9 million in cash and a new mortgage loan for $13.9 million. The new mortgage loan with Cascade was secured by the same six skilled nursing facilities purchased by Cascade and was for a combined principal amount of $33.9 million, with the Company’s $13.9 million portion of the indebtedness initially bearing interest at a variable rate equal to LIBOR plus 4.00%, subject to a LIBOR floor of 1.75%. The new mortgage loan had a maturity date of April 29, 2022 and included two six-month extension options. In July 2020, prepayment for the mortgage loan of $13.9 million and accrued interest was received in full by the Company.
As of December 31, 2020, the Company had no remaining mortgage loan receivables.
During the years ended December 31, 2020, 2019 and 2018, the Company recognized $2.3 million, $2.8 million and $1.2 million, respectively, of interest income related to the mortgage and mezzanine loans. During the years ended December 31, 2020, 2019 and 2018, the Company recognized $0.3 million, $0.2 million and $0.2 million, respectively, of interest income related to its other loans receivable.
Preferred Equity Investments—In July 2016, the Company completed a $2.2 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Nampa, Idaho. In connection with its investment, CareTrust REIT obtained an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the fourth quarter of 2017 and began lease-up during the first quarter of 2018. In June 2019, the Company purchased the skilled nursing facility for approximately $16.2 million, inclusive of transaction costs. The Company paid $12.9 million after receiving back its initial investment of $2.2 million and cumulative contractual preferred return through June 18, 2019, the acquisition date, of $1.1 million.
In September 2016, the Company completed a $2.3 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Boise, Idaho. In connection with its investment, CareTrust REIT obtained an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the first quarter of 2018 and began lease-up during the second quarter of 2018. In January 2020, the Company purchased the skilled nursing facility for approximately $18.7 million, inclusive of transaction costs. The Company paid $15.0 million after receiving back its initial investment of $2.3 million and cumulative contractual preferred return through January 17, 2020, the acquisition date, of $1.4 million.
During the years ended December 31, 2020, 2019 and 2018, the Company recognized less than $0.1 million, $1.3 million (including $0.6 million for unrecognized preferred return related to prior periods) and $0.2 million, respectively, of interest income related to these preferred equity investments.
As of December 31, 2020, the Company had no remaining preferred equity investments.
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. GAAP guidance defines three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.

Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.

The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and, depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. The Company does not expect that changes in classifications between levels will be frequent.
Items Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2020, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands):
Level 1Level 2Level 3Balance as of December 31, 2020
Assets:
Mezzanine loan receivable$— $— $15,000 $15,000 
Mezzanine loan receivable: The fair value of the mezzanine loan receivable was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. As such, the Company classifies the instrument as Level 3 due to the significant unobservable inputs used in determining market interest rates for investments with similar terms. However, the fair value is not sensitive to changes in market interest rates due to the recent issuance of the loan at market interest rates. Future changes in market interest rates could materially impact the estimated discounted cash flows. As of December 31, 2020, the Company did not have any loans that were 90 days or more past due.
For the year ended December 31, 2020, there were no changes in assets and liabilities with Level 3 inputs in the fair value hierarchy.
Items Measured at Fair Value on a Non-Recurring Basis
Real Estate Investments: The Company performs quarterly impairment review procedures, primarily through continuous monitoring of events and changes in circumstances that could indicate the carrying value of its real estate assets may not be recoverable. The Company estimates fair values using Level 3 inputs and uses a combined income and market approach. Specifically, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. For the year ended December 31, 2020, there were no real estate assets deemed to be impaired. For the year ended December 31, 2019, the Company recorded an impairment expense of $16.7 million. See Note 3, Real Estate Investments, Net, for additional information.
Items Disclosed at Fair Value
Considerable judgment is necessary to estimate the fair value disclosure of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020 and December 31, 2019 using Level 2 inputs for the Notes (as defined in Note 6, Debt, below), and Level 3 inputs, for all other financial instruments, is as follows (dollars in thousands):  
 December 31, 2020December 31, 2019
Face
Value
Carrying
Amount
Fair
Value
Face
Value
Carrying
Amount
Fair
Value
Financial assets:
Preferred equity investments$— $— $— $2,327 $3,800 $3,674 
Mortgage loans receivable— — — 29,500 29,500 29,500 
Financial liabilities:
Senior unsecured notes payable$300,000 $296,669 $311,430 $300,000 $295,911 $312,750 
Cash and cash equivalents, accounts and other receivables, other loans receivable, and accounts payable and accrued liabilities: These balances approximate their fair values due to the short-term nature of these instruments.
Preferred equity investments: The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements.
Mortgage loans receivable: The fair values of the mortgage loans receivable were estimated using an internal valuation model that considered the expected future cash flows of the investments, the underlying collateral value, market interest rates and other credit enhancements.
Senior unsecured notes payable: The fair value of the Notes (as defined in Note 6, Debt, below) was determined using third-party quotes derived from orderly trades.
Unsecured revolving credit facility and senior unsecured term loan: The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates for similar debt arrangements.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Debt
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Debt DEBT
The following table summarizes the balance of the Company’s indebtedness as of December 31, 2020 and 2019 (in thousands):
December 31, 2020December 31, 2019
PrincipalDeferredCarryingPrincipalDeferredCarrying
AmountLoan FeesValueAmountLoan FeesValue
Senior unsecured notes payable$300,000 $(3,331)$296,669 $300,000 $(4,089)$295,911 
Senior unsecured term loan200,000 (1,075)198,925 200,000 (1,287)198,713 
Unsecured revolving credit facility50,000 — 50,000 60,000 — 60,000 
$550,000 $(4,406)$545,594 $560,000 $(5,376)$554,624 
Senior Unsecured Notes Payable
On May 10, 2017, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed an underwritten public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The Company used the net proceeds from the offering of the Notes to redeem all $260.0 million aggregate principal amount outstanding of its 5.875% Senior Notes due 2021, including payment of
the redemption price at 102.938% and all accrued and unpaid interest thereon. The Company used the remaining portion of the net proceeds of the Notes offering to pay borrowings outstanding under its senior unsecured revolving credit facility. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2017.
As of June 1, 2020, the Issuers may redeem the Notes any time at the redemption prices set forth in the indenture. As of December 31, 2020, the Issuers have not elected to redeem any of the Notes. If certain changes of control of the Company occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.
The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and certain of the Company’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers); provided, however, that such guarantees are subject to automatic release under certain customary circumstances, including if the subsidiary guarantor is sold or sells all or substantially all of its assets, the subsidiary guarantor is designated “unrestricted” for covenant purposes under the indenture, the subsidiary guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied.
The indenture contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.
As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the indenture.

Unsecured Revolving Credit Facility and Term Loan
On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Prior Credit Agreement”). As later amended on February 1, 2016, the Prior Credit Agreement provided the following: (i) a $400.0 million unsecured asset based revolving credit facility (the “Prior Revolving Facility”), (ii) a $100.0 million non-amortizing unsecured term loan (the “Prior Term Loan” and, together with the Prior Revolving Facility, the “Prior Credit Facility”), and (iii) a $250.0 million uncommitted incremental facility. The Prior Revolving Facility was scheduled to mature on August 5, 2019, subject to two, six-month extension options. The Prior Term Loan was scheduled to mature on February 1, 2023 and could be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance.
On February 8, 2019, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries entered into an amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Amended Credit Agreement”). The Amended Credit Agreement, which amended and restated the Prior Credit Agreement, provides for: (i) an unsecured revolving credit facility (the “Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) an unsecured term loan credit facility (the “Term Loan” and, together with the Revolving Facility, the “Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Borrowing availability under the Revolving Facility is subject to no default or event of default under the Amended Credit Agreement having occurred at the time of borrowing. The proceeds of the Term Loan were used, in part, to repay in full all outstanding borrowings under the Prior Term Loan and Prior Revolving Facility under the Prior Credit Agreement. Future borrowings under the Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
The interest rates applicable to loans under the Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.10% to 0.55% per annum or LIBOR plus a margin ranging from 1.10% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or LIBOR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and its consolidated subsidiaries (unless the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based on the credit ratings of the Company’s senior long-term unsecured debt). As of December 31, 2020, the Operating Partnership had $200.0 million outstanding under the Term Loan and $50.0 million outstanding under the Revolving Facility.
The Revolving Facility has a maturity date of February 8, 2023, and includes, at the sole discretion of the Operating Partnership, two, six-month extension options. The Term Loan has a maturity date of February 8, 2026.
The Amended Credit Facility is guaranteed, jointly and severally, by the Company and its wholly owned subsidiaries that are party to the Amended Credit Agreement (other than the Operating Partnership). The Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend organizational documents and pay certain dividends and other restricted payments. The Amended Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio, a maximum secured recourse debt to asset value ratio, a maximum unsecured debt to unencumbered properties asset value ratio, a minimum unsecured interest coverage ratio and a minimum rent coverage ratio. The Amended Credit Agreement also contains certain customary events of default, including the failure to make timely payments under the Amended Credit Facility or other material indebtedness, the failure to satisfy certain covenants (including the financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency.
As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.
Schedule of Debt Maturities
As of December 31, 2020, the Company’s debt maturities were (dollars in thousands):  
Year
Amount
2021$— 
2022— 
202350,000 
2024— 
2025300,000 
Thereafter200,000 
 $550,000 
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Equity
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Equity EQUITY
Common Stock
Public Offering of Common Stock—On April 15, 2019, the Company completed an underwritten public offering of 6,641,250 shares of its common stock, par value $0.01 per share, at an initial price to the public of $23.35, including 866,250 shares of common stock sold pursuant to the full exercise of an option to purchase additional shares of common stock granted to the underwriters, resulting in approximately $149.0 million in net proceeds, after deducting the underwriting discount and offering expenses. The Company used the proceeds from the offering to repay a portion of the outstanding borrowings on its Revolving Facility, which had been used to fund a portion of the purchase price of acquisitions in the second quarter of 2019.
At-The-Market Offering—On March 10, 2020, the Company entered into a new equity distribution agreement to issue and sell, from time to time, up to $500.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “New ATM Program”). In connection with the entry into the equity distribution agreement and the commencement of the New ATM Program, the Company’s “at-the-market” equity offering program pursuant to the Company’s prior equity distribution agreement, dated as of March 4, 2019, was terminated (the “Prior ATM Program”).
There was no New ATM Program or Prior ATM Program activity (or activity under any predecessor at-the-market equity offering programs) for 2020. The following table summarizes predecessor at-the-market equity offering program activity for the year ended 2019 (in thousands, except per share amounts):
For the Year Ended December 31,
2019
Number of shares2,459 
Average sales price per share$19.48 
Gross proceeds(1)
$47,893 
(1)    Total gross proceeds is before $0.6 million of commissions paid to the sales agents during the year ended December 31, 2019 under the predecessor ATM Program.
As of December 31, 2020, the Company had $500.0 million available for future issuances under the New ATM Program.
Share Repurchase Program — On March 20, 2020, the Company’s Board of Directors authorized a share repurchase program up to $150.0 million of outstanding shares of the Company’s common stock (the “Repurchase Program”). Repurchases under the Repurchase Program, which expires on March 31, 2023, may be made through open market purchases, privately negotiated transactions, structured or derivative transactions, including accelerated share repurchase transactions, or other methods of acquiring shares, in each case subject to market conditions and at such times as shall be permitted by applicable securities laws and determined by management. Repurchases under the Repurchase Program may also be made pursuant to a plan adopted under Rule 10b5-1 promulgated under the Exchange Act. The Company expects to finance any share repurchases under the Repurchase Program using available cash and may also use short-term borrowings under the Revolving Facility. The Company did not repurchase any shares of common stock under the Repurchase Program during the year ended December 31, 2020. The Repurchase Program may be modified, discontinued or suspended at any time.
Dividends on Common Stock — The following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2020, 2019 and 2018 (dollars in thousands, except per share amounts):
For the Three Months Ended
2020March 31,June 30,September 30,December 31,
Dividends declared$0.25 $0.25 $0.25 $0.25 
Dividends payment dateApril 15, 2020July 15, 2020October 15, 2020January 15, 2021
Dividends payable as of record date$23,931 $23,931 $23,934 $23,933 
Dividends record dateMarch 31, 2020June 30, 2020September 30, 2020December 31, 2020
2019
Dividends declared$0.225 $0.225 $0.225 $0.225 
Dividends payment dateApril 15, 2019July 15, 2019October 15, 2019January 15, 2020
Dividends payable as of record date$20,011 $21,508 $21,500 $21,500 
Dividends record dateMarch 29, 2019June 28, 2019September 30, 2019December 31, 2019
2018
Dividends declared$0.205 $0.205 $0.205 $0.205 
Dividends payment dateApril 13, 2018July 13, 2018October 15, 2018January 15, 2019
Dividends payable as of record date$15,608 $16,224 $17,196 $17,710 
Dividends record dateMarch 30, 2018June 29, 2018September 28, 2018December 31, 2018
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation STOCK-BASED COMPENSATION
All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company.
The following table summarizes restricted stock award and performance award activity for the years ended December 31, 2020 and 2019:
SharesWeighted Average Share Price
Unvested balance at December 31, 2018519,272 $14.69 
Granted180,629 22.22 
Vested(247,534)14.50 
Forfeited(134)15.21 
Unvested balance at December 31, 2019452,233 17.90 
Granted270,191 19.11 
Vested(201,563)17.41 
Forfeited(3,175)20.30 
Unvested balance at December 31, 2020517,686 $18.71 

The following table summarizes the stock-based compensation expense recognized (dollars in thousands):
 For Year Ended December 31,
 202020192018
Stock-based compensation expense$3,790 $4,104 $3,848 
As of December 31, 2020, there was $5.5 million of unamortized stock-based compensation expense related to these unvested awards and the weighted-average remaining vesting period of such awards was 2.3 years. 
In connection with the separation of Ensign’s healthcare business and its real estate business into two separate and independently publicly traded companies (the “Spin-Off”) on June 1, 2014, employees of Ensign who had unvested shares of restricted stock were given one share of CareTrust REIT unvested restricted stock totaling 207,580 shares at the Spin-Off. These restricted shares were subject to a time vesting provision only and the Company did not recognize any stock compensation expense associated with these awards. During the year ended December 31, 2020, 1,760 shares were forfeited. At December 31, 2020, there were no unvested restricted stock awards outstanding.
In January 2020 and March 2020, the Compensation Committee of the Company’s Board of Directors granted 27,000 and 107,790 shares of restricted stock, respectively, to officers and employees. Each share had a fair market value on the date of grant of $22.18 and $19.06 per share, respectively, based on the closing market price of the Company’s common stock on that date, and the shares vest in four equal installments beginning on the first anniversary of the grant date. Additionally, in March 2020, the Compensation Committee granted 107,790 performance stock awards to officers. Each share had a fair market value on the date of grant of $19.06 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a one-to four-year period. The amount of performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding a fixed per share amount.
In April 2020, the Compensation Committee of the Company’s Board of Directors granted 27,611 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $16.48 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in full on the earlier to occur of April 29, 2021 or the Company’s 2021 Annual Meeting of Stockholders.
In February 2019, the Compensation Committee of the Company’s Board of Directors granted 91,440 shares of restricted stock to officers and employees. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in four equal annual installments beginning on the first anniversary of the grant date. Additionally, in February 2019, the Compensation Committee granted 71,440 performance stock awards to officers. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a one- to four-year period. The amount of performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding fiscal year over year growth of 5.0% or greater.
In May 2019, the Compensation Committee of the Company's Board of Directors granted 17,749 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $24.23 per share, based on the closing market price of the Company's common stock on that date, and the shares vested in full on April 30, 2020.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Common Share
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Common Share EARNINGS PER COMMON SHARE
The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the years ended December 31, 2020, 2019 and 2018, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the years ended December 31, 2020, 2019 and 2018 (amounts in thousands, except per share amounts):
 
 Year Ended December 31,
 202020192018
Numerator:
Net income$80,867 $46,359 $57,923 
Less: Net income allocated to participating securities(298)(296)(364)
Numerator for basic and diluted earnings available to common stockholders$80,569 $46,063 $57,559 
Denominator:
Weighted-average basic common shares outstanding95,200 93,088 79,386 
   Dilutive performance stock awards10 
Weighted-average diluted common shares outstanding95,207 93,098 79,392 
Earnings per common share, basic$0.85 $0.49 $0.73 
Earnings per common share, diluted$0.85 $0.49 $0.72 
The Company’s unvested restricted shares associated with its incentive award plan and unvested restricted shares issued to employees of Ensign at the Spin-Off have been excluded from the above calculation of earnings per share for the years ended December 31, 2020, 2019 and 2018, when their inclusion would have been anti-dilutive.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies
12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies COMMITMENTS AND CONTINGENCIES The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which are not individually or in the aggregate anticipated to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. Claims and lawsuits may include matters involving general or professional liability asserted against the Company’s tenants, which are the responsibility of the Company’s tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.Capital expenditures for each property leased under the Company’s triple-net leases are generally the responsibility of the tenant, except that, for the facilities leased to subsidiaries of Ensign, under the Ensign Master Leases, and The Pennant Group, Inc., the tenant will have an option to require the Company to finance certain capital expenditures up to an aggregate of 20% of its initial investment in such property, subject to a corresponding rent increase at the time of funding. For the Company’s other triple-net master leases, the tenants also have the option to request capital expenditure funding that would generally be subject to a corresponding rent increase at the time of funding, which are subject to tenant compliance with the conditions to the Company’s approval and funding of their requests. As of December 31, 2020, the Company had committed to fund expansions, construction and capital improvements at certain triple-net leased facilities totaling $15.4 million, of which $14.2 million is subject to rent increase at the time of funding.
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Concentration of Risk
12 Months Ended
Dec. 31, 2020
Risks and Uncertainties [Abstract]  
Concentration of Risk CONCENTRATION OF RISKMajor operator concentration – As of December 31, 2020, Ensign leased 89 skilled nursing, assisted living and independent living facilities which had a total of 9,546 beds and units and are located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Texas, Utah and Washington. The four states in which Ensign leases the highest concentration of properties are Texas, California, Arizona and Utah. During the years ended December 31, 2020, 2019 and 2018, Ensign represented 32%, 38% and 42%, respectively, of the Company’s rental income, exclusive of operating expense reimbursements. On October 1, 2019, Ensign completed the Pennant Spin. See Note 3, Real Estate Investments, Net, for additional information regarding the Company’s facilities leased to Ensign subsequent to the Pennant Spin.Ensign is subject to the registration and reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s financial statements, as filed with the SEC, can be found at http://www.sec.gov. The Company has not verified this information through an independent investigation or otherwise. As of December 31, 2020, PMG leased 15 skilled nursing facilities which had a total of 2,145 beds and units and are located in Louisiana and Texas. During the years ended December 31, 2020, 2019 and 2018, PMG represented 16%, 15% and 8%, respectively, of the Company’s rental income, exclusive of operating expense reimbursements.
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Selected Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Selected Quarterly Financial Data (Unaudited) SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)
The following table presents selected quarterly financial data for the Company. This information has been prepared on a basis consistent with that of the Company’s audited consolidated financial statements. The Company’s quarterly results of operations for the periods presented are not necessarily indicative of future results of operations. This unaudited quarterly data should be read together with the accompanying consolidated financial statements and related notes thereto (in thousands, except per share amounts):
 For the Year Ended December 31, 2020
 First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Operating data:
Total revenues$44,340 $44,168 $45,687 $44,137 
Net income$19,325 $18,935 $21,552 $21,055 
Earnings per common share, basic$0.20 $0.20 $0.23 $0.22 
Earnings per common share, diluted$0.20 $0.20 $0.23 $0.22 
Other data:
Weighted-average number of common shares outstanding, basic95,161 95,208 95,214 95,215 
Weighted-average number of common shares outstanding, diluted95,161 95,208 95,214 95,244 
 For the Year Ended December 31, 2019
 First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Operating data:
Total revenues$39,658 $46,201 $33,314 $44,228 
Net income (loss)$16,053 $19,698 $(10,054)$20,662 
Earnings per common share, basic$0.18 $0.21 $(0.11)$0.22 
Earnings per common share, diluted$0.18 $0.21 $(0.11)$0.22 
Other data:
Weighted-average number of common shares outstanding, basic88,010 94,036 95,103 95,103 
Weighted-average number of common shares outstanding, diluted88,010 94,036 95,103 95,144 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Subsequent Events
12 Months Ended
Dec. 31, 2020
Subsequent Events [Abstract]  
Subsequent Events SUBSEQUENT EVENTS
The Company evaluates subsequent events in accordance with ASC 855, Subsequent Events. The Company evaluates subsequent events up until the date the consolidated financial statements are issued.
Asset Sale
On February 1, 2021, the Company closed on the sale of one skilled nursing facility consisting of 90 units located in Washington with a carrying value of $7.2 million, for gross sales proceeds of $7.3 million. The Company does not expect to record a material gain or loss in connection with the sale. The facility was classified as held for sale as of December 31, 2020.
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule III - Real Estate Assets and Accumulated Depreciation
12 Months Ended
Dec. 31, 2020
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]  
Schedule III - Real Estate Assets and Accumulated Depreciation
Initial Cost to Company Gross Carrying Value
DescriptionFacilityLocationEncum.LandBuilding
Improvs.
Costs
Cap.
Since
Acq.
LandBuilding
Improvs.
Total (1)Accum. Depr.Const./Ren. DateAcq.
Date
Skilled Nursing Properties:
Ensign Highland LLCHighland ManorPhoenix, AZ$— $257 $976 $926 $257 $1,902 $2,159 $(1,311)20132000
Meadowbrook Health Associates LLCSabino CanyonTucson, AZ— 425 3,716 1,940 425 5,656 6,081 (3,103)20122000
Terrace Holdings AZ LLCDesert TerracePhoenix, AZ— 113 504 971 113 1,475 1,588 (865)20042002
Rillito Holdings LLCCatalinaTucson, AZ— 471 2,041 3,055 471 5,096 5,567 (3,029)20132003
Valley Health Holdings LLCNorth MountainPhoenix, AZ— 629 5,154 1,519 629 6,673 7,302 (3,801)20092004
Cedar Avenue Holdings LLCUplandUpland, CA— 2,812 3,919 1,994 2,812 5,913 8,725 (3,475)20112005
Granada Investments LLCCamarilloCamarillo, CA— 3,526 2,827 1,522 3,526 4,349 7,875 (2,595)20102005
Plaza Health Holdings LLCPark ManorWalla Walla, WA— 450 5,566 1,055 450 6,621 7,071 (3,878)20092006
Mountainview Communitycare LLCPark View GardensSanta Rosa, CA— 931 2,612 653 931 3,265 4,196 (2,082)19632006
CM Health Holdings LLCCarmel MountainSan Diego, CA— 3,028 3,119 2,071 3,028 5,190 8,218 (2,981)20122006
Polk Health Holdings LLCTimberwoodLivingston, TX— 60 4,391 1,167 60 5,558 5,618 (3,116)20092006
Snohomish Health Holdings LLCEmerald HillsLynnwood, WA— 741 1,663 1,998 741 3,661 4,402 (2,564)20092006
Cherry Health Holdings LLCPacific CareHoquiam, WA— 171 1,828 2,038 171 3,866 4,037 (2,525)20102006
Golfview Holdings LLCCambridge SNFRichmond, TX— 1,105 3,110 1,067 1,105 4,177 5,282 (2,246)20072006
Tenth East Holdings LLCArlington HillsSalt Lake City, UT— 332 2,426 2,507 332 4,933 5,265 (3,054)20132006
Trinity Mill Holdings LLCCarrolltonCarrollton, TX— 664 2,294 902 664 3,196 3,860 (2,262)20072006
Cottonwood Health Holdings LLCHolladaySalt Lake City, UT— 965 2,070 958 965 3,028 3,993 (2,275)20082007
Verde Villa Holdings LLCLake VillageLewisville, TX— 600 1,890 470 600 2,360 2,960 (1,438)20112007
Mesquite Health Holdings LLCWillow BendMesquite, TX— 470 1,715 8,661 470 10,376 10,846 (7,112)20122007
Arrow Tree Health Holdings LLCArbor GlenGlendora, CA— 2,165 1,105 324 2,165 1,429 3,594 (1,010)19652007
Fort Street Health Holdings LLCDraperDraper, UT— 443 2,394 759 443 3,153 3,596 (1,603)20082007
Trousdale Health Holdings LLCBrookfieldDowney, CA— 1,415 1,841 1,861 1,415 3,702 5,117 (2,052)20132007
Ensign Bellflower LLCRose VillaBellflower, CA— 937 1,168 357 937 1,525 2,462 (925)20092007
RB Heights Health Holdings LLCOsbornScottsdale, AZ— 2,007 2,793 1,762 2,007 4,555 6,562 (2,528)20092008
San Corrine Health Holdings LLCSalado CreekSan Antonio, TX— 310 2,090 719 310 2,809 3,119 (1,456)20052008
Temple Health Holdings LLCWellingtonTemple, TX— 529 2,207 1,163 529 3,370 3,899 (1,806)20082008
Anson Health Holdings LLCNorthern OaksAbilene, TX— 369 3,220 1,725 369 4,945 5,314 (2,544)20122008
Willits Health Holdings LLCNorthbrookWillits, CA— 490 1,231 500 490 1,731 2,221 (889)20112008
Lufkin Health Holdings LLCSouthlandLufkin, TX— 467 4,644 782 467 5,426 5,893 (1,630)19882009
Lowell Health Holdings LLCLittletonLittleton, CO— 217 856 1,735 217 2,591 2,808 (1,421)20122009
Jefferson Ralston Holdings LLCArvadaArvada, CO— 280 1,230 834 280 2,064 2,344 (920)20122009
Lafayette Health Holdings LLCJulia TempleEnglewood, CO— 1,607 4,222 6,195 1,607 10,417 12,024 (5,021)20122009
Hillendahl Health Holdings LLCGolden AcresDallas, TX— 2,133 11,977 1,421 2,133 13,398 15,531 (5,530)19842009
Price Health Holdings LLCPinnaclePrice, UT— 193 2,209 849 193 3,058 3,251 (1,102)20122009
Silver Lake Health Holdings LLCProvoProvo, UT— 2,051 8,362 2,011 2,051 10,373 12,424 (3,208)20112009
Jordan Health Properties LLCCopper RidgeWest Jordan, UT— 2,671 4,244 1,507 2,671 5,751 8,422 (1,817)20132009
Regal Road Health Holdings LLCSunviewYoungstown, AZ— 767 4,648 729 767 5,377 6,144 (2,063)20122009
Paredes Health Holdings LLCAlta VistaBrownsville, TX— 373 1,354 190 373 1,544 1,917 (464)19692009
Expressway Health Holdings LLCVerandaHarlingen, TX— 90 675 430 90 1,105 1,195 (455)20112009
Rio Grande Health Holdings LLCGrand TerraceMcAllen, TX— 642 1,085 870 642 1,955 2,597 (934)20122009
Fifth East Holdings LLCParamountSalt Lake City, UT— 345 2,464 1,065 345 3,529 3,874 (1,355)20112009
Emmett Healthcare Holdings LLCRiver's EdgeEmmet, ID— 591 2,383 69 591 2,452 3,043 (801)19722010
Burley Healthcare Holdings LLCParke ViewBurley, ID— 250 4,004 424 250 4,428 4,678 (1,589)20112010
Josey Ranch Healthcare Holdings LLCHeritage GardensCarrollton, TX— 1,382 2,293 478 1,382 2,771 4,153 (934)19962010
Everglades Health Holdings LLCVictoria VenturaVentura, CA— 1,847 5,377 682 1,847 6,059 7,906 (1,667)19902011
Irving Health Holdings LLCBeatrice ManorBeatrice, NE— 60 2,931 245 60 3,176 3,236 (1,063)20112011
Falls City Health Holdings LLCCareage Estates of Falls CityFalls City, NE— 170 2,141 82 170 2,223 2,393 (677)19722011
Gillette Park Health Holdings LLCCareage of CherokeeCherokee, IA— 163 1,491 12 163 1,503 1,666 (576)19672011
Gazebo Park Health Holdings LLCCareage of ClarionClarion, IA— 80 2,541 97 80 2,638 2,718 (1,052)19782011
Oleson Park Health Holdings LLCCareage of Ft. DodgeFt. Dodge, IA— 90 2,341 759 90 3,100 3,190 (1,527)20122011
Arapahoe Health Holdings LLCOceanviewTexas City, TX— 158 4,810 759 128 5,599 5,727 (2,030)20122011
Dixie Health Holdings LLCHurricaneHurricane, UT— 487 1,978 98 487 2,076 2,563 (525)19782011
Memorial Health Holdings LLCPocatelloPocatello, ID— 537 2,138 698 537 2,836 3,373 (1,077)20072011
Bogardus Health Holdings LLCWhittier EastWhittier, CA— 1,425 5,307 1,079 1,425 6,386 7,811 (2,258)20112011
South Dora Health Holdings LLCUkiahUkiah, CA— 297 2,087 1,621 297 3,708 4,005 (2,096)20132011
Silverada Health Holdings LLCRosewoodReno, NV— 1,012 3,282 103 1,012 3,385 4,397 (803)19702011
Orem Health Holdings LLCOremOrem, UT— 1,689 3,896 3,235 1,689 7,131 8,820 (2,940)20112011
Wisteria Health Holdings LLCWisteriaAbilene, TX— 746 9,903 290 746 10,193 10,939 (2,267)20082011
Renee Avenue Health Holdings LLCMonte VistaPocatello, ID— 180 2,481 966 180 3,447 3,627 (1,219)20132012
Stillhouse Health Holdings LLCStillhouseParis, TX— 129 7,139 129 7,145 7,274 (1,079)20092012
Fig Street Health Holdings LLCPalomar VistaEscondido, CA— 329 2,653 1,094 329 3,747 4,076 (1,627)20072012
Lowell Lake Health Holdings LLCOwyheeOwyhee, ID— 49 1,554 29 49 1,583 1,632 (312)19902012
Queensway Health Holdings LLCAtlantic MemorialLong Beach, CA— 999 4,237 2,331 999 6,568 7,567 (2,886)20082012
Long Beach Health Associates LLCShorelineLong Beach, CA— 1,285 2,343 2,172 1,285 4,515 5,800 (1,943)20132012
Kings Court Health Holdings LLCRichland HillsFt. Worth, TX— 193 2,311 318 193 2,629 2,822 (635)19652012
51st Avenue Health Holdings LLCLegacyAmarillo, TX— 340 3,925 32 340 3,957 4,297 (895)19702013
Ives Health Holdings LLCSan MarcosSan Marcos, TX— 371 2,951 274 371 3,225 3,596 (697)19722013
Guadalupe Health Holdings LLCThe Courtyard (Victoria East)Victoria, TX— 80 2,391 15 80 2,406 2,486 (422)20132013
49th Street Health Holdings LLCOmahaOmaha, NE— 129 2,418 24 129 2,442 2,571 (629)19602013
Willows Health Holdings LLCCascade VistaRedmond, WA— 1,388 2,982 202 1,388 3,184 4,572 (909)19702013
Tulalip Bay Health Holdings LLCMountain ViewMarysville, WA— 1,722 2,642 (980)742 2,642 3,384 (660)19662013
Sky Holdings AZ LLCBella Vita Health and Rehabilitation CenterGlendale, AZ— 228 1,124 1,380 228 2,504 2,731 (1,727)20042002
Lemon River Holdings LLCPlymouth TowerRiverside, CA— 152 357 1,493 152 1,850 2,002 (1,163)20122009
CTR Partnership, L.P.Bethany Rehabilitation CenterLakewood, CO— 1,668 15,375 56 1,668 15,431 17,099 (2,285)19892015
CTR Partnership, L.P.Mira Vista Care CenterMount Vernon, WA— 1,601 7,425 — 1,601 7,425 9,026 (1,067)19892015
CTR Partnership, L.P.Shoreline Health and Rehabilitation CenterShoreline, WA— 1,462 5,034 — 1,462 5,034 6,496 (703)19872015
CTR Partnership, L.P.Shamrock Nursing and Rehabilitation CenterDublin, GA— 251 7,855 — 251 7,855 8,106 (1,080)20102015
CTR Partnership, L.P.BeaverCreek Health and RehabBeavercreek, OH— 892 17,159 13 892 17,172 18,064 (2,254)20142015
CTR Partnership, L.P.Premier Estates of Cincinnati-RiverviewCincinnati, OH— 833 18,086 192 833 18,278 19,111 (2,416)19922015
CTR Partnership, L.P.Englewood Health and RehabEnglewood, OH— 1,014 18,541 88 1,014 18,629 19,643 (2,464)19622015
CTR Partnership, L.P.Portsmouth Health and RehabPortsmouth, OH— 282 9,726 428 282 10,154 10,436 (1,400)20082015
CTR Partnership, L.P.West Cove Care & Rehabilitation CenterToledo, OH— 93 10,365 — 93 10,365 10,458 (1,360)20072015
CTR Partnership, L.P.BellBrook Health and RehabBellbrook, OH— 214 2,573 231 214 2,804 3,018 (385)20032015
CTR Partnership, L.P.Xenia Health and RehabXenia, OH— 205 3,564 23 205 3,587 3,792 (471)19812015
CTR Partnership, L.P.Jamestown Place Health and RehabJamestown, OH— 266 4,725 268 266 4,993 5,259 (694)19672015
CTR Partnership, L.P.Casa de PazSioux City, IA— 119 7,727 — 119 7,727 7,846 (950)19742016
CTR Partnership, L.P.Denison Care CenterDenison, IA— 96 2,784 — 96 2,784 2,880 (342)20152016
CTR Partnership, L.P.Garden View Care CenterShenandoah, IA— 105 3,179 — 105 3,179 3,284 (391)20132016
CTR Partnership, L.P.Grandview Health Care CenterDayton, IA— 39 1,167 — 39 1,167 1,206 (143)20142016
CTR Partnership, L.P.Grundy Care CenterGrundy Center, IA— 65 1,935 — 65 1,935 2,000 (238)20112016
CTR Partnership, L.P.Iowa City Rehab and Health Care CenterIowa City, IA— 522 5,690 — 522 5,690 6,212 (699)20142016
CTR Partnership, L.P.Lenox Care CenterLenox, IA— 31 1,915 — 31 1,915 1,946 (235)20122016
CTR Partnership, L.P.OsageOsage, IA— 126 2,255 — 126 2,255 2,381 (277)20142016
CTR Partnership, L.P.Pleasant Acres Care CenterHull, IA— 189 2,544 — 189 2,544 2,733 (313)20142016
CTR Partnership, L.P.Cedar Falls Health Care CenterCedar Falls, IA— 324 4,366 — 324 4,366 4,690 (518)20152016
CTR Partnership, L.P.Premier Estates of HighlandsNorwood, OH— 364 2,199 282 364 2,481 2,845 (293)20122016
CTR Partnership, L.P.Shaw Mountain at CascadiaBoise, ID— 1,801 6,572 395 1,801 6,967 8,768 (908)19892016
CTR Partnership, L.P.The OaksPetaluma, CA— 3,646 2,873 110 3,646 2,983 6,629 (353)20152016
CTR Partnership, L.P.Arbor Nursing CenterLodi, CA— 768 10,712 — 768 10,712 11,480 (1,183)19822016
CTR Partnership, L.P.Broadmoor Medical LodgeRockwall, TX— 1,232 22,152 — 1,232 22,152 23,384 (2,262)19842016
CTR Partnership, L.P.Decatur Medical LodgeDecatur, TX— 990 24,909 — 990 24,909 25,899 (2,543)20132016
CTR Partnership, L.P.Royse City Medical LodgeRoyse City, TX— 606 14,660 — 606 14,660 15,266 (1,497)20092016
CTR Partnership, L.P.Saline Care Nursing & Rehabilitation CenterHarrisburg, IL— 1,022 5,713 — 1,022 5,713 6,735 (547)20092017
CTR Partnership, L.P.Carrier Mills Nursing & Rehabilitation CenterCarrier Mills, IL— 775 8,377 — 775 8,377 9,152 (803)19682017
CTR Partnership, L.P.StoneBridge Nursing & Rehabilitation CenterBenton, IL— 439 3,475 — 439 3,475 3,914 (333)20142017
CTR Partnership, L.P.DuQuoin Nursing & Rehabilitation CenterDuQuoin, IL— 511 3,662 — 511 3,662 4,173 (351)20142017
CTR Partnership, L.P.Pinckneyville Nursing & Rehabilitation CenterPinckneyville, IL— 406 3,411 — 406 3,411 3,817 (327)20142017
CTR Partnership, L.P.Wellspring Health and Rehabilitation of CascadiaNampa, ID— 774 5,044 111 774 5,155 5,929 (462)20112017
CTR Partnership, L.P.The Rio at Fox HollowBrownsville, TX— 1,178 12,059 — 1,178 12,059 13,237 (1,080)20162017
CTR Partnership, L.P.The Rio at CabezonAlbuquerque, NM— 2,055 9,749 — 2,055 9,749 11,804 (873)20162017
CTR Partnership, L.P.Eldorado Rehab & HealthcareEldorado, IL— 940 2,093 — 940 2,093 3,033 (183)19932017
CTR Partnership, L.P.Secora Health and Rehabilitation of CascadiaPortland, OR— 1,481 2,216 110 1,481 2,326 3,807 (194)20122017
CTR Partnership, L.P.Mountain ValleyKellogg, ID— 916 7,874 — 916 7,874 8,790 (656)19712017
CTR Partnership, L.P.Caldwell CareCaldwell, ID— 906 7,020 516 906 7,536 8,442 (585)19472017
CTR Partnership, L.P.Canyon WestCaldwell, ID— 312 10,410 431 312 10,841 11,153 (868)19692017
CTR Partnership, L.P.Lewiston Health and RehabilitationLewiston, ID— 625 12,087 152 625 12,239 12,864 (982)19642017
CTR Partnership, L.P.The OrchardsNampa, ID— 785 8,923 47 785 8,970 9,755 (725)19582017
CTR Partnership, L.P.Weiser CareWeiser, ID— 80 4,419 30 80 4,449 4,529 (359)19642017
CTR Partnership, L.P.Aspen ParkMoscow, ID— 698 5,092 274 698 5,366 6,064 (438)19652017
CTR Partnership, L.P.Ridgmar Medical LodgeFort Worth, TX— 681 6,587 1,256 681 7,843 8,524 (702)20062017
CTR Partnership, L.P.Mansfield Medical LodgeMansfield, TX— 607 4,801 1,178 607 5,979 6,586 (513)20062017
CTR Partnership, L.P.Grapevine Medical LodgeGrapevine, TX— 1,602 4,536 891 1,602 5,427 7,029 (486)20062017
CTR Partnership, L.P.Brookfield Health and RehabBattle Ground, WA— 320 500 — 320 500 820 (42)20122017
CTR Partnership, L.P.The Oaks at LakewoodTacoma, WA— 1,000 1,779 — 1,000 1,779 2,779 (145)19892017
CTR Partnership, L.P.The Oaks at TimberlineVancouver, WA— 445 869 — 445 869 1,314 (71)19722017
CTR Partnership, L.P.Providence Waterman Nursing CenterSan Bernardino, CA— 3,831 19,791 — 3,831 19,791 23,622 (1,608)19672017
CTR Partnership, L.P.Providence Orange TreeRiverside, CA— 2,897 14,700 — 2,897 14,700 17,597 (1,194)19692017
CTR Partnership, L.P.Providence OntarioOntario, CA— 4,204 21,880 — 4,204 21,880 26,084 (1,778)19802017
CTR Partnership, L.P.Greenville Nursing & Rehabilitation CenterGreenville, IL— 188 3,972 — 188 3,972 4,160 (366)19732017
CTR Partnership, L.P.Copper Ridge Health and Rehabilitation CenterButte, MT— 220 4,974 — 220 4,974 5,194 (398)20102018
CTR Partnership, L.P.Prairie Heights Healthcare CenterAberdeen, SD— 1,372 7,491 — 1,372 7,491 8,863 (510)19652018
CTR Partnership, L.P.The Meadows on UniversityFargo, ND— 989 3,275 — 989 3,275 4,264 (196)19662018
CTR Partnership, L.P.The Suites - ParkerParker, CO— 1,178 17,857 — 1,178 17,857 19,035 (952)20122018
CTR Partnership, L.P.Huntington Park Nursing CenterHuntington Park, CA— 3,131 8,876 299 3,131 9,175 12,306 (464)19552019
CTR Partnership, L.P.Shoreline Care CenterOxnard, CA— 1,699 9,004 — 1,699 9,004 10,703 (443)19622019
CTR Partnership, L.P.Downey Care CenterDowney, CA— 2,502 6,141 — 2,502 6,141 8,643 (303)19672019
CTR Partnership, L.P.Courtyard Healthcare CenterDavis, CA— 2,351 9,256 — 2,351 9,256 11,607 (464)19692019
Gulf Coast Buyer 1 LLCAlpine Skilled Nursing and RehabilitationRuston, LA— 2,688 23,825 — 2,688 23,825 26,513 (1,100)20142019
Gulf Coast Buyer 1 LLCThe Bradford Skilled Nursing and RehabilitationShreveport, LA— 3,758 21,325 17 3,758 21,342 25,100 (992)19802019
Gulf Coast Buyer 1 LLCColonial Oaks Skilled Nursing and RehabilitationBossier City, LA— 1,635 21,180 — 1,635 21,180 22,815 (954)20132019
Gulf Coast Buyer 1 LLCThe Guest House Skilled Nursing and RehabilitationShreveport, LA— 3,437 20,889 184 3,437 21,073 24,510 (984)20062019
Gulf Coast Buyer 1 LLCPilgrim Manor Skilled Nursing and RehabilitationBossier City, LA— 2,979 24,617 — 2,979 24,617 27,596 (1,123)20082019
Gulf Coast Buyer 1 LLCShreveport Manor Skilled Nursing and RehabilitationShreveport, LA— 676 10,238 361 676 10,599 11,275 (481)20082019
Gulf Coast Buyer 1 LLCBooker T. Washington Skilled Nursing and RehabilitationShreveport, LA— 2,452 9,148 113 2,452 9,261 11,713 (447)20132019
Gulf Coast Buyer 1 LLCLegacy West Rehabilitation and HealthcareCorsicana, TX— 120 6,682 409 120 7,091 7,211 (340)20022019
Gulf Coast Buyer 1 LLCLegacy at JacksonvilleJacksonville, TX— 173 7,481 127 173 7,608 7,781 (369)20062019
Gulf Coast Buyer 1 LLCPecan Tree Rehabilitation and HealthcareGainesville, TX— 219 10,097 285 219 10,382 10,601 (481)19902019
Lakewest SNF Realty, LLCLakewest Rehabilitation and Skilled CareDallas, TX— — 6,905 — — 6,905 6,905 (322)20112019
CTR Partnership, L.P.Cascadia of NampaNampa, ID— 880 14,117 — 880 14,117 14,997 (594)20172019
CTR Partnership, L.P.Valley Skilled NursingModesto, CA— 798 7,671 — 798 7,671 8,469 (249)20162019
CTR Partnership, L.P.Cascadia of BoiseBoise, ID— 1,597 15,692 — 1,597 15,692 17,289 (412)20182020
CTR Partnership, L.P.Cooney Healthcare and RehabilitationHelena, MT— 867 7,431 — 867 7,431 8,298 (65)19842020
CTR Partnership, L.P.Elkhorn Healthcare and RehabilitationClancy, MT— 183 7,380 — 183 7,380 7,563 (66)19602020
CTR Partnership, L.P.Beacon Harbor Healthcare and RehabilitationRockwall, TX— 1,295 17,069 — 1,295 17,069 18,364 (76)19962020
CTR Partnership, L.P.Pleasant Manor Healthcare and RehabilitationWaxahachie, TX— 629 7,433 — 629 7,433 8,062 (33)19722020
CTR Partnership, L.P.Rowlett Health and Rehabilitation CenterRowlett, TX— 1,036 10,516 — 1,036 10,516 11,552 (47)19902020
— 145,155 963,927 92,226 144,145 1,057,163 1,201,307 (194,390)
Multi-Service Campus Properties:
Ensign Southland LLCSouthland CareNorwalk, CA— 966 5,082 2,213 966 7,295 8,261 (5,292)20111999
Mission CCRC LLCSt. Joseph's VillaSalt Lake City, UT— 1,962 11,035 464 1,962 11,499 13,461 (3,327)19942011
Wayne Health Holdings LLCCareage of WayneWayne, NE— 130 3,061 122 130 3,183 3,313 (994)19782011
4th Street Holdings LLCWest Bend Care CenterWest Bend, IA— 180 3,352 — 180 3,352 3,532 (991)20062011
Big Sioux River Health Holdings LLCHillcrest HealthHawarden, IA— 110 3,522 75 110 3,597 3,707 (998)19742011
Prairie Health Holdings LLCColonial Manor of RandolphRandolph, NE— 130 1,571 22 130 1,593 1,723 (758)20112011
Salmon River Health Holdings LLCDiscovery Care CenterSalmon, ID— 168 2,496 — 168 2,496 2,664 (525)20122012
CTR Partnership, L.P.Centerville Senior Independent LivingDayton, OH— 3,912 22,458 117 3,781 22,706 26,487 (3,018)20072015
CTR Partnership, L.P.Liberty Nursing Center of WillardWillard, OH— 143 11,097 50 143 11,147 11,290 (1,477)19852015
CTR Partnership, L.P.Premier Estates of Middletown/Premier Retirement Estates of MiddletownMiddletown, OH— 990 7,484 172 990 7,656 8,646 (1,025)19852015
CTR Partnership, L.P.Premier Estates of Norwood Towers/Premier Retirement Estates of Norwood TowersNorwood, OH— 1,316 10,071 499 1,316 10,570 11,886 (1,249)19912016
CTR Partnership, L.P.Turlock Nursing and Rehabilitation CenterTurlock, CA— 1,258 16,526 — 1,258 16,526 17,784 (1,825)19862016
CTR Partnership, L.P.Bridgeport Medical LodgeBridgeport, TX— 980 27,917 — 980 27,917 28,897 (2,850)20142016
CTR Partnership, L.P.The Villas at SaratogaSaratoga, CA— 8,709 9,736 1,396 8,709 11,132 19,841 (617)20042018
CTR Partnership, L.P.Madison Park HealthcareHuntington, WV— 601 6,385 — 601 6,385 6,986 (359)19242018
CTR Partnership, L.P.Oakview Heights Nursing & Rehabilitation CenterMt. Carmel, IL— 298 8,393 — 298 8,393 8,691 (455)20042019
Gulf Coast Buyer 1 LLCSpring Lake Skilled Nursing and RehabilitationShreveport, LA— 3,217 21,195 2,525 3,217 23,720 26,937 (1,008)20082019
Gulf Coast Buyer 1 LLCThe Village at Heritage OaksCorsicana, TX— 143 11,429 549 143 11,978 12,121 (560)20072019
CTR Partnership, L.P.City Creek Post-Acute and Assisted LivingSacramento, CA— 3,980 10,106 408 3,980 10,514 14,494 (344)19902019
CTR Partnership, L.P.Crestwood Health and Rehabilitation CenterWills Point, TX— 143 6,075 — 143 6,075 6,218 (28)19802020
— 29,336 198,991 8,612 29,205 207,734 236,939 (27,700)
Assisted and Independent Living Properties:
Avenue N Holdings LLCCambridge ALFRosenburg, TX— 124 2,301 392 124 2,693 2,817 (1,367)20072006
Moenium Holdings LLCGrand CourtMesa, AZ— 1,893 5,268 1,210 1,893 6,478 8,371 (3,453)19862007
Lafayette Health Holdings LLCChateau Des MonsEnglewood, CO— 420 1,160 189 420 1,349 1,769 (433)20112009
Expo Park Health Holdings LLCCanterbury GardensAurora, CO— 570 1,692 248 570 1,940 2,510 (858)19862010
Wisteria Health Holdings LLCWisteria INDAbilene, TX— 244 3,241 81 244 3,322 3,566 (1,487)20082011
Everglades Health Holdings LLCLexingtonVentura, CA— 1,542 4,012 113 1,542 4,125 5,667 (894)19902011
Flamingo Health Holdings LLCDesert Springs ALFLas Vegas, NV— 908 4,767 281 908 5,048 5,956 (2,509)19862011
18th Place Health Holdings LLCRose CourtPhoenix, AZ— 1,011 2,053 490 1,011 2,543 3,554 (937)19742011
Boardwalk Health Holdings LLCPark PlaceReno, NV— 367 1,633 51 367 1,684 2,051 (510)19932012
Willows Health Holdings LLCCascade PlazaRedmond, WA— 2,835 3,784 395 2,835 4,179 7,014 (1,199)20132013
Lockwood Health Holdings LLCSanta MariaSanta Maria, CA— 1,792 2,253 585 1,792 2,838 4,630 (1,248)19672013
Saratoga Health Holdings LLCLake RidgeOrem, UT— 444 2,265 176 444 2,441 2,885 (464)19952013
Sky Holdings AZ LLCDesert Sky Assisted LivingGlendale, AZ— 61 304 372 61 676 738 (466)20042002
Lemon River Holdings LLCThe Grove Assisted LivingRiverside, CA— 342 802 3,360 342 4,162 4,504 (2,616)20122009
Mission CCRC LLCSt. Joseph's Villa INDSalt Lake City, UT— 411 2,312 258 411 2,570 2,981 (1,432)19942011
CTR Partnership, L.P.Prelude Cottages of WoodburyWoodbury, MN— 430 6,714 — 430 6,714 7,144 (1,007)20112014
CTR Partnership, L.P.English Meadows Senior Living CommunityChristiansburg, VA— 250 6,114 43 250 6,157 6,407 (919)20112014
CTR Partnership, L.P.Bristol Court Assisted LivingSaint Petersburg, FL— 645 7,322 421 645 7,512 8,157 (1,013)20102015
CTR Partnership, L.P.Asbury Place Assisted LivingPensacola, FL— 212 4,992 240 212 5,213 5,425 (672)19972015
CTR Partnership, L.P.New Haven Assisted Living of San AngeloSan Angelo, TX— 284 4,478 — 284 4,478 4,762 (550)20122016
CTR Partnership, L.P.Lamplight Inn of Fort WayneFort Wayne, IN— 452 8,703 214 452 8,889 9,341 (1,052)20152016
CTR Partnership, L.P.Lamplight Inn of West AllisWest Allis, WI— 97 6,102 173 97 6,255 6,352 (737)20132016
CTR Partnership, L.P.Lamplight Inn of BaltimoreBaltimore, MD— — 3,697 267 — 3,919 3,919 (447)20142016
CTR Partnership, L.P.Fort Myers Assisted LivingFort Myers, FL— 1,489 3,531 765 1,489 4,665 6,154 (455)19802016
CTR Partnership, L.P.English Meadows Elks Home CampusBedford, VA— 451 9,023 268 451 9,291 9,742 (1,107)20142016
CTR Partnership, L.P.Croatan VillageNew Bern, NC— 312 6,919 — 312 6,919 7,231 (807)20102016
CTR Partnership, L.P.Countryside VillagePikeville, NC— 131 4,157 — 131 4,157 4,288 (485)20112016
CTR Partnership, L.P.The Pines of ClarkstonVillage of Clarkston, MI— 603 9,326 — 603 9,326 9,929 (1,069)20102016
CTR Partnership, L.P.The Pines of GoodrichGoodrich, MI— 241 4,112 241 4,121 4,362 (471)20142016
CTR Partnership, L.P.The Pines of BurtonBurton, MI— 492 9,199 — 492 9,199 9,691 (1,054)20142016
CTR Partnership, L.P.The Pines of LapeerLapeer, MI— 302 5,773 — 302 5,773 6,075 (662)20082016
CTR Partnership, L.P.Arbor PlaceLodi, CA— 392 3,605 — 392 3,605 3,997 (398)19842016
CTR Partnership, L.P.Applewood of BrookfieldBrookfield, WI— 493 14,002 — 493 14,002 14,495 (1,371)20132017
CTR Partnership, L.P.Applewood of New BerlinNew Berlin, WI— 356 10,812 — 356 10,812 11,168 (1,059)20162017
CTR Partnership, L.P.Tangerine Cove of BrooksvilleBrooksville, FL— 995 927 463 995 1,364 2,359 (114)19842017
CTR Partnership, L.P.Memory Care Cottages in White Bear LakeWhite Bear Lake, MN— 1,611 5,633 — 1,611 5,633 7,244 (493)20162017
CTR Partnership, L.P.CulpeperCulpepper, VA— 318 3,897 85 318 3,982 4,300 (374)19972017
CTR Partnership, L.P.LouisaLouisa, VA— 407 4,660 97 407 4,757 5,164 (455)20022017
CTR Partnership, L.P.WarrentonWarrenton, VA— 1,238 7,247 98 1,238 7,345 8,583 (671)19992017
CTR Partnership, L.P.Vista Del LagoEscondido, CA— 4,362 7,997 — 4,362 7,997 12,359 (279)20152019
CTR Partnership, L.P.Inn at Barton CreekBountiful, UT— 2,479 4,804 15 2,479 4,819 7,298 (119)19992020
— 32,006 201,593 11,359 32,006 212,952 244,959 (37,713)
— $206,497 $1,364,511 $112,197 $205,356 $1,477,849 $1,683,205 $(259,803)
(1) The aggregate cost of real estate for federal income tax purposes was $1.7 billion.
 Year Ended December 31,
Real estate:202020192018
Balance at the beginning of the period$1,605,081 $1,368,157 $1,266,484 
Acquisitions84,630 318,070 106,208 
Improvements7,223 3,103 7,230 
Impairment— (21,465)— 
Sales of real estate(13,729)(62,784)(11,765)
Balance at the end of the period$1,683,205 $1,605,081 $1,368,157 
Accumulated depreciation:
Balance at the beginning of the period$(220,359)$(185,926)$(152,185)
Depreciation expense(41,914)(40,373)(34,676)
Impairment— 5,220 — 
Sales of real estate2,470 720 935 
Balance at the end of the period$(259,803)$(220,359)$(185,926)
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule IV - Mortgage Loans on Real Estate
12 Months Ended
Dec. 31, 2020
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]  
Schedule IV - Mortgage Loans on Real Estate
DescriptionContractual Interest RateMaturity DatePeriodic Payment TermsPrior LiensPrincipal Balance
Book Value (2)
Carrying Amount of Loans Subject to Delinquent Principal or Interest
Mezzanine Loan:
Virginia (9 SNF facilities)12.0 %2025(1)$110,000 (3)$15,000 $15,000 N/A
$110,000 $15,000 $15,000 

(1)     Interest is due monthly, and principal is due at the maturity date.
(2)    The aggregate cost of investments in real estate mortgage loans for federal income tax purposes was $15.0 million.
(3)    The first mortgage loans on these properties are not held by the Company. Accordingly, the amounts of the prior liens at December 31, 2020 are estimated.

Changes in mortgage loans are summarized as follows (in thousands):

Year Ended December 31,
202020192018
Balance at beginning of period$29,500 $12,375 $12,517 
Additions during period:
New mortgage loans61,258 40,889 — 
Deductions during period:
Paydowns/Repayments(75,758)(23,764)(142)
Balance at end of period$15,000 $29,500 $12,375 
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation—The accompanying consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its wholly-owned subsidiaries prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). All intercompany transactions and account balances within the Company have been eliminated.
Lessor Accounting
Lessor Accounting—The Company recognizes lease revenue in accordance with ASC 842, Leases. The Company’s lease agreements typically contain annual escalators based on the percentage change in the Consumer Price Index which are accounted for as variable lease payments in the period in which the change occurs. For lease agreements that contain fixed rent escalators, the Company generally recognizes lease revenue on a straight-line basis of accounting. The Company generates revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Tenant reimbursements related to property taxes and insurance paid by lessee directly to a third-party on behalf of a lessor are required to be excluded from variable payments and from recognition in the lessor’s income statements. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental revenues recognized by the lessor on a gross basis in its income statements.
For the year ended December 31, 2018, the Company recognized tenant recoveries for real estate taxes of $11.9 million which was classified as tenant reimbursements on the Company’s consolidated income statements. Prior to the adoption of ASC 842, the Company recognized tenant recoveries as tenant reimbursement revenues regardless of whether the third party was paid by the lessor or lessee. Effective January 1, 2019, such tenant recoveries are recognized to the extent that the Company pays the third party directly and classified as rental income on the Company’s consolidated income statements. Due to the application of ASC 842, the Company recognized, on a gross basis, tenant recoveries related to real estate taxes of $3.1 million and $2.9 million, for the years ended December 31, 2020 and December 31, 2019, respectively.
The Company’s assessment of collectibility of its tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection. The Company considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Such write-offs and recoveries are recorded as decreases or increases through rental income on the Company’s consolidated income statements. For the year ended December 31, 2020, the Company recorded recovery adjustments of $1.0 million and did not recognize any write-off adjustments to rental income. For the year ended December 31, 2019, the Company recorded $11.8 million of write-off adjustments to rental income related to rental income recognized in prior periods. See Note 3, Real Estate Investments, Net for further detail.
Estimates and Assumptions Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.
Real Estate Acquisition Valuation
Real Estate Acquisition Valuation— In accordance with ASC 805, Business Combinations, the Company’s acquisitions of real estate investments generally do not meet the definition of a business, and are treated as asset acquisitions. The assets acquired and liabilities assumed are measured at their acquisition date relative fair values. Acquisition costs are capitalized as incurred. The Company allocates the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.

As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement.
Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis when earn-out becomes probable and estimable. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets—At each reporting period, the Company evaluates its real estate investments to be held and used for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, the Company evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.

The Company classifies its real estate investments as held for sale when the applicable criteria have been met, which entails a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, the Company writes down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and ceases depreciation.

In the event of impairment, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers.

The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.
Other Real Estate Investments
Other Real Estate Investments—Included in other real estate investments, net, on the Company’s consolidated balance sheets at December 31, 2020, is one mezzanine loan receivable. At December 31, 2019, included in other real estate investments, net is one preferred equity investment and two mortgage loans receivable. The preferred equity investment was accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. Any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.
Prior to the adoption of ASU 2016-13, mortgage and mezzanine loans receivable were recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. Interest income on the Company’s mortgage and mezzanine loans receivable was recognized over the life of the applicable investment using the interest method. Origination costs and fees directly related to loans receivable were amortized over the term of the loan as an adjustment to interest income.
For instruments recorded at amortized cost, the Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.
The Company adopted ASU 2016-13 on January 1, 2020. Fair value was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. Instruments for which the fair value option has been elected are measured at fair value on a
recurring basis with changes in fair value recognized in other (loss) income on our consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.
Prepaid expenses and other assets Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. Included in other loans receivable at December 31, 2019 is a bridge loan to Priority Life Care, LLC (“Priority”) under which the Company agreed to fund up to $1.4 million until the earlier of (i) October 31, 2019, (ii) the date that a new credit facility is established such that the borrower may submit draw requests to the applicable lender, or (iii) the date on which Priority’s lease is terminated with respect to any facility. Borrowings under the bridge loan accrue interest at an annual base rate of 8.0%. During the year ended December 31, 2019, the Company determined that the remaining contractual obligations under the bridge loan agreement to Priority were not collectible and recorded a $1.1 million provision for loan losses in the Company’s consolidated income statements.
Income Taxes Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions.
Real Estate Depreciation and Amortization
Real Estate Depreciation and Amortization—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:
Building
25-40 years
Building improvements
10-25 years
Tenant improvementsShorter of lease term or expected useful life
Integral equipment, furniture and fixtures
5 years
Identified intangible assetsShorter of lease term or expected useful life
Cash and Cash Equivalents Cash and Cash Equivalents—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.
Deferred Financing Costs Deferred Financing Costs—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. For senior unsecured notes payable and the senior unsecured term loan, deferred financing costs are netted against the outstanding debt amounts on the balance sheet. For the unsecured revolving credit facility, deferred financing costs are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in
the consolidated income statements. Accumulated amortization of deferred financing costs was $9.0 million and $7.1 million at December 31, 2020 and December 31, 2019, respectively.
When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s consolidated income statements.
Stock-Based Compensation Stock-Based Compensation—The Company accounts for share-based payment awards in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees. The Company measures and recognizes compensation expense for all share-based payment awards made to directors, officers and employees based on the grant date fair value, amortized over the requisite service period of the award.
Concentration of Credit Risk Concentration of Credit Risk—The Company is subject to concentrations of credit risk consisting primarily of operating leases on its owned properties. See Note 11, Concentration of Risk, for a discussion of major operator concentration.
Segment Disclosures Segment Disclosures —The Company is subject to disclosures about segments of an enterprise and related information in accordance with ASC Topic 280, Segment Reporting. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.
Earnings (Loss) Per Share Earnings Per Share—The Company calculates earnings per share (“EPS”) in accordance with ASC 260, Earnings Per Share. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities.
Beds, Units, Occupancy and Other Measures Beds, Units, Occupancy and Other Measures—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the consolidated financial statements are presented on an unaudited basis and are not subject to audit by the independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board.
Recent Accounting Pronouncements
Recent Accounting Standards Adopted by the Company—In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Loses on Financial Instruments (“ASU 2016-13”), that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected credit losses, rather than incurred losses as previously required by the other-than-temporary impairment model. ASU 2016-13 applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans receivable, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). In November 2018, the FASB released ASU No. 2018-19, Codification Improvements to Topic 326 Financial Instruments - Credit Losses (“ASU 2018-19”). ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of ASU 2016-13. Instead, impairment of receivables arising from operating leases should be accounted for under Subtopic 842-30 “Leases - Lessor.” Additionally, the FASB issued ASU No. 2019-05, Targeted Transition Relief (“ASU 2019-05”), to allow companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option on financial instruments. The fair value option election does not apply to held-to-maturity debt securities. Entities are required to make this election on an instrument-by-instrument basis. ASU 2016-13 became effective for reporting periods beginning after December 15, 2019, and was applied as a cumulative adjustment to retained earnings as of the effective date. The Company adopted ASU 2016-13 on January 1, 2020. With the Company’s primary business being leasing real property to third-party tenants, the majority of receivables that arise in the ordinary course of business qualify as operating leases and are not in the scope of ASU 2016-13.  However, based on the instruments held upon adoption on January 1, 2020, the standard applied to the Company’s then outstanding mortgage loans receivable, for which the Company elected the fair value option as provided for by ASU 2019-05. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other (loss) income on the Company’s consolidated income statements. Interest income is recognized as earned within interest and other income in the consolidated income statements. As of December 31, 2020, the Company had one mezzanine loan receivable for which the fair value option had been elected.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) (“ASU 2018-13”), which modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. ASU 2018-13 was effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods, with early adoption permitted. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company adopted ASU 2018-13 on January 1, 2020. Adoption of the new standard did not have a material impact on the Company’s consolidated financial statements.
In October 2020, the FASB issued ASU No. 2020-09, Debt (Topic 470) (“ASU 2020-09”), which amends and supersedes the SEC paragraphs in the Accounting Standards Codification (“ASC”) to reflect the issuance of SEC Release No. 33-10762. In March 2020, the SEC adopted amendments to reduce and simplify the financial disclosure requirements for guarantors and issuers of guaranteed registered securities. The amendments were effective January 4, 2021, but voluntary compliance with the amendments in advance of January 4, 2021 was permitted. The Company elected to comply with these amendments effective in the first quarter of 2020. As a result, the Company will no longer include in the financial statement footnotes of its Quarterly and Annual Reports on Form 10-Q and Form 10-K separate condensed consolidating financial
information for its wholly owned subsidiaries that issued or guaranteed the Notes (See Note 6, Debt, for further detail). In addition, in accordance with the amendments adopted by the SEC and FASB, because the assets, liabilities and results of operations of the combined issuers and guarantors of the Notes are not materially different than the corresponding amounts presented in the Company’s consolidated financial statements, it is also not required to present combined summary financial information regarding such subsidiary issuers and guarantors.Recent Accounting Pronouncements— In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), that provides optional relief to applying reference rate reform to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”), which will be discontinued by the end of 2021. The amendments in this update are effective immediately and may be applied through December 31, 2022. The Company is still evaluating the impact of ASU 2020-04 and expects to take full advantage of the offered optional expedients and exceptions, but does not expect the adoption of the standard to have a material impact on the Company’s consolidated financial statements.
Fair Value Measurements
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. GAAP guidance defines three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.

Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.

The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and, depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. The Company does not expect that changes in classifications between levels will be frequent.
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Summary of Estimated Useful Lives of Assets The Company anticipates the estimated useful lives of its assets by class to be generally as follows:
Building
25-40 years
Building improvements
10-25 years
Tenant improvementsShorter of lease term or expected useful life
Integral equipment, furniture and fixtures
5 years
Identified intangible assetsShorter of lease term or expected useful life
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net (Tables)
12 Months Ended
Dec. 31, 2020
Real Estate [Abstract]  
Summary of Investment in Owned Properties
The following table summarizes the Company’s investment in owned properties at December 31, 2020 and December 31, 2019 (dollars in thousands):
 
December 31, 2020December 31, 2019
Land$205,356 $204,154 
Buildings and improvements1,477,849 1,400,927 
Integral equipment, furniture and fixtures97,836 93,005 
Identified intangible assets2,352 1,650 
Real estate investments1,783,393 1,699,736 
Accumulated depreciation and amortization(335,294)(285,536)
Real estate investments, net$1,448,099 $1,414,200 
Schedule of Total Future Contractual Minimum Rental Income
As of December 31, 2020, the Company’s total future contractual minimum rental income for all of its tenants, excluding operating expense reimbursements, were (dollars in thousands):
YearAmount
2021$174,400 
2022174,497 
2023174,193 
2024174,294 
2025174,396 
Thereafter1,026,675 
$1,898,455 
Schedule of Tenant Purchase Options
Certain of the Company’s operators hold purchase options allowing them to acquire properties they currently lease from the Company. A summary of these purchase options is presented below (dollars in thousands):
Asset TypePropertiesLease Expiration1st Option Open DateOption Type
Current Cash Rent(1)
ALF7October 20341/1/2021A$3,207 
SNF11January 20311/1/2022C$4,800 
SNF1March 20304/1/2022
B / C(2)
$766 
SNF / Campus2October 20321/1/2023B$959 
SNF4November 203412/1/2024B$3,789 
ALF2October 20341/1/2026A$1,559 
Option Type:
A - Fixed base price plus a specified share on any appreciation.
B - Fixed base price.
C - Fixed capitalization rate on lease revenue.
Notes:
(1) Based on annualized cash revenue for contracts in place at December 31, 2020.
(2) Purchase option reflects two option types.
Schedule of Rental Income
The following table summarizes components of the Company’s rental income (dollars in thousands):
For the Year Ended December 31,
20202019
Rental Income
Contractual rent due(1)
$171,309 $166,056 
Straight-line rent77 1,385 
Adjustment for collectibility(2)
— (11,774)
Recovery of previously reversed rent(3)
1,047 — 
Lease termination revenue(4)
1,179 — 
Total$173,612 $155,667 

(1)Includes initial cash rent and tenant operating expense reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by the Company. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received.
(2)During the year ended December 31, 2019, and in accordance with ASC 842, the Company evaluated the collectibility of lease payments through maturity and determined that it was not probable that the Company would collect substantially all of the contractual obligations from five operators through maturity. As such, the Company reversed $7.8 million of contractual rent, $3.5 million of straight-line rent and $0.5 million of property tax reimbursements during the year ended December 31, 2019. If lease payments are subsequently deemed probable of collection, the Company increases rental income for such recoveries.
(3)During the year ended December 31, 2020, the Company recovered $1.0 million in rental income that was previously written off related to one operator.
(4)During the year ended December 31, 2020, in connection with the agreement to terminate its lease agreements with affiliates of Metron Integrated Health Systems (“Metron”) and to sell the facilities to a third-party, the Company received $1.2 million from Metron affiliates.
Schedule of Real Estate Acquisitions
The following table summarizes the Company’s acquisitions for the year ended December 31, 2020 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$75,545 $6,453 715 
Multi-service campuses6,876 555 184 
Assisted living7,396 590 62 
Total$89,817 $7,598 961 
The following table summarizes the Company’s acquisitions for the year ended December 31, 2019 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$254,760 $22,909 17 2,099 
Multi-service campuses59,344 5,203 762 
Assisted living12,596 1,031 96 
Total$326,700 $29,143 22 2,957 
The following table summarizes the Company’s acquisitions for the year ended December 31, 2018 (dollar amounts in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing$85,814 $7,715 10 926 
Multi-service campuses27,520 (4)2,240 177 
Assisted living— — — — 
Total$113,334 $9,955 12 1,103 
(1)    Purchase price includes capitalized acquisition costs.
(2)    Initial annual cash rent excludes ground lease income.
(3)    The number of beds/units includes operating beds at acquisition date.
(4)    The Company committed to fund approximately $1.4 million in revenue-producing capital expenditures over 24 months based on the in-place yield, which was included in the purchase price.
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2020, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands):
Level 1Level 2Level 3Balance as of December 31, 2020
Assets:
Mezzanine loan receivable$— $— $15,000 $15,000 
Summary of Fair Value and Carrying Value of Financial Instruments A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020 and December 31, 2019 using Level 2 inputs for the Notes (as defined in Note 6, Debt, below), and Level 3 inputs, for all other financial instruments, is as follows (dollars in thousands):  
 December 31, 2020December 31, 2019
Face
Value
Carrying
Amount
Fair
Value
Face
Value
Carrying
Amount
Fair
Value
Financial assets:
Preferred equity investments$— $— $— $2,327 $3,800 $3,674 
Mortgage loans receivable— — — 29,500 29,500 29,500 
Financial liabilities:
Senior unsecured notes payable$300,000 $296,669 $311,430 $300,000 $295,911 $312,750 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Debt (Tables)
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Debt Instruments
The following table summarizes the balance of the Company’s indebtedness as of December 31, 2020 and 2019 (in thousands):
December 31, 2020December 31, 2019
PrincipalDeferredCarryingPrincipalDeferredCarrying
AmountLoan FeesValueAmountLoan FeesValue
Senior unsecured notes payable$300,000 $(3,331)$296,669 $300,000 $(4,089)$295,911 
Senior unsecured term loan200,000 (1,075)198,925 200,000 (1,287)198,713 
Unsecured revolving credit facility50,000 — 50,000 60,000 — 60,000 
$550,000 $(4,406)$545,594 $560,000 $(5,376)$554,624 
Schedule of Debt Maturities
As of December 31, 2020, the Company’s debt maturities were (dollars in thousands):  
Year
Amount
2021$— 
2022— 
202350,000 
2024— 
2025300,000 
Thereafter200,000 
 $550,000 
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Equity (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Summary of the At-The-Market Equity Offering Program The following table summarizes predecessor at-the-market equity offering program activity for the year ended 2019 (in thousands, except per share amounts):
For the Year Ended December 31,
2019
Number of shares2,459 
Average sales price per share$19.48 
Gross proceeds(1)
$47,893 
(1)    Total gross proceeds is before $0.6 million of commissions paid to the sales agents during the year ended December 31, 2019 under the predecessor ATM Program.
Summary of Dividends on Common Stock The following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2020, 2019 and 2018 (dollars in thousands, except per share amounts):
For the Three Months Ended
2020March 31,June 30,September 30,December 31,
Dividends declared$0.25 $0.25 $0.25 $0.25 
Dividends payment dateApril 15, 2020July 15, 2020October 15, 2020January 15, 2021
Dividends payable as of record date$23,931 $23,931 $23,934 $23,933 
Dividends record dateMarch 31, 2020June 30, 2020September 30, 2020December 31, 2020
2019
Dividends declared$0.225 $0.225 $0.225 $0.225 
Dividends payment dateApril 15, 2019July 15, 2019October 15, 2019January 15, 2020
Dividends payable as of record date$20,011 $21,508 $21,500 $21,500 
Dividends record dateMarch 29, 2019June 28, 2019September 30, 2019December 31, 2019
2018
Dividends declared$0.205 $0.205 $0.205 $0.205 
Dividends payment dateApril 13, 2018July 13, 2018October 15, 2018January 15, 2019
Dividends payable as of record date$15,608 $16,224 $17,196 $17,710 
Dividends record dateMarch 30, 2018June 29, 2018September 28, 2018December 31, 2018
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Restricted Stock and Performance Award Activity
The following table summarizes restricted stock award and performance award activity for the years ended December 31, 2020 and 2019:
SharesWeighted Average Share Price
Unvested balance at December 31, 2018519,272 $14.69 
Granted180,629 22.22 
Vested(247,534)14.50 
Forfeited(134)15.21 
Unvested balance at December 31, 2019452,233 17.90 
Granted270,191 19.11 
Vested(201,563)17.41 
Forfeited(3,175)20.30 
Unvested balance at December 31, 2020517,686 $18.71 
Schedule of Stock-Based Compensation Expense
The following table summarizes the stock-based compensation expense recognized (dollars in thousands):
 For Year Ended December 31,
 202020192018
Stock-based compensation expense$3,790 $4,104 $3,848 
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Common Share (Tables)
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Reconciliation of Weighted-Average Common Shares Outstanding Used in Calculation of Basic EPS to Diluted EPS
The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the years ended December 31, 2020, 2019 and 2018, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the years ended December 31, 2020, 2019 and 2018 (amounts in thousands, except per share amounts):
 
 Year Ended December 31,
 202020192018
Numerator:
Net income$80,867 $46,359 $57,923 
Less: Net income allocated to participating securities(298)(296)(364)
Numerator for basic and diluted earnings available to common stockholders$80,569 $46,063 $57,559 
Denominator:
Weighted-average basic common shares outstanding95,200 93,088 79,386 
   Dilutive performance stock awards10 
Weighted-average diluted common shares outstanding95,207 93,098 79,392 
Earnings per common share, basic$0.85 $0.49 $0.73 
Earnings per common share, diluted$0.85 $0.49 $0.72 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Selected Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Selected Quarterly Financial Data This unaudited quarterly data should be read together with the accompanying consolidated financial statements and related notes thereto (in thousands, except per share amounts):
 For the Year Ended December 31, 2020
 First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Operating data:
Total revenues$44,340 $44,168 $45,687 $44,137 
Net income$19,325 $18,935 $21,552 $21,055 
Earnings per common share, basic$0.20 $0.20 $0.23 $0.22 
Earnings per common share, diluted$0.20 $0.20 $0.23 $0.22 
Other data:
Weighted-average number of common shares outstanding, basic95,161 95,208 95,214 95,215 
Weighted-average number of common shares outstanding, diluted95,161 95,208 95,214 95,244 
 For the Year Ended December 31, 2019
 First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Operating data:
Total revenues$39,658 $46,201 $33,314 $44,228 
Net income (loss)$16,053 $19,698 $(10,054)$20,662 
Earnings per common share, basic$0.18 $0.21 $(0.11)$0.22 
Earnings per common share, diluted$0.18 $0.21 $(0.11)$0.22 
Other data:
Weighted-average number of common shares outstanding, basic88,010 94,036 95,103 95,103 
Weighted-average number of common shares outstanding, diluted88,010 94,036 95,103 95,144 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Organization (Details)
12 Months Ended
Dec. 31, 2020
facility
bed
state
Real Estate Properties [Line Items]  
Number of facilities 218
Number of states with properties | state 28
Skilled nursing, assisted living and independent living facilities  
Real Estate Properties [Line Items]  
Number of facilities 218
Number of operational beds and units in facilities | bed 22,466
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Narrative (Details)
12 Months Ended
Dec. 31, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Accounting Policies [Abstract]      
Tenant recoveries related to real estate taxes     $ 11,924,000
Gross real estate taxes offset to rental income $ 3,100,000 $ 2,900,000  
Recovery of previously reserved rent 1,047,000 0  
Adjustment for collectibility of rental income 0 11,774,000  
Accumulated amortization of deferred financing costs 9,000,000.0 7,100,000  
Stock-based compensation expense $ 3,790,000 4,104,000 3,848,000
Number of reportable segments | segment 1    
Accounting Policies [Line Items]      
Provision for loan losses $ 0 1,076,000 $ 0
Bridge loan | Priority      
Accounting Policies [Line Items]      
Bridge loan funding in loans receivable   $ 1,400,000  
Loan receivable interest rate (percent)   8.00%  
Provision for loan losses   $ 1,100,000  
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details)
12 Months Ended
Dec. 31, 2020
Building | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 25 years
Building | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 40 years
Building Improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 10 years
Building Improvements | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 25 years
Integral Equipment, Furniture and Fixtures  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 5 years
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Investment in Owned Properties (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Real Estate [Abstract]    
Land $ 205,356 $ 204,154
Buildings and improvements 1,477,849 1,400,927
Integral equipment, furniture and fixtures 97,836 93,005
Identified intangible assets 2,352 1,650
Real estate investments 1,783,393 1,699,736
Accumulated depreciation and amortization (335,294) (285,536)
Real estate investments, net $ 1,448,099 $ 1,414,200
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
facility
renewal_option
property
Dec. 31, 2019
property
Dec. 31, 2018
property
Dec. 01, 2020
extension_option
Oct. 01, 2019
facility
Real Estate [Line Items]          
Number of facilities 218        
Number of facilities acquired | property 8 22 12    
Initial lease term (in years)       14 years  
Number of renewal options | extension_option       2  
Lease renewal term (in years)       5 years  
Ensign | Minimum          
Real Estate [Line Items]          
Annualized contractual rental income escalation rate (percent) 0.00%        
Ensign | Maximum          
Real Estate [Line Items]          
Annualized contractual rental income escalation rate (percent) 2.50%        
Ensign | Ensign Master leases          
Real Estate [Line Items]          
Number of facilities 85       85
Annualized contractual rental income | $ $ 53.4        
Ensign | Other Ensign leases          
Real Estate [Line Items]          
Number of facilities acquired 4        
Annualized contractual rental income | $ $ 3.8        
PMG          
Real Estate [Line Items]          
Number of facilities 15        
Initial lease term (in years) 15 years        
Number of renewal options | renewal_option 2        
Lease renewal term (in years) 5 years        
Annualized contractual rental income | $ $ 27.9        
PMG | Minimum          
Real Estate [Line Items]          
Annualized contractual rental income escalation rate (percent) 0.00%        
PMG | Maximum          
Real Estate [Line Items]          
Annualized contractual rental income escalation rate (percent) 3.00%        
Various other operators          
Real Estate [Line Items]          
Number of facilities 114        
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Future Contractual Minimum Rental Income (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Future Contractual Minimum Rental Income  
2021 $ 174,400
2022 174,497
2023 174,193
2024 174,294
2025 174,396
Thereafter 1,026,675
Total $ 1,898,455
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Tenant Purchase Options (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
property
ALF | Lease Expiration October 2034, First option 2021  
Lessor, Lease, Description [Line Items]  
Properties | property 7
Current Cash Rent | $ $ 3,207
ALF | Lease Expiration October 2034, First option 2026  
Lessor, Lease, Description [Line Items]  
Properties | property 2
Current Cash Rent | $ $ 1,559
SNF | Lease Expiration January 2031, First option 2022  
Lessor, Lease, Description [Line Items]  
Properties | property 11
Current Cash Rent | $ $ 4,800
SNF | Lease Expiration March 2030, First option 2022  
Lessor, Lease, Description [Line Items]  
Properties | property 1
Current Cash Rent | $ $ 766
SNF | Lease Expiration November 2034, First option 2024  
Lessor, Lease, Description [Line Items]  
Properties | property 4
Current Cash Rent | $ $ 3,789
SNF / Campus | Lease Expiration October 2032, First option 2023  
Lessor, Lease, Description [Line Items]  
Properties | property 2
Current Cash Rent | $ $ 959
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Rental Income (Details)
12 Months Ended
Dec. 31, 2020
USD ($)
operator
Dec. 31, 2019
USD ($)
operator
Dec. 31, 2018
USD ($)
Lessor, Lease, Description [Line Items]      
Contractual rent due $ 171,309,000 $ 166,056,000  
Straight-line rent 77,000 1,385,000 $ 2,333,000
Adjustment for collectibility 0 (11,774,000)  
Recovery of previously reserved rent 1,047,000 0  
Lease termination revenue 1,179,000 0  
Total $ 173,612,000 $ 155,667,000  
Number of operators for which collectability not probable | operator   5  
Number of operators for which rental income was recovered after previous write off | operator 1    
Contractual rent      
Lessor, Lease, Description [Line Items]      
Adjustment for collectibility   $ (7,800,000)  
Straight-line rent      
Lessor, Lease, Description [Line Items]      
Adjustment for collectibility   (3,500,000)  
Property taxes      
Lessor, Lease, Description [Line Items]      
Adjustment for collectibility   $ (500,000)  
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Recent Real Estate Acquisitions (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Jan. 31, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2020
USD ($)
property
unit
Dec. 31, 2019
USD ($)
property
unit
Dec. 31, 2018
USD ($)
property
unit
Business Acquisition [Line Items]          
Purchase Price     $ 89,817 $ 326,700 $ 113,334
Initial Annual Cash Rent     $ 7,598 $ 29,143 $ 9,955
Number of Properties | property     8 22 12
Number of Beds/Units | unit     961 2,957 1,103
Skilled nursing          
Business Acquisition [Line Items]          
Purchase Price $ 18,700 $ 16,200 $ 75,545 $ 254,760 $ 85,814
Initial Annual Cash Rent     $ 6,453 $ 22,909 $ 7,715
Number of Properties | property     6 17 10
Number of Beds/Units | unit     715 2,099 926
Multi-service campuses          
Business Acquisition [Line Items]          
Purchase Price     $ 6,876 $ 59,344 $ 27,520
Initial Annual Cash Rent     $ 555 $ 5,203 $ 2,240
Number of Properties | property     1 4 2
Number of Beds/Units | unit     184 762 177
Funding commitment for revenue-producing capital expenditures         $ 1,400
Assisted living          
Business Acquisition [Line Items]          
Purchase Price     $ 7,396 $ 12,596 0
Initial Annual Cash Rent     $ 590 $ 1,031 $ 0
Number of Properties | property     1 1 0
Number of Beds/Units | unit     62 96 0
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Lease Amendments (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 01, 2020
USD ($)
facility
extension_option
Oct. 01, 2019
USD ($)
bed
extension_option
facility
Sep. 30, 2019
USD ($)
Dec. 31, 2020
USD ($)
facility
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Nov. 04, 2019
USD ($)
facility
Sep. 01, 2019
USD ($)
renewal_option
property
Aug. 16, 2019
property
Jul. 15, 2019
property
May 01, 2018
Real Estate [Line Items]                      
Number of facilities | facility       218              
Lease term (in years) 14 years                    
Number of renewal options | extension_option 2                    
Lease renewal term (in years) 5 years                    
Initial annual cash rent       $ 7,598 $ 29,143 $ 9,955          
Noble                      
Real Estate [Line Items]                      
Number of properties transferred | facility 5                    
Initial annual cash rent $ 3,200                    
Pennant                      
Real Estate [Line Items]                      
Number of facilities | facility   11                  
Number of beds in leased facilities | bed   1,151                  
Lease term (in years)   15 years                  
Number of renewal options | extension_option   2                  
Lease renewal term (in years)   5 years                  
Initial annual cash rent   $ 7,800                  
Trillium | Iowa                      
Real Estate [Line Items]                      
Properties in terminated master lease | property                   10  
Properties covered in new master lease | property                 10    
Trillium | Ohio                      
Real Estate [Line Items]                      
Properties in terminated master lease | property                   7  
Trillium | Georgia                      
Real Estate [Line Items]                      
Properties in terminated master lease | property                   1  
Properties covered in new master lease | property                 1    
Accounts and other receivables                      
Real Estate [Line Items]                      
Write-off of accounts and straight-line rent receivable     $ 3,800                
Skilled Nursing Properties                      
Real Estate [Line Items]                      
Initial annual cash rent       $ 6,453 $ 22,909 $ 7,715          
Skilled Nursing Properties | Trillium | Ohio                      
Real Estate [Line Items]                      
Properties in terminated master lease | property                   7  
Skilled Nursing Properties | Providence | Ohio                      
Real Estate [Line Items]                      
Number of properties transferred | property               4      
Ensign Master leases | Ensign                      
Real Estate [Line Items]                      
Number of facilities | facility   85   85              
Number of beds in leased facilities | bed   8,908                  
Reduction to contractual annual cash rent as result of spin   $ 7,800                  
Triple-net master lease | Providence                      
Real Estate [Line Items]                      
Lease term (in years)               13 years      
Number of renewal options | renewal_option               2      
Lease renewal term (in years)               5 years      
Annual cash rent increase under amended lease               $ 2,100      
Trio Healthcare Master Lease                      
Real Estate [Line Items]                      
Lease term (in years)                     15 years
Trio Healthcare Master Lease | Trio                      
Real Estate [Line Items]                      
Number of facilities | facility             7        
Lease term (in years)             13 years        
Number of renewal options | facility             2        
Lease renewal term (in years)             5 years        
Annual cash rent increase under amended lease             $ 4,700        
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Pristine Lease Termination (Details)
$ in Millions
May 01, 2018
USD ($)
facility
Dec. 01, 2020
Nov. 04, 2019
Feb. 27, 2018
property
Real Estate [Line Items]        
Initial lease term (in years)   14 years    
Pristine Lease Termination Agreement        
Real Estate [Line Items]        
Number of properties | property       9
Pristine Lease Termination Agreement | Trio        
Real Estate [Line Items]        
Number of transitioned facilities 7      
Pristine Lease Termination Agreement | Hillstone Healthcare        
Real Estate [Line Items]        
Number of transitioned facilities 2      
Trio and Hillstone Master Lease        
Real Estate [Line Items]        
Aggregate annual base rent due under master lease | $ $ 10.0      
Trio Healthcare Master Lease        
Real Estate [Line Items]        
Initial lease term (in years) 15 years      
Trio Healthcare Master Lease | Trio        
Real Estate [Line Items]        
Initial lease term (in years)     13 years  
Hillstone Healthcare Master Lease        
Real Estate [Line Items]        
Initial lease term (in years) 12 years      
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Real Estate Investments, Net - Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 01, 2020
USD ($)
facility
unit
Jul. 31, 2020
USD ($)
Apr. 30, 2020
USD ($)
property
Feb. 29, 2020
USD ($)
facility
Dec. 31, 2019
USD ($)
unit
facility
Sep. 30, 2019
USD ($)
facility
property
Dec. 31, 2020
USD ($)
property
Dec. 31, 2019
USD ($)
unit
facility
Dec. 31, 2018
USD ($)
unit
facility
Sep. 01, 2019
USD ($)
property
Jul. 15, 2019
property
Real Estate [Line Items]                      
Assets held for sale, net         $ 34,590,000   $ 7,226,000 $ 34,590,000      
Proceeds from sale             6,608,000 3,499,000 $ 13,004,000    
Gain (loss) on sale of real estate             (37,000) 1,777,000 $ 2,051,000    
Real estate investments, net         1,414,200,000   1,448,099,000 $ 1,414,200,000      
Trillium | Ohio                      
Real Estate [Line Items]                      
Properties in terminated master lease | property                     7
Mortgage loan receivable                      
Real Estate [Line Items]                      
Loan receivable             $ 0        
Mortgage loan receivable | CommuniCare                      
Real Estate [Line Items]                      
Facilities utilized to secure mortgage loan           3       3  
Loan receivable           $ 26,500,000       $ 26,500,000  
Mortgage loan receivable interest rate (percent)           10.00%          
Mortgage loan receivable | Cascade Capital Group, LLC                      
Real Estate [Line Items]                      
Facilities utilized to secure mortgage loan | property     6                
Loan receivable       $ 32,400,000              
Mortgage loan receivable interest rate (percent)       7.50%              
Proceeds from settlement of loan   $ 13,900,000 $ 18,900,000                
Loan receivable     $ 13,900,000                
Disposed of by sale | Trillium skilled nursing facilities                      
Real Estate [Line Items]                      
Number of properties sold | property                   3  
Contract purchase price                   $ 28,000,000.0  
Impairment expense to reduce carrying value to fair value less costs to sell         $ 7,800,000            
Disposed of by sale | Metron skilled nursing facilities                      
Real Estate [Line Items]                      
Number of properties sold | facility       6              
Contract purchase price       $ 36,000,000.0              
Proceeds from sale       3,500,000              
Gain (loss) on sale of real estate       $ (100,000)              
Disposed of by sale | Owned and operated living facilities                      
Real Estate [Line Items]                      
Number of properties sold | facility 1       1     1      
Proceeds from sale $ 4,500,000             $ 3,300,000      
Gain (loss) on sale of real estate $ 20,000             $ 1,600,000      
Number of units available in living facilities | unit 168       38     38      
Real estate investments, net $ 4,200,000       $ 1,700,000     $ 1,700,000      
Disposed of by sale | Idaho assisted living facilities                      
Real Estate [Line Items]                      
Number of properties sold | facility                 3    
Proceeds from sale                 $ 13,000,000.0    
Gain (loss) on sale of real estate                 $ 2,100,000    
Number of units available in living facilities | unit                 102    
Real estate investments, net                 $ 10,900,000    
Held for sale | Metron skilled nursing facilities                      
Real Estate [Line Items]                      
Number of properties held for sale | property           6          
Impairment expense to reduce carrying value to fair value less costs to sell           $ 8,800,000          
Held for sale | Five Oaks skilled nursing facility                      
Real Estate [Line Items]                      
Number of properties held for sale | property             1        
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Other Real Estate Investments, Net (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2020
USD ($)
facility
Jul. 31, 2020
USD ($)
Apr. 30, 2020
USD ($)
extension_option
property
Jan. 31, 2020
USD ($)
Jul. 31, 2019
USD ($)
bed
Jun. 30, 2019
USD ($)
Feb. 28, 2019
USD ($)
extension_option
facility
Sep. 30, 2016
USD ($)
bed
Jul. 31, 2016
USD ($)
bed
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Feb. 29, 2020
USD ($)
facility
Sep. 30, 2019
USD ($)
facility
Sep. 01, 2019
USD ($)
property
Oct. 31, 2017
USD ($)
Real Estate Properties [Line Items]                                
Preferred equity investment                   $ 0            
Aggregate purchase price                   89,817,000 $ 326,700,000 $ 113,334,000        
Payment to acquire facility                   89,650,000 321,458,000 111,640,000        
Return of initial investment                   2,327,000 2,204,000 0        
Interest income related to preferred equity investments                   100,000 1,300,000 200,000        
Recognition of unrecognized preferred return from prior periods                   600,000            
Metron skilled nursing facilities | Disposed of by sale                                
Real Estate Properties [Line Items]                                
Number of properties sold | facility                         6      
Mortgage and mezzanine loans receivable                                
Real Estate Properties [Line Items]                                
Interest income related to mortgage loans                   2,300,000 2,800,000 1,200,000        
Mortgage loan receivable                                
Real Estate Properties [Line Items]                                
Loan receivable                   0            
Other loans receivable                                
Real Estate Properties [Line Items]                                
Interest income related to mortgage loans                   300,000 200,000 200,000        
Next VA Star Realty Holdings LLC | Mezzanine loan receivable                                
Real Estate Properties [Line Items]                                
Number of facilities in agreement secured by membership interests | facility 9                              
Loan receivable $ 15,000,000.0                              
Loan receivable interest rate (percent) 12.00%                              
Period of unpaid interest payments due upon prepayment 24 months                              
Next VA Star Realty Holdings LLC | Mezzanine loan receivable | Maximum                                
Real Estate Properties [Line Items]                                
Loans receivable exit fee (percent) 3.00%                              
Next VA Star Realty Holdings LLC | Mezzanine loan receivable | Minimum                                
Real Estate Properties [Line Items]                                
Loans receivable exit fee (percent) 1.00%                              
Providence | Mortgage loan receivable                                
Real Estate Properties [Line Items]                                
Loan receivable                               $ 12,500,000
Loan receivable interest rate (percent)                               9.00%
Covenant Care | Mortgage loan receivable                                
Real Estate Properties [Line Items]                                
Loan receivable             $ 11,400,000                  
Loan receivable interest rate (percent)             9.00%                  
Facilities utilized to secure mortgage loan | facility             5                  
Number of extension options | extension_option             2                  
Extension option term (in months)             6 months                  
MCRC, LLC                                
Real Estate Properties [Line Items]                                
Purchase and sale agreement amount         $ 16,400,000                      
MCRC, LLC | Mortgage loan receivable                                
Real Estate Properties [Line Items]                                
Loan receivable         $ 3,000,000.0                      
Loan receivable interest rate (percent)         8.00%                      
Number of beds in facility utilized to secure loan | bed         176                      
CommuniCare | Mortgage loan receivable                                
Real Estate Properties [Line Items]                                
Loan receivable                           $ 26,500,000 $ 26,500,000  
Loan receivable interest rate (percent)                           10.00%    
Facilities utilized to secure mortgage loan                           3 3  
Cascade Capital Group, LLC                                
Real Estate Properties [Line Items]                                
Combined principal amount of loan     $ 33,900,000                          
Cascade Capital Group, LLC | Mortgage loan receivable                                
Real Estate Properties [Line Items]                                
Loan receivable                         $ 32,400,000      
Loan receivable interest rate (percent)                         7.50%      
Facilities utilized to secure mortgage loan | property     6                          
Number of extension options | extension_option     2                          
Extension option term (in months)     6 months                          
Proceeds from settlement of loan   $ 13,900,000 $ 18,900,000                          
Loan receivable     $ 13,900,000                          
LIBOR floor for loan (percent)     1.75%                          
Cascade Capital Group, LLC | Mortgage loan receivable | LIBOR                                
Real Estate Properties [Line Items]                                
Basis spread on variable rate for loan (percent)     4.00%                          
Cascadia Development, Nampa ID                                
Real Estate Properties [Line Items]                                
Preferred equity investment                 $ 2,200,000              
Preferred equity instrument minimum yield                 12.00%              
Number of beds planned for construction | bed                 99              
Initial lease yield (percent)                 9.00%              
Return of initial investment           $ 2,200,000                    
Cumulative contractual preferred return through acquisition date           1,100,000                    
Cascadia Development, Nampa ID | Prime Rate                                
Real Estate Properties [Line Items]                                
Basis spread on preferred equity investment yield                 9.50%              
Cascadia Development, Boise ID                                
Real Estate Properties [Line Items]                                
Preferred equity investment               $ 2,300,000                
Preferred equity instrument minimum yield               12.00%                
Number of beds planned for construction | bed               99                
Initial lease yield (percent)               9.00%                
Return of initial investment       $ 2,300,000                        
Cumulative contractual preferred return through acquisition date       1,400,000                        
Cascadia Development, Boise ID | Prime Rate                                
Real Estate Properties [Line Items]                                
Basis spread on preferred equity investment yield               9.50%                
Skilled Nursing Properties                                
Real Estate Properties [Line Items]                                
Aggregate purchase price       18,700,000   16,200,000       $ 75,545,000 $ 254,760,000 $ 85,814,000        
Payment to acquire facility       $ 15,000,000.0   $ 12,900,000                    
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements - Assets and Liabilities at Fair Value on Recurring Basis (Details) - Recurring - Mezzanine loan receivable
$ in Thousands
Dec. 31, 2020
USD ($)
Assets:  
Mezzanine loan receivable $ 15,000
Level 1  
Assets:  
Mezzanine loan receivable 0
Level 2  
Assets:  
Mezzanine loan receivable 0
Level 3  
Assets:  
Mezzanine loan receivable $ 15,000
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Fair Value Disclosures [Abstract]      
Impairment of real estate investments $ 0 $ 16,692 $ 0
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements - Fair Value and Carrying Value of Financial Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Financial assets:    
Preferred equity investments - face value $ 0 $ 2,327
Mortgage loan receivable    
Financial assets:    
Mortgage loans receivable - face value 0 29,500
Senior Unsecured Notes    
Financial liabilities:    
Senior unsecured notes payable - face value 300,000 300,000
Carrying Amount | Level 2 | Senior Unsecured Notes    
Financial liabilities:    
Senior unsecured notes payable 296,669 295,911
Carrying Amount | Level 3    
Financial assets:    
Preferred equity investments 0 3,800
Carrying Amount | Level 3 | Mortgage loan receivable    
Financial assets:    
Mortgage loans receivable 0 29,500
Fair Value | Level 2 | Senior Unsecured Notes    
Financial liabilities:    
Senior unsecured notes payable 311,430 312,750
Fair Value | Level 3    
Financial assets:    
Preferred equity investments 0 3,674
Fair Value | Level 3 | Mortgage loan receivable    
Financial assets:    
Mortgage loans receivable $ 0 $ 29,500
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Principal Amount $ 550,000 $ 560,000
Deferred Loan Fees (4,406) (5,376)
Carrying Value 545,594 554,624
Senior unsecured notes payable    
Debt Instrument [Line Items]    
Principal Amount 300,000 300,000
Deferred Loan Fees (3,331) (4,089)
Carrying Value 296,669 295,911
Senior unsecured term loan    
Debt Instrument [Line Items]    
Principal Amount 200,000 200,000
Deferred Loan Fees (1,075) (1,287)
Carrying Value 198,925 198,713
Unsecured revolving credit facility    
Debt Instrument [Line Items]    
Principal Amount 50,000 60,000
Deferred Loan Fees 0 0
Carrying Value $ 50,000 $ 60,000
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Debt - Senior Unsecured Notes Payable Narrative (Details) - USD ($)
12 Months Ended
Jun. 01, 2020
May 10, 2017
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]          
Gross proceeds from issuance of senior notes     $ 0 $ 200,000,000 $ 0
Senior Unsecured Notes          
Debt Instrument [Line Items]          
Debt instrument face amount     $ 300,000,000 $ 300,000,000  
Senior Unsecured Notes | 5.25% Senior Notes due 2025          
Debt Instrument [Line Items]          
Debt instrument face amount   $ 300,000,000.0      
Interest rate (percent)   5.25%      
Gross proceeds from issuance of senior notes   $ 300,000,000.0      
Net proceeds from issuance of senior notes   $ 294,000,000.0      
Redemption price, percentage upon change of control (percent) 101.00%        
Senior Unsecured Notes | 5.875% Senior Notes due 2021          
Debt Instrument [Line Items]          
Interest rate (percent)   5.875%      
Redemption price of notes (percent)   102.938%      
Payments for redemption of senior notes   $ 260,000,000.0      
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Debt - Unsecured Revolving Credit Facility and Term Loan Narrative (Details)
Feb. 08, 2019
USD ($)
extension_option
Feb. 01, 2016
USD ($)
extension_option
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Line of Credit Facility [Line Items]        
Outstanding amounts     $ 550,000,000 $ 560,000,000
Outstanding borrowings     545,594,000 554,624,000
Revolving Credit Facility | New Revolving Facility        
Line of Credit Facility [Line Items]        
Credit facility borrowing capacity $ 600,000,000.0      
Number of extension options | extension_option 2      
Extension option term (in months) 6 months      
Revolving Credit Facility | New Revolving Facility | Maximum        
Line of Credit Facility [Line Items]        
Facility fee on revolving commitment fees (percent) 0.35%      
Facility fee on revolving commitment fee based on investment grade ratings (percent) 0.30%      
Revolving Credit Facility | New Revolving Facility | Maximum | Base Rate        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 0.55%      
Revolving Credit Facility | New Revolving Facility | Maximum | LIBOR        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 1.55%      
Revolving Credit Facility | New Revolving Facility | Minimum        
Line of Credit Facility [Line Items]        
Facility fee on revolving commitment fees (percent) 0.15%      
Facility fee on revolving commitment fee based on investment grade ratings (percent) 0.125%      
Revolving Credit Facility | New Revolving Facility | Minimum | Base Rate        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 0.10%      
Revolving Credit Facility | New Revolving Facility | Minimum | LIBOR        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 1.10%      
Letter of Credit        
Line of Credit Facility [Line Items]        
Subfacility capacity as percentage of available revolving commitments (percent) 10.00%      
Swingline Loan        
Line of Credit Facility [Line Items]        
Subfacility capacity as percentage of available revolving commitments (percent) 10.00%      
Revolving Facility        
Line of Credit Facility [Line Items]        
Outstanding amounts     50,000,000 60,000,000
Outstanding borrowings     50,000,000 60,000,000
Revolving Facility | Prior Term Loan        
Line of Credit Facility [Line Items]        
Credit facility borrowing capacity   $ 100,000,000.0    
Prepayment premium in first year (percent)   2.00%    
Prepayment premium in second year (percent)   1.00%    
Revolving Facility | Prior Revolving Facility        
Line of Credit Facility [Line Items]        
Credit facility borrowing capacity   $ 400,000,000.0    
Uncommitted incremental facility limit   $ 250,000,000.0    
Number of extension options | extension_option   2    
Extension option term (in months)   6 months    
New Term Loan        
Line of Credit Facility [Line Items]        
Outstanding amounts     200,000,000 200,000,000
Outstanding borrowings     $ 198,925,000 $ 198,713,000
New Term Loan | New Term Loan Feb 2019        
Line of Credit Facility [Line Items]        
Debt instrument face amount $ 200,000,000.0      
New Term Loan | New Term Loan Feb 2019 | Maximum | Base Rate        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 1.20%      
New Term Loan | New Term Loan Feb 2019 | Maximum | LIBOR        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 2.20%      
New Term Loan | New Term Loan Feb 2019 | Minimum | Base Rate        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 0.50%      
New Term Loan | New Term Loan Feb 2019 | Minimum | LIBOR        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (percent) 1.50%      
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Debt - Schedule of Debt Maturities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Debt, Fiscal Year Maturity [Abstract]    
2021 $ 0  
2022 0  
2023 50,000  
2024 0  
2025 300,000  
Thereafter 200,000  
Total debt $ 550,000 $ 560,000
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Equity - Narrative (Details) - USD ($)
12 Months Ended
Apr. 15, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Mar. 20, 2020
Mar. 10, 2020
Class of Stock [Line Items]            
Common stock, par value (usd per share)   $ 0.01 $ 0.01      
Gross proceeds     $ 195,924,000 $ 179,882,000    
Share repurchase program authorization         $ 150,000,000.0  
Shares repurchased (shares)   0        
Underwritten Public Offering            
Class of Stock [Line Items]            
Issuance of common stock, net (shares) 6,641,250          
Common stock, par value (usd per share) $ 0.01          
Share price to the public (usd per share) $ 23.35          
Gross proceeds $ 149,000,000.0          
Over-Allotment Option            
Class of Stock [Line Items]            
Issuance of common stock, net (shares) 866,250          
ATM Program            
Class of Stock [Line Items]            
Issuance of common stock, net (shares)   0        
Remaining offering amount available   $ 500,000,000.0        
Maximum | ATM Program            
Class of Stock [Line Items]            
Authorized aggregate offering price of common stock           $ 500,000,000.0
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Equity - At-The-Market Offering (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
ATM Program Activity      
Gross proceeds   $ 195,924 $ 179,882
Commissions paid on stock issuance $ 404    
Prior ATM Program      
ATM Program Activity      
Number of shares (shares)   2,459  
Average sales price per share (usd per share)   $ 19.48  
Gross proceeds   $ 47,893  
Commissions paid on stock issuance   $ 600  
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Equity - Dividends on Common Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Equity [Abstract]                              
Dividends declared (usd per share) $ 0.25 $ 0.25 $ 0.25 $ 0.25 $ 0.225 $ 0.225 $ 0.225 $ 0.225 $ 0.205 $ 0.205 $ 0.205 $ 0.205 $ 1.00 $ 0.90 $ 0.82
Dividends payment date Jan. 15, 2021 Oct. 15, 2020 Jul. 15, 2020 Apr. 15, 2020 Jan. 15, 2020 Oct. 15, 2019 Jul. 15, 2019 Apr. 15, 2019 Jan. 15, 2019 Oct. 15, 2018 Jul. 13, 2018 Apr. 13, 2018      
Dividends payable as of record date $ 23,933 $ 23,934 $ 23,931 $ 23,931 $ 21,500 $ 21,500 $ 21,508 $ 20,011 $ 17,710 $ 17,196 $ 16,224 $ 15,608 $ 23,933 $ 21,500 $ 17,710
Dividends record date Dec. 31, 2020 Sep. 30, 2020 Jun. 30, 2020 Mar. 31, 2020 Dec. 31, 2019 Sep. 30, 2019 Jun. 28, 2019 Mar. 29, 2019 Dec. 31, 2018 Sep. 28, 2018 Jun. 29, 2018 Mar. 30, 2018      
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Restricted Stock and Performance Awards (Details) - Restricted Stock Award and Performance Award - $ / shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Shares    
Unvested, beginning balance (shares) 452,233 519,272
Granted (shares) 270,191 180,629
Vested (shares) (201,563) (247,534)
Forfeited (shares) (3,175) (134)
Unvested, ending balance (shares) 517,686 452,233
Weighted Average Share Price    
Unvested, beginning balance (usd per share) $ 17.90 $ 14.69
Granted (usd per share) 19.11 22.22
Vested (usd per share) 17.41 14.50
Forfeited (usd per share) 20.30 15.21
Unvested, ending balance (usd per share) $ 18.71 $ 17.90
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Payment Arrangement [Abstract]      
Stock-based compensation expense $ 3,790 $ 4,104 $ 3,848
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Narrative (Details)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Jun. 01, 2014
company
shares
Apr. 30, 2020
$ / shares
shares
Mar. 31, 2020
installment
$ / shares
shares
Jan. 31, 2020
installment
$ / shares
shares
May 31, 2019
$ / shares
shares
Feb. 28, 2019
installment
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
shares
Dec. 31, 2018
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of separate and independent companies after spin-off | company 2                
Restricted Stock Award and Performance Award                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unamortized stock-based compensation expense related to unvested awards | $             $ 5.5    
Weighted average remaining vesting period related to expense recognition             2 years 3 months 18 days    
Shares vested (shares)             201,563 247,534  
Shares forfeited (shares)             3,175 134  
Unvested stock awards outstanding (shares)             517,686 452,233 519,272
Number of shares granted (shares)             270,191 180,629  
Restricted Stock Award | Ensign Employees                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock award conversion ratio related to the spin-off 1                
Stock awards unvested during spin-off (shares) 207,580                
Shares forfeited (shares)             1,760    
Unvested stock awards outstanding (shares)             0    
Restricted Stock Award | Officers and Employees                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares granted (shares)     107,790 27,000   91,440      
Grant date fair market value (usd per share) | $ / shares     $ 19.06 $ 22.18   $ 22.00      
Number of equal annual vesting installments | installment     4 4   4      
Restricted Stock Award | Board of Directors                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares granted (shares)   27,611     17,749        
Grant date fair market value (usd per share) | $ / shares   $ 16.48     $ 24.23        
Performance Stock Award | Officers                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares granted (shares)     107,790     71,440      
Grant date fair market value (usd per share) | $ / shares     $ 19.06     $ 22.00      
Vesting metric, Normalized Funds from Operations, minimum (percent)           5.00%      
Performance Stock Award | Officers | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period (in years)     1 year     1 year      
Performance Stock Award | Officers | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period (in years)     4 years     4 years      
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Numerator:                      
Net income $ 21,055 $ 21,552 $ 18,935 $ 19,325 $ 20,662 $ (10,054) $ 19,698 $ 16,053 $ 80,867 $ 46,359 $ 57,923
Less: Net income allocated to participating securities                 (298) (296) (364)
Numerator for basic and diluted earnings available to common stockholders                 $ 80,569 $ 46,063 $ 57,559
Denominator:                      
Weighted-average basic common shares outstanding (shares) 95,215 95,214 95,208 95,161 95,103 95,103 94,036 88,010 95,200 93,088 79,386
Dilutive performance stock awards (shares)                 7 10 6
Weighted-average diluted common shares outstanding (shares) 95,244 95,214 95,208 95,161 95,144 95,103 94,036 88,010 95,207 93,098 79,392
Earnings per common share, basic (usd per share) $ 0.22 $ 0.23 $ 0.20 $ 0.20 $ 0.22 $ (0.11) $ 0.21 $ 0.18 $ 0.85 $ 0.49 $ 0.73
Earnings per common share, diluted (usd per share) $ 0.22 $ 0.23 $ 0.20 $ 0.20 $ 0.22 $ (0.11) $ 0.21 $ 0.18 $ 0.85 $ 0.49 $ 0.72
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies (Details)
$ in Millions
Dec. 31, 2020
USD ($)
Ensign and Pennant  
Other Commitments [Line Items]  
Aggregate required financing of capital expenditures as percentage of initial investment in property (percent) 20.00%
Expansion, construction and capital improvements at triple-net leased facilities  
Other Commitments [Line Items]  
Funding commitment $ 15.4
Portion of funding commitments subject to rent increase at time of funding $ 14.2
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.20.4
Concentration of Risk (Details)
12 Months Ended
Dec. 31, 2020
facility
state
unit_bed
Dec. 31, 2019
Dec. 31, 2018
Concentration Risk [Line Items]      
Number of facilities 218    
Skilled nursing, assisted living and independent living facilities      
Concentration Risk [Line Items]      
Number of facilities 218    
Ensign      
Concentration Risk [Line Items]      
Number of states where Ensign leases the highest concentration of properties | state 4    
Ensign | Customer Concentration Risk | Revenue, exclusive of operating expense reimbursements      
Concentration Risk [Line Items]      
Concentration risk (percent) 32.00% 38.00% 42.00%
PMG | Customer Concentration Risk | Revenue, exclusive of operating expense reimbursements      
Concentration Risk [Line Items]      
Concentration risk (percent) 16.00% 15.00% 8.00%
Ensign | Skilled nursing, assisted living and independent living facilities      
Concentration Risk [Line Items]      
Number of facilities 89    
Number of beds and units in facilities | unit_bed 9,546    
PMG      
Concentration Risk [Line Items]      
Number of facilities 15    
PMG | Skilled Nursing and Campus Facilities      
Concentration Risk [Line Items]      
Number of facilities 15    
Number of beds and units in facilities 2,145    
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.20.4
Selected Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]                      
Total revenues $ 44,137 $ 45,687 $ 44,168 $ 44,340 $ 44,228 $ 33,314 $ 46,201 $ 39,658 $ 178,332 $ 163,401 $ 156,941
Net income (loss) $ 21,055 $ 21,552 $ 18,935 $ 19,325 $ 20,662 $ (10,054) $ 19,698 $ 16,053 $ 80,867 $ 46,359 $ 57,923
Earnings per common share, basic (usd per share) $ 0.22 $ 0.23 $ 0.20 $ 0.20 $ 0.22 $ (0.11) $ 0.21 $ 0.18 $ 0.85 $ 0.49 $ 0.73
Earnings per common share, diluted (usd per share) $ 0.22 $ 0.23 $ 0.20 $ 0.20 $ 0.22 $ (0.11) $ 0.21 $ 0.18 $ 0.85 $ 0.49 $ 0.72
Weighted-average number of common shares outstanding, basic (shares) 95,215 95,214 95,208 95,161 95,103 95,103 94,036 88,010 95,200 93,088 79,386
Weighted-average number of common shares outstanding, diluted (shares) 95,244 95,214 95,208 95,161 95,144 95,103 94,036 88,010 95,207 93,098 79,392
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.20.4
Subsequent Events (Details)
$ in Thousands
12 Months Ended
Feb. 01, 2021
USD ($)
unit
facility
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Subsequent Event [Line Items]        
Real estate investments, net   $ 1,448,099 $ 1,414,200  
Proceeds from sale   $ 6,608 $ 3,499 $ 13,004
Subsequent event | Disposed of by sale | Skill Nursing Facility Washington [Member]        
Subsequent Event [Line Items]        
Number of properties sold | facility 1      
Number of units in property sold | unit 90      
Real estate investments, net $ 7,200      
Proceeds from sale $ 7,300      
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule III - Real Estate Assets and Accumulated Depreciation - By Property (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 206,497      
Initial Cost to Company, Buildings and Improvements 1,364,511      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 112,197      
Gross Carrying Value        
Gross Carrying Value, Land 205,356      
Gross Carrying Value, Buildings and Improvements 1,477,849      
Gross Carrying Value, Total 1,683,205 $ 1,605,081 $ 1,368,157 $ 1,266,484
Accumulated Depreciation (259,803) $ (220,359) $ (185,926) $ (152,185)
Aggregate cost of real estate for federal income tax purposes 1,700,000      
Skilled Nursing Properties        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances 0      
Initial Cost to Company        
Initial Cost to Company, Land 145,155      
Initial Cost to Company, Buildings and Improvements 963,927      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 92,226      
Gross Carrying Value        
Gross Carrying Value, Land 144,145      
Gross Carrying Value, Buildings and Improvements 1,057,163      
Gross Carrying Value, Total 1,201,307      
Accumulated Depreciation (194,390)      
Skilled Nursing Properties | Ensign Highland LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances 0      
Initial Cost to Company        
Initial Cost to Company, Land 257      
Initial Cost to Company, Buildings and Improvements 976      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 926      
Gross Carrying Value        
Gross Carrying Value, Land 257      
Gross Carrying Value, Buildings and Improvements 1,902      
Gross Carrying Value, Total 2,159      
Accumulated Depreciation $ (1,311)      
Construction/Renovation Date 2013      
Acquisition Date 2000      
Skilled Nursing Properties | Meadowbrook Health Associates LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 425      
Initial Cost to Company, Buildings and Improvements 3,716      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,940      
Gross Carrying Value        
Gross Carrying Value, Land 425      
Gross Carrying Value, Buildings and Improvements 5,656      
Gross Carrying Value, Total 6,081      
Accumulated Depreciation $ (3,103)      
Construction/Renovation Date 2012      
Acquisition Date 2000      
Skilled Nursing Properties | Terrace Holdings AZ LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 113      
Initial Cost to Company, Buildings and Improvements 504      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 971      
Gross Carrying Value        
Gross Carrying Value, Land 113      
Gross Carrying Value, Buildings and Improvements 1,475      
Gross Carrying Value, Total 1,588      
Accumulated Depreciation $ (865)      
Construction/Renovation Date 2004      
Acquisition Date 2002      
Skilled Nursing Properties | Rillito Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 471      
Initial Cost to Company, Buildings and Improvements 2,041      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 3,055      
Gross Carrying Value        
Gross Carrying Value, Land 471      
Gross Carrying Value, Buildings and Improvements 5,096      
Gross Carrying Value, Total 5,567      
Accumulated Depreciation $ (3,029)      
Construction/Renovation Date 2013      
Acquisition Date 2003      
Skilled Nursing Properties | Valley Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 629      
Initial Cost to Company, Buildings and Improvements 5,154      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,519      
Gross Carrying Value        
Gross Carrying Value, Land 629      
Gross Carrying Value, Buildings and Improvements 6,673      
Gross Carrying Value, Total 7,302      
Accumulated Depreciation $ (3,801)      
Construction/Renovation Date 2009      
Acquisition Date 2004      
Skilled Nursing Properties | Cedar Avenue Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,812      
Initial Cost to Company, Buildings and Improvements 3,919      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,994      
Gross Carrying Value        
Gross Carrying Value, Land 2,812      
Gross Carrying Value, Buildings and Improvements 5,913      
Gross Carrying Value, Total 8,725      
Accumulated Depreciation $ (3,475)      
Construction/Renovation Date 2011      
Acquisition Date 2005      
Skilled Nursing Properties | Granada Investments LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,526      
Initial Cost to Company, Buildings and Improvements 2,827      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,522      
Gross Carrying Value        
Gross Carrying Value, Land 3,526      
Gross Carrying Value, Buildings and Improvements 4,349      
Gross Carrying Value, Total 7,875      
Accumulated Depreciation $ (2,595)      
Construction/Renovation Date 2010      
Acquisition Date 2005      
Skilled Nursing Properties | Plaza Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 450      
Initial Cost to Company, Buildings and Improvements 5,566      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,055      
Gross Carrying Value        
Gross Carrying Value, Land 450      
Gross Carrying Value, Buildings and Improvements 6,621      
Gross Carrying Value, Total 7,071      
Accumulated Depreciation $ (3,878)      
Construction/Renovation Date 2009      
Acquisition Date 2006      
Skilled Nursing Properties | Mountainview Community Care LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 931      
Initial Cost to Company, Buildings and Improvements 2,612      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 653      
Gross Carrying Value        
Gross Carrying Value, Land 931      
Gross Carrying Value, Buildings and Improvements 3,265      
Gross Carrying Value, Total 4,196      
Accumulated Depreciation $ (2,082)      
Construction/Renovation Date 1963      
Acquisition Date 2006      
Skilled Nursing Properties | CM Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,028      
Initial Cost to Company, Buildings and Improvements 3,119      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,071      
Gross Carrying Value        
Gross Carrying Value, Land 3,028      
Gross Carrying Value, Buildings and Improvements 5,190      
Gross Carrying Value, Total 8,218      
Accumulated Depreciation $ (2,981)      
Construction/Renovation Date 2012      
Acquisition Date 2006      
Skilled Nursing Properties | Polk Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 60      
Initial Cost to Company, Buildings and Improvements 4,391      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,167      
Gross Carrying Value        
Gross Carrying Value, Land 60      
Gross Carrying Value, Buildings and Improvements 5,558      
Gross Carrying Value, Total 5,618      
Accumulated Depreciation $ (3,116)      
Construction/Renovation Date 2009      
Acquisition Date 2006      
Skilled Nursing Properties | Snohomish Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 741      
Initial Cost to Company, Buildings and Improvements 1,663      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,998      
Gross Carrying Value        
Gross Carrying Value, Land 741      
Gross Carrying Value, Buildings and Improvements 3,661      
Gross Carrying Value, Total 4,402      
Accumulated Depreciation $ (2,564)      
Construction/Renovation Date 2009      
Acquisition Date 2006      
Skilled Nursing Properties | Cherry Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 171      
Initial Cost to Company, Buildings and Improvements 1,828      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,038      
Gross Carrying Value        
Gross Carrying Value, Land 171      
Gross Carrying Value, Buildings and Improvements 3,866      
Gross Carrying Value, Total 4,037      
Accumulated Depreciation $ (2,525)      
Construction/Renovation Date 2010      
Acquisition Date 2006      
Skilled Nursing Properties | Golfview Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,105      
Initial Cost to Company, Buildings and Improvements 3,110      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,067      
Gross Carrying Value        
Gross Carrying Value, Land 1,105      
Gross Carrying Value, Buildings and Improvements 4,177      
Gross Carrying Value, Total 5,282      
Accumulated Depreciation $ (2,246)      
Construction/Renovation Date 2007      
Acquisition Date 2006      
Skilled Nursing Properties | Tenth East Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 332      
Initial Cost to Company, Buildings and Improvements 2,426      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,507      
Gross Carrying Value        
Gross Carrying Value, Land 332      
Gross Carrying Value, Buildings and Improvements 4,933      
Gross Carrying Value, Total 5,265      
Accumulated Depreciation $ (3,054)      
Construction/Renovation Date 2013      
Acquisition Date 2006      
Skilled Nursing Properties | Trinity Mill Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 664      
Initial Cost to Company, Buildings and Improvements 2,294      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 902      
Gross Carrying Value        
Gross Carrying Value, Land 664      
Gross Carrying Value, Buildings and Improvements 3,196      
Gross Carrying Value, Total 3,860      
Accumulated Depreciation $ (2,262)      
Construction/Renovation Date 2007      
Acquisition Date 2006      
Skilled Nursing Properties | Cottonwood Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 965      
Initial Cost to Company, Buildings and Improvements 2,070      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 958      
Gross Carrying Value        
Gross Carrying Value, Land 965      
Gross Carrying Value, Buildings and Improvements 3,028      
Gross Carrying Value, Total 3,993      
Accumulated Depreciation $ (2,275)      
Construction/Renovation Date 2008      
Acquisition Date 2007      
Skilled Nursing Properties | Verde Villa Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 600      
Initial Cost to Company, Buildings and Improvements 1,890      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 470      
Gross Carrying Value        
Gross Carrying Value, Land 600      
Gross Carrying Value, Buildings and Improvements 2,360      
Gross Carrying Value, Total 2,960      
Accumulated Depreciation $ (1,438)      
Construction/Renovation Date 2011      
Acquisition Date 2007      
Skilled Nursing Properties | Mesquite Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 470      
Initial Cost to Company, Buildings and Improvements 1,715      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 8,661      
Gross Carrying Value        
Gross Carrying Value, Land 470      
Gross Carrying Value, Buildings and Improvements 10,376      
Gross Carrying Value, Total 10,846      
Accumulated Depreciation $ (7,112)      
Construction/Renovation Date 2012      
Acquisition Date 2007      
Skilled Nursing Properties | Arrow Tree Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,165      
Initial Cost to Company, Buildings and Improvements 1,105      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 324      
Gross Carrying Value        
Gross Carrying Value, Land 2,165      
Gross Carrying Value, Buildings and Improvements 1,429      
Gross Carrying Value, Total 3,594      
Accumulated Depreciation $ (1,010)      
Construction/Renovation Date 1965      
Acquisition Date 2007      
Skilled Nursing Properties | Fort Street Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 443      
Initial Cost to Company, Buildings and Improvements 2,394      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 759      
Gross Carrying Value        
Gross Carrying Value, Land 443      
Gross Carrying Value, Buildings and Improvements 3,153      
Gross Carrying Value, Total 3,596      
Accumulated Depreciation $ (1,603)      
Construction/Renovation Date 2008      
Acquisition Date 2007      
Skilled Nursing Properties | Trousdale Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,415      
Initial Cost to Company, Buildings and Improvements 1,841      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,861      
Gross Carrying Value        
Gross Carrying Value, Land 1,415      
Gross Carrying Value, Buildings and Improvements 3,702      
Gross Carrying Value, Total 5,117      
Accumulated Depreciation $ (2,052)      
Construction/Renovation Date 2013      
Acquisition Date 2007      
Skilled Nursing Properties | Ensign Bellflower LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 937      
Initial Cost to Company, Buildings and Improvements 1,168      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 357      
Gross Carrying Value        
Gross Carrying Value, Land 937      
Gross Carrying Value, Buildings and Improvements 1,525      
Gross Carrying Value, Total 2,462      
Accumulated Depreciation $ (925)      
Construction/Renovation Date 2009      
Acquisition Date 2007      
Skilled Nursing Properties | RB Heights Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,007      
Initial Cost to Company, Buildings and Improvements 2,793      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,762      
Gross Carrying Value        
Gross Carrying Value, Land 2,007      
Gross Carrying Value, Buildings and Improvements 4,555      
Gross Carrying Value, Total 6,562      
Accumulated Depreciation $ (2,528)      
Construction/Renovation Date 2009      
Acquisition Date 2008      
Skilled Nursing Properties | San Corrine Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 310      
Initial Cost to Company, Buildings and Improvements 2,090      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 719      
Gross Carrying Value        
Gross Carrying Value, Land 310      
Gross Carrying Value, Buildings and Improvements 2,809      
Gross Carrying Value, Total 3,119      
Accumulated Depreciation $ (1,456)      
Construction/Renovation Date 2005      
Acquisition Date 2008      
Skilled Nursing Properties | Temple Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 529      
Initial Cost to Company, Buildings and Improvements 2,207      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,163      
Gross Carrying Value        
Gross Carrying Value, Land 529      
Gross Carrying Value, Buildings and Improvements 3,370      
Gross Carrying Value, Total 3,899      
Accumulated Depreciation $ (1,806)      
Construction/Renovation Date 2008      
Acquisition Date 2008      
Skilled Nursing Properties | Anson Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 369      
Initial Cost to Company, Buildings and Improvements 3,220      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,725      
Gross Carrying Value        
Gross Carrying Value, Land 369      
Gross Carrying Value, Buildings and Improvements 4,945      
Gross Carrying Value, Total 5,314      
Accumulated Depreciation $ (2,544)      
Construction/Renovation Date 2012      
Acquisition Date 2008      
Skilled Nursing Properties | Willits Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 490      
Initial Cost to Company, Buildings and Improvements 1,231      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 500      
Gross Carrying Value        
Gross Carrying Value, Land 490      
Gross Carrying Value, Buildings and Improvements 1,731      
Gross Carrying Value, Total 2,221      
Accumulated Depreciation $ (889)      
Construction/Renovation Date 2011      
Acquisition Date 2008      
Skilled Nursing Properties | Lufkin Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 467      
Initial Cost to Company, Buildings and Improvements 4,644      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 782      
Gross Carrying Value        
Gross Carrying Value, Land 467      
Gross Carrying Value, Buildings and Improvements 5,426      
Gross Carrying Value, Total 5,893      
Accumulated Depreciation $ (1,630)      
Construction/Renovation Date 1988      
Acquisition Date 2009      
Skilled Nursing Properties | Lowell Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 217      
Initial Cost to Company, Buildings and Improvements 856      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,735      
Gross Carrying Value        
Gross Carrying Value, Land 217      
Gross Carrying Value, Buildings and Improvements 2,591      
Gross Carrying Value, Total 2,808      
Accumulated Depreciation $ (1,421)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Skilled Nursing Properties | Jefferson Ralston Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 280      
Initial Cost to Company, Buildings and Improvements 1,230      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 834      
Gross Carrying Value        
Gross Carrying Value, Land 280      
Gross Carrying Value, Buildings and Improvements 2,064      
Gross Carrying Value, Total 2,344      
Accumulated Depreciation $ (920)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Skilled Nursing Properties | Lafayette Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,607      
Initial Cost to Company, Buildings and Improvements 4,222      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 6,195      
Gross Carrying Value        
Gross Carrying Value, Land 1,607      
Gross Carrying Value, Buildings and Improvements 10,417      
Gross Carrying Value, Total 12,024      
Accumulated Depreciation $ (5,021)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Skilled Nursing Properties | Hillendahl Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,133      
Initial Cost to Company, Buildings and Improvements 11,977      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,421      
Gross Carrying Value        
Gross Carrying Value, Land 2,133      
Gross Carrying Value, Buildings and Improvements 13,398      
Gross Carrying Value, Total 15,531      
Accumulated Depreciation $ (5,530)      
Construction/Renovation Date 1984      
Acquisition Date 2009      
Skilled Nursing Properties | Price Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 193      
Initial Cost to Company, Buildings and Improvements 2,209      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 849      
Gross Carrying Value        
Gross Carrying Value, Land 193      
Gross Carrying Value, Buildings and Improvements 3,058      
Gross Carrying Value, Total 3,251      
Accumulated Depreciation $ (1,102)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Skilled Nursing Properties | Silver Lake Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,051      
Initial Cost to Company, Buildings and Improvements 8,362      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,011      
Gross Carrying Value        
Gross Carrying Value, Land 2,051      
Gross Carrying Value, Buildings and Improvements 10,373      
Gross Carrying Value, Total 12,424      
Accumulated Depreciation $ (3,208)      
Construction/Renovation Date 2011      
Acquisition Date 2009      
Skilled Nursing Properties | Jordan Health Properties LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,671      
Initial Cost to Company, Buildings and Improvements 4,244      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,507      
Gross Carrying Value        
Gross Carrying Value, Land 2,671      
Gross Carrying Value, Buildings and Improvements 5,751      
Gross Carrying Value, Total 8,422      
Accumulated Depreciation $ (1,817)      
Construction/Renovation Date 2013      
Acquisition Date 2009      
Skilled Nursing Properties | Regal Road Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 767      
Initial Cost to Company, Buildings and Improvements 4,648      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 729      
Gross Carrying Value        
Gross Carrying Value, Land 767      
Gross Carrying Value, Buildings and Improvements 5,377      
Gross Carrying Value, Total 6,144      
Accumulated Depreciation $ (2,063)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Skilled Nursing Properties | Paredes Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 373      
Initial Cost to Company, Buildings and Improvements 1,354      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 190      
Gross Carrying Value        
Gross Carrying Value, Land 373      
Gross Carrying Value, Buildings and Improvements 1,544      
Gross Carrying Value, Total 1,917      
Accumulated Depreciation $ (464)      
Construction/Renovation Date 1969      
Acquisition Date 2009      
Skilled Nursing Properties | Expressway Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 90      
Initial Cost to Company, Buildings and Improvements 675      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 430      
Gross Carrying Value        
Gross Carrying Value, Land 90      
Gross Carrying Value, Buildings and Improvements 1,105      
Gross Carrying Value, Total 1,195      
Accumulated Depreciation $ (455)      
Construction/Renovation Date 2011      
Acquisition Date 2009      
Skilled Nursing Properties | Rio Grande Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 642      
Initial Cost to Company, Buildings and Improvements 1,085      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 870      
Gross Carrying Value        
Gross Carrying Value, Land 642      
Gross Carrying Value, Buildings and Improvements 1,955      
Gross Carrying Value, Total 2,597      
Accumulated Depreciation $ (934)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Skilled Nursing Properties | Fifth East Holdings        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 345      
Initial Cost to Company, Buildings and Improvements 2,464      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,065      
Gross Carrying Value        
Gross Carrying Value, Land 345      
Gross Carrying Value, Buildings and Improvements 3,529      
Gross Carrying Value, Total 3,874      
Accumulated Depreciation $ (1,355)      
Construction/Renovation Date 2011      
Acquisition Date 2009      
Skilled Nursing Properties | Emmett Healthcare Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 591      
Initial Cost to Company, Buildings and Improvements 2,383      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 69      
Gross Carrying Value        
Gross Carrying Value, Land 591      
Gross Carrying Value, Buildings and Improvements 2,452      
Gross Carrying Value, Total 3,043      
Accumulated Depreciation $ (801)      
Construction/Renovation Date 1972      
Acquisition Date 2010      
Skilled Nursing Properties | Burley Healthcare Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 250      
Initial Cost to Company, Buildings and Improvements 4,004      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 424      
Gross Carrying Value        
Gross Carrying Value, Land 250      
Gross Carrying Value, Buildings and Improvements 4,428      
Gross Carrying Value, Total 4,678      
Accumulated Depreciation $ (1,589)      
Construction/Renovation Date 2011      
Acquisition Date 2010      
Skilled Nursing Properties | Josey Ranch Healthcare Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,382      
Initial Cost to Company, Buildings and Improvements 2,293      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 478      
Gross Carrying Value        
Gross Carrying Value, Land 1,382      
Gross Carrying Value, Buildings and Improvements 2,771      
Gross Carrying Value, Total 4,153      
Accumulated Depreciation $ (934)      
Construction/Renovation Date 1996      
Acquisition Date 2010      
Skilled Nursing Properties | Everglades Health Holdings        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,847      
Initial Cost to Company, Buildings and Improvements 5,377      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 682      
Gross Carrying Value        
Gross Carrying Value, Land 1,847      
Gross Carrying Value, Buildings and Improvements 6,059      
Gross Carrying Value, Total 7,906      
Accumulated Depreciation $ (1,667)      
Construction/Renovation Date 1990      
Acquisition Date 2011      
Skilled Nursing Properties | Irving Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 60      
Initial Cost to Company, Buildings and Improvements 2,931      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 245      
Gross Carrying Value        
Gross Carrying Value, Land 60      
Gross Carrying Value, Buildings and Improvements 3,176      
Gross Carrying Value, Total 3,236      
Accumulated Depreciation $ (1,063)      
Construction/Renovation Date 2011      
Acquisition Date 2011      
Skilled Nursing Properties | Falls City Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 170      
Initial Cost to Company, Buildings and Improvements 2,141      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 82      
Gross Carrying Value        
Gross Carrying Value, Land 170      
Gross Carrying Value, Buildings and Improvements 2,223      
Gross Carrying Value, Total 2,393      
Accumulated Depreciation $ (677)      
Construction/Renovation Date 1972      
Acquisition Date 2011      
Skilled Nursing Properties | Gillette Park Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 163      
Initial Cost to Company, Buildings and Improvements 1,491      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 12      
Gross Carrying Value        
Gross Carrying Value, Land 163      
Gross Carrying Value, Buildings and Improvements 1,503      
Gross Carrying Value, Total 1,666      
Accumulated Depreciation $ (576)      
Construction/Renovation Date 1967      
Acquisition Date 2011      
Skilled Nursing Properties | Gazebo Park Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 80      
Initial Cost to Company, Buildings and Improvements 2,541      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 97      
Gross Carrying Value        
Gross Carrying Value, Land 80      
Gross Carrying Value, Buildings and Improvements 2,638      
Gross Carrying Value, Total 2,718      
Accumulated Depreciation $ (1,052)      
Construction/Renovation Date 1978      
Acquisition Date 2011      
Skilled Nursing Properties | Oleson Park Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 90      
Initial Cost to Company, Buildings and Improvements 2,341      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 759      
Gross Carrying Value        
Gross Carrying Value, Land 90      
Gross Carrying Value, Buildings and Improvements 3,100      
Gross Carrying Value, Total 3,190      
Accumulated Depreciation $ (1,527)      
Construction/Renovation Date 2012      
Acquisition Date 2011      
Skilled Nursing Properties | Arapahoe Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 158      
Initial Cost to Company, Buildings and Improvements 4,810      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 759      
Gross Carrying Value        
Gross Carrying Value, Land 128      
Gross Carrying Value, Buildings and Improvements 5,599      
Gross Carrying Value, Total 5,727      
Accumulated Depreciation $ (2,030)      
Construction/Renovation Date 2012      
Acquisition Date 2011      
Skilled Nursing Properties | Dixie Health Holdings        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 487      
Initial Cost to Company, Buildings and Improvements 1,978      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 98      
Gross Carrying Value        
Gross Carrying Value, Land 487      
Gross Carrying Value, Buildings and Improvements 2,076      
Gross Carrying Value, Total 2,563      
Accumulated Depreciation $ (525)      
Construction/Renovation Date 1978      
Acquisition Date 2011      
Skilled Nursing Properties | Memorial Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 537      
Initial Cost to Company, Buildings and Improvements 2,138      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 698      
Gross Carrying Value        
Gross Carrying Value, Land 537      
Gross Carrying Value, Buildings and Improvements 2,836      
Gross Carrying Value, Total 3,373      
Accumulated Depreciation $ (1,077)      
Construction/Renovation Date 2007      
Acquisition Date 2011      
Skilled Nursing Properties | Bogardus Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,425      
Initial Cost to Company, Buildings and Improvements 5,307      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,079      
Gross Carrying Value        
Gross Carrying Value, Land 1,425      
Gross Carrying Value, Buildings and Improvements 6,386      
Gross Carrying Value, Total 7,811      
Accumulated Depreciation $ (2,258)      
Construction/Renovation Date 2011      
Acquisition Date 2011      
Skilled Nursing Properties | South Dora Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 297      
Initial Cost to Company, Buildings and Improvements 2,087      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,621      
Gross Carrying Value        
Gross Carrying Value, Land 297      
Gross Carrying Value, Buildings and Improvements 3,708      
Gross Carrying Value, Total 4,005      
Accumulated Depreciation $ (2,096)      
Construction/Renovation Date 2013      
Acquisition Date 2011      
Skilled Nursing Properties | Silverada Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,012      
Initial Cost to Company, Buildings and Improvements 3,282      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 103      
Gross Carrying Value        
Gross Carrying Value, Land 1,012      
Gross Carrying Value, Buildings and Improvements 3,385      
Gross Carrying Value, Total 4,397      
Accumulated Depreciation $ (803)      
Construction/Renovation Date 1970      
Acquisition Date 2011      
Skilled Nursing Properties | Orem Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,689      
Initial Cost to Company, Buildings and Improvements 3,896      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 3,235      
Gross Carrying Value        
Gross Carrying Value, Land 1,689      
Gross Carrying Value, Buildings and Improvements 7,131      
Gross Carrying Value, Total 8,820      
Accumulated Depreciation $ (2,940)      
Construction/Renovation Date 2011      
Acquisition Date 2011      
Skilled Nursing Properties | Wisteria Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 746      
Initial Cost to Company, Buildings and Improvements 9,903      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 290      
Gross Carrying Value        
Gross Carrying Value, Land 746      
Gross Carrying Value, Buildings and Improvements 10,193      
Gross Carrying Value, Total 10,939      
Accumulated Depreciation $ (2,267)      
Construction/Renovation Date 2008      
Acquisition Date 2011      
Skilled Nursing Properties | Renne Avenue Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 180      
Initial Cost to Company, Buildings and Improvements 2,481      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 966      
Gross Carrying Value        
Gross Carrying Value, Land 180      
Gross Carrying Value, Buildings and Improvements 3,447      
Gross Carrying Value, Total 3,627      
Accumulated Depreciation $ (1,219)      
Construction/Renovation Date 2013      
Acquisition Date 2012      
Skilled Nursing Properties | Stillhouse Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 129      
Initial Cost to Company, Buildings and Improvements 7,139      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 6      
Gross Carrying Value        
Gross Carrying Value, Land 129      
Gross Carrying Value, Buildings and Improvements 7,145      
Gross Carrying Value, Total 7,274      
Accumulated Depreciation $ (1,079)      
Construction/Renovation Date 2009      
Acquisition Date 2012      
Skilled Nursing Properties | Fig Street Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 329      
Initial Cost to Company, Buildings and Improvements 2,653      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,094      
Gross Carrying Value        
Gross Carrying Value, Land 329      
Gross Carrying Value, Buildings and Improvements 3,747      
Gross Carrying Value, Total 4,076      
Accumulated Depreciation $ (1,627)      
Construction/Renovation Date 2007      
Acquisition Date 2012      
Skilled Nursing Properties | Lowell Lake Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 49      
Initial Cost to Company, Buildings and Improvements 1,554      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 29      
Gross Carrying Value        
Gross Carrying Value, Land 49      
Gross Carrying Value, Buildings and Improvements 1,583      
Gross Carrying Value, Total 1,632      
Accumulated Depreciation $ (312)      
Construction/Renovation Date 1990      
Acquisition Date 2012      
Skilled Nursing Properties | Queensway Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 999      
Initial Cost to Company, Buildings and Improvements 4,237      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,331      
Gross Carrying Value        
Gross Carrying Value, Land 999      
Gross Carrying Value, Buildings and Improvements 6,568      
Gross Carrying Value, Total 7,567      
Accumulated Depreciation $ (2,886)      
Construction/Renovation Date 2008      
Acquisition Date 2012      
Skilled Nursing Properties | Long Beach Health Associates LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,285      
Initial Cost to Company, Buildings and Improvements 2,343      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,172      
Gross Carrying Value        
Gross Carrying Value, Land 1,285      
Gross Carrying Value, Buildings and Improvements 4,515      
Gross Carrying Value, Total 5,800      
Accumulated Depreciation $ (1,943)      
Construction/Renovation Date 2013      
Acquisition Date 2012      
Skilled Nursing Properties | Kings Court Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 193      
Initial Cost to Company, Buildings and Improvements 2,311      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 318      
Gross Carrying Value        
Gross Carrying Value, Land 193      
Gross Carrying Value, Buildings and Improvements 2,629      
Gross Carrying Value, Total 2,822      
Accumulated Depreciation $ (635)      
Construction/Renovation Date 1965      
Acquisition Date 2012      
Skilled Nursing Properties | 51st Avenue Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 340      
Initial Cost to Company, Buildings and Improvements 3,925      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 32      
Gross Carrying Value        
Gross Carrying Value, Land 340      
Gross Carrying Value, Buildings and Improvements 3,957      
Gross Carrying Value, Total 4,297      
Accumulated Depreciation $ (895)      
Construction/Renovation Date 1970      
Acquisition Date 2013      
Skilled Nursing Properties | Ives Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 371      
Initial Cost to Company, Buildings and Improvements 2,951      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 274      
Gross Carrying Value        
Gross Carrying Value, Land 371      
Gross Carrying Value, Buildings and Improvements 3,225      
Gross Carrying Value, Total 3,596      
Accumulated Depreciation $ (697)      
Construction/Renovation Date 1972      
Acquisition Date 2013      
Skilled Nursing Properties | Guadalupe Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 80      
Initial Cost to Company, Buildings and Improvements 2,391      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 15      
Gross Carrying Value        
Gross Carrying Value, Land 80      
Gross Carrying Value, Buildings and Improvements 2,406      
Gross Carrying Value, Total 2,486      
Accumulated Depreciation $ (422)      
Construction/Renovation Date 2013      
Acquisition Date 2013      
Skilled Nursing Properties | 49th Street Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 129      
Initial Cost to Company, Buildings and Improvements 2,418      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 24      
Gross Carrying Value        
Gross Carrying Value, Land 129      
Gross Carrying Value, Buildings and Improvements 2,442      
Gross Carrying Value, Total 2,571      
Accumulated Depreciation $ (629)      
Construction/Renovation Date 1960      
Acquisition Date 2013      
Skilled Nursing Properties | Willows Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,388      
Initial Cost to Company, Buildings and Improvements 2,982      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 202      
Gross Carrying Value        
Gross Carrying Value, Land 1,388      
Gross Carrying Value, Buildings and Improvements 3,184      
Gross Carrying Value, Total 4,572      
Accumulated Depreciation $ (909)      
Construction/Renovation Date 1970      
Acquisition Date 2013      
Skilled Nursing Properties | Tulalip Bay Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,722      
Initial Cost to Company, Buildings and Improvements 2,642      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition (980)      
Gross Carrying Value        
Gross Carrying Value, Land 742      
Gross Carrying Value, Buildings and Improvements 2,642      
Gross Carrying Value, Total 3,384      
Accumulated Depreciation $ (660)      
Construction/Renovation Date 1966      
Acquisition Date 2013      
Skilled Nursing Properties | Sky Holdings AZ LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 228      
Initial Cost to Company, Buildings and Improvements 1,124      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,380      
Gross Carrying Value        
Gross Carrying Value, Land 228      
Gross Carrying Value, Buildings and Improvements 2,504      
Gross Carrying Value, Total 2,731      
Accumulated Depreciation $ (1,727)      
Construction/Renovation Date 2004      
Acquisition Date 2002      
Skilled Nursing Properties | Lemon River Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 152      
Initial Cost to Company, Buildings and Improvements 357      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,493      
Gross Carrying Value        
Gross Carrying Value, Land 152      
Gross Carrying Value, Buildings and Improvements 1,850      
Gross Carrying Value, Total 2,002      
Accumulated Depreciation $ (1,163)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Skilled Nursing Properties | CTR Partnership, L.P. | Bethany Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,668      
Initial Cost to Company, Buildings and Improvements 15,375      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 56      
Gross Carrying Value        
Gross Carrying Value, Land 1,668      
Gross Carrying Value, Buildings and Improvements 15,431      
Gross Carrying Value, Total 17,099      
Accumulated Depreciation $ (2,285)      
Construction/Renovation Date 1989      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Mira Vista Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,601      
Initial Cost to Company, Buildings and Improvements 7,425      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,601      
Gross Carrying Value, Buildings and Improvements 7,425      
Gross Carrying Value, Total 9,026      
Accumulated Depreciation $ (1,067)      
Construction/Renovation Date 1989      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Shoreline Health and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,462      
Initial Cost to Company, Buildings and Improvements 5,034      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,462      
Gross Carrying Value, Buildings and Improvements 5,034      
Gross Carrying Value, Total 6,496      
Accumulated Depreciation $ (703)      
Construction/Renovation Date 1987      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Shamrock Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 251      
Initial Cost to Company, Buildings and Improvements 7,855      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 251      
Gross Carrying Value, Buildings and Improvements 7,855      
Gross Carrying Value, Total 8,106      
Accumulated Depreciation $ (1,080)      
Construction/Renovation Date 2010      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | BeaverCreek Health and Rehab        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 892      
Initial Cost to Company, Buildings and Improvements 17,159      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 13      
Gross Carrying Value        
Gross Carrying Value, Land 892      
Gross Carrying Value, Buildings and Improvements 17,172      
Gross Carrying Value, Total 18,064      
Accumulated Depreciation $ (2,254)      
Construction/Renovation Date 2014      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Premier Estates of Cincinnati-Riverview        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 833      
Initial Cost to Company, Buildings and Improvements 18,086      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 192      
Gross Carrying Value        
Gross Carrying Value, Land 833      
Gross Carrying Value, Buildings and Improvements 18,278      
Gross Carrying Value, Total 19,111      
Accumulated Depreciation $ (2,416)      
Construction/Renovation Date 1992      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Englewood Health and Rehab        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,014      
Initial Cost to Company, Buildings and Improvements 18,541      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 88      
Gross Carrying Value        
Gross Carrying Value, Land 1,014      
Gross Carrying Value, Buildings and Improvements 18,629      
Gross Carrying Value, Total 19,643      
Accumulated Depreciation $ (2,464)      
Construction/Renovation Date 1962      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Portsmouth Health and Rehab        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 282      
Initial Cost to Company, Buildings and Improvements 9,726      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 428      
Gross Carrying Value        
Gross Carrying Value, Land 282      
Gross Carrying Value, Buildings and Improvements 10,154      
Gross Carrying Value, Total 10,436      
Accumulated Depreciation $ (1,400)      
Construction/Renovation Date 2008      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | West Cove Care & Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 93      
Initial Cost to Company, Buildings and Improvements 10,365      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 93      
Gross Carrying Value, Buildings and Improvements 10,365      
Gross Carrying Value, Total 10,458      
Accumulated Depreciation $ (1,360)      
Construction/Renovation Date 2007      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | BellBrook Health and Rehab        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 214      
Initial Cost to Company, Buildings and Improvements 2,573      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 231      
Gross Carrying Value        
Gross Carrying Value, Land 214      
Gross Carrying Value, Buildings and Improvements 2,804      
Gross Carrying Value, Total 3,018      
Accumulated Depreciation $ (385)      
Construction/Renovation Date 2003      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Xenia Health and Rehab        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 205      
Initial Cost to Company, Buildings and Improvements 3,564      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 23      
Gross Carrying Value        
Gross Carrying Value, Land 205      
Gross Carrying Value, Buildings and Improvements 3,587      
Gross Carrying Value, Total 3,792      
Accumulated Depreciation $ (471)      
Construction/Renovation Date 1981      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Jamestown Place Health and Rehab        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 266      
Initial Cost to Company, Buildings and Improvements 4,725      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 268      
Gross Carrying Value        
Gross Carrying Value, Land 266      
Gross Carrying Value, Buildings and Improvements 4,993      
Gross Carrying Value, Total 5,259      
Accumulated Depreciation $ (694)      
Construction/Renovation Date 1967      
Acquisition Date 2015      
Skilled Nursing Properties | CTR Partnership, L.P. | Casa de Paz        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 119      
Initial Cost to Company, Buildings and Improvements 7,727      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 119      
Gross Carrying Value, Buildings and Improvements 7,727      
Gross Carrying Value, Total 7,846      
Accumulated Depreciation $ (950)      
Construction/Renovation Date 1974      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Denison Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 96      
Initial Cost to Company, Buildings and Improvements 2,784      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 96      
Gross Carrying Value, Buildings and Improvements 2,784      
Gross Carrying Value, Total 2,880      
Accumulated Depreciation $ (342)      
Construction/Renovation Date 2015      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Garden View Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 105      
Initial Cost to Company, Buildings and Improvements 3,179      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 105      
Gross Carrying Value, Buildings and Improvements 3,179      
Gross Carrying Value, Total 3,284      
Accumulated Depreciation $ (391)      
Construction/Renovation Date 2013      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Grandview Health Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 39      
Initial Cost to Company, Buildings and Improvements 1,167      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 39      
Gross Carrying Value, Buildings and Improvements 1,167      
Gross Carrying Value, Total 1,206      
Accumulated Depreciation $ (143)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Grundy Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 65      
Initial Cost to Company, Buildings and Improvements 1,935      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 65      
Gross Carrying Value, Buildings and Improvements 1,935      
Gross Carrying Value, Total 2,000      
Accumulated Depreciation $ (238)      
Construction/Renovation Date 2011      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Iowa City Rehab and Health Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 522      
Initial Cost to Company, Buildings and Improvements 5,690      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 522      
Gross Carrying Value, Buildings and Improvements 5,690      
Gross Carrying Value, Total 6,212      
Accumulated Depreciation $ (699)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Lenox Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 31      
Initial Cost to Company, Buildings and Improvements 1,915      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 31      
Gross Carrying Value, Buildings and Improvements 1,915      
Gross Carrying Value, Total 1,946      
Accumulated Depreciation $ (235)      
Construction/Renovation Date 2012      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Osage        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 126      
Initial Cost to Company, Buildings and Improvements 2,255      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 126      
Gross Carrying Value, Buildings and Improvements 2,255      
Gross Carrying Value, Total 2,381      
Accumulated Depreciation $ (277)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Pleasant Acres Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 189      
Initial Cost to Company, Buildings and Improvements 2,544      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 189      
Gross Carrying Value, Buildings and Improvements 2,544      
Gross Carrying Value, Total 2,733      
Accumulated Depreciation $ (313)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Cedar Falls Health Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 324      
Initial Cost to Company, Buildings and Improvements 4,366      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 324      
Gross Carrying Value, Buildings and Improvements 4,366      
Gross Carrying Value, Total 4,690      
Accumulated Depreciation $ (518)      
Construction/Renovation Date 2015      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Premier Estates of Highlands        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 364      
Initial Cost to Company, Buildings and Improvements 2,199      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 282      
Gross Carrying Value        
Gross Carrying Value, Land 364      
Gross Carrying Value, Buildings and Improvements 2,481      
Gross Carrying Value, Total 2,845      
Accumulated Depreciation $ (293)      
Construction/Renovation Date 2012      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Shaw Mountain at Cascadia        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,801      
Initial Cost to Company, Buildings and Improvements 6,572      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 395      
Gross Carrying Value        
Gross Carrying Value, Land 1,801      
Gross Carrying Value, Buildings and Improvements 6,967      
Gross Carrying Value, Total 8,768      
Accumulated Depreciation $ (908)      
Construction/Renovation Date 1989      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | The Oaks        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,646      
Initial Cost to Company, Buildings and Improvements 2,873      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 110      
Gross Carrying Value        
Gross Carrying Value, Land 3,646      
Gross Carrying Value, Buildings and Improvements 2,983      
Gross Carrying Value, Total 6,629      
Accumulated Depreciation $ (353)      
Construction/Renovation Date 2015      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Arbor Nursing Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 768      
Initial Cost to Company, Buildings and Improvements 10,712      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 768      
Gross Carrying Value, Buildings and Improvements 10,712      
Gross Carrying Value, Total 11,480      
Accumulated Depreciation $ (1,183)      
Construction/Renovation Date 1982      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Broadmoor Medical Lodge        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,232      
Initial Cost to Company, Buildings and Improvements 22,152      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,232      
Gross Carrying Value, Buildings and Improvements 22,152      
Gross Carrying Value, Total 23,384      
Accumulated Depreciation $ (2,262)      
Construction/Renovation Date 1984      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Decatur Medical Lodge        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 990      
Initial Cost to Company, Buildings and Improvements 24,909      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 990      
Gross Carrying Value, Buildings and Improvements 24,909      
Gross Carrying Value, Total 25,899      
Accumulated Depreciation $ (2,543)      
Construction/Renovation Date 2013      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Royse City Medical Lodge        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 606      
Initial Cost to Company, Buildings and Improvements 14,660      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 606      
Gross Carrying Value, Buildings and Improvements 14,660      
Gross Carrying Value, Total 15,266      
Accumulated Depreciation $ (1,497)      
Construction/Renovation Date 2009      
Acquisition Date 2016      
Skilled Nursing Properties | CTR Partnership, L.P. | Saline Care Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,022      
Initial Cost to Company, Buildings and Improvements 5,713      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,022      
Gross Carrying Value, Buildings and Improvements 5,713      
Gross Carrying Value, Total 6,735      
Accumulated Depreciation $ (547)      
Construction/Renovation Date 2009      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Carrier Mills Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 775      
Initial Cost to Company, Buildings and Improvements 8,377      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 775      
Gross Carrying Value, Buildings and Improvements 8,377      
Gross Carrying Value, Total 9,152      
Accumulated Depreciation $ (803)      
Construction/Renovation Date 1968      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | StoneBridge Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 439      
Initial Cost to Company, Buildings and Improvements 3,475      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 439      
Gross Carrying Value, Buildings and Improvements 3,475      
Gross Carrying Value, Total 3,914      
Accumulated Depreciation $ (333)      
Construction/Renovation Date 2014      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | DuQuoin Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 511      
Initial Cost to Company, Buildings and Improvements 3,662      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 511      
Gross Carrying Value, Buildings and Improvements 3,662      
Gross Carrying Value, Total 4,173      
Accumulated Depreciation $ (351)      
Construction/Renovation Date 2014      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Pinckneyville Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 406      
Initial Cost to Company, Buildings and Improvements 3,411      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 406      
Gross Carrying Value, Buildings and Improvements 3,411      
Gross Carrying Value, Total 3,817      
Accumulated Depreciation $ (327)      
Construction/Renovation Date 2014      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Wellspring Health and Rehabilitation Of Cascadia        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 774      
Initial Cost to Company, Buildings and Improvements 5,044      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 111      
Gross Carrying Value        
Gross Carrying Value, Land 774      
Gross Carrying Value, Buildings and Improvements 5,155      
Gross Carrying Value, Total 5,929      
Accumulated Depreciation $ (462)      
Construction/Renovation Date 2011      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | The Rio at Fox Hollow        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,178      
Initial Cost to Company, Buildings and Improvements 12,059      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,178      
Gross Carrying Value, Buildings and Improvements 12,059      
Gross Carrying Value, Total 13,237      
Accumulated Depreciation $ (1,080)      
Construction/Renovation Date 2016      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | The Rio at Cabezon        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,055      
Initial Cost to Company, Buildings and Improvements 9,749      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 2,055      
Gross Carrying Value, Buildings and Improvements 9,749      
Gross Carrying Value, Total 11,804      
Accumulated Depreciation $ (873)      
Construction/Renovation Date 2016      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Eldorado Rehab & Healthcare        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 940      
Initial Cost to Company, Buildings and Improvements 2,093      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 940      
Gross Carrying Value, Buildings and Improvements 2,093      
Gross Carrying Value, Total 3,033      
Accumulated Depreciation $ (183)      
Construction/Renovation Date 1993      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Secora Health and Rehabilitation of Cascadia        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,481      
Initial Cost to Company, Buildings and Improvements 2,216      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 110      
Gross Carrying Value        
Gross Carrying Value, Land 1,481      
Gross Carrying Value, Buildings and Improvements 2,326      
Gross Carrying Value, Total 3,807      
Accumulated Depreciation $ (194)      
Construction/Renovation Date 2012      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Mountain Valley        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 916      
Initial Cost to Company, Buildings and Improvements 7,874      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 916      
Gross Carrying Value, Buildings and Improvements 7,874      
Gross Carrying Value, Total 8,790      
Accumulated Depreciation $ (656)      
Construction/Renovation Date 1971      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Caldwell Care        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 906      
Initial Cost to Company, Buildings and Improvements 7,020      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 516      
Gross Carrying Value        
Gross Carrying Value, Land 906      
Gross Carrying Value, Buildings and Improvements 7,536      
Gross Carrying Value, Total 8,442      
Accumulated Depreciation $ (585)      
Construction/Renovation Date 1947      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Canyon West        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 312      
Initial Cost to Company, Buildings and Improvements 10,410      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 431      
Gross Carrying Value        
Gross Carrying Value, Land 312      
Gross Carrying Value, Buildings and Improvements 10,841      
Gross Carrying Value, Total 11,153      
Accumulated Depreciation $ (868)      
Construction/Renovation Date 1969      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Lewiston Health and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 625      
Initial Cost to Company, Buildings and Improvements 12,087      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 152      
Gross Carrying Value        
Gross Carrying Value, Land 625      
Gross Carrying Value, Buildings and Improvements 12,239      
Gross Carrying Value, Total 12,864      
Accumulated Depreciation $ (982)      
Construction/Renovation Date 1964      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | The Orchards        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 785      
Initial Cost to Company, Buildings and Improvements 8,923      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 47      
Gross Carrying Value        
Gross Carrying Value, Land 785      
Gross Carrying Value, Buildings and Improvements 8,970      
Gross Carrying Value, Total 9,755      
Accumulated Depreciation $ (725)      
Construction/Renovation Date 1958      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Weiser Care        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 80      
Initial Cost to Company, Buildings and Improvements 4,419      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 30      
Gross Carrying Value        
Gross Carrying Value, Land 80      
Gross Carrying Value, Buildings and Improvements 4,449      
Gross Carrying Value, Total 4,529      
Accumulated Depreciation $ (359)      
Construction/Renovation Date 1964      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Aspen Park]        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 698      
Initial Cost to Company, Buildings and Improvements 5,092      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 274      
Gross Carrying Value        
Gross Carrying Value, Land 698      
Gross Carrying Value, Buildings and Improvements 5,366      
Gross Carrying Value, Total 6,064      
Accumulated Depreciation $ (438)      
Construction/Renovation Date 1965      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Ridgmar Medical Lodge        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 681      
Initial Cost to Company, Buildings and Improvements 6,587      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,256      
Gross Carrying Value        
Gross Carrying Value, Land 681      
Gross Carrying Value, Buildings and Improvements 7,843      
Gross Carrying Value, Total 8,524      
Accumulated Depreciation $ (702)      
Construction/Renovation Date 2006      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Mansfield Medical Lodge        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 607      
Initial Cost to Company, Buildings and Improvements 4,801      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,178      
Gross Carrying Value        
Gross Carrying Value, Land 607      
Gross Carrying Value, Buildings and Improvements 5,979      
Gross Carrying Value, Total 6,586      
Accumulated Depreciation $ (513)      
Construction/Renovation Date 2006      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Grapevine Medical Lodge        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,602      
Initial Cost to Company, Buildings and Improvements 4,536      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 891      
Gross Carrying Value        
Gross Carrying Value, Land 1,602      
Gross Carrying Value, Buildings and Improvements 5,427      
Gross Carrying Value, Total 7,029      
Accumulated Depreciation $ (486)      
Construction/Renovation Date 2006      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Brookfield Health and Rehab        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 320      
Initial Cost to Company, Buildings and Improvements 500      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 320      
Gross Carrying Value, Buildings and Improvements 500      
Gross Carrying Value, Total 820      
Accumulated Depreciation $ (42)      
Construction/Renovation Date 2012      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | The Oaks at Lakewood        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,000      
Initial Cost to Company, Buildings and Improvements 1,779      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,000      
Gross Carrying Value, Buildings and Improvements 1,779      
Gross Carrying Value, Total 2,779      
Accumulated Depreciation $ (145)      
Construction/Renovation Date 1989      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | The Oaks at Timberline        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 445      
Initial Cost to Company, Buildings and Improvements 869      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 445      
Gross Carrying Value, Buildings and Improvements 869      
Gross Carrying Value, Total 1,314      
Accumulated Depreciation $ (71)      
Construction/Renovation Date 1972      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Providence Waterman Nursing Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,831      
Initial Cost to Company, Buildings and Improvements 19,791      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 3,831      
Gross Carrying Value, Buildings and Improvements 19,791      
Gross Carrying Value, Total 23,622      
Accumulated Depreciation $ (1,608)      
Construction/Renovation Date 1967      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Providence Orange Tree        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,897      
Initial Cost to Company, Buildings and Improvements 14,700      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 2,897      
Gross Carrying Value, Buildings and Improvements 14,700      
Gross Carrying Value, Total 17,597      
Accumulated Depreciation $ (1,194)      
Construction/Renovation Date 1969      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Providence Ontario        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 4,204      
Initial Cost to Company, Buildings and Improvements 21,880      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 4,204      
Gross Carrying Value, Buildings and Improvements 21,880      
Gross Carrying Value, Total 26,084      
Accumulated Depreciation $ (1,778)      
Construction/Renovation Date 1980      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Greenville Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 188      
Initial Cost to Company, Buildings and Improvements 3,972      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 188      
Gross Carrying Value, Buildings and Improvements 3,972      
Gross Carrying Value, Total 4,160      
Accumulated Depreciation $ (366)      
Construction/Renovation Date 1973      
Acquisition Date 2017      
Skilled Nursing Properties | CTR Partnership, L.P. | Copper Ridge Health and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 220      
Initial Cost to Company, Buildings and Improvements 4,974      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 220      
Gross Carrying Value, Buildings and Improvements 4,974      
Gross Carrying Value, Total 5,194      
Accumulated Depreciation $ (398)      
Construction/Renovation Date 2010      
Acquisition Date 2018      
Skilled Nursing Properties | CTR Partnership, L.P. | Prairie Heights Healthcare Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,372      
Initial Cost to Company, Buildings and Improvements 7,491      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,372      
Gross Carrying Value, Buildings and Improvements 7,491      
Gross Carrying Value, Total 8,863      
Accumulated Depreciation $ (510)      
Construction/Renovation Date 1965      
Acquisition Date 2018      
Skilled Nursing Properties | CTR Partnership, L.P. | The Meadows on University        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 989      
Initial Cost to Company, Buildings and Improvements 3,275      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 989      
Gross Carrying Value, Buildings and Improvements 3,275      
Gross Carrying Value, Total 4,264      
Accumulated Depreciation $ (196)      
Construction/Renovation Date 1966      
Acquisition Date 2018      
Skilled Nursing Properties | CTR Partnership, L.P. | The Suites - Parker        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,178      
Initial Cost to Company, Buildings and Improvements 17,857      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,178      
Gross Carrying Value, Buildings and Improvements 17,857      
Gross Carrying Value, Total 19,035      
Accumulated Depreciation $ (952)      
Construction/Renovation Date 2012      
Acquisition Date 2018      
Skilled Nursing Properties | CTR Partnership, L.P. | Huntington Park Nursing Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,131      
Initial Cost to Company, Buildings and Improvements 8,876      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 299      
Gross Carrying Value        
Gross Carrying Value, Land 3,131      
Gross Carrying Value, Buildings and Improvements 9,175      
Gross Carrying Value, Total 12,306      
Accumulated Depreciation $ (464)      
Construction/Renovation Date 1955      
Acquisition Date 2019      
Skilled Nursing Properties | CTR Partnership, L.P. | Shoreline Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,699      
Initial Cost to Company, Buildings and Improvements 9,004      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,699      
Gross Carrying Value, Buildings and Improvements 9,004      
Gross Carrying Value, Total 10,703      
Accumulated Depreciation $ (443)      
Construction/Renovation Date 1962      
Acquisition Date 2019      
Skilled Nursing Properties | CTR Partnership, L.P. | Downey Care Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,502      
Initial Cost to Company, Buildings and Improvements 6,141      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 2,502      
Gross Carrying Value, Buildings and Improvements 6,141      
Gross Carrying Value, Total 8,643      
Accumulated Depreciation $ (303)      
Construction/Renovation Date 1967      
Acquisition Date 2019      
Skilled Nursing Properties | CTR Partnership, L.P. | Courtyard Healthcare Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,351      
Initial Cost to Company, Buildings and Improvements 9,256      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 2,351      
Gross Carrying Value, Buildings and Improvements 9,256      
Gross Carrying Value, Total 11,607      
Accumulated Depreciation $ (464)      
Construction/Renovation Date 1969      
Acquisition Date 2019      
Skilled Nursing Properties | CTR Partnership, L.P. | Cascadia of Nampa        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 880      
Initial Cost to Company, Buildings and Improvements 14,117      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 880      
Gross Carrying Value, Buildings and Improvements 14,117      
Gross Carrying Value, Total 14,997      
Accumulated Depreciation $ (594)      
Construction/Renovation Date 2017      
Acquisition Date 2019      
Skilled Nursing Properties | CTR Partnership, L.P. | Valley Skilled Nursing        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 798      
Initial Cost to Company, Buildings and Improvements 7,671      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 798      
Gross Carrying Value, Buildings and Improvements 7,671      
Gross Carrying Value, Total 8,469      
Accumulated Depreciation $ (249)      
Construction/Renovation Date 2016      
Acquisition Date 2019      
Skilled Nursing Properties | CTR Partnership, L.P. | Cascadia of Boise        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,597      
Initial Cost to Company, Buildings and Improvements 15,692      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,597      
Gross Carrying Value, Buildings and Improvements 15,692      
Gross Carrying Value, Total 17,289      
Accumulated Depreciation $ (412)      
Construction/Renovation Date 2018      
Acquisition Date 2020      
Skilled Nursing Properties | CTR Partnership, L.P. | Cooney Healthcare and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 867      
Initial Cost to Company, Buildings and Improvements 7,431      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 867      
Gross Carrying Value, Buildings and Improvements 7,431      
Gross Carrying Value, Total 8,298      
Accumulated Depreciation $ (65)      
Construction/Renovation Date 1984      
Acquisition Date 2020      
Skilled Nursing Properties | CTR Partnership, L.P. | Elkhorn Healthcare and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 183      
Initial Cost to Company, Buildings and Improvements 7,380      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 183      
Gross Carrying Value, Buildings and Improvements 7,380      
Gross Carrying Value, Total 7,563      
Accumulated Depreciation $ (66)      
Construction/Renovation Date 1960      
Acquisition Date 2020      
Skilled Nursing Properties | CTR Partnership, L.P. | Beacon Harbor Healthcare and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,295      
Initial Cost to Company, Buildings and Improvements 17,069      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,295      
Gross Carrying Value, Buildings and Improvements 17,069      
Gross Carrying Value, Total 18,364      
Accumulated Depreciation $ (76)      
Construction/Renovation Date 1996      
Acquisition Date 2020      
Skilled Nursing Properties | CTR Partnership, L.P. | Pleasant Manor Healthcare and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 629      
Initial Cost to Company, Buildings and Improvements 7,433      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 629      
Gross Carrying Value, Buildings and Improvements 7,433      
Gross Carrying Value, Total 8,062      
Accumulated Depreciation $ (33)      
Construction/Renovation Date 1972      
Acquisition Date 2020      
Skilled Nursing Properties | CTR Partnership, L.P. | Rowlett Health and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,036      
Initial Cost to Company, Buildings and Improvements 10,516      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,036      
Gross Carrying Value, Buildings and Improvements 10,516      
Gross Carrying Value, Total 11,552      
Accumulated Depreciation $ (47)      
Construction/Renovation Date 1990      
Acquisition Date 2020      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Alpine Skilled Nursing and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,688      
Initial Cost to Company, Buildings and Improvements 23,825      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 2,688      
Gross Carrying Value, Buildings and Improvements 23,825      
Gross Carrying Value, Total 26,513      
Accumulated Depreciation $ (1,100)      
Construction/Renovation Date 2014      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | The Bradford Skilled Nursing and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,758      
Initial Cost to Company, Buildings and Improvements 21,325      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 17      
Gross Carrying Value        
Gross Carrying Value, Land 3,758      
Gross Carrying Value, Buildings and Improvements 21,342      
Gross Carrying Value, Total 25,100      
Accumulated Depreciation $ (992)      
Construction/Renovation Date 1980      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Colonial Oaks Skilled Nursing And Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,635      
Initial Cost to Company, Buildings and Improvements 21,180      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,635      
Gross Carrying Value, Buildings and Improvements 21,180      
Gross Carrying Value, Total 22,815      
Accumulated Depreciation $ (954)      
Construction/Renovation Date 2013      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | The Guest House Skilled Nursing And Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,437      
Initial Cost to Company, Buildings and Improvements 20,889      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 184      
Gross Carrying Value        
Gross Carrying Value, Land 3,437      
Gross Carrying Value, Buildings and Improvements 21,073      
Gross Carrying Value, Total 24,510      
Accumulated Depreciation $ (984)      
Construction/Renovation Date 2006      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Pilgrim Manor Skilled Nursing And Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,979      
Initial Cost to Company, Buildings and Improvements 24,617      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 2,979      
Gross Carrying Value, Buildings and Improvements 24,617      
Gross Carrying Value, Total 27,596      
Accumulated Depreciation $ (1,123)      
Construction/Renovation Date 2008      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Shreveport Manor Skilled Nursing and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 676      
Initial Cost to Company, Buildings and Improvements 10,238      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 361      
Gross Carrying Value        
Gross Carrying Value, Land 676      
Gross Carrying Value, Buildings and Improvements 10,599      
Gross Carrying Value, Total 11,275      
Accumulated Depreciation $ (481)      
Construction/Renovation Date 2008      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Booker T Washington Skilled Nursing and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,452      
Initial Cost to Company, Buildings and Improvements 9,148      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 113      
Gross Carrying Value        
Gross Carrying Value, Land 2,452      
Gross Carrying Value, Buildings and Improvements 9,261      
Gross Carrying Value, Total 11,713      
Accumulated Depreciation $ (447)      
Construction/Renovation Date 2013      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Legacy West Rehabilitation and Healthcare        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 120      
Initial Cost to Company, Buildings and Improvements 6,682      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 409      
Gross Carrying Value        
Gross Carrying Value, Land 120      
Gross Carrying Value, Buildings and Improvements 7,091      
Gross Carrying Value, Total 7,211      
Accumulated Depreciation $ (340)      
Construction/Renovation Date 2002      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Legacy at Jacksonville        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 173      
Initial Cost to Company, Buildings and Improvements 7,481      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 127      
Gross Carrying Value        
Gross Carrying Value, Land 173      
Gross Carrying Value, Buildings and Improvements 7,608      
Gross Carrying Value, Total 7,781      
Accumulated Depreciation $ (369)      
Construction/Renovation Date 2006      
Acquisition Date 2019      
Skilled Nursing Properties | Gulf Coast Buyer 1 LLC | Pecan Tree Rehabilitation and Healthcare        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 219      
Initial Cost to Company, Buildings and Improvements 10,097      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 285      
Gross Carrying Value        
Gross Carrying Value, Land 219      
Gross Carrying Value, Buildings and Improvements 10,382      
Gross Carrying Value, Total 10,601      
Accumulated Depreciation $ (481)      
Construction/Renovation Date 1990      
Acquisition Date 2019      
Skilled Nursing Properties | Lakewest SNF Realty LLC | Lakewest Rehabilitation and Skilled Care        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 0      
Initial Cost to Company, Buildings and Improvements 6,905      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 0      
Gross Carrying Value, Buildings and Improvements 6,905      
Gross Carrying Value, Total 6,905      
Accumulated Depreciation $ (322)      
Construction/Renovation Date 2011      
Acquisition Date 2019      
Multi-Service Campus Properties        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 29,336      
Initial Cost to Company, Buildings and Improvements 198,991      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 8,612      
Gross Carrying Value        
Gross Carrying Value, Land 29,205      
Gross Carrying Value, Buildings and Improvements 207,734      
Gross Carrying Value, Total 236,939      
Accumulated Depreciation (27,700)      
Multi-Service Campus Properties | Ensign Southland LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances 0      
Initial Cost to Company        
Initial Cost to Company, Land 966      
Initial Cost to Company, Buildings and Improvements 5,082      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,213      
Gross Carrying Value        
Gross Carrying Value, Land 966      
Gross Carrying Value, Buildings and Improvements 7,295      
Gross Carrying Value, Total 8,261      
Accumulated Depreciation $ (5,292)      
Construction/Renovation Date 2011      
Acquisition Date 1999      
Multi-Service Campus Properties | Mission CCRC LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,962      
Initial Cost to Company, Buildings and Improvements 11,035      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 464      
Gross Carrying Value        
Gross Carrying Value, Land 1,962      
Gross Carrying Value, Buildings and Improvements 11,499      
Gross Carrying Value, Total 13,461      
Accumulated Depreciation $ (3,327)      
Construction/Renovation Date 1994      
Acquisition Date 2011      
Multi-Service Campus Properties | Wayne Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 130      
Initial Cost to Company, Buildings and Improvements 3,061      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 122      
Gross Carrying Value        
Gross Carrying Value, Land 130      
Gross Carrying Value, Buildings and Improvements 3,183      
Gross Carrying Value, Total 3,313      
Accumulated Depreciation $ (994)      
Construction/Renovation Date 1978      
Acquisition Date 2011      
Multi-Service Campus Properties | 4th Street Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 180      
Initial Cost to Company, Buildings and Improvements 3,352      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 180      
Gross Carrying Value, Buildings and Improvements 3,352      
Gross Carrying Value, Total 3,532      
Accumulated Depreciation $ (991)      
Construction/Renovation Date 2006      
Acquisition Date 2011      
Multi-Service Campus Properties | Big Sioux River Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 110      
Initial Cost to Company, Buildings and Improvements 3,522      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 75      
Gross Carrying Value        
Gross Carrying Value, Land 110      
Gross Carrying Value, Buildings and Improvements 3,597      
Gross Carrying Value, Total 3,707      
Accumulated Depreciation $ (998)      
Construction/Renovation Date 1974      
Acquisition Date 2011      
Multi-Service Campus Properties | Prairie Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 130      
Initial Cost to Company, Buildings and Improvements 1,571      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 22      
Gross Carrying Value        
Gross Carrying Value, Land 130      
Gross Carrying Value, Buildings and Improvements 1,593      
Gross Carrying Value, Total 1,723      
Accumulated Depreciation $ (758)      
Construction/Renovation Date 2011      
Acquisition Date 2011      
Multi-Service Campus Properties | Salmon River Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 168      
Initial Cost to Company, Buildings and Improvements 2,496      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 168      
Gross Carrying Value, Buildings and Improvements 2,496      
Gross Carrying Value, Total 2,664      
Accumulated Depreciation $ (525)      
Construction/Renovation Date 2012      
Acquisition Date 2012      
Multi-Service Campus Properties | CTR Partnership, L.P. | Centerville Senior Independent Living        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,912      
Initial Cost to Company, Buildings and Improvements 22,458      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 117      
Gross Carrying Value        
Gross Carrying Value, Land 3,781      
Gross Carrying Value, Buildings and Improvements 22,706      
Gross Carrying Value, Total 26,487      
Accumulated Depreciation $ (3,018)      
Construction/Renovation Date 2007      
Acquisition Date 2015      
Multi-Service Campus Properties | CTR Partnership, L.P. | Liberty Nursing Center of Willard        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 143      
Initial Cost to Company, Buildings and Improvements 11,097      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 50      
Gross Carrying Value        
Gross Carrying Value, Land 143      
Gross Carrying Value, Buildings and Improvements 11,147      
Gross Carrying Value, Total 11,290      
Accumulated Depreciation $ (1,477)      
Construction/Renovation Date 1985      
Acquisition Date 2015      
Multi-Service Campus Properties | CTR Partnership, L.P. | Premier Estates of Middletown/Premier Retirement Estates of Middletown        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 990      
Initial Cost to Company, Buildings and Improvements 7,484      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 172      
Gross Carrying Value        
Gross Carrying Value, Land 990      
Gross Carrying Value, Buildings and Improvements 7,656      
Gross Carrying Value, Total 8,646      
Accumulated Depreciation $ (1,025)      
Construction/Renovation Date 1985      
Acquisition Date 2015      
Multi-Service Campus Properties | CTR Partnership, L.P. | Premier Estates of Norwood Towers/Premier Retirement Estates of Norwood Towers        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,316      
Initial Cost to Company, Buildings and Improvements 10,071      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 499      
Gross Carrying Value        
Gross Carrying Value, Land 1,316      
Gross Carrying Value, Buildings and Improvements 10,570      
Gross Carrying Value, Total 11,886      
Accumulated Depreciation $ (1,249)      
Construction/Renovation Date 1991      
Acquisition Date 2016      
Multi-Service Campus Properties | CTR Partnership, L.P. | Turlock Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,258      
Initial Cost to Company, Buildings and Improvements 16,526      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,258      
Gross Carrying Value, Buildings and Improvements 16,526      
Gross Carrying Value, Total 17,784      
Accumulated Depreciation $ (1,825)      
Construction/Renovation Date 1986      
Acquisition Date 2016      
Multi-Service Campus Properties | CTR Partnership, L.P. | Bridgeport Medical Lodge        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 980      
Initial Cost to Company, Buildings and Improvements 27,917      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 980      
Gross Carrying Value, Buildings and Improvements 27,917      
Gross Carrying Value, Total 28,897      
Accumulated Depreciation $ (2,850)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Multi-Service Campus Properties | CTR Partnership, L.P. | The Villas at Saratoga        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 8,709      
Initial Cost to Company, Buildings and Improvements 9,736      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,396      
Gross Carrying Value        
Gross Carrying Value, Land 8,709      
Gross Carrying Value, Buildings and Improvements 11,132      
Gross Carrying Value, Total 19,841      
Accumulated Depreciation $ (617)      
Construction/Renovation Date 2004      
Acquisition Date 2018      
Multi-Service Campus Properties | CTR Partnership, L.P. | Madison Park Healthcare        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 601      
Initial Cost to Company, Buildings and Improvements 6,385      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 601      
Gross Carrying Value, Buildings and Improvements 6,385      
Gross Carrying Value, Total 6,986      
Accumulated Depreciation $ (359)      
Construction/Renovation Date 1924      
Acquisition Date 2018      
Multi-Service Campus Properties | CTR Partnership, L.P. | Oakview Heights Nursing and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 298      
Initial Cost to Company, Buildings and Improvements 8,393      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 298      
Gross Carrying Value, Buildings and Improvements 8,393      
Gross Carrying Value, Total 8,691      
Accumulated Depreciation $ (455)      
Construction/Renovation Date 2004      
Acquisition Date 2019      
Multi-Service Campus Properties | CTR Partnership, L.P. | City Creek Post-Acute and Assisted Living        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,980      
Initial Cost to Company, Buildings and Improvements 10,106      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 408      
Gross Carrying Value        
Gross Carrying Value, Land 3,980      
Gross Carrying Value, Buildings and Improvements 10,514      
Gross Carrying Value, Total 14,494      
Accumulated Depreciation $ (344)      
Construction/Renovation Date 1990      
Acquisition Date 2019      
Multi-Service Campus Properties | CTR Partnership, L.P. | Crestwood Health and Rehabilitation Center        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 143      
Initial Cost to Company, Buildings and Improvements 6,075      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 143      
Gross Carrying Value, Buildings and Improvements 6,075      
Gross Carrying Value, Total 6,218      
Accumulated Depreciation $ (28)      
Construction/Renovation Date 1980      
Acquisition Date 2020      
Multi-Service Campus Properties | Gulf Coast Buyer 1 LLC | Spring Lake Skilled Nursing and Rehabilitation        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 3,217      
Initial Cost to Company, Buildings and Improvements 21,195      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 2,525      
Gross Carrying Value        
Gross Carrying Value, Land 3,217      
Gross Carrying Value, Buildings and Improvements 23,720      
Gross Carrying Value, Total 26,937      
Accumulated Depreciation $ (1,008)      
Construction/Renovation Date 2008      
Acquisition Date 2019      
Multi-Service Campus Properties | Gulf Coast Buyer 1 LLC | The Village at Heritage Oaks        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 143      
Initial Cost to Company, Buildings and Improvements 11,429      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 549      
Gross Carrying Value        
Gross Carrying Value, Land 143      
Gross Carrying Value, Buildings and Improvements 11,978      
Gross Carrying Value, Total 12,121      
Accumulated Depreciation $ (560)      
Construction/Renovation Date 2007      
Acquisition Date 2019      
Assisted and Independent Living Properties        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 32,006      
Initial Cost to Company, Buildings and Improvements 201,593      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 11,359      
Gross Carrying Value        
Gross Carrying Value, Land 32,006      
Gross Carrying Value, Buildings and Improvements 212,952      
Gross Carrying Value, Total 244,959      
Accumulated Depreciation (37,713)      
Assisted and Independent Living Properties | Lafayette Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances 0      
Initial Cost to Company        
Initial Cost to Company, Land 420      
Initial Cost to Company, Buildings and Improvements 1,160      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 189      
Gross Carrying Value        
Gross Carrying Value, Land 420      
Gross Carrying Value, Buildings and Improvements 1,349      
Gross Carrying Value, Total 1,769      
Accumulated Depreciation $ (433)      
Construction/Renovation Date 2011      
Acquisition Date 2009      
Assisted and Independent Living Properties | Everglades Health Holdings        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,542      
Initial Cost to Company, Buildings and Improvements 4,012      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 113      
Gross Carrying Value        
Gross Carrying Value, Land 1,542      
Gross Carrying Value, Buildings and Improvements 4,125      
Gross Carrying Value, Total 5,667      
Accumulated Depreciation $ (894)      
Construction/Renovation Date 1990      
Acquisition Date 2011      
Assisted and Independent Living Properties | Wisteria Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 244      
Initial Cost to Company, Buildings and Improvements 3,241      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 81      
Gross Carrying Value        
Gross Carrying Value, Land 244      
Gross Carrying Value, Buildings and Improvements 3,322      
Gross Carrying Value, Total 3,566      
Accumulated Depreciation $ (1,487)      
Construction/Renovation Date 2008      
Acquisition Date 2011      
Assisted and Independent Living Properties | Willows Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,835      
Initial Cost to Company, Buildings and Improvements 3,784      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 395      
Gross Carrying Value        
Gross Carrying Value, Land 2,835      
Gross Carrying Value, Buildings and Improvements 4,179      
Gross Carrying Value, Total 7,014      
Accumulated Depreciation $ (1,199)      
Construction/Renovation Date 2013      
Acquisition Date 2013      
Assisted and Independent Living Properties | Sky Holdings AZ LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 61      
Initial Cost to Company, Buildings and Improvements 304      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 372      
Gross Carrying Value        
Gross Carrying Value, Land 61      
Gross Carrying Value, Buildings and Improvements 676      
Gross Carrying Value, Total 738      
Accumulated Depreciation $ (466)      
Construction/Renovation Date 2004      
Acquisition Date 2002      
Assisted and Independent Living Properties | Lemon River Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 342      
Initial Cost to Company, Buildings and Improvements 802      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 3,360      
Gross Carrying Value        
Gross Carrying Value, Land 342      
Gross Carrying Value, Buildings and Improvements 4,162      
Gross Carrying Value, Total 4,504      
Accumulated Depreciation $ (2,616)      
Construction/Renovation Date 2012      
Acquisition Date 2009      
Assisted and Independent Living Properties | Mission CCRC LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 411      
Initial Cost to Company, Buildings and Improvements 2,312      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 258      
Gross Carrying Value        
Gross Carrying Value, Land 411      
Gross Carrying Value, Buildings and Improvements 2,570      
Gross Carrying Value, Total 2,981      
Accumulated Depreciation $ (1,432)      
Construction/Renovation Date 1994      
Acquisition Date 2011      
Assisted and Independent Living Properties | Avenue N Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 124      
Initial Cost to Company, Buildings and Improvements 2,301      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 392      
Gross Carrying Value        
Gross Carrying Value, Land 124      
Gross Carrying Value, Buildings and Improvements 2,693      
Gross Carrying Value, Total 2,817      
Accumulated Depreciation $ (1,367)      
Construction/Renovation Date 2007      
Acquisition Date 2006      
Assisted and Independent Living Properties | Moenium Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,893      
Initial Cost to Company, Buildings and Improvements 5,268      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 1,210      
Gross Carrying Value        
Gross Carrying Value, Land 1,893      
Gross Carrying Value, Buildings and Improvements 6,478      
Gross Carrying Value, Total 8,371      
Accumulated Depreciation $ (3,453)      
Construction/Renovation Date 1986      
Acquisition Date 2007      
Assisted and Independent Living Properties | Expo Park Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 570      
Initial Cost to Company, Buildings and Improvements 1,692      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 248      
Gross Carrying Value        
Gross Carrying Value, Land 570      
Gross Carrying Value, Buildings and Improvements 1,940      
Gross Carrying Value, Total 2,510      
Accumulated Depreciation $ (858)      
Construction/Renovation Date 1986      
Acquisition Date 2010      
Assisted and Independent Living Properties | Flamingo Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 908      
Initial Cost to Company, Buildings and Improvements 4,767      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 281      
Gross Carrying Value        
Gross Carrying Value, Land 908      
Gross Carrying Value, Buildings and Improvements 5,048      
Gross Carrying Value, Total 5,956      
Accumulated Depreciation $ (2,509)      
Construction/Renovation Date 1986      
Acquisition Date 2011      
Assisted and Independent Living Properties | 18th Place Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,011      
Initial Cost to Company, Buildings and Improvements 2,053      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 490      
Gross Carrying Value        
Gross Carrying Value, Land 1,011      
Gross Carrying Value, Buildings and Improvements 2,543      
Gross Carrying Value, Total 3,554      
Accumulated Depreciation $ (937)      
Construction/Renovation Date 1974      
Acquisition Date 2011      
Assisted and Independent Living Properties | Boardwalk Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 367      
Initial Cost to Company, Buildings and Improvements 1,633      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 51      
Gross Carrying Value        
Gross Carrying Value, Land 367      
Gross Carrying Value, Buildings and Improvements 1,684      
Gross Carrying Value, Total 2,051      
Accumulated Depreciation $ (510)      
Construction/Renovation Date 1993      
Acquisition Date 2012      
Assisted and Independent Living Properties | Lockwood Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,792      
Initial Cost to Company, Buildings and Improvements 2,253      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 585      
Gross Carrying Value        
Gross Carrying Value, Land 1,792      
Gross Carrying Value, Buildings and Improvements 2,838      
Gross Carrying Value, Total 4,630      
Accumulated Depreciation $ (1,248)      
Construction/Renovation Date 1967      
Acquisition Date 2013      
Assisted and Independent Living Properties | Saratoga Health Holdings LLC        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 444      
Initial Cost to Company, Buildings and Improvements 2,265      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 176      
Gross Carrying Value        
Gross Carrying Value, Land 444      
Gross Carrying Value, Buildings and Improvements 2,441      
Gross Carrying Value, Total 2,885      
Accumulated Depreciation $ (464)      
Construction/Renovation Date 1995      
Acquisition Date 2013      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Prelude Cottages of Woodbury        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 430      
Initial Cost to Company, Buildings and Improvements 6,714      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 430      
Gross Carrying Value, Buildings and Improvements 6,714      
Gross Carrying Value, Total 7,144      
Accumulated Depreciation $ (1,007)      
Construction/Renovation Date 2011      
Acquisition Date 2014      
Assisted and Independent Living Properties | CTR Partnership, L.P. | English Meadows Senior Living Community        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 250      
Initial Cost to Company, Buildings and Improvements 6,114      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 43      
Gross Carrying Value        
Gross Carrying Value, Land 250      
Gross Carrying Value, Buildings and Improvements 6,157      
Gross Carrying Value, Total 6,407      
Accumulated Depreciation $ (919)      
Construction/Renovation Date 2011      
Acquisition Date 2014      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Bristol Court Assisted Living        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 645      
Initial Cost to Company, Buildings and Improvements 7,322      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 421      
Gross Carrying Value        
Gross Carrying Value, Land 645      
Gross Carrying Value, Buildings and Improvements 7,512      
Gross Carrying Value, Total 8,157      
Accumulated Depreciation $ (1,013)      
Construction/Renovation Date 2010      
Acquisition Date 2015      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Asbury Place Assisted Living        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 212      
Initial Cost to Company, Buildings and Improvements 4,992      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 240      
Gross Carrying Value        
Gross Carrying Value, Land 212      
Gross Carrying Value, Buildings and Improvements 5,213      
Gross Carrying Value, Total 5,425      
Accumulated Depreciation $ (672)      
Construction/Renovation Date 1997      
Acquisition Date 2015      
Assisted and Independent Living Properties | CTR Partnership, L.P. | New Haven Assisted Living of San Angelo        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 284      
Initial Cost to Company, Buildings and Improvements 4,478      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 284      
Gross Carrying Value, Buildings and Improvements 4,478      
Gross Carrying Value, Total 4,762      
Accumulated Depreciation $ (550)      
Construction/Renovation Date 2012      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Lamplight Inn of Fort Wayne        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 452      
Initial Cost to Company, Buildings and Improvements 8,703      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 214      
Gross Carrying Value        
Gross Carrying Value, Land 452      
Gross Carrying Value, Buildings and Improvements 8,889      
Gross Carrying Value, Total 9,341      
Accumulated Depreciation $ (1,052)      
Construction/Renovation Date 2015      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Lamplight Inn of West Allis        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 97      
Initial Cost to Company, Buildings and Improvements 6,102      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 173      
Gross Carrying Value        
Gross Carrying Value, Land 97      
Gross Carrying Value, Buildings and Improvements 6,255      
Gross Carrying Value, Total 6,352      
Accumulated Depreciation $ (737)      
Construction/Renovation Date 2013      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Lamplight Inn of Baltimore        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 0      
Initial Cost to Company, Buildings and Improvements 3,697      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 267      
Gross Carrying Value        
Gross Carrying Value, Land 0      
Gross Carrying Value, Buildings and Improvements 3,919      
Gross Carrying Value, Total 3,919      
Accumulated Depreciation $ (447)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Fort Myers Assisted Living        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,489      
Initial Cost to Company, Buildings and Improvements 3,531      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 765      
Gross Carrying Value        
Gross Carrying Value, Land 1,489      
Gross Carrying Value, Buildings and Improvements 4,665      
Gross Carrying Value, Total 6,154      
Accumulated Depreciation $ (455)      
Construction/Renovation Date 1980      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | English Meadows Elks Home Campus        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 451      
Initial Cost to Company, Buildings and Improvements 9,023      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 268      
Gross Carrying Value        
Gross Carrying Value, Land 451      
Gross Carrying Value, Buildings and Improvements 9,291      
Gross Carrying Value, Total 9,742      
Accumulated Depreciation $ (1,107)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Croatan Village        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 312      
Initial Cost to Company, Buildings and Improvements 6,919      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 312      
Gross Carrying Value, Buildings and Improvements 6,919      
Gross Carrying Value, Total 7,231      
Accumulated Depreciation $ (807)      
Construction/Renovation Date 2010      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Countryside Village        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 131      
Initial Cost to Company, Buildings and Improvements 4,157      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 131      
Gross Carrying Value, Buildings and Improvements 4,157      
Gross Carrying Value, Total 4,288      
Accumulated Depreciation $ (485)      
Construction/Renovation Date 2011      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | The Pines of Clarkston        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 603      
Initial Cost to Company, Buildings and Improvements 9,326      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 603      
Gross Carrying Value, Buildings and Improvements 9,326      
Gross Carrying Value, Total 9,929      
Accumulated Depreciation $ (1,069)      
Construction/Renovation Date 2010      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | The Pines of Goodrich        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 241      
Initial Cost to Company, Buildings and Improvements 4,112      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 9      
Gross Carrying Value        
Gross Carrying Value, Land 241      
Gross Carrying Value, Buildings and Improvements 4,121      
Gross Carrying Value, Total 4,362      
Accumulated Depreciation $ (471)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | The Pines of Burton        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 492      
Initial Cost to Company, Buildings and Improvements 9,199      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 492      
Gross Carrying Value, Buildings and Improvements 9,199      
Gross Carrying Value, Total 9,691      
Accumulated Depreciation $ (1,054)      
Construction/Renovation Date 2014      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | The Pines of Lapeer        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 302      
Initial Cost to Company, Buildings and Improvements 5,773      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 302      
Gross Carrying Value, Buildings and Improvements 5,773      
Gross Carrying Value, Total 6,075      
Accumulated Depreciation $ (662)      
Construction/Renovation Date 2008      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Arbor Place        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 392      
Initial Cost to Company, Buildings and Improvements 3,605      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 392      
Gross Carrying Value, Buildings and Improvements 3,605      
Gross Carrying Value, Total 3,997      
Accumulated Depreciation $ (398)      
Construction/Renovation Date 1984      
Acquisition Date 2016      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Applewood of Brookfield        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 493      
Initial Cost to Company, Buildings and Improvements 14,002      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 493      
Gross Carrying Value, Buildings and Improvements 14,002      
Gross Carrying Value, Total 14,495      
Accumulated Depreciation $ (1,371)      
Construction/Renovation Date 2013      
Acquisition Date 2017      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Applewood of New Berlin        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 356      
Initial Cost to Company, Buildings and Improvements 10,812      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 356      
Gross Carrying Value, Buildings and Improvements 10,812      
Gross Carrying Value, Total 11,168      
Accumulated Depreciation $ (1,059)      
Construction/Renovation Date 2016      
Acquisition Date 2017      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Tangerine Cove Of Brooksville        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 995      
Initial Cost to Company, Buildings and Improvements 927      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 463      
Gross Carrying Value        
Gross Carrying Value, Land 995      
Gross Carrying Value, Buildings and Improvements 1,364      
Gross Carrying Value, Total 2,359      
Accumulated Depreciation $ (114)      
Construction/Renovation Date 1984      
Acquisition Date 2017      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Memory Care Cottages in White Bear Lake        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,611      
Initial Cost to Company, Buildings and Improvements 5,633      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 1,611      
Gross Carrying Value, Buildings and Improvements 5,633      
Gross Carrying Value, Total 7,244      
Accumulated Depreciation $ (493)      
Construction/Renovation Date 2016      
Acquisition Date 2017      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Culpeper        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 318      
Initial Cost to Company, Buildings and Improvements 3,897      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 85      
Gross Carrying Value        
Gross Carrying Value, Land 318      
Gross Carrying Value, Buildings and Improvements 3,982      
Gross Carrying Value, Total 4,300      
Accumulated Depreciation $ (374)      
Construction/Renovation Date 1997      
Acquisition Date 2017      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Louisa        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 407      
Initial Cost to Company, Buildings and Improvements 4,660      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 97      
Gross Carrying Value        
Gross Carrying Value, Land 407      
Gross Carrying Value, Buildings and Improvements 4,757      
Gross Carrying Value, Total 5,164      
Accumulated Depreciation $ (455)      
Construction/Renovation Date 2002      
Acquisition Date 2017      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Warrenton        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 1,238      
Initial Cost to Company, Buildings and Improvements 7,247      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 98      
Gross Carrying Value        
Gross Carrying Value, Land 1,238      
Gross Carrying Value, Buildings and Improvements 7,345      
Gross Carrying Value, Total 8,583      
Accumulated Depreciation $ (671)      
Construction/Renovation Date 1999      
Acquisition Date 2017      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Vista Del Lago        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 4,362      
Initial Cost to Company, Buildings and Improvements 7,997      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 0      
Gross Carrying Value        
Gross Carrying Value, Land 4,362      
Gross Carrying Value, Buildings and Improvements 7,997      
Gross Carrying Value, Total 12,359      
Accumulated Depreciation $ (279)      
Construction/Renovation Date 2015      
Acquisition Date 2019      
Assisted and Independent Living Properties | CTR Partnership, L.P. | Inn at Barton Creek        
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]        
Encumbrances $ 0      
Initial Cost to Company        
Initial Cost to Company, Land 2,479      
Initial Cost to Company, Buildings and Improvements 4,804      
Cost Capitalized Since Acquisition        
Costs Capitalized Since Acquisition 15      
Gross Carrying Value        
Gross Carrying Value, Land 2,479      
Gross Carrying Value, Buildings and Improvements 4,819      
Gross Carrying Value, Total 7,298      
Accumulated Depreciation $ (119)      
Construction/Renovation Date 1999      
Acquisition Date 2020      
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule III - Real Estate Assets and Accumulated Depreciation - Rollforward (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Real estate:      
Balance at the beginning of the period $ 1,605,081 $ 1,368,157 $ 1,266,484
Acquisitions 84,630 318,070 106,208
Improvements 7,223 3,103 7,230
Impairment 0 (21,465) 0
Sales of real estate (13,729) (62,784) (11,765)
Balance at the end of the period 1,683,205 1,605,081 1,368,157
Accumulated depreciation:      
Balance at the beginning of the period (220,359) (185,926) (152,185)
Depreciation expense (41,914) (40,373) (34,676)
Impairment 0 5,220 0
Sales of real estate 2,470 720 935
Balance at the end of the period $ (259,803) $ (220,359) $ (185,926)
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule IV - Mortgage Loans on Real Estate - Mortgage Loan (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Prior Liens $ 110,000      
Principal Balance 15,000      
Book Value $ 15,000 $ 29,500 $ 12,375 $ 12,517
Skilled Nursing Facility | Next Healthcare Inc - Virginia        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Contractual Interest Rate 12.00%      
Prior Liens $ 110,000      
Principal Balance 15,000      
Book Value $ 15,000      
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule IV - Mortgage Loan on Real Estate - Mortgage Loan Rollforward (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]      
Mortgage loans, beginning of period $ 29,500 $ 12,375 $ 12,517
Additions during period:      
New mortgage loans 61,258 40,889 0
Deductions during period:      
Paydowns/Repayments (75,758) (23,764) (142)
Mortgage loans, end of period $ 15,000 $ 29,500 $ 12,375
EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ͬ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

-8?20$3;8T.P6BP^0"X99K>]9!:G#P8#'R^4)7T?]A'9:!E M9ETE VRZ^< _.B4+OU J5.4@&@ZS026UZ1T=KL]UXP9XPP:5!VT-[&QVW&OU MY-_;FTVQU%Y/=:G#\[C7_EVJGJBTT95^4<6X-^P)O[!/?UFG7ZP)LISDSI;E MN#=:-=PK%W3^R^Y) WDGI[[=$^3T5@+(N)<-X80S[7QHCVC/+X%QJ>#@U58= M[+DN@W*G,J@_G:T?M9DWIX&[&*#;:/MA_;OJQ /W?[K1SF8Z5Z<@<:&MQ%T>)QHAAO2UW MU0OQ39;2Y$JT7>@18$0 1EL#%#LW$D'&!&3\A9 7)K<5,#8LS?_ACDP(QN0+ M&=_AA)V)LY^U1I I 9EN$?)'A" S C+;&N2)] L$N4M [O)"7KNY-/JE;4!$ M>P31'B_1I*XJZ9Z;;IKHN='P;]($<9SGMC8!OX#[!.0^+^2MDJ4X:Z\. WFI M?&B?[>_B2@4\8P^I*7O(_&C#0CFQD11CDF9A5LNYU$[>O6SAH/$V?+#Y!91BHB8%3&!25C2BWQ5M628$RROK55M:08DU)+O$VU]'%F'%-JB9G5 M0F)V1PZEEIA9+30FCB=B2C8QLVQHS,X0HN03,\N'QNP,(4H^\18+8.)'AFO9 ME'P29OG0F+L8DY)/PBP?&G,/8U(62I@M1&/N8TS*0@FSA3,B%%F8+ M;=PC26A+)0P6V@S9MN",2D+)&(]#_VZA^I?2/<"EKF"Q8TQ*0>F7K-0 YJE>ZD*9HJE3OB7I MG2=.*2C=TA).6POV'4QRM9]9001FTX0Q*06ES HB,)L1A3$I!:7<5;?-=:-F MM&-,2D$ILX+(U3&Q@S$I!:7,"OIT?>S3>3.C%)1MM0J'D_2,4E#&O=+S<:7L M\YZD#)1QE^*H-;/NMT>4@3+N4AR)V7G@E($R;@-12WO=WJ0,E'$;:#-F(W:, M27YQUAIHT![LCPX+-=-&%5=P"0_[U65Y ONN#5RN M6'^)NOZ*]N@_4$L#!!0 ( #&!2E(>WYE>' ( #TG : >&PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;'/-VDMNHT 4A>&M6"P@Y?NJ)*TXHYYDVLH& MD%-^*+9!%*U.=M^6,[ /ZD%/(LX(%8C+/^$3 IY^E4,[[KM3W>W[NO@X'DYU MU>S&L?^14EWORK&M=UU?3N]V5,C:+UW;8EG'5I(_#=7=-EXW< MG2W53.\O$F3Y@Y2"-+Y@PR";/X@AR"?/R@@*.8/RA"4YP^ZAZ#[^8,> M(.AA_J!'"'J"8 N!V()D"X'9@F@+@=J"; N! MVX)P"X'<@G0+@=V"> N!WHIZ*X'>BGHK@=XZ>=@FT%M1;R706U%O)=!;46\E MT%M1;R706U%O)=!;46\ET%M1;R70VU!O(]#;4&\CT-M0;R/0VR8O2PCT-M3; M"/0VU-L(]#;4VPCT-M3;"/0VU-L(]#;4VPCT=M3;"?1VU-L)]';4VPGT=M3; M"?3VRF4#OC'IG KTSZIT)],Z3GTV^4^\Z?AY*O?9\K?'ZWTGU M>#ZW7"]_67[MG-SC%YS3;45]_@M02P,$% @ ,8%*4J5_#G'N 0 D"8 M !, !;0V]N=&5N=%]4>7!E&ULS=K+3L,P$ 707ZFR18WK)P_1;H M ML. '3#*E49/8LETH?X^3 A((*E"1N)M&K>VY$X]T5CV_>_84)]NN[>.\6*7D MSQB+U8HZ&TOGJ<\K2QTM)LV M3:ZV^>?8N'Y>!&IC,;G8;1RRYH7UOFTJF_(Z>^SK3RG3UX0RGQSWQ%7CXU'> M4+ O$X:5[P->S]T\4@A-39-;&]*U[?(NMFU93,\MQ7)_B2]Z=,ME4U'MJDV7 MCY31![)U7!&EKBUW18_V)Z=\P[3[Y ?GCV7V!>:=M\'YF"<6Z/=Q;R,93D]] M+D0A-?M?\3TQES[X_6B8=DWU#[/S]3ZYL![G$=GX./R./\[XO?XO^Q @?4B0 M/A1('QJD#P/2QS%('R<@?9R"],%G*(V@B,I12.4HIG(45#F*JAR%58[B*D>! ME:/(*E!D%2BR"A19!8JL D56@2*K0)%5H,@J4&05*+)*%%DEBJP215:)(JM$ MD56BR"I19)4HLDH4626*K I%5H4BJT*15:'(JE!D52BR*A19%8JL"D56A2*K M1I%5H\BJ4635*+)J%%DUBJP:15:-(JM&D56CR&I09#4HLAH460V*K 9%5H,B MJ_E/6>^=6_]Q_/@L.]OT;_EL_"/:X@502P$"% ,4 " Q@4I2!T%-8H$ M "Q $ @ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 M Q0 ( #&!2E+=*R&Y[@ "L" 1 " :\ !D;V-0 M&UL4$L! A0#% @ M,8%*4H^4R=65!@ >QH !@ ("!#0@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%*4K_/#@3T"0 WRL !@ ("! MS"8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M,8%*4O*R?H1'%P 14T !D ("!-E8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%*4M!:6/T'! N0D !D M ("!I:$ 'AL+W=O&PO=V]R:W-H M965T?G@, )L' 9 M " @?"J !X;"]W;W)K&UL4$L! M A0#% @ ,8%*4DA%F*U.! S H !D ("!Q:X 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%* M4HEW/?<=! Q@@ !D ("!<-P 'AL+W=O\B #V<@ &0 M @('$X >&PO=V]R:W-H965TH# 0!X;"]W;W)K M&UL4$L! A0#% @ ,8%*4I[\8I3Y"0 J1H M !D ("!R08! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%*4ET=ZWP,! M0H !D M ("!S1@! 'AL+W=ON,V4# #N!P &0 @($0'0$ >&PO=V]R:W-H965T M&UL4$L! A0# M% @ ,8%*4AT8C&2R P 1 D !D ("!A20! 'AL+W=O M&PO=V]R:W-H965TEN*@0 *P- 9 " @3HK M 0!X;"]W;W)K&UL4$L! A0#% @ ,8%*4A!/ MY_'; @ P0H !D ("!FR\! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%*4LMA,NQF @ F@8 !D M ("!ZSH! 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ ,8%*4C[H/RT7!0 618 !D ("! M8$4! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ ,8%*4@_V -5I!P O"8 !D ("!K%4! 'AL+W=O&UL4$L! A0#% @ ,8%*4NDK."I< M @ O@4 !D ("!!VL! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%*4MU65;>' P ] T !D M ("!%74! 'AL+W=O $ >&PO=V]R M:W-H965T&UL M4$L! A0#% @ ,8%*4B?+O2?S P 3 \ !D ("!&8(! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M,8%*4B&PO=V]R:W-H965T 9 " @564 0!X;"]W M;W)K&UL4$L! A0#% @ ,8%*4N\9V@(4!0 M1A8 !D ("!^IH! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%*4ID;UHCG! 9Q4 !D M ("!<:&PO=V]R:W-H M965T&UL4$L! M A0#% @ ,8%*4N$:,.SJ P .PX !D ("!JEH" 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,8%* M4L1<3"!# @ ?@L T ( !IF4" 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% @ ,8%*4A[? MF5X< @ /2< !H ( !36X" 'AL+U]R96QS+W=O XML 82 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 84 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 690 408 1 false 321 0 false 16 false false R1.htm 0001001 - Document - Cover Sheet http://www.caretrustreit.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - Consolidated Balance Sheets Sheet http://www.caretrustreit.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1002003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Consolidated Income Statements Sheet http://www.caretrustreit.com/role/ConsolidatedIncomeStatements Consolidated Income Statements Statements 4 false false R5.htm 1004005 - Statement - Consolidated Statements of Equity Sheet http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity Consolidated Statements of Equity Statements 5 false false R6.htm 1005006 - Statement - Consolidated Statements of Equity (Parenthetical) Sheet http://www.caretrustreit.com/role/ConsolidatedStatementsofEquityParenthetical Consolidated Statements of Equity (Parenthetical) Statements 6 false false R7.htm 1006007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101101 - Disclosure - Organization Sheet http://www.caretrustreit.com/role/Organization Organization Notes 8 false false R9.htm 2103102 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.caretrustreit.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2108103 - Disclosure - Real Estate Investments, Net Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNet Real Estate Investments, Net Notes 10 false false R11.htm 2119104 - Disclosure - Other Real Estate Investments, Net Sheet http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNet Other Real Estate Investments, Net Notes 11 false false R12.htm 2121105 - Disclosure - Fair Value Measurements Sheet http://www.caretrustreit.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 2126106 - Disclosure - Debt Sheet http://www.caretrustreit.com/role/Debt Debt Notes 13 false false R14.htm 2132107 - Disclosure - Equity Sheet http://www.caretrustreit.com/role/Equity Equity Notes 14 false false R15.htm 2137108 - Disclosure - Stock-Based Compensation Sheet http://www.caretrustreit.com/role/StockBasedCompensation Stock-Based Compensation Notes 15 false false R16.htm 2142109 - Disclosure - Earnings Per Common Share Sheet http://www.caretrustreit.com/role/EarningsPerCommonShare Earnings Per Common Share Notes 16 false false R17.htm 2145110 - Disclosure - Commitments and Contingencies Sheet http://www.caretrustreit.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 2147111 - Disclosure - Concentration of Risk Sheet http://www.caretrustreit.com/role/ConcentrationofRisk Concentration of Risk Notes 18 false false R19.htm 2149112 - Disclosure - Selected Quarterly Financial Data (Unaudited) Sheet http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnaudited Selected Quarterly Financial Data (Unaudited) Notes 19 false false R20.htm 2152113 - Disclosure - Subsequent Events Sheet http://www.caretrustreit.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 2154114 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation Sheet http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciation Schedule III - Real Estate Assets and Accumulated Depreciation Notes 21 false false R22.htm 2157115 - Disclosure - Schedule IV - Mortgage Loans on Real Estate Sheet http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstate Schedule IV - Mortgage Loans on Real Estate Notes 22 false false R23.htm 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.caretrustreit.com/role/SummaryofSignificantAccountingPolicies 23 false false R24.htm 2305301 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.caretrustreit.com/role/SummaryofSignificantAccountingPolicies 24 false false R25.htm 2309302 - Disclosure - Real Estate Investments, Net (Tables) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetTables Real Estate Investments, Net (Tables) Tables http://www.caretrustreit.com/role/RealEstateInvestmentsNet 25 false false R26.htm 2322303 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.caretrustreit.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.caretrustreit.com/role/FairValueMeasurements 26 false false R27.htm 2327304 - Disclosure - Debt (Tables) Sheet http://www.caretrustreit.com/role/DebtTables Debt (Tables) Tables http://www.caretrustreit.com/role/Debt 27 false false R28.htm 2333305 - Disclosure - Equity (Tables) Sheet http://www.caretrustreit.com/role/EquityTables Equity (Tables) Tables http://www.caretrustreit.com/role/Equity 28 false false R29.htm 2338306 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.caretrustreit.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.caretrustreit.com/role/StockBasedCompensation 29 false false R30.htm 2343307 - Disclosure - Earnings Per Common Share (Tables) Sheet http://www.caretrustreit.com/role/EarningsPerCommonShareTables Earnings Per Common Share (Tables) Tables http://www.caretrustreit.com/role/EarningsPerCommonShare 30 false false R31.htm 2350308 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedTables Selected Quarterly Financial Data (Unaudited) (Tables) Tables http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnaudited 31 false false R32.htm 2402401 - Disclosure - Organization (Details) Sheet http://www.caretrustreit.com/role/OrganizationDetails Organization (Details) Details http://www.caretrustreit.com/role/Organization 32 false false R33.htm 2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 33 false false R34.htm 2407403 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) Sheet http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) Details 34 false false R35.htm 2410404 - Disclosure - Real Estate Investments, Net - Investment in Owned Properties (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails Real Estate Investments, Net - Investment in Owned Properties (Details) Details 35 false false R36.htm 2411405 - Disclosure - Real Estate Investments, Net - Narrative (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails Real Estate Investments, Net - Narrative (Details) Details 36 false false R37.htm 2412406 - Disclosure - Real Estate Investments, Net - Future Contractual Minimum Rental Income (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails Real Estate Investments, Net - Future Contractual Minimum Rental Income (Details) Details 37 false false R38.htm 2413407 - Disclosure - Real Estate Investments, Net - Tenant Purchase Options (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails Real Estate Investments, Net - Tenant Purchase Options (Details) Details 38 false false R39.htm 2414408 - Disclosure - Real Estate Investments, Net - Rental Income (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails Real Estate Investments, Net - Rental Income (Details) Details 39 false false R40.htm 2415409 - Disclosure - Real Estate Investments, Net - Recent Real Estate Acquisitions (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails Real Estate Investments, Net - Recent Real Estate Acquisitions (Details) Details 40 false false R41.htm 2416410 - Disclosure - Real Estate Investments, Net - Lease Amendments (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails Real Estate Investments, Net - Lease Amendments (Details) Details 41 false false R42.htm 2417411 - Disclosure - Real Estate Investments, Net - Pristine Lease Termination (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails Real Estate Investments, Net - Pristine Lease Termination (Details) Details 42 false false R43.htm 2418412 - Disclosure - Real Estate Investments, Net - Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale (Details) Sheet http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails Real Estate Investments, Net - Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale (Details) Details 43 false false R44.htm 2420413 - Disclosure - Other Real Estate Investments, Net (Details) Sheet http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails Other Real Estate Investments, Net (Details) Details http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNet 44 false false R45.htm 2423414 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value on Recurring Basis (Details) Sheet http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails Fair Value Measurements - Assets and Liabilities at Fair Value on Recurring Basis (Details) Details 45 false false R46.htm 2424415 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.caretrustreit.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 46 false false R47.htm 2425416 - Disclosure - Fair Value Measurements - Fair Value and Carrying Value of Financial Instruments (Details) Sheet http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails Fair Value Measurements - Fair Value and Carrying Value of Financial Instruments (Details) Details 47 false false R48.htm 2428417 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.caretrustreit.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 48 false false R49.htm 2429418 - Disclosure - Debt - Senior Unsecured Notes Payable Narrative (Details) Notes http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails Debt - Senior Unsecured Notes Payable Narrative (Details) Details 49 false false R50.htm 2430419 - Disclosure - Debt - Unsecured Revolving Credit Facility and Term Loan Narrative (Details) Sheet http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails Debt - Unsecured Revolving Credit Facility and Term Loan Narrative (Details) Details 50 false false R51.htm 2431420 - Disclosure - Debt - Schedule of Debt Maturities (Details) Sheet http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails Debt - Schedule of Debt Maturities (Details) Details 51 false false R52.htm 2434421 - Disclosure - Equity - Narrative (Details) Sheet http://www.caretrustreit.com/role/EquityNarrativeDetails Equity - Narrative (Details) Details 52 false false R53.htm 2435422 - Disclosure - Equity - At-The-Market Offering (Details) Sheet http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails Equity - At-The-Market Offering (Details) Details 53 false false R54.htm 2436423 - Disclosure - Equity - Dividends on Common Stock (Details) Sheet http://www.caretrustreit.com/role/EquityDividendsonCommonStockDetails Equity - Dividends on Common Stock (Details) Details 54 false false R55.htm 2439424 - Disclosure - Stock-Based Compensation - Restricted Stock and Performance Awards (Details) Sheet http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails Stock-Based Compensation - Restricted Stock and Performance Awards (Details) Details 55 false false R56.htm 2440425 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details) Sheet http://www.caretrustreit.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails Stock-Based Compensation - Stock-Based Compensation Expense (Details) Details 56 false false R57.htm 2441426 - Disclosure - Stock-Based Compensation - Narrative (Details) Sheet http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails Stock-Based Compensation - Narrative (Details) Details 57 false false R58.htm 2444427 - Disclosure - Earnings Per Common Share (Details) Sheet http://www.caretrustreit.com/role/EarningsPerCommonShareDetails Earnings Per Common Share (Details) Details http://www.caretrustreit.com/role/EarningsPerCommonShareTables 58 false false R59.htm 2446428 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.caretrustreit.com/role/CommitmentsandContingencies 59 false false R60.htm 2448429 - Disclosure - Concentration of Risk (Details) Sheet http://www.caretrustreit.com/role/ConcentrationofRiskDetails Concentration of Risk (Details) Details http://www.caretrustreit.com/role/ConcentrationofRisk 60 false false R61.htm 2451430 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details) Sheet http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails Selected Quarterly Financial Data (Unaudited) (Details) Details http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedTables 61 false false R62.htm 2453431 - Disclosure - Subsequent Events (Details) Sheet http://www.caretrustreit.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.caretrustreit.com/role/SubsequentEvents 62 false false R63.htm 2455432 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation - By Property (Details) Sheet http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails Schedule III - Real Estate Assets and Accumulated Depreciation - By Property (Details) Details http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciation 63 false false R64.htm 2456433 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation - Rollforward (Details) Sheet http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails Schedule III - Real Estate Assets and Accumulated Depreciation - Rollforward (Details) Details http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciation 64 false false R65.htm 2458434 - Disclosure - Schedule IV - Mortgage Loans on Real Estate - Mortgage Loan (Details) Sheet http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails Schedule IV - Mortgage Loans on Real Estate - Mortgage Loan (Details) Details 65 false false R66.htm 2459435 - Disclosure - Schedule IV - Mortgage Loan on Real Estate - Mortgage Loan Rollforward (Details) Sheet http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails Schedule IV - Mortgage Loan on Real Estate - Mortgage Loan Rollforward (Details) Details 66 false false All Reports Book All Reports ctre-20201231.htm ctre-20201231.xsd ctre-20201231_cal.xml ctre-20201231_def.xml ctre-20201231_lab.xml ctre-20201231_pre.xml ctre20201231ex211q4.htm ctre20201231ex231q4.htm ctre20201231ex232q4.htm ctre20201231ex311q4.htm ctre20201231ex312q4.htm ctre20201231ex32q4.htm ctre-20201231_g1.jpg http://xbrl.sec.gov/dei/2020-01-31 http://xbrl.sec.gov/stpr/2018-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 true true JSON 87 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ctre-20201231.htm": { "axisCustom": 1, "axisStandard": 30, "contextCount": 690, "dts": { "calculationLink": { "local": [ "ctre-20201231_cal.xml" ] }, "definitionLink": { "local": [ "ctre-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "ctre-20201231.htm" ] }, "labelLink": { "local": [ "ctre-20201231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ctre-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ctre-20201231.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 812, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 8, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 12 }, "keyCustom": 85, "keyStandard": 323, "memberCustom": 279, "memberStandard": 38, "nsprefix": "ctre", "nsuri": "http://www.caretrustreit.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.caretrustreit.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateOwnedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108103 - Disclosure - Real Estate Investments, Net", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNet", "shortName": "Real Estate Investments, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateOwnedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ctre:OtherRealEstateInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119104 - Disclosure - Other Real Estate Investments, Net", "role": "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNet", "shortName": "Other Real Estate Investments, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ctre:OtherRealEstateInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121105 - Disclosure - Fair Value Measurements", "role": "http://www.caretrustreit.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2126106 - Disclosure - Debt", "role": "http://www.caretrustreit.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2132107 - Disclosure - Equity", "role": "http://www.caretrustreit.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2137108 - Disclosure - Stock-Based Compensation", "role": "http://www.caretrustreit.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2142109 - Disclosure - Earnings Per Common Share", "role": "http://www.caretrustreit.com/role/EarningsPerCommonShare", "shortName": "Earnings Per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2145110 - Disclosure - Commitments and Contingencies", "role": "http://www.caretrustreit.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2147111 - Disclosure - Concentration of Risk", "role": "http://www.caretrustreit.com/role/ConcentrationofRisk", "shortName": "Concentration of Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2149112 - Disclosure - Selected Quarterly Financial Data (Unaudited)", "role": "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnaudited", "shortName": "Selected Quarterly Financial Data (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RealEstateInvestmentPropertyNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Consolidated Balance Sheets", "role": "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RealEstateInvestmentsJointVentures", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2152113 - Disclosure - Subsequent Events", "role": "http://www.caretrustreit.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2154114 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation", "role": "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciation", "shortName": "Schedule III - Real Estate Assets and Accumulated Depreciation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2157115 - Disclosure - Schedule IV - Mortgage Loans on Real Estate", "role": "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstate", "shortName": "Schedule IV - Mortgage Loans on Real Estate", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309302 - Disclosure - Real Estate Investments, Net (Tables)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTables", "shortName": "Real Estate Investments, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2322303 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.caretrustreit.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2327304 - Disclosure - Debt (Tables)", "role": "http://www.caretrustreit.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2333305 - Disclosure - Equity (Tables)", "role": "http://www.caretrustreit.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2338306 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.caretrustreit.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2343307 - Disclosure - Earnings Per Common Share (Tables)", "role": "http://www.caretrustreit.com/role/EarningsPerCommonShareTables", "shortName": "Earnings Per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2350308 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables)", "role": "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedTables", "shortName": "Selected Quarterly Financial Data (Unaudited) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402401 - Disclosure - Organization (Details)", "role": "http://www.caretrustreit.com/role/OrganizationDetails", "shortName": "Organization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:NumberOfStatesInWhichEntityOperates", "reportCount": 1, "unique": true, "unitRef": "state", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "iaaed1f7b1ef1453ea48383a2dc4d49af_D20180101-20181231", "decimals": "-3", "first": true, "lang": "en-US", "name": "ctre:TenantReimbursementRevenue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "role": "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:LessorLeasesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "ctre:RealEstateTaxesPaidOffsetToRentalIncomeGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i71ac3b4924b14a33a2b8eaa0c70ca030_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details)", "role": "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "shortName": "Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i71ac3b4924b14a33a2b8eaa0c70ca030_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Real Estate Investments, Net - Investment in Owned Properties (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails", "shortName": "Real Estate Investments, Net - Investment in Owned Properties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - Real Estate Investments, Net - Narrative (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "shortName": "Real Estate Investments, Net - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i9c22eecd8e1848a1b705cbf8e1db76c8_I20201231", "decimals": "INF", "lang": "en-US", "name": "ctre:LessorOperatingLeaseAnnualEscalationRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - Real Estate Investments, Net - Future Contractual Minimum Rental Income (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails", "shortName": "Real Estate Investments, Net - Future Contractual Minimum Rental Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctre:ScheduleOfTenantPurchaseOptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i9289909e5d644bdb973dcfee6e008f63_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctre:NumberOfPropertiesWithTenantPurchaseOption", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - Real Estate Investments, Net - Tenant Purchase Options (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails", "shortName": "Real Estate Investments, Net - Tenant Purchase Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctre:ScheduleOfTenantPurchaseOptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i9289909e5d644bdb973dcfee6e008f63_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctre:NumberOfPropertiesWithTenantPurchaseOption", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414408 - Disclosure - Real Estate Investments, Net - Rental Income (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails", "shortName": "Real Estate Investments, Net - Rental Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLeaseIncome", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Consolidated Income Statements", "role": "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "shortName": "Consolidated Income Statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "iaaed1f7b1ef1453ea48383a2dc4d49af_D20180101-20181231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeasesIncomeStatementLeaseRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctre:ScheduleOfAssetsAcquisitionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "ctre:AssetAcquisitionConsiderationTransferred", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415409 - Disclosure - Real Estate Investments, Net - Recent Real Estate Acquisitions (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails", "shortName": "Real Estate Investments, Net - Recent Real Estate Acquisitions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctre:ScheduleOfAssetsAcquisitionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "INF", "lang": "en-US", "name": "ctre:NumberOfBedsOrUnitsInPropertiesAcquired", "reportCount": 1, "unique": true, "unitRef": "unit", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416410 - Disclosure - Real Estate Investments, Net - Lease Amendments (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "shortName": "Real Estate Investments, Net - Lease Amendments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i975eb69a23c6484ba40a7af963096354_I20201201", "decimals": "INF", "lang": "en-US", "name": "ctre:NumberOfPropertiesTransferred", "reportCount": 1, "unique": true, "unitRef": "facility", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i19a7d69bd7344c248dd784b8d22cd556_I20201201", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseTermOfContract", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417411 - Disclosure - Real Estate Investments, Net - Pristine Lease Termination (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails", "shortName": "Real Estate Investments, Net - Pristine Lease Termination (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i2399c589fefe4451a8a09019f5f0fbf5_I20180227", "decimals": "INF", "lang": "en-US", "name": "ctre:NumberOfProperties", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i563eb88f8a8c4eed90f445d793165835_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418412 - Disclosure - Real Estate Investments, Net - Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale (Details)", "role": "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "shortName": "Real Estate Investments, Net - Impairment of Real Estate Investments, Asset Sales and Assets Held for Sale (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i6720e67ff3fd400b845cc228b39e4869_I20190901", "decimals": "INF", "lang": "en-US", "name": "ctre:NumberOfPropertiesSold", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420413 - Disclosure - Other Real Estate Investments, Net (Details)", "role": "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "shortName": "Other Real Estate Investments, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i6cc84d251a144c489439b8e6db49ee43_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LoansReceivableFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423414 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value on Recurring Basis (Details)", "role": "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "shortName": "Fair Value Measurements - Assets and Liabilities at Fair Value on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i6cc84d251a144c489439b8e6db49ee43_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LoansReceivableFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentLossesRelatedToRealEstatePartnerships", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424415 - Disclosure - Fair Value Measurements - Narrative (Details)", "role": "http://www.caretrustreit.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentAggregateCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425416 - Disclosure - Fair Value Measurements - Fair Value and Carrying Value of Financial Instruments (Details)", "role": "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails", "shortName": "Fair Value Measurements - Fair Value and Carrying Value of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentAggregateCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428417 - Disclosure - Debt - Schedule of Debt (Details)", "role": "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "shortName": "Debt - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredFinanceCostsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfUnsecuredDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429418 - Disclosure - Debt - Senior Unsecured Notes Payable Narrative (Details)", "role": "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "shortName": "Debt - Senior Unsecured Notes Payable Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i09505e4b5cc54a459f01f854dccbfe54_I20170510", "decimals": "INF", "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i04041e3079a8450295531a2979723979_I20171231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Consolidated Statements of Equity", "role": "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity", "shortName": "Consolidated Statements of Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i04041e3079a8450295531a2979723979_I20171231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430419 - Disclosure - Debt - Unsecured Revolving Credit Facility and Term Loan Narrative (Details)", "role": "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "shortName": "Debt - Unsecured Revolving Credit Facility and Term Loan Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i07c931bd2cf74d099a1376de8b75cf21_I20190208", "decimals": "INF", "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431420 - Disclosure - Debt - Schedule of Debt Maturities (Details)", "role": "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails", "shortName": "Debt - Schedule of Debt Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434421 - Disclosure - Equity - Narrative (Details)", "role": "http://www.caretrustreit.com/role/EquityNarrativeDetails", "shortName": "Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i15c460ad8c50483aa658576b50d348d4_I20200320", "decimals": "-5", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i599c7388d5734f12a4cadd405193a168_D20190101-20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435422 - Disclosure - Equity - At-The-Market Offering (Details)", "role": "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails", "shortName": "Equity - At-The-Market Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "iaa88ddc7f79e446b89cc22f8016feb83_D20190101-20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ia1ad1c8c4f464c43ad0362f916710a72_D20201001-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436423 - Disclosure - Equity - Dividends on Common Stock (Details)", "role": "http://www.caretrustreit.com/role/EquityDividendsonCommonStockDetails", "shortName": "Equity - Dividends on Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ia1ad1c8c4f464c43ad0362f916710a72_D20201001-20201231", "decimals": null, "lang": "en-US", "name": "us-gaap:DividendPayableDateToBePaidDayMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i1067c2f36ebd4b8d87c2008f5f9d5b35_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439424 - Disclosure - Stock-Based Compensation - Restricted Stock and Performance Awards (Details)", "role": "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails", "shortName": "Stock-Based Compensation - Restricted Stock and Performance Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ib2953d4e4471427daa94644c1a8620ed_I20181231", "decimals": "2", "lang": "en-US", "name": "ctre:SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440425 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)", "role": "http://www.caretrustreit.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails", "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i9fc6ba7581474c008253cffdc9a92bd7_I20140601", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctre:NumberOfSeparateAndIndependentCompaniesAfterSpinOff", "reportCount": 1, "unique": true, "unitRef": "company", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441426 - Disclosure - Stock-Based Compensation - Narrative (Details)", "role": "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "shortName": "Stock-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i9fc6ba7581474c008253cffdc9a92bd7_I20140601", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctre:NumberOfSeparateAndIndependentCompaniesAfterSpinOff", "reportCount": 1, "unique": true, "unitRef": "company", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ia1ad1c8c4f464c43ad0362f916710a72_D20201001-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444427 - Disclosure - Earnings Per Common Share (Details)", "role": "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails", "shortName": "Earnings Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "ctre:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicAndDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ibbda1c2f66594277a8c2f4ddd2ccb1b6_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctre:AggregateRequiredFinancingOfCapitalExpendituresAsPercentageOfInitialInvestmentInProperty", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446428 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ibbda1c2f66594277a8c2f4ddd2ccb1b6_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctre:AggregateRequiredFinancingOfCapitalExpendituresAsPercentageOfInitialInvestmentInProperty", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ia1ad1c8c4f464c43ad0362f916710a72_D20201001-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Consolidated Statements of Equity (Parenthetical)", "role": "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquityParenthetical", "shortName": "Consolidated Statements of Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448429 - Disclosure - Concentration of Risk (Details)", "role": "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "shortName": "Concentration of Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i9195a6ccf2d94f2aaf7eaf4929125481_D20200101-20201231", "decimals": "INF", "lang": "en-US", "name": "ctre:ConcentrationRiskNumberOfStates", "reportCount": 1, "unique": true, "unitRef": "state", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ia1ad1c8c4f464c43ad0362f916710a72_D20201001-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451430 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details)", "role": "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails", "shortName": "Selected Quarterly Financial Data (Unaudited) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "ia1ad1c8c4f464c43ad0362f916710a72_D20201001-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RealEstateInvestmentPropertyNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2453431 - Disclosure - Subsequent Events (Details)", "role": "http://www.caretrustreit.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "iaac370be389947c0bcf7f83cf6846a4a_I20210201", "decimals": "INF", "lang": "en-US", "name": "ctre:NumberOfPropertiesSold", "reportCount": 1, "unique": true, "unitRef": "facility", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "srt:RealEstateAndAccumulatedDepreciationAmountOfEncumbrances", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2455432 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation - By Property (Details)", "role": "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails", "shortName": "Schedule III - Real Estate Assets and Accumulated Depreciation - By Property (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "srt:RealEstateAndAccumulatedDepreciationAmountOfEncumbrances", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i563eb88f8a8c4eed90f445d793165835_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RealEstateGrossAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2456433 - Disclosure - Schedule III - Real Estate Assets and Accumulated Depreciation - Rollforward (Details)", "role": "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails", "shortName": "Schedule III - Real Estate Assets and Accumulated Depreciation - Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RealEstateOtherAcquisitions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "srt:MortgageLoansOnRealEstatePriorLiens1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458434 - Disclosure - Schedule IV - Mortgage Loans on Real Estate - Mortgage Loan (Details)", "role": "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails", "shortName": "Schedule IV - Mortgage Loans on Real Estate - Mortgage Loan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "if88740f715694f54869630cf9295e556_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "srt:MortgageLoansOnRealEstatePriorLiens1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i563eb88f8a8c4eed90f445d793165835_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:MortgageLoansOnRealEstate", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2459435 - Disclosure - Schedule IV - Mortgage Loan on Real Estate - Mortgage Loan Rollforward (Details)", "role": "http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails", "shortName": "Schedule IV - Mortgage Loan on Real Estate - Mortgage Loan Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Organization", "role": "http://www.caretrustreit.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctre-20201231.htm", "contextRef": "i32994e36c8774ede916adcdca3a0a708_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 321, "tag": { "ctre_AdditionsDuringPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additions During Period [Abstract]", "label": "Additions During Period [Abstract]", "terseLabel": "Additions during period:" } } }, "localname": "AdditionsDuringPeriodAbstract", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails" ], "xbrltype": "stringItemType" }, "ctre_AggregateRequiredFinancingOfCapitalExpendituresAsPercentageOfInitialInvestmentInProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate Required Financing Of Capital Expenditures As Percentage Of Initial Investment In Property", "label": "Aggregate Required Financing Of Capital Expenditures As Percentage Of Initial Investment In Property", "terseLabel": "Aggregate required financing of capital expenditures as percentage of initial investment in property (percent)" } } }, "localname": "AggregateRequiredFinancingOfCapitalExpendituresAsPercentageOfInitialInvestmentInProperty", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "percentItemType" }, "ctre_AlpineSkilledNursingandRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alpine Skilled Nursing and Rehabilitation [Member]", "label": "Alpine Skilled Nursing and Rehabilitation [Member]", "terseLabel": "Alpine Skilled Nursing and Rehabilitation" } } }, "localname": "AlpineSkilledNursingandRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_AmendedTripleNetMasterLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Triple Net Master Lease [Member]", "label": "Amended Triple Net Master Lease [Member]", "terseLabel": "Triple-net master lease" } } }, "localname": "AmendedTripleNetMasterLeaseMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "ctre_AmerisistOfCulpeperMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amerisist Of Culpeper [Member]", "label": "Amerisist Of Culpeper [Member]", "terseLabel": "Culpeper" } } }, "localname": "AmerisistOfCulpeperMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_AmerisistOfLouisaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amerisist Of Louisa [Member]", "label": "Amerisist Of Louisa [Member]", "terseLabel": "Louisa" } } }, "localname": "AmerisistOfLouisaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_AmerisistOfWarrentonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amerisist Of Warrenton [Member]", "label": "Amerisist Of Warrenton [Member]", "terseLabel": "Warrenton" } } }, "localname": "AmerisistOfWarrentonMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_AnnualCashRentIncreaseUnderAmendedLease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Annual Cash Rent Increase Under Amended Lease", "label": "Annual Cash Rent Increase Under Amended Lease", "terseLabel": "Annual cash rent increase under amended lease" } } }, "localname": "AnnualCashRentIncreaseUnderAmendedLease", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "monetaryItemType" }, "ctre_AnnualizedLeaseRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Annualized Lease Revenue", "label": "Annualized Lease Revenue", "terseLabel": "Annualized contractual rental income" } } }, "localname": "AnnualizedLeaseRevenue", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_AnsonHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Anson Health Holdings LLC [Member]", "label": "Anson Health Holdings LLC [Member]", "terseLabel": "Anson Health Holdings LLC" } } }, "localname": "AnsonHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ApplewoodofBrookfieldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Applewood of Brookfield [Member]", "label": "Applewood of Brookfield [Member]", "terseLabel": "Applewood of Brookfield" } } }, "localname": "ApplewoodofBrookfieldMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ApplewoodofNewBerlinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Applewood of New Berlin [Member]", "label": "Applewood of New Berlin [Member]", "terseLabel": "Applewood of New Berlin" } } }, "localname": "ApplewoodofNewBerlinMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ArapahoeHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arapahoe Health Holdings LLC [Member]", "label": "Arapahoe Health Holdings LLC [Member]", "terseLabel": "Arapahoe Health Holdings LLC" } } }, "localname": "ArapahoeHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ArborNursingCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arbor Nursing Center [Member]", "label": "Arbor Nursing Center [Member]", "terseLabel": "Arbor Nursing Center" } } }, "localname": "ArborNursingCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ArborPlaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arbor Place [Member]", "label": "Arbor Place [Member]", "terseLabel": "Arbor Place" } } }, "localname": "ArborPlaceMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ArrowTreeHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrow Tree Health Holdings LLC [Member]", "label": "Arrow Tree Health Holdings LLC [Member]", "terseLabel": "Arrow Tree Health Holdings LLC" } } }, "localname": "ArrowTreeHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_AsburyPlaceAssistedLivingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asbury Place Assisted Living [Member]", "label": "Asbury Place Assisted Living [Member]", "terseLabel": "Asbury Place Assisted Living" } } }, "localname": "AsburyPlaceAssistedLivingMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_AssetAcquisitionConsiderationTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Consideration Transferred", "label": "Asset Acquisition, Consideration Transferred", "terseLabel": "Purchase Price", "verboseLabel": "Aggregate purchase price" } } }, "localname": "AssetAcquisitionConsiderationTransferred", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ctre_AssistedAndIndependentLivingPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assisted and Independent Living Properties [Member]", "label": "Assisted and Independent Living Properties [Member]", "terseLabel": "Assisted and Independent Living Properties" } } }, "localname": "AssistedAndIndependentLivingPropertiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_AssistedLivingFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assisted Living Facility [Member]", "label": "Assisted Living Facility [Member]", "terseLabel": "Assisted living", "verboseLabel": "ALF" } } }, "localname": "AssistedLivingFacilityMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_AtTheMarketOfferingProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "At-The-Market Offering Program [Member]", "label": "At-The-Market Offering Program [Member]", "terseLabel": "ATM Program" } } }, "localname": "AtTheMarketOfferingProgramMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_AvenueNHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Avenue N Holdings LLC [Member]", "label": "Avenue N- Holdings LLC [Member]", "terseLabel": "Avenue N Holdings LLC" } } }, "localname": "AvenueNHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BeaconHarborHealthcareAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Beacon Harbor Healthcare And Rehabilitation", "label": "Beacon Harbor Healthcare And Rehabilitation [Member]", "terseLabel": "Beacon Harbor Healthcare and Rehabilitation" } } }, "localname": "BeaconHarborHealthcareAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BeaverCreekHealthAndRehabMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BeaverCreek Health And Rehab [Member]", "label": "BeaverCreek Health And Rehab [Member]", "terseLabel": "BeaverCreek Health and Rehab" } } }, "localname": "BeaverCreekHealthAndRehabMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BellBrookHealthAndRehabMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BellBrook Health And Rehab [Member]", "label": "BellBrook Health And Rehab [Member]", "terseLabel": "BellBrook Health and Rehab" } } }, "localname": "BellBrookHealthAndRehabMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BethanyRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bethany rehabilitation center.", "label": "Bethany Rehabilitation Center Member", "terseLabel": "Bethany Rehabilitation Center" } } }, "localname": "BethanyRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BigSiouxRiverHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Big Sioux River Health Holdings LLC [Member]", "label": "Big Sioux River Health Holdings LLC [Member]", "terseLabel": "Big Sioux River Health Holdings LLC" } } }, "localname": "BigSiouxRiverHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BoardwalkHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boardwalk Health Holdings LLC [Member]", "label": "Boardwalk Health Holdings LLC [Member]", "terseLabel": "Boardwalk Health Holdings LLC" } } }, "localname": "BoardwalkHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BogardusHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bogardus Health Holdings LLC [Member]", "label": "Bogardus Health Holdings LLC [Member]", "terseLabel": "Bogardus Health Holdings LLC" } } }, "localname": "BogardusHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BookerTWashingtonSkilledNursingAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Booker T Washington Skilled Nursing And Rehabilitation [Member]", "label": "Booker T Washington Skilled Nursing And Rehabilitation [Member]", "terseLabel": "Booker T Washington Skilled Nursing and Rehabilitation" } } }, "localname": "BookerTWashingtonSkilledNursingAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BridgeportMedicalLodgeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridgeport Medical Lodge [Member]", "label": "Bridgeport Medical Lodge [Member]", "terseLabel": "Bridgeport Medical Lodge" } } }, "localname": "BridgeportMedicalLodgeMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BristolCourtAssistedLivingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bristol Court Assisted Living [Member]", "label": "Bristol Court Assisted Living [Member]", "terseLabel": "Bristol Court Assisted Living" } } }, "localname": "BristolCourtAssistedLivingMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BroadmoorMedicalLodgeRockwallMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Broadmoor Medical Lodge - Rockwall [Member]", "label": "Broadmoor Medical Lodge - Rockwall [Member]", "terseLabel": "Broadmoor Medical Lodge" } } }, "localname": "BroadmoorMedicalLodgeRockwallMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BrookfieldHealthAndRehabMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Brookfield Health And Rehab [Member]", "label": "Brookfield Health And Rehab [Member]", "terseLabel": "Brookfield Health and Rehab" } } }, "localname": "BrookfieldHealthAndRehabMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_BurleyHealthcareHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Burley Healthcare Holdings LLC [Member]", "label": "Burley Healthcare Holdings LLC [Member]", "terseLabel": "Burley Healthcare Holdings LLC" } } }, "localname": "BurleyHealthcareHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CarrierMillsNursingAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carrier Mills Nursing And Rehabilitation Center [Member]", "label": "Carrier Mills Nursing And Rehabilitation Center [Member]", "terseLabel": "Carrier Mills Nursing and Rehabilitation Center" } } }, "localname": "CarrierMillsNursingAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CasadePazMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Casa de Paz [Member]", "label": "Casa de Paz [Member]", "terseLabel": "Casa de Paz" } } }, "localname": "CasadePazMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CascadeCapitalGroupLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cascade Capital Group LLC [Member]", "label": "Cascade Capital Group LLC [Member]", "terseLabel": "Cascade Capital Group, LLC" } } }, "localname": "CascadeCapitalGroupLLCMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "ctre_CascadiaOfBoiseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cascadia Of Boise", "label": "Cascadia Of Boise [Member]", "terseLabel": "Cascadia of Boise" } } }, "localname": "CascadiaOfBoiseMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CascadiaOfNampaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cascadia Of Nampa [Member]", "label": "Cascadia Of Nampa [Member]", "terseLabel": "Cascadia of Nampa" } } }, "localname": "CascadiaOfNampaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CedarAvenueHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cedar Avenue Holdings LLC [Member]", "label": "Cedar Avenue Holdings LLC [Member]", "terseLabel": "Cedar Avenue Holdings LLC" } } }, "localname": "CedarAvenueHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CedarFallsHealthCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cedar Falls Health Care Center [Member]", "label": "Cedar Falls Health Care Center [Member]", "terseLabel": "Cedar Falls Health Care Center" } } }, "localname": "CedarFallsHealthCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CentervilleSeniorIndependentLivingCentervilleHealthAndRehabCentervillePlaceAssistedLivingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centerville Senior Independent Living/Centerville Health And Rehab/Centerville Place Assisted Living [Member]", "label": "Centerville Senior Independent Living/Centerville Health And Rehab/Centerville Place Assisted Living [Member]", "terseLabel": "Centerville Senior Independent Living" } } }, "localname": "CentervilleSeniorIndependentLivingCentervilleHealthAndRehabCentervillePlaceAssistedLivingMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CherryHealthHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cherry Health Holdings, Inc. [Member]", "label": "Cherry Health Holdings, Inc. [Member]", "terseLabel": "Cherry Health Holdings LLC" } } }, "localname": "CherryHealthHoldingsIncMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CityCreekPostAcuteAndAssistedLivingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "City Creek Post-Acute And Assisted Living [Member]", "label": "City Creek Post-Acute And Assisted Living [Member]", "terseLabel": "City Creek Post-Acute and Assisted Living" } } }, "localname": "CityCreekPostAcuteAndAssistedLivingMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CmHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CM Health Holdings LLC [Member]", "label": "CM Health Holdings LLC [Member]", "terseLabel": "CM Health Holdings LLC" } } }, "localname": "CmHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ColonialOaksSkilledNursingAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Colonial Oaks Skilled Nursing And Rehabilitation [Member]", "label": "Colonial Oaks Skilled Nursing And Rehabilitation [Member]", "terseLabel": "Colonial Oaks Skilled Nursing And Rehabilitation" } } }, "localname": "ColonialOaksSkilledNursingAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CommuniCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CommuniCare [Member]", "label": "CommuniCare [Member]", "terseLabel": "CommuniCare" } } }, "localname": "CommuniCareMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "ctre_ConcentrationRiskNumberOfStates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of states where the entity's major tenants lease the highest concentration of properties.", "label": "Concentration Risk, Number Of States", "terseLabel": "Number of states where Ensign leases the highest concentration of properties" } } }, "localname": "ConcentrationRiskNumberOfStates", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "integerItemType" }, "ctre_ConstructionAndCapitalImprovementsAtTripleNetLeasedFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Construction And Capital Improvements At Triple-Net Leased Facilities [Member]", "label": "Construction And Capital Improvements At Triple-Net Leased Facilities [Member]", "terseLabel": "Expansion, construction and capital improvements at triple-net leased facilities" } } }, "localname": "ConstructionAndCapitalImprovementsAtTripleNetLeasedFacilitiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "ctre_CooneyHealthcareAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cooney Healthcare And Rehabilitation", "label": "Cooney Healthcare And Rehabilitation [Member]", "terseLabel": "Cooney Healthcare and Rehabilitation" } } }, "localname": "CooneyHealthcareAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CopperRidgeHealthAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Copper Ridge Health And Rehabilitation Center [Member]", "label": "Copper Ridge Health And Rehabilitation Center [Member]", "terseLabel": "Copper Ridge Health and Rehabilitation Center" } } }, "localname": "CopperRidgeHealthAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CottonwoodHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cottonwood Health Holdings LLC [Member]", "label": "Cottonwood Health Holdings LLC [Member]", "terseLabel": "Cottonwood Health Holdings LLC" } } }, "localname": "CottonwoodHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CountrysideVillageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countryside Village [Member]", "label": "Countryside Village [Member]", "terseLabel": "Countryside Village" } } }, "localname": "CountrysideVillageMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CourtyardHealthcareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Courtyard Healthcare Center [Member]", "label": "Courtyard Healthcare Center [Member]", "terseLabel": "Courtyard Healthcare Center" } } }, "localname": "CourtyardHealthcareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CovenantCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Care [Member]", "label": "Covenant Care [Member]", "terseLabel": "Covenant Care" } } }, "localname": "CovenantCareMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "ctre_CrestwoodHealthAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crestwood Health And Rehabilitation Center", "label": "Crestwood Health And Rehabilitation Center [Member]", "terseLabel": "Crestwood Health and Rehabilitation Center" } } }, "localname": "CrestwoodHealthAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CroatanVillageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Croatan Village [Member]", "label": "Croatan Village [Member]", "terseLabel": "Croatan Village" } } }, "localname": "CroatanVillageMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_CtrPartnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CTR Partnership, L.P. [Member]", "label": "CTR Partnership, L.P. [Member]", "terseLabel": "CTR Partnership, L.P." } } }, "localname": "CtrPartnershipMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_DebtInstrumentRedemptionPriceUponChangeOfControlAsPercentageOfPrincipalAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument redemption price upon change of control as percentage of principal amount.", "label": "Debt Instrument Redemption Price Upon Change Of Control As Percentage Of Principal Amount", "terseLabel": "Redemption price, percentage upon change of control (percent)" } } }, "localname": "DebtInstrumentRedemptionPriceUponChangeOfControlAsPercentageOfPrincipalAmount", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_DecaturMedicalLodgeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Decatur Medical Lodge [Member]", "label": "Decatur Medical Lodge [Member]", "terseLabel": "Decatur Medical Lodge" } } }, "localname": "DecaturMedicalLodgeMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_DeductionsDuringPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deductions During Period [Abstract]", "label": "Deductions During Period [Abstract]", "terseLabel": "Deductions during period:" } } }, "localname": "DeductionsDuringPeriodAbstract", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails" ], "xbrltype": "stringItemType" }, "ctre_DenisonCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Denison Care Center [Member]", "label": "Denison Care Center [Member]", "terseLabel": "Denison Care Center" } } }, "localname": "DenisonCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_DisposalGroupIncludingDiscontinuedOperationContractPurchasePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Contract Purchase Price", "label": "Disposal Group, Including Discontinued Operation, Contract Purchase Price", "terseLabel": "Contract purchase price" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationContractPurchasePrice", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "monetaryItemType" }, "ctre_DixieHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dixie Health Holdings LLC [Member]", "label": "Dixie Health Holdings LLC [Member]", "terseLabel": "Dixie Health Holdings" } } }, "localname": "DixieHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_DowneyCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Downey Care Center [Member]", "label": "Downey Care Center [Member]", "terseLabel": "Downey Care Center" } } }, "localname": "DowneyCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_DuQuoinNursingAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuQuoin Nursing And Rehabilitation Center [Member]", "label": "DuQuoin Nursing And Rehabilitation Center [Member]", "terseLabel": "DuQuoin Nursing and Rehabilitation Center" } } }, "localname": "DuQuoinNursingAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EighteenthPlaceHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteenth Place Health Holdings LLC [Member]", "label": "Eighteenth Place Health Holdings LLC [Member]", "terseLabel": "18th Place Health Holdings LLC" } } }, "localname": "EighteenthPlaceHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EldoradoRehabAndHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eldorado Rehab And Healthcare [Member]", "label": "Eldorado Rehab And Healthcare [Member]", "terseLabel": "Eldorado Rehab & Healthcare" } } }, "localname": "EldoradoRehabAndHealthcareMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ElkhornHealthcareAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Elkhorn Healthcare And Rehabilitation", "label": "Elkhorn Healthcare And Rehabilitation [Member]", "terseLabel": "Elkhorn Healthcare and Rehabilitation" } } }, "localname": "ElkhornHealthcareAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EmmettHealthcareHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emmett Healthcare Holdings LLC [Member]", "label": "Emmett Healthcare Holdings LLC [Member]", "terseLabel": "Emmett Healthcare Holdings LLC" } } }, "localname": "EmmettHealthcareHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EnglewoodHealthAndRehabMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Englewood Health And Rehab [Member]", "label": "Englewood Health And Rehab [Member]", "terseLabel": "Englewood Health and Rehab" } } }, "localname": "EnglewoodHealthAndRehabMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EnglishMeadowsElksHomeCampusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "English Meadows Elks Home Campus [Member]", "label": "English Meadows Elks Home Campus [Member]", "terseLabel": "English Meadows Elks Home Campus" } } }, "localname": "EnglishMeadowsElksHomeCampusMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EnglishMeadowsSeniorLivingCommunityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "English Meadows Senior Living Community [Member]", "label": "English Meadows Senior Living Community [Member]", "terseLabel": "English Meadows Senior Living Community" } } }, "localname": "EnglishMeadowsSeniorLivingCommunityMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignAndPennantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign And Pennant", "label": "Ensign And Pennant [Member]", "terseLabel": "Ensign and Pennant" } } }, "localname": "EnsignAndPennantMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignBellflowerLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign Bellflower LLC [Member]", "label": "Ensign Bellflower LLC [Member]", "terseLabel": "Ensign Bellflower LLC" } } }, "localname": "EnsignBellflowerLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign Employees [Member]", "label": "Ensign Employees [Member]", "terseLabel": "Ensign Employees" } } }, "localname": "EnsignEmployeesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignHighlandLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign Highland LLC [Member]", "label": "Ensign Highland LLC [Member]", "terseLabel": "Ensign Highland LLC" } } }, "localname": "EnsignHighlandLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignMasterLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign Master Leases [Member]", "label": "Ensign Master Leases [Member]", "terseLabel": "Ensign Master leases" } } }, "localname": "EnsignMasterLeasesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign [Member]", "label": "Ensign [Member]", "terseLabel": "Ensign" } } }, "localname": "EnsignMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignOtherLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign Other Leases", "label": "Ensign Other Leases [Member]", "terseLabel": "Other Ensign leases" } } }, "localname": "EnsignOtherLeasesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_EnsignSouthlandLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ensign Southland LLC [Member]", "label": "Ensign Southland LLC [Member]", "terseLabel": "Ensign Southland LLC" } } }, "localname": "EnsignSouthlandLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_EquityMethodInvestmentCumulativeContractualPreferredReturn": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Cumulative Contractual Preferred Return", "label": "Equity Method Investment, Cumulative Contractual Preferred Return", "terseLabel": "Cumulative contractual preferred return through acquisition date" } } }, "localname": "EquityMethodInvestmentCumulativeContractualPreferredReturn", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "ctre_EquityMethodInvestmentRateOfReturnFloor": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Rate Of Return, Floor", "label": "Equity Method Investment, Rate Of Return, Floor", "terseLabel": "Preferred equity instrument minimum yield" } } }, "localname": "EquityMethodInvestmentRateOfReturnFloor", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "percentItemType" }, "ctre_EquityMethodInvestmentsBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investments, Basis Spread On Variable Rate", "label": "Equity Method Investments, Basis Spread On Variable Rate", "terseLabel": "Basis spread on preferred equity investment yield" } } }, "localname": "EquityMethodInvestmentsBasisSpreadOnVariableRate", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "percentItemType" }, "ctre_EvergladesHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Everglades Health Holdings LLC [Member]", "label": "Everglades Health Holdings LLC [Member]", "terseLabel": "Everglades Health Holdings" } } }, "localname": "EvergladesHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ExpoParkHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expo Park Health Holdings LLC [Member]", "label": "Expo Park Health Holdings LLC [Member]", "terseLabel": "Expo Park Health Holdings LLC" } } }, "localname": "ExpoParkHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ExpresswayHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expressway Health Holdings LLC [Member]", "label": "Expressway Health Holdings LLC [Member]", "terseLabel": "Expressway Health Holdings LLC" } } }, "localname": "ExpresswayHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FallsCityHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Falls City Health Holdings LLC [Member]", "label": "Falls City Health Holdings LLC [Member]", "terseLabel": "Falls City Health Holdings LLC" } } }, "localname": "FallsCityHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FifthEastHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifth East Holdings LLC [Member]", "label": "Fifth East Holdings LLC [Member]", "terseLabel": "Fifth East Holdings" } } }, "localname": "FifthEastHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FiftyOneAvenueHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifty One Avenue Health Holdings Llc [Member]", "label": "Fifty One Avenue Health Holdings Llc [Member]", "terseLabel": "51st Avenue Health Holdings LLC" } } }, "localname": "FiftyOneAvenueHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FigStreetHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fig Street Health Holdings Llc [Member]", "label": "Fig Street Health Holdings Llc [Member]", "terseLabel": "Fig Street Health Holdings LLC" } } }, "localname": "FigStreetHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FiveOaksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five Oaks", "label": "Five Oaks [Member]", "terseLabel": "Five Oaks skilled nursing facility" } } }, "localname": "FiveOaksMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "ctre_FivePointEightSevenFiveSeniorNotesDue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five Point Eight Seven Five Senior Notes Due 2021 [Member]", "label": "Five Point Eight Seven Five Senior Notes Due 2021 [Member]", "terseLabel": "5.875% Senior Notes due 2021" } } }, "localname": "FivePointEightSevenFiveSeniorNotesDue2021Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_FivePointTwoFiveSeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five Point Two Five Senior Notes Due 2025 [Member]", "label": "Five Point Two Five Senior Notes Due 2025 [Member]", "terseLabel": "5.25% Senior Notes due 2025" } } }, "localname": "FivePointTwoFiveSeniorNotesDue2025Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_FlamingoHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Flamingo Health Holdings LLC [Member]", "label": "Flamingo Health Holdings LLC [Member]", "terseLabel": "Flamingo Health Holdings LLC" } } }, "localname": "FlamingoHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FortMyersAssistedLivingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fort Myers Assisted Living [Member]", "label": "Fort Myers Assisted Living [Member]", "terseLabel": "Fort Myers Assisted Living" } } }, "localname": "FortMyersAssistedLivingMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FortStreetHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fort Street Health Holdings LLC [Member]", "label": "Fort Street Health Holdings LLC [Member]", "terseLabel": "Fort Street Health Holdings LLC" } } }, "localname": "FortStreetHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FortyNineStreetHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forty Nine Street Health Holdings Llc [Member]", "label": "Forty Nine Street Health Holdings Llc [Member]", "terseLabel": "49th Street Health Holdings LLC" } } }, "localname": "FortyNineStreetHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FourthStreetHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fourth Street Health Holdings LLC [Member]", "label": "Fourth Street Health Holdings LLC [Member]", "terseLabel": "4th Street Holdings LLC" } } }, "localname": "FourthStreetHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_FundingCommitmentCapitalExpenditures": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Funding Commitment, Capital Expenditures", "label": "Funding Commitment, Capital Expenditures", "terseLabel": "Funding commitment for revenue-producing capital expenditures" } } }, "localname": "FundingCommitmentCapitalExpenditures", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ctre_GardenViewCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Garden View Care Center [Member]", "label": "Garden View Care Center [Member]", "terseLabel": "Garden View Care Center" } } }, "localname": "GardenViewCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GazeboParkHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gazebo Park Health Holdings LLC [Member]", "label": "Gazebo Park Health Holdings LLC [Member]", "terseLabel": "Gazebo Park Health Holdings LLC" } } }, "localname": "GazeboParkHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GilletteParkHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gillette Park Health Holdings LLC [Member]", "label": "Gillette Park Health Holdings LLC [Member]", "terseLabel": "Gillette Park Health Holdings LLC" } } }, "localname": "GilletteParkHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GolfviewHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Golfview Holdings LLC [Member]", "label": "Golfview Holdings LLC [Member]", "terseLabel": "Golfview Holdings LLC" } } }, "localname": "GolfviewHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GranadaInvestmentsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Granada Investments LLC [Member]", "label": "Granada Investments LLC [Member]", "terseLabel": "Granada Investments LLC" } } }, "localname": "GranadaInvestmentsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GrandviewHealthCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grandview Health Care Center [Member]", "label": "Grandview Health Care Center [Member]", "terseLabel": "Grandview Health Care Center" } } }, "localname": "GrandviewHealthCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GreenvilleNursingandRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Greenville Nursing and Rehabilitation Center [Member]", "label": "Greenville Nursing and Rehabilitation Center [Member]", "terseLabel": "Greenville Nursing and Rehabilitation Center" } } }, "localname": "GreenvilleNursingandRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GrundyCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grundy Care Center [Member]", "label": "Grundy Care Center [Member]", "terseLabel": "Grundy Care Center" } } }, "localname": "GrundyCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GuadalupeHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guadalupe Health Holdings Llc [Member]", "label": "Guadalupe Health Holdings Llc [Member]", "terseLabel": "Guadalupe Health Holdings LLC" } } }, "localname": "GuadalupeHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_GulfCoastBuyer1LLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gulf Coast Buyer 1 LLC [Member]", "label": "Gulf Coast Buyer 1 LLC [Member]", "terseLabel": "Gulf Coast Buyer 1 LLC" } } }, "localname": "GulfCoastBuyer1LLCMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_HillendahlHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hillendahl Health Holdings LLC [Member]", "label": "Hillendahl Health Holdings LLC [Member]", "terseLabel": "Hillendahl Health Holdings LLC" } } }, "localname": "HillendahlHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_HillstoneHealthcareIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hillstone Healthcare Inc [Member]", "label": "Hillstone Healthcare Inc [Member]", "terseLabel": "Hillstone Healthcare" } } }, "localname": "HillstoneHealthcareIncMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "domainItemType" }, "ctre_HillstoneHealthcareMasterLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hillstone Healthcare Master Lease [Member]", "label": "Hillstone Healthcare Master Lease [Member]", "terseLabel": "Hillstone Healthcare Master Lease" } } }, "localname": "HillstoneHealthcareMasterLeaseMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "domainItemType" }, "ctre_HuntingtonParkNursingCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Huntington Park Nursing Center [Member]", "label": "Huntington Park Nursing Center [Member]", "terseLabel": "Huntington Park Nursing Center" } } }, "localname": "HuntingtonParkNursingCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_IdahoAssistedLivingFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Idaho Assisted Living Facilities [Member]", "label": "Idaho Assisted Living Facilities [Member]", "terseLabel": "Idaho assisted living facilities" } } }, "localname": "IdahoAssistedLivingFacilitiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "ctre_IncreaseDecreaseInDividendsPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Dividends Payable", "label": "Increase Decrease In Dividends Payable", "terseLabel": "Increase in dividends payable" } } }, "localname": "IncreaseDecreaseInDividendsPayable", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctre_InitialLeaseYield": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Lease Yield", "label": "Initial Lease Yield", "terseLabel": "Initial lease yield (percent)" } } }, "localname": "InitialLeaseYield", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "percentItemType" }, "ctre_InnAtBartonCreekMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inn At Barton Creek", "label": "Inn At Barton Creek [Member]", "terseLabel": "Inn at Barton Creek" } } }, "localname": "InnAtBartonCreekMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_IowaCityRehabandHealthCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Iowa City Rehab and Health Care Center [Member]", "label": "Iowa City Rehab and Health Care Center [Member]", "terseLabel": "Iowa City Rehab and Health Care Center" } } }, "localname": "IowaCityRehabandHealthCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_IrvingHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Irving Health Holdings LLC [Member]", "label": "Irving Health Holdings LLC [Member]", "terseLabel": "Irving Health Holdings LLC" } } }, "localname": "IrvingHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_IvesHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ives Health Holdings Llc [Member]", "label": "Ives Health Holdings Llc [Member]", "terseLabel": "Ives Health Holdings LLC" } } }, "localname": "IvesHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_JamestownPlaceHealthAndRehabMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jamestown Place Health And Rehab [Member]", "label": "Jamestown Place Health And Rehab [Member]", "terseLabel": "Jamestown Place Health and Rehab" } } }, "localname": "JamestownPlaceHealthAndRehabMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_JeffersonRalstonHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jefferson Ralston Holdings LLC [Member]", "label": "Jefferson Ralston Holdings LLC [Member]", "terseLabel": "Jefferson Ralston Holdings LLC" } } }, "localname": "JeffersonRalstonHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_JordanHealthPropertiesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jordan Health Properties LLC [Member]", "label": "Jordan Health Properties LLC [Member]", "terseLabel": "Jordan Health Properties LLC" } } }, "localname": "JordanHealthPropertiesLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_JoseyRanchHealthcareHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Josey Ranch Healthcare Holdings LLC [Member]", "label": "Josey Ranch Healthcare Holdings LLC [Member]", "terseLabel": "Josey Ranch Healthcare Holdings LLC" } } }, "localname": "JoseyRanchHealthcareHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredNursingAndRehabilitationAspenParkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Nursing And Rehabilitation - Aspen Park [Member]", "label": "Kindred Nursing And Rehabilitation - Aspen Park [Member]", "terseLabel": "Aspen Park]" } } }, "localname": "KindredNursingAndRehabilitationAspenParkMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredNursingAndRehabilitationCaldwellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Nursing And Rehabilitation - Caldwell [Member]", "label": "Kindred Nursing And Rehabilitation - Caldwell [Member]", "terseLabel": "Caldwell Care" } } }, "localname": "KindredNursingAndRehabilitationCaldwellMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredNursingAndRehabilitationCanyonWestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Nursing And Rehabilitation - Canyon West [Member]", "label": "Kindred Nursing And Rehabilitation - Canyon West [Member]", "terseLabel": "Canyon West" } } }, "localname": "KindredNursingAndRehabilitationCanyonWestMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredNursingAndRehabilitationMountainValleyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Nursing And Rehabilitation - Mountain Valley [Member]", "label": "Kindred Nursing And Rehabilitation - Mountain Valley [Member]", "terseLabel": "Mountain Valley" } } }, "localname": "KindredNursingAndRehabilitationMountainValleyMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredNursingAndRehabilitationNampaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Nursing And Rehabilitation - Nampa [Member]", "label": "Kindred Nursing And Rehabilitation - Nampa [Member]", "terseLabel": "The Orchards" } } }, "localname": "KindredNursingAndRehabilitationNampaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredNursingAndRehabilitationWeiserMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Nursing And Rehabilitation - Weiser [Member]", "label": "Kindred Nursing And Rehabilitation - Weiser [Member]", "terseLabel": "Weiser Care" } } }, "localname": "KindredNursingAndRehabilitationWeiserMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredTransitionalCareAndRehabilitationLewistonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Transitional Care And Rehabilitation - Lewiston", "label": "Kindred Transitional Care And Rehabilitation - Lewiston [Member]", "terseLabel": "Lewiston Health and Rehabilitation" } } }, "localname": "KindredTransitionalCareAndRehabilitationLewistonMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredTransitionalCareandRehabilitationGrapevineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Transitional Care and Rehabilitation - Grapevine [Member]", "label": "Kindred Transitional Care and Rehabilitation - Grapevine [Member]", "terseLabel": "Grapevine Medical Lodge" } } }, "localname": "KindredTransitionalCareandRehabilitationGrapevineMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredTransitionalCareandRehabilitationMansfieldPlazaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Transitional Care and Rehabilitation - Mansfield Plaza [Member]", "label": "Kindred Transitional Care and Rehabilitation - Mansfield Plaza [Member]", "terseLabel": "Mansfield Medical Lodge" } } }, "localname": "KindredTransitionalCareandRehabilitationMansfieldPlazaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KindredTransitionalCareandRehabilitationRidgmarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kindred Transitional Care and Rehabilitation - Ridgmar [Member]", "label": "Kindred Transitional Care and Rehabilitation - Ridgmar [Member]", "terseLabel": "Ridgmar Medical Lodge" } } }, "localname": "KindredTransitionalCareandRehabilitationRidgmarMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_KingsCourtHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kings Court Health Holdings Llc [Member]", "label": "Kings Court Health Holdings Llc [Member]", "terseLabel": "Kings Court Health Holdings LLC" } } }, "localname": "KingsCourtHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LafayetteHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lafayette Health Holdings LLC [Member]", "label": "Lafayette Health Holdings LLC [Member]", "terseLabel": "Lafayette Health Holdings LLC" } } }, "localname": "LafayetteHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LakewestRehabilitationAndSkilledCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lakewest Rehabilitation And Skilled Care [Member]", "label": "Lakewest Rehabilitation And Skilled Care [Member]", "terseLabel": "Lakewest Rehabilitation and Skilled Care" } } }, "localname": "LakewestRehabilitationAndSkilledCareMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LakewestSNFRealtyLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lakewest SNF Realty LLC [Member]", "label": "Lakewest SNF Realty LLC [Member]", "terseLabel": "Lakewest SNF Realty LLC" } } }, "localname": "LakewestSNFRealtyLLCMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LamplightInnOfBaltimoreMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lamplight Inn Of Baltimore [Member]", "label": "Lamplight Inn Of Baltimore [Member]", "terseLabel": "Lamplight Inn of Baltimore" } } }, "localname": "LamplightInnOfBaltimoreMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LamplightInnOfFortWayneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lamplight Inn Of Fort Wayne [Member]", "label": "Lamplight Inn Of Fort Wayne [Member]", "terseLabel": "Lamplight Inn of Fort Wayne" } } }, "localname": "LamplightInnOfFortWayneMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LamplightInnOfWestAllisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lamplight Inn Of West Allis [Member]", "label": "Lamplight Inn Of West Allis [Member]", "terseLabel": "Lamplight Inn of West Allis" } } }, "localname": "LamplightInnOfWestAllisMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LeaseArrangementsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Arrangements [Axis]", "label": "Lease Arrangements [Axis]", "terseLabel": "Lease Arrangements [Axis]" } } }, "localname": "LeaseArrangementsAxis", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "stringItemType" }, "ctre_LeaseArrangementsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Lease Arrangements [Axis]", "label": "Lease Arrangements [Domain]", "terseLabel": "Lease Arrangements [Domain]" } } }, "localname": "LeaseArrangementsDomain", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "domainItemType" }, "ctre_LeaseIncomeContractualRentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Income, Contractual Rent [Member]", "label": "Lease Income, Contractual Rent [Member]", "terseLabel": "Contractual rent" } } }, "localname": "LeaseIncomeContractualRentMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "domainItemType" }, "ctre_LeaseIncomePropertyTaxesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Income, Property Taxes [Member]", "label": "Lease Income, Property Taxes [Member]", "terseLabel": "Property taxes" } } }, "localname": "LeaseIncomePropertyTaxesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "domainItemType" }, "ctre_LeaseIncomeStraightLineRentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Income, Straight Line Rent [Member]", "label": "Lease Income, Straight Line Rent [Member]", "terseLabel": "Straight-line rent" } } }, "localname": "LeaseIncomeStraightLineRentMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "domainItemType" }, "ctre_LegacyAtJacksonvilleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy At Jacksonville [Member]", "label": "Legacy At Jacksonville [Member]", "terseLabel": "Legacy at Jacksonville" } } }, "localname": "LegacyAtJacksonvilleMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LegacyWestRehabilitationAndHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy West Rehabilitation And Healthcare [Member]", "label": "Legacy West Rehabilitation And Healthcare [Member]", "terseLabel": "Legacy West Rehabilitation and Healthcare" } } }, "localname": "LegacyWestRehabilitationAndHealthcareMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LemonRiverHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lemon River Holdings LLC [Member]", "label": "Lemon River Holdings LLC [Member]", "terseLabel": "Lemon River Holdings LLC" } } }, "localname": "LemonRiverHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LenoxCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lenox Care Center [Member]", "label": "Lenox Care Center [Member]", "terseLabel": "Lenox Care Center" } } }, "localname": "LenoxCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LessorAnnualizedCashRevenueForContractsInPlace": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessor, Annualized Cash Revenue For Contracts In Place", "label": "Lessor, Annualized Cash Revenue For Contracts In Place", "terseLabel": "Current Cash Rent" } } }, "localname": "LessorAnnualizedCashRevenueForContractsInPlace", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "monetaryItemType" }, "ctre_LessorOperatingLeaseAnnualEscalationRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Lease, Annual Escalation Rate", "label": "Lessor, Operating Lease, Annual Escalation Rate", "terseLabel": "Annualized contractual rental income escalation rate (percent)" } } }, "localname": "LessorOperatingLeaseAnnualEscalationRate", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_LessorOperatingLeaseNumberOfRenewalOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Lease, Number Of Renewal Options", "label": "Lessor, Operating Lease, Number Of Renewal Options", "terseLabel": "Number of renewal options" } } }, "localname": "LessorOperatingLeaseNumberOfRenewalOptions", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "integerItemType" }, "ctre_LibertyNursingCenterOfWillardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liberty Nursing Center Of Willard [Member]", "label": "Liberty Nursing Center Of Willard [Member]", "terseLabel": "Liberty Nursing Center of Willard" } } }, "localname": "LibertyNursingCenterOfWillardMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LineOfCreditCommitmentFeeBasedOnInvestmentGradeRatingPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit, Commitment Fee Based On Investment Grade Rating, Percentage", "label": "Line Of Credit, Commitment Fee Based On Investment Grade Rating, Percentage", "terseLabel": "Facility fee on revolving commitment fee based on investment grade ratings (percent)" } } }, "localname": "LineOfCreditCommitmentFeeBasedOnInvestmentGradeRatingPercentage", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_LineOfCreditFacilityExtensionOptionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of credit facility extension option term.", "label": "Line Of Credit Facility Extension Option Term", "terseLabel": "Extension option term (in months)" } } }, "localname": "LineOfCreditFacilityExtensionOptionTerm", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "durationItemType" }, "ctre_LineOfCreditFacilityNumberOfExtensionOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility, Number Of Extension Options", "label": "Line Of Credit Facility, Number Of Extension Options", "terseLabel": "Number of extension options" } } }, "localname": "LineOfCreditFacilityNumberOfExtensionOptions", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "integerItemType" }, "ctre_LineOfCreditFacilityPrepaymentPremiumInFirstYearAfterIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility, Prepayment Premium In First Year After Issuance", "label": "Line Of Credit Facility, Prepayment Premium In First Year After Issuance", "terseLabel": "Prepayment premium in first year (percent)" } } }, "localname": "LineOfCreditFacilityPrepaymentPremiumInFirstYearAfterIssuance", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_LineOfCreditFacilityPrepaymentPremiumInSecondYearAfterIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility, Prepayment Premium In Second Year After Issuance", "label": "Line Of Credit Facility, Prepayment Premium In Second Year After Issuance", "terseLabel": "Prepayment premium in second year (percent)" } } }, "localname": "LineOfCreditFacilityPrepaymentPremiumInSecondYearAfterIssuance", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_LineOfCreditFacilityUncommittedIncrementalFacilityLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility, Uncommitted Incremental Facility, Limit", "label": "Line Of Credit Facility, Uncommitted Incremental Facility, Limit", "terseLabel": "Uncommitted incremental facility limit" } } }, "localname": "LineOfCreditFacilityUncommittedIncrementalFacilityLimit", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_LineOfCreditSubfacilityCapacityAsPercentageOfAvailableRevolvingCommitments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit, Subfacility, Capacity As Percentage Of Available Revolving Commitments", "label": "Line Of Credit, Subfacility, Capacity As Percentage Of Available Revolving Commitments", "terseLabel": "Subfacility capacity as percentage of available revolving commitments (percent)" } } }, "localname": "LineOfCreditSubfacilityCapacityAsPercentageOfAvailableRevolvingCommitments", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_LoanReceivableExtensionOptionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Receivable, Extension Option Term", "label": "Loan Receivable, Extension Option Term", "terseLabel": "Extension option term (in months)" } } }, "localname": "LoanReceivableExtensionOptionTerm", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "durationItemType" }, "ctre_LoanReceivableNumberOfBedsInPropertyUtilizedToSecureLoan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Receivable, Number Of Beds In Property Utilized To Secure Loan", "label": "Loan Receivable, Number Of Beds In Property Utilized To Secure Loan", "terseLabel": "Number of beds in facility utilized to secure loan" } } }, "localname": "LoanReceivableNumberOfBedsInPropertyUtilizedToSecureLoan", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "integerItemType" }, "ctre_LoanReceivableNumberOfExtensionOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Receivable, Number Of Extension Options", "label": "Loan Receivable, Number Of Extension Options", "terseLabel": "Number of extension options" } } }, "localname": "LoanReceivableNumberOfExtensionOptions", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "integerItemType" }, "ctre_LoanReceivableNumberOfFacilitiesInAgreementSecuredByMembershipInterests": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Receivable, Number Of Facilities In Agreement Secured By Membership Interests", "label": "Loan Receivable, Number Of Facilities In Agreement Secured By Membership Interests", "terseLabel": "Number of facilities in agreement secured by membership interests" } } }, "localname": "LoanReceivableNumberOfFacilitiesInAgreementSecuredByMembershipInterests", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "integerItemType" }, "ctre_LoanReceivableNumberOfFacilitiesUtilizedToSecureMortgageLoan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Receivable Number Of Facilities Utilized To Secure Mortgage Loan", "label": "Loan Receivable, Number Of Facilities Utilized To Secure Mortgage Loan", "terseLabel": "Facilities utilized to secure mortgage loan" } } }, "localname": "LoanReceivableNumberOfFacilitiesUtilizedToSecureMortgageLoan", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "integerItemType" }, "ctre_LoanReceivablePeriodOfUnpaidInterestPaymentsDueUponPrepayment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Receivable, Period Of Unpaid Interest Payments Due Upon Prepayment", "label": "Loan Receivable, Period Of Unpaid Interest Payments Due Upon Prepayment", "terseLabel": "Period of unpaid interest payments due upon prepayment" } } }, "localname": "LoanReceivablePeriodOfUnpaidInterestPaymentsDueUponPrepayment", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "durationItemType" }, "ctre_LoansReceivableExitFeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans Receivable, Exit Fee, Percent", "label": "Loans Receivable, Exit Fee, Percent", "terseLabel": "Loans receivable exit fee (percent)" } } }, "localname": "LoansReceivableExitFeePercent", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "percentItemType" }, "ctre_LoansReceivableFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans Receivable, Fixed Interest Rate", "label": "Loans Receivable, Fixed Interest Rate", "terseLabel": "Mortgage loan receivable interest rate (percent)", "verboseLabel": "Loan receivable interest rate (percent)" } } }, "localname": "LoansReceivableFixedInterestRate", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_LoansReceivableLIBORFloorPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans Receivable, LIBOR Floor, Percentage", "label": "Loans Receivable, LIBOR Floor, Percentage", "terseLabel": "LIBOR floor for loan (percent)" } } }, "localname": "LoansReceivableLIBORFloorPercentage", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "percentItemType" }, "ctre_LockwoodHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lockwood Health Holdings LLC [Member]", "label": "Lockwood Health Holdings LLC [Member]", "terseLabel": "Lockwood Health Holdings LLC" } } }, "localname": "LockwoodHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LongBeachHealthAssociatesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long Beach Health Associates Llc [Member]", "label": "Long Beach Health Associates Llc [Member]", "terseLabel": "Long Beach Health Associates LLC" } } }, "localname": "LongBeachHealthAssociatesLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LowellHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lowell Health Holdings LLC [Member]", "label": "Lowell Health Holdings LLC [Member]", "terseLabel": "Lowell Health Holdings LLC" } } }, "localname": "LowellHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LowellLakeHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lowell Lake Health Holdings Llc [Member]", "label": "Lowell Lake Health Holdings Llc [Member]", "terseLabel": "Lowell Lake Health Holdings LLC" } } }, "localname": "LowellLakeHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_LufkinHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lufkin Health Holdings LLC [Member]", "label": "Lufkin Health Holdings LLC [Member]", "terseLabel": "Lufkin Health Holdings LLC" } } }, "localname": "LufkinHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MadisonParkHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Madison Park Healthcare [Member]", "label": "Madison Park Healthcare [Member]", "terseLabel": "Madison Park Healthcare" } } }, "localname": "MadisonParkHealthcareMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MantecaValleyPostAcuteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manteca Valley Post Acute [Member]", "label": "Manteca Valley Post Acute [Member]", "terseLabel": "MCRC, LLC" } } }, "localname": "MantecaValleyPostAcuteMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "ctre_MeadowbrookHealthAssociatesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Meadowbrook Health Associates LLC [Member]", "label": "Meadowbrook Health Associates LLC [Member]", "terseLabel": "Meadowbrook Health Associates LLC" } } }, "localname": "MeadowbrookHealthAssociatesLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MemorialHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Memorial Health Holdings LLC [Member]", "label": "Memorial Health Holdings LLC [Member]", "terseLabel": "Memorial Health Holdings LLC" } } }, "localname": "MemorialHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MemoryCareCottagesinWhiteBearLakeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Memory Care Cottages in White Bear Lake [Member]", "label": "Memory Care Cottages in White Bear Lake [Member]", "terseLabel": "Memory Care Cottages in White Bear Lake" } } }, "localname": "MemoryCareCottagesinWhiteBearLakeMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MesquiteHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mesquite Health Holdings LLC [Member]", "label": "Mesquite Health Holdings LLC [Member]", "terseLabel": "Mesquite Health Holdings LLC" } } }, "localname": "MesquiteHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MetronSkilledNursingFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metron Skilled Nursing Facilities [Member]", "label": "Metron Skilled Nursing Facilities [Member]", "terseLabel": "Metron skilled nursing facilities" } } }, "localname": "MetronSkilledNursingFacilitiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "ctre_MezzanineAndMortgageLoanReceivablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mezzanine And Mortgage Loan Receivables", "label": "Mezzanine And Mortgage Loan Receivables [Member]", "terseLabel": "Mortgage and mezzanine loans receivable" } } }, "localname": "MezzanineAndMortgageLoanReceivablesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "ctre_MezzanineLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mezzanine Loan", "label": "Mezzanine Loan [Member]", "terseLabel": "Mezzanine loan receivable" } } }, "localname": "MezzanineLoanMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "ctre_MiraVistaCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mira Vista Care Center [Member]", "label": "Mira Vista Care Center [Member]", "terseLabel": "Mira Vista Care Center" } } }, "localname": "MiraVistaCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MissionCcrcLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mission CCRC LLC [Member]", "label": "Mission CCRC LLC [Member]", "terseLabel": "Mission CCRC LLC" } } }, "localname": "MissionCcrcLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MoeniumHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Moenium Holdings LLC [Member]", "label": "Moenium Holdings LLC [Member]", "terseLabel": "Moenium Holdings LLC" } } }, "localname": "MoeniumHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MortgageLoanCombinedPrincipal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Mortgage Loan, Combined Principal", "label": "Mortgage Loan, Combined Principal", "terseLabel": "Combined principal amount of loan" } } }, "localname": "MortgageLoanCombinedPrincipal", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "ctre_MountainviewCommunityCareLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mountainview Community Care LLC [Member]", "label": "Mountainview Community Care LLC [Member]", "terseLabel": "Mountainview Community Care LLC" } } }, "localname": "MountainviewCommunityCareLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_MultiServiceCampusPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-Service Campus Properties [Member]", "label": "Multi-Service Campus Properties [Member]", "terseLabel": "Multi-service campuses" } } }, "localname": "MultiServiceCampusPropertiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "domainItemType" }, "ctre_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income (loss) available to common stockholders basic and diluted.", "label": "Net Income Loss Available To Common Stockholders Basic And Diluted", "totalLabel": "Numerator for basic and diluted earnings available to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "ctre_NewHavenAssistedLivingofSanAngeloMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Haven Assisted Living of San Angelo [Member]", "label": "New Haven Assisted Living of San Angelo [Member]", "terseLabel": "New Haven Assisted Living of San Angelo" } } }, "localname": "NewHavenAssistedLivingofSanAngeloMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_NewRevolvingFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Revolving Facility [Member]", "label": "New Revolving Facility [Member]", "terseLabel": "New Revolving Facility" } } }, "localname": "NewRevolvingFacilityMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_NewTermLoanFeb2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Term Loan Feb 2019 [Member]", "label": "New Term Loan Feb 2019 [Member]", "terseLabel": "New Term Loan Feb 2019" } } }, "localname": "NewTermLoanFeb2019Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_NextVAStarRealtyHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Next VA Star Realty Holdings LLC", "label": "Next VA Star Realty Holdings LLC [Member]", "terseLabel": "Next VA Star Realty Holdings LLC", "verboseLabel": "Next Healthcare Inc - Virginia" } } }, "localname": "NextVAStarRealtyHoldingsLLCMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "domainItemType" }, "ctre_NobleSeniorServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noble Senior Services", "label": "Noble Senior Services [Member]", "terseLabel": "Noble" } } }, "localname": "NobleSeniorServicesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "ctre_NumberOfBedsInLeasedFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Beds In Leased Facilities", "label": "Number Of Beds In Leased Facilities", "terseLabel": "Number of beds in leased facilities" } } }, "localname": "NumberOfBedsInLeasedFacilities", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfBedsOrUnitsInPropertiesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Beds Or Units In Properties Acquired", "label": "Number Of Beds Or Units In Properties Acquired", "terseLabel": "Number of Beds/Units" } } }, "localname": "NumberOfBedsOrUnitsInPropertiesAcquired", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfBedsPlannedForConstruction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Beds Planned For Construction", "label": "Number Of Beds Planned For Construction", "terseLabel": "Number of beds planned for construction" } } }, "localname": "NumberOfBedsPlannedForConstruction", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfOperationalBedsAndUnitsInFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Operational Beds And Units In Facilities", "label": "Number Of Operational Beds And Units In Facilities", "terseLabel": "Number of operational beds and units in facilities" } } }, "localname": "NumberOfOperationalBedsAndUnitsInFacilities", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfOperatorsCollectionOfLeasePaymentRecoveredAfterWriteOff": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Operators, Collection Of Lease Payment Recovered After Write-Off", "label": "Number Of Operators, Collection Of Lease Payment Recovered After Write-Off", "terseLabel": "Number of operators for which rental income was recovered after previous write off" } } }, "localname": "NumberOfOperatorsCollectionOfLeasePaymentRecoveredAfterWriteOff", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfOperatorsCollectionOfLeasePaymentThroughMaturityNotProbable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Operators, Collection Of Lease Payment Through Maturity Not Probable", "label": "Number Of Operators, Collection Of Lease Payment Through Maturity Not Probable", "terseLabel": "Number of operators for which collectability not probable" } } }, "localname": "NumberOfOperatorsCollectionOfLeasePaymentThroughMaturityNotProbable", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties", "label": "Number Of Properties", "terseLabel": "Number of properties" } } }, "localname": "NumberOfProperties", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfPropertiesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties Acquired", "label": "Number Of Properties Acquired", "terseLabel": "Number of Properties", "verboseLabel": "Number of facilities acquired" } } }, "localname": "NumberOfPropertiesAcquired", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfPropertiesNewMasterLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties, New Master Lease", "label": "Number Of Properties, New Master Lease", "terseLabel": "Properties covered in new master lease" } } }, "localname": "NumberOfPropertiesNewMasterLease", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfPropertiesSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties Sold", "label": "Number Of Properties Sold", "terseLabel": "Number of properties sold" } } }, "localname": "NumberOfPropertiesSold", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfPropertiesTerminatedMasterLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties, Terminated Master Lease", "label": "Number Of Properties, Terminated Master Lease", "terseLabel": "Properties in terminated master lease" } } }, "localname": "NumberOfPropertiesTerminatedMasterLease", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfPropertiesToBeSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties To Be Sold", "label": "Number Of Properties To Be Sold", "terseLabel": "Number of properties held for sale" } } }, "localname": "NumberOfPropertiesToBeSold", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfPropertiesTransferred": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties Transferred", "label": "Number Of Properties Transferred", "terseLabel": "Number of properties transferred" } } }, "localname": "NumberOfPropertiesTransferred", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfPropertiesWithTenantPurchaseOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties With Tenant Purchase Option", "label": "Number Of Properties With Tenant Purchase Option", "terseLabel": "Properties" } } }, "localname": "NumberOfPropertiesWithTenantPurchaseOption", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfSeparateAndIndependentCompaniesAfterSpinOff": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Separate And Independent Companies After Spin Off", "label": "Number Of Separate And Independent Companies After Spin Off", "terseLabel": "Number of separate and independent companies after spin-off" } } }, "localname": "NumberOfSeparateAndIndependentCompaniesAfterSpinOff", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfTransitionedFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Transitioned Facilities", "label": "Number Of Transitioned Facilities", "terseLabel": "Number of transitioned facilities" } } }, "localname": "NumberOfTransitionedFacilities", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfUnitsAndBedsInFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Units And Beds In Facilities", "label": "Number Of Units And Beds In Facilities", "terseLabel": "Number of beds and units in facilities" } } }, "localname": "NumberOfUnitsAndBedsInFacilities", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "integerItemType" }, "ctre_NumberOfUnitsInPropertySold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Units In Property Sold", "label": "Number Of Units In Property Sold", "terseLabel": "Number of units in property sold" } } }, "localname": "NumberOfUnitsInPropertySold", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "ctre_OakviewHeightsNursingAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oakview Heights Nursing And Rehabilitation Center [Member]", "label": "Oakview Heights Nursing And Rehabilitation Center [Member]", "terseLabel": "Oakview Heights Nursing and Rehabilitation Center" } } }, "localname": "OakviewHeightsNursingAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_OfficerAndEmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Officer And Employee [Member]", "label": "Officer And Employee [Member]", "terseLabel": "Officers and Employees" } } }, "localname": "OfficerAndEmployeeMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_OlesonParkHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oleson Park Health Holdings LLC [Member]", "label": "Oleson Park Health Holdings LLC [Member]", "terseLabel": "Oleson Park Health Holdings LLC" } } }, "localname": "OlesonParkHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_OperatingLeaseLeaseIncomeAdjustmentsForCollectibility": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeaseLeaseIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Lease Income, Adjustments For Collectibility", "label": "Operating Lease, Lease Income, Adjustments For Collectibility", "negatedTerseLabel": "Adjustment for collectibility", "terseLabel": "Adjustment for collectibility of rental income" } } }, "localname": "OperatingLeaseLeaseIncomeAdjustmentsForCollectibility", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_OperatingLeaseLeaseIncomeAdjustmentsForRecovery": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeaseLeaseIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Lease Lease Income Adjustments For Recovery", "label": "Operating Lease Lease Income Adjustments For Recovery", "terseLabel": "Recovery of previously reserved rent" } } }, "localname": "OperatingLeaseLeaseIncomeAdjustmentsForRecovery", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_OperatingLeasesAnticipatedInitialAnnualLeaseRevenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Anticipated Initial Annual Lease Revenues", "label": "Operating Leases, Anticipated Initial Annual Lease Revenues", "terseLabel": "Initial Annual Cash Rent", "verboseLabel": "Initial annual cash rent" } } }, "localname": "OperatingLeasesAnticipatedInitialAnnualLeaseRevenues", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ctre_OperatingLeasesReductionToAnticipatedInitialAnnualLeaseRevenuesDueToSpin": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Reduction To Anticipated Initial Annual Lease Revenues Due To Spin", "label": "Operating Leases, Reduction To Anticipated Initial Annual Lease Revenues Due To Spin", "terseLabel": "Reduction to contractual annual cash rent as result of spin" } } }, "localname": "OperatingLeasesReductionToAnticipatedInitialAnnualLeaseRevenuesDueToSpin", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "monetaryItemType" }, "ctre_OremHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orem Health Holdings LLC [Member]", "label": "Orem Health Holdings LLC [Member]", "terseLabel": "Orem Health Holdings LLC" } } }, "localname": "OremHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_OsageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Osage [Member]", "label": "Osage [Member]", "terseLabel": "Osage" } } }, "localname": "OsageMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_OtherNonfinancialMeasuresPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Non-financial Measures [Policy Text Block]", "label": "Other Non-financial Measures [Policy Text Block]", "terseLabel": "Beds, Units, Occupancy and Other Measures" } } }, "localname": "OtherNonfinancialMeasuresPolicyTextBlock", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctre_OtherRealEstateInvestmentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Real Estate Investments [Text Block]", "label": "Other Real Estate Investments [Text Block]", "terseLabel": "Other Real Estate Investments, Net" } } }, "localname": "OtherRealEstateInvestmentsTextBlock", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNet" ], "xbrltype": "textBlockItemType" }, "ctre_OwnedAndOperatedLivingFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Owned And Operated Living Facilities [Member]", "label": "Owned And Operated Living Facilities [Member]", "terseLabel": "Owned and operated living facilities" } } }, "localname": "OwnedAndOperatedLivingFacilitiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "ctre_ParedesHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paredes Health Holdings LLC [Member]", "label": "Paredes Health Holdings LLC [Member]", "terseLabel": "Paredes Health Holdings LLC" } } }, "localname": "ParedesHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments To Acquire Equipment, Furniture And Fixtures And Develop Real Estate Assets", "label": "Payments To Acquire Equipment, Furniture And Fixtures And Develop Real Estate Assets", "negatedLabel": "Purchases of, and improvements to, equipment, furniture and fixtures and real estate" } } }, "localname": "PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctre_PecanTreeRehabilitationAndHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pecan Tree Rehabilitation And Healthcare [Member]", "label": "Pecan Tree Rehabilitation And Healthcare [Member]", "terseLabel": "Pecan Tree Rehabilitation and Healthcare" } } }, "localname": "PecanTreeRehabilitationAndHealthcareMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PennantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pennant [Member]", "label": "Pennant [Member]", "terseLabel": "Pennant" } } }, "localname": "PennantMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "ctre_PilgrimManorSkilledNursingAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pilgrim Manor Skilled Nursing And Rehabilitation [Member]", "label": "Pilgrim Manor Skilled Nursing And Rehabilitation [Member]", "terseLabel": "Pilgrim Manor Skilled Nursing And Rehabilitation" } } }, "localname": "PilgrimManorSkilledNursingAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PinckneyvilleNursingAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pinckneyville Nursing And Rehabilitation Center [Member]", "label": "Pinckneyville Nursing And Rehabilitation Center [Member]", "terseLabel": "Pinckneyville Nursing and Rehabilitation Center" } } }, "localname": "PinckneyvilleNursingAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PlazaHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plaza Health Holdings LLC [Member]", "label": "Plaza Health Holdings LLC [Member]", "terseLabel": "Plaza Health Holdings LLC" } } }, "localname": "PlazaHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PleasantAcresCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pleasant Acres Care Center [Member]", "label": "Pleasant Acres Care Center [Member]", "terseLabel": "Pleasant Acres Care Center" } } }, "localname": "PleasantAcresCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PleasantManorHealthcareAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pleasant Manor Healthcare And Rehabilitation", "label": "Pleasant Manor Healthcare And Rehabilitation [Member]", "terseLabel": "Pleasant Manor Healthcare and Rehabilitation" } } }, "localname": "PleasantManorHealthcareAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PolkHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Polk Health Holdings LLC [Member]", "label": "Polk Health Holdings LLC [Member]", "terseLabel": "Polk Health Holdings LLC" } } }, "localname": "PolkHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PortionOfCommitmentSubjectToRentIncreaseAtTimeOfFunding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Portion Of Commitment Subject To Rent Increase At Time Of Funding", "label": "Portion Of Commitment Subject To Rent Increase At Time Of Funding", "terseLabel": "Portion of funding commitments subject to rent increase at time of funding" } } }, "localname": "PortionOfCommitmentSubjectToRentIncreaseAtTimeOfFunding", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "ctre_PortsmouthHealthAndRehabMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portsmouth Health And Rehab [Member]", "label": "Portsmouth Health And Rehab [Member]", "terseLabel": "Portsmouth Health and Rehab" } } }, "localname": "PortsmouthHealthAndRehabMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PrairieHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prairie Health Holdings LLC [Member]", "label": "Prairie Health Holdings LLC [Member]", "terseLabel": "Prairie Health Holdings LLC" } } }, "localname": "PrairieHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PrairieHeightsHealthcareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prairie Heights Healthcare Center [Member]", "label": "Prairie Heights Healthcare Center [Member]", "terseLabel": "Prairie Heights Healthcare Center" } } }, "localname": "PrairieHeightsHealthcareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Equity Investment, Cascadia Development, Boise ID [Member]", "label": "Preferred Equity Investment, Cascadia Development, Boise ID [Member]", "terseLabel": "Cascadia Development, Boise ID" } } }, "localname": "PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "ctre_PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Equity Investment, Cascadia Development, Nampa ID [Member]", "label": "Preferred Equity Investment, Cascadia Development, Nampa ID [Member]", "terseLabel": "Cascadia Development, Nampa ID" } } }, "localname": "PreferredEquityInvestmentCascadiaDevelopmentNampaIDMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "ctre_PreludeCottagesOfWoodburyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prelude Cottages of Woodbury [Member]", "label": "Prelude Cottages of Woodbury [Member]", "terseLabel": "Prelude Cottages of Woodbury" } } }, "localname": "PreludeCottagesOfWoodburyMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Premier Estates Of Middletown Premier Retirement Estates Of Middletown [Member]", "label": "Premier Estates Of Middletown Premier Retirement Estates Of Middletown [Member]", "terseLabel": "Premier Estates of Middletown/Premier Retirement Estates of Middletown" } } }, "localname": "PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PremierEstatesofNorwoodTowersPremierRetirementEstatesofNorwoodTowersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Premier Estates of Norwood Towers Premier Retirement Estates of Norwood Towers [Member]", "label": "Premier Estates of Norwood Towers Premier Retirement Estates of Norwood Towers [Member]", "terseLabel": "Premier Estates of Norwood Towers/Premier Retirement Estates of Norwood Towers" } } }, "localname": "PremierEstatesofNorwoodTowersPremierRetirementEstatesofNorwoodTowersMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PrepaidExpensesAndOtherAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepaid Expenses And Other Assets [Policy Text Block]", "label": "Prepaid Expenses And Other Assets [Policy Text Block]", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpensesAndOtherAssetsPolicyTextBlock", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctre_PriceHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price Health Holdings LLC [Member]", "label": "Price Health Holdings LLC [Member]", "terseLabel": "Price Health Holdings LLC" } } }, "localname": "PriceHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PriorAtTheMarketOfferingProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior At-The-Market Offering Program [Member]", "label": "Prior At-The-Market Offering Program [Member]", "terseLabel": "Prior ATM Program" } } }, "localname": "PriorAtTheMarketOfferingProgramMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails" ], "xbrltype": "domainItemType" }, "ctre_PriorTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior Term Loan [Member]", "label": "Prior Term Loan [Member]", "terseLabel": "Prior Term Loan" } } }, "localname": "PriorTermLoanMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_PriorityLifeCareLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Priority Life Care LLC [Member]", "label": "Priority Life Care LLC [Member]", "terseLabel": "Priority" } } }, "localname": "PriorityLifeCareLLCMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_PriorityManagementGroupLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Priority Management Group LLC [Member]", "label": "Priority Management Group LLC [Member]", "terseLabel": "PMG" } } }, "localname": "PriorityManagementGroupLLCMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_PristineLeaseTerminationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pristine Lease Termination Agreement [Member]", "label": "Pristine Lease Termination Agreement [Member]", "terseLabel": "Pristine Lease Termination Agreement" } } }, "localname": "PristineLeaseTerminationAgreementMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "domainItemType" }, "ctre_PristineSeniorLivingofCincinnatiRiverviewMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pristine Senior Living of Cincinnati-Riverview [Member]", "label": "Pristine Senior Living of Cincinnati-Riverview [Member]", "terseLabel": "Premier Estates of Cincinnati-Riverview" } } }, "localname": "PristineSeniorLivingofCincinnatiRiverviewMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PropertiesWithPurchaseOptionLeaseExpirationJanuary2031FirstOption2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Properties With Purchase Option, Lease Expiration January 2031, First Option 2022", "label": "Properties With Purchase Option, Lease Expiration January 2031, First Option 2022 [Member]", "terseLabel": "Lease Expiration January 2031, First option 2022" } } }, "localname": "PropertiesWithPurchaseOptionLeaseExpirationJanuary2031FirstOption2022Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_PropertiesWithPurchaseOptionLeaseExpirationMarch2030FirstOption2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Properties With Purchase Option, Lease Expiration March 2030, First Option 2022", "label": "Properties With Purchase Option, Lease Expiration March 2030, First Option 2022 [Member]", "terseLabel": "Lease Expiration March 2030, First option 2022" } } }, "localname": "PropertiesWithPurchaseOptionLeaseExpirationMarch2030FirstOption2022Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_PropertiesWithPurchaseOptionLeaseExpirationNovember2034FirstOption2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Properties With Purchase Option, Lease Expiration November 2034, First Option 2024", "label": "Properties With Purchase Option, Lease Expiration November 2034, First Option 2024 [Member]", "terseLabel": "Lease Expiration November 2034, First option 2024" } } }, "localname": "PropertiesWithPurchaseOptionLeaseExpirationNovember2034FirstOption2024Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_PropertiesWithPurchaseOptionLeaseExpirationOctober2032FirstOption2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Properties With Purchase Option, Lease Expiration October 2032, First Option 2023", "label": "Properties With Purchase Option, Lease Expiration October 2032, First Option 2023 [Member]", "terseLabel": "Lease Expiration October 2032, First option 2023" } } }, "localname": "PropertiesWithPurchaseOptionLeaseExpirationOctober2032FirstOption2023Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Properties With Purchase Option, Lease Expiration October 2034, First Option 2021", "label": "Properties With Purchase Option, Lease Expiration October 2034, First Option 2021 [Member]", "terseLabel": "Lease Expiration October 2034, First option 2021" } } }, "localname": "PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2021Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Properties With Purchase Option, Lease Expiration October 2034. First Option 2026", "label": "Properties With Purchase Option, Lease Expiration October 2034. First Option 2026 [Member]", "terseLabel": "Lease Expiration October 2034, First option 2026" } } }, "localname": "PropertiesWithPurchaseOptionLeaseExpirationOctober2034FirstOption2026Member", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_ProvidenceGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Providence Group [Member]", "label": "Providence Group [Member]", "terseLabel": "Providence" } } }, "localname": "ProvidenceGroupMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "ctre_ProvidenceOntarioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Providence Ontario [Member]", "label": "Providence Ontario [Member]", "terseLabel": "Providence Ontario" } } }, "localname": "ProvidenceOntarioMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ProvidenceOrangeTreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Providence Orange Tree [Member]", "label": "Providence Orange Tree [Member]", "terseLabel": "Providence Orange Tree" } } }, "localname": "ProvidenceOrangeTreeMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ProvidenceWatermanNursingCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Providence Waterman Nursing Center [Member]", "label": "Providence Waterman Nursing Center [Member]", "terseLabel": "Providence Waterman Nursing Center" } } }, "localname": "ProvidenceWatermanNursingCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_PurchaseAndSaleAgreementAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase And Sale Agreement, Amount", "label": "Purchase And Sale Agreement, Amount", "terseLabel": "Purchase and sale agreement amount" } } }, "localname": "PurchaseAndSaleAgreementAmount", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "ctre_QueenswayHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Queensway Health Holdings Llc [Member]", "label": "Queensway Health Holdings Llc [Member]", "terseLabel": "Queensway Health Holdings LLC" } } }, "localname": "QueenswayHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_RbHeightsHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RB Heights Health Holdings LLC [Member]", "label": "RB Heights Health Holdings LLC [Member]", "terseLabel": "RB Heights Health Holdings LLC" } } }, "localname": "RbHeightsHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_RealEstateAcquisitionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate Acquisitions [Policy Text Block]", "label": "Real Estate Acquisitions [Policy Text Block]", "terseLabel": "Real Estate Acquisition Valuation" } } }, "localname": "RealEstateAcquisitionsPolicyTextBlock", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctre_RealEstateAndAccumulatedDepreciationYearAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate and Accumulated Depreciation, Year Acquired", "label": "Real Estate and Accumulated Depreciation, Year Acquired", "terseLabel": "Acquisition Date" } } }, "localname": "RealEstateAndAccumulatedDepreciationYearAcquired", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "gYearItemType" }, "ctre_RealEstateAndAccumulatedDepreciationYearOfConstruction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year real estate investment property was constructed for entities with a substantial portion of business acquiring and holding investment real estate, in CCYY format.", "label": "Real Estate and Accumulated Depreciation, Year of Construction", "terseLabel": "Construction/Renovation Date" } } }, "localname": "RealEstateAndAccumulatedDepreciationYearOfConstruction", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "gYearItemType" }, "ctre_RealEstateOtherInvestmentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate, Other Investments [Policy Text Block]", "label": "Real Estate, Other Investments [Policy Text Block]", "terseLabel": "Other Real Estate Investments" } } }, "localname": "RealEstateOtherInvestmentsPolicyTextBlock", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctre_RealEstateTaxesPaidOffsetToRentalIncomeGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real Estate Taxes, Paid, Offset To Rental Income, Gross", "label": "Real Estate Taxes, Paid, Offset To Rental Income, Gross", "terseLabel": "Gross real estate taxes offset to rental income" } } }, "localname": "RealEstateTaxesPaidOffsetToRentalIncomeGross", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_RegalRoadHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regal Road Health Holdings LLC [Member]", "label": "Regal Road Health Holdings LLC [Member]", "terseLabel": "Regal Road Health Holdings LLC" } } }, "localname": "RegalRoadHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_RenneAvenueHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Renne Avenue Health Holdings LLC [Member]", "label": "Renne Avenue Health Holdings LLC [Member]", "terseLabel": "Renne Avenue Health Holdings LLC" } } }, "localname": "RenneAvenueHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_RentalIncomeExpectedAnnualBaseRentToBeReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rental Income, Expected Annual Base Rent To Be Received", "label": "Rental Income, Expected Annual Base Rent To Be Received", "terseLabel": "Aggregate annual base rent due under master lease" } } }, "localname": "RentalIncomeExpectedAnnualBaseRentToBeReceived", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "monetaryItemType" }, "ctre_RestrictedStockAndPerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock And Performance Shares [Member]", "label": "Restricted Stock And Performance Shares [Member]", "terseLabel": "Restricted Stock Award and Performance Award" } } }, "localname": "RestrictedStockAndPerformanceSharesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "domainItemType" }, "ctre_RevolvingCreditFacilityAsAmendedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit Facility As Amended [Member]", "label": "Revolving Credit Facility As Amended [Member]", "terseLabel": "Prior Revolving Facility" } } }, "localname": "RevolvingCreditFacilityAsAmendedMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_RillitoHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rillito Holdings LLC [Member]", "label": "Rillito Holdings LLC [Member]", "terseLabel": "Rillito Holdings LLC" } } }, "localname": "RillitoHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_RioGrandeHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rio Grande Health Holdings LLC [Member]", "label": "Rio Grande Health Holdings LLC [Member]", "terseLabel": "Rio Grande Health Holdings LLC" } } }, "localname": "RioGrandeHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_RowlettHealthAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rowlett Health And Rehabilitation Center", "label": "Rowlett Health And Rehabilitation Center [Member]", "terseLabel": "Rowlett Health and Rehabilitation Center" } } }, "localname": "RowlettHealthAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_RoyceCityHealthandRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royce City Health and Rehabilitation Center [Member]", "label": "Royce City Health and Rehabilitation Center [Member]", "terseLabel": "Royse City Medical Lodge" } } }, "localname": "RoyceCityHealthandRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SalineCareNursingAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Saline Care Nursing And Rehabilitation Center [Member]", "label": "Saline Care Nursing And Rehabilitation Center [Member]", "terseLabel": "Saline Care Nursing and Rehabilitation Center" } } }, "localname": "SalineCareNursingAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SalmonRiverHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Salmon River Health Holdings LLC [Member]", "label": "Salmon River Health Holdings LLC [Member]", "terseLabel": "Salmon River Health Holdings LLC" } } }, "localname": "SalmonRiverHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SanCorrineHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "San Corrine Health Holdings LLC [Member]", "label": "San Corrine Health Holdings LLC [Member]", "terseLabel": "San Corrine Health Holdings LLC" } } }, "localname": "SanCorrineHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SaratogaHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Saratoga Health Holdings LLC [Member]", "label": "Saratoga Health Holdings LLC [Member]", "terseLabel": "Saratoga Health Holdings LLC" } } }, "localname": "SaratogaHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ScheduleOfAssetsAcquisitionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Assets Acquisitions [Table Text Block]", "label": "Schedule Of Assets Acquisitions [Table Text Block]", "terseLabel": "Schedule of Real Estate Acquisitions" } } }, "localname": "ScheduleOfAssetsAcquisitionsTableTextBlock", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "ctre_ScheduleOfTenantPurchaseOptionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Tenant Purchase Options", "label": "Schedule Of Tenant Purchase Options [Table Text Block]", "terseLabel": "Schedule of Tenant Purchase Options" } } }, "localname": "ScheduleOfTenantPurchaseOptionsTableTextBlock", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "ctre_SecoraHealthAndRehabilitationOfCascadiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secora Health And Rehabilitation Of Cascadia [Member]", "label": "Secora Health And Rehabilitation Of Cascadia [Member]", "terseLabel": "Secora Health and Rehabilitation of Cascadia" } } }, "localname": "SecoraHealthAndRehabilitationOfCascadiaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SecuritiesOfferingAuthorizedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Securities Offering, Authorized Amount", "label": "Securities Offering, Authorized Amount", "terseLabel": "Authorized aggregate offering price of common stock" } } }, "localname": "SecuritiesOfferingAuthorizedAmount", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_SecuritiesOfferingRemainingAuthorizedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Securities Offering, Remaining Authorized Amount", "label": "Securities Offering, Remaining Authorized Amount", "terseLabel": "Remaining offering amount available" } } }, "localname": "SecuritiesOfferingRemainingAuthorizedAmount", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_SeniorUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes [Member]", "label": "Senior Unsecured Notes [Member]", "terseLabel": "Senior Unsecured Notes" } } }, "localname": "SeniorUnsecuredNotesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ctre_SeniorUnsecuredTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Term Loan [Member]", "label": "Senior Unsecured Term Loan [Member]", "terseLabel": "New Term Loan", "verboseLabel": "Senior unsecured term loan" } } }, "localname": "SeniorUnsecuredTermLoanMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_ShamrockNursingAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shamrock Nursing And Rehabilitation Center [Member]", "label": "Shamrock Nursing And Rehabilitation Center [Member]", "terseLabel": "Shamrock Nursing and Rehabilitation Center" } } }, "localname": "ShamrockNursingAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingNumberOfEqualAnnualInstallments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting, Number of Equal Annual Installments", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting, Number Of Equal Annual Installments", "terseLabel": "Number of equal annual vesting installments" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingNumberOfEqualAnnualInstallments", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "ctre_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSpinOffInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options nonvested spin off in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Spin Off In Period", "terseLabel": "Stock awards unvested during spin-off (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSpinOffInPeriod", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ctre_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeited In Period, Weighted Average Exercise Price", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeited In Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "perShareItemType" }, "ctre_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]", "terseLabel": "Weighted Average Share Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "stringItemType" }, "ctre_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingConditionNFFOGrowthMinimumPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Condition, NFFO Growth, Minimum, Percentage", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Condition, NFFO Growth, Minimum, Percentage", "terseLabel": "Vesting metric, Normalized Funds from Operations, minimum (percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingConditionNFFOGrowthMinimumPercentage", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctre_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsGrantsinPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (usd per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsGrantsinPeriodWeightedAverageExercisePrice", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "perShareItemType" }, "ctre_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Unvested, ending balance (usd per share)", "periodStartLabel": "Unvested, beginning balance (usd per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "perShareItemType" }, "ctre_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsVestedinPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested in Period, Weighted Average Exercise Price", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested in Period, Weighted Average Exercise Price", "terseLabel": "Vested (usd per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsVestedinPeriodWeightedAverageExercisePrice", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "perShareItemType" }, "ctre_SharesIssuedDuringPeriodAveragePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Issued During Period, Average Price Per Share", "label": "Shares Issued During Period, Average Price Per Share", "terseLabel": "Average sales price per share (usd per share)" } } }, "localname": "SharesIssuedDuringPeriodAveragePricePerShare", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails" ], "xbrltype": "perShareItemType" }, "ctre_ShawMountainAtCascadiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shaw Mountain At Cascadia [Member]", "label": "Shaw Mountain At Cascadia [Member]", "terseLabel": "Shaw Mountain at Cascadia" } } }, "localname": "ShawMountainAtCascadiaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ShorelineCareCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shoreline Care Center [Member]", "label": "Shoreline Care Center [Member]", "terseLabel": "Shoreline Care Center" } } }, "localname": "ShorelineCareCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ShorelineHealthAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shoreline Health And Rehabilitation Center [Member]", "label": "Shoreline Health And Rehabilitation Center [Member]", "terseLabel": "Shoreline Health and Rehabilitation Center" } } }, "localname": "ShorelineHealthAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ShreveportManorSkilledNursingAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shreveport Manor Skilled Nursing And Rehabilitation [Member]", "label": "Shreveport Manor Skilled Nursing And Rehabilitation [Member]", "terseLabel": "Shreveport Manor Skilled Nursing and Rehabilitation" } } }, "localname": "ShreveportManorSkilledNursingAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SilverLakeHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Silver Lake Health Holdings LLC [Member]", "label": "Silver Lake Health Holdings LLC [Member]", "terseLabel": "Silver Lake Health Holdings LLC" } } }, "localname": "SilverLakeHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SilveradaHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Silverada Health Holdings LLC [Member]", "label": "Silverada Health Holdings LLC [Member]", "terseLabel": "Silverada Health Holdings LLC" } } }, "localname": "SilveradaHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SkillNursingFacilityWashingtonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Skill Nursing Facility Washington", "label": "Skill Nursing Facility Washington [Member]", "terseLabel": "Skill Nursing Facility Washington [Member]" } } }, "localname": "SkillNursingFacilityWashingtonMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "ctre_SkilledNursingAndCampusFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Skilled Nursing And Campus Facilities", "label": "Skilled Nursing And Campus Facilities [Member]", "terseLabel": "Skilled Nursing and Campus Facilities", "verboseLabel": "SNF / Campus" } } }, "localname": "SkilledNursingAndCampusFacilitiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "ctre_SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Skilled Nursing, Assisted Living and Independent Living Facilities [Member]", "label": "Skilled Nursing, Assisted Living and Independent Living Facilities [Member]", "terseLabel": "Skilled nursing, assisted living and independent living facilities" } } }, "localname": "SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/OrganizationDetails" ], "xbrltype": "domainItemType" }, "ctre_SkilledNursingCampusPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Skilled Nursing Campus Properties [Member]", "label": "Skilled Nursing Campus Properties [Member]", "terseLabel": "Multi-Service Campus Properties" } } }, "localname": "SkilledNursingCampusPropertiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SkilledNursingFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Skilled Nursing Facility [Member]", "label": "Skilled Nursing Facility [Member]", "terseLabel": "Skilled Nursing Facility", "verboseLabel": "SNF" } } }, "localname": "SkilledNursingFacilityMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails", "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "domainItemType" }, "ctre_SkilledNursingPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Skilled Nursing Properties [Member]", "label": "Skilled Nursing Properties [Member]", "terseLabel": "Skilled Nursing Properties", "verboseLabel": "Skilled nursing" } } }, "localname": "SkilledNursingPropertiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails", "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SkyHoldingsAzLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sky Holdings AZ LLC [Member]", "label": "Sky Holdings AZ LLC [Member]", "terseLabel": "Sky Holdings AZ LLC" } } }, "localname": "SkyHoldingsAzLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SnohomishHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Snohomish Health Holdings LLC [Member]", "label": "Snohomish Health Holdings LLC [Member]", "terseLabel": "Snohomish Health Holdings LLC" } } }, "localname": "SnohomishHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SouthDoraHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "South Dora Health Holdings LLC [Member]", "label": "South Dora Health Holdings LLC [Member]", "terseLabel": "South Dora Health Holdings LLC" } } }, "localname": "SouthDoraHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SpringLakeSkilledNursingAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spring Lake Skilled Nursing And Rehabilitation [Member]", "label": "Spring Lake Skilled Nursing And Rehabilitation [Member]", "terseLabel": "Spring Lake Skilled Nursing and Rehabilitation" } } }, "localname": "SpringLakeSkilledNursingAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_StillhouseHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stillhouse Health Holdings LLC [Member]", "label": "Stillhouse Health Holdings LLC [Member]", "terseLabel": "Stillhouse Health Holdings LLC" } } }, "localname": "StillhouseHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_StockholdersEquityNoteSpinoffTransactionRestrictedStockAwardConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders' Equity Note, Spinoff Transaction, Restricted Stock Award Conversion Ratio", "label": "Stockholders' Equity Note, Spinoff Transaction, Restricted Stock Award Conversion Ratio", "terseLabel": "Restricted stock award conversion ratio related to the spin-off" } } }, "localname": "StockholdersEquityNoteSpinoffTransactionRestrictedStockAwardConversionRatio", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "pureItemType" }, "ctre_StoneBridgeNursingAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "StoneBridge Nursing And Rehabilitation Center [Member]", "label": "StoneBridge Nursing And Rehabilitation Center [Member]", "terseLabel": "StoneBridge Nursing and Rehabilitation Center" } } }, "localname": "StoneBridgeNursingAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_SwinglineLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swingline Loan [Member]", "label": "Swingline Loan [Member]", "terseLabel": "Swingline Loan" } } }, "localname": "SwinglineLoanMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_TangerineCoveOfBrooksvilleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangerine Cove Of Brooksville [Member]", "label": "Tangerine Cove Of Brooksville [Member]", "terseLabel": "Tangerine Cove Of Brooksville" } } }, "localname": "TangerineCoveOfBrooksvilleMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TempleHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temple Health Holdings LLC [Member]", "label": "Temple Health Holdings LLC [Member]", "terseLabel": "Temple Health Holdings LLC" } } }, "localname": "TempleHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TenantReimbursementRevenue": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 5.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tenant Reimbursement Revenue", "label": "Tenant Reimbursement Revenue", "terseLabel": "Tenant reimbursements", "verboseLabel": "Tenant recoveries related to real estate taxes" } } }, "localname": "TenantReimbursementRevenue", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctre_TenthEastHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tenth East Holdings LLC [Member]", "label": "Tenth East Holdings LLC [Member]", "terseLabel": "Tenth East Holdings LLC" } } }, "localname": "TenthEastHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TerraceHoldingsAzLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Terrace Holdings AZ LLC [Member]", "label": "Terrace Holdings AZ LLC [Member]", "terseLabel": "Terrace Holdings AZ LLC" } } }, "localname": "TerraceHoldingsAzLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheBradfordSkilledNursingandRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Bradford Skilled Nursing and Rehabilitation [Member]", "label": "The Bradford Skilled Nursing and Rehabilitation [Member]", "terseLabel": "The Bradford Skilled Nursing and Rehabilitation" } } }, "localname": "TheBradfordSkilledNursingandRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheGuestHouseSkilledNursingAndRehabilitationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Guest House Skilled Nursing And Rehabilitation [Member]", "label": "The Guest House Skilled Nursing And Rehabilitation [Member]", "terseLabel": "The Guest House Skilled Nursing And Rehabilitation" } } }, "localname": "TheGuestHouseSkilledNursingAndRehabilitationMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheMeadowsOnUniversityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Meadows On University [Member]", "label": "The Meadows On University [Member]", "terseLabel": "The Meadows on University" } } }, "localname": "TheMeadowsOnUniversityMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheOaksAtLakewoodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Oaks At Lakewood [Member]", "label": "The Oaks At Lakewood [Member]", "terseLabel": "The Oaks at Lakewood" } } }, "localname": "TheOaksAtLakewoodMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheOaksAtTimberlineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Oaks At Timberline [Member]", "label": "The Oaks At Timberline [Member]", "terseLabel": "The Oaks at Timberline" } } }, "localname": "TheOaksAtTimberlineMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheOaksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Oaks [Member]", "label": "The Oaks [Member]", "terseLabel": "The Oaks" } } }, "localname": "TheOaksMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ThePinesofBurtonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Pines of Burton [Member]", "label": "The Pines of Burton [Member]", "terseLabel": "The Pines of Burton" } } }, "localname": "ThePinesofBurtonMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ThePinesofClarkstonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Pines of Clarkston [Member]", "label": "The Pines of Clarkston [Member]", "terseLabel": "The Pines of Clarkston" } } }, "localname": "ThePinesofClarkstonMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ThePinesofGoodrichMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Pines of Goodrich [Member]", "label": "The Pines of Goodrich [Member]", "terseLabel": "The Pines of Goodrich" } } }, "localname": "ThePinesofGoodrichMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ThePinesofLapeerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Pines of Lapeer [Member]", "label": "The Pines of Lapeer [Member]", "terseLabel": "The Pines of Lapeer" } } }, "localname": "ThePinesofLapeerMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheRioAtCabezonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Rio At Cabezon [Member]", "label": "The Rio At Cabezon [Member]", "terseLabel": "The Rio at Cabezon" } } }, "localname": "TheRioAtCabezonMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheRioAtFoxHollowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Rio At Fox Hollow [Member]", "label": "The Rio At Fox Hollow [Member]", "terseLabel": "The Rio at Fox Hollow" } } }, "localname": "TheRioAtFoxHollowMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheSuitesParkerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Suites Parker [Member]", "label": "The Suites Parker [Member]", "terseLabel": "The Suites - Parker" } } }, "localname": "TheSuitesParkerMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheVillageAtHeritageOaksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Village At Heritage Oaks [Member]", "label": "The Village At Heritage Oaks [Member]", "terseLabel": "The Village at Heritage Oaks" } } }, "localname": "TheVillageAtHeritageOaksMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TheVillasAtSaratogaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Villas At Saratoga [Member]", "label": "The Villas At Saratoga [Member]", "terseLabel": "The Villas at Saratoga" } } }, "localname": "TheVillasAtSaratogaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TransferOfPreacquisitionCostsToAcquiredAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transfer Of Preacquisition Costs To Acquired Assets", "label": "Transfer Of Preacquisition Costs To Acquired Assets", "terseLabel": "Transfer of pre-acquisition costs to acquired assets" } } }, "localname": "TransferOfPreacquisitionCostsToAcquiredAssets", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctre_TrilliumHealthcareGroupLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trillium Healthcare Group LLC [Member]", "label": "Trillium Healthcare Group LLC [Member]", "terseLabel": "Trillium" } } }, "localname": "TrilliumHealthcareGroupLLCMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "ctre_TrilliumSkilledNursingFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trillium Skilled Nursing Facilities [Member]", "label": "Trillium Skilled Nursing Facilities [Member]", "terseLabel": "Trillium skilled nursing facilities" } } }, "localname": "TrilliumSkilledNursingFacilitiesMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "ctre_TrinityMillHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trinity Mill Holdings LLC [Member]", "label": "Trinity Mill Holdings LLC [Member]", "terseLabel": "Trinity Mill Holdings LLC" } } }, "localname": "TrinityMillHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TrioHealthcareAndHillstoneHealthcareMasterLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trio Healthcare And Hillstone Healthcare Master Lease [Member]", "label": "Trio Healthcare And Hillstone Healthcare Master Lease [Member]", "terseLabel": "Trio and Hillstone Master Lease" } } }, "localname": "TrioHealthcareAndHillstoneHealthcareMasterLeaseMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "domainItemType" }, "ctre_TrioHealthcareIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trio Healthcare Inc [Member]", "label": "Trio Healthcare Inc [Member]", "terseLabel": "Trio" } } }, "localname": "TrioHealthcareIncMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "domainItemType" }, "ctre_TrioHealthcareMasterLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trio Healthcare Master Lease [Member]", "label": "Trio Healthcare Master Lease [Member]", "terseLabel": "Trio Healthcare Master Lease" } } }, "localname": "TrioHealthcareMasterLeaseMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "domainItemType" }, "ctre_TrousdaleHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trousdale Health Holdings LLC [Member]", "label": "Trousdale Health Holdings LLC [Member]", "terseLabel": "Trousdale Health Holdings LLC" } } }, "localname": "TrousdaleHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TulalipBayHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tulalip Bay Holdings [Member]", "label": "Tulalip Bay Holdings [Member]", "terseLabel": "Tulalip Bay Health Holdings LLC" } } }, "localname": "TulalipBayHoldingsMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_TurlockNursingandRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Turlock Nursing and Rehabilitation Center [Member]", "label": "Turlock Nursing and Rehabilitation Center [Member]", "terseLabel": "Turlock Nursing and Rehabilitation Center" } } }, "localname": "TurlockNursingandRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_UnderwrittenPublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwritten Public Offering", "label": "Underwritten Public Offering [Member]", "terseLabel": "Underwritten Public Offering" } } }, "localname": "UnderwrittenPublicOfferingMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicAndDiluted": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails": { "order": 2.0, "parentTag": "ctre_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Undistributed earnings (loss) allocated to participating securities, basic and diluted.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic and Diluted", "negatedLabel": "Less: Net income allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicAndDiluted", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "ctre_UnrecognizedPreferredReturnFromPriorPeriodRecognizedInCurrentPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrecognized Preferred Return From Prior Period, Recognized In Current Period", "label": "Unrecognized Preferred Return From Prior Period, Recognized In Current Period", "terseLabel": "Recognition of unrecognized preferred return from prior periods" } } }, "localname": "UnrecognizedPreferredReturnFromPriorPeriodRecognizedInCurrentPeriod", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "ctre_ValleyHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valley Health Holdings LLC [Member]", "label": "Valley Health Holdings LLC [Member]", "terseLabel": "Valley Health Holdings LLC" } } }, "localname": "ValleyHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_ValleySkilledNursingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valley Skilled Nursing [Member]", "label": "Valley Skilled Nursing [Member]", "terseLabel": "Valley Skilled Nursing" } } }, "localname": "ValleySkilledNursingMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_VariousOtherOperatorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Various Other Operators [Member]", "label": "Various Other Operators [Member]", "terseLabel": "Various other operators" } } }, "localname": "VariousOtherOperatorsMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctre_VerdeVillaHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Verde Villa Holdings LLC [Member]", "label": "Verde Villa Holdings LLC [Member]", "terseLabel": "Verde Villa Holdings LLC" } } }, "localname": "VerdeVillaHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_VictoryParkNursingHomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Victory Park Nursing Home [Member]", "label": "Victory Park Nursing Home [Member]", "terseLabel": "Premier Estates of Highlands" } } }, "localname": "VictoryParkNursingHomeMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_VistaDelLagoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vista Del Lago [Member]", "label": "Vista Del Lago [Member]", "terseLabel": "Vista Del Lago" } } }, "localname": "VistaDelLagoMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_WayneHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wayne Health Holdings LLC [Member]", "label": "Wayne Health Holdings LLC [Member]", "terseLabel": "Wayne Health Holdings LLC" } } }, "localname": "WayneHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_WellspringHealthAndRehabilitationOfCascadiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wellspring Health And Rehabilitation Of Cascadia [Member]", "label": "Wellspring Health And Rehabilitation Of Cascadia [Member]", "terseLabel": "Wellspring Health and Rehabilitation Of Cascadia" } } }, "localname": "WellspringHealthAndRehabilitationOfCascadiaMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_WestCoveCareAndRehabilitationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "West Cove Care And Rehabilitation Center [Member]", "label": "West Cove Care And Rehabilitation Center [Member]", "terseLabel": "West Cove Care & Rehabilitation Center" } } }, "localname": "WestCoveCareAndRehabilitationCenterMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_WillitsHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Willits Health Holdings LLC [Member]", "label": "Willits Health Holdings LLC [Member]", "terseLabel": "Willits Health Holdings LLC" } } }, "localname": "WillitsHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_WillowsHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Willows Health Holdings Llc [Member]", "label": "Willows Health Holdings Llc [Member]", "terseLabel": "Willows Health Holdings LLC" } } }, "localname": "WillowsHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_WisteriaHealthHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wisteria Health Holdings LLC [Member]", "label": "Wisteria Health Holdings LLC [Member]", "terseLabel": "Wisteria Health Holdings LLC" } } }, "localname": "WisteriaHealthHoldingsLlcMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "ctre_XeniaHealthAndRehabMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Xenia Health And Rehab [Member]", "label": "Xenia Health And Rehab [Member]", "terseLabel": "Xenia Health and Rehab" } } }, "localname": "XeniaHealthAndRehabMember", "nsuri": "http://www.caretrustreit.com/20201231", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r410", "r411", "r412" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityByLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity by Location [Axis]", "terseLabel": "Entity by Location [Axis]" } } }, "localname": "EntityByLocationAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r410", "r411", "r412" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A domain representing all geographic locations. Depending on the axis, it may contain members that are specific geographies, or synthetic entity-specific geographical groups.", "label": "Location [Domain]", "terseLabel": "Location [Domain]" } } }, "localname": "LocationDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r40", "r84", "r426" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails", "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails", "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Person serving on board of directors.", "label": "Director [Member]", "terseLabel": "Board of Directors" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment, including named security. Excludes consolidated entity.", "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r163", "r222", "r225", "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r236", "r238", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r377", "r381" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r236", "r238", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r377", "r381" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]" } } }, "localname": "MortgageLoansOnRealEstateAbstract", "nsuri": "http://fasb.org/srt/2020-01-31", "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateByLoanDisclosureTextBlock": { "auth_ref": [ "r393", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Includes, but is not limited to, information for each mortgage loan receivable equaling or exceeding three percent of carrying amount of mortgage.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Text Block]", "terseLabel": "Schedule IV - Mortgage Loans on Real Estate" } } }, "localname": "MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstate" ], "xbrltype": "textBlockItemType" }, "srt_MortgageLoansOnRealEstateCollectionsOfPrincipal": { "auth_ref": [ "r392", "r419" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from collection of principal.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Collections of Principal", "negatedTerseLabel": "Paydowns/Repayments" } } }, "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipal", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "auth_ref": [ "r391", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r416", "r417" ], "lang": { "en-us": { "role": { "documentation": "Information by type of real estate property.", "label": "Real Estate, Type of Property [Axis]", "terseLabel": "Real Estate, Type of Property [Axis]" } } }, "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails", "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateFaceAmountOfMortgages": { "auth_ref": [ "r389", "r423" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual principal due at origination of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages", "terseLabel": "Principal Balance" } } }, "localname": "MortgageLoansOnRealEstateFaceAmountOfMortgages", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "monetaryItemType" }, "srt_MortgageLoansOnRealEstateInterestRate": { "auth_ref": [ "r387", "r421" ], "lang": { "en-us": { "role": { "documentation": "Interest rate of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate", "terseLabel": "Contractual Interest Rate" } } }, "localname": "MortgageLoansOnRealEstateInterestRate", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "percentItemType" }, "srt_MortgageLoansOnRealEstateLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]" } } }, "localname": "MortgageLoansOnRealEstateLineItems", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "auth_ref": [ "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Land and any structures permanently fixed to it.", "label": "Real Estate [Domain]", "terseLabel": "Real Estate [Domain]" } } }, "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails", "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstatePriorLiens1": { "auth_ref": [ "r388", "r422" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of prior lien on real estate securing mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Prior Lien, Amount", "terseLabel": "Prior Liens" } } }, "localname": "MortgageLoansOnRealEstatePriorLiens1", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "monetaryItemType" }, "srt_MortgageLoansOnRealEstateScheduleTable": { "auth_ref": [ "r393", "r425" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]" } } }, "localname": "MortgageLoansOnRealEstateScheduleTable", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r163", "r222", "r225", "r380" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "domainItemType" }, "srt_OfficerMember": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of officer.", "label": "Officer [Member]", "terseLabel": "Officers" } } }, "localname": "OfficerMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r160", "r222", "r223", "r339", "r376", "r378" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r160", "r222", "r223", "r339", "r376", "r378" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r226", "r236", "r238", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r377", "r381" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r226", "r236", "r238", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r377", "r381" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances": { "auth_ref": [ "r395", "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lien or mortgage outstanding on real estate investment properties for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Amount of Encumbrances", "terseLabel": "Encumbrances" } } }, "localname": "RealEstateAndAccumulatedDepreciationAmountOfEncumbrances", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "monetaryItemType" }, "srt_RealEstateAndAccumulatedDepreciationByPropertyTable": { "auth_ref": [ "r406", "r424" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about real estate investments and accompanying accumulated depreciation for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table]", "terseLabel": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table]" } } }, "localname": "RealEstateAndAccumulatedDepreciationByPropertyTable", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "auth_ref": [ "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r424", "r427" ], "lang": { "en-us": { "role": { "documentation": "Information by name of property.", "label": "Name of Property [Axis]", "terseLabel": "Name of Property [Axis]" } } }, "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/OrganizationDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails", "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]", "terseLabel": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]" } } }, "localname": "RealEstateAndAccumulatedDepreciationDisclosureAbstract", "nsuri": "http://fasb.org/srt/2020-01-31", "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationDisclosureTextBlock": { "auth_ref": [ "r406", "r424" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of real estate investments and associated accumulated depreciation for entities with a significant portion of their business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Text Block]", "terseLabel": "Schedule III - Real Estate Assets and Accumulated Depreciation" } } }, "localname": "RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciation" ], "xbrltype": "textBlockItemType" }, "srt_RealEstateAndAccumulatedDepreciationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]", "terseLabel": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]" } } }, "localname": "RealEstateAndAccumulatedDepreciationLineItems", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "auth_ref": [ "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center.", "label": "Name of Property [Domain]", "terseLabel": "Name of Property [Domain]" } } }, "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/OrganizationDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails", "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "domainItemType" }, "srt_RealEstateFederalIncomeTaxBasis": { "auth_ref": [ "r405", "r418" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost basis of real estate investments for federal income tax purposes for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Federal Income Tax Basis", "terseLabel": "Aggregate cost of real estate for federal income tax purposes" } } }, "localname": "RealEstateFederalIncomeTaxBasis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "monetaryItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails", "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails", "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment, including named security. Excludes consolidated entity.", "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r161", "r162", "r222", "r224", "r379", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r161", "r162", "r222", "r224", "r379", "r391", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r416", "r417" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r164", "r325" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_GA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GEORGIA", "terseLabel": "Georgia" } } }, "localname": "GA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "stpr_IA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IOWA", "terseLabel": "Iowa" } } }, "localname": "IA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "stpr_OH": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OHIO", "terseLabel": "Ohio" } } }, "localname": "OH", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]", "terseLabel": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Accounts Payable and Other Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r17", "r360" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "verboseLabel": "Accounts and other receivables, net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedAmortizationDeferredFinanceCosts": { "auth_ref": [ "r27", "r306" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of debt issuance costs.", "label": "Accumulated Amortization, Debt Issuance Costs", "terseLabel": "Accumulated amortization of deferred financing costs" } } }, "localname": "AccumulatedAmortizationDeferredFinanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDistributionsInExcessOfNetIncome": { "auth_ref": [ "r386" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount as of the balance sheet date by which cumulative distributions to shareholders (or partners) exceed retained earnings (or accumulated earnings).", "label": "Accumulated Distributions in Excess of Net Income", "negatedLabel": "Cumulative distributions in excess of earnings" } } }, "localname": "AccumulatedDistributionsInExcessOfNetIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Cumulative distributions to shareholders (or partners) in excess of retained earnings (or accumulated earnings).", "label": "Accumulated Distributions in Excess of Net Income [Member]", "terseLabel": "Cumulative Distributions in Excess of Earnings" } } }, "localname": "AccumulatedDistributionsInExcessOfNetIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r18" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r88", "r89", "r90", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r239", "r241", "r258", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Amortization of stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r241", "r251", "r257" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Amortization of stock-based compensation", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "terseLabel": "Write-off of accounts and straight-line rent receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r71", "r306" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of deferred financing costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r83", "r142", "r152", "r158", "r175", "r272", "r274", "r294", "r341", "r361" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup": { "auth_ref": [ "r189" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets held-for-sale that are not part of a disposal group.", "label": "Assets Held-for-sale, Not Part of Disposal Group", "terseLabel": "Assets held for sale, net" } } }, "localname": "AssetsHeldForSaleNotPartOfDisposalGroup", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r242", "r253" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BridgeLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place.", "label": "Bridge Loan [Member]", "terseLabel": "Bridge loan" } } }, "localname": "BridgeLoanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingImprovementsMember": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building Improvements [Member]", "terseLabel": "Building Improvements" } } }, "localname": "BuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Amount" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r23", "r73" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r8", "r74", "r80" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r66", "r73", "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r66", "r295" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental schedule of noncash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock Disclosures [Abstract]", "terseLabel": "ATM Program Activity" } } }, "localname": "ClassOfStockDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r34", "r201", "r347", "r366" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 10)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r198", "r199", "r200", "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Common dividend (usd per share)", "verboseLabel": "Dividends declared (usd per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquityParenthetical", "http://www.caretrustreit.com/role/EquityDividendsonCommonStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r88", "r89" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (usd per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized (shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued (shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r212" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, outstanding (shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.01 par value; 500,000,000 shares authorized, 95,215,797 and 95,103,270 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r130", "r131", "r163", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r130", "r131", "r163", "r291", "r292", "r385" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r130", "r131", "r163", "r291", "r292", "r385" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r125", "r358" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Concentration of Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r130", "r131", "r163", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r128", "r130", "r131", "r132", "r291", "r293" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r130", "r131", "r163", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r52", "r339" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Independent living facilities" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r51" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r129", "r163" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r10", "r11", "r12", "r342", "r344", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate (percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r12", "r205", "r344", "r359" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Principal Amount", "totalLabel": "Total debt", "verboseLabel": "Outstanding amounts" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r305", "r307" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument face amount", "verboseLabel": "Senior unsecured notes payable - face value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price of notes (percent)" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r33", "r85", "r213", "r216", "r217", "r218", "r304", "r305", "r307", "r357" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r27", "r80" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Deferred Financing Costs" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r306" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "negatedTerseLabel": "Deferred Loan Fees" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r27", "r306" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Deferred financing costs, net" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r71", "r191" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r71", "r141" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization (including below-market ground leases)" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.", "label": "Depreciation, Depletion, and Amortization [Policy Text Block]", "terseLabel": "Real Estate Depreciation and Amortization" } } }, "localname": "DepreciationDepletionAndAmortizationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsHeldforsaleMember": { "auth_ref": [ "r0", "r1", "r2" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.", "label": "Discontinued Operations, Held-for-sale [Member]", "terseLabel": "Held for sale" } } }, "localname": "DiscontinuedOperationsHeldforsaleMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r190", "r196" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposed of by sale" } } }, "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": { "auth_ref": [ "r71", "r190", "r195" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down", "terseLabel": "Impairment expense to reduce carrying value to fair value less costs to sell" } } }, "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r235", "r237" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Date the declared dividend will be paid, in CCYY-MM-DD format.", "label": "Dividends Payable, Date to be Paid", "terseLabel": "Dividends payment date" } } }, "localname": "DividendPayableDateToBePaidDayMonthAndYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityDividendsonCommonStockDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r219", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedLabel": "Common dividends ($1.00, $0.90 and $0.82 per share for the years ended 2020, 2019 and 2018, respectively)" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsDeclaredTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.", "label": "Dividends Declared [Table Text Block]", "terseLabel": "Summary of Dividends on Common Stock" } } }, "localname": "DividendsDeclaredTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r7", "r31" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current", "terseLabel": "Dividends payable as of record date" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityDividendsonCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r11", "r13", "r343", "r362" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Dividends payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the holder must own the stock to be entitled to the dividend, in CCYY-MM-DD format.", "label": "Dividends Payable, Date of Record", "terseLabel": "Dividends record date" } } }, "localname": "DividendsPayableDateOfRecordDayMonthAndYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityDividendsonCommonStockDetails" ], "xbrltype": "dateItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per common share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r48", "r93", "r94", "r95", "r96", "r97", "r101", "r103", "r108", "r109", "r110", "r114", "r115", "r351", "r371" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (usd per share)", "verboseLabel": "Earnings per common share, basic (usd per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails", "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r48", "r93", "r94", "r95", "r96", "r97", "r103", "r108", "r109", "r110", "r114", "r115", "r351", "r371" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (usd per share)", "verboseLabel": "Earnings per common share, diluted (usd per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails", "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r80", "r111", "r112" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r111", "r112", "r113", "r116" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EarningsPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r252" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unamortized stock-based compensation expense related to unvested awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average remaining vesting period related to expense recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r88", "r89", "r90", "r92", "r98", "r100", "r120", "r176", "r212", "r219", "r254", "r255", "r256", "r268", "r269", "r296", "r297", "r298", "r299", "r300", "r301", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentAggregateCost": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.", "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Preferred equity investments - face value" } } }, "localname": "EquityMethodInvestmentAggregateCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentDividendsOrDistributions": { "auth_ref": [ "r46", "r65", "r71", "r369" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.", "label": "Proceeds from Equity Method Investment, Distribution", "terseLabel": "Interest income distribution from other real estate investment" } } }, "localname": "EquityMethodInvestmentDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r24", "r143", "r173" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Preferred equity investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "auth_ref": [ "r172" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investments accounted under the equity method.", "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Preferred equity investments" } } }, "localname": "EquityMethodInvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r277", "r278", "r279", "r284" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r277", "r278", "r279", "r283", "r284" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Fair Value and Carrying Value of Financial Instruments" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r277", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r278", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r277", "r285" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r277", "r278", "r280", "r281", "r286" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r227", "r228", "r233", "r234", "r278", "r329" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r227", "r228", "r233", "r234", "r278", "r330" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r278", "r331" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r282", "r286" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]", "terseLabel": "Financial assets:" } } }, "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]", "terseLabel": "Financial liabilities:" } } }, "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": { "auth_ref": [ "r167", "r168", "r169", "r179", "r180", "r182", "r183", "r184", "r185", "r186" ], "lang": { "en-us": { "role": { "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Axis]", "terseLabel": "Class of Financing Receivable [Axis]" } } }, "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Domain]", "terseLabel": "Class of Financing Receivable [Domain]" } } }, "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r187", "r340" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails": { "order": 4.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Identified intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FixturesAndEquipmentGross": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails": { "order": 3.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of fixtures and equipment. Includes, but is not limited to, machinery, equipment, and engines.", "label": "Fixtures and Equipment, Gross", "terseLabel": "Integral equipment, furniture and fixtures" } } }, "localname": "FixturesAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Integral Equipment, Furniture and Fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnTerminationOfLease": { "auth_ref": [ "r309" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingLeaseLeaseIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.", "label": "Gain (Loss) on Termination of Lease", "terseLabel": "Lease termination revenue" } } }, "localname": "GainLossOnTerminationOfLease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "auth_ref": [ "r49", "r50", "r71", "r349", "r372", "r373", "r374", "r375" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.", "label": "Gains (Losses) on Sales of Investment Real Estate", "negatedTerseLabel": "Loss (gain) on sale of real estate", "terseLabel": "(Loss) gain on sale of real estate", "verboseLabel": "Gain (loss) on sale of real estate" } } }, "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r53" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentLossesRelatedToRealEstatePartnerships": { "auth_ref": [ "r72", "r194" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment losses measured as the amount by which the carrying amount of the business or real estate partnerships exceeds the fair value of the business or partnership.", "label": "Impairment Losses Related to Real Estate Partnerships", "terseLabel": "Impairment of real estate investments" } } }, "localname": "ImpairmentLossesRelatedToRealEstatePartnerships", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r80", "r188", "r197" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r235", "r237" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r43", "r80", "r262", "r263", "r264", "r265", "r266", "r267", "r394" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r70" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r70" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts and other receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r70" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets, net" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r104", "r105", "r106", "r110" ], "calculation": { "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Dilutive performance stock awards (shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestAndFeeIncomeLoansCommercialRealEstate": { "auth_ref": [ "r352" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest and fee income generated from loans secured by commercial properties. Examples of properties commonly securing commercial real estate loans may include office buildings, apartment buildings, shopping centers, industrial property, and hotels.", "label": "Interest and Fee Income, Loans, Commercial, Real Estate", "terseLabel": "Interest income related to mortgage loans" } } }, "localname": "InterestAndFeeIncomeLoansCommercialRealEstate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest and Other Income", "terseLabel": "Interest and other income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r44", "r140", "r303", "r306", "r353" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "terseLabel": "Interest income related to preferred equity investments" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r64", "r68", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentBuildingAndBuildingImprovements": { "auth_ref": [ "r368" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails": { "order": 2.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.", "label": "Investment Building and Building Improvements", "terseLabel": "Buildings and improvements" } } }, "localname": "InvestmentBuildingAndBuildingImprovements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Land": { "auth_ref": [ "r6", "r25" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails": { "order": 1.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]", "terseLabel": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement.", "label": "Lease Contractual Term [Domain]", "terseLabel": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LessorLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessor, Lease, Description [Line Items]", "terseLabel": "Lessor, Lease, Description [Line Items]" } } }, "localname": "LessorLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorLeaseDescriptionTable": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessor's leases.", "label": "Lessor, Lease, Description [Table]", "terseLabel": "Lessor, Lease, Description [Table]" } } }, "localname": "LessorLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTenantPurchaseOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r316", "r320", "r321", "r324" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Lessor, Leases [Policy Text Block]", "terseLabel": "Lessor Accounting" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]", "terseLabel": "Future Contractual Minimum Rental Income" } } }, "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r317" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "Lessor, Operating Lease, Payments to be Received", "totalLabel": "Total" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r317" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails": { "order": 5.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Five", "terseLabel": "2025" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "auth_ref": [ "r317" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails": { "order": 4.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "terseLabel": "2024" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Schedule of Total Future Contractual Minimum Rental Income" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r317" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "terseLabel": "2021" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": { "auth_ref": [ "r317" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails": { "order": 6.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r317" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "terseLabel": "2023" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r317" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "terseLabel": "2022" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetFutureContractualMinimumRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Renewal Term", "terseLabel": "Lease renewal term (in years)" } } }, "localname": "LessorOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Lease term (in years)", "verboseLabel": "Initial lease term (in years)" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r30", "r83", "r153", "r175", "r273", "r274", "r275", "r294" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r83", "r175", "r294", "r345", "r364" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Equity:" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r12", "r344", "r359" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "verboseLabel": "Unsecured revolving credit facility" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Facility fee on revolving commitment fees (percent)" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Credit facility borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r28", "r85" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Unsecured revolving credit facility", "verboseLabel": "Revolving Facility" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansReceivableBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points (also referred to as 'margin') added to the reference rate as stated in the loan agreement and used to compute the variable rate on the loans receivable. For instance, the loan agreement might state that the interest rate the borrower is obligated to pay is the London Interbank Offered Rate (LIBOR) plus three quarters (3/4) of a percentage point adjusted quarterly (each three months). LIBOR in this example is the index or reference rate, 3/4 percentage point is the margin, the reference rate plus the margin is the fully indexed rate. This element would be used to report separately the margin.", "label": "Loans Receivable, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate for loan (percent)" } } }, "localname": "LoansReceivableBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LoansReceivableFairValueDisclosure": { "auth_ref": [ "r171" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of loan receivable, including, but not limited to, mortgage loans held for investment, finance receivables held for investment, policy loans on insurance contracts.", "label": "Loans Receivable, Fair Value Disclosure", "terseLabel": "Mortgage loans receivable", "verboseLabel": "Mezzanine loan receivable" } } }, "localname": "LoansReceivableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An amount of money or property, or a portion thereof, leant to a borrower (debtor) in exchange for a promise to repay the amount borrowed plus interest at a date certain in the future.", "label": "Loans Receivable [Member]", "terseLabel": "Other loans receivable" } } }, "localname": "LoansReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansReceivableWithFixedRatesOfInterest1": { "auth_ref": [ "r165" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loan with fixed rate of interest.", "label": "Loans Receivable with Fixed Rates of Interest", "terseLabel": "Bridge loan funding in loans receivable" } } }, "localname": "LoansReceivableWithFixedRatesOfInterest1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r12", "r206", "r344", "r363" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Carrying Value", "verboseLabel": "Outstanding borrowings" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Debt, Fiscal Year Maturity [Abstract]", "terseLabel": "Debt, Fiscal Year Maturity [Abstract]" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r86", "r203" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r86", "r203" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r86", "r203" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r86", "r203" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r86", "r203" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r86", "r203" ], "calculation": { "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r33" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Loans Payable, Noncurrent", "terseLabel": "Senior unsecured term loan, net" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r33", "r204" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails", "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails", "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MortgageLoansOnRealEstate": { "auth_ref": [ "r390" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate", "periodEndLabel": "Mortgage loans, end of period", "periodStartLabel": "Mortgage loans, beginning of period", "terseLabel": "Book Value" } } }, "localname": "MortgageLoansOnRealEstate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails", "http://www.caretrustreit.com/role/ScheduleIVMortgageLoansonRealEstateMortgageLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": { "auth_ref": [ "r392" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan", "terseLabel": "New mortgage loans" } } }, "localname": "MortgageLoansOnRealEstateNewMortgageLoans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageReceivablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amounts due the Company for loans secured by the collateral of specified real estate property and which loan the borrower (debtor) is obligated to repay in accordance with a predetermined set of payments.", "label": "Mortgage Receivable [Member]", "terseLabel": "Mortgage loan receivable" } } }, "localname": "MortgageReceivablesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInMortgageLoansOnRealEstateRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]" } } }, "localname": "MovementInMortgageLoansOnRealEstateRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIVMortgageLoanonRealEstateMortgageLoanRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r66", "r69", "r72" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r41", "r42", "r47", "r72", "r83", "r91", "r93", "r94", "r95", "r96", "r99", "r100", "r107", "r142", "r151", "r154", "r157", "r159", "r175", "r294", "r350", "r370" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails": { "order": 1.0, "parentTag": "ctre_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity", "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails", "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": { "auth_ref": [ "r76", "r77", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.", "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Received", "terseLabel": "Sale of real estate settled with notes receivable" } } }, "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other (loss) income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableFairValueDisclosure": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of notes payable.", "label": "Notes Payable, Fair Value Disclosure", "terseLabel": "Senior unsecured notes payable" } } }, "localname": "NotesPayableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableGross": { "auth_ref": [ "r181", "r185", "r186" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable.", "label": "Financing Receivable, before Allowance for Credit Loss", "terseLabel": "Mortgage loans receivable - face value" } } }, "localname": "NotesReceivableGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r17", "r165", "r181" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "terseLabel": "Loan receivable" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfRealEstateProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of real estate properties owned as of the balance sheet date.", "label": "Number of Real Estate Properties", "terseLabel": "Number of facilities" } } }, "localname": "NumberOfRealEstateProperties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails", "http://www.caretrustreit.com/role/OrganizationDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of states the entity operates in as of the balance sheet date.", "label": "Number of States in which Entity Operates", "terseLabel": "Number of states with properties" } } }, "localname": "NumberOfStatesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfUnitsInRealEstateProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of units in a real estate property owned as of the balance sheet date.", "label": "Number of Units in Real Estate Property", "terseLabel": "Number of units available in living facilities" } } }, "localname": "NumberOfUnitsInRealEstateProperty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLeaseIncome": { "auth_ref": [ "r118", "r315", "r323" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 }, "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.", "label": "Operating Lease, Lease Income", "terseLabel": "Rental income", "totalLabel": "Total" } } }, "localname": "OperatingLeaseLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": { "auth_ref": [ "r118", "r322" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLeaseIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.", "label": "Operating Lease, Lease Income, Lease Payments", "terseLabel": "Contractual rent due" } } }, "localname": "OperatingLeaseLeaseIncomeLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r118", "r323" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from operating lease.", "label": "Operating Lease, Lease Income [Table Text Block]", "terseLabel": "Schedule of Rental Income" } } }, "localname": "OperatingLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLeasesIncomeStatementLeaseRevenue": { "auth_ref": [ "r308" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 4.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of revenue recognized for the period from operating leases, including minimum lease revenue, contingent revenue, percentage revenue and sublease revenue.", "label": "Operating Leases, Income Statement, Lease Revenue", "terseLabel": "Rental income" } } }, "localname": "OperatingLeasesIncomeStatementLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r4", "r276" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Funding commitment" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]", "terseLabel": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "terseLabel": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]", "terseLabel": "Accounting Policies [Line Items]", "verboseLabel": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]", "terseLabel": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/CommitmentsandContingenciesDetails", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncashIncome": { "auth_ref": [ "r72" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income or gain included in net income that result in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income", "negatedTerseLabel": "Noncash interest income" } } }, "localname": "OtherNoncashIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForDepositsOnRealEstateAcquisitions": { "auth_ref": [ "r58" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow related to amounts given in advance to show or confirm an intention to complete an acquisition of land, buildings, other structures, or any item classified as real estate.", "label": "Payments for Deposits on Real Estate Acquisitions", "negatedTerseLabel": "Escrow deposits for potential acquisitions of real estate" } } }, "localname": "PaymentsForDepositsOnRealEstateAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r61" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid on common stock" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r63" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedLabel": "Payments of deferred financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r63" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedTerseLabel": "Proceeds from (costs paid for) the issuance of common stock, net", "terseLabel": "Commissions paid on stock issuance" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r61" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Net-settle adjustment on restricted stock" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireCommercialRealEstate": { "auth_ref": [ "r58" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the acquisition of property as primarily intended to generate income for its owner.", "label": "Payments to Acquire Commercial Real Estate", "negatedTerseLabel": "Acquisitions of real estate, net of deposits applied", "terseLabel": "Payment to acquire facility" } } }, "localname": "PaymentsToAcquireCommercialRealEstate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireLoansReceivable": { "auth_ref": [ "r57" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services.", "label": "Payments to Acquire Loans Receivable", "negatedTerseLabel": "Investment in real estate mortgage and other loans receivable" } } }, "localname": "PaymentsToAcquireLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Stock Award" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r287" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (usd per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized (shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, issued (shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding (shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r15" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01 par value; 100,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2020 and December 31, 2019" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other assets, net" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "auth_ref": [ "r54" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.", "label": "Proceeds from Collection of Loans Receivable", "terseLabel": "Principal payments received on real estate mortgage and other loans receivable" } } }, "localname": "ProceedsFromCollectionOfLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "terseLabel": "Net proceeds from issuance of senior notes" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "auth_ref": [ "r55", "r65" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.", "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Repayment of other real estate investment", "verboseLabel": "Return of initial investment" } } }, "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r59" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from (costs paid for) the issuance of common stock, net", "verboseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": { "auth_ref": [ "r60" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.", "label": "Proceeds from Issuance of Unsecured Debt", "terseLabel": "Proceeds from the issuance of senior unsecured term loan", "verboseLabel": "Gross proceeds from issuance of senior notes" } } }, "localname": "ProceedsFromIssuanceOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLoans": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from principal payments made on loans related to operating activities.", "label": "Proceeds from Loans", "terseLabel": "Proceeds from settlement of loan" } } }, "localname": "ProceedsFromLoans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r60" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-term Lines of Credit", "terseLabel": "Borrowings under unsecured revolving credit facility" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": { "auth_ref": [ "r56" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.", "label": "Proceeds from Sale of Real Estate Held-for-investment", "terseLabel": "Net proceeds from sales of real estate", "verboseLabel": "Proceeds from sale" } } }, "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r26", "r193" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r9", "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Summary of Estimated Useful Lives of Assets" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r9", "r192" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful life (in years)" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForLoanLossesExpensed": { "auth_ref": [ "r177", "r348" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable.", "label": "Financing Receivable, Credit Loss, Expense (Reversal)", "terseLabel": "Provision for loan losses" } } }, "localname": "ProvisionForLoanLossesExpensed", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]", "terseLabel": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "Selected Quarterly Financial Data (Unaudited)" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnaudited" ], "xbrltype": "textBlockItemType" }, "us-gaap_RealEstateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate [Abstract]", "terseLabel": "Real Estate [Abstract]" } } }, "localname": "RealEstateAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RealEstateAccumulatedDepreciation": { "auth_ref": [ "r399" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation pertaining to real estate investments for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation", "negatedPeriodEndLabel": "Balance at the end of the period", "negatedPeriodStartLabel": "Balance at the beginning of the period", "negatedTerseLabel": "Accumulated Depreciation" } } }, "localname": "RealEstateAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails", "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAccumulatedDepreciationOtherDeductions": { "auth_ref": [ "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other deductions to accumulated depreciation, excluding sales, for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Other Deduction", "terseLabel": "Impairment" } } }, "localname": "RealEstateAccumulatedDepreciationOtherDeductions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAccumulatedDepreciationRealEstateSold": { "auth_ref": [ "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to accumulated depreciation for real estate investments sold for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Investment in Real Estate Sold", "terseLabel": "Sales of real estate" } } }, "localname": "RealEstateAccumulatedDepreciationRealEstateSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements": { "auth_ref": [ "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of buildings and improvements for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Building and Improvements, Amount", "terseLabel": "Gross Carrying Value, Buildings and Improvements" } } }, "localname": "RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand": { "auth_ref": [ "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of land for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Land, Amount", "terseLabel": "Gross Carrying Value, Land" } } }, "localname": "RealEstateAndAccumulatedDepreciationCarryingAmountOfLand", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLandAndBuildingsAndImprovementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross [Abstract]", "terseLabel": "Gross Carrying Value" } } }, "localname": "RealEstateAndAccumulatedDepreciationCarryingAmountOfLandAndBuildingsAndImprovementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts": { "auth_ref": [ "r397" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost capitalized subsequent to acquisition for real estate investment property, including, but not limited to, real estate tax and insurance, by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Excludes initial purchase price and improvement, and real estate not held as investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Cost Capitalized Subsequent to Acquisition, Cost", "terseLabel": "Costs Capitalized Since Acquisition" } } }, "localname": "RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationInitialCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost [Abstract]", "terseLabel": "Initial Cost to Company" } } }, "localname": "RealEstateAndAccumulatedDepreciationInitialCostAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements": { "auth_ref": [ "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial cost of buildings and improvements for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Building and Improvements", "terseLabel": "Initial Cost to Company, Buildings and Improvements" } } }, "localname": "RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand": { "auth_ref": [ "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial cost of land for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Land", "terseLabel": "Initial Cost to Company, Land" } } }, "localname": "RealEstateAndAccumulatedDepreciationInitialCostOfLand", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateCostOfRealEstateSold": { "auth_ref": [ "r404" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investments sold for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Cost of Investment in Real Estate Sold", "negatedLabel": "Sales of real estate" } } }, "localname": "RealEstateCostOfRealEstateSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateGrossAtCarryingValue": { "auth_ref": [ "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation, of real estate investment by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Excludes real estate not held as investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross", "periodEndLabel": "Balance at the end of the period", "periodStartLabel": "Balance at the beginning of the period", "terseLabel": "Gross Carrying Value, Total" } } }, "localname": "RealEstateGrossAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails", "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateImprovements": { "auth_ref": [ "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in real estate investments related to improvements for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Improvements", "terseLabel": "Improvements" } } }, "localname": "RealEstateImprovements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": { "auth_ref": [ "r367" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails": { "order": 2.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes.", "label": "Real Estate Investment Property, Accumulated Depreciation", "negatedLabel": "Accumulated depreciation and amortization" } } }, "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyAtCost": { "auth_ref": [ "r368" ], "calculation": { "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails": { "order": 1.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property, at Cost", "totalLabel": "Real estate investments" } } }, "localname": "RealEstateInvestmentPropertyAtCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyNet": { "auth_ref": [ "r368" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property, Net", "terseLabel": "Real estate investments, net", "totalLabel": "Real estate investments, net" } } }, "localname": "RealEstateInvestmentPropertyNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetInvestmentinOwnedPropertiesDetails", "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentsJointVentures": { "auth_ref": [ "r368" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The book value of investments in real estate joint ventures including direct and indirect investments.", "label": "Real Estate Investments, Joint Ventures", "terseLabel": "Other real estate investments, net" } } }, "localname": "RealEstateInvestmentsJointVentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Real Estate [Line Items]", "terseLabel": "Real Estate [Line Items]" } } }, "localname": "RealEstateLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateOtherAcquisitions": { "auth_ref": [ "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in real estate investments from acquisitions other than through foreclosure for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Acquisition", "terseLabel": "Acquisitions" } } }, "localname": "RealEstateOtherAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateOtherDeductions": { "auth_ref": [ "r404" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other deductions to real estate investments, excluding sales, for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Deduction", "negatedTerseLabel": "Impairment" } } }, "localname": "RealEstateOtherDeductions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateOwnedTextBlock": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for real estate owned (as defined). Generally, the largest component of real estate owned by lenders is assets taken in settlement of troubled loans through surrender or foreclosure. Real estate investments, real estate loans that qualify as investments in real estate, and premises that are no longer used in operations may also be included in real estate owned.", "label": "Real Estate Owned [Text Block]", "terseLabel": "Real Estate Investments, Net" } } }, "localname": "RealEstateOwnedTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_RealEstatePropertiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Real Estate Properties [Line Items]", "terseLabel": "Real Estate Properties [Line Items]" } } }, "localname": "RealEstatePropertiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OrganizationDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions.", "label": "Real Estate [Table]", "terseLabel": "Real Estate [Table]" } } }, "localname": "RealEstateTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetPristineLeaseTerminationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateTaxExpense": { "auth_ref": [ "r261" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A tax based on the assessed value of real estate by the local government. The tax is usually based on the value of property (including the land).", "label": "Real Estate Tax Expense", "terseLabel": "Property taxes" } } }, "localname": "RealEstateTaxExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable [Domain]", "terseLabel": "Receivable [Domain]" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueonRecurringBasisDetails", "http://www.caretrustreit.com/role/FairValueMeasurementsFairValueandCarryingValueofFinancialInstrumentsDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesFairValueDisclosure": { "auth_ref": [ "r22", "r39", "r346", "r365" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables.", "label": "Receivables, Fair Value Disclosure", "terseLabel": "Loan receivable" } } }, "localname": "ReceivablesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetImpairmentofRealEstateInvestmentsAssetSalesandAssetsHeldforSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfCarryingAmountOfRealEstateInvestmentsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate [Roll Forward]", "terseLabel": "Real estate:" } } }, "localname": "ReconciliationOfCarryingAmountOfRealEstateInvestmentsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfRealEstateAccumulatedDepreciationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation [Roll Forward]", "terseLabel": "Accumulated depreciation:" } } }, "localname": "ReconciliationOfRealEstateAccumulatedDepreciationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r62" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-term Lines of Credit", "negatedTerseLabel": "Payments on unsecured revolving credit facility" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments of Senior Debt", "terseLabel": "Payments for redemption of senior notes" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtSeniorUnsecuredNotesPayableNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfUnsecuredDebt": { "auth_ref": [ "r62" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.", "label": "Repayments of Unsecured Debt", "negatedTerseLabel": "Payments on senior unsecured term loan" } } }, "localname": "RepaymentsOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock Award" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings", "terseLabel": "Vesting of restricted common stock, net of shares withheld for employee taxes (shares)" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings", "terseLabel": "Vesting of restricted common stock, net of shares withheld for employee taxes" } } }, "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r138", "r139", "r150", "r155", "r156", "r160", "r161", "r163", "r221", "r222", "r339" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Independent living facilities" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.", "label": "Revenue from Contract with Customer, Product and Service [Extensible List]", "terseLabel": "Independent living facilities, revenue services" } } }, "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "extensibleListItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r45", "r83", "r138", "r139", "r150", "r155", "r156", "r160", "r161", "r163", "r175", "r294", "r354" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Total revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r311", "r312" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use asset obtained in exchange for new operating lease obligation" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]", "terseLabel": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense": { "auth_ref": [ "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of depreciation expense of real estate investments for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Depreciation Expense", "negatedTerseLabel": "Depreciation expense" } } }, "localname": "SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SECScheduleIIIRealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Cost Capitalized Subsequent to Acquisition [Abstract]", "terseLabel": "Cost Capitalized Since Acquisition" } } }, "localname": "SECScheduleIIIRealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ScheduleIIIRealEstateAssetsandAccumulatedDepreciationByPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r130", "r163" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue, exclusive of operating expense reimbursements" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConcentrationofRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesTypeLeaseImpairmentLoss": { "auth_ref": [ "r177", "r313", "r314" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on net investment in sales-type lease.", "label": "Sales-type Lease, Net Investment in Lease, Credit Loss Expense (Reversal)", "terseLabel": "Adjustment for collectibility of rental income" } } }, "localname": "SalesTypeLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRecentRealEstateAcquisitionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r33", "r85", "r213", "r216", "r217", "r218", "r304", "r305", "r307", "r357" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Reconciliation of Weighted-Average Common Shares Outstanding Used in Calculation of Basic EPS to Diluted EPS" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EarningsPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r241", "r250", "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Stock-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of Debt Maturities" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r26", "r193" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Quarterly Financial Information [Table Text Block]", "terseLabel": "Schedule of Selected Quarterly Financial Data" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRealEstatePropertiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning real estate properties and units within those properties by ownership of the property.", "label": "Schedule of Real Estate Properties [Table]", "terseLabel": "Schedule of Real Estate Properties [Table]" } } }, "localname": "ScheduleOfRealEstatePropertiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/OrganizationDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRealEstatePropertiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of real estate properties and units in those properties that are included in the discussion of the nature of an entity's operations.", "label": "Schedule of Real Estate Properties [Table Text Block]", "terseLabel": "Summary of Investment in Owned Properties" } } }, "localname": "ScheduleOfRealEstatePropertiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r242", "r253" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock and Performance Award Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r35", "r81", "r121", "r122", "r208", "r210", "r211", "r213", "r214", "r215", "r216", "r217", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r14", "r15", "r16", "r209", "r210", "r211", "r213", "r214", "r215", "r216", "r217", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Summary of the At-The-Market Equity Offering Program" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r80", "r144", "r145", "r146", "r147", "r148", "r149", "r161" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Disclosures" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior unsecured notes payable" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited (shares)", "terseLabel": "Shares forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (shares)", "verboseLabel": "Number of shares granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Grant date fair market value (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Unvested, ending balance (shares)", "periodStartLabel": "Unvested, beginning balance (shares)", "terseLabel": "Unvested stock awards outstanding (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (shares)", "terseLabel": "Shares vested (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r240", "r244" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/StockBasedCompensationNarrativeDetails", "http://www.caretrustreit.com/role/StockBasedCompensationRestrictedStockandPerformanceAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r80", "r242", "r245" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Share price to the public (usd per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (shares)", "periodStartLabel": "Beginning balance (shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r36", "r88", "r89", "r90", "r92", "r98", "r100", "r120", "r176", "r212", "r219", "r254", "r255", "r256", "r268", "r269", "r296", "r297", "r298", "r299", "r300", "r301", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r88", "r89", "r90", "r120", "r339" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r15", "r16", "r212", "r219" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of shares (shares)", "verboseLabel": "Issuance of common stock, net (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity", "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r15", "r16", "r212", "r219" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock, net" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Share repurchase program authorization" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r19", "r20", "r83", "r170", "r175", "r294" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets", "http://www.caretrustreit.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r82", "r219", "r220" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StraightLineRent": { "auth_ref": [ "r70" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLeaseIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between actual rental income due and rental income recognized on a straight-line basis.", "label": "Straight Line Rent", "negatedTerseLabel": "Straight-line rental income", "verboseLabel": "Straight-line rent" } } }, "localname": "StraightLineRent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows", "http://www.caretrustreit.com/role/RealEstateInvestmentsNetRentalIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r302", "r327" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r302", "r327" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r302", "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r302", "r327" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r326", "r328" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityAtTheMarketOfferingDetails", "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TradeAccountsReceivableMember": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business.", "label": "Trade Accounts Receivable [Member]", "terseLabel": "Accounts and other receivables" } } }, "localname": "TradeAccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/RealEstateInvestmentsNetLeaseAmendmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r16", "r212", "r219" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Shares repurchased (shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TypeOfCostGoodOrServiceExtensibleList": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of cost from product sold and service rendered.", "label": "Cost, Product and Service [Extensible List]", "terseLabel": "Independent living facilities, cost of services" } } }, "localname": "TypeOfCostGoodOrServiceExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "extensibleListItemType" }, "us-gaap_UnsecuredLongTermDebt": { "auth_ref": [ "r33" ], "calculation": { "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Unsecured Long-term Debt, Noncurrent", "terseLabel": "Senior unsecured notes payable, net" } } }, "localname": "UnsecuredLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r123", "r124", "r126", "r127", "r133", "r134", "r135" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Estimates and Assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/DebtUnsecuredRevolvingCreditFacilityandTermLoanNarrativeDetails", "http://www.caretrustreit.com/role/OtherRealEstateInvestmentsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r102", "r110" ], "calculation": { "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "netLabel": "Weighted-average number of common shares outstanding, diluted (shares)", "terseLabel": "Diluted (shares)", "totalLabel": "Weighted-average diluted common shares outstanding (shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails", "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominator:", "verboseLabel": "Weighted-average number of common shares:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r101", "r110" ], "calculation": { "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "netLabel": "Weighted-average number of common shares outstanding, basic (shares)", "terseLabel": "Basic (shares)", "verboseLabel": "Weighted-average basic common shares outstanding (shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.caretrustreit.com/role/ConsolidatedIncomeStatements", "http://www.caretrustreit.com/role/EarningsPerCommonShareDetails", "http://www.caretrustreit.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 16 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=SL77927221-108306" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4437-111522" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5066-111524" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5111-111524" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953401-111524" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921833-210448" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922355-210448" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=121558832&loc=d3e400-110220" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35301-107843" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r276": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20,22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121549951&loc=d3e39896-112707" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121604053&loc=SL77918607-209975" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121604594&loc=SL77919101-209958" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121605909&loc=SL77930333-209968" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919311-209978" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919352-209981" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919359-209981" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919359-209981" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL117410129-209981" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL117410129-209981" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981" }, "r324": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "14", "Topic": "842", "URI": "http://asc.fasb.org/section&trid=77888298" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r328": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(14)(d))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(d))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(1),(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117337397&loc=d3e23415-158514" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117337397&loc=d3e23439-158514" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117337411&loc=d3e23528-158515" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=d3e9120-115832" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column B))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column E))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column F))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13728-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column G))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 6))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 6))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28)", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r407": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r408": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r409": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r410": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r411": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r412": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r413": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r414": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r415": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r416": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r417": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r418": { "Footnote": "6", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r419": { "Footnote": "6", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r420": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r421": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r422": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r423": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r424": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r425": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r426": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r427": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule III", "Subsection": "04" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" } }, "version": "2.1" } ZIP 88 0001628280-21-001797-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-21-001797-xbrl.zip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

:%WL?0-H?M%(,BKX5#"-.%90J"2&9H\&29A&,$8QQ2B. M.%)!"_Z[C?@YT'<3SP:\W(@)(;?;+(T'XNR;(X^.@UG**4)T^^*8)V#DY MXT\*V^G3_GSP3N]=?I_:]S0OZW&NJTINJVO]3N=-KIE^,GZ7M'HLI3 [)OY8 MEDTVVL=B4W9_K>,./^0;>;.5]]6*QDD:!=1\+E(.$4XE9!QG,*"9C)7>^0@< MN7R91Y5N:1]RHUSW^6[TJY/-#C0$G8J-5Z+5JK[J4,TVBO=/HRFH575T*XW[ M$-@1Z4];VHEY]Z>LJC,/3X+^F+0]KH"SLOPDV+[\*$PSB=\WY*W!9;,MZWW] MY[SZZ]>\XNO"B+"/:B8B$2)3*4QB02$B*H0T4PPFBG,9I1&.4Z=-F\VD2V/\ M(YF-*6OD=J-J*ZSM&'AL!"4N$(W)?E;SSDIJ+DB\Y"JG M>R]NZV:.4S6]26$V.')3-=V0RU(_2_5I0/7F>7_-IZ;TUK4Y &BZDTF)%)4* M094&)OXB9I!BS5B4*9;1.,YP9.6L'UVRI9'94>LS(S9D1FYPJ!PXU,ZT1CN\ ML-40U"I>W&;NPF6WH\R?LIA3.PKF7<=+VMZ-@_E$3?(N%.YGM=0;!].>!GPC M3>"9@BVKJBAO'Z3Y^&SN/FC#6+9S5%^+-[+)H)3BJWXHI"FY6*THII'(D"F, M2 A$.%$0HTS 2#',*8MHD+@E8SN+L#2FU\]^[)AJ[0Z['0%/"^;$3-L(?P5V MXH-:_JL=@VX+P"3H=+AJJKS6JHR8BNV-X*A)V>Y2S)N>[8W2JT1M_Y%\RIF; MX9L.RFW;^.>O](?Q"-2G_CC%0B4!ARE+D#9N PQQ3"C,!$9?#XVG51C'J8S"# 8BB2#B(H(4:<,F#17EBA(JD7UK++>YE_;Z7M_=E?+. M1'C06F9@O#2@-/L+\2C!XT:O +BGE>D=L3;4Z?!!=UP5"]MH.JPG9HE&\-T7 MOI,=-,*;PUNSD].@?RW F_VF;CJP':RIZ4"?R;H:&WPW>\L/OE[[RW'(^>PQ M/UV/[#//(?PYIO5B)%/!5(0)EQ M 9&0$K(T26$J$0U5' 4J<S%;X\5(.@Y8#A;B.*#-9 WZ@N=F M]0U#TFOA]=P^GS4WK,.1Y69QN0=;7C_)S:/\>")/-LBR*$L0C#&EI@RV@)1B M;:@%.$@$R51B5U.V=Y:E,64C)_CHFQU[%DT+:AP#HXF)L8,'7IP/>Q8H!UH< M ["92/'D/;F^?AP2/XC-AR\V&_'^K'8RNH3?3;1+KNH[GV$ MY"K%28A5F,&4)$Q;D"K5%J3*($8"(9HHHD(K"])ROJ7QXQ>YR;7)^+BI3.RZ M%&!CY U-+_5_N3&UO\V.7V_*.;O)_UA^;M\6F*M:Y:"+P-N*3?M:Z#]&M>I]OZ(;G M=/W%I!K6\2G7K-J6E&]72B8"4Z8Y2&8<(AIQR%! (KDKD/%S,YXIQK8ZP;^[+1S=,"-L\YV!#C[ZDU,DW,MG#.CC@KT MF+P[CF"SLO.H6+[D\'$']VT\]^6;7*^[IF@QDS*EDD#.0PRUK6C,1JZ@B$@4 M()K1E%F'J[P>?FG*%-UJVI8)>NV[HFPC!&U-1]H4&L(.(DABPA%$H5D305 MB6D MGY/Q;X'$V41^FWL]DV/EG1GULWPH2I.#\$F;)_RY^7.?-*YP+ *J4IB*S(30 M40)9'&2FOEI*2,)PR *GQ%>;69=&-JW0!_X1RU0!-ZSM>&=T!"81DW^M)IXWL1.%RQ>)6TZW7QI:<=]T;$N:O^CW)K><2FB M,H:9DJG>MO 0DDQ@DWV9A &76 5.GJ:!^9;&/W7M-=D4:,L/VTMN_-M+G@8Z M#668220@#B,"D8IB2&-DS_N\ M!W7CPC?Q"Q_ MN@/J+L6IOQ/J!04#>W&9IF+@Z2E_4LG 7OW/UPSLO\TGQ33?R%OUMI0BWWYY M9(IR4W7J^2W5SXO^[W7UJ>G.3>_T9==/-%_7O8CE4[%^TA\5T\0J;UZV%45* M"I$F4'.1:13*4HAI3& 0A$&8XC2.E%6;FY'E6MI'X4 ;P%MU *W PTXAXY6F MG4J@['0"?*^4:]?TL=>ZGP9_X@I.3)=&*1.:UJAU!0X4NP*=:N"Z GOES.4[ M]$W9^REG,E]\Z[IH[9P*,CWY\Y/-YT,V89CX[1<4;R^,/[ MG@F]>?Y0-&'NUS_R:A4''%.E DA"*:$)'X(L81)F+ M2SD.FN%6>Y+D)EO;I M;,]!V#/HI 1_&CDM3]?/XFA[/.2/SCP'1 [ >)P2G=;^XG.B%\/.?%)T6JG7 M9T5GKO.PN&^_;TS&G&B*R$CQ(3Y@^ED";R%:3L^G!/S0X.D MEAAT(H-&9K 7VB<*VQ)2!TMS?&AGLB+'@=C-.'0#J]?PLQQJ/J/.3;$D*F]E5&(. L@R^*@MLDR*4.$&'6SQ Y&7QHO MM]9&(R&H170UP ZQL[6^/!&9Q_2R L/#Z#JA],46U^&8,YM;)]1Y;6N=NL@G M,ZVN2F":\-8UI?2&S&1\K"@788:R!*(D-FY*@B'A80@923(5IDR_L?;%94[/ ML;07=B\ET"M5AR>:PAIE4WG0;6PG"Z'*Z)W^8#I)J:;ZV(EZ/C MDI=V,4IS9:6YHN68C]:+0W\VVNE;9\Q%ZY7].!.M_U(/YGM3YN*N/O?_78J< MT_6'0O^],\;#0$E"*60X#4U%9 YQ2B5$J4@S0B,5$_N\W+Z9EL:">UE!*RRH MI75XMWN!M>"_L>":F 7/(>6S1>Q_%NU)<2SH9J)&?PC=.-(&EEZF[!U@/KZT MT>.(-:UN<-_:_=H^'E_UK:N,9IA2P:%( JSM11E!FFJC.HXSKFDR1EEL=:+] MW =?E7'06OB%]1B' M"U[KGL%G>\F'%3Q\Y2VN]MBMO*45%?(3_6=K%"(:A,0<=4FEWWT4L0!2RA%4 MD4R$WJ,P'-J??+T8?&DONQ$/" FT@ XV]4O$+'8>%^ P\6M\ ('/_N(E%@Y; MB@LPF6D7X82-V\;AC/*]>X67]\RW/3@C[=&.X-PU?JD--QM>&G?,K[+Y[\WF MFO/B<;/MJGM<;X3^3?DH#WNUKC11I8BA",98,QABD8 4,PD3'F:!D$PD*G/) M>/ 38VDTU\G<%?JI#_5I(S98[^5VB]7W7*)^MIP/^*G-HU8!\$NGPM] O@&[ MI?ATL!2M(H=]K<<+^K\,R3%S 3PEF35%X#*T7F8.7#B:AS7W6TDW5-!]HL)A M2<@D2S&/,DA#:A+@J828Q]JR0R(C*HVX95+JT$1+H[]6U(,$&]>ZD'VH6EA_ M(V$U,6.=@N99& MFK5LP+%5:1^6=G;?2 A-3)6'54$:0:] "]B4M4'.8S))29 3T_V<2B#G]3Y; M *3G%@^K:M^!^;JJY+:ZYO_SF%>Y^9Y4=6?E?34*31=IFBD!HS0R]3XD@LPT M*N BHXR(5*7<*N?><=ZET<=A(_3#).=##1P,"H<%L+#'IH%U8L[9(6J2WVJQ MC\!L>\5;506Y"%\'^VT:G&MU]YS&&X^\\]=QR-KT.-V#]9_ M7Y@$_WPCO^B_R>U_:!K;?GM=\CY 41I2B6$0:-I':1I!AC(% Q%'!*F$A\+* MY^@PY]+8'I'M-]!(#!J1?3LP6&)N0?+C(SFU46D$!D;BLU"NN<]NW!)3!V(? M']N92'TDC-T(W0VM7C*W'&H^(G?3[8C$'6_UV]U_.,@>;Y]SG!&299Q#P4V* MD*3:0@\1@DG <(#"5 :8NVSJ7T^Q-'K^^Z[?PT$UDUK>+I73LKYO'ZHT8RQ6 M!*92;WD0B1"D@BCP6DG9_D,G F M_I(9X>W'=(2[SHSX M1)]KQ^MA@]FOWV0IJ=J:\LHJR@2-.>18F<0&$4.*$88RR5#"B!")6UL+=Q&6 M1KM[R1Q)P1U\2]*8%-*I2:46_@KLQ&^2GJY JP'8%H#MVU-?@5H!\%^2EN"] M_LV([.,-XZCLY"[%O.SEC=(K=O,?R6/7___*34X;8_1Z(S[+;Y2U7V8>2Y)2 M@F!&S?FYQ#%D,DEA@M)8DYM*26)?8>_L-$MCL5K0;IMDHE5J61VVG^/??YN^?;9@]J<+2S M'K[:)Y]?[Z?*CX]E98JJZ2=#ENVC23,51>94/&6(0H20"1A/-#E=7YHP M&=MG])^996FL6,L)6D%!(ZE+EOHY,"TH<0R()F;$4^AXM9D]!Y-+.O\(<,V5 MT.\%FV-6_P <_7G]YVZ>,;-_0/[CW/ZAB\>KNU_]KR+?;/_0/YD^%ZLPHSQA M'$&*3,G7!I#WFZU.0[*24O#OP#=;A<\+I03 M,^GI O$:OUI@T$D\;8WXT^A,72;^Q:P_O5+\:11LBL6?N=,G6:\LZ)9N_LC7 M:[HKXY!1R14F$0PY99IKL@ 2Q#779"A-A6 J2HE]QMZ)&99&+:V,H!72)5WM M%'X6-M>EJ$S,$B\ \4KD.X6,2S;?A0C-E=+GBI1C6E\/"OVY?:=NG#'!KT?N MXRR_O@L]".UFL[G>OJ'EMMB\+:7\:Q=30Z@2IORNB;E&@920X@S!.$)!&&<, M<6IU1MLSQ])(34L)Z!8T:N7O\R++B>/ M<2DQ26":1L(462&09 B;N@L9BWD6BTA8$]V929;&='LQ02NGPVM\#D@+IAL! MGHFI[C4R/DQW#B('JAL!JIFXS@N.[W(<),Q'$4PE2E""),%&0959 CP;- $A$AJQ+ YR98&M]U\@$C MH%/+E+,0VGFZ+@%F8J9SPL39B75.\3%=5J_FF-5!=4[#E^ZHL]=Y=K_>)5Z\ M>:SRC:R.4B_>/!_\K<[#6(41(D1%%#*B31L4<@IQ(#E4/,2<97&8V?FF? 58 M&A<V)WJAMMEUE MF+?CMB="KYIO^X[CQXH'/>:N-^)ML3%A:MJ,,N6.LBP1E"*N]W;2-"3A'&(D M(AAA37V*)&FHG$H(],RU-*X[$+4.'..'PH)?/A;ZRQ\&EBU4;;"V([&1$)S: MI?\"O",YQ^,D"S#&I)^^Z69E&@N]7Y**S2T>GJ$_I+ZR]J>_3LE+:410QB@4 M*%6:/% &94,1F'&L@A'+.'VWJ&>B9;&'+6HS1F-;R)I'ZP6OJ*1P)IZ%W4& M)Q^O41]@#IZCD8";R7OD#Z";#\D"E5X_4M_]\_F2++0X\B?97.^Y#_U&2_F& M5E+S\/V#W%1-;]"RU(LKS7/SYGE_29LK[^),N\$.$JC7@: M8TEA@#2W(B)2R&)B:A^'A/,PPC&R"F"=0KCE,7,M'7BHQ0._Y!OP+&E9.5IQ MHZZ?Y=[U)ZW*U/M:([.V"K30X% Q<*"9V=D>7M=E3-6:737_ =W*-BJ.N.N= M /=1=\1CRC?O;GD"9%_MI*>8P[-0WV.YR4T$G;:^W^<_ZEBZUCY)F&(L1GI7 MG8011";ME,08P81SBI-(QJFTLI.'IUH:']]LMO*N-#&B__.8/QCTK\!.^GKC MV,GO6,GO/-AV=#L.A!.3YVFDIBCA-XC&J!7\SL\V;P&_0:U?U>\;OL.W7_"U M$'JPZHL)S;TMZZ-.K<0*28DSAF(8,&6J@? 8$LG,3X33,.$Q3ZR[W/1-M#3B M:!OGML)>@5I<#2GH!';M*7P&WWZV&!.UB;G"'S"/OL/]:%S<@OC,\#-W(^Y7 M\G5CXH'K9]Y)F@_N]OEF4VW+VE-1U0DO7[_1S>U#?9 M"@.H!,L@,@6(",LX3(,,"XZ3(.#):B/O3,OTKS-L-AWEMWH32?,FOM)BVOVH MWM'\4AD=9]N%NJY]I&(FE"D5P#.]]@F)]$I7!T[_$HD_LEIAP*9?OLFB4!P?:@R;?<*OU!RT 5Z!EAWRS'*^&Y[(MPN/A M*ON_AC?$,\FA,>8[E[34YNALTO8>OUUE3>$' 2--D&66!FE""8%9G&*( M IQ"*J,4AGHCF.$@TEM$IUBPD[,LC5<;N^PPG,DKHO4THG8V]L4X34RC[A Y MVZN]$(QI7)Z>:%9+L%?7EV9;_\4^O6),J>6ZC]^M4MIBV]Q=/VZ_%67^3RFN M[TWSOQ5381"E80B#E B(>, A34,,12AERB*5B= ^K&MXOJ4QPEX^0._NRMI9 M!(I6>/!0YKR.TN9Z4?2FL-H6W"43V@)_"QML7%2GWE#OA 6=M%?@ .5&X'$Q M=&D#,RJ6<[5_N0Q3QY8OU@CUMWH9'F;&%B_6.AVW=K&_S8.]G?[R M\;TIU+-]UK9U%T,0(402*?4'+32Q7WH73"CFD+&$!!RK "/[*CKGYUD:&7>2 M BTJ:&1UW/'V8&I!M.,@-3'!G@')9XO;@Y8#I8Z#VDQ4ZHV>&XD.8])+GCVW MST>:PSHJLJ5$HA2A,,*0LPC'D8"A($) WM MNT8?#;TT*FR%56;.,+ I<:$+Q9S59:PQ<2QG,0I MM?N+2!S=,6/IB%.2'A>,.'F%SZ9Y6VSDFS(7=[(MU]H5KC9-=>J%/JK_RX4D M,>$)I#)-C"#NFIM]@G0+X^![(/C;JB[;+_G@[UN3;CXZ+ON#GW@Z]_I^XXYHS;=C]M MC_?PGF/X?#CJ$*";JGJ4XM?'UP?]YM0!5>"7QTKL_VH9 M7N6^&C;?BXDPGOICT82I-7*#1O V ND*=-C7PIO?-G%.4Z'L\IV8".VY/A)C MHN[XB?! KO_[X#+@C!\'#SV/OPP^ WA\%C[+.[K^7%!Q+I(D0Z;N'$Z@_A-! M)$(!680B_2E(E,A$'!*$K3\%0[,MC?YK>8$1^,)@IT&8+3A^3/ FYO5^W'RL M_D$ '>A[3"!GHNQ+ 75C:5N >IEY<)#YV-A6GR,&MK[)C76K))"I((8(II%D*4D@I&21(9IP*BRLKA/#[\T7NV$0:Y?N:\'(^)J=(6"NLWN%_CG@@F?>-!])+^V\O(I3,CS_(>]VO5O;@#5_F% M*-YLN![J*_WQJ5CG_/FK_+%]HT7Z:Y7&08K,2QI@I7?),4,01UD 0RX#D0H2 M*[M^?D,3+>WM;>0$6E#79/FS4/:_Q&,"-/'KO,?F"C12@C_;_QIQ02WOB.&* M0Y",&;%X=JY9@Q:'-'X9MSAXO1\K='V5;]7[?$,WW#3.*ZIMM8JC% ?Z_S * M>:@W3"K5&Z8$P1#I[5(8I"FC69>^:L<+YZ:R>NR/,TVG/AAN)351B4(J6992 M -4)#;B1VHTQSL)LQQ@703?3B?(!9CLAP=M>J)QI8@B',6GB[%RSTL20QB]I M8O!Z/YJX%O_]V/:V^UI<"U&7TJ7K3S07-YNW]"'?TG7MQ&$O$^(^RZ;TKOPB MRZ?&VY,7XK/DQ=VF'N4/NGZ4*T4Q#;79 ;-$U9788L@2Q&"B9!"%4O(@3EV, MD*D%7IHQ6'VCG1EN3+[L=_2UI,2>FT>M/-V^O M3F="[S-+KX"V!DJI_QFHHJQ)%ASH-![?S@7\F+P]N2?YIS/77[X&NKY7FW_^2M'R?/\F5".* MIED,I:QKM"MDFM=3F%%$1802'K/(Y3OC*\C2OA]?OTE-*,HZ8NCBA;!C_CG@ MG9C1C0K0Z ",$E>@5>/Y"M1P R,R,#*/1]N7HC8F'7O+,BO-7HK82_J\>#S? M1O5/E4J\A#AJ61XQ3'V] M&$9;$3MJG!CGR8]6:^F!>15!)S_XKA4 G0978*<#Z)0P'LGQ>/("",>D2!\Q M9F7'"W!Z28R7#.41%_)5O\+?WM%J^_JD/5(!BQG%,$ZT_8=4%$',> ))2@(L MLB@-!+.."#D_S]*XK984&%%]@T!Z,.UGKA&1FIB=SH#D$_'1@Y9#K,&-GEMXQS FO8$=/;?/%](QK,-1,(?%Y1XD^:8LBK]4+M=MC$@7O-TU)>(1 M$0E14$14$V40AI E20Q5&F=I1IGF3WNB[)]K:62YE[:+5]HEVCA0P "^%J0Y M'FH3$^=KP'9I&S[D.8"< X&.A^!,)'H1DFY$:H=-+YD.##$?H=KIR<^ZA>O M-$]R?>S!C+ U(8M&7"!IN:FM#=HI";;%45VA5D\'"O)?0PM>GV5E)J9\K0-H MPX6,%F"G!OA:@$81<*@)J%6IV:Q59I;5K\LM;J_&WP MW7C]7OW;2-^9BW'M_03YCS[?U^EB!(X^7)>/YA[S_47>F:?V-UG+ SZ/9__$8#:.)OPUN\#C%A@^J?VF(^/D)9HL4']3Q,&!\^&*/#(^BW-[1 M.TTP=%/=;DS-H7>5::D3]++O,G,]2['_GVO33A3%P_+BLB)1/*=/>AG$*440HQ,BTHJ0@3 MBF46<&E?/K)OJJ5Q7?-RE#MI@=3B B7U#N.AD=BEA$0_RA9[Z-&PFYB6&MCV M@IKC;8V;EO4*M-*.!IM+9(_CQUV]Z3VT\ M;K<;$^&9;^H/WJWZ8/(Q5J%$(4H#"F5"$H@(#B#&D;8-22#3($MPQIU:OO1- MMC2.JH4"V[V[C1B.K_ZQ, MGPAM_FA**=9U2#:O1>\BLY\=$[('%\&.:4:%=F*ZZ61M@J[KO!1#UJ"6US!. M(_&(Z=JVX(R:MSTXZ;P)W+88O,KDMK[1)^1/TB=9ZG'D7RD 0_UA@S1#-E73AV8;''DLQ?WHJB_ 8@M7%LC CQM;2__PTL0Z/^XLK_B@6MU[/7RA3Y>D4C[07+S[82H=R$JS1-U*U"2J;:N7 MA> 2' =)2E,8*)5 ).,$XA0QJ+"*@X#'@MN5&7">>6DO?RL[D*WPM2E5U/UO M:2V_2^4RI1 D0E%4RJ4(E:1<2Z3+NT3T(@-N)8; ME$VD55N\JO'MT49VL.[U=_NO@<678 )D)_X(M* :D8&1>5\1K)8:M&(/'"+X M@^K ^Q. .Q/ECP.R&]4[HM7+\K9CS4?PCMH=<;OKO7ZG,XUO]7U[J%"79F?< M]$3%%/*(!! QO6/',0Y@%B6*Q:%,LL"I-N7K*99&V8V$H!/1J;Y]#Y!V1RJ7 MP3,Q[SHBXWQD2U?GH+T7.EAMMVN]:.P^43+O\[U7TDQ M-Z>K)FJ#*8@X$Y $"8,Q)BR41&7$H='HX'1+>^\;@8&1^,).0<-(6YAEH^(W M,3$,0.=S"#*,H8,5-BJ6,]E?%V/J9GI90]1K= V/,I^Y9:W1D:%E?Y>7&[5X MRH74LO]6%H\/[8.,,RFP3%.88(H@BJF"6# *$0E2R@*!,V$5\7)^BJ51[5Y( M)]?<*?"L7)T70C*Y3[.3#]0">C6F/PF.DX/R0I!F\T2Z@N7J;>S!8<"M>.K. M.?V'/9*_G!:_^9;X2V5<_U/[ZN'F1-J>UCB8)0)9)3F+ DA"@+.,02 M,1AJ*S-4-(AH8M^/TFWNI3%A+5[]D7=YVQWQMN#(Z5"[WF6QUU:$KD#<-O'^I MN\]7EKG#%A#;>1O' 6YR\[C#[$N#V5'O\S$#MH? &#=2^^QL,X=H#VG].C9[ M\ X/$_)T/Y6#OC_L>7])VQ;H^CLMQ<=B<_M@KFURX&XVU;:L/WW5'[+:2KUY M;YJP_$/F=]_TW]ONZ^]^R)+G5=.%?<6D2D*91%#A4$&49@G$2L90I!*S*$EB MR\XH/U^5I3%>(SGXY;$2X$&6H"8ZEQH)/_?!L#"=_V66>V*>/NS;=8C$8?,N MP)Y/]_%P!C0AL( %MCO(!*%>@?9;R#6B N0(=-*#%!G3@@!J=?YG'S&'/ M\"_SN,VT!?E7>NS<=C>+6.G>S=+/E7"^O=CTH$NS?8Q,CAWE##1V>S=7A2?^^O?J MZM[$[4"Y41NRF7'G;:YVH,FK1FF'_^;Y+LFJ*LK;!U,:/-_KKM\Y=B+58*Q2R)50;CB)NR9E0; MY5D:0\GT8XA4AB)D%5 Z--'2C(%&5%-IXM$(:[83#ZVXH-+RNC0"Z('7PF$Q M$F@3#.42&;W&HSV3J-L%>@ M$[>N>-1D]'C$0@R#Z%)^=TPPYRK!>S&HCH5X;3'J+\8[.,J,!7EM-3HNRFM] MUP7VZM>2;JK::J^YGJR48D5YA@.2,HB4,%UV$J9),--,2+)0H(29.GK. M%N? I$MCOKWI:03_]UIN#[-I"&H'LW-$ &>S/XW,X+9\Y03,31&G5O )4/6P M2D=$=W;S]"*4_6Q52[BLC-:AL>:W7BVU.VG&VM[KP=^?B^]KN=T>UTK=)5"\ MU8^<+%L_6)!D2$F<:CM6FNI7,H*:U2DD3$9A$L:(1YDUA=O/NS06;R5_54QZ MGR#42._ 00Z+8$'NTT [,;^_0/5$VE4CN(^+UP%>!Y:?!N:9B-X6[I$HWAVK M7I9W&&X^HG?7\8CK/6[WVM><_VL/:[U3^)7^5!*GC>/?4AXB&*>02F0 MU 8[9I!E,C8] [( \YBR#*\V\L[<^-7>;S$XL=5[0IKWY-7TT[TK!]*"0W'= MW!'#L',1)+&B&FR$!43&8T2%D% DYFB4\SC2P[5Z-R&M7[:TW/X\\%\*,=T2 MO*'ZKUP"N@7;;Q(P>9=O-B9JR[CQ]2\>:DG&7I!("4R3#$.*<:P7!">0*!6; MZ!Z$$I[&*,R.%^3=1OSLY>A$F&TQI"D!/>4RV#GFQD'T9_6TQI8]K0\NN@+. MQ.3LK[,&=4P/W?"DL_KDK#%XZ86SO_'RSF,F7=6\E+=*/SKW1>/O6PF$XRPC M&.I/2P91EF#(PEA_8!(4I1@I1.W*WUG/N+2]VG&/K%]X46TK4-?]5D7YMYJS M\E8/PV&\UJ3+9-](RV <^P51(D4A"F,8RRR"B"-LNH4PJ"*<1BKA84R2U9,L M6?%3EN1PYND6Y;>RJ"H3*EH+/C;$=E^+46&;^&MQ_!#?'#ROC;S-$#/KZO/7?Z$?ZQV'N!S%$7TUG[WTG!Q2R L:0YZD>C/! M]6:"A1&%&4*4!EBE@EFU?'.<=VD?@,[*,F^+B:S2UE,CMAOMV*)N1SX38#DQ M!;U*DSD,&@1_UG*/VRC#$ZLQ*KMOW9,W/8F\;Y[WEQPF M\M9_F)Q=+5YW\O'N?Q[INBD5;Q)[Z7I=I_6L@D#$"',,-8T%$,4QAR3"'*HD MRD@2BRQ#Q*V\R<02+XT8]V?1T@@,:-,NTMCD"6MJ)3 M^Q/J2A!O^BM&O.DJ1KPY53&B_@]H-;\"^X/@6GO0]LZX6?!CX5IQ9$&/Q[]. M89'3CTGA\YAXE Z9:B%_S]:,YA3K>!6@+!$LB$VV-X 2B%&&($YG"E' F*&8A0['+WLM3 MCJ69')^E>2#S=>/\-*31E62!7=6ASJ'1U$.\?=SJM=R8:O7@[U53L.@M77/C M26U'J $ [SY],?GZ+0KFKV[;.]^%MMONS;!\4]L7![OH3@=3.JI9J*MV%4PD M3+<$4VX)+\1SS"VBKRBS;ADOQ.OE%O+2X3RVE%_+O&@"([B>1F]8N[+K>EDB M$U2,1:8@PB2"#.,0ACB,HS!D84"LRN[V3;(T%C5B.IC>YZ"SV$2- ,C$O&0D M!'L1C3_*)S[L'$8..XH1L)II$^"%F9NM/@!&KWE][M[Y+.(!Z8^,V*%K?0)R MY5.Q?M*T^J)76M5V16R?314E*8EYHB%4*40\C2!F*(,!,S$K21*&W"JIS&'. MI3'A)PU^"7:R[[KXN42&VH%M09;C0S@Q=^YQ>]D$\;K:M4+U";:U@]0ET'9T M:.<*LAT%8L=(6R>P^J-L[8::,<+62;?CZ%JW6[TJW=Q1_OP/66U?]*#8B/T7 MHFM+F7*<9#2"0J:!"0,)(8D3 7&(D4I"S -LWT?<8>*E,7@C.C"ROPP_-YO) MO?A.]5SLU\&"UR="=V)R[P'V^@A8OXHY]@@[U)'63"4$WZH):7V ^&V"G9>V5= PO=%X\.P_PE$LR\9=D#^]5 MMQH[](O-2[0G]?OZHCBFP]=9AED]O;X(O73Q>H_C6?([WY@8R=HR7X4\H2') M& P4R2!*>02)MHAA(!2/DI#I!S9R"Y$^'-[ES9HG&OKOF\J JE^GX3BH]:^G7T0AP13F<%0< :1D!(R+@F,LE1@3CC#W+X+ M^.DY%F>[_/6\[VE__?^9MO8N85*G<;38I5Z.SM0GR*^!\=EZGD'()?3K8J3F M"M;R0"2DA#F4 DDQC23._O%%9ZGTEO3N+PZ4MQ_1R4**0LB 4-J A>#4%ML@8PABE*6:6LM3+"PM]@&YUL:0342 M@UKDKC+.[A/L:,H-@VUCUHT*X=0FW@!Z7O;>,(PNMM^H<,YE!UX,JZ-1: U2 MOX$X/,R,QJ*U3L>&H_UM?D;D1[E]2ZMOG\KB*1=2O'DV4H=^=EAQP+;JI M(%#+;E)6BEV"*MT)[F98.JR%G64Y#<(3D[@!UT@-/AV ^TL;?/^W@W9YU\,P M.]N6[HB-:5PZS#ZK=>F.RDOSTF,$-SX3,E^]VVSS[;.I4U>:)!PA?_RG?%Y) MI;3I& M(122AYJ@8DE1*R&D0'\N+,0P*!: MW7L^?*''=O%M46SD\SXXXE5)RL[+G^*(A $QO8,"B$B"( FD@AC16# :)4E@ MOV>TG'1I+WTC]F&0S^NJP Z['EOH+7:0$P Z,4V\QO)$<5J/K:0MJ [[R0G MG6E3:0/R2/M)1Y!Z-Y6V8\VWLW34[FA[Z7KOY54"/Q1T4ZU$@#-%,Y,PDC"( M.*>0QIQ!CJ,XC01%(8M\JP+6,RR-GH\+J%5RNUTWM0X*!=9:8/\2= V@=OO! MBV":F'2/$:JEFZ:>W)'B4]6/:R;Y:?7BCG3LJP]W?*%/SH$9H&EO;L+N/MR\ MN?W\?ET4Y2>I'PS]%;F3*T)3'K),VV7L'<+L"TLLI$AG)@8:FG!7MPKT.!92WP% M]C*/#*1+WL"X@,Z5+W QL(YI O8H]:<'6(PS8UJ O5;'Z0 .]WG6CGGWM@MD MO[FY&2P%??CSNQ^F'(Y<4#2RL>SF9T=9BU,HR METLU;Y&9T5!\56]FO)$]3.Q_Y)6V4G-Z+OR )%A$) L@8TH;U5D00R88A1'' MDL=!@"FQ;XHV,-G23.M.W MC988@MC"J1P1N8K+LP\S'K3D$GH,A/2*(,QG1 MEX'I9D!;HM-K/ ^-,9_A;*G-D=%L>X^GP2PW>5%^++:RZDK<\)"'6%,KYR9_ M)$H1I(C%QEDI%>9)DBFK_)&S,RR-3QL!P>,N(VQC9 4/]-EL4AQ-V5=P6EJF MEX TM:'9X%,+-^+K/:CZJ';=JTGF-=/.Z?C*ZCI[H5_]ODV^??X]7Z]??Z%X MQFC"< 95FA']FE,,B21$&U1!E"0\"BBV.HX8G&EIKWLK*S#"^MI.OA4D20 ,99&D+$D(24&D-JX8"1SL4V.H+*QH#T!6!JB['5W+[Y3>_2;>T1TSVG2G)#TVXDY>X<8Z5;E=?3%G%&9-?Y/% M74D?ON6HT1":F*QJT^E24DT.55=;GV821*Q!(;$1-]I(P32 M1*4PRL(@$J%^\S.KID#6,RZ- 7Y_7&]S^$663SDW5K21&>R%=JH"9(&WA>TR M-HI3N[\;<4$K[VL(_2HJ66#I5%]I7$QGJ[9T,;:NM9?L<1JHQ&0QT)QUF>SU M>E&ER>%&SW3[MEO5R$.HB1-(RA9FD!D CDP(R%DC"N6 MB"33SY'+D>/@C$LCZ7U#QTX;](/S]G#T) MJ!-S]A[/6MH706\=OXR0 ^L,SJBI\X.3SILQ;XO!JT1YZQL]K,3_91Z3;?%] M\VFMGY4FB*)+^6J_LY0'.$:I@!DU$0\X3"$1"8%IC(DTYZ$J8-8VXO!\2R.? MG<2@%KF+ZMGETCJ8-19@6QB(XT(X,=6<06^7V.EC'5K Z& ;C@OG3);AY;"Z M&8;V(/6:A1;#S&<4VNMT9!(ZW.89<]9Y VZ5*9#R?EU\KZY9M2TIWZYX(A$1 M$D.]08_UAEUI6Y"P #*494'&11!CI[J=?9,MC8EWLM9%MTT]H%I<\&8 2^,$M@$&8+ M>VY,\";FD7[]T^UC6/JG/\H$^UX7%;]6G,M_P_,$4Q/HO24FQ-);6SQYR[#+C!;Z=J3 -6JO&R]!YFV*AK\;4P)U>1:?X7]^+0IS;1H1*Q8Q3 M! 5"Q#2WCB!-!(*IB$.14DF4) X%IWHG6QKU=.)>N-<=@MABJSLB<)-;2^4VFIT4"@G%3_&'.6DK+2YD49*;M[/%AV'_KR MCWS[[9-^/K[12MX^F,?G@]0_OOOQD)?UT_2_Z.:1EL]1$(?O\[+:-A=IK*/V MB4><90$2(0QDI"!*(\W(5!N'&>)II$22<+N"GV,+MCCV-N*#O?R@50 8#:Y MK0,H:B6 T<*!E,9<3@OV_TF+-+TIVD7C&;5 IQ=H9+X"5@MXNU] G\_+F"OI M\"GZ22LZTV=K])4=Z1,W >J]G\,QYYOOTSD!2D>?V2G&]VJ@MWE;F.[G9T]0 M9)RF$0D)3!)6=SMAD 0H@0$/*14L5@39QV\-3K>TSZ<6&+027]P];PAIBV_@ MJ/A-'370#YU?Z[PA#)TZYXV(Y6R-\R[$U+5OGB5$ VWSAD:9LVN>I48OFN;9 MWN7=8ZJXOR\V7[9Z\_7E&]6/S.WCMMK2C9EFE0E&DBB.880IADB0&&+C[\.) M2%2<48J%59J5W71+H^"NQU(M,JAEO@*-U.! ;.=F5'V(]U/Q^#A.3,670NC3 MM;>^&VWD6M1-&N3]P[IXEA)LZ0_];[\TUUAV M:[AX4>U.\>98JHFY;J_""Z)KU.C.^=I?FH71NH!#9<8[]+L4SC&/ KUEF?6 M\%+$7AX;7CR>9QB7-A5OU=M2BGS[ODDM?/YJ4@Y7-%1!FE )LQ0+B'B,(,Z" M" 8D01&6G"5VIQI!Z_CQ6E30R0K^K*5UC+T_CZ\=SXV"VM1GB)Z MN4=;#8$Q:D35V\>8QK[GG>B.Z'V_N33_P.L"_ M6DD<91E/0AB%4C.'X!EDC(50&V2)E)*&Q"X&P7GFI3%))V-59U'F!Y*ZD8@] M]':D,@F@$Y/,0>^23M(:U=U?;FS@=:8<9ZC&I"#[R6>E)&=,7E*4^P"^E*7? M3!*'P;CTL?)F6;F MBCYM7Q-#[]6^><9Z/]7LI'Y]+#7#?))E7H@_Z/I1?I3?ZW^I5D%,,I2&%$:Q MT,P0\AAB%2L8JY % >8!ED[;':M9%\<1!Z':K]Q%KDG'-JC;T<;H6$Y]H&CD M[=PXC<2@$?D*U$*;(.[OS04CVBI.,(V;FFPS\*@1&!B)+PUF M&$2ZGX+&QV]J[NF'SBN881!#EV"&,;&<*YCA4DP=@QEL(>H/9A@<9<9@!EN- MCH,9K.]R#V;X8II\Y=OG,&)?\^U:KL(018&(3*=VH@F7_LUKQZ*JFU(\79-JRI7.:\)OZY!3@@5F2G@+KC> MK2%,,HA#JE]>'$;:2,I2Q:G+OFU@OJ6]RIVX;4.48X&=2KW; FZW91L1QHG? M_HL0=-ZC6>(RYNYL:,I9]V66^K_YI-1>^*\[._&[W2?;[=2W&QX63NC MZ;K[UP^Y_J>58$&$,$*0RY!#A' &68HPS)(X8K$04:#LP\T]A5@:&QV(;)S+ MG)GL#92NZ23>BZ.Q:9N!L@G9BZC ;A]=>Y^!0Z7X4"/@RL^S+0.+NF^ MTZ_'7&G 4ZV+8X;P98#V9PY[CCUC1O%EVA]G&E\XEN>Y!?\FQ>-:S_RJ%'8N MJR:(B(LP"Y5@4 ;F/#.C <0H3F"LH@PS%6*,G$KF6\RYM&].)[+9P)VH[EYW MC_")W+*!W_+X8EQ0IW8@7HZG^\F%/4*CGEM83#OOJ84]#J_.+!QN]>2C=V^[ M26YN;O:S7&_$-=U_HOX53Z4DN?U)[:N=M,VE,S_*<671U;)_WG43/FU MN.;_\YA7>6W!=[6(D<@D2^,02D43B,),:I/:..(XE2'*DC"+K=*'9I-X:5QH MQ <'XH,ON3G-/9#@D[9*Q!&,,)71T3\MKA_H!O] M4E^!@Z"X%[U-3/S* 33@$)LK\/HYV<$#ML7A\S)-Z>RYEG/4C\7D0L_[J9EK M#5Y]J&:;V,,9]&Y3Y7<;+MT79VZ=SSO1+_N1\V'@4L^T+UE517FK=P?49(K6 M=5P^M:5SOQ9OY&?)9?XDQ=?OA2F>6ZU(0J50&,$DXBE$,LD@C:(,QCP,8TH% M1W9]VWT%6!H]VE<@\X;$LBI_=>UZ%=@)WQ3:.H*M/(;4Y1)T&G0%O#6 MBHR84>:)WJB)9JXRS)M_YHG0J[0TWW$N2_UX]^-!;BJY$C0**9$AU-,(;<'% M"61$9C#B<49XDH9I+'QR/MKQET9/NSP&VO=G=X>WA?E-O]G8QRC M,-!O+4': HD(1 D6D" NH R"2)JF<6EJ=?SN,NG2WO)#F>N=&CT0%OR2;_CZ MLJ'E9+8T<78P,^,8<<.]!V C>.M@.1 M1PP5<@!HU'@AFWGG#1IR0.)5Y)#+O1X>H_\T$7T0K?F M/GXGBZ?5W@4U*I8S>:,NQM3-1V4-4:^[:GB4^3Q7UAH=.;'L[_)VVK?/+Z&K$VLCG[G%U=\8MCQ=:?[.UT M]W6U+Y;2; 'Q\:X[^]1_DB=]T']^$/?'M;?I'E4\YEG0L1B$3A M&%&8<*'))DQ#2(7(H$CT[E3_1'!H%7YW;H*E<4XK8[WI:<5TRC$Y"V0_'8T! MS\2LY(&,]?LXI'[/YD_?>K#QTW][N>D[._8L;_"09MV+/'C=Y0T=N](7M^KO MF\JDL)D8!+9=J216+(@RB!AG$ 4)A\P<@4GC,4Y$K!+IU+'68LX%OO4'30BW MW^2IEHZ/G09@:WJOK@OJ&&MFLQB4\I!(*F% D%X,'*;0E/K5]$L%243("S<>R,#.SU]'V!Y6 9G)W'=?7.:-IL# M^$S59_/8 #GV=-H=N=33XM@_EZN9ZE0C%24PB&"J9ZB^ 8) IO:U, MT@ IS*-,<"OR;\=;&K'?%-^II>'6 C)@I[FK.?7)W^T_KDA^X$1JT4M=AA,=R PAJT3W=X=9/LI-?? *@YW.0CP:X MLZ_<$;8AI[GM<+-ZSQUU?.E&=[W=;V?\KFT!TNZUZ^8#;V@EA4D^D9NJF:ZH MTT^DN/YNB.UKL:7KPW\WUGR8N[C8G=;RKIO2_*]E?FNG"%XS!+ M0_UQB&/1?B9PINVL+(X5%3CC8>Q4?'->\9?VM?F'S.^^F:0?JK>C]$Z"4M[3 M?&/>YJ>V,\Q#K8?^AR8[:%MT@6+Z5SO%W+:.,S\R=KO0Y3X($W\W:TTA,ZKN MPFFORU)?4F>J7X&=TJ#6NLT)TVJ"9[D%>T6OVLJE=0.:SQ8/A_-.^.>LT9B; MZIDUF'5__G-6Y^56_R=)X9E<46SNOLKRWC@@?J=;4PTME]5G^="&.]^J3V6^ MX?D#7=]L3+#SU^_%*DP1"I'",,,DA$C$!)*01Y"S(!%2X$A&3DTS?(18VH?, M(\G"!WJ[3\G4@$[\03#B0R-_[<>\ JT*SY-D55P U:B9%3YRS)M=<0%2KS(L M+AG+.^SF2_&X_::?-''0B#O%*:5Q!,/$9,L20B!5BD*2) $168K2P#[@\=PL M2^.J-@IC)ZAC<.-9,"T<.V- -#'[G$+'/X3G!$S.X3R7P35O:(\C;#Z!/N?A ML CZ.7'SW % Y^4_$0S4<[%/,7]M.9:TB6M\Y9*Y56]IQ:G(.S]BFD11G+($ M)I)(B#+-BYBQ6/\U(I%D.!*9?2D!IZF7QIB-\%T4+GWM9S0M!5L-7*K5.RV' M!;U.!O+4+H C?$_X<6_W^'JU!7 "VJ5%P%2 S]4N8%3@'7L'^WT? :<09 M>PKX:'K<7\!KA,M#S=X6Z[7DS20?"KJIFMSGINMND(09#P1,J. 016$$:2H5 M1 E-(IF&4:*\P\UZYEW:MV&W4P'=[L4XINL$<:!?H-)4NI)-I2N3QW5GO-S[ MOG8F^*R[P6CG'P/5MU1V;H,)%F#B[\9Q+-1>9O,]KJ4&GX>1O2@>R@*GJ6*B M^J;^:7%1%GCTQ4;9W.YA]^IWM"CK6K=*OJ6EU'N3]EM/,$=)0A44C#&(& L@ MHYA G(B4*H*84E8--ONG62!G%?9M5 8@M+!+1P%FFW#\W?/9P<.:G!D\PU?[6??O:=Y6?<'O*XJN:VT M.?DA;ZS)7%:_2UJ9B-3;S6<3FEHVL1L?BTW9_?4-K?*VIK1F[8B1+(,HB/4? M"8DA0XI#&@0H4HHIB9RZ$X\FV=+XUBC6M=/<25];@8?R^Q7_'F\Y[:S$G[)( M$W/_2.OC;$F.CN68MN9XPLUJC8Z.Z4M[=?P)/"S:7XOO&_EL/@MOI:EHU!H8 M48 T 3,$L8J$-F=5!'',.,0B2H(L)#3DRMJ6/0.0@R%[.5 S6;$^@+E9L/U0])JO9VZ=SW;ME_W(SCMA*Y\NI:5<7P=>!S=+,D!B.W,PQ%@^Q=J7M#&HFK4 MS_U_%X4HE!ORJ+X2^5R M+=IO9$!"3"0B,*$\@4@D!!(F"4QE%A%!XA0']J[%GHF69I#M1#6OQ5Y8!Z.C M#U4+TVPDK";FGS,P^1AI?7@Y6&HCX3:3N>:-GYO-9@%*K^'6=_]\UIN%%DU]^%V@'V5?[8OM%R_[6*%8EP M+"G$220ABH2$) H#F"9(ZE_%VGIRBB7QDF)I+''8WO*+-.?B4H"=/F"G$/B5 M;BW##B];)3M^F1S[B2GH%,('G ,"(#FK9)^DNZH'=-/U&703Y21U(/; Z MWY/49S _JCSL(9=K"L[9HYFCNMF\^\%E5=VJCU*3,R_N96O,8\DY5AF'2:E3EZ M=7W)#OT7>_C3?Y?__"?5WVK38O?W-EK>Q 'OPX"KSA2*LQAC%$"5Q0BB##-( M<91"3!,4D3#$<6R?G&8][=(XXO?#C(+[3@O/K +'%;#PQ$^"Z\2,LI.Y3H?: M 6S$/L@FJ'S\]/;8.GCM)\%X)A^^)=8CN?*=D>IU[-N/-I^;WUG#(Z>_^]T^ M)Z:;JMB5U//^] MDN)FL^MH?,VW^5,=KGS-])Z>\NT*$3B2'NOHRE+679:@HTT06"U^TO_WOR-:TU-%X1:5<">0;%K)$YW>OY? MCO[)*9X#2Q?F3U[=J3\QQPN[4_#0K_F+4?)OYI^-GN#3P=K^8G35#\#?#MK% M[_4%?W8:C^D3G7!!1G6;3B'GO)[5"9%^Y7R=V6&J1&YM$-J#NTD$.$A,.LA+&,SU>U83P161EY]]Y_L]W' ?UTPC4*H%:)W@[ZPHY&.4SKM1,!OL,*^9FT(\$<:^Q?^D<\VT$1D+C:),P MUI@^WIVCJ*U.D'<_MG)3F>D?ZAC^%8MQ0#+S'612_Q&F(60,9$C% M]M7"[.9<[C=/=I+JKU\MJHM/P@YO&P?/Z"A.[>,YCM6\ GNFVTD-;J="U,71 M,SJR<_EZQD#8T=OCA%6_P\=NJ!E]/DZZ';M]W&Z=/"MTE: (F9Q0&,I40A1$ M"22(9!"'49;&(5$906Y5SQQF]SCAG9C,#[)!QZ(+YW MS@#]*8F?D\0N.4R_U&3/LY%&'D-XU@=Y9)7\GT?]V7SWI/_HVC!D68)2(J"@ M=0D@;82R+-&\%M(L19GD CLE>)Z<96FVYUY(((V4CB4\3@)I1ST7PS.U9WF/ M3"W@!%GDO1",6DGCY$3S5LKHT_55)8S>BQU/L[8/Y>KV/U8JCGF$8PQQ($*( MHH1"G#$)21($B"C,F+**)&C'6]J+?/LM/]^2^"0@ R=#[FI._$+>_L?-[0A' M,<=Z[=^RJGO-*LG_[:YX^G=SI=8NQ/5/T/QT>+#2CC//2_]NG& MJ0%XD@]%N?V=;HKRRU_Y>BU%>ZC\JLM;2_"A"F*18 D#&5']I8REJ?6.((]$ M1B(J1))8-5_WEF!I+]]>!U K 5HM=K$1K]MUNG2.]%DC"S_/U,A/_8$> OU$ M*TF?OIT^Z+NT[YQX%>;JXCG%:C@V\[P R?Z>GCX#S]C:\P*]CSM\7C*09ZT= MH]]F6]8C?LZKO]X\?]4CU:5$$4M#JF*] R-8?V94FD&,L]CD ^(,AX2RQ.IH MP&*NI7U0CD0%1E9@1/4JTMH'L=U6;23@)OX>>&+F7HEG&(U1Z_'T3#=O59YA MO5_5YK&XQ<-H???CH?A$R[_.)XV>@O:NV^3TUT2"[GG.['_9QE>UCS0B1648) M3*3F7*1P!DD<4ABEF<0\2K35YE0;UF7RI1'QOI^CF[GF!+B=_385C%.S1)!$AD90AM8_!'IIM:=2TD_="&W$090LC<4SL)N:C M7MA\K,1!_!S,Q#%QG,E.O!!/-SO1%I]>0W%PD/DL15M]CDQ%ZYM\^V,^--'$ MIAZOW.1%:5J[K *JJ$HC8I*V XBRD$ L3,< FJA QDG&I=5Q4?\T2R/9-K"Z M25\II9#W=6B>,6:J6FBP*;8]=45=$+8S R_';6*"W0O8M)NI43(RCMFZL@^# M<5M6GIQIYE:5?=J^;E'9>_6E/7.O-^(PQ$L^E)+G]2?F+2W+9W/$<%\\;K:W MZ@/=B%40)C"G.:(+B-)61&VOX";(T7OFM-.6#.DF; M/=$5,)+Z=MIU7!A;LID>[JD/F,?HSEL?_1\%K!X T*S;%6@ F*)!KQ_XT[3N M=93E)S7U]4/L?+M?S_%\\I+E]\_RJ5@_Z3'?4VX.:I_;C43$PRA)XPR25"F( M II!%B<*!B2,0ASC+$3V1:W/S[,TKM22@IVHH)/5)=_T/*06>]MQ@)J8Y4YC MY+.=[0'+)>]V%-#F2JGU!,\Q3W80DOX4V/.WSYC=.JC#<>+J\.4>#/E>+_SV MVQ?]H]R>\[DD5*:1I*$F2(%,D41M=PJB<>6*1X(GJ;0K&FH[X=(X$VV_@49@ M7[>@#+Q@)N:AWLP\Z+@ ?!BWHO =&1=.W3Z&7=@ MC!G9UDZ;8Z:UO,?/$7OH>= _KZ7YP3@G[HMRF_^S_OVG8IWSYWWQ0*5PDDFE MR9<3T^M91I &<:RM8L73"%."F%-'%@\9EL;)AZZ]0W4:/]^!'F[>6)_5L7/$ M3HSYQ'1^["W=R?__4_=NS7'C6+;P7\'#B3A5$4(W+R )S)LLV]6*L2U_MKLZ M)NI!@:O%KU))#9F22_WK#T R;U(F$T""-'NBQV5+)+#V KFX 6SL??&*;O!' M9P0(FK@Q (DAUU)]8$RZC'H&3R]74,]IRL,/W90K:;-BM7]TN09V"J"\K^H^ M3];S;903@0HB(*480X1S!DD18TAS@K"@2*2%_3*!8^?ST\0.E]FU72=@7#P# MW86LGZ1HTS8ZN%RN0V'AOXY(\,@"N"W?U.7FZ_[L"T#M%HG2\-<)^UQ6N%W) M=O!W1R1](O\W+/EN_K G>X/^L6N;T_G+GM;N^<^^;?CYT_N]-5U/7XU?:#IJ M?_C%I%1YE+?:6\Y2+A7$491 %!488EZDD*4D8VF<@.?-LYQN.P..WGH(T\:-5H _RB5ZD>>S@?V)VOD*ZO0^^3>KSNK+QT=#U: M\#DS67Z_6TG=X-WGA7ZTCBUG*[?6 MKL^Y:52,5W>@!7SN$4H[RBWEVJY^_^5FS*>M:BJ^KBO_YF=8W=?N1$&T$ MZ&=9?[VC&HLH$H$$DC!"66(6:B6DVLF$2A41S_-$1H75P2:W;N>FX1O4H#&P M+\ #K<%3>WSPE\=& /W)!8T!_JN;$VHY"'8.:'AJ1U;U+:M?.U8U9F!2_;2H M^^.9&C=H@8?S/-V("NEU6O8\JM$K*\?=M__EI'MGZH:M/X MF^YZ94&^!@ M%[DIX;[!;B=1;MP/*]1HC(Z]6W2:S,"5O;R8&D@ZJ=OKU$G_Y:4HN?4UB29Y MF;^6)+^;_;RG#]7R^S=9WYL331_IZK%N"]+OGGCZ7)=+7C[0Q?7RD^[TVP^Y M>)(?*^W4-;<)E0G&A="#460081I#FE"D9\6(9E&H$F] MLB#8FB::VU@SXS6'.6A]@/G*?KN3 MSTT.FG5H'G+X0H_]MM]J*9=/)H%RGS^9OLR?W)5L[W!P]:1XX!8[,J-1_/(4N+"L,\N MG2/5#KMUXU$^T:Y=6.K==N_\R!O!L#B&J-#?6$R%GI%1D24JE=@R$[Y5;W/['FSPGAF.<9)E"\D/ MR=W((C](FU_;+D=C> MY'D@KGPJA5R*YJWD"UI+\_Z?=/G8\XW:"<+N%_8 TCCUCW]"V MA@K^:,&.=$;-CIB@Y]%.=#GMV3,[^U^=,[.\S;/4K'E-OL@'_4S=T49^KJOO M-;V_?%S=577Y;RFZW%_QK8H(SVA"("\A81B!E620HBW-DEZ#+L=_9 MB8X)/@'U!C=XZ( #VB/W.%IK.P1V\C,"L6,[@@8QV$(&/>8+L$4=/ .A(TU! MB]U:=CUM^5LW/EX5Q'6\W4^LKN\?:%D;7_JF?ELV#U5#%S?*;$)^*)]T)TTC M5\W+4^A$QA)%%,$B0@PB7#"M85S *%&,TT@F CD%G/J F)N,;6TP[E.[A=^" M!QUZ-_WR&A4[,1N;ZY&5;9?F&JP-.$CY!>C3 XR:)N .2?7P'*9> MBN-9;9V;U?H;_>O=7P]RV$$HEAK(A%2.W(%BV)$*$.19\;J M;2=S4SK])7J0]>H9K.A?[LGL#Y!H)USG4C.R,.TFB=$ 08]PC 3/K^T?)WGS M3C\_*3'S:TN/)UT^<*W?B_[_/=):OT>+Y_?EDBYY:0*M5%7?=VE)-A6++EFS MJBE?W49%DE"%)>28FY5Z9#2@4##!*J-$\811JYAVS_[G)@\;^&"#'^P8 +86 M@#_6-CB6MW4=(3N!&9'WD;4G+.7.RN1)7$C1Y M6#2K:MF?:^2TEA]IHSMOCZ:O]WYBDG).-)4E@% MB5KW.#>EVV &6]"@0]TE9'#8:;-BW&*W,C2/(RO720I]=BWMGE[[GQF 6[<=3!>>!GN:/^#Z^AK O6(^W5K"8$T?.VTZ M9\B&E7^B@1A[TV+TVDM[CG#0U< (S#@#NO6=UQA_:^7;O YW4^BHP'X62MK MB*9\R@L_UJ8)J^C6K*!IK%(!44H3B)(<0987%"(-Z789!PM_>21V1Y9*:V*]2A0[,.Q2K7@ZZK[4EU@Q3\T6%U7-,]PJO=TNWY;(TLV'Y$>9WF M/\Y#Z&/Z!WJ:_/S]<6L/':P?N-K#);PR99*>:2VVT_L7!_R(E 7'$!%J4H@( M9>H811"IG#%6Q'F$K<)D;#J;FS)LX.XN/CD[>Z<8MG#P O(VLD8,4.;CQIWB MSL%U"\CA1.[:65RZ.6B6Y PZ9:?:F,X1L[1FS_FRO<GKVIQU M;YY3)+\Y0CF!61GH;GVC$C/(M@DK,B M):1@!;5*HG .B+E)\N_:!C-UJ90IT]&; WAWMJ//F;F4;?ABFR>S 3^,-7(A M@*IJ(.\?%M6SE'YA/QYC:.?ZC3TR(XO^%OXZP69KP4673[,!G1'@4S3*8*QB8K)%$YSRCFD12Y-WG<, M<<$3F'"$$YQ1F6+K7)Q[+<]-^%IPSL%&KPD;%J2S:!C=M;1DP"W7TR%KSTGV MM-?>=-F>#IFQE^[IX 5^WLP;4]J!KM91"!&*F,H4ATJ8V@N9?@>) MA$B5Q,3)3]EO?FXOXINV2(EU:J0];]_*;>N0JC_6=#[)IJGJ_5LOE06C=B'9:.QB!X MHC6D4$2[+2>Y$C:XKF3=V'0+3*[V[:TT.=_LYZ2]^]_',3=/*ZTGB_-,B5@55U7/P87J4\3:"?8OJ2,[:COQ7R,4[)AK-".3?L_K:#" M4!C'JVL\)OEUI9]9LOM\D-8YHPHA(.21PCB%0D(=5B M!R-.3>JF#$61?1COZ?[FYLCM(@8;R,!@=DS#:<&UQ5P]+(,CO_PGR/,)Z+!@ MT6%B'I;-B:;D9[/J-A>WYVAP%F[1S'3S;WN;]F;>#K?Y>9M7!KM9-FSG\&7S MYYOG-W+)[^YI_>?E7V5SBUBAY].FRBG6GRU48 P)4ASRB"5$.Z=2Q$ZI5DYU M.#2R^5HMQ"WB-&6F$ >)4JTQ@A40HYS MA*08XR+*I)M>.4U:]5X^0='M/$/MF9?@E, M#-;G/AGGS8.1IG;[X=U?#V6G5!]URW>)%H[W9:VAM)=HEI.U;RXBIA*90ZI, M2"K%.20*I5 PS@NJ6,Q8:CV;# 9K;CK4):;8H@,XX5%A/_)'$ M'!*"(L@95G%"6!(5LJ^/R1WJ0Q8>-2PLF A;N6*HPXGK55C8_KI*APLQ@7$*LT@SBF-,YXGL=T&K5UW M9LXK ?1)"EVR/X>DVJ5,46^AN0.)&5MTASGPT]^3S::^X 4F<2&_/(]--;2W9&=3:4VU, MI[26UNSIK.T]GC7")5M=+YM5W3XXG_2H]ZDH,Y45+)8%C#!F$ F%(3-_9%B@ M3!$<4>24XO-81W-35X,3;(%> /5,\OG47+M%BI#4#:RKGJRY5[Z^P0506M^ M'^MKVF+?)RQ^5>7[U/7N%3<^ELOR_O&^_Z0A3D4B(PI%+C!$,F.0F'1S620I M492DB%LE4'K5\MP4H =G7^9BGZ?A=_LLZT=^F7M< 3_A1ZT]M_S#?J.3%74X M:,MNJ8;#%WA,@&[,J?%MX8?M\==F6R8E2LUI5"%A'L'<7M06\EXYE!W4%R:+H(-';T.XQ90H,(TCO_&##-H5C?%CTF%^ M%)C1B>9( 9AUFR@YT#0X6;)I9[H)DX-5>Y,FE_L\U/E]J59W[VBS^D>?IG)[ M*)%QRDB,,)0RCR"*%(+4E!NC>9(4B/(XQ[FU*!_O9VY:W"(%!BKXQZETK4Y\ M6FAN&)9&EMH#!/D>C1U@RT%7P[ VD9QZL^H*# 2$8>*,)/"'#%(<D &, 6!MP9B$.TCTF,1/)-RA!\!- MSWT)'%1YYT:GTWY?>_>^"-Z->,4]-N7WY3_*[W?ZJ1%;/P;G!5(9C2!.J#(1 MCS%D48P@X3E)2*[B-+5:;!SJ9&ZJW\$$:YR.66>.,6FA[P'X&5G&#U#C%[%X MF".G,,6SN9HL-M&#,]=PQ$$R3L0@'KYWRL##0?0OH@V'K_60OFM![ZK+IBD; MK:T?VB0$[S7<3@CPXS\ MFL./3;TTW#*\_82'7FU_O MU=O35-DNV0ZT]%/6:4];=FQQUN).]Z*9[Y:K:U/8 MZE;@@J0,89CSK( H)0C26*4P*PJL%$\0C:AM#8G*]9I8^1N[4ZKZWUFQ*MO=_(C MK?\T%7J5;-W$NOI>TW70*4YO9<$"FQIX0KZ#&"CNP8(UVS9O/0N1) ETFQ@&)G&IN M?":ACA-D2X*&Y\BG&IEPFFQIS_Y,V?8FO[-X7^237#[*9K.RHPI.J)X=0T+3 M%"*:*DA,7196%#1.B$HSZE0O^64'%X: MEZS=H]@\J:S &&4$0XF$@@@K$^*"FPAV8%U3H]K2;"=NHY W MLJ;M8OZ_ZYK !C;8X@Y\^,Z;KK!Y56T[GSC'JB,GK_.MNC;@T9P2OZ4*[HHLT)+YS2,D:9(B*%26F.*V9E+&.>0R%X6@>1)G]@FG M;'J.3M!9TM72+WWAB7PVTVHV&Q-!::XY&5 M:TWO%N\%Z!&#=R,RZ7)@,#"C4QT=/)=9QR.$#BP-'R:T:6C"8X4.=NT?,'2Y MT<_#_$R?N[/=57\FY4-%E\T7R67Y1-E"WC**8L15#HL49^8XB?8I)550I'&2 MHT@I4N2W2_G=''/Y9N]?GNK7ZFT@W=OPJO?QWHCM:7@]T],*;L2ZV]B_K^K5 M=_J].ZI5M2D,%L8D?=':)C>G].3(V/FB08B>J'!4#Q6LJO5I-M"B!5].<^CL M==H2$]+9/-GGI#ZF+0,O74OK^SP\RF]W\G.YU ^5>O-8KZKE.H-6+@1E60[3 M3$0049Y"2CB%F2 1QBC-.+6/=#O?#6/?\\A.7.KG@WW0 M+=ZHJUIJEZX_C/&\]?G>2_E9UJ;.L?8N;BD6:9H@!I/4"&$D8HA%1F&L*%/: M42MH;!5'YM'WW 1R#1F@=C(1TVE^XG]=T\>'GIQODTX;F- M<4=K^88V4IBR3W+9M-^[K@CDY5)>P/$ MH(>L9;>?X8#+NM:7M&7+Q@G6#T!=T,T0#QC3;HOX\_1J@^2,ICPFME]IK9^! M[[1+1?\Z_1Q*14X5I5#F5.M=4BC($"604YHAR5,EN?TNR8G.9B=L/=QU483= M/'4.,[I3%%M,?@,2-[9<#7#F,QT^19[#O#@@B1--D,\CTVVF;,G.X)3Y5!O3 MS9TMK=F;1-O>@]\&Q\IU=KJ[!FUF=P<#0%S/W+L-@J5;&9K:L94Y!*O^!8EM6!JE,/%@QS^G0+$- M%T<+%5O=[.$)_HL^+^6QSVPA(B$QH9 DR&QT, Q9CA)8<.T$(I44++<_#3;4 MT]RTJ,5ZI@,XR*R%]Q>*KY$%YBA5/G[?(&<.3E\H[B;R^,[@T,W=L^%ET-<; M;& Z1\_&CCTOS^H&#_F\JMJ9>=T^(%_*YL]/CZ9)H]9:N!MSTCX6>2(A(RJ& MB#$.L2@RF%(9I8HA$E-LK: G.IN;B';HC-_1!J4TX,>=K"7H\UDN)&WTSU9W M$MR5W^]DLP)\USYSWT-M3HTX)@@\-206TAN0Z)'5=P\I,% O0,_[C?'W#-R MW#E(<$ .)U+A(\^K>4)E>Q[__S;@GO[_50U6MY?T:_.7/V@M/JT7;#OO?%O$K[EY7.E' MJ@V?_%(M%N^KVEQ_BT1$4BD59(G2[G6&,-3/J(1(%4F,,S,7Z]G[!!P 78H M '\8$D#/PNC;92..W/B;;&. G\'6W(AC8K>A-R8 [ZH-[^X?%M6SW"9]%BFF M282A%$1_EG DN^H-)(MY+'B:Y=B^'.7!+N;V_>BG)!N4SJ4(7E)H,<F9 MR:.?&'R1#U6],LLEB3%4<(%KGB$)&(02JB L9&ZZ*(D!1E3AD[ MCG8U-[7;SG/K#5;0]& =,W(P*-DUP$391Q MO+=I$V*0%5P[7Q+E7.51'DNK>'JKWN:FJ"U>8 "? M&V)ZBF8+80U)WMBKA8.\>869GB+0)2:ACJ*DE0<.QIJ<:F3#8 MU-*>_6A3VYN\8A$>EZOZN2F%_+U<+.AWV3_%2481,YEG.:,8(LX)I#QGL) B MS2C% F?VSNNQ7N:FLCLX00_4:2/\")=6T0/G,S1ZV, K:ZN3_,QHE=_2,W3[F=/XS_Q3[^B8M]*APNR3E'^*1D8Q( MS#@D1.7Z@\(BB$6.8*;R/,F3F*3,WGT/Q>(D%2+V*]B&XM/BHQ**I9$_+$[FIMH;L">LX(\ M3*Z%@ :C;&0%?<7662O(P[0Y[<0'HF^R'7E_&EWWYBV8.;%'/]3"E'OU%I:\ MV+.WN<-O[WZ3R/Z#B;)N_[A>\NI>WBJF1;.(0Z4_5DF1L[3 MV>VJTAU/R>:FO_'8_&;Z",7B\!R6ZDVR6CN'^KJ279A/H2I+,V9@!E'"41%1B&1J/UG*E5&HY@X M9<8*AFQNVMV#!@:UR2ELPH+I\OD"; QH_>)=$URKIX4:4SLM^RDC-?86X[LK M\)7?2?&XT,(7)S#!%V"W8G8W:J5L+L!^]NW=B\PX[A "=ADQ]^T\"&T*U(X6 M^^'WJ!07>*C"EI@+!6[BVG2!.7U=U"YT![XI;&I:?K];?2B7TCB@MTIF49H6 M! JE=1_1)(4XU_XC32(2:YJ32B+)(9%G:[$V=1.NFFQ&LVSR31[MMU#C%C M?X)Z:,!@ U^&&/%(RW/8[+ 9>%[T,7&RG<,6OLZK<^0Z-XULZI653IMNKE?R MOKDM)*(\H01&C,<0Q8E^R9FI%JH0$441JX)9K5TX]SPW?WA\5PO\T;Y"K?66 M:Z;NXSFL-Z..TG^\+VPW0-8JYTWV@/SI-G>D3__KI>RY=SJ)'GISL19*_P;\ MO,R/?<6BMGK+S7+;]6V2R4@Q)"#.B%F?Q!*26#N>49Q'(LJ8BE.GU=ZC/+1T;$\3F6>)#P3A,&4HA0BB0N(8Q'#O%!1+E"DTB2_?9!U68FO M*UJO)B3T9:_CT;J&VU7$N@!,?B^72S,!-^E:6ABA^!9*X#B/.<0IUS.E(F80 M)ZF"(HX2A"E2&:8]W^^68G*VUWU.Q[4TYIS;)W,'\V;??X/:\72-%>/# MVC,*CR-KT$D*?<)0K+ATB$8)S>E$02D!N'6+37'A:3!$Q:JAZ2)57.S:"UAQ MNC%PW$K[UW6YRELJLX)CSB AB$%$,P(QI@646#&I$L(R::75;MW.3;"OJF6; MPOI1.RMF]1<(U]F.)=UV3F)X$D=6Z\%@C?6_UK@G"-XXR-,DD1S[/<\CK.,@ M&]8Q'H?O]A.EM^53*?3L2S=G$F:\U8+WK7JC6R_%6_K\4;^%)GCO?R2M;S'* M,8L2#K,(QQ"10DL4SU,8LSRE2J%<4:?U%ONNYR9.:^0->.B3#HJAV=2YQ-M) MU#ATCBQ36R9[V!? #=Q,,SH4WE\,O!]VM%;57F'C7H8/]]?<76ON,7.TP* M PZUQ33\YPS@R+IZXTO]5NKGY+'^*$7)Z>)#)3;9'Q@ITD)A#D6L"HC:@^+( MG'P4B8I)@26)B?6']V@W<_N.]D!!CQ2T4!V4]#B?%E^W("R-/0DX1)#/-^JH8N?JNKQX?N M'U+ F9W ]O"-C\.>@;;*>2WFC)&Q79V9AN_1UVLZ,T!KQP5X M0;TQQI3>6(%=>\#6H(#:%)+9L L]9^"9>.GG?.9>+P8%:-/W[**QNUQT\8X2*120&31 LMXBF!)!$,1D6L MI,(DD9G5NE H0'/3V39R2+: _\OU".*90V,GLE,2/K+0A@FR'JNR42BBPQX7 M/!/3Q*<$PS#X^G!@H'8])OX?'M6?Y?)8RMQ49HC*E,&4M3GV<@&92@5,DQ3% MA8PQ5VL%=G>X::F0Y>W;_B'Y5M-E4[;E3-NB)K<, M"Y86$89V=#Z?_\M)U&VQZDM?>QKCU M"V]UK?LQX6_E:B%OU/52F#B*1[JX_*ML;E%.8I,J!^8\D1!%PAQS4PS2C.9% MGB>(8JL2P$=[F-M+WH(TRTA;F. / ]3AA.YA*H??\" $C?QZ>W#C=#AVT/YS M#\$>;GRRPZZ#MNT>:AV^T&,Z].UNG;W\#PWW-;MW_6Z;)Y^NP!HP,(@=?/L3!%O,B<+1 M-K8"[#!V^8(QGVG1">HE6Y3(SMR!N=&)YJ8;G)D9\O>[,CR M%L\2KG+5A\-737/)FO:XR"UEG*FTT!,B9E25QPA2HK#^@PDD,&8R=:O>>JB7 MN>GI)_W>U.8Y=%R6/TRAW5K[V<2,K)@:7W_:!?QB(/ZJ7_957;+'KDKKJ@*? M:7NPZ(\U^(#KXX/D!"W6>K"C:>NT#MGZJD3KX,6>0E MJ_51F:[Q=W\]R&4C M-T]TQG JHIC !',.42(I)()A*#E-A"P*)3!U$H53/NEP^/J^:#?)*+9!W9RA5AC!101*F"*$UB2%)5P#Q+4[)9TSV9E@*><%,9XK.(<8$2P5>UW&QD-8QV1Y9= \3?7F,:*^:QZZ,N]1" M'I'YJ6HDAQX!Q_K)G@P.UU5V;73">LN>]N[78?9MQ.-#\CNMR^JQ:5>JNH,! MU>8 .,H82E1"8,I(;#+]1OJ;@9C^9K!$)CE2*;<_-SK0T=P^#SU44+7+=]4: MK(,H#;%JH?B!N!I9W-!^)M(FGVYL]-@BU(&53;H?NG M$U8+*_8TU.9ZQZ"QU4-]^]OE+5)2T(QCF,F(0\2+'&(]UE J2?.4QCPC5HL* M?7MS$[_?I+ZTI);17STGPYKF8>G(TO7;NYLOOUU?!@CCVC=M("#37*D-C''[ M-VC^MANQU;G3#XGN+1P)$(R-/(K MN88*MEB[T\Z^1U!.\N>4WR@POKUCO[X:(X2TG)YN;JB#:>BI&M137FLW9 8XB)/M$>"8LB2-#&Y0F,D M9)IAAVV.H9[F)J@&*UB#-2&M:[@.,C'(K(7$AN)K9'G=I^IR2Y6/M YRYB"K MH;B;2%+/X-!-3FUX&932P0:FDU$;._8DU.H&S[*ICZR1__MH$K ]Z3\^;"K& M49XB$44%C$FJYW-89)#D"84%ESG2REE(8K7*=:JCV8GG!B=H@7J4YSO)[;!^ MAF1L;/GT(LN](.@))H(6!CW6U[0%0D]8_*I0Z*GK_=3AJI:B7+VG)H7#ZOEM M=:\%Z#;&B"84(4A28@H )P7$,J.0)S@J5$$R'EGY54.=S$T5.HQ@#1+\T<%T M%(2#=-J)P;DDC;VCZW+S\F/@UXO>5>4=K4\RV^2QK/;NMY1O:E/PVDKQ@ M(F4PSY,%>S$]P>*=B%ZJ8! [S:"4$8MD96@X-$C7!2[#09(75AH+=)Q>&TU2\5PN(. MCTW4+]4SEU?EZKE+'$@'P\1SJN>1*B4PH@1!1% &6:YGF0I31@G+$E)@ZTU5 MEY[G)B(:>R/!51M*X%E*Q8EXBSW7L>@<665:V!V3?7[0HT=.?'9EG5AVV*4= MB^V)=FV#LNZVC^O#W."^KE.#T^WS^MBYM^_KU8![>M=WRY7NXWVYD)\>N[> MY3*G<0P31-KR+LJ$(V90")%&22Z*PJXDY:'&YZ;C'3Y@ ((.H7T:UU?$#8OT MN72,/?>S9\(I7>LQD\](T_JJR;I6;]2[ MOU9RV9C$^@]MW9+;0JE"I#B'!=8>&I(%@CC"!,8HR2.5*ZH]-_ND]@X]S^VE M[G":U6FY1@JJ#JI+MG87[BW\L[$8'5D7#&QPH\"+/=Z+7B3,KS;HP_(5<1G0',>GJHC='+Q<=_1OR+4SZ5 JY%,U5NW'W=57Q M/V^Q4#*AB9Z')B;,*,4<$IYC2"*"BEC0F$IYNY3?Z4H*.SD[U(W5:T:ZUVRW ML_'>M@X<$&NPX)?_$_\MBB[ _XG^1J)VR4;_#2?;S4R@JAJL[B1X-F,!]$U2 M /,(7^@_8]+>8DY97@"-\T'RE1Z[Q;/C%NC!,;+3/F_>IRHIVL.[ #WW+<*0 M!4*/VQ^V\.>!?B8NZ'G%.@>N]=.1RT4[&%*L-U.E,%4*M5/6>NY]-LY; MK@0J>,2ARFD$$R[7ONEE7>M+VHW3"_#N!*?.TNY&44BQ MM^QY4OEW8^/E!\'Q;I^SPS^T-ZM_*3]4=+FN:Q^3.$J$A''$]2<@4P+B.)$P MX8RE259D$;/?W3[0P=QD?P,1&(PN1UT/D&>Q GHF)6,KQAX;7B> #]#BH^CWC_).W"=GYO;Y9;_:F*TS=B_H7JL MN/QZ)^7J=;_>*@:NF@S,32ZB<6CB2LRUU1+ M/019PGA&D!!*6"5*G1;VW/1V M;4"?16=?==C1>^L(3 M]^Y?'_IRN7RDB[Z4,>91RG D8)8G*40B-_'E,868%0+K,8A28N5+'^M@=MJ^ MKGK<@?2N";U'XK "AZ!F;*UT8\6K#O0ATP/4@-YK=O+ZSX>,.E3[^>!U'M/A MCW2YDIS^3A<+^?RY:E:7_'$E^SE,C#@1"4\@BTT"+2%SR%"10_TSK 17,F'V MJ;2&>IK;2_WQZLO5A4D-YS )'&328I()NAP @,4M$A])LZ#G#G, MH$-Q-]%4^@P.W6;5-KP,3J\'&YANGFUCQ]Z$V^H&O\R#!Y8E=]:7WSQO+^F7 MGR]_T%K\+ANSC7Y5+3NW[=/[]S?:1_NQNOM8+LO[Q_O/4C]<2U.<]E:++[FJ2WX!/E7U/5V4_Y8" MO']>B,LMP8G^Z9L%EEG=E(3[+1TQH#=@W>W>T!;Y[! M[G6;#2%C]@58/R<;R_6CHFT'G?$7H#?_ FP)F-MSX99?RJUW_15+LNJOEX*^6#"R4QZ MP2>#8'M%=SYM78UGYQ>?%_I=O&R:LC&Q9T0B.[*Y8#=[? M=Z_JS^=NJI/M_;(U&:QM[F_WJA@W\D/@4F!N/@_#5/7H9O%0.!:QFV:4AFO> MC8QAPA)YT["Y7U%OHCY]UEU/1":$EQNG0N9)3J,H+ZR.J[MV/#>W8 ,45#UT0%N@ M@#[14EMHF_S2>01L%B7&X77LM84-:K"&?0&V/&^1@P[Z2/RZ3.['X7FJ.7HH MOAUGU^ZD#4^2'=J;<*[K;N7^E-7C?@_I_Y?^J)2KIOO>_*-J,UXU'Q9\':,; M):GDIE8:23%$>2HA-KE*A(PSRF*.!3:V;*GLI:W.%9I MK5>WVV3.)FJ,Z\?F<6%.6+R5#[7D9?L O7G^7)O*SJOG;\9=O"W2+$4IQC G M>0Y11&*3WK^ 1$@F)>-IIJRJ 'GV/SIE#O>;QL"ON>V8S?>8TN78)I MZ)MNH*\!5% I,Y&91/)G9,5RH<;Y9,&0[2'/ 1SL9]*H_2%+7\;8#UX;I+1B][%->)QG*LI@ M7,0F19]2VJ'B%$9YD9(TISE-U!EE%>?I-;VJ$NCBU@S2:?>ZGTO2V Z**S_G M%E"T=1/.+9XXH4]@8^F)HHDAONYO)5M=+YM5W<[)^SD4B46.,@8111E$G*:0 M%IC"@J%"8)(1@JP6K ;ZF-T;W[O;)I7(AVKY'>I.[X$!#K;(&S\=.$2QG0R< M2=S8*A"&,_>$1,=9"9J/Z$ WTZ8C.F[GJVQ$ Y=Z^@*^T5[O_O>Q7#WO/ W MJSM9?[NCZ[R2O^DF5LWU\K.LRTK\2Y;?[_3\Y?))UO2[;'_Y5D]HWM.R_ITN M'K4:%3QF).&0B0A#E$2I*0"#(4.,T2+5#@EUFFK,QK*Y:6"+$ BS=J T1G!/ MZS_E"CP9K.<5H)H-Y;;NUUSPSDGM=[(3'0U&9NM@9'8H&+EC9^_CT/(#3*6 M=4K@"]!Q9):S.I8NP)HGT!/570(,5C=G' MG/O9 ?38"O]V)S^72RT[ZFJA/Q_-JEIG%9*,*\21@@H3 9',]0<](B:+88Z4 MC(00Q&IC9KB;N7U3-5#0(C5.\@:KPP[N<4(MMKV#T#3R=^4P0SZ;W<>IU\HS9%VQBB%#$<%+"1/ M8H)9FBFG'-+N$.8F5@8^4(OJ1W_$OEQ#!W2#_;_<5CT\QL5N>6) MM&2OX9M%@U^,!9KS7\'&"+"U ORQMB/@*K(_B2$GXQXH)ITU^[/T M_E;?C;;Q7]1L2]#EI\>ZV9P/6F>)$C++TBR#JH?9=SD[TM:+!K8?2U5!Q?&CG0+URXXE2-KVFD6?3Q".SH=?,7@M$[D M18:@U\W%=&)JT/FT:VDZM]3)LCV'U>U.GX1^94U_+YL5O:*UW'O&<9[G$<]R M&!6FAKO@"-)89OIO&9:\X";3LWTVOV/=S$V;#5#0(@4&JKL>'R?40H.#T#2R M[AYFR"N=WU&J7'+YA:!LJD1^GM0Y9O$[Q[3?% M_^>R,4<9I3!Q-M^T^)J CUN$$QQ)ED.NE'9?(XRAGL0+2$6.XR0BB'#A,HL_ MV,O<5+%/-O&XQ@J6U4I/$1_HLXEZN0!+:7FF>9A;NYGXV8R-+) ;?"\"M$QB MP:7^12U#G$BV8B/DK/EP1Y-.C =M?3GW';[8NXQ&;2I;OI7=?Z^7EYR;D\S- M-C+\5DDB8\8C* O)(,IP#EE,$QCS/%>95@PB8K(B&%?MV&A*,T6DD90T7_+(&_*L)U=DPO 4=M+:$-46!*T.<[G?J MN@[63!RHRF!_K_MIW8]5O?I.O[>%@IJ;Y?:@VE6U6)BRK97^L?I/M#% M;1HAHB*40B6T+*$TSB"3*H=28$YPDF69+-;:],WNP*XC! ^=^C;%FAQ]%M6/ M9?/W+_*A+UML?Y[6=12&-6HL4G_6.5IB>8YV;7-;,*P!U=[)6E-H=V.Y";W8 MV![F!*TGX>>>GG7M=K*3LYY\[)Z:]6W"]\3LNODV$N^2_^]CV;2I3YO;.$YS M1=($REP5$#&M>E2)"!9&]7):Y 5S*DLVT-?<9FZ[V%P/SAXGU,[)"D33Y(+E MM/OU =W3M_CI2Q_\JQ6K+;]\W32/ MIK[65=6LFMM\P(!P<-^0*+MO@:AZ!M[6[F' M:9[.%BA8(P4MU'"R;D-(2%T?[&]28;>Q_*6R6]WCL0'ZW^52U%+TVZKKQ+7E MHNPV@Z[H0OR0B\4Z>"5G4N8Q@I'@&421$7HN"RB9Q%I6\B)."^M-4:>N9Z

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end

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